PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bacharier, LB				Bacharier, Leonard B.			Evaluation of the child with recurrent wheezing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							GASTROESOPHAGEAL-REFLUX; RESPIRATORY SYMPTOMS; INFANTS; PARENTS; ASTHMA		[Bacharier, Leonard B.] Washington Univ, Sch Med, Dept Pediat, St Louis Childrens Hosp, St Louis, MO 63110 USA; [Bacharier, Leonard B.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA	St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL)	Bacharier, LB (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis Childrens Hosp, 1 Childrens Pl, St Louis, MO 63110 USA.	bacharier_L@kids.wustl.edu		Bacharier, Leonard/0000-0003-0432-2704				Baraldi E, 2009, EARLY HUM DEV, V85, pS1, DOI 10.1016/j.earlhumdev.2009.08.002; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Cane RS, 2001, ARCH DIS CHILD, V84, P31, DOI 10.1136/adc.84.1.31; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2010, J ALLERGY CLIN IMMUN, V126, P212, DOI 10.1016/j.jaci.2010.06.032; Elphick HE, 2001, ARCH DIS CHILD, V84, P35, DOI 10.1136/adc.84.1.35; Galant SP, 2007, J PEDIATR-US, V151, P457, DOI 10.1016/j.jpeds.2007.05.004; Galant SP, 2010, CURR OPIN ALLERGY CL, V10, P149, DOI 10.1097/ACI.0b013e328335ce48; Lea E, 2005, J PEDIATR SURG, V40, P1122, DOI 10.1016/j.jpedsurg.2005.03.049; Patra S, 2011, PEDIATR PULM, V46, P272, DOI 10.1002/ppul.21363; Payne DNR, 2000, BRIT MED J, V321, P687, DOI 10.1136/bmj.321.7262.687; Sheikh S, 1999, PEDIATR PULM, V28, P181, DOI 10.1002/(SICI)1099-0496(199909)28:3<181::AID-PPUL4>3.0.CO;2-S; Turner A, 2005, EUR J PEDIATR, V164, P266, DOI 10.1007/s00431-004-1607-6; Weinberger M, 2004, PEDIATR PULM, P197, DOI 10.1002/ppul.70104	14	8	11	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2011	128	3					690	U385		10.1016/j.jaci.2011.07.034	http://dx.doi.org/10.1016/j.jaci.2011.07.034			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	812HS	21878246				2022-12-18	WOS:000294283400044
J	Montanez, MI; Torres, MJ; Perez-Inestrosa, E; Blanca, M				Isabel Montanez, Maria; Jose Torres, Maria; Perez-Inestrosa, Ezequiel; Blanca, Miguel			Clarification concerning amoxicillin skin testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BETA-LACTAMS; PENICILLINS; HYPERSENSITIVITY; ALLERGY		[Isabel Montanez, Maria; Jose Torres, Maria; Blanca, Miguel] Carlos Haya Hosp, Malaga, Spain; [Perez-Inestrosa, Ezequiel] Univ Malaga, E-29071 Malaga, Spain	Hospital Carlos Haya; Universidad de Malaga	Montanez, MI (corresponding author), Carlos Haya Hosp, Malaga, Spain.	maribelmv@uma.es	Perez-Inestrosa, Ezequiel/H-9801-2015; Torres, Maria/GVU-3391-2022; Montanez, Maria I/B-7194-2014; Torres, María José/T-3518-2017	Perez-Inestrosa, Ezequiel/0000-0001-7546-5273; Montanez, Maria I/0000-0001-6641-5979; Torres, María José/0000-0001-5228-471X				BLANCA M, 1990, CLIN EXP ALLERGY, V20, P475, DOI 10.1111/j.1365-2222.1990.tb03139.x; Blanca M, 2009, ALLERGY, V64, P183, DOI [10.1111/j.1398-9995.2008.01924.x, 10.1111/j.1398-9995.2008.01916.x]; BUDAVARI S, 2001, MERCK INDEX, P96; Macy E, 2011, J ALLERGY CLIN IMMUN, V127, P1638, DOI 10.1016/j.jaci.2010.12.1125; Romano A, 2010, J ALLERGY CLIN IMMUN, V126, P994, DOI 10.1016/j.jaci.2010.06.052; Torres MJ, 2001, ALLERGY, V56, P850, DOI 10.1034/j.1398-9995.2001.00089.x; TSUJI A, 1978, J PHARM SCI, V67, P1059, DOI 10.1002/jps.2600670810	7	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2011	128	3					685	685		10.1016/j.jaci.2011.04.054	http://dx.doi.org/10.1016/j.jaci.2011.04.054			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	812HS	21665258	Bronze			2022-12-18	WOS:000294283400038
J	Chipps, B; Spector, S; Farrar, J; Carr, W; Meltzer, E; Storms, W; Kaliner, M; Luskin, A; Bukstein, D; Oppenheimer, J; Smart, B; Derebery, J; Harder, J; Dykewicz, M; Benninger, M				Chipps, Bradley; Spector, Sheldon; Farrar, Judith; Carr, Warner; Meltzer, Eli; Storms, William; Kaliner, Michael; Luskin, Allan; Bukstein, Donald; Oppenheimer, John; Smart, Brian; Derebery, Jenifer; Harder, Julia; Dykewicz, Mark; Benninger, Michael			Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AZELASTINE NASAL SPRAY; QUALITY-OF-LIFE; FLUTICASONE; COMBINATION; OLOPATADINE; MANAGEMENT; CETIRIZINE; SYMPTOMS		[Chipps, Bradley; Harder, Julia] Capital Allergy & Resp Dis Ctr, Sacramento, CA USA; [Spector, Sheldon] Calif Allergy & Asthma Med Grp, Los Angeles, CA USA; [Farrar, Judith] Life Sci Press, Washington, DC USA; [Carr, Warner] Allergy & Asthma Associates So Calif, Mission Viejo, CA USA; [Meltzer, Eli] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA; [Storms, William] William Storms Allergy Clin, Colorado Springs, CO USA; [Kaliner, Michael] Inst Asthma & Allergy, Chevy Chase, MD USA; [Luskin, Allan] Univ Wisconsin, Dept Med, Madison, WI USA; [Bukstein, Donald] Dean Clin, Madison, WI USA; [Oppenheimer, John] Pulm & Allergy Associates, Summit, NJ USA; [Smart, Brian] DuPage Med Grp, Glen Ellyn, IL USA; [Derebery, Jenifer] House Ear Clin, Los Angeles, CA USA; [Dykewicz, Mark] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom & Personalized Med Res, Winston Salem, NC USA; [Benninger, Michael] Cleveland Clin, Head & Neck Inst, Cleveland, OH USA	University of Wisconsin System; University of Wisconsin Madison; House Research Institute; Wake Forest University; Wake Forest Baptist Medical Center; Cleveland Clinic Foundation	Chipps, B (corresponding author), Capital Allergy & Resp Dis Ctr, Sacramento, CA USA.	bchipps@capitalallergy.com						Bachert C, 2004, J ALLERGY CLIN IMMUN, V114, P838, DOI 10.1016/j.jaci.2004.05.070; Benninger M, 2010, ANN ALLERG ASTHMA IM, V104, P13, DOI 10.1016/j.anai.2009.11.020; Berger W, 2006, ANN ALLERG ASTHMA IM, V97, P375, DOI 10.1016/S1081-1206(10)60804-6; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Chipps BE, 2009, ALLERGY ASTHMA PROC, V30, P589, DOI 10.2500/aap.2009.30.3287; Corren J, 2005, CLIN THER, V27, P543, DOI 10.1016/j.clinthera.2005.04.012; Hampel FC, 2010, ANN ALLERG ASTHMA IM, V105, P168, DOI 10.1016/j.anai.2010.06.008; Kaliner MA, 2007, ANN ALLERG ASTHMA IM, V99, P383, DOI 10.1016/S1081-1206(10)60560-1; Kaliner MA, 2010, ALLERGY ASTHMA PROC, V31, P112, DOI 10.2500/aap.2010.31.3317; Kaliner MA, 2009, ALLERGY ASTHMA PROC, V30, P255, DOI 10.2500/aap.2009.30.3232; Kalpaklioglu AF, 2010, AM J RHINOL ALLERGY, V24, P29, DOI 10.2500/ajra.2010.24.3423; LaForce CF, 2010, ALLERGY ASTHMA PROC, V31, P132, DOI 10.2500/aap.2010.31.3326; Lee TA, 2007, PHARMACOTHERAPY, V27, P852, DOI 10.1592/phco.27.6.852; Portnoy JM, 2004, CURR ALLERGY ASTHM R, V4, P439, DOI 10.1007/s11882-004-0009-1; Ratner PH, 2008, ANN ALLERG ASTHMA IM, V100, P74, DOI 10.1016/S1081-1206(10)60408-5; Van Hoecke H, 2007, DRUGS, V67, P2717, DOI 10.2165/00003495-200767180-00006; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003	17	8	10	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1640	U487		10.1016/j.jaci.2011.01.070	http://dx.doi.org/10.1016/j.jaci.2011.01.070			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21481444				2022-12-18	WOS:000291048500056
J	Liss, GM; Murphy-Berendts, K; Epstein, T; Bernstein, DI				Liss, Gary M.; Murphy-Berendts, Karen; Epstein, Tolly; Bernstein, David I.			Factors associated with severe versus mild immunotherapy-related systemic reactions: A case-referent study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FATAL REACTIONS; INJECTIONS; SURVEILLANCE		[Liss, Gary M.] Univ Toronto, Gage Occupat & Environm Hlth Unit, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Murphy-Berendts, Karen] Bernstein Clin Res Ctr, Cincinnati, OH USA; [Epstein, Tolly; Bernstein, David I.] Univ Cincinnati, Coll Med, Dept Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Epstein, Tolly] VA Med Ctr, Cincinnati, OH USA	University of Toronto; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Liss, GM (corresponding author), Univ Toronto, Gage Occupat & Environm Hlth Unit, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	gary.liss@utoronto.ca			NCATS NIH HHS [UL1 TR000077] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Amin HS, 2006, J ALLERGY CLIN IMMUN, V117, P169, DOI 10.1016/j.jaci.2005.10.010; Bernstein DI, 2010, ANN ALLERG ASTHMA IM, V104, P530, DOI 10.1016/j.anai.2010.04.008; Bernstein DI, 2004, J ALLERGY CLIN IMMUN, V113, P1129, DOI 10.1016/j.jaci.2004.02.006; Cox L, 2007, J ALLERGY CLIN IMMUN, V120, pS25, DOI 10.1016/j.jaci.2007.06.019; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; delaCuesta CG, 1997, ALLERGY, V52, P580; Epstein T, 2011, J ALLERGY CLIN IMMUN, V127, pAB218, DOI 10.1016/j.jaci.2010.12.869	7	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2011	127	5					1298	1300		10.1016/j.jaci.2010.12.1086	http://dx.doi.org/10.1016/j.jaci.2010.12.1086			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	756NG	21315434				2022-12-18	WOS:000290018600028
J	Molderings, GJ; Homann, J; Raithel, M; Frieling, T				Molderings, Gerhard J.; Homann, Juergen; Raithel, Martin; Frieling, Thomas		Interdisciplinary Multictr Res Grp	Toward a global classification of mast cell activation diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MASTOCYTOSIS; KIT		[Molderings, Gerhard J.] Univ Hosp Bonn, Inst Human Genet, Bonn, Germany; [Homann, Juergen] Evangel Kliniken Waldkrankenhaus, Dept Internal Med, Bonn, Germany; [Raithel, Martin] Univ Hosp Erlangen, Med Klin 1, Erlangen, Germany; [Frieling, Thomas] HELIOS Klinikum Krefeld, Med Klin 1, Krefeld, Germany	University of Bonn; University of Erlangen Nuremberg; Helios Kliniken	Molderings, GJ (corresponding author), Univ Hosp Bonn, Inst Human Genet, Bonn, Germany.	molderings@uni-bonn.de						Akin C, 2010, J ALLERGY CLIN IMMUN, V126, P1099, DOI 10.1016/j.jaci.2010.08.035; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Homann J, 2010, MED KLIN, V105, P544, DOI 10.1007/s00063-010-1093-8; Molderings GJ, 2010, IMMUNOGENETICS, V62, P721, DOI 10.1007/s00251-010-0474-8; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Yang Y, 2010, BLOOD, V116, P1114, DOI 10.1182/blood-2009-06-226027	7	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2011	127	5					1311	1311		10.1016/j.jaci.2010.12.1113	http://dx.doi.org/10.1016/j.jaci.2010.12.1113			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	756NG	21306766	Bronze			2022-12-18	WOS:000290018600034
J	Wasserman, RL; Sugerman, RW; Mireku-Akomeah, N; Gallucci, AR; Pence, DM; Long, NA				Wasserman, R. L.; Sugerman, R. W.; Mireku-Akomeah, N.; Gallucci, A. R.; Pence, D. M.; Long, N. A.			Peanut Oral Immunotherapy (OIT) of Food Allergy (FA) Carries a Significant Risk of Eosinophilic Esophagitis (EoE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Wasserman, R. L.; Sugerman, R. W.; Mireku-Akomeah, N.; Gallucci, A. R.; Pence, D. M.; Long, N. A.] DallasAllergyImmunol, Dallas, TX USA										0	8	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB28	AB28		10.1016/j.jaci.2010.12.121	http://dx.doi.org/10.1016/j.jaci.2010.12.121			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI		Bronze			2022-12-18	WOS:000295846400105
J	Chinn, IK; Olson, JA; Skinner, MA; McCarthy, EA; Gupton, SE; Chen, DF; Bonilla, FA; Roberts, RL; Kanariou, MG; Devlin, BH; Markert, ML				Chinn, Ivan K.; Olson, John A.; Skinner, Michael A.; McCarthy, Elizabeth A.; Gupton, Stephanie E.; Chen, Dong-Feng; Bonilla, Francisco A.; Roberts, Robert L.; Kanariou, Maria G.; Devlin, Blythe H.; Markert, M. Louise			Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allorecognition; anergy; class II; DiGeorge; parathyroid; tetramers; thymus; tolerance; transplantation	COMPLETE DIGEORGE-SYNDROME; CLASS-II TETRAMERS; T-CELL ANERGY; RENAL-TRANSPLANT; ALLOTRANSPLANTATION; IMMUNOSUPPRESSION; HORMONE; ASSAYS; EXPRESSION; REJECTION	Background: The induction of tolerance toward third-party solid organ grafts with allogeneic thymus tissue transplantation has not been previously demonstrated in human subjects. Objective: Infants with complete DiGeorge anomaly (having neither thymus nor parathyroid function) were studied for conditions and mechanisms required for the development of tolerance to third-party solid organ tissues. Methods: Four infants who met the criteria received parental parathyroid with allogeneic thymus transplantation and were studied. Results: Two of 3 survivors showed function of both grafts but subsequently lost parathyroid function. They demonstrated alloreactivity against the parathyroid donor in mixed lymphocyte cultures. For these 2 recipients, parathyroid donor HLA class II alleles were mismatched with the recipient and thymus. MHC class II tetramers confirmed the presence of recipient CD4(+) T cells with specificity toward a mismatched parathyroid donor class II allele. The third survivor has persistent graft function and lacks alloreactivity toward the parathyroid donor. All parathyroid donor class II alleles were shared with either the recipient or the thymus graft, with minor differences between the parathyroid (HLA-DRB1*1104) and thymus (HLA-DRB1*1101). Tetramer analyses detected recipient T cells specific for the parathyroid HLA-DRB1*1104 allele. Alloreactivity toward the parathyroid donor was restored with low doses of IL-2. Conclusion: Tolerance toward parathyroid grafts in combined parental parathyroid and allogeneic thymus transplantation requires matching of thymus tissue to parathyroid HLA class II alleles to promote negative selection and suppression of recipient T cells that have alloreactivity toward the parathyroid grafts. This matching strategy may be applied toward tolerance induction in future combined thymus and solid organ transplantation efforts. (J Allergy Clin Immunol 2010;126:814-20.)	[Chinn, Ivan K.; McCarthy, Elizabeth A.; Gupton, Stephanie E.; Devlin, Blythe H.; Markert, M. Louise] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Olson, John A.] Duke Univ, Med Ctr, Dept Surg, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Chen, Dong-Feng] Duke Univ, Med Ctr, Dept Pathol, Transplantat Immunol Lab, Durham, NC 27710 USA; [Markert, M. Louise] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Skinner, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Pediat Surg, Dallas, TX 75390 USA; [Bonilla, Francisco A.] Harvard Univ, Sch Med, Dept Pediat, Div Immunol, Boston, MA 02115 USA; [Roberts, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90095 USA; [Kanariou, Maria G.] Aghia Sophia Childrens Hosp, Dept Immunol & Histocompatibil, Athens, Greece	Duke University; Duke University; Duke University; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; The Aghia Sophia Children's Hospital	Chinn, IK (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Box 3068, Durham, NC 27710 USA.	chinn001@mc.duke.edu		Chinn, Ivan/0000-0001-5684-5457	American Academy of Allergy, Asthma Immunology; National Institutes of Health, General Clinical Research Center, National Center for Research Resources [R01 AI 047040, R21 AI 060967, M03 RR 30, T32 AI 007062-28A2, 2 K12 HD043494 06]; Talecris Biotherapeutics, Inc; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060967, R01AI047040, T32AI007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088188] Funding Source: NIH RePORTER	American Academy of Allergy, Asthma Immunology; National Institutes of Health, General Clinical Research Center, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Talecris Biotherapeutics, Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the American Academy of Allergy, Asthma & Immunology 2006 Third-Year Fellow-in-Training Research and 2008 Senior Allergy/Immunology Fellow Transition Awards and National Institutes of Health grants R01 AI 047040, R21 AI 060967, M03 RR 30 (General Clinical Research Center, National Center for Research Resources), T32 AI 007062-28A2, and 2 K12 HD043494 06. F. A. B. has grant support from Talecris Biotherapeutics, Inc. M. L. M. is a member of the Duke Comprehensive Cancer Center.; Disclosure of potential conflict of interest: I. K. Chinn has received research support from the National Institutes of Health and the American Academy of Allergy, Asthma & Immunology. F. A. Bonilla has received research support from Talecris Biotherapeutics, Inc; is an author/editor for UpToDate; has given talks for CSL Behring and Baxter Healthcare; and is a consultant for ENTRA Pharmaceuticals, Prescription Solutions, and the Immune Deficiency Foundation. B. H. Devlin and M. L. Markert have received research support from the National Institutes of Health. The rest of the authors have declared that they have no conflict of interest.	ALFREY EJ, 1992, SURGERY, V111, P234; Benitez F, 2008, CLIN LAB MED, V28, P365, DOI 10.1016/j.cll.2008.07.002; BJERNEROTH G, 1993, TRANSPLANTATION, V56, P717, DOI 10.1097/00007890-199309000-00040; Blumenthal RL, 2001, J ALLERGY CLIN IMMUN, V107, P258, DOI 10.1067/mai.2001.112845; Chinn IK, 2008, CLIN IMMUNOL, V126, P277, DOI 10.1016/j.clim.2007.11.009; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Ekong UD, 2009, PEDIATR TRANSPLANT, V13, P25, DOI 10.1111/j.1399-3046.2008.01042.x; ESSERY G, 1988, IMMUNOLOGY, V64, P413; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; FEIND CR, 1979, TRANSPLANT P, V11, P1011; FIREMAN P, 1965, J PEDIATR-US, V67, P907; Hasse C, 1997, LANCET, V350, P1296, DOI 10.1016/S0140-6736(05)62473-7; HONG R, 1991, Immunodeficiency Reviews, V3, P1; HONG R, 1986, CLIN IMMUNOL IMMUNOP, V40, P136, DOI 10.1016/0090-1229(86)90077-2; Jeras M, 2002, TRANSPL IMMUNOL, V10, P205, DOI 10.1016/S0966-3274(02)00067-9; KUNORI T, 1991, TOHOKU J EXP MED, V165, P33, DOI 10.1620/tjem.165.33; Kwok WW, 2002, J IMMUNOL METHODS, V268, P71, DOI 10.1016/S0022-1759(02)00201-6; MACLAURIN BP, 1972, CLIN EXP IMMUNOL, V10, P649; Markert M.L., 2008, THYMUS GLAND PATHOLO, P255; Markert ML, 2007, BLOOD, V109, P4539, DOI 10.1182/blood-2006-10-048652; Markert ML, 1998, J PEDIATR-US, V132, P15, DOI 10.1016/S0022-3476(98)70478-0; Markert ML, 2004, BLOOD, V104, P2574, DOI 10.1182/blood-2003-08-2984; Markert ML, 2004, J ALLERGY CLIN IMMUN, V113, P734, DOI 10.1016/j.jaci.2004.01.766; Markert ML, 2003, BLOOD, V102, P1121, DOI 10.1182/blood-2002-08-2545; Markert ML, 1997, J IMMUNOL, V158, P998; Martin KJ, 2001, CURR OPIN NEPHROL HY, V10, P569, DOI 10.1097/00041552-200109000-00004; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; MULLER W, 1988, EUR J PEDIATR, V147, P496; Najafian N, 2002, J AM SOC NEPHROL, V13, P252, DOI 10.1681/ASN.V131252; Nawrot I, 2007, TRANSPLANTATION, V83, P734, DOI 10.1097/01.tp.0000258601.17505.9d; PICKER LJ, 1993, J IMMUNOL, V150, P1105; Remijn JA, 2007, CLIN CHEM, V53, P534, DOI 10.1373/clinchem.2006.083667; Rice HE, 2004, J PEDIATR SURG, V39, P1607, DOI 10.1016/j.jpedsurg.2004.07.020; ROSS AJ, 1979, SURGERY, V85, P382; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SCHWARZ MR, 1968, J EXP MED, V127, P879, DOI 10.1084/jem.127.5.879; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; SILVERS W K, 1970, Science (Washington D C), V167, P1264, DOI 10.1126/science.167.3922.1264; SOLLINGER HW, 1983, TRANSPLANTATION, V36, P599, DOI 10.1097/00007890-198336060-00001; Sykes M, 2009, TRANSPLANTATION, V87, pS67, DOI 10.1097/TP.0b013e3181a2a6b8; Thomas R A, 1987, Am J Med Genet Suppl, V3, P43; TOLLOCZKO T, 1994, TRANSPLANT P, V26, P1901; Zarkhin V, 2008, CLIN LAB MED, V28, P385, DOI 10.1016/j.cll.2008.08.003; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	45	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					814	U208		10.1016/j.jaci.2010.07.016	http://dx.doi.org/10.1016/j.jaci.2010.07.016			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20832849	Green Accepted			2022-12-18	WOS:000282510000020
J	Schatz, M; Zeiger, RS				Schatz, Michael; Zeiger, Robert S.			Ineffectiveness of telephone-based environmental control intervention to improve asthma outcomes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Schatz, Michael; Zeiger, Robert S.] Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA USA	Kaiser Permanente	Schatz, M (corresponding author), Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA USA.	michael.x.schatz@kp.org		Zeiger, Robert/0000-0001-5788-5063				[Anonymous], 2007, J ALLERGY CLIN IMM S, V120, pS94; Donald KJ, 2008, AUST FAM PHYSICIAN, V37, P170; Patel R, 2009, J ASTHMA, V46, P30, DOI 10.1080/02770900802460563; Schatz M, 2007, J ALLERGY CLIN IMMUN, V119, P336, DOI 10.1016/j.jaci.2006.08.042; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P995, DOI 10.1016/j.jaci.2006.01.053; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053	6	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					873	875		10.1016/j.jaci.2010.07.035	http://dx.doi.org/10.1016/j.jaci.2010.07.035			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20920777				2022-12-18	WOS:000282510000030
J	Larche, M				Larche, Mark			Immune mechanisms of sublingual immunotherapy: Are oral Langerhans cells the masters of tolerance?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Immune mechanisms; sublingual immunotherapy; Langerhans cells; tolerance	FC-EPSILON-RI; DENDRITIC CELLS; INDUCTION; ALLERGEN		[Larche, Mark] McMaster Univ, Fac Hlth Sci, Dept Med, Div Clin Immunol & Allergy, Hamilton, ON L8N 3Z5, Canada; [Larche, Mark] Firestone Inst Resp Hlth, Hamilton, ON, Canada	McMaster University; McMaster University	Larche, M (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Med, Div Clin Immunol & Allergy, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	larche@mcmaster.ca	Larché, Margaret J/B-2327-2008	Larche, Mark/0000-0002-1439-7593				Allam JP, 2010, J ALLERGY CLIN IMMUN, V126, P638, DOI 10.1016/j.jaci.2010.04.039; Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Geissmann F, 1999, J IMMUNOL, V162, P4567; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Lira SA, 2005, NAT IMMUNOL, V6, P866, DOI 10.1038/ni0905-866; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wills-Karp M, 2010, MUCOSAL IMMUNOL, V3, P104, DOI 10.1038/mi.2009.138	12	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2010	126	3					646	647		10.1016/j.jaci.2010.07.027	http://dx.doi.org/10.1016/j.jaci.2010.07.027			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	646CF	20816196	Bronze			2022-12-18	WOS:000281512500035
J	Helbig, G; Moskwa, A; Hus, M; Wozniczka, K; Wieczorkiewicz, A; Dziaczkowska-Suszek, J; Soja, A; Bartkowska-Chrobok, A; Kyrcz-Krzemien, S				Helbig, Grzegorz; Moskwa, Andrzej; Hus, Marek; Wozniczka, Krzysztof; Wieczorkiewicz, Agata; Dziaczkowska-Suszek, Joanna; Soja, Anna; Bartkowska-Chrobok, Aleksandra; Kyrcz-Krzemien, Slawomira			Heterogeneity among characteristics of hypereosinophilic syndromes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Helbig, Grzegorz; Wozniczka, Krzysztof; Wieczorkiewicz, Agata; Dziaczkowska-Suszek, Joanna; Soja, Anna; Bartkowska-Chrobok, Aleksandra; Kyrcz-Krzemien, Slawomira] Silesian Med Univ, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland; [Moskwa, Andrzej] Provincial Hosp, Dept Hematol, Gorzow Wielkopolski, Poland; [Hus, Marek] Med Univ, Dept Haematol, Lublin, Poland	Medical University Silesia; Medical University of Lublin	Helbig, G (corresponding author), Silesian Med Univ, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland.	ghelbig@o2.pl	Helbig, Grzegorz/AAO-4439-2020	Kyrcz-Krzemien, Slawomira/0000-0002-6643-9214; Hus, Marek/0000-0002-9036-6625				CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Helbig G, 2009, HAEMATOL-HEMATOL J, V94, P1236, DOI 10.3324/haematol.2008.005447; Hodges E, 2003, J CLIN PATHOL, V56, P1, DOI 10.1136/jcp.56.1.1; Klion AD, 2006, J ALLERGY CLIN IMMUN, V117, P1292, DOI 10.1016/j.jaci.2006.02.042; Ogbogu PU, 2009, J ALLERGY CLIN IMMUN, V124, P1319, DOI 10.1016/j.jaci.2009.09.022; POSNETT DN, 1994, J EXP MED, V178, P303; Roufosse F, 2007, IMMUNOL ALLERGY CLIN, V27, P389, DOI 10.1016/j.iac.2007.07.002	7	8	8	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2010	125	6					1399	1401		10.1016/j.jaci.2010.02.024	http://dx.doi.org/10.1016/j.jaci.2010.02.024			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	611PH	20392489				2022-12-18	WOS:000278831000034
J	Suttner, K; Depner, M; Wetzke, M; Klopp, N; von Mutius, E; Illig, T; Sparwasser, T; Kabesch, M				Suttner, Kathrin; Depner, Martin; Wetzke, Martin; Klopp, Norman; von Mutius, Erika; Illig, Thomas; Sparwasser, Tim; Kabesch, Michael			Genetic variants harbored in the forkhead box protein 3 locus increase hay fever risk	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EXONIC SPLICING ENHANCERS; CHILDREN		[Suttner, Kathrin; Wetzke, Martin; Kabesch, Michael] Hannover Med Sch, Ctr Pediat, Clin Pediat Pneumol & Neonatol, Munich, Germany; [Depner, Martin; von Mutius, Erika] Univ Munich, Univ Childrens Hosp, Munich, Germany; [Klopp, Norman; Illig, Thomas] Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center for Infection Research	Suttner, K (corresponding author), Hannover Med Sch, Ctr Pediat, Clin Pediat Pneumol & Neonatol, Munich, Germany.	kabesch.michael@mh-hannover.de	Kabesch, Michael/GZM-1583-2022; Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019; Kabesch, Michael/AAB-5701-2020; Wetzke, Martin/HDM-2614-2022	Sparwasser, Tim/0000-0001-5645-902X; von Mutius, Erika/0000-0002-8893-4515				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grabe Niels, 2002, In Silico Biology, V2, pS1; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P1062, DOI 10.1016/j.jaci.2009.02.025; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weiland SK, 1999, EUR RESPIR J, V14, P862, DOI 10.1034/j.1399-3003.1999.14d23.x; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	13	8	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2010	125	6					1395	1399		10.1016/j.jaci.2010.02.017	http://dx.doi.org/10.1016/j.jaci.2010.02.017			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	611PH	20398921				2022-12-18	WOS:000278831000033
J	Feldman, JM; Mayefsky, L; Beckmann, L; Lehrer, PM; Serebrisky, D; Shim, C				Feldman, Jonathan M.; Mayefsky, Lauren; Beckmann, Lacey; Lehrer, Paul M.; Serebrisky, Denise; Shim, Chang			Ethnic differences in asthma-panic disorder comorbidity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							VALIDATION; UTILITY; ADULTS; CARE		[Feldman, Jonathan M.; Mayefsky, Lauren; Beckmann, Lacey] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA; [Feldman, Jonathan M.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Lehrer, Paul M.] UMDNJ Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ USA; [Serebrisky, Denise] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Pediat, Bronx, NY 10467 USA; [Shim, Chang] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine	Feldman, JM (corresponding author), Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA.	jonathan.feldman@einstein.yu.edu	Lehrer, Paul/AAE-8257-2020	Lehrer, Paul/0000-0002-9010-6129				Alegria M, 2006, J CLIN PSYCHIAT, V67, P56, DOI 10.4088/JCP.v67n0109; Breslau J, 2006, PSYCHOL MED, V36, P57, DOI 10.1017/S0033291705006161; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Feldman JM, 2005, J ASTHMA, V42, P179, DOI 10.1081/JAS-200054633; Feldman JM, 2000, MANAGEMENT OF STRESS AND ANXIETY IN MEDICAL DISORDERS, P220; Hasler G, 2005, AM J RESP CRIT CARE, V171, P1224, DOI 10.1164/rccm.200412-1669OC; Lewis-Fernandez R, 2002, CULT MED PSYCHIAT, V26, P199, DOI 10.1023/A:1016349624867; Rose D, 2006, AM J PUBLIC HEALTH, V96, P880, DOI 10.2105/AJPH.2004.050039; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737	9	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2010	125	3					760	762		10.1016/j.jaci.2009.11.002	http://dx.doi.org/10.1016/j.jaci.2009.11.002			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	573BK	20132974				2022-12-18	WOS:000275883200042
J	Mudd, K; Paterakis, M; Curtin-Brosnan, J; Matsui, E; Wood, R				Mudd, Kim; Paterakis, Melissa; Curtin-Brosnan, Jean; Matsui, Elizabeth; Wood, Robert			Predicting outcome of repeat milk, egg, or peanut oral food challenges	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Mudd, Kim; Paterakis, Melissa; Curtin-Brosnan, Jean; Matsui, Elizabeth; Wood, Robert] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Mudd, K (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.	Kmudd2@JHMI.edu		Matsui, Elizabeth/0000-0001-8134-5593				Bindslev-Jensen C, 2004, ALLERGY, V59, P690, DOI 10.1111/j.1398-9995.2004.00466.x; BOCK SA, 1988, J ALLERGY CLIN IMMUN, V82, P986; BRANUM AM, NCHS OCT 2008 DATA B, P2991; Niggemann B, 2005, ALLERGY, V60, P865, DOI 10.1111/j.1398-9995.2005.00828.x; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P1164, DOI 10.1016/j.jaci.2004.07.063	6	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2009	124	5					1115	1116		10.1016/j.jaci.2009.08.023	http://dx.doi.org/10.1016/j.jaci.2009.08.023			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	523XI	19895997				2022-12-18	WOS:000272108000039
J	Salfeld, P; Kopp, MV				Salfeld, Peter; Kopp, Matthias V.			Probiotics cannot be generally recommended foe primary prevention of atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; DISEASE; SUPPLEMENTATION		[Salfeld, Peter; Kopp, Matthias V.] Univ Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany	University of Freiburg	Kopp, MV (corresponding author), Univ Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany.	matthias.kopp@uniklinik-freiburg.de						Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kopp MV, 2008, PEDIATRICS, V121, pE850, DOI 10.1542/peds.2007-1492; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Rautava S, 2002, J ALLERGY CLIN IMMUN, V109, P119, DOI 10.1067/mai.2002.120273; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036	7	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2009	124	1					170	170		10.1016/j.jaci.2009.02.038	http://dx.doi.org/10.1016/j.jaci.2009.02.038			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	469OR	19427684				2022-12-18	WOS:000267909700025
J	Letz, AG; Tankersley, MS; Dice, JP; England, RW				Letz, Adrian G.; Tankersley, Michael S.; Dice, John P.; England, Ronald W.			Monitoring bacteriostasis in allergen extract mixing: 10 years of culture data	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Letz, Adrian G.; Tankersley, Michael S.; Dice, John P.; England, Ronald W.] Wilford Hall USAF Med Ctr, San Antonio, TX 78236 USA	United States Department of Defense; United States Air Force	Letz, AG (corresponding author), Wilford Hall USAF Med Ctr, San Antonio, TX 78236 USA.	adrian.letz@lackland.af.mil						Cox L, 2007, J ALLERGY CLIN IMMUN, V120, pS25, DOI 10.1016/j.jaci.2007.06.019; *JOINT COUNC ALL, ASTHM IMM; Lay PC, 2007, OTOLARYNG HEAD NECK, V137, P243, DOI 10.1016/j.otohns.2007.02.012; Lay P Chase, 2008, Otolaryngol Head Neck Surg, V139, P364, DOI 10.1016/j.otohns.2008.06.016; Noon L, 1911, LANCET, V1, P1572; *US PHARM, 2008, USP 797 GUID PHARM C; 2008, J ALLERGY CLIN IMMUN, V122, P842	7	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2009	123	5					1175	1176		10.1016/j.jaci.2009.01.048	http://dx.doi.org/10.1016/j.jaci.2009.01.048			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	449CW	19251313				2022-12-18	WOS:000266309400030
J	Sheikh, J; Sani, SS; Kulczycki, A; Dreskin, SC				Sheikh, Javed; Sani, Sarbjit S.; Kulczycki, Anthony, Jr.; Dreskin, Stephen C.		Urticaria & Angioedema Comm Amer A	A survey of allergists regarding the association of thyroid autoimmunity with chronic urticaria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Sheikh, Javed] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Allergy & Inflammat,Dept Med, Boston, MA 02215 USA; [Sani, Sarbjit S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Immunol & Allergy, Baltimore, MD 21205 USA; [Kulczycki, Anthony, Jr.] Washington Univ, Sch Med, Div Allergy & Immunol, St Louis, MO USA; [Dreskin, Stephen C.] Univ Colorado, Natl Jewish Med & Res Ctr, Div Allergy & Immunol, Denver, CO 80202 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Washington University (WUSTL); National Jewish Health; University of Colorado System; University of Colorado Denver	Sheikh, J (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Allergy & Inflammat,Dept Med, Boston, MA 02215 USA.	jsheikh@bidmc.harvard.edu						ALTRICH M, 2008, ALLERGY ASTHMA PROC, V29, P5; Coifman RE, 2007, J ALLERGY CLIN IMMUN, V119, P1012, DOI 10.1016/j.jaci.2007.01.029; Dreskin SC, 2005, CURR OPIN ALLERGY CL, V5, P408, DOI 10.1097/01.all.0000182546.83465.5a; Kikuchi Y, 2003, J ALLERGY CLIN IMMUN, V112, P218, DOI 10.1067/mai.2003.1605; O'Donnell BF, 2005, BRIT J DERMATOL, V153, P331, DOI 10.1111/j.1365-2133.2005.06646.x; Schocket AL, 2006, ALLERGY ASTHMA PROC, V27, P90; Sheikh J, 2008, ANN ALLERG ASTHMA IM, V100, P389, DOI 10.1016/S1081-1206(10)60604-7	7	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2009	123	5					1173	1175		10.1016/j.jaci.2008.12.1130	http://dx.doi.org/10.1016/j.jaci.2008.12.1130			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	449CW	19251315				2022-12-18	WOS:000266309400029
J	Sheehan, WJ; Delmonte, OM; Miller, DT; Roberts, AE; Bonilla, FA; Morra, M; Giliani, S; Pai, SY; Notarangelo, LD; Oettgen, HC				Sheehan, William J.; Delmonte, Ottavia M.; Miller, David T.; Roberts, Amy E.; Bonilla, Francisco A.; Morra, Massimo; Giliani, Silvia; Pai, Sung-Yun; Notarangelo, Luigi D.; Oettgen, Hans C.			Novel presentation of Omenn syndrome in association with aniridia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PAX6 GENE; IMMUNODEFICIENCY; MUTATIONS; DEFECTS		[Sheehan, William J.; Delmonte, Ottavia M.; Bonilla, Francisco A.; Notarangelo, Luigi D.; Oettgen, Hans C.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Miller, David T.; Roberts, Amy E.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Pai, Sung-Yun] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Sheehan, William J.; Delmonte, Ottavia M.; Miller, David T.; Roberts, Amy E.; Pai, Sung-Yun] Harvard Univ, Sch Med, Boston, MA USA; [Delmonte, Ottavia M.] Univ Turin, Osped Regina Margherita, Turin, Italy; [Morra, Massimo] Correlagen Diagnost, Waltham, MA USA; [Giliani, Silvia] Univ Brescia, Angelo Nocivelli Inst Mol Med, Brescia, Italy; [Pai, Sung-Yun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; A.O.U. Citta della Salute e della Scienza di Torino; Ospedale Infantile Regina Margherita; University of Turin; University of Brescia; Harvard University; Dana-Farber Cancer Institute	Sheehan, WJ (corresponding author), Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	Hans.Oettgen@childrens.harvard.edu	Pai, Sung-Yun/AAH-7762-2019; Giliani, Silvia/AAX-8843-2020; Notarangelo, Luigi D/F-9718-2016	Pai, Sung-Yun/0000-0002-0158-8147; Giliani, Silvia/0000-0001-8137-4642; Notarangelo, Luigi D/0000-0002-8335-0262	NIAID NIH HHS [T32 AI007512-23, T32 AI007512] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aleman K, 2001, EUR J PEDIATR, V160, P718, DOI 10.1007/s004310100816; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; DAVIS A, 1993, HUM MOL GENET, V2, P2093, DOI 10.1093/hmg/2.12.2093; Haq IJ, 2007, CLIN IMMUNOL, V124, P165, DOI 10.1016/j.clim.2007.04.013; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Robinson DO, 2008, AM J MED GENET A, V146A, P558, DOI 10.1002/ajmg.a.32209; Vihinen M, 2001, ADV GENET, V43, P103, DOI 10.1016/S0065-2660(01)43005-7; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81	9	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2009	123	4					966	969		10.1016/j.jaci.2008.12.007	http://dx.doi.org/10.1016/j.jaci.2008.12.007			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	431JW	19178939	Bronze, Green Accepted			2022-12-18	WOS:000265058600031
J	Baker, JW; Sheffer, A; Christensen, J; Hurewitz, D; Lazar, R; Kalfus, I; Banerji, A				Baker, J. W.; Sheffer, A.; Christensen, J.; Hurewitz, D.; Lazar, R.; Kalfus, I.; Banerji, A.			Cinryze (TM) Replacement Therapy in Hereditary Angioedema and Pregnancy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Baker, J. W.] Allergy Asthma & Dermatol Res Ctr, Lake Oswego, OR USA; [Sheffer, A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Christensen, J.] Nevada Access Res & Educ Soc, Las Vegas, NV USA; [Hurewitz, D.] Allergy Clin Tulsa, Tulsa, OK USA; [Lazar, R.] Grand Traverse Allergy, Traverse City, MA USA; [Kalfus, I.] Lev Pharmaceut, New York, NY USA; [Banerji, A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital			Banerji, Aleena/ABG-1245-2021						0	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				400	S106	S106		10.1016/j.jaci.2008.12.385	http://dx.doi.org/10.1016/j.jaci.2008.12.385			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596300413
J	Motosue, AM; Petronella, S; Sullivan, J; Castillo, S; Garcia, T; Murillo, M; Calhoun, JD; Chhickara, R; Bethel, D; Ward, JB; Brooks, EG				Motosue, A. M.; Petronella, S.; Sullivan, J.; Castillo, S.; Garcia, T.; Murillo, M.; Calhoun, J. D.; Chhickara, R.; Bethel, D.; Ward, J. B., Jr.; Brooks, E. G.			Lead Exposure Risk is Associated with Asthma in a Low-income Urban Hispanic Population: Results of the Communities Organized against Asthma and Lead (COAL) Project	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Motosue, A. M.; Petronella, S.; Sullivan, J.; Bethel, D.; Ward, J. B., Jr.; Brooks, E. G.] Univ Texas Med Branch, Galveston, TX 77058 USA; [Castillo, S.; Garcia, T.; Murillo, M.] De Madres A Madres Social Serv Ctr, Houston, TX USA; [Calhoun, J. D.; Chhickara, R.] Univ Houston Clear Lake, Houston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Houston System; University of Houston; University of Houston Clear Lake									0	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				61	S20	S20		10.1016/j.jaci.2008.12.089	http://dx.doi.org/10.1016/j.jaci.2008.12.089			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596300072
J	Becker, AB				Becker, Allan B.			Asthma in the preschool child: Still a rose by any other name?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; preschool	RISK		Univ Manitoba, Dept Pediat & Child Hlth, Allergy & Clin Immunol Sect, Winnipeg, MB R3E 0Z2, Canada	University of Manitoba	Becker, AB (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Allergy & Clin Immunol Sect, AE301,671 William Ave, Winnipeg, MB R3E 0Z2, Canada.	becker@cc.umanitoba.ca						Bacharier LB, 2007, J ALLERGY CLIN IMMUN, V119, P604, DOI 10.1016/j.jaci.2006.12.607; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; BISGAARD H, 1998, NEW ENGL J MED, V19, P354; BRUNETTE MG, 1988, PEDIATRICS, V81, P624; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P181; SCHUH S, 1999, J PEDIATR, V135, P5; Silverman M, 1997, ARCH DIS CHILD, V77, P62, DOI 10.1136/adc.77.1.62	10	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1136	1137		10.1016/j.jaci.2008.10.038	http://dx.doi.org/10.1016/j.jaci.2008.10.038			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA	19084109				2022-12-18	WOS:000261711800010
J	Tripp, K; McVicar, WK; Nair, P; Corren, J; Pleskow, WW; Goodwin, E; Baumgartner, RA; Hanrahan, JP				Tripp, Kenneth; McVicar, William K.; Nair, Parameswaran; Corren, Jonathan; Pleskow, Warren W.; Goodwin, Elizabeth; Baumgartner, Rudolf A.; Hanrahan, John P.			A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; safety; efficacy; relative potency; cumulative dose; levalbuterol HFA MDI; racemic albuterol HFA MDI	PEDIATRIC-PATIENTS; BETA-AGONISTS; RS-ALBUTEROL; PLACEBO	Background: The short-acting beta(2)-agonists levalbuterol and racemic albuterol are available for administration through a hydrofluoroalkane-134a (HFA) metered-dose inhaler (MDI). Objective: This study compared the short-term safety and efficacy of cumulative doses of levalbuterol HFA MDI and racemic albuterol HFA MDI in asthmatic subjects. Methods: This was a randomized, modified-blind, active-controlled, multicenter, 2-way crossover study. Subjects (n = 49) were randomized to 16 cumulative doses (I X, 2 X, 4 X, 8 X, and 16 X) of levalbuterol (45 mu g per dose) or racemic albuterol (90 mu g per dose) administered over a 2-hour period. After a 7-day washout period, subjects were crossed over to the other treatment. After each dose, safety outcomes and pulmonary function were assessed. Results: Heart rate and (R)-albuterol exposure increased for both racemic albuterol HFA and levalbuterol HFA. For cumulative doses of 8 x or greater, racemic albuterol HFA treatment had greater increases in mean heart rate than levalbuterol HFA (least-squares mean [ SD] difference at the 8 x dose was 2.8 beats/min [95% Cl, 0.3-5.3] and at the 16x dose was 3.5 beats/min [95% Cl, 0.6-6.41). (R)-albuterol plasma levels ranged from 10% to 18% higher after racemic albuterol HFA MDI dosing versus after levalbuterol HFA MDI. FEV(1) improvements were similar for both treatments. The relative potencies of the 2 therapies, based on FEV(1), were similar (ratio, 1.1 [90% CI, 0.9-1.2]; Finney method). Conclusion: In this study single-day cumulative dosing of asthmatic subjects with levalbuterol HFA MDI or racemic albuterol HFA MDI resulted in similar improvements in FEV(1) and tolerability. Plasma (R)-albuterol levels and mean heart rate were less with levalbuterol HFA MDI.	[Tripp, Kenneth; McVicar, William K.; Goodwin, Elizabeth; Baumgartner, Rudolf A.; Hanrahan, John P.] Sepracor Inc, Marlborough, MA 01752 USA; [Nair, Parameswaran] McMaster Univ, Div Respirol, Hamilton, ON L8S 4L8, Canada; [Corren, Jonathan] Allergy Res Fdn Inc, Los Angeles, CA USA	Dainippon Sumitomo Pharmaceutical Company; Sunovion Pharmaceuticals Inc.; McMaster University	Hanrahan, JP (corresponding author), Sepracor Inc, 84Waterford Dr, Marlborough, MA 01752 USA.	john.hanrahan@sepracor.com			Sepracor. Inc.	Sepracor. Inc.	Supported by Sepracor. Inc.	Ahrens RC, 1999, AM J RESP CRIT CARE, V160, P1238, DOI 10.1164/ajrccm.160.4.9806101; Berger WE, 2006, CURR MED RES OPIN, V22, P1217, DOI 10.1185/030079906X112534; BRITTON J, 1984, THORAX, V39, P597, DOI 10.1136/thx.39.8.597; FINNEY D, 1978, STAT METHODS BIOL; Fishwick D, 2001, AM J RESP CRIT CARE, V163, P474, DOI 10.1164/ajrccm.163.2.2003027; Lotvall J, 2001, J ALLERGY CLIN IMMUN, V108, P726; Maier G, 2007, PULM PHARMACOL THER, V20, P534, DOI 10.1016/j.pupt.2006.05.003; Milgrom H, 2001, J ALLERGY CLIN IMMUN, V108, P938, DOI 10.1067/mai.2001.120134; *NAT HEART LUNG BL, 1997, 974051 NIH NAT HEART; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, pS77, DOI 10.1016/S0091-6749(99)70277-0; Nelson HS, 1998, J ALLERGY CLIN IMMUN, V102, P943, DOI 10.1016/S0091-6749(98)70332-X; Parameswaran K, 1999, J ALLERGY CLIN IMMUN, V104, pS243, DOI 10.1016/S0091-6749(99)70039-4; Penn RB, 1996, CLIN REV ALLERG IMMU, V14, P37, DOI 10.1007/BF02772201; United Nations Environment Programme, 1991, MONTR PROT SUBST DEP, P231; *US FDA, GUID IND DOS RESP IN; [No title captured]	16	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2008	122	3					544	549		10.1016/j.jaci.2008.06.015	http://dx.doi.org/10.1016/j.jaci.2008.06.015			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	348TW	18692886				2022-12-18	WOS:000259234000016
J	Hasdenteufel, F; Luyasu, S; Renaudin, JM; Paquay, JL; Carbutti, G; Beaudouin, E; Moneret-Vautrin, DA; Kanny, G				Hasdenteufel, Frederic; Luyasu, Samuel; Renaudin, Jean-Marie; Paquay, Jean-Louis; Carbutti, Giuseppe; Beaudouin, Etienne; Moneret-Vautrin, Denise Anne; Kanny, Gisele			Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: A few comments - Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Hasdenteufel, Frederic; Renaudin, Jean-Marie; Beaudouin, Etienne; Moneret-Vautrin, Denise Anne; Kanny, Gisele] Univ Hosp, EA Allergy Dis Diag & Therapeut 3999, Dept Internal Med Clin Immunol & Allergol, Nancy, France; [Luyasu, Samuel; Paquay, Jean-Louis; Carbutti, Giuseppe] Clin S Luxemburg, Dept Internal Med & Intens Care, Arlon, Belgium	CHU de Nancy	Hasdenteufel, F (corresponding author), Univ Hosp, EA Allergy Dis Diag & Therapeut 3999, Dept Internal Med Clin Immunol & Allergol, Nancy, France.	frederic.hasdenteufel@wanadoo.fr	Kanny, Gisèle/AHA-8910-2022					Brockow K, 2002, ALLERGY, V57, P45; Hasdenteufel F, 2008, J ALLERGY CLIN IMMUN, V121, P527, DOI 10.1016/j.jaci.2007.08.027; Hasdenteufel F, 2007, ANN PHARMACOTHER, V41, P1069, DOI 10.1345/aph.1K050; Idee JM, 2008, J ALLERGY CLIN IMMUN, V122, P215, DOI 10.1016/j.jaci.2008.05.013	4	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2008	122	1					216	217		10.1016/j.jaci.2008.05.014	http://dx.doi.org/10.1016/j.jaci.2008.05.014			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	325RD					2022-12-18	WOS:000257605100040
J	Appleton, SL; Wilson, DH; Tucker, G; Ruffin, RE; Taylor, AW; Adams, RJ				Appleton, Sarah L.; Wilson, David H.; Tucker, Graenie; Ruffin, Richard E.; Taylor, Anne W.; Adams, Robert J.		N W Adelaide Cohort Hlth Study	Sex differences in asthma morbidity associated with obesity in a representative population sample	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BODY-MASS INDEX; SEVERITY; WEIGHT		[Appleton, Sarah L.; Wilson, David H.; Ruffin, Richard E.; Adams, Robert J.] Univ Adelaide, Discipline Med, Woodville, SA, Australia; [Tucker, Graenie] S Australian Dept Hlth, Hlth Stat Unit, Adelaide, SA, Australia; [Taylor, Anne W.] S Australian Dept Hlth, Populat Res & Outcome Studies Unit, Adelaide, SA, Australia	University of Adelaide	Appleton, SL (corresponding author), Univ Adelaide, Discipline Med, Queen Elizabeth Hosp Campus, Woodville, SA, Australia.	sarah.appleton@adelaide.edu.au	Tucker, Graeme R/AAP-4228-2020; Adams, Robert/Z-3197-2019; Taylor, Anne w/F-5708-2010; Appleton, Sarah/Y-5206-2019; Appleton, Sarah/E-9149-2017	Taylor, Anne w/0000-0002-4422-7974; Appleton, Sarah/0000-0001-7292-9714				Appleton SL, 2006, J ALLERGY CLIN IMMUN, V118, P1284, DOI 10.1016/j.jaci.2006.08.011; Dixon AE, 2006, J ASTHMA, V43, P553, DOI 10.1080/02770900600859123; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; GRANT J, 1920, EPIDEMIOL PERSPECT I, V3, P4; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; REUTHER D, 2006, AM J RESP CRIT CARE, V174, P112; Santillan AA, 2003, INT J OBESITY, V27, P1430, DOI 10.1038/sj.ijo.0802395; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; Varraso R, 2005, AM J RESP CRIT CARE, V171, P334, DOI 10.1164/rccm.200405-674OC	9	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2008	121	5					1285	1287		10.1016/j.jaci.2008.03.022	http://dx.doi.org/10.1016/j.jaci.2008.03.022			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	302IJ	18466787				2022-12-18	WOS:000255961700031
J	Barry, PJ; O'Mahony, A; Finnegan, C; O'Connor, TM				Barry, Peter J.; O'Mahony, Ann; Finnegan, Collette; O'Connor, Terence M.			Delayed allergic reactions to omalizumab: Are patients reporting all cases?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Barry, Peter J.; O'Mahony, Ann; O'Connor, Terence M.] Mercy Univ Hosp, Dept Resp Med, Cork, Ireland	University College Cork	Barry, PJ (corresponding author), Mercy Univ Hosp, Dept Resp Med, Cork, Ireland.	peter_barry@hotmail.com						Limb SL, 2007, J ALLERGY CLIN IMMUN, V120, P1378, DOI 10.1016/j.jaci.2007.09.022	1	8	8	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					785	786		10.1016/j.jaci.2007.12.1184	http://dx.doi.org/10.1016/j.jaci.2007.12.1184			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18328902				2022-12-18	WOS:000253918900050
J	Mandelin, J; Rentitz, A; Virtanen, H; Reitanto, S				Mandelin, Johanna; Rentitz, Anita; Virtanen, Hannele; Reitanto, Sakari			Recall antigen reactions in patients with atopic dermatitis treated with tacrolimus ointment for 1 year	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ADULTS		[Mandelin, Johanna; Rentitz, Anita; Virtanen, Hannele; Reitanto, Sakari] Univ Helsinki, Cent Hosp, Dept Dermatol, Skin & Allergy Hosp, FIN-00014 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Reitanto, S (corresponding author), Univ Helsinki, Cent Hosp, Dept Dermatol, Skin & Allergy Hosp, FIN-00014 Helsinki, Finland.	sakari.reitamo@hus.fi		Mandelin, Johanna/0000-0002-3816-1809				CZAMECKI D, 1995, CANCER, V15, P228; Reitamo S, 2000, ARCH DERMATOL, V136, P999, DOI 10.1001/archderm.136.8.999; Reitamo S, 2007, ACTA DERM-VENEREOL, V87, P406, DOI 10.2340/00015555-0282; Remitz A, 2001, J ALLERGY CLIN IMMUN, V107, P196, DOI 10.1067/mai.2001.112131; STENGER D, 1983, Z HAUTKRANKHEITEN, V58, P293	5	8	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					777	779		10.1016/j.jaci.2007.12.1179	http://dx.doi.org/10.1016/j.jaci.2007.12.1179			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18328896				2022-12-18	WOS:000253918900041
J	Beyer, K; Bardina, L; Grishina, G; Ashraf, A; Teuber, S; Niggemann, B; Sampson, HA				Beyer, K.; Bardina, L.; Grishina, G.; Ashraf, A.; Teuber, S.; Niggemann, B.; Sampson, H. A.			Identification of a new Brazil nut allergen - Ber e 2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Beyer, K.; Niggemann, B.] Charite Campus Virchow Klin, Berlin, Germany; [Bardina, L.; Grishina, G.; Ashraf, A.; Sampson, H. A.] Mt Sinai Sch Med, New York, NY USA; [Teuber, S.] Univ Calif Davis, Davis, CA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis									0	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		955	S247	S247		10.1016/j.jaci.2007.12.980	http://dx.doi.org/10.1016/j.jaci.2007.12.980			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401419
J	Chung, S; Champagne, ET				Chung, S.; Champagne, E. T.			Using phenolic compounds to reduce the allergenic properties of peanut extracts and peanut butter slurries	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Chung, S.; Champagne, E. T.] USDA ARS, New Orleans, LA USA	United States Department of Agriculture (USDA)									0	8	9	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		960	S249	S249		10.1016/j.jaci.2007.12.985	http://dx.doi.org/10.1016/j.jaci.2007.12.985			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401424
J	Schneider, LC; Weinberg, A; Boguniewicz, M; Zaccaro, D; Taylor, P; Borras-Coughlin, I; Heughan, L; Samuels, R; Leung, D				Schneider, L. C.; Weinberg, A.; Boguniewicz, M.; Zaccaro, D.; Taylor, P.; Borras-Coughlin, I.; Heughan, L.; Samuels, R.; Leung, D.			Abnormal immune response to varicella vaccine in subjects with atopic dermatitis compared to non-atopic controls	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Schneider, L. C.; Borras-Coughlin, I.; Samuels, R.] Childrens Hosp, Boston, MA USA; [Weinberg, A.] Univ Colorado, Denver, CO USA; [Boguniewicz, M.; Taylor, P.; Leung, D.] Natl Jewish Med & Res Ctr, Denver, CO USA; [Zaccaro, D.] Rho Inc, Chapel Hill, NC USA	Harvard University; Boston Children's Hospital; University of Colorado System; University of Colorado Denver; National Jewish Health; Rho									0	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		1052	S272	S273		10.1016/j.jaci.2007.12.1080	http://dx.doi.org/10.1016/j.jaci.2007.12.1080			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	266HZ		Bronze			2022-12-18	WOS:000253426401516
J	Shearer, WT; Pahwa, S; Read, JS; Chen, J; Wijayawardana, SR; Palumbo, P; Abrams, EJ; Nesheim, SR; Yin, W; Thompson, B; Easley, KA				Shearer, William T.; Pahwa, Savita; Read, Jennifer S.; Chen, Jian; Wijayawardana, Sameera R.; Palumbo, Paul; Abrams, Elaine J.; Nesheim, Stephen R.; Yin, Wanrong; Thompson, Bruce; Easley, Kirk A.			CD4/CD8 T-cell ratio predicts HIV infection in infants: The National Heart, Lung, and Blood Institute (PC2)-C-2 Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CD4/CD8 T-cell ratio; mother-to-child transmission of HIV; HIV infection	CHILDREN; TRANSMISSION; MORTALITY; THERAPY; AIDS; AGE	Background: In resource-poor regions of the world, HIV virologic testing is not available. Objective: We sought to evaluate the diagnostic usefulness of the CD4/CD8 T-cell ratio in predicting HIV infection in infants. Methods: Data from the 3- and 9-month visits for non-breastfed infants born to HIV-infected mothers enrolled (1990-1994) in the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study (mother-to-child transmission of HIV, 17%) were analyzed. Data from the 3-month visit for infants enrolled (1985-1996) in the Perinatal AIDS Collaborative Transmission Study (mother-to-child transmission of HIV, 18%) were used for validation. Results: At 3 months of age, data were available on 79 HIV-infected and 409 uninfected non-breast-fed infants in the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study. The area under the curve (AUC) of the receiver operating characteristic curve at 3 months was higher for the CD4/CD8 ratio compared with the CD4(+) T-cell count (AUC, 0.83 and 0.75; P = .03). The mean CD4/CD8 ratio at the 3-month visit was 1.7 for HIV-infected infants and 3.0 for uninfected infants. A CD4/CD8 ratio of 2.4 at 3 months of age was almost 2.5 times more likely to occur in an HIV-infected infant compared with an uninfected infant (test sensitivity, 81%; posttest probability of HIV, 33%). Model performance in the Centers for Disease Control and Prevention Perinatal AIDS Collaborative Transmission Study validation test (224 HIV-infected and 1015 uninfected 3-month-old infants) was equally good (AUC, 0.78 for CD4/CD8 ratio). Conclusion: The CD4/CD8 T-cell ratio is a more sensitive predictor of HIV infection in infants than the CD4(+) T-cell count. Clinical implications: The CD4/CD8 T-cell ratio can be used with caution to predict HIV infection in children.	[Shearer, William T.] Baylor Coll Med, Dept Pediat, Sect Allergy & Immunol, Houston, TX USA; [Pahwa, Savita] Univ Miami, Miller Sch Med, Dept Microbiol, Coral Gables, FL 33124 USA; [Pahwa, Savita] Univ Miami, Miller Sch Med, Dept Immunol, Coral Gables, FL 33124 USA; [Pahwa, Savita] Univ Miami, Miller Sch Med, Dept Pediat, Coral Gables, FL 33124 USA; [Read, Jennifer S.] NICHHD, Bethesda, MD 20892 USA; [Chen, Jian; Wijayawardana, Sameera R.; Easley, Kirk A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; [Palumbo, Paul] Dartmouth Med Sch, Hanover, NH USA; [Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Nesheim, Stephen R.] Emory Univ, Sch Med, Atlanta, GA USA; [Yin, Wanrong; Thompson, Bruce] Clin Trial & Survey Corp, Baltimore, MD USA	Baylor College of Medicine; University of Miami; University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Emory University; Rollins School Public Health; Dartmouth College; Columbia University; Emory University	Shearer, WT (corresponding author), Texas Childrens Hosp, 6621 Fannin St MC FC330-01, Houston, TX 77030 USA.	wtsheare@TexasChildrensHospital.org	Easley, Kirk A/K-6910-2015; Pahwa, Savita/AAA-4900-2019	Easley, Kirk A/0000-0003-4419-2617; Pahwa, Savita/0000-0002-4470-4216; Shearer, William/0000-0002-2483-2130	NCRR NIH HHS [RR0188, M01 RR000188, K01 RR000188] Funding Source: Medline; NHLBI NIH HHS [HL079533, R01 HL072705, HL72705, N01 HR096043, R01 HL079533, N01 HR096037, HL96040] Funding Source: Medline; NIAID NIH HHS [P30 AI036211, AI41089, U01 AI041089, AI27551, AI36211, U01 AI027551] Funding Source: Medline; NICHD NIH HHS [U01 HD041983, HD41983] Funding Source: Medline; PHS HHS [P30 A1050409] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR096037, N01HR096043] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041983] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188, K01RR000188] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072705, R01HL079533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041089, U01AI027551, P30AI036211] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baum LL, 2007, CURR OPIN HIV AIDS, V2, P234, DOI 10.1097/COH.0b013e3280ef6909; CALVELLI T, 1993, CYTOMETRY, V14, P702, DOI 10.1002/cyto.990140703; Chinen J, 2001, J ALLERGY CLIN IMMUN, V108, P265, DOI 10.1067/mai.2001.116573; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demmler GJ, 2004, TXB PEDIAT INFECT DI, P1912; Gona P, 2006, JAMA-J AM MED ASSOC, V296, P292, DOI 10.1001/jama.296.3.292; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kattan M, 1996, J CLIN EPIDEMIOL, V49, P1285; Mofenson LM, 2003, LANCET, V362, P1625, DOI 10.1016/S0140-6736(03)14825-8; PALUMBO P, 2003, MED MANAGEMENT AIDS, P107; PALUMBO PE, 1995, J PEDIATR-US, V126, P592, DOI 10.1016/S0022-3476(95)70357-8; Paul ME, 2005, J ALLERGY CLIN IMMUN, V115, P848, DOI 10.1016/j.jaci.2004.11.054; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pitt J, 1998, J CLIN EPIDEMIOL, V51, P159, DOI 10.1016/S0895-4356(97)00239-4; READ JS, 2007, 14 C RETR OPP INF FE; ROYSTON P, 1995, STAT MED, V14, P1417, DOI 10.1002/sim.4780141303; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Shearer W, 2007, CLIN IMMUNOL, V123, pS46, DOI 10.1016/j.clim.2007.03.307; Shearer WT, 2000, J ALLERGY CLIN IMMUN, V106, P559, DOI 10.1067/mai.2000.109433; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Simonds RJ, 1998, AIDS, V12, P301, DOI 10.1097/00002030-199803000-00008; Zijenah LS, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-6	24	8	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1449	1456		10.1016/j.jaci.2007.08.037	http://dx.doi.org/10.1016/j.jaci.2007.08.037			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	17920669	Green Accepted			2022-12-18	WOS:000251653800030
J	Frew, AJ				Frew, Anthony J.			How does sublingual immunotherapy work?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							GRASS-POLLEN IMMUNOTHERAPY; SEASONAL ALLERGIC RHINOCONJUNCTIVITIS; RANDOMIZED CONTROLLED-TRIAL; CYTOKINE MESSENGER-RNA; INTERFERON-GAMMA; ORAL-MUCOSA; HAY-FEVER; CELLS; RESPONSES; EXPRESSION		Brighton Gen Hosp, Dept Resp Med, Brighton BN2 3EW, E Sussex, England	Brighton and Sussex University Hospitals NHS Trust; Brighton General Hospital	Frew, AJ (corresponding author), Brighton Gen Hosp, Dept Resp Med, Brighton BN2 3EW, E Sussex, England.	anthonsl.frew@bsuh.nhs.uk	Kelly, Frank J/C-6125-2009; ognibene, toni/C-1520-2009	Kelly, Frank J/0000-0003-2558-8392; 				Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; Bagnasco M, 1997, J ALLERGY CLIN IMMUN, V100, P122, DOI 10.1016/S0091-6749(97)70203-3; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Ciprandi G, 2005, ANN ALLERG ASTHMA IM, V95, P38, DOI 10.1016/S1081-1206(10)61186-6; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; Cosmi L, 2006, CLIN EXP ALLERGY, V36, P261, DOI 10.1111/j.1365-2222.2006.02429.x; Dahl R, 2006, ALLERGY, V61, P185, DOI 10.1111/j.1398-9995.2005.00949.x; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; Durham SR, 2006, J ALLERGY CLIN IMMUN, V117, P802, DOI 10.1016/j.jaci.2005.12.1358; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; EWAN PW, 1993, CLIN EXP ALLERGY, V23, P647, DOI 10.1111/j.1365-2222.1993.tb01791.x; Fanta C, 1999, INT ARCH ALLERGY IMM, V120, P218, DOI 10.1159/000024270; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Ippoliti F, 2003, PEDIATR ALLERGY IMMU, V14, P216, DOI 10.1034/j.1399-3038.2003.00025.x; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; JUTEL M, 1995, J IMMUNOL, V154, P4187; Kinaciyan T, 2007, J ALLERGY CLIN IMMUN, V119, P937, DOI 10.1016/j.jaci.2006.11.010; LAMBIN P, 1993, J IMMUNOL METHODS, V165, P99, DOI 10.1016/0022-1759(93)90111-J; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; Marogna M, 2005, J ALLERGY CLIN IMMUN, V115, P1184, DOI 10.1016/j.jaci.2005.02.031; MCHUGH SM, 1995, CLIN EXP ALLERGY, V25, P828, DOI 10.1111/j.1365-2222.1995.tb00025.x; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Pajno GB, 2000, ALLERGY, V55, P842, DOI 10.1034/j.1398-9995.2000.00495.x; PIENKOWSKI MM, 1985, J ALLERGY CLIN IMMUN, V76, P729, DOI 10.1016/0091-6749(85)90679-7; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Savolainen J, 2006, ALLERGY, V61, P1184, DOI 10.1111/j.1398-9995.2006.01206.x; Smith H, 2004, J ALLERGY CLIN IMMUN, V114, P831, DOI 10.1016/j.jaci.2004.06.058; VARNEY VA, 1993, J CLIN INVEST, V92, P644, DOI 10.1172/JCI116633; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	31	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2007	120	3					533	536		10.1016/j.jaci.2007.08.003	http://dx.doi.org/10.1016/j.jaci.2007.08.003			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	211DV	17765753				2022-12-18	WOS:000249505400008
J	Brass, DM; Hollingsworth, JW; Fessler, MB; Savov, JD; Maxwell, AB; Whitehead, GS; Burch, LH; Schwartz, DA				Brass, David M.; Hollingsworth, John W.; Fessler, Michael B.; Savov, Jordan D.; Maxwell, Abby B.; Whitehead, Gregory S.; Burch, Lauranell H.; Schwartz, David A.			The IL-1 type 1 receptor is required for the development of LPS-induced airways disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						LPS; endotoxin; airway disease; IL-1; IL-1 receptor; airway remodeling	TOLL-LIKE RECEPTOR-4; PLASMINOGEN-ACTIVATOR; PULMONARY-FIBROSIS; EXPRESSION; GENE; MICE; FIBROBLASTS; INHALATION; IL-1-BETA; MEDIATORS	Background: The contribution of IL-1 beta signaling through the IL-1 type 1 receptor (Il-1R1) to the development of persistent LPS-induced airway disease has not been investigated. Objective: To determine the importance of signaling through the IL-1 type I receptor in the development of LPS-induced airway disease. Methods: We exposed IL-1R1-deficient (C57BL/6(IL-1RI-/-)) mice to an aerosol of LPS or filtered air for I day, I week, or 4 weeks. Results: After 4 weeks of LPS inhalation, C57BL/6(IL-1RI-/-) mice failed to develop significant submucosal thickening, whereas C57BL/6 mice had significantly thickened submucosa in small, medium, and large airways compared with those of unexposed control mice. Cell proliferation in the airways of both the 1-week and 4-week LPS-exposed C57BL/6(IL-1RI-/-) mice was significantly reduced compared with LPS-exposed C57BL/6 mice. mRNA for type III alpha-3 procollagen was significantly elevated over baseline in C57BL/6 yet remained unchanged compared with baseline in C57BL/6(IL-1RI-/-) mice after 1 week or 4 weeks of LPS inhalation. mRNA for tissue inhibitor of metalloprotease 1 in C57BL/6 mice in the 1-week and 4-week groups was significantly elevated over both control mice and C57BL/6(IL-1RI-/-) Mice. Conclusion: These data support the hypothesis that signaling through the IL-1 receptor modulates extracellular matrix homeostasis in response to inhaled LPS. Clinical implications: Attenuating IL-1R1-mediated signaling might be an effective therapy against the development of airway remodeling in chronic inflammatory diseases.	Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27706 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Brass, DM (corresponding author), Natl Inst Environm Hlth Sci, Rall Bldg,Room C224,POB 12233,MD C2-15,111 Alexan, Res Triangle Pk, NC 27709 USA.	brassd@niehs.nih.gov	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613	Intramural NIH HHS [Z01 ES101947, Z01 ES101946, Z01 ES101945-03, Z01 ES101947-03, Z01 ES101945, Z01 ES101946-03] Funding Source: Medline; NIEHS NIH HHS [ES12717, K08 ES012717] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101947, Z01ES102005, Z01ES102546, Z01ES101946, Z01ES101945, K08ES012717] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Brass DM, 2003, AM J PHYSIOL-LUNG C, V285, pL755, DOI 10.1152/ajplung.00001.2003; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Elner SG, 2003, EXP EYE RES, V76, P585, DOI 10.1016/S0014-4835(03)00028-9; Fernandez L, 2002, PATHOBIOLOGY, V70, P191, DOI 10.1159/000069328; Fessler MB, 2004, J BIOL CHEM, V279, P39989, DOI 10.1074/jbc.M401080200; George CLS, 2001, AM J PHYSIOL-LUNG C, V280, pL203, DOI 10.1152/ajplung.2001.280.2.L203; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; Iwamoto J, 2003, DIGEST DIS SCI, V48, P2247, DOI 10.1023/B:DDAS.0000007859.10680.b1; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Lorenz E, 2001, AM J PHYSIOL-LUNG C, V281, pL1106, DOI 10.1152/ajplung.2001.281.5.L1106; Moreland JG, 2001, AM J PHYSIOL-LUNG C, V280, pL173, DOI 10.1152/ajplung.2001.280.1.L173; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Savov JD, 2003, AM J PHYSIOL-LUNG C, V285, pL940, DOI 10.1152/ajplung.00102.2003; Savov JD, 2002, AM J PHYSIOL-LUNG C, V283, pL952, DOI 10.1152/ajplung.00420.2001; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Wills-Karp M, 2000, Respir Res, V1, P19, DOI 10.1186/rr7; Wohlford-Lenane CL, 1999, AM J PHYSIOL-LUNG C, V276, pL736, DOI 10.1152/ajplung.1999.276.5.L736; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	24	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2007	120	1					121	127		10.1016/j.jaci.2007.03.051	http://dx.doi.org/10.1016/j.jaci.2007.03.051			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	190NS	17512577	Green Accepted			2022-12-18	WOS:000248066400017
J	Sanak, M; Potaczek, DP; Mastalerz, L; Nizankowska, E; Szczeklik, A				Sanak, Marek; Potaczek, Daniel P.; Mastalerz, Lucyna; Nizankowska, Ewa; Szczeklik, Andrew			FCERIA gene promoter polymorphisms: Lack of association with aspirin hypersensitivity in whites	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALPHA-CHAIN		Jagiellonian Univ, Sch Med, Dept Med, Krakow, Poland	Jagiellonian University	Sanak, M (corresponding author), Jagiellonian Univ, Sch Med, Dept Med, Krakow, Poland.	mmszczek@cyf-kr.edu.pl	Mastalerz, Lucyna/U-5974-2018; Sanak, Marek/A-2115-2008; Sanak, Marek/AAV-1628-2021	Mastalerz, Lucyna/0000-0002-8994-0036; Sanak, Marek/0000-0001-7635-8103; Potaczek, Daniel Piotr/0000-0003-0324-8506				Bae JS, 2007, J ALLERGY CLIN IMMUN, V119, P449, DOI 10.1016/j.jaci.2006.10.006; Hasegawa M, 2003, J IMMUNOL, V171, P1927, DOI 10.4049/jimmunol.171.4.1927; Potaczek DP, 2006, ALLERGY, V61, P1230, DOI 10.1111/j.1398-9995.2006.01195.x; Shikanai T, 2002, J APPL PHYSIOL, V93, P37, DOI 10.1152/japplphysiol.00993.2001	4	8	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2007	119	5					1280	1281		10.1016/j.jaci.2007.01.030	http://dx.doi.org/10.1016/j.jaci.2007.01.030			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	167CB	17335883	Green Submitted			2022-12-18	WOS:000246427200040
J	Creticos, PS				Creticos, Peter Socrates			Legends in allergy: Philip S. Norman and Lawrence M. Lichtenstein - The Hopkins experience	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							RAGWEED HAY-FEVER; NASAL AIRWAY CHALLENGE; RINKEL METHOD; DOUBLE-BLIND; ANTIGEN E; IMMUNOTHERAPY; POLLEN; ANTIBODY; VITRO; SPECIFICITY		Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Creticos, PS (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle,2B 71, Baltimore, MD 21224 USA.	pcretic@jhmi.edu						BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; CRETICOS PS, 1985, J CLIN INVEST, V76, P2247, DOI 10.1172/JCI112233; CRETICOS PS, 1984, NEW ENGL J MED, V310, P1626, DOI 10.1056/NEJM198406213102502; CRETICOS PS, 1989, J ALLERGY CLIN IMMUN, V84, P197, DOI 10.1016/0091-6749(89)90325-4; FRANKLIN W, 1967, JAMA-J AM MED ASSOC, V201, P95; FURIN MJ, 1991, J ALLERGY CLIN IMMUN, V88, P27, DOI 10.1016/0091-6749(91)90297-2; ILIOPOULOS O, 1991, J ALLERGY CLIN IMMUN, V87, P855, DOI 10.1016/0091-6749(91)90134-A; ISHIZAKA K, 1968, J ALLERGY, V42, P330, DOI 10.1016/0021-8707(68)90095-6; KING TP, 1962, BIOCHEMISTRY-US, V1, P709, DOI 10.1021/bi00910a027; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; KING TP, 1967, BIOCHEMISTRY-US, V6, P1992, DOI 10.1021/bi00859a017; KING TP, 1967, ANN ALLERGY, V25, P541; LEVY DA, 1971, J CLIN INVEST, V50, P360, DOI 10.1172/JCI106503; LICHTENS.LM, 1968, AM J MED, V44, P514, DOI 10.1016/0002-9343(68)90052-1; LICHTENSTEIN LM, 1968, J IMMUNOL, V101, P317; LICHTENSTEIN LM, 1968, J ALLERGY, V41, P49, DOI 10.1016/0021-8707(68)90007-5; LICHTENSTEIN LM, 1971, ANN INTERN MED, V75, P663, DOI 10.7326/0003-4819-75-5-663; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; LICHTENSTEIN LM, 1967, J ALLERGY, V40, P160, DOI 10.1016/0021-8707(67)90005-6; LICHTENSTEIN LM, 1966, J CLIN INVEST, V45, P1126, DOI 10.1172/JCI105419; Loveless MH, 1943, J IMMUNOL, V47, P165; LOWELL FC, 1963, J ALLERGY, V34, P165, DOI 10.1016/0021-8707(63)90069-8; LOWELL FC, 1965, NEW ENGL J MED, V273, P675, DOI 10.1056/NEJM196509232731302; MAJCHEL AM, 1992, J ALLERGY CLIN IMMUN, V90, P85, DOI 10.1016/S0091-6749(06)80014-X; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; NORMAN PS, 1971, J ALLERGY, V47, P273, DOI 10.1016/S0091-6749(71)80005-2; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P210, DOI 10.1016/0091-6749(73)90059-6; NORMAN PS, 1978, J ALLERGY CLIN IMMUN, V61, P370, DOI 10.1016/0091-6749(78)90116-1; PRAUSNITZ C, 1921, ZBL BAKT           1, V86, P160; PROUD D, 1983, J CLIN INVEST, V72, P1678, DOI 10.1172/JCI111127; VANMETRE TE, 1982, J ALLERGY CLIN IMMUN, V69, P181, DOI 10.1016/0091-6749(82)90098-7; VANMETRE TE, 1980, J ALLERGY CLIN IMMUN, V65, P288, DOI 10.1016/0091-6749(80)90158-X; VANMETRE TE, 1980, J ALLERGY CLIN IMMUN, V66, P500, DOI 10.1016/0091-6749(80)90012-3	35	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2007	119	4					1031	1038		10.1016/j.jaci.2007.02.035	http://dx.doi.org/10.1016/j.jaci.2007.02.035			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	157OK	17418665	Bronze			2022-12-18	WOS:000245729500048
J	Baur, X				Baur, Xaver			Evidence for allergic reactions in isocyanate asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Ordinariat & Zent Inst Arbeitsmed, Hamburg, Germany		Baur, X (corresponding author), Ordinariat & Zent Inst Arbeitsmed, Hamburg, Germany.	baur@uke.uni-hamburg.de						BAUR X, 1994, INT ARCH OCC ENV HEA, V66, P141, DOI 10.1007/BF00380772; Jones MG, 2006, J ALLERGY CLIN IMMUN, V117, P663, DOI 10.1016/j.jaci.2005.09.053; Maestrelli P, 1997, CLIN EXP ALLERGY, V27, P1292; Wisnewski AV, 2004, J ALLERGY CLIN IMMUN, V113, P1178, DOI 10.1016/j.jaci.2004.03.009	4	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					757	758		10.1016/j.jaci.2006.10.037	http://dx.doi.org/10.1016/j.jaci.2006.10.037			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17240441				2022-12-18	WOS:000244925000039
J	Bleecker, ER; Postma, DS; Lawrance, R; Meyers, DA; Ambrose, H; Goldman, M				Bleecker, E. R.; Postma, D. S.; Lawrance, R.; Meyers, D. A.; Ambrose, H.; Goldman, M.			Effect of polymorphisms in the beta(2)-adrenergic receptor gene (ADRB2) on response to long-acting beta(2)-agonist (LABA) therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	AAAAI Annual Meeting	FEB 23-27, 2007	San Diego, CA						Wake Forest Univ, Sch Med, Ctr Human Genet, Winston Salem, NC 27109 USA; Univ Groningen, Med Ctr, NL-9700 AB Groningen, Netherlands; AstraZeneca, Macclesfield, Cheshire, England; AstraZeneca LP, Wilmington, DE USA	Wake Forest University; University of Groningen; AstraZeneca; AstraZeneca									0	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2007	119	2				LB8	524	525		10.1016/j.jaci.2006.12.632	http://dx.doi.org/10.1016/j.jaci.2006.12.632			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	137YB					2022-12-18	WOS:000244327900058
J	Gelardi, M; Bonini, M; Bonini, S; Candreva, T; Fiorella, M; Ventura, M				Gelardi, M.; Bonini, M.; Bonini, S.; Candreva, T.; Fiorella, M.; Ventura, M.			Non allergic rhinitis in competitive swimmers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Gelardi, M.; Candreva, T.; Fiorella, M.] Univ Bari, Dept Ophthalmol & Otolaryngol, I-70121 Bari, Italy; [Bonini, M.] UCSC, Inst Sports Med, Rome, Italy; [Bonini, M.; Bonini, S.] Inst Neurobiol & Mol Med, CNR, Rome, Italy; [Bonini, S.] Univ Naples Federico 2, Chair Allergy & Clin Immunol, Naples, Italy; [Ventura, M.] Univ Bari, MIDIM, Dept Internal Med, I-70121 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Universita degli Studi di Bari Aldo Moro			Bonini, Matteo/AAB-1093-2019; Bonini, Sergio/T-6594-2019	Bonini, Sergio/0000-0003-0079-3031					0	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		640	S163	S163		10.1016/j.jaci.2006.11.692	http://dx.doi.org/10.1016/j.jaci.2006.11.692			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT		Bronze			2022-12-18	WOS:000251460401025
J	Simon, HU; Seger, R				Simon, Hans-Uwe; Seger, Reinhard			Hyper-IgE syndrome associated with an IL-4-producing gamma/delta(+) T-cell clone	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EOSINOPHILIA		Univ Bern, Dept Pharmacol, Bern, Switzerland; Univ Zurich, Dept Pediat, Zurich, Switzerland	University of Bern; University of Zurich	Simon, HU (corresponding author), Univ Bern, Dept Pharmacol, Bern, Switzerland.	hus@pki.unibe.ch	Simon, Hans-Uwe/AAU-7410-2020	Simon, Hans-Uwe/0000-0002-9404-7736				Bonilla FA, 2006, J ALLERGY CLIN IMMUN, V117, pS435, DOI 10.1016/j.jaci.2005.09.051; COGAN E, 1994, NEW ENGL J MED, V330, P535, DOI 10.1056/NEJM199402243300804; FANCONI S, 1984, EUR J PEDIATR, V142, P292, DOI 10.1007/BF00540256; Grimbacher B, 2005, IMMUNOL REV, V203, P244, DOI 10.1111/j.0105-2896.2005.00228.x; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503; Simon HU, 1996, J EXP MED, V183, P1071, DOI 10.1084/jem.183.3.1071; Simon HU, 2001, INT ARCH ALLERGY IMM, V124, P242, DOI 10.1159/000053723	8	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1					246	248		10.1016/j.jaci.2006.08.025	http://dx.doi.org/10.1016/j.jaci.2006.08.025			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	127YL	17208609				2022-12-18	WOS:000243622200035
J	Steinke, JW; Baramki, D; Borish, L				Steinke, John W.; Baramki, Dawn; Borish, Larry			Opposing actions of (R,R)-isomers and (S,S)-isomers of formoterol on T-cell function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SMOOTH-MUSCLE; MODULATION; (R)-ISOMERS; (S)-ISOMERS; ENANTIOMERS; AGONISTS		Univ Virginia, Hlth Syst, Beirne Carter Ctr Immunol Res, Asthma & Allerg Dis Ctr, Charlottesville, VA 22903 USA	University of Virginia	Steinke, JW (corresponding author), Univ Virginia, Hlth Syst, Beirne Carter Ctr Immunol Res, Asthma & Allerg Dis Ctr, Charlottesville, VA 22903 USA.							Abraha D, 2004, INT ARCH ALLERGY IMM, V133, P380, DOI 10.1159/000077358; Agrawal DK, 2004, J ALLERGY CLIN IMMUN, V113, P503, DOI 10.1016/j.jaci.2003.12.039; Ameredes BT, 2005, J ALLERGY CLIN IMMUN, V116, P65, DOI 10.1016/j.jaci.2005.03.007; Baramki D, 2002, J ALLERGY CLIN IMMUN, V109, P449, DOI 10.1067/mai.2002.122159; Cockcroft DW, 1999, J ALLERGY CLIN IMMUN, V103, P1049, DOI 10.1016/S0091-6749(99)70178-8; Ramer-Quinn DS, 1997, J IMMUNOL, V159, P4857; Volcheck GW, 2005, CLIN EXP ALLERGY, V35, P1341, DOI 10.1111/j.1365-2222.2005.02347.x	7	8	8	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2006	118	4					963	965		10.1016/j.jaci.2006.07.027	http://dx.doi.org/10.1016/j.jaci.2006.07.027			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	097GD	17030255				2022-12-18	WOS:000241434200031
J	Khoo, SK; Zhang, G; Backer, V; Porsbjerg, C; Nepper-Christensen, S; Creegan, R; Baynam, G; de Klerk, N; Rossi, GA; Hagel, I; Di Prisco, MC; Lynch, N; Britton, J; Hall, I; Musk, AW; Goldblatt, J; Le Souef, PN				Khoo, Siew-Kim; Zhang, Guicheng; Backer, Vibeke; Porsbjerg, Celeste; Nepper-Christensen, Steen; Creegan, Rhona; Baynam, Gareth; de Klerk, Nicholas; Rossi, Giovanni A.; Hagel, Isabel; Di Prisco, Maria C.; Lynch, Neil; Britton, John; Hall, Ian; Musk, Arthur W.; Goldblatt, Jack; Le Souef, Peter N.		Greenlandic Population Study Grp	Associations of a novel IL4RA polymorphism, Ala57Thr, in Greenlander Inuit	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL4RA polymorphism; atopy; asthma; rhinitis; Inuit	RECEPTOR-ALPHA CHAIN; YOUNG DANISH ADULTS; INTERLEUKIN-4 RECEPTOR; IL-4 RECEPTOR; ATOPIC ASTHMA; SUSCEPTIBILITY ALLELES; RESPIRATORY SYMPTOMS; ALLERGEN EXPOSURE; UNDERLYING ASTHMA; HUMAN GENES	Background: A novel IL4RA polymorphism, Ala57Thr, was identified in Greenlander Inuit. Objective: We sought to determine whether the novel Thr57 allele is population specific and to assess the associations of Ala57Thr and Ile50Val with atopy in 2 Inuit populations. Methods: Ala57Thr and Ile50Val were genotyped in 651 Inuit living in Denmark, 1295 Inuit living in Greenland, and 1329 individuals from 7 populations from widely differing global locations. In Inuit the polymorphisms were evaluated for associations with atopy, rhinitis, asthma, and pulmonary function. Results: Thr57 was in linkage disequilibrium with Ile50 (D' = 1, r(2) = 0.13) and was common (33%) in the Inuit but rare (< 0.6%) in all other populations. In Inuit living in Denmark, the Thr57 allele (in a dose-dependent manner) and the Ile50/Thr57 haplotype were associated with lower risk of atopy (P-linear = .003 and P = .034, respectively), with similar trends observed for atopic rhinitis and atopic asthma. In Inuit living in Greenland, Thr57 was not associated with atopy or atopic diseases, but Ile50 was weakly associated with lower risk of atopy. Conclusion: The novel IL4RA Ala57Thr was common in and population specific to Greenlander Inuit, with Thr57 associated with a lower risk of atopy in those living in Denmark. Hence a full investigation of genotype-phenotype relationships in a given population can only be achieved if each gene is screened for novel polymorphisms in that population. Clinical implications: Clinical risk attributable to variations in a gene in an ethnic group requires that all variations of the gene are known for that group.	Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6001, Australia; Univ Copenhagen Hosp, Resp Unit, Dept Internal Med, DK-2100 Copenhagen, Denmark; Princess Margaret Hosp, Genet Serv Western Australia, Perth, WA, Australia; Bispebjerg Hosp, Perth, WA, Australia; Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; G Gaslini Inst Children, Pulm Dis Unit, Genoa, Italy; Cent Univ Venezuela, Inst Biomed, Caracas, Venezuela; Sir Charles Gairdner Hosp, Dept Med Res, Perth, WA, Australia; Univ Nottingham, Nottingham NG7 2RD, England	University of Western Australia; University of Copenhagen; Telethon Kids Institute; University of Western Australia; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Central Venezuela; University of Western Australia; University of Nottingham	Khoo, SK (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, GPO Box D184, Perth, WA 6001, Australia.	kim@ichr.uwa.edu.au	Khoo, Siew-Kim/B-6493-2012; Khoo, Siew-Kim/D-7655-2016; de Klerk, Nicholas H/D-8388-2016; Backer, Vibeke/AAQ-9379-2021; Backer, Vibeke/I-9573-2014; Zhang, Brad/AAF-8719-2021; Le Souef, Peter N/H-5256-2014	de Klerk, Nicholas H/0000-0001-9223-0767; Backer, Vibeke/0000-0002-7806-7219; Porsbjerg, Celeste/0000-0003-4825-9436; Le Souef, Peter/0000-0003-0930-1654; Hall, Ian/0000-0001-9933-3216; Hagel, Isabel/0000-0003-4464-1830; Zhang, Guicheng/0000-0001-9888-5385				APPLE RJ, 1994, NAT GENET, V6, P157, DOI 10.1038/ng0294-157; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Backer V, 2004, ANN ALLERG ASTHMA IM, V93, P76, DOI 10.1016/S1081-1206(10)61450-0; Backer V, 2002, ANN ALLERG ASTHMA IM, V89, P148, DOI 10.1016/S1081-1206(10)61930-8; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Betensky RA, 2001, GENET EPIDEMIOL, V20, P228; Bjerregaard P, 2002, J EPIDEMIOL COMMUN H, V56, P279, DOI 10.1136/jech.56.4.279; Bottini N, 2002, CLIN GENET, V61, P288, DOI 10.1034/j.1399-0004.2002.610408.x; Bremner PR, 1998, AM J RESP CRIT CARE, V158, P1724, DOI 10.1164/ajrccm.158.6.9702068; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; COOKSON WOCM, 1989, LANCET, V1, P1292; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Deichmann KA, 1998, CLIN EXP ALLERGY, V28, P151; DREBORG S, 1989, J AM ACAD DERMATOL, V21, P820, DOI 10.1016/S0190-9622(89)70256-5; Hagel I, 2004, CLIN REV ALLERG IMMU, V26, P75, DOI 10.1007/s12016-004-0002-4; Halushka MK, 1999, PHYSIOL GENOMICS, V1, P75, DOI 10.1152/physiolgenomics.1999.1.2.75; HARPER AB, 1980, ANN HUM BIOL, V7, P547, DOI 10.1080/03014468000004661; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Hytonen AM, 2004, CLIN EXP ALLERGY, V34, P1570, DOI 10.1111/j.1365-2222.2004.02069.x; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; Izuhara K, 2000, J ALLERGY CLIN IMMUN, V106, pS65, DOI 10.1067/mai.2000.106776; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kruse S, 1999, IMMUNOLOGY, V96, P365; Le Souef PN, 2000, LANCET, V356, P242; LEWONTIN RC, 1964, GENETICS, V50, P757; Lezcano-Meza D, 2003, ALLERGY, V58, P1011, DOI 10.1034/j.1398-9995.2003.00174.x; Lynch NR, 1998, J ALLERGY CLIN IMMUN, V101, P217, DOI 10.1016/S0091-6749(98)70386-0; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Migliaccio C, 2003, EUR J IMMUNOGENET, V30, P349, DOI 10.1046/j.1365-2370.2003.00415.x; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Morrison JA, 2004, METABOLISM, V53, P465, DOI 10.1016/j.metabol.2003.10.029; MORTON NE, 1992, CLIN EXP ALLERGY, V22, P1041, DOI 10.1111/j.1365-2222.1992.tb00126.x; Noguchi E, 1999, AM J RESP CRIT CARE, V160, P342, DOI 10.1164/ajrccm.160.1.9807130; O'Donnell AR, 2004, AM J RESP CRIT CARE, V169, P615, DOI 10.1164/rccm.200302-278OC; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Ober C, 1999, CLIN EXP ALLERGY, V29, P11; OEFNER P, 1998, CURRENT PROTOCOLS HU; Ortiz D, 2003, MEM I OSWALDO CRUZ, V98, P721, DOI 10.1590/S0074-02762003000600002; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Porsbjerg C, 2002, RESP MED, V96, P736, DOI 10.1053/rmed.2002.1341; Risma KA, 2002, J IMMUNOL, V169, P1604, DOI 10.4049/jimmunol.169.3.1604; Rothman KJ., 1986, MODERN EPIDEMIOLOGY; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Scrivener S, 2001, LANCET, V358, P1493, DOI 10.1016/S0140-6736(01)06579-5; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Takabayashi A, 2000, EXP CLIN IMMUNOGENET, V17, P63, DOI 10.1159/000019125; von Linstow ML, 2002, CLIN EXP ALLERGY, V32, P520, DOI 10.1046/j.0954-7894.2002.01326.x; YOUNG S, 1991, NEW ENGL J MED, V324, P1168, DOI 10.1056/NEJM199104253241704	50	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					627	634		10.1016/j.jaci.2006.05.009	http://dx.doi.org/10.1016/j.jaci.2006.05.009			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950281	Bronze			2022-12-18	WOS:000240649000015
J	Shapiro, GG				Shapiro, Gail G.			Among young children who wheeze, which children will have persistent asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						airway hyperresponsiveness; allergic rhinitis; atopy; childhood asthma; childhood eczema	PRESCHOOL-CHILDREN; RISK		Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shapiro, GG (corresponding author), 4540 Sand Point Way NE, Seattle, WA 98105 USA.	ggs@nwasthma.com						Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; *NAT ASTHM ED PREV, 2002, NIH PUBL; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC	9	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					562	564		10.1016/j.jaci.2006.07.011	http://dx.doi.org/10.1016/j.jaci.2006.07.011			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950270				2022-12-18	WOS:000240649000004
J	Bluth, MH; Smith-Norowitz, TA; Hagler, M; Beckford, R; Chice, S; Shah, V; Gross, R; Nowakowski, M; Schulze, R; Zenilman, M				Bluth, MH; Smith-Norowitz, TA; Hagler, M; Beckford, R; Chice, S; Shah, V; Gross, R; Nowakowski, M; Schulze, R; Zenilman, M			Sophorolipids decrease IgE production in U266 cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Ctr Allergy & Asthma Res, Brooklyn, NY 11203 USA; Polytech Univ, NSF, Ctr Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; National Science Foundation (NSF); New York University; Polytechnic University Puerto Rico									0	8	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		779	S202	S202		10.1016/j.jaci.2005.12.797	http://dx.doi.org/10.1016/j.jaci.2005.12.797			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR		Bronze			2022-12-18	WOS:000235865301276
J	Leath, TM; Grier, TJ; Jacobson, RS; Fontana-Penn, ME				Leath, TM; Grier, TJ; Jacobson, RS; Fontana-Penn, ME			Anaphylaxis to Pachycondyla Chinensis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Greer Labs Inc, Res & Dev Lab, Lenoir, NC USA	Wake Forest University									0	8	9	0	7	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		505	S129	S129		10.1016/j.jaci.2005.12.517	http://dx.doi.org/10.1016/j.jaci.2005.12.517			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR		Bronze			2022-12-18	WOS:000235865301002
J	Salo, PM; Arbes, SJ; Cohn, RD; Burge, HA; London, SJ; Zeldin, DC				Salo, PM; Arbes, SJ; Cohn, RD; Burge, HA; London, SJ; Zeldin, DC			Alternaria alternata antigens in US homes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									NIEHS, NIH, Res Triangle Pk, NC 27709 USA; Constella Grp Inc, Durham, NC USA; EMLab Inc, San Bruno, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Salo, PM (corresponding author), NIEHS, NIH, 111 Alexander Dr,Mail Drop D2-01, Res Triangle Pk, NC 27709 USA.		Zeldin, Darryl C/Y-7091-2018; London, Stephanie/C-3734-2019	Zeldin, Darryl C/0000-0002-2087-7307; London, Stephanie/0000-0003-4911-5290	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025041] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BOGDEN JD, 1981, J NATL CANCER I, V66, P27; Dreborg S, 2005, J ALLERGY CLIN IMMUN, V116, P620, DOI 10.1016/j.jaci.2005.06.027; Esch RE, 2004, J ALLERGY CLIN IMMUN, V113, P210, DOI 10.1016/j.jaci.2003.11.024; Salo PM, 2005, J ALLERGY CLIN IMMUN, V116, P623, DOI 10.1016/j.jaci.2005.05.030; SALO PM, 2004, AM J RESP CARE ME S7, V169, pA368; WELTY RE, 1968, APPL MICROBIOL, V16, P1309, DOI 10.1128/AEM.16.9.1309-1313.1968	6	8	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2					473	473		10.1016/j.jaci.2005.10.034	http://dx.doi.org/10.1016/j.jaci.2005.10.034			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IM	16461157				2022-12-18	WOS:000235687300038
J	Borish, L				Borish, L			Maybe rhinitis, maybe sinusitis, maybe rhinitis and sinusitis, but certainly not rhinosinusitis!	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						chronic sinusitis; perennial nonallergic rhinitis; headache; rhinosinusitis	ASTHMA; INFLAMMATION; HEADACHE; MIGRAINE		Univ Virginia, Asthma & Allerg Dis Ctr, Hlth Syst, Bernie Carter Ctr Immunol Res, Charlottesville, VA 22908 USA	University of Virginia	Borish, L (corresponding author), Univ Virginia, Asthma & Allerg Dis Ctr, Hlth Syst, Bernie Carter Ctr Immunol Res, Box 801355, Charlottesville, VA 22908 USA.	lb4m@virginia.edu						Bhattacharyya N, 2001, AM J RHINOL, V15, P169, DOI 10.2500/105065801779954184; Bresciani M, 2001, J ALLERGY CLIN IMMUN, V107, P73, DOI 10.1067/mai.2001.111593; Cady RK, 2002, NEUROLOGY, V58, pS10, DOI 10.1212/WNL.58.9_suppl_6.S10; COUCH JR, 1988, SEMIN NEUROL, V8, P298, DOI 10.1055/s-2008-1041393; DEMOLY P, 1994, J ALLERGY CLIN IMMUN, V94, P95, DOI 10.1016/0091-6749(94)90076-0; HARLIN SL, 1988, J ALLERGY CLIN IMMUN, V81, P867, DOI 10.1016/0091-6749(88)90944-X; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Nathan RA, 2004, ANN ALLERG ASTHMA IM, V92, P668, DOI 10.1016/S1081-1206(10)61435-4; NEWMAN LJ, 1994, JAMA-J AM MED ASSOC, V271, P363, DOI 10.1001/jama.271.5.363; Perry BF, 2004, OTOLARYNG HEAD NECK, V130, P449, DOI 10.1016/j.otohns.2004.01.005; Peters E, 1999, INT ARCH ALLERGY IMM, V118, P372, DOI 10.1159/000024140; Peters EJ, 2003, ANN ALLERG ASTHMA IM, V90, P316, DOI 10.1016/S1081-1206(10)61800-5; PFISTER R, 1994, J ALLERGY CLIN IMMUN, V94, P804, DOI 10.1016/0091-6749(94)90146-5; Ponikau JU, 2003, J ALLERGY CLIN IMMUN, V112, P877, DOI 10.1016/j.jaci.2003.08.009; Schreiber CP, 2004, ARCH INTERN MED, V164, P1769, DOI 10.1001/archinte.164.16.1769; SHAPIRO GG, 1992, J ALLERGY CLIN IMMUN, V90, P417, DOI 10.1016/0091-6749(92)90160-4; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; ten Brinke A, 2002, J ALLERGY CLIN IMMUN, V109, P621, DOI 10.1067/mai.2002.122458	18	8	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2005	116	6					1269	1271		10.1016/j.jaci.2005.08.038	http://dx.doi.org/10.1016/j.jaci.2005.08.038			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IJ	16337457				2022-12-18	WOS:000235687000016
J	Ballow, M				Ballow, M			-ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							MONOCLONAL-ANTIBODY THERAPY; EOSINOPHILS; NATALIZUMAB; MOLECULES; PROTEINS; DISEASE; ASTHMA		SUNY Buffalo, Womens & Childrens Hosp Buffalo, Div Clin Immunol & Allergy, Dept Pediat,Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo	Ballow, M (corresponding author), Childrens Hosp Buffalo, 219 Bryant St, Buffalo, NY 14222 USA.	ballow@acsu.buffalo.edu						BALLOW M, 2003, PEDIAT ALLERGY PRINC, P183; Bochner BS, 2004, IMMUNOL ALLERGY CLIN, V24, P615, DOI 10.1016/j.iac.2004.06.003; Bochner BS, 2004, J ALLERGY CLIN IMMUN, V113, P868, DOI 10.1016/j.jaci.2004.02.016; BOGUNIEWICZ M, 2001, CLIN IMMUNOLOGY; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Boushey HA, 2001, J ALLERGY CLIN IMMUN, V108, pS77, DOI 10.1067/mai.2001.116434; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Etzioni A, 2004, PEDIATR RES, V56, P519, DOI 10.1203/01.PDR.0000139318.65842.4A; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Garrett JK, 2004, J ALLERGY CLIN IMMUN, V113, P115, DOI 10.1016/j.jaci.2003.10.049; Geha RS, 2005, J ALLERGY CLIN IMMUN, V116, P937, DOI 10.1016/j.jaci.2005.07.025; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Kon OM, 1998, LANCET, V352, P1109, DOI 10.1016/S0140-6736(97)12261-9; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kroczek R, 2005, J ALLERGY CLIN IMMUN, V116, P906, DOI 10.1016/j.jaci.2005.07.005; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee SJ, 2005, J ALLERGY CLIN IMMUN, V116, P900, DOI 10.1016/j.jaci.2005.03.028; Liossis SNC, 2005, J ALLERGY CLIN IMMUN, V116, P721, DOI 10.1016/j.jaci.2005.06.035; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mazer BD, 2005, J ALLERGY CLIN IMMUN, V116, P941, DOI 10.1016/j.jaci.2005.07.021; McCune SL, 2001, JAMA-J AM MED ASSOC, V286, P1149, DOI 10.1001/jama.286.10.1149; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Miller AL, 2004, IMMUNOL ALLERGY CLIN, V24, P667, DOI 10.1016/j.iac.2004.06.004; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Nelson HS, 2005, J ALLERGY CLIN IMM S, V115, pS134; Presta LG, 2005, J ALLERGY CLIN IMMUN, V116, P731, DOI 10.1016/j.jaci.2005.08.003; Schulman ES, 2001, AM J RESP CRIT CARE, V164, pS6, DOI 10.1164/ajrccm.164.supplement_1.2103025; Sornasse TR, 2005, J ALLERGY CLIN IMMUN, V115, pS73; Springer TA, 2002, NAT IMMUNOL, V3, P501, DOI 10.1038/ni0602-501; Stocker M, 2005, J ALLERGY CLIN IMMUN, V116, P910, DOI 10.1016/j.jaci.2005.07.022; VANLAAN S, MONOCLONAL ANTIBODIE; Weaver AL, 2004, RHEUMATOLOGY, V43, P17, DOI 10.1093/rheumatology/keh203	33	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2005	116	4					738	743		10.1016/j.jaci.2005.07.020	http://dx.doi.org/10.1016/j.jaci.2005.07.020			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IF	16210044	Bronze			2022-12-18	WOS:000235686600003
J	Asero, R; Mistrello, G; Roncarolo, D; Amato, S; di Allergologia, A				Asero, R; Mistrello, G; Roncarolo, D; Amato, S; di Allergologia, A			Detection of novel latex allergens associated with clinically relevant allergy to plant-derived foods	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Clin San Carlo, Ambulatorio Allergol, I-20037 Paderno Dugnano, MI, Italy; Lofarma SpA, Milan, Italy		Asero, R (corresponding author), Clin San Carlo, Ambulatorio Allergol, Via Osped 21, I-20037 Paderno Dugnano, MI, Italy.	r.asero@libero.it	Amato, Sandra/AAH-4430-2021	Amato, Sandra/0000-0002-3277-0662				Asero R, 2000, INT ARCH ALLERGY IMM, V122, P20, DOI 10.1159/000024355; Blanco C, 2003, CURR ALLERGY ASTHM R, V3, P47, DOI 10.1007/s11882-003-0012-y; BLANCO C, 1994, ANN ALLERGY, V73, P309; Brehler R, 1997, ALLERGY, V52, P404, DOI 10.1111/j.1398-9995.1997.tb01019.x; BRERTENEDER H, 2000, J ALLERGY CLIN IMMUN, V106, P27; Moller M, 1998, ALLERGY, V53, P289, DOI 10.1111/j.1398-9995.1998.tb03889.x; Salcedo G, 2001, CURR OPIN ALLERGY CL, V1, P177, DOI 10.1097/00130832-200104000-00010; Schmidt MHH, 2002, ANN ALLERG ASTHMA IM, V89, P613, DOI 10.1016/S1081-1206(10)62110-2; Yeang HY, 2002, METHODS, V27, P32, DOI 10.1016/S1046-2023(02)00049-X	9	8	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2005	115	6					1312	1314		10.1016/j.jaci.2005.02.018	http://dx.doi.org/10.1016/j.jaci.2005.02.018			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	935WZ	15940153				2022-12-18	WOS:000229815400033
J	Holloway, JW; Yang, IA				Holloway, JW; Yang, IA			beta(2)-adrenergic receptor polymorphism and asthma: True or false?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							AIRWAY SMOOTH-MUSCLE; GENETIC-ASSOCIATION; BETA-2-ADRENERGIC RECEPTOR; BETA(2) ADRENOCEPTOR; NOCTURNAL ASTHMA; COMPLEX DISEASES; METAANALYSIS; SUSCEPTIBILITY; POPULATION; ALBUTEROL		Univ Southampton, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England; Univ Southampton, Sch Med, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; Univ Queensland, Dept Thorac Med, Prince Charles Hosp, Brisbane, Qld, Australia; Univ Queensland, Sch Med, Brisbane, Qld, Australia	University of Southampton; University of Southampton; Prince Charles Hospital; University of Queensland; University of Queensland	Holloway, JW (corresponding author), Univ Southampton, Sch Med, Div Human Genet, Duthie Bldg, Southampton SO16 6YD, Hants, England.	J.W.Holloway@soton.ac.uk	Holloway, John W/B-5424-2009; Yang, Ian A/B-9609-2008	Holloway, John W/0000-0001-9998-0464; Yang, Ian A/0000-0001-8338-1993				Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; BLAKEY J, 2005, IN PRESS THORAX; Calhoun WJ, 2003, CHEST, V123, p399S, DOI 10.1378/chest.123.3_suppl.399S; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; Dewar JC, 1997, J ALLERGY CLIN IMMUN, V100, P261, DOI 10.1016/S0091-6749(97)70234-3; Egger M, 2002, INT J EPIDEMIOL, V31, P1, DOI 10.1093/ije/31.1.1; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Green SA, 2001, EUR J PHARMACOL, V421, P141, DOI 10.1016/S0014-2999(01)01049-4; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; HALL IP, 1995, LANCET, V345, P1213, DOI 10.1016/S0140-6736(95)91994-5; Hancox RJ, 1998, EUR RESPIR J, V11, P589; Holgate ST, 2004, CURR OPIN ALLERGY CL, V4, P37, DOI 10.1097/01.all.0000113676.18759.95; Holloway JW, 2000, CLIN EXP ALLERGY, V30, P1097; Hopes E, 1998, BRIT MED J, V316, P664, DOI 10.1136/bmj.316.7132.664; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Kedda MA, 2004, J ALLERGY CLIN IMMUN, V113, P889, DOI 10.1016/j.jaci.2004.02.008; Kelly EAB, 2004, CLIN EXP ALLERGY, V34, P227, DOI 10.1111/j.1365-2222.2004.01866.x; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Leineweber K, 2004, LIFE SCI, V74, P2803, DOI 10.1016/j.lfs.2003.10.025; Lipworth B, 2002, THORAX, V57, P61, DOI 10.1136/thorax.57.1.61; Lipworth BJ, 1999, CHEST, V115, P324, DOI 10.1378/chest.115.2.324; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Migita O, 2004, INT ARCH ALLERGY IMM, V134, P150, DOI 10.1159/000078648; Moore PE, 2000, AM J RESP CRIT CARE, V162, P2117, DOI 10.1164/ajrccm.162.6.9909046; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Sutherland ER, 2003, J ALLERGY CLIN IMMUN, V112, P52, DOI 10.1067/mai.2003.1608; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Wills-Karp M, 2004, NAT REV GENET, V5, P376, DOI 10.1038/nrg1326; Wjst M, 1998, BIOINFORMATICS, V14, P827, DOI 10.1093/bioinformatics/14.9.827; Yang IA, 2004, CLIN EXP ALLERGY, V34, P163, DOI 10.1111/j.1365-2222.2004.01893.x; 1999, NAT GENET, V22, P1	40	8	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2005	115	5					960	962		10.1016/j.jaci.2005.02.005	http://dx.doi.org/10.1016/j.jaci.2005.02.005			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	925LR	15867852				2022-12-18	WOS:000229055100010
J	Bodtger, U; Malling, HJ; Poulsen, LK				Bodtger, U; Malling, HJ; Poulsen, LK			Out-of-season recollection of drug use for seasonal IgE-mediated rhinitis: Useful but an overestimation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IgE; rhinitis; allergy; retrospective; recollection; immunotherapy; medication; birch	SELF-REPORT; MEDICATION ADHERENCE; ALLERGIC RHINITIS; IMMUNOTHERAPY; SYMPTOMS; EFFICACY; BIRCH; PAIN	Background: The history of seasonal, IgE-mediated (allergic) rhinitis is often obtained postseasonally as a retrospective assessment. It is not known whether recollected drug use is representative for the in-seasonal medication history. Objectives: To investigate the agreement between in-seasonal and out-seasonal reports on drugs and drug doses, and to investigate whether retrospective assessment was sufficiently sensitive to detect the effect of intervention. Material and methods: Thirty-five patients allergic to birch pollen were allocated to allergen-specific immunotherapy (SIT) or placebo in a double-blind study. Drug use was recorded daily during the season 2000 and out-seasonally 6 months after the seasons 1999 and 2000. The mean daily drug use was transformed into a 4-point categorical scale for simplicity and was calculated for the out-seasonal rating and for 6 in-seasonal periods of different durations. In-seasonal and postseasonal ratings were compared with the Cohen weighted kappa (kappa(w)). Results: We observed a high level of agreement between in-seasonal and retrospective reports of drugs used (kappa(w) > 0.60) and drug doses (kappa(w) > 0.50). The highest agreement was observed for the in-seasonal day, week, or 2 weeks with the highest drug intake. Out-seasonal ratings significantly overestimated the daily oral and nasal antihistamine use compared with in-seasonal periods > 2 weeks. Despite being comparable pretreatment, only the SIT group had a significant decrease in recollected total drug use during SIT. Conclusion: Out-seasonal recollection of hay fever drugs represented a period of a maximum 14 days. It appeared sufficiently sensitive to detect the effect of intervention.	Natl Univ Hosp, Allergy Clin, DK-2100 Copenhagen, Denmark		Bodtger, U (corresponding author), Natl Univ Hosp, Allergy Clin, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	ub@dadlnet.dk	Poulsen, Lars K/J-3065-2019	Poulsen, Lars K/0000-0002-1730-847X; Bodtger, Uffe/0000-0002-1231-9209				Bender B, 2000, ANN ALLERG ASTHMA IM, V85, P416, DOI 10.1016/S1081-1206(10)62557-4; Bodtger U, 2003, CLIN EXP ALLERGY, V33, P496, DOI 10.1046/j.1365-2222.2003.01611.x; Bodtger U, 2002, ALLERGY, V57, P297, DOI 10.1034/j.1398-9995.2002.1o3532.x; Bousquet J, 1998, ALLERGY, V53, P4; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Druce HM, 1998, ALLERGY PRINCIPLES P, P1005; Feine JS, 1998, PAIN, V77, P137, DOI 10.1016/S0304-3959(98)00089-X; Gao X, 2000, ANN PHARMACOTHER, V34, P1117; HODAL L, 2000, 0012 AAF; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Linneberg A, 1999, ALLERGY, V54, P1194, DOI 10.1034/j.1398-9995.1999.00180.x; PEDERSEN C, 2004, DANISH INDEX PHARM D; PORZELIUS J, 1995, CLIN J PAIN, V11, P112, DOI 10.1097/00002508-199506000-00005; Sawyer SM, 2003, J PAEDIATR CHILD H, V39, P2, DOI 10.1046/j.1440-1754.2003.00081.x; Svensson E, 2000, STAT MED, V19, P3483, DOI 10.1002/1097-0258(20001230)19:24<3483::AID-SIM786>3.0.CO;2-A; VARNEY VA, 1991, BRIT MED J, V302, P265, DOI 10.1136/bmj.302.6771.265; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Winther L, 2000, ALLERGY, V55, P818, DOI 10.1034/j.1398-9995.2000.00367.x	20	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					786	790		10.1016/j.jaci.2005.01.032	http://dx.doi.org/10.1016/j.jaci.2005.01.032			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15805999				2022-12-18	WOS:000228373400018
J	Burns, R; Luzina, I; Nasir, A; Haidaris, CG; Barth, RK; Gaspari, AA				Burns, R; Luzina, I; Nasir, A; Haidaris, CG; Barth, RK; Gaspari, AA			Keratinocyte-derived, CD80-mediated costimulation is associated with hapten-specific IgE production during contact hypersensitivity to T(H)1 haptens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						contact dermatitis; keratinocytes; costimulation; IgE; transgenic mice	TRANSGENIC MICE; ATOPIC-DERMATITIS; IMMUNE-RESPONSE; TH2 RESPONSES; IN-VITRO; EXPRESSION; ANTIGEN; B7-1; CELLS; CD28	Background: B7-1 transgenic mice exhibit exaggerated and persistent contact hypersensitivity responses compared with normal mice. Objective: Because B7-1 and B7-2 deliver different costimulatory signals to T cells during antigen presentation, the purpose of this study was to compare B7-1 and B7-2 on keratinocytes and to compare their effects on contact hypersensitivity. Methods: Contact hypersensitivity was studied in transgenic mice whose keratinocytes constitutively expressed B7-1, B7-2, or no costimulatory molecules (nontransgenic mice). Results: B7-1 transgenic mice, and to a lesser extent B7-2 transgenic mice, developed exaggerated ear swelling responses after sensitization and challenge with haptens such as trinitrochlorobenzene or dinitrofluorobenzene. Ear swelling responses in B7-1 transgenic mice were characterized by the presence of markedly elevated inflammatory cytokine transcripts (IL-6, TNF-alpha, and lymphotoxin beta) as well as IL-10 compared with either B7-2 or nontransgenic mice. Hapten-specific IgE was detected by ELISA in B7-1 transgenic mice but not B7-2 transgenic or nontransgenic mice. Only B7-1 transgenic mice exhibited significant immediate type ear swelling responses to the hapten trinitrochlorobenzene. In addition, their sera can passively transfer cutaneous anaphylaxis to naive C57BL/6 mice, indicating that the hapten-specific IgE was relevant to the immediate ear swelling responses. Conclusion: These data suggest that keratinocyte-derived costimulation mediated by B7-1 but not B7-2 results in the emergence of T(H)2-lymphocyte immune responses to Till haptens. Because human keratinocytes have been noted to express B7-1-like molecules in certain inflammatory skin diseases, this model may be important in understanding the pathophysiology of T,12-lymphocyte-mediated skin diseases such as atopic dermatitis.	Univ Rochester, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21201 USA; Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27514 USA; Univ Rochester, Sch Med, Dept Microbiol Immunol, Rochester, NY 14627 USA; Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA	University of Rochester; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of Rochester; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gaspari, AA (corresponding author), Univ Rochester, Sch Med, Dept Dermatol, 405 W Redwood St,6th Floor, Baltimore, MD 21201 USA.	agasp001@umaryland.edu			BHP HRSA HHS [1R01AH/OH4108-01] Funding Source: Medline	BHP HRSA HHS		BAL V, 1990, EUR J IMMUNOL, V20, P1893, DOI 10.1002/eji.1830200904; Bellinghausen I, 1999, J ALLERGY CLIN IMMUN, V103, P298, DOI 10.1016/S0091-6749(99)70505-1; Boguniewicz M, 1998, ARCH DERMATOL, V134, P870, DOI 10.1001/archderm.134.7.870; Boguniewicz M, 2001, SEMIN CUTAN MED SURG, V20, P217, DOI 10.1053/sder.2001.29379; Burns RP, 1999, CELL IMMUNOL, V194, P162, DOI 10.1006/cimm.1999.1510; CAUGHMAN SW, 1992, J INVEST DERMATOL, V98, pS61, DOI 10.1111/1523-1747.ep12462226; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dearman RJ, 1995, IMMUNOLOGY, V86, P545; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; FLEMING TE, 1993, J INVEST DERMATOL, V101, P754, DOI 10.1111/1523-1747.ep12371688; Gaspari AA, 2002, CLIN IMMUNOL, V105, P9, DOI 10.1006/clim.2002.5262; GASPARI AA, 1993, CELL IMMUNOL, V149, P291, DOI 10.1006/cimm.1993.1156; GASPARI AA, 1988, J IMMUNOL, V141, P2216; GASPARI AA, 1988, J IMMUNOL, V140, P2956; Gaspari AA, 1998, INFECT IMMUN, V66, P4440; Gaspari AA, 1998, CLIN IMMUNOL IMMUNOP, V86, P259, DOI 10.1006/clin.1997.4491; Gaspari AA, 1997, IMMUNOL ALLERGY CLIN, V17, P377, DOI 10.1016/S0889-8561(05)70316-7; GASPARI AA, 1990, CONTACT HYPERSENSITI, P1; Jirapongsananuruk O, 1998, J IMMUNOL, V160, P4622; KITAGAKI H, 1995, J INVEST DERMATOL, V105, P749, DOI 10.1111/1523-1747.ep12325538; Kitagaki H, 1997, J IMMUNOL, V159, P2484; Kitagaki H, 1999, J IMMUNOL, V163, P1265; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LEASK A, 1990, GENE DEV, V4, P1985, DOI 10.1101/gad.4.11.1985; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NASIR A, 1995, J INVEST DERMATOL, V104, P763, DOI 10.1111/1523-1747.ep12606982; NASIR A, 1994, J CLIN INVEST, V94, P892, DOI 10.1172/JCI117411; NAYLOR MS, 1995, CYTOKINES PRACTICAL, P35; NICKOLOFF BJ, 1993, AM J PATHOL, V142, P1029; Rauschmayr-Kopp T, 1998, EUR J IMMUNOL, V28, P4221, DOI 10.1002/(SICI)1521-4141(199812)28:12<4221::AID-IMMU4221>3.0.CO;2-M; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; Rulifson IC, 1997, J IMMUNOL, V158, P658; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; SAMBROOK J, 1996, J EXP MED, V183, P1339; SIMON JC, 1994, J INVEST DERMATOL, V103, P539, DOI 10.1111/1523-1747.ep12395743; Tang AM, 1996, J IMMUNOL, V157, P117; VANDENBERGHE P, 1993, INT IMMUNOL, V5, P317, DOI 10.1093/intimm/5.3.317; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wakem P, 2000, J INVEST DERMATOL, V114, P1085, DOI 10.1046/j.1523-1747.2000.00997.x; Wang LF, 1999, CLIN EXP ALLERGY, V29, P271; WILLIAMS IR, 1994, P NATL ACAD SCI USA, V91, P12780, DOI 10.1073/pnas.91.26.12780	44	8	11	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2005	115	2					383	390		10.1016/j.jaci.2004.11.019	http://dx.doi.org/10.1016/j.jaci.2004.11.019			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	897YU	15696100				2022-12-18	WOS:000227043600028
J	Hamid, Q; Cosio, M; Lim, S				Hamid, Q; Cosio, M; Lim, S			Images in allergy and immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ASTHMA		McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada	McGill University	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.							Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Sutherland ER, 2004, J ALLERGY CLIN IMMUN, V114, P715, DOI 10.1016/j.jaci.2004.07.044; van den Berge M, 2004, J ALLERGY CLIN IMMUN, V114, P737, DOI 10.1016/j.jaci.2004.05.071	4	8	10	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2004	114	6					1479	1481		10.1016/j.jaci.2004.10.016	http://dx.doi.org/10.1016/j.jaci.2004.10.016			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	877NN	15577859	Bronze			2022-12-18	WOS:000225577400038
J	Miyake, Y; Ohya, Y; Sasaki, S; Miyamoto, S; Matsunaga, I; Yoshida, T; Hirota, Y; Oda, H				Miyake, Y; Ohya, Y; Sasaki, S; Miyamoto, S; Matsunaga, I; Yoshida, T; Hirota, Y; Oda, H			Was the prevalence of Japanese childhood atopic eczema symptoms overestimated in the ISAAC study?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA		Fukuoka Univ, Sch Med, Dept Publ Hlth, Fukuoka 81401, Japan; Osaka Prefectural Inst Publ Hlth, Osaka 537, Japan; Osaka City Univ, Sch Med, Dept Publ Hlth, Osaka 545, Japan; Natl Inst Hlth & Nutr, Project Sci Evaluat & Dietary Reference Intakes, Tokyo 162, Japan; Natl Ctr Child Hlth & Dev, Dept Med Specialties, Div Allergy, Tokyo, Japan	Fukuoka University; Osaka Prefectural Institute of Public Health; Osaka Metropolitan University; National Institute of Health & Nutrition - Japan; National Center for Child Health & Development - Japan	Miyake, Y (corresponding author), Fukuoka Univ, Sch Med, Dept Publ Hlth, Fukuoka 81401, Japan.		Miyake, Yoshihiro/ABF-1774-2020; Anabwani, Gabriel/I-2371-2016	Miyake, Yoshihiro/0000-0003-1244-4488; Anabwani, Gabriel/0000-0002-8555-4373; williams, hywel/0000-0002-5646-3093				Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1	2	8	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2004	113	3					571	571		10.1016/j.jaci.2003.11.036	http://dx.doi.org/10.1016/j.jaci.2003.11.036			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	802DM	15007367	Bronze			2022-12-18	WOS:000220144200038
J	Blanca, M; Jaen, MJT; Mayorga, C; Padial, A				Blanca, M; Jaen, MJT; Mayorga, C; Padial, A			Penicillin allergy is a global problem: The European experience	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BETA-LACTAMS; AMOXICILLIN; CHALLENGE; DIAGNOSIS		Carlos Haya Hosp, Allergy Unit, Malaga, Spain; Hosp La Paz, Allergy Unit, Madrid, Spain	Hospital Carlos Haya; Hospital Universitario La Paz	Blanca, M (corresponding author), Carlos Haya Hosp, Allergy Unit, Malaga, Spain.		Mayorga, Cristobalina/D-7167-2018; Mayorga, Lina/FBO-7730-2022	Mayorga, Cristobalina/0000-0001-8852-8077; Macy, Eric/0000-0002-5857-9444				BLANCA M, 1994, CLIN EXP ALLERGY, V24, P407, DOI 10.1111/j.1365-2222.1994.tb00928.x; BLANCA M, 1990, CLIN EXP ALLERGY, V20, P475, DOI 10.1111/j.1365-2222.1990.tb03139.x; Blanca M, 2002, CLIN EXP ALLERGY, V32, P192, DOI 10.1046/j.1365-2222.2002.01299.x; Macy E, 1998, J ALLERGY CLIN IMMUN, V102, P281, DOI 10.1016/S0091-6749(98)70097-1; Macy E, 1997, J ALLERGY CLIN IMMUN, V100, P586, DOI 10.1016/S0091-6749(97)70159-3; Macy E, 2003, J ALLERGY CLIN IMMUN, V111, P1111, DOI 10.1067/mai.2003.1385; MINH HBC, 2003, ALLERGY S74, V58, P51; Pichichero ME, 1998, J PEDIATR-US, V132, P137, DOI 10.1016/S0022-3476(98)70499-8; Ponvert C, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e45; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x	10	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2003	112	5					1014	1015		10.1016/j.jaci.2003.08.040	http://dx.doi.org/10.1016/j.jaci.2003.08.040			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	743BV	14610500	Bronze			2022-12-18	WOS:000186553300032
J	Prussin, C; Metcalfe, DD				Prussin, C; Metcalfe, DD			IgE, mast cells, basophils, and eosinophils (vol 111, pg S487, 2003)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		PRUSSIN C, 2003, J ALLERGY CLIN IMMUN, V111, P487	1	8	8	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2003	112	2					267	267						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	709WY					2022-12-18	WOS:000184650600006
J	Van Durme, P; Ceuppens, JL; Cadot, P				Van Durme, P; Ceuppens, JL; Cadot, P			Allergy to ingested mycoprotein in a patient with mold spore inhalant allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Hosp Gasthuisberg, Div Clin Immunol & Allergy, B-3000 Louvain, Belgium; Gasthuisberg O&N, Expt Immunol Lab, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven	Van Durme, P (corresponding author), Univ Hosp Gasthuisberg, Div Clin Immunol & Allergy, B-3000 Louvain, Belgium.			Ceuppens, Jan/0000-0003-4502-2679				Dauby PAL, 2002, ANN ALLERG ASTHMA IM, V89, P319, DOI 10.1016/S1081-1206(10)61962-X; Kurup VP, 2002, INT ARCH ALLERGY IMM, V129, P181, DOI 10.1159/000066780; Rodger G, 2001, FOOD TECHNOL-CHICAGO, V55, P36; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; TEE RD, 1993, CLIN EXP ALLERGY, V23, P257, DOI 10.1111/j.1365-2222.1993.tb00319.x; VOORHORST R, 1980, ALLERGY, V35, P247, DOI 10.1111/j.1398-9995.1980.tb01762.x	6	8	8	1	6	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2003	112	2					452	454		10.1067/mai.2003.1613	http://dx.doi.org/10.1067/mai.2003.1613			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	709WY	12897757				2022-12-18	WOS:000184650600035
J	Ferguson, BVJ				Ferguson, BVJ			Antifungal nasal washes for chronic rhinosinusitis: What's therapeutic - the wash or the antifungal?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IRRIGATION		Univ Pittsburgh, Sch Med, Dept Otolaryngol, Div Sino Nasal Disorders & Allergy, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ferguson, BVJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Otolaryngol, Div Sino Nasal Disorders & Allergy, 200 Lothrop St Suite 500, Pittsburgh, PA 15213 USA.							Heatley DG, 2001, OTOLARYNG HEAD NECK, V125, P44, DOI 10.1067/mhn.2001.115909; Ponikau JU, 2002, J ALLERGY CLIN IMMUN, V110, P862, DOI 10.1067/mai.2002.130051; Tomooka LT, 2000, LARYNGOSCOPE, V110, P1189, DOI 10.1097/00005537-200007000-00023; 1925, VITAL HLTH STAT, V10	4	8	9	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2003	111	5					1137	1138		10.1067/mai.2003.1481	http://dx.doi.org/10.1067/mai.2003.1481			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	679DA	12743587				2022-12-18	WOS:000182904500037
J	Gelfand, EW; Winkelstein, J				Gelfand, EW; Winkelstein, J			Are all IGIVs the same?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Natl Jewish Med & Res Ctr, Denver, CO 80206 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA	National Jewish Health; Johns Hopkins University	Gelfand, EW (corresponding author), Natl Jewish Med & Res Ctr, Denver, CO 80206 USA.							Grillo JA, 2001, NEUROLOGY, V57, P1699, DOI 10.1212/WNL.57.9.1699; *REN INS FAIL ASS, 1999, MMWR-MORBID MORTAL W, V48, P518	2	8	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2002	110	6					938	938		10.1067/mai.2002.129359	http://dx.doi.org/10.1067/mai.2002.129359			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	624TL	12464965	Bronze			2022-12-18	WOS:000179777400021
J	Wong, J; Davies, T; O'Callaghan, C				Wong, J; Davies, T; O'Callaghan, C			Estimation of the dose of fluticasone propionate inhaled by infants after bronchiolitis: Effect on urinary cortisol excretion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						inhaled steroid; aerosol; Babyhaler; spacer device; aerosol drug delivery; urinary cortisol creatinine ratio; bronchiolitis; infant	YOUNG-CHILDREN; CONTROLLED-TRIAL; SPACER; CORTICOSTEROIDS; BUDESONIDE	Background: Information on the dose of steroid infants inhale from spacer devices and its potential effect on adrenal suppression is limited. Objective: We sought to determine the total dose of fluticasone propionate (FP) inhaled from a spacer device (Babyhaler) with face mask attachment by infants recovering from acute bronchiolitis and the effect of inhaled FP on the infants' overnight urinary cortisol/creatinine ratios (UCCRs). Methods: Infants studied were recovering from acute bronchiolitis. In study 1, 22 infants inhaled 150 mug of FP through the Babyhaler. The likely inhaled dose was estimated by trapping it on a filter held within the face mask. In study 2, 40 infants had UCCRs measured before and during 3 months of treatment with either FP (150 mug twice daily, n = 20) or placebo (n = 20). Results: In study 1 the mean +/- SD dose of captured FP was 12.8 +/- 6.9 mug (ie, 2.1 +/- 1.2 mug/kg). In study 2 the pretreatment UCCR medians (interquartile ranges) were as follows: FP, 22.8 (23.0) nmol/mmol; placebo, 24.0 (28.3) nmol/mmol. Within-group UCCR changes (median and interquartile range DeltaUCCR) were significantly different in the FP group (-8.9 and -20.6 nmol/mmol at 6 weeks and -12.6 and -25.9 nmol/mmol at 12 weeks, respectively; P = .0008) but not in the placebo group (-5.8 and -10.7 nmol/mmol at 6 weeks and +0.3 and -17.9 nmol/mmol at 12 weeks, respectively; P = .45). Intergroup changes were insignificant in the follow-up period (6 weeks, P = .52; 12 weeks, P = .19). Conclusion: After bronchiolitis, infants are likely to inhale approximately 8% of the nominal steroid dose from the Babyhaler. UCCRs can be used to monitor the bioavailability of inhaled steroids in young infants.	Univ Leicester, Leicester Royal Infirm, Dept Child Hlth, Leicester LE2 7LX, Leics, England; Univ Leicester, Leicester Royal Infirm, Inst Lung Hlth, Leicester LE2 7LX, Leics, England; Univ Leicester, Leicester Royal Infirm, Dept Chem Pathol, Leicester LE2 7LX, Leics, England	University of Leicester; University of Leicester; University of Leicester	O'Callaghan, C (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Child Hlth, Clin Sci Bldg,POB 65, Leicester LE2 7LX, Leics, England.							AGERTOFT L, 1994, ARCH DIS CHILD, V71, P217, DOI 10.1136/adc.71.3.217; BISGAARD H, 1995, EUR RESPIR J, V8, P856; BROIDE J, 1995, J CLIN ENDOCR METAB, V80, P1243, DOI 10.1210/jc.80.4.1243; Cade A, 2000, ARCH DIS CHILD, V82, P126, DOI 10.1136/adc.82.2.126; CARLSEN K, 1988, ARCH DIS CHILD, V63, P1428, DOI 10.1136/adc.63.12.1428; COURT SDM, 1973, POSTGRAD MED J, V49, P771, DOI 10.1136/pgmj.49.577.771; deBlic J, 1996, J ALLERGY CLIN IMMUN, V98, P14, DOI 10.1016/S0091-6749(96)70221-X; Fox GF, 1999, ARCH DIS CHILD, V80, P343, DOI 10.1136/adc.80.4.343; GOODWIN A, 1995, BR J CLIN RES, V6, P113; HANUKOGLU A, 1995, EUR J ENDOCRINOL, V133, P552, DOI 10.1530/eje.0.1330552; Lipworth BJ, 1997, THORAX, V52, P476, DOI 10.1136/thx.52.5.476; MCINTYRE DH, 1995, THORAX, V51, P281; PETERSEN SA, 1994, P PHYSL SOC P, V85, pP85; PRICE DA, 1983, ARCH DIS CHILD, V58, P454, DOI 10.1136/adc.58.6.454; Reijonen T, 1996, ARCH PEDIAT ADOL MED, V150, P512, DOI 10.1001/archpedi.1996.02170300066013; Scott MB, 1999, J ALLERGY CLIN IMMUN, V104, pS200, DOI 10.1016/S0091-6749(99)70062-X; SIPPELL WG, 1980, PEDIATR RES, V14, P39, DOI 10.1203/00006450-198014010-00010; SPRINGER C, 1990, PEDIATR PULM, V9, P181, DOI 10.1002/ppul.1950090311; Tal A, 1996, J PEDIATR-US, V128, P479, DOI 10.1016/S0022-3476(96)70357-8; UMEDA T, 1981, CLIN CHIM ACTA, V110, P245; Wong JYW, 2000, EUR RESPIR J, V15, P388, DOI 10.1034/j.1399-3003.2000.15b27.x	21	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2002	110	5					721	727		10.1067/mai.2002.128858	http://dx.doi.org/10.1067/mai.2002.128858			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	612NN	12417880				2022-12-18	WOS:000179082500006
J	Bolte, G; Krauss-Etschmann, S; Konstantopoulos, N; Bischof, W; Fahlbusch, B; Schendel, DJ; Wichmann, HE; Heinrich, J				Bolte, G; Krauss-Etschmann, S; Konstantopoulos, N; Bischof, W; Fahlbusch, B; Schendel, DJ; Wichmann, HE; Heinrich, J		LISA Study Grp	Different effects of endotoxin versus mite and cat allergen exposure on T-cell differentiation in infants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						endotoxin; mite allergen; cat allergen; CCR5; CCR3; allergy	CHEMOKINE RECEPTOR EXPRESSION; HOUSE-DUST ENDOTOXIN; LYMPHOCYTES; ATOPY; SENSITIZATION; ENVIRONMENT; CHILDREN; DISEASE; PROTECT; HYGIENE	Background: Early exposure to bacterial endotoxin has been proposed to protect against allergy development in children. Whether endotoxin is able to direct T-cell differentiation into a predominance of type I immunity is still unresolved. Objective: We sought to compare the effects of endotoxin and mite and cat allergens on T-cell differentiation in infants. Methods: In a random population sample of 135 2-year-old children of an ongoing birth-cohort study, peripheral blood CD4(+) and CD8(+) T-cell subsets were defined by the expression of the chemokine receptors CCR5 and CCR3 as surrogate markers for type I and type 2 T cells, respectively. Endotoxin and mite and cat allergens were measured in house dust collected from the mother's mattress at the child's age of 3 months to assess early exposure. Results: In the CD4(+) T-cell subset, endotoxin levels were positively associated with high proportions of type 1 CCR5(+) cells (odds ratio for fourth exposure quartile [ORQ4], 7.68; 95% CI, 1.35-43.75), whereas cat allergen levels were associated with increased proportions of type 2 CCR3(+) cells (ORQ4, 4.07; 95% CI, 1.05-15.85). In contrast to endotoxin, allergen levels were associated with CD8+ T cells, showing an inverse relationship between mite allergen concentrations and high proportions of CCR5(+) or CCR3(+) cells (CCR5(+) cells: ORQ4, 0.14; 95% CI, 0.03-0.74; CCR3(+) cells: ORQ4, 0.16; 95% CI, 0.03-0.89) and a positive association of cat allergen levels with increased proportions of CCR5(+) cells (ORQ4, 9.24, 95% CI, 1.61-53.10), as well as CCR3(+) cells (ORQ3, 6.64; 95% CI, 1.21-36.51). Conclusion: Our results indicate that endotoxin has the potential to promote the development of type 1 CD4(+) T cells, where-as mite and cat allergens primarily modify the proportion of CD8(+) cells of both types.	GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; GSF Munich, Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Munich, Germany; Univ Jena, Inst Occupat Social & Environm Med, Dept Indoor Climatol, Erfurt, Germany; Univ Jena, Inst Clin Immunol, D-6900 Jena, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Bolte, G (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.		Heinrich, Joachim/N-1720-2013; Wichmann, Heinz Erich/AAA-5695-2022; Krauss-Etschmann, Susanne/H-5198-2018	Heinrich, Joachim/0000-0002-9620-1629; Krauss-Etschmann, Susanne/0000-0001-5945-5702; Bolte, Gabriele/0000-0002-0269-5059				Agace WW, 2000, EUR J IMMUNOL, V30, P819, DOI 10.1002/1521-4141(200003)30:3<819::AID-IMMU819>3.0.CO;2-Y; Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; Annunziato F, 1999, J LEUKOCYTE BIOL, V65, P691, DOI 10.1002/jlb.65.5.691; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Erb KJ, 1999, IMMUNOL TODAY, V20, P317, DOI 10.1016/S0167-5699(99)01475-9; Gehring U, 2001, J ALLERGY CLIN IMMUN, V108, P847, DOI 10.1067/mai.2001.119026; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gereda JE, 2001, J ALLERGY CLIN IMMUN, V107, P790, DOI 10.1067/mai.2001.115245; Ghaemmaghami AM, 2001, EUR J IMMUNOL, V31, P1211, DOI 10.1002/1521-4141(200104)31:4&lt;1211::AID-IMMU1211&gt;3.0.CO;2-R; GRUBER R, 1993, J IMMUNOL METHODS, V163, P173, DOI 10.1016/0022-1759(93)90120-V; Hastie T.J., 1990, GEN ADDITIVE MODELS, V43; Heinrich J, 2001, CLIN EXP ALLERGY, V31, P1839, DOI 10.1046/j.1365-2222.2001.01220.x; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Juffermans NP, 2000, BLOOD, V96, P2649; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; Kilpelainen M, 2000, CLIN EXP ALLERGY, V30, P201, DOI 10.1046/j.1365-2222.2000.00800.x; Kitani A, 2000, J IMMUNOL, V165, P691, DOI 10.4049/jimmunol.165.2.691; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 2000, CLIN EXP ALLERGY, V30, P1506, DOI 10.1046/j.1365-2222.2000.00994.x; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Misu T, 2001, J NEUROIMMUNOL, V114, P207, DOI 10.1016/S0165-5728(00)00456-2; Nafstad P, 2001, ALLERGY, V56, P307, DOI 10.1034/j.1398-9995.2001.00881.x; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; Park JH, 2000, ENVIRON HEALTH PERSP, V108, P1023, DOI 10.2307/3434953; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Prezzi C, 2001, EUR J IMMUNOL, V31, P894, DOI 10.1002/1521-4141(200103)31:3<894::AID-IMMU894>3.0.CO;2-I; Rizzo MC, 1997, PEDIAT ALLERG IMM-UK, V8, P121; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Suzuki N, 1999, INT IMMUNOL, V11, P553, DOI 10.1093/intimm/11.4.553; Svanes C, 1999, J ALLERGY CLIN IMMUN, V103, P415, DOI 10.1016/S0091-6749(99)70465-3; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230	37	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2002	110	4					634	640		10.1067/mai.2002.128652	http://dx.doi.org/10.1067/mai.2002.128652			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	602JJ	12373273	Bronze			2022-12-18	WOS:000178501900015
J	Tomazic-Jezic, VJ; Lucas, AD				Tomazic-Jezic, VJ; Lucas, AD			Protein and allergen assays for natural rubber latex products	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on Natural Rubber Latex Sensitivity	FEB 09-10, 2001	SAN FRANCISCO, CA	Malaysian Rubber Res Inst		natural rubber latex; protein measurement; glove powder; standard test; reference protein	HEV B 1; AMMONIATED LATEX; SPINA-BIFIDA; IGE; QUANTIFICATION; POWDER; GLOVES; IDENTIFICATION; SENSITIZATION; SENSITIVITY	The major issues in the efforts to alleviate allergy to natural rubber latex (NRL) proteins are prevention of allergic reactions and decreasing future sensitization. An accurate estimate of the potential allergenicity of NRL products is essential as guidance to manufacturers and users. Development of a reliable in vitro method for the quantitation of NRL allergens has been impeded by (1) limited knowledge of the individual allergens among NRL proteins, (2) variations in the protein profiles among NRL products, and (3) heterogeneity of responses to NRL allergens among sensitized individuals. The current methods include measurement of either the total or the antigenic NRL proteins. Although these methods provide valuable information, all except one have not been validated or standardized. The lack of sensitivity and specificity of this standardized method and poor correlation with the allergenic protein levels have mandated the need for a better assay. In the past year, an immunologic method for the quantitation of all antigenic proteins has been developed as a national standard. The method provides a significant improvement in sensitivity and specificity of NRL protein measurement, but the question of relevance to allergen content remains open. In the last several years, the intensive research aimed at purifying and characterizing individual allergens among NRL proteins resulted in the identification of more than 10 major allergens. On the basis of this knowledge, present efforts are focused on the development of a method for quantitation of relevant allergenic NRL proteins.	US FDA, Ctr Devices & Radiol Hlth, Off Sci & Technol, Div Life Sci, Rockville, MD 20852 USA	US Food & Drug Administration (FDA)	Tomazic-Jezic, VJ (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Off Sci & Technol, Div Life Sci, HFZ-112,12709 Twinbrook Pkwy, Rockville, MD 20852 USA.							ALENIUS H, 1993, INT ARCH ALLERGY IMM, V102, P61, DOI 10.1159/000236551; Allmers H, 1998, J ALLERGY CLIN IMMUN, V102, P841, DOI 10.1016/S0091-6749(98)70026-0; ASAKAVA A, 1995, J ALLERGY CLIN IMMUN, V95, P1196; *ASTM, 1995, D5712 ASTM; Beezhold D, 1996, J ALLERGY CLIN IMMUN, V98, P1097, DOI 10.1016/S0091-6749(96)80197-7; BEEZHOLD D, 1992, GUTHRIE J, V61, P77; BEEZHOLD DH, 1994, CLIN EXP IMMUNOL, V98, P408; Bernardini R, 1998, J ALLERGY CLIN IMMUN, V101, P621, DOI 10.1016/S0091-6749(98)70169-1; Breiteneder H, 1998, INT ARCH ALLERGY IMM, V116, P83, DOI 10.1159/000023930; de Silva HD, 2000, J ALLERGY CLIN IMMUN, V105, P1017, DOI 10.1067/mai.2000.105806; *FDA, 1996, FDA GUID PROT LEV LA, P6; Hamilton RG, 2000, J ALLERGY CLIN IMMUN, V105, pS82, DOI 10.1016/S0091-6749(00)90678-X; HAMILTON RG, 1994, J LAB CLIN MED, V123, P594; Hamilton RG, 1996, J ALLERGY CLIN IMMUN, V98, P872, DOI 10.1016/S0091-6749(96)80003-0; Hermesch C B, 1999, J Dent Educ, V63, P814; Kurup VP, 2001, ALLERGY, V56, P2, DOI 10.1034/j.1398-9995.2001.00130.x; Kurup VP, 2000, CLIN EXP ALLERGY, V30, P359; Levy DA, 1999, JAMA-J AM MED ASSOC, V281, P988, DOI 10.1001/jama.281.11.988; Palosuo T, 1998, ALLERGY, V53, P59, DOI 10.1111/j.1398-9995.1998.tb03774.x; Posch A, 1998, CLIN EXP ALLERGY, V28, P134; Posch A, 1997, J ALLERGY CLIN IMMUN, V99, P385, DOI 10.1016/S0091-6749(97)70057-5; Raulf-Heimsoth M, 2000, INT ARCH ALLERGY IMM, V123, P236, DOI 10.1159/000024449; Rihs HP, 2000, CLIN EXP ALLERGY, V30, P1285; Swanson M, 2000, J ALLERGY CLIN IMMUN, V105, pS55, DOI 10.1016/S0091-6749(00)90597-9; Tarlo SM, 1997, J ALLERGY CLIN IMMUN, V99, P396, DOI 10.1016/S0091-6749(97)70058-7; The American Society for Testing and Materials (ASTM) Standards, 2000, ANN BOOK ASTM STAND; TOMAZIC VJ, 1994, J ALLERGY CLIN IMMUN, V93, P751, DOI 10.1016/0091-6749(94)90255-0; TOMAZIC VJ, 1995, J ALLERGY CLIN IMMUN, V96, P635, DOI 10.1016/S0091-6749(95)70262-8; TOMAZIC VJ, 1996, J ALLERGY CLIN IMMUN, V98, pS113; Tomazic-Jezic VJ, 1999, J ALLERGY CLIN IMMUN, V103, pS162; Turjanmaa K, 1997, ALLERGY, V52, P41, DOI 10.1111/j.1398-9995.1997.tb02544.x; Wagner S, 2001, J ALLERGY CLIN IMMUN, V107, pS117; Yeang HY, 1996, J ALLERGY CLIN IMMUN, V98, P628, DOI 10.1016/S0091-6749(96)70097-0; Yeang HY, 2001, J ALLERGY CLIN IMMUN, V107, pS118; Yeang HY, 2000, J INVEST ALLERG CLIN, V10, P215; Yip L, 2000, INT ARCH ALLERGY IMM, V121, P292, DOI 10.1159/000024342	36	8	8	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2		S			S40	S46		10.1067/mai.2002.125335	http://dx.doi.org/10.1067/mai.2002.125335			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	586ET	12170242				2022-12-18	WOS:000177572200007
J	Park, HS; Frew, AJ				Park, HS; Frew, AJ			Genetic markers for occupational asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						occupational asthma; genetics; isocyanates; toluene diisocyanate; asthma	GLUTATHIONE-S-TRANSFERASE; TOLUENE-DIISOCYANATE; ALLERGEN CHALLENGE; BRONCHIAL-MUCOSA; IGE ANTIBODIES; HUMAN-LUNG; WORKERS; CONJUGATE; EXPOSURE; AIRWAYS		Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon 441749, South Korea; Univ Southampton, Sch Med, Infect Inflammat & Repair Res Div, Southampton, Hants, England	Ajou University; University of Southampton	Frew, AJ (corresponding author), Southampton Gen Hosp, Mailpoint 810, Southampton SO16 6YD, Hants, England.		Kelly, Frank J/C-6125-2009; Park, Hae-Sim/S-7974-2019	Kelly, Frank J/0000-0003-2558-8392; Park, Hae-Sim/0000-0003-2614-0303				BARNES PJ, 1990, FREE RADICAL BIO MED, V9, P235, DOI 10.1016/0891-5849(90)90034-G; BENTLEY AM, 1992, J ALLERGY CLIN IMMUN, V89, P821, DOI 10.1016/0091-6749(92)90437-7; Bodey KJ, 1999, ALLERGY, V54, P1083, DOI 10.1034/j.1398-9995.1999.00889.x; CHANYEUNG M, 1995, NEW ENGL J MED, V333, P107, DOI 10.1056/NEJM199507133330207; DANKS JM, 1981, CLIN ALLERGY, V11, P161, DOI 10.1111/j.1365-2222.1981.tb01580.x; Elms J, 2001, TOXICOL IN VITRO, V15, P631, DOI 10.1016/S0887-2333(01)00078-9; Frew AJ, 1996, J ALLERGY CLIN IMMUN, V98, P133, DOI 10.1016/S0091-6749(96)70235-X; Fryer AA, 2000, AM J RESP CRIT CARE, V161, P1437, DOI 10.1164/ajrccm.161.5.9903006; FRYER AA, 1986, BIOCHIM BIOPHYS ACTA, V883, P448, DOI 10.1016/0304-4165(86)90283-7; KAROL MH, 1978, AM IND HYG ASSOC J, V39, P454, DOI 10.1080/0002889778507789; Kelly FK, 1999, LANCET, V354, P482, DOI 10.1016/S0140-6736(99)01812-7; MAESTRELLI P, 1994, SCAND J WORK ENV HEA, V20, P376, DOI 10.5271/sjweh.1383; MAESTRELLI P, 1995, AM J RESP CRIT CARE, V151, P607; Mapp CE, 2002, J ALLERGY CLIN IMMUN, V109, P867, DOI 10.1067/mai.2002.123234; Park HS, 1999, J ALLERGY CLIN IMMUN, V104, P847, DOI 10.1016/S0091-6749(99)70297-6; Park HS, 1997, CLIN EXP ALLERGY, V27, P1145; Park HS, 1999, CLIN EXP ALLERGY, V29, P1395; PEZZINI A, 1984, CLIN ALLERGY, V14, P453, DOI 10.1111/j.1365-2222.1984.tb02229.x; Tee RD, 1998, J ALLERGY CLIN IMMUN, V101, P709, DOI 10.1016/S0091-6749(98)70181-2; Wisnewski AV, 1999, J ALLERGY CLIN IMMUN, V104, P341, DOI 10.1016/S0091-6749(99)70377-5	20	8	8	0	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2002	109	5					774	776		10.1067/mai.2002.124664	http://dx.doi.org/10.1067/mai.2002.124664			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	553QW	11994698	Green Published			2022-12-18	WOS:000175687800004
J	Bloomberg, GR; Chen, E; Strunk, RC; Fisher, EB				Bloomberg, GR; Chen, E; Strunk, RC; Fisher, EB			The impact of pyschosocial and socio-environmental factors on repeat asthma hospitalization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Washington Univ, Sch Med, St Louis Childrens Hosp, St Louis, MO 63130 USA	St. Louis Children's Hospital; Washington University (WUSTL)			Fisher, Edwin/M-5094-2019	Fisher, Edwin/0000-0003-0234-7465					0	8	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		794	S260	S260		10.1016/S0091-6749(02)81929-7	http://dx.doi.org/10.1016/S0091-6749(02)81929-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800791
J	Jerrim, KL; Whitmore, LF; Hughes, JF; McKechnie, MT				Jerrim, KL; Whitmore, LF; Hughes, JF; McKechnie, MT			Airborne dust and allergen generation during dusting with and without spray polish	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						dusting; airborne particles; dust; house dust mite; cat; allergen; polish	VACUUM CLEANERS; MITE ALLERGEN; CAT ALLERGEN; P-I; F-I; DERMATOPHAGOIDES; EXPOSURE	Background: Dusting is a commonly used method for dust removal from surfaces in the home. However, the process of dusting may contribute to airborne dust levels by disturbing dust particles from a surface and failing to remove it from the indoor environment. Objective: We sought to measure the quantity of allergen-laden dust disturbed into the air during dusting and discover whether applying spray polish to either the dusty surface or the cleaning cloth reduced this amount. Methods: A common furniture polish was tested for its ability to prevent dust particles and major house dust mite (Der p 1) or major cat (Fel d 1) allergen from becoming airborne during dusting. Tests were completed with a repeatable mechanized dusting procedure with polish sprayed onto either a cleaning cloth or directly onto a surface, and this was compared with a control procedure with a standard duster. Airborne dust was measured with an air-particle counter and by means of anti-Der p 1 or anti-Fel d I ELISA. Results: Considerable quantities of dust became airborne during dusting. When polish was sprayed onto the cleaning cloth, the concentration of airborne dust particles was reduced by a mean of 83.4%, house dust mite allergen by 50.3%, and cat allergen by 57.4% when compared with dry-cloth controls. Spraying polish directly onto the surface was even more effective at reducing the generation of airborne particles (92.9%) and allergens (Der p 1 by greater than or equal to95% to below the sensitivity of the ELISA and Fel d 1 by 95%). All reductions were significant when compared with dry-cloth controls (P <.01, Mann-Whitney U test). Conclusions: This study showed that application of a polish spray to either the surface or the cloth during dusting greatly reduced dust and allergen evolution into the air, which should reduce exposure to airborne allergens in the home.	Univ Southampton, Dept Elect & Comp Sci, Bioelectrostat Res Ctr, Southampton SO17 1BJ, Hants, England; Reckitt Benckiser Plc, Kingston Upon Hull, N Humberside, England	University of Southampton; Reckitt Benckiser	Jerrim, KL (corresponding author), Univ Southampton, Dept Elect & Comp Sci, Bioelectrostat Res Ctr, Univ Rd, Southampton SO17 1BJ, Hants, England.							BONER AL, 1985, ANN ALLERGY, V54, P42; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; CHAPMAN MD, 1987, J ALLERGY CLIN IMMUN, V80, P184, DOI 10.1016/0091-6749(87)90128-X; de Blay F, 1998, ALLERGY, V53, P411, DOI 10.1111/j.1398-9995.1998.tb03914.x; Gaynor PT, 1998, MED BIOL ENG COMPUT, V36, P615, DOI 10.1007/BF02524433; HEGARTY JM, 1995, RESP MED, V89, P279, DOI 10.1016/0954-6111(95)90088-8; KUEHR J, 1994, J ALLERGY CLIN IMMUN, V94, P44, DOI 10.1016/0091-6749(94)90070-1; Lewis RD, 1998, AM IND HYG ASSOC J, V59, P606, DOI 10.1080/15428119891010776; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; PLATTSMILLS TAE, 1986, J ALLERGY CLIN IMMUN, V77, P850, DOI 10.1016/0091-6749(86)90383-0; SWANSON MC, 1989, J ALLERGY CLIN IMMUN, V83, P776, DOI 10.1016/0091-6749(89)90014-6; Woodcock A, 1998, THORAX, V53, pS47, DOI 10.1136/thx.53.2008.S47; WOODFOLK JA, 1993, J ALLERGY CLIN IMMUN, V91, P829, DOI 10.1016/0091-6749(93)90339-H	13	8	10	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1					63	67		10.1067/mai.2002.120272	http://dx.doi.org/10.1067/mai.2002.120272			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519RM	11799367	Bronze			2022-12-18	WOS:000173739300010
J	Saadeh, CK; Brown, DM; Chumney-Malacara, JM; Crow, J				Saadeh, CK; Brown, DM; Chumney-Malacara, JM; Crow, J			Infliximab therapy for rheumatoid arthritis (RA) induced significant control of asthma in patients with both RA and asthma or athma/COPD in addition to improving RA status	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Allergy ARTS, Amarillo, TX USA; Centocor Inc, Malvern, PA 19355 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc									0	8	10	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		741	S243	S243		10.1016/S0091-6749(02)81876-0	http://dx.doi.org/10.1016/S0091-6749(02)81876-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX					2022-12-18	WOS:000173744800738
J	Meiser, JB; Nelson, HS				Meiser, JB; Nelson, HS			Comparing conventional and acetone-precipitated dog allergen extract skin testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	National Jewish Health	Meiser, JB (corresponding author), Natl Jewish Med & Res Ctr, 1440 Jackson St K735, Denver, CO 80206 USA.							Baldwin L, 1999, J ALLERGY CLIN IMMUN, V103, pS30; DREBORG S, 1987, THESIS LINKOPING U M; Nelson HS, 1998, J ALLERGY CLIN IMMUN, V101, P153, DOI 10.1016/S0091-6749(98)70409-9; Nelson HS, 2000, J ALLERGY CLIN IMMUN, V106, P41, DOI 10.1067/mai.2000.107197	4	8	8	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2001	107	4					744	745		10.1067/mai.2001.114340	http://dx.doi.org/10.1067/mai.2001.114340			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	423RG	11295672				2022-12-18	WOS:000168190100035
J	Higuero, NC; Zabala, BB; Villamuza, YG; Gomez, CM; de Gregorio, AM; Sanchez, CS				Higuero, NC; Zabala, BB; Villamuza, YG; Gomez, CM; de Gregorio, AM; Sanchez, CS			Occupational asthma caused by IgE-mediated reactivity to Antiaris wood dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Virgen Valle Hosp, Allergy Sect, Toledo, Spain; Bial Aristegui, Bilbao, Spain		Higuero, NC (corresponding author), Virgen Valle Hosp, Allergy Sect, Toledo, Spain.							COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Dreborg S, 1984, ALLERGY, V39, P596; HANSEN BM, 1981, WOODS INJURIOUS HUMA; HINOJOSA M, 1986, CLIN ALLERGY, V16, P145, DOI 10.1111/j.1365-2222.1986.tb00758.x; RIVAS MF, 1997, ALLERGY, V52, P196; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x	6	8	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2001	107	3					554	556		10.1067/mai.2001.112276	http://dx.doi.org/10.1067/mai.2001.112276			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	416RE	11240960				2022-12-18	WOS:000167793300022
J	Zimmerman, B; Urch, B				Zimmerman, B; Urch, B			Peanut allergy: Children who lose the positive skin test response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RESOLUTION; FOOD		St Michaels Hosp, Hlth Sci Res Ctr, Gage Occupat & Environm Hlth Unit, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Zimmerman, B (corresponding author), St Michaels Hosp, Hlth Sci Res Ctr, Gage Occupat & Environm Hlth Unit, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Urch, R. Bruce/C-9162-2014					David T, 1998, BRIT MED J, V317, P1317, DOI 10.1136/bmj.317.7168.1317; Hourihane JO, 1998, BRIT MED J, V316, P1271, DOI 10.1136/bmj.316.7140.1271; Kelso JM, 2000, J ALLERGY CLIN IMMUN, V106, P777, DOI 10.1067/mai.2000.107399; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; ZIMMERMAN B, 1988, J ALLERGY CLIN IMMUN, V81, P63, DOI 10.1016/0091-6749(88)90221-7; ZIMMERMAN B, 1989, J ALLERGY CLIN IMMUN, V83, P764, DOI 10.1016/0091-6749(89)90012-2	6	8	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2001	107	3					558	559		10.1067/mai.2001.113526	http://dx.doi.org/10.1067/mai.2001.113526			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	416RE	11240965				2022-12-18	WOS:000167793300026
J	Storms, WW; Bird, S; Firriolo, KM; Edelman, JM				Storms, WW; Bird, S; Firriolo, KM; Edelman, JM			The effect of rescue short-acting beta-agonist bronchodilation in patients on Montelukast or Salmeterol	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Asthma & Allergy Assoc, Colorado Springs, CO USA; Merck & Co Inc, W Point, PA USA	Merck & Company									0	8	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		1032	S316	S316						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172301028
J	Taylor, ML; Brummet, ME; Hudson, SA; Miura, K; Bochner, BS				Taylor, ML; Brummet, ME; Hudson, SA; Miura, K; Bochner, BS			Expression and function of P-selectin glycoprotein ligand 1 (CD162) on human basophils	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						basophils; eosinophils; neutrophils; KU812 cells; P-selectin glycoprotein ligand 1; P-selectin; endothelial cells; adhesion; histamine release	CELL ADHESION MOLECULES; LATE-PHASE RESPONSE; ENDOTHELIAL-CELLS; HUMAN NEUTROPHILS; MAST-CELLS; TYROSINE PHOSPHORYLATION; EOSINOPHILS; LEUKOCYTE; ANTIGEN; ADHERENCE	Background: The endothelial cell adhesion molecule P-selectin may contribute to selective leukocyte migration in allergic diseases by binding to its ligand, P-selectin glycoprotein ligand 1 (PSGL-1), on eosinophils and other leukocytes. Although expression of PSGL-1 on basophils has been detected in leukocyte typing workshops, its function on basophils has not been explored. Objective: We sought to characterize the expression and function of PSGL-1 on human basophils and a basophil-like cell line (KU812) and to compare these characteristics with those for PSGL-1 on eosinophils and neutrophils. Methods: Basophils, eosinophils, and neutrophils were enriched from peripheral blood by using density gradient centrifugation and immunomagnetic negative selection, KU812 cells were cultured by using standard techniques. Indirect immunofluorescence and flow cytometry were used to determine surface PSGL-1 expression under various conditions, and Western blotting was used to analyze the molecular forms of PSGL-1 on each cell type, Static adhesion assays were performed by using immobilized recombinant P-selectin and relevant blocking antibodies. Histamine release assays were done by using adherent and nonadherent basophils to determine whether adhesion by means of PSGL-1 altered basophil releasability. Results: The expression of PSGL-1 on basophils was similar to that on neutrophils but was approximately 30% less bright than levels on eosinophils. Levels on basophils were 10-fold higher than on KU812 cells. Basophil activation by means of IgE cross-linking resulted in reductions in surface expression of PSGL-1 and L-selectin, as well as increased CD11b expression. Western blot analysis of PSGL-1 revealed that the molecular weights of the bands for neutrophils and basophils were similar, whereas those for eosinophils were of greater molecular weights. Static adhesion assays demonstrated that basophils bound well to P-selectin, whereas KU812 cells bound poorly. Adhesion of basophils to P-selectin was completely blocked by antibodies to either P-selectin or PSGL-1, Finally, adhesion to P-selectin did not alter the magnitude or kinetics of anti-IgE-induced histamine release. Conclusion: Expression of PSGL-1 on basophils is more similar to that on neutrophils than that on eosinophils, KU812 cells express much lower levels of this molecule but, like basophils and other cells, bind to P-selectin by means of PSGL-1. P-selectin expression at sites of allergic inflammation is likely to play an important role in human basophil recruitment, but adhesion by means of PSGL-1 does not alter IgE-dependent basophil histamine release.	Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Dept Med,Div Clin Immunol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Bochner, BS (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Dept Med,Div Clin Immunol, 5501 Hopkins Bay View Circle, Baltimore, MD 21224 USA.							Abraham WM, 1999, AM J RESP CRIT CARE, V159, P1205, DOI 10.1164/ajrccm.159.4.9806002; BASCOM R, 1988, J ALLERGY CLIN IMMUN, V81, P570, DOI 10.1016/0091-6749(88)90198-4; BLOM T, 1992, EUR J IMMUNOL, V22, P2025, DOI 10.1002/eji.1830220811; Bochner B. S., 1997, ADHESION MOL ALLERGI; BOCHNER BS, 1989, J IMMUNOL METHODS, V125, P265, DOI 10.1016/0022-1759(89)90102-6; Bochner BS, 1996, J IMMUNOL, V157, P844; BOCHNER BS, 1994, J IMMUNOL, V152, P774; BOCHNER BS, 1990, J IMMUNOL, V145, P1832; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; BOCHNER BS, 1989, J IMMUNOL, V142, P3180; BOCHNER BS, 1988, J CLIN INVEST, V81, P1355, DOI 10.1172/JCI113463; BOCHNER BS, 1991, J IMMUNOL, V146, P2367; BOCHNER BS, 1994, J ALLERGY CLIN IMMUN, V94, P1157, DOI 10.1016/0091-6749(94)90326-3; BOCHNER BS, 1995, SAMTERS IMMUNOLOGICA, P259; BOCHNER BS, 1998, ALLERGY PRINCIPLES P, P94; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; Davenpeck KL, 1997, J IMMUNOL, V159, P1977; Davenpeck KL, 2000, J ALLERGY CLIN IMMUN, V105, P769, DOI 10.1067/mai.2000.105121; DAVENPECK KL, IN PRESS J IMMUNOL; DVORAK HF, 1972, J EXP MED, V135, P235, DOI 10.1084/jem.135.2.235; GILBERT HS, 1975, BLOOD, V46, P279; GUO CB, 1994, AM J RESP CELL MOL, V10, P384, DOI 10.1165/ajrcmb.10.4.7510984; HAMAWY MM, 1993, J BIOL CHEM, V268, P5227; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; HILDRETH JEK, 1985, J IMMUNOL, V134, P3272; Irani AMA, 1998, J ALLERGY CLIN IMMUN, V101, P354, DOI 10.1016/S0091-6749(98)70248-9; KIMURA I, 1975, Clinical Allergy, V5, P95, DOI 10.1111/j.1365-2222.1975.tb01840.x; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lavens SE, 1996, AM J RESP CELL MOL, V14, P95, DOI 10.1165/ajrcmb.14.1.8534491; LORANT DE, 1995, J CLIN INVEST, V96, P171, DOI 10.1172/JCI118018; Macfarlane AJ, 2000, J ALLERGY CLIN IMMUN, V105, P99, DOI 10.1016/S0091-6749(00)90184-2; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; MOORE KL, 1994, J BIOL CHEM, V269, P23318; Patel KD, 1998, BLOOD, V92, P3904, DOI 10.1182/blood.V92.10.3904.422k41_3904_3911; Patel KD, 1997, J IMMUNOL, V159, P4555; SIRAGANIAN RP, 1975, J IMMUNOL METHODS, V7, P283, DOI 10.1016/0022-1759(75)90025-3; SYMON FA, 1994, J EXP MED, V180, P371, DOI 10.1084/jem.180.1.371; Symon FA, 1996, J IMMUNOL, V157, P1711; VLIAGOFTIS H, 1997, ADHESION MOL ALLERGI, P151; WALSH GM, 1997, ADHESION MOL ALLERGI, P187; WARNER JA, 1987, J IMMUNOL METHODS, V105, P107, DOI 10.1016/0022-1759(87)90419-4; WEIN M, 1995, AM J RESP CELL MOL, V12, P315, DOI 10.1165/ajrcmb.12.3.7532979; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Wimazal F, 1999, TISSUE ANTIGENS, V54, P499, DOI 10.1034/j.1399-0039.1999.540507.x	45	8	9	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2000	106	5					918	924		10.1067/mai.2000.110230	http://dx.doi.org/10.1067/mai.2000.110230			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	417ZK	11080715				2022-12-18	WOS:000167865200017
J	Dolen, WK				Dolen, WK			It is not yet time to stop skin testing, but ...	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						radioallergosorbent test; immunoglobulin E; skin testing	IGE; DIAGNOSIS; INVITRO; ASSAYS		Med Coll Georgia, Dept Pediat, Sect Allergy Immunol, Augusta, GA 30912 USA; Med Coll Georgia, Dept Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Dolen, WK (corresponding author), Med Coll Georgia, Dept Pediat, Sect Allergy Immunol, Augusta, GA 30912 USA.							Crouch TE, 1999, J ALLERGY CLIN IMMUN, V103, pS89; Ford JL, 1997, J ALLERGY CLIN IMMUN, V100, P425, DOI 10.1016/S0091-6749(97)70259-8; ISHIZAKA K, 1967, J IMMUNOL, V99, P1187; Mari A, 1999, J ALLERGY CLIN IMMUN, V103, P1005, DOI 10.1016/S0091-6749(99)70171-5; NALEBUFF DJ, 1979, OTOLARYNG HEAD NECK, V87, P351, DOI 10.1177/019459987908700313; Selner JC, 1999, ANN ALLERG ASTHMA IM, V82, P407, DOI 10.1016/S1081-1206(10)62714-7; van Ree R, 1999, J ALLERGY CLIN IMMUN, V103, P1000, DOI 10.1016/S0091-6749(99)70169-7; VANDERZEE JS, 1988, J ALLERGY CLIN IMMUN, V82, P270, DOI 10.1016/0091-6749(88)91011-1; WIDE L, 1967, LANCET, V2, P1105; WILLIAMS PB, 1992, ANN ALLERGY, V68, P35; Witteman AM, 1996, J ALLERGY CLIN IMMUN, V97, P16, DOI 10.1016/S0091-6749(96)70278-6	11	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2000	105	6	1				1074	1076		10.1067/mai.2000.107151	http://dx.doi.org/10.1067/mai.2000.107151			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	327EX	10856138				2022-12-18	WOS:000087781800005
J	Busse, WW; Gern, JE				Busse, WW; Gern, JE			Do allergies protect against the effects of a rhinovirus cold?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						allergy; rhinovirus	RESPIRATORY SYNCYTIAL VIRUS; INDUCED AIRWAY HYPERRESPONSIVENESS; INTERFERON-GAMMA PRODUCTION; IN-VIVO; ASTHMA; INFECTION; INDUCTION; CELLS; INTERLEUKIN-6; INFLAMMATION		Univ Wisconsin Hosp, Allergy Sect, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Busse, WW (corresponding author), Univ Wisconsin Hosp, Allergy Sect, H6-387 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.							Adamko DJ, 1999, J EXP MED, V190, P1465, DOI 10.1084/jem.190.10.1465; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Corne JM, 1997, THORAX, V52, P380, DOI 10.1136/thx.52.4.380; DICOSMO BF, 1994, J CLIN INVEST, V94, P2028, DOI 10.1172/JCI117556; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; DUFF AL, 1993, PEDIATRICS, V92, P535; Einarsson O, 1996, J CLIN INVEST, V97, P915, DOI 10.1172/JCI118514; Folkerts G, 1998, AM J RESP CRIT CARE, V157, P1708, DOI 10.1164/ajrccm.157.6.9707163; Garofalo R, 1996, J IMMUNOL, V157, P2506; GAROFALO R, 1992, J PEDIATR-US, V120, P28, DOI 10.1016/S0022-3476(05)80592-X; GEM JE, 1995, AM J RESP CRIT CARE, V152, pS40; Grunberg K, 1997, CLIN EXP ALLERGY, V27, P36, DOI 10.1111/j.1365-2222.1997.tb00670.x; Handzel ZT, 1998, J IMMUNOL, V160, P1279; Johnston SL, 1998, ALLERGY, V53, P922, DOI 10.1111/j.1398-9995.1998.tb03792.x; Johnston SL, 1998, J IMMUNOL, V160, P6172; KIMPEN JLL, 1992, PEDIATR RES, V32, P160, DOI 10.1203/00006450-199208000-00007; LEMANSKE RF, 1989, J CLIN INVEST, V153, P743; MARTINEZ FD, 1995, J ALLERGY CLIN IMMUN, V96, P652, DOI 10.1016/S0091-6749(95)70264-4; PATTEMORE PK, 1992, CLIN EXP ALLERGY, V22, P325, DOI 10.1111/j.1365-2222.1992.tb03094.x; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Renzi PM, 1999, AM J RESP CRIT CARE, V159, P1417, DOI 10.1164/ajrccm.159.5.9805080; Sanders SP, 1999, P SOC EXP BIOL MED, V220, P123, DOI 10.1046/j.1525-1373.1999.d01-19.x; STERK PJ, 1993, EUR RESPIR J, V6, P894; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Terajima M, 1997, AM J PHYSIOL-LUNG C, V273, pL749, DOI 10.1152/ajplung.1997.273.4.L749; WINTHER B, 1984, ACTA OTO-LARYNGOL, P19; Zhu Z, 1996, J CLIN INVEST, V97, P421, DOI 10.1172/JCI118431	27	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2000	105	5					889	891		10.1067/mai.2000.106378	http://dx.doi.org/10.1067/mai.2000.106378			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	316TW	10808166				2022-12-18	WOS:000087185000004
J	Daley-Yates, PT; Kunka, RL; Shen, YY; Andrews, SM; Callejas, S; Ng, C				Daley-Yates, PT; Kunka, RL; Shen, YY; Andrews, SM; Callejas, S; Ng, C			The relative systemic exposure to fluticasone propionate (FP) and mometasone furoate (MF) administered as aqueous nasal sprays in healthy subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Glaxo Wellcome Res & Dev Ltd, Clin Pharmacol & Biomet, Greenford, Middx, England; Glaxo Wellcome Res & Dev Ltd, Clin Pharmacol & Biomet, Ware, Herts, England; Glaxo Wellcome Res & Dev Ltd, Clin Pharmacol & Biomet, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline									0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		603	S201	S201		10.1016/S0091-6749(00)91031-5	http://dx.doi.org/10.1016/S0091-6749(00)91031-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100599
J	Ferreira, F; Hebenstreit, D; Kramer, B; Himly, M; Breiteneder, H; Scheiner, O; Briza, P; Ebner, C; Breitenbach, M				Ferreira, F; Hebenstreit, D; Kramer, B; Himly, M; Breiteneder, H; Scheiner, O; Briza, P; Ebner, C; Breitenbach, M			Amino acid positions involved in the formation of IgE-binding epitopes of Api g 1 and Mal d 1 allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Salzburg Univ, Inst Genet & Allg Biol, A-5020 Salzburg, Austria; Univ Vienna, Inst Allg & Exp Pathol, Vienna, Austria	Salzburg University; University of Vienna			hebenstreit, daniel/GWZ-2082-2022; Briza, Peter/D-7309-2012; Ferreira, Fatima/E-4889-2011; Himly, Martin/D-1568-2015	hebenstreit, daniel/0000-0003-0144-6728; Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Himly, Martin/0000-0001-5416-085X					0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		413	S137	S137		10.1016/S0091-6749(00)90842-X	http://dx.doi.org/10.1016/S0091-6749(00)90842-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100410
J	Molet, S; Chakir, J; Hamid, QA; Hamilos, D				Molet, S; Chakir, J; Hamid, QA; Hamilos, D			Upper airways remodeling in patients with chronic sinusitits: Effect of topical steroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; Hop Laval, St Foy, PQ, Canada; Washington Univ, Sch Med, St Louis, MO USA	McGill University; Laval University; Washington University (WUSTL)									0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		634	S214	S214		10.1016/S0091-6749(00)91062-5	http://dx.doi.org/10.1016/S0091-6749(00)91062-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100630
J	Toogood, JH; Hodsman, AB; Fraher, LJ; Markov, AE; Baskerville, JC				Toogood, JH; Hodsman, AB; Fraher, LJ; Markov, AE; Baskerville, JC			Serum osteocalcin and procollagen as markers for the risk of osteoporotic fracture in corticosteroid-treated asthmatic adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; glucocorticoids; inhaled steroids; steroid complications; osteoporosis; fracture risk; bone densitometry; osteocalcin; type I procollagen	INHALED CORTICOSTEROIDS; MINERAL DENSITY; BONE LOSS; PREDNISOLONE; BUDESONIDE; THERAPY	Background: Dual energy x-ray absorptiometry provides the definitive measure of osteoporotic fracture risk. Objective: We sought to determine whether metabolic measures of bone formation and/or common features of clinical hypercortisonism provide a useful guide in selecting corticosteroid-treated asthmatic patients for referral for bone densitometry, Methods: We measured bone density and 8 AM serum osteocalcin, procollagen, and cortisol levels in 52 asthmatic adults aged 60.7 +/- 12.6 years (mean +/- SD), Years of steroid exposure for these patients was 11.8 +/- 10.7 (prednisone) and 11.78 +/- 4.98 (inhaled steroid). Using stepwise logistic regression, we assessed the capacity of the osteocalcin and procollagen levels, with or without the cortisol level, age, clinical features of hypercortisonism, and different lifetime exposures to inhaled and oral steroids for distinguishing between patients with greater or lesser risk of fracture. Results: Osteoporosis, defined as a bone density T score below -2.5, affected 26% of the group at the spine and 63% at the hip, At the spine, greater risk was associated only with lower cortisol levels (P = .003), Diagnostic accuracy was 71%, the false-positive rate was 26%, and the false-negative rate was 31%. At the hip, greater risk was associated with lower cortisol levels (P = .002), longer prednisone exposure, (P = .003), loser current doses of prednisone (P = .01) and inhaled steroid (P = .02), and older age (P = .01), Diagnostic accuracy was 83%, the false-positive rate was 13%, and the false-negative rate was 21%, Conclusions: Neither osteocalcin nor procollagen nor any of the clinical criteria analyzed proved sufficiently accurate to be reliable as indicators of the risk of fracture in these elderly, corticosteroid-treated asthmatic adults. They are therefore not useful for selecting such patients for diagnostic densitometry.	London Hlth Sci Ctr, Dept Med, London, ON N6A 4G5, Canada; Univ Western Ontario, Dept Med, London, ON N6A 3K7, Canada; Lawson Res Inst, London, ON, Canada; St Josephs Hlth Ctr, Dept Med, London, ON, Canada; Inst TB & Pulmonol, Dept Allergol, Kiev, Ukraine; Univ Western Ontario, Dept Stat & Actuarial Sci, London, ON N6A 3K7, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Toogood, JH (corresponding author), London Hlth Sci Ctr, Dept Med, Victoria Campus,800 Commissioners Rd E, London, ON N6A 4G5, Canada.		Hodsman, Anthony/G-3303-2011					ADINOFF AD, 1983, NEW ENGL J MED, V309, P265, DOI 10.1056/NEJM198308043090502; *AM COLL RHEUM TAS, 1996, ARTHRITIS RHEUM, V39, P791; ARMITAGE P, 1977, STAT METHODS MED RES; DELMAS PD, 1991, AM J MED, V91, pS59, DOI 10.1016/0002-9343(91)90250-2; GAMBERTOGLIO JG, 1980, J CLIN ENDOCR METAB, V51, P561, DOI 10.1210/jcem-51-3-561; HANANIA NA, 1995, J ALLERGY CLIN IMMUN, V96, P571, DOI 10.1016/S0091-6749(95)70254-7; HODSMAN AB, 1991, J CLIN ENDOCR METAB, V72, P530, DOI 10.1210/jcem-72-3-530; Hotta M, 1998, EUR J ENDOCRINOL, V139, P276, DOI 10.1530/eje.0.1390276; Josse R, 1996, CAN MED ASSOC J, V155, P1113; KOZOWER M, 1974, J CLIN ENDOCR METAB, V38, P407, DOI 10.1210/jcem-38-3-407; Lentle BC, 1998, CAN MED ASSOC J, V159, P1261; LIBANATI CR, 1992, CHEST, V102, P1426, DOI 10.1378/chest.102.5.1426; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; PANSINI K, 1992, GYNECOL OBSTET INVES, V232, P231; REID IR, 1990, ARCH INTERN MED, V150, P2545, DOI 10.1001/archinte.150.12.2545; ROSS PD, 1990, CALCIFIED TISSUE INT, V46, P149, DOI 10.1007/BF02555036; SAITO JK, 1995, CALCIFIED TISSUE INT, V57, P115, DOI 10.1007/BF00298431; SORVA R, 1992, J ALLERGY CLIN IMMUN, V90, P808, DOI 10.1016/0091-6749(92)90106-C; Toogood JH, 1998, J ALLERGY CLIN IMMUN, V102, P705, DOI 10.1016/S0091-6749(98)70007-7; TOOGOOD JH, 1995, J ALLERGY CLIN IMMUN, V96, P157, DOI 10.1016/S0091-6749(95)70003-X; *WHO STUD GROUP, 1994, WHO TECHN REP SER, V183	21	8	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1999	104	4	1				769	774		10.1016/S0091-6749(99)70286-1	http://dx.doi.org/10.1016/S0091-6749(99)70286-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	248NG	10518820				2022-12-18	WOS:000083281200007
J	Lin, FL; Kelso, JM				Lin, FL; Kelso, JM			Pulmonary function studies in healthy Filipino adults residing in the United States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						spirometry; pulmonary function; forced expiratory volume; forced viral capacity; racial differences; Filipino	NORMAL SPIROMETRIC VALUES	Background: Differences in lung volumes among various ethnic groups are known to occur; however, this has not been studied in Filipinos. Objective: We sought to assess pulmonary function in healthy, nonsmoking Filipinos residing in the United States compared with standards for white subjects. Methods: Healthy adult Filipinos, age 18 years or greater, were recruited. All subjects were screened with health questionnaires to exclude those with cardiopulmonary disease. Pulmonary function tests were performed by using forced expiratory maneuvers. Values for FEV1, forced vital capacity (FVC), FEV1/FVC, forced expiratory flow from 25% to 75% of FVC, and peak expiratory flow rate were compared with predicted values for white subjects (ie, without a racial adjustment). Results: Two hundred twenty-four healthy subjects (121 men and 103 women) completed the study. The group means (as a percentage of the predicted standard for white subjects) were as follows: FEV1, 86%; FVC, 84%; FEV1/FVC, 103%; forced expiratory flow from 25% to 75% of FVC, 96%; and peak expiratory flow rate, 107%, These findings are very similar to those for African Americans and other Asians. Conclusion: We conclude that it is appropriate to use an 85% racial adjustment for FEV1 and FVC when interpreting pulmonary function test results in Filipinos.	USN, Dept Internal Med, Div Allergy, Med Ctr, San Diego, CA 92152 USA	United States Department of Defense; United States Navy	Lin, FL (corresponding author), USN, Dept Clin Res, Med Ctr, San Diego, CA 92134 USA.							[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; BROWN P, 1978, AM J EPIDEMIOL, V108, P259, DOI 10.1093/oxfordjournals.aje.a112618; Chin N K, 1997, Respirology, V2, P143, DOI 10.1111/j.1440-1843.1997.tb00070.x; CHING B, 1977, THORAX, V32, P352, DOI 10.1136/thx.32.3.352; CRAPO RO, 1990, CHEST, V98, P1435, DOI 10.1378/chest.98.6.1435; CRAPO RO, 1988, J OCCUP ENVIRON MED, V30, P556; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; DACOSTA JL, 1971, AM REV RESPIR DIS, V104, P128; Enright PL, 1996, CHEST, V110, P1416, DOI 10.1378/chest.110.6.1416; GHIO AJ, 1990, CHEST, V97, P400, DOI 10.1378/chest.97.2.400; JACOBS DR, 1992, AM REV RESPIR DIS, V146, P644, DOI 10.1164/ajrccm/146.3.644; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; MARCUS EB, 1988, AM REV RESPIR DIS, V138, P1393, DOI 10.1164/ajrccm/138.6.1393; MASSEY DG, 1986, ENVIRON RES, V39, P418, DOI 10.1016/S0013-9351(86)80066-4; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; Singh Rabindarjeet, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P341	17	8	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1999	104	2	1				338	340		10.1016/S0091-6749(99)70376-3	http://dx.doi.org/10.1016/S0091-6749(99)70376-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	232HH	10452754				2022-12-18	WOS:000082364800025
J	Wood, RA				Wood, RA			Animal allergens: Looking beyond the tip of the iceberg	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							FEL-D-I; HOUSEHOLD-DUST SAMPLES; DER-P-I; CAN-F-I; DOG CAN-F-1; COCKROACH ALLERGENS; DOMESTIC ALLERGENS; PUBLIC PLACES; SCHOOL DUST; MITE		Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Div Allergy & Immunol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Wood, RA (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Div Allergy & Immunol, CMSC 1102, Baltimore, MD 21287 USA.							Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, P1012, DOI 10.1016/S0091-6749(99)70172-7; Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, pS22; Arshad SH, 1998, AM J RESP CRIT CARE, V157, P1900, DOI 10.1164/ajrccm.157.6.9603034; Berge M, 1998, PEDIATR ALLERGY IMMU, V9, P25, DOI 10.1111/j.1399-3038.1998.tb00296.x; Bollinger ME, 1998, J ALLERGY CLIN IMMUN, V101, P124, DOI 10.1016/S0091-6749(98)70203-9; Bollinger ME, 1996, J ALLERGY CLIN IMMUN, V97, P907, DOI 10.1016/S0091-6749(96)80064-9; Custovic A, 1998, CLIN EXP ALLERGY, V28, P53, DOI 10.1046/j.1365-2222.1998.00183.x; CUSTOVIC A, 1994, CLIN EXP ALLERGY, V24, P1164, DOI 10.1111/j.1365-2222.1994.tb03323.x; Custovic A, 1996, CLIN EXP ALLERGY, V26, P1246, DOI 10.1111/j.1365-2222.1996.tb00521.x; DAmato G, 1997, J ALLERGY CLIN IMMUN, V99, P577, DOI 10.1016/S0091-6749(97)70088-5; DEANDRADE AD, 1995, J ALLERGY CLIN IMMUN, V95, P1158, DOI 10.1016/S0091-6749(95)70071-4; Dotterud LK, 1997, CLIN EXP ALLERGY, V27, P252, DOI 10.1111/j.1365-2222.1997.tb00703.x; DYBENDAL T, 1992, CLIN EXP ALLERGY, V22, P1100, DOI 10.1111/j.1365-2222.1992.tb00136.x; ENBERG RN, 1993, ANN ALLERGY, V70, P471; IHRE E, 1993, CLIN EXP ALLERGY, V23, P298, DOI 10.1111/j.1365-2222.1993.tb00326.x; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; MUNIR AKM, 1993, J ALLERGY CLIN IMMUN, V91, P1067, DOI 10.1016/0091-6749(93)90221-Z; MUNIR AKM, 1995, CLIN EXP ALLERGY, V25, P119, DOI 10.1111/j.1365-2222.1995.tb01016.x; MUNIR AKM, 1993, ALLERGY, V48, P158, DOI 10.1111/j.1398-9995.1993.tb00706.x; Patchett K, 1997, J ALLERGY CLIN IMMUN, V100, P755, DOI 10.1016/S0091-6749(97)70269-0; Perzanowski MS, 1999, J ALLERGY CLIN IMMUN, V103, P1018, DOI 10.1016/S0091-6749(99)70173-9; SAKAGUCHI M, 1993, J ALLERGY CLIN IMMUN, V92, P797, DOI 10.1016/0091-6749(93)90056-L; VANDERBREMPT X, 1991, J ALLERGY CLIN IMMUN, V87, P595, DOI 10.1016/0091-6749(91)90020-O; WOOD RA, 1988, AM REV RESPIR DIS, V137, P358, DOI 10.1164/ajrccm/137.2.358; WOOD RA, 1989, J ALLERGY CLIN IMMUN, V83, P730, DOI 10.1016/0091-6749(89)90006-7; Wood RA, 1998, AM J RESP CRIT CARE, V158, P115, DOI 10.1164/ajrccm.158.1.9712110	26	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1999	103	6					1002	1004		10.1016/S0091-6749(99)70170-3	http://dx.doi.org/10.1016/S0091-6749(99)70170-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	207GT	10359877				2022-12-18	WOS:000080929500004
J	Moffitt, JE; deShazo, RD; Freeman, TM; Golden, DBK; Reisman, RE; Stafford, CT; Valentine, MD; Yunginger, JW				Moffitt, JE; deShazo, RD; Freeman, TM; Golden, DBK; Reisman, RE; Stafford, CT; Valentine, MD; Yunginger, JW			Stinging insect hypersensitivity: A practice parameter	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMPORTED FIRE ANT; HYMENOPTERA VENOM IMMUNOTHERAPY; WHOLE-BODY EXTRACTS; BETA-BLOCKER DRUGS; ALLERGY; SENSITIVITY; ANAPHYLAXIS; CHALLENGE; SAFETY; RISK		Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; Wilford Hall USAF Med Ctr, Med Wing 59, MMIA, Lackland AFB, TX 78236 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; SUNY Buffalo, Buffalo, NY 14260 USA; Med Coll Georgia, Allergy Immunol Sect, Augusta, GA 30912 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA	University of Mississippi; University of Mississippi Medical Center; United States Department of Defense; United States Air Force; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Georgia; Augusta University; University System of Maryland; University of Maryland Baltimore; Mayo Clinic								BERNSTEIN DI, 1989, J ALLERGY CLIN IMMUN, V84, P951, DOI 10.1016/0091-6749(89)90394-1; BIRNBAUM J, 1993, CLIN EXP ALLERGY, V23, P226, DOI 10.1111/j.1365-2222.1993.tb00886.x; BLAAUW P, 1984, J ALLERGY CLIN IMMUN, V75, P66; BOUSQUET J, 1989, J ALLERGY CLIN IMMUN, V84, P944, DOI 10.1016/0091-6749(89)90393-X; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P1096, DOI 10.1016/0091-6749(88)90875-5; CHAFEE FH, 1970, ACTA ALLERGOL, V25, P292, DOI 10.1111/j.1398-9995.1970.tb01265.x; DESHAZO R, 1990, NEW ENGL J MED, V323, P463; FREEMAN TM, 1992, J ALLERGY CLIN IMMUN, V90, P210, DOI 10.1016/0091-6749(92)90073-B; GEORGITIS JW, 1985, J ALLERGY CLIN IMMUN, V76, P803, DOI 10.1016/0091-6749(85)90752-3; GOLDEN DBK, 1980, ANN INTERN MED, V92, P620, DOI 10.7326/0003-4819-92-5-620; GOLDEN DBK, 1989, ALLERGY PROC, V10, P103, DOI 10.2500/108854189778960964; GOLDEN DBK, 1981, J ALLERGY CLIN IMMUN, V67, P482, DOI 10.1016/0091-6749(81)90102-0; Golden DBK, 1996, J ALLERGY CLIN IMMUN, V97, P579, DOI 10.1016/S0091-6749(96)70302-0; Golden DBK, 1998, J ALLERGY CLIN IMMUN, V101, P298, DOI 10.1016/S0091-6749(98)70239-8; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; GOLDEN DBK, 1981, J ALLERGY CLIN IMMUN, V67, P370, DOI 10.1016/0091-6749(81)90082-8; Graft DF, 1998, J ALLERGY CLIN IMMUN, V101, P573, DOI 10.1016/S0091-6749(98)70161-7; HALLGUARD L, 1991, J ALLERGY CLIN IMMUN, V87, P70; HANNAN CJ, 1986, J ALLERGY CLIN IMMUN, V78, P331, DOI 10.1016/S0091-6749(86)80085-9; HEPNER MJ, 1990, J ALLERGY CLIN IMMUN, V86, P407, DOI 10.1016/S0091-6749(05)80105-8; Hermann K, 1997, INT ARCH ALLERGY IMM, V112, P251, DOI 10.1159/000237462; HOFFMAN D, 1988, J ALLERGY CLIN IMMUN, V92, P828; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V92, P707, DOI 10.1016/0091-6749(93)90014-7; HOFFMAN DR, 1991, ANN ALLERGY, V66, P29; HUNT K, 1978, NEW ENGL J MED, V299, P156; HUNT KJ, 1976, ANN INTERN MED, V85, P56, DOI 10.7326/0003-4819-85-1-56; KEATING MU, 1991, J ALLERGY CLIN IMMUN, V88, P339, DOI 10.1016/0091-6749(91)90095-6; KING T, 1985, J ALLERGY CLIN IMMUN, V75, P651; LICHTENSTEIN LM, 1983, HOSP PRACT, V18, P36; LIGHT WC, 1977, J ALLERGY CLIN IMMUN, V59, P391, DOI 10.1016/0091-6749(77)90024-0; LOCKEY RF, 1990, J ALLERGY CLIN IMMUN, V86, P775, DOI 10.1016/S0091-6749(05)80182-4; MAURIELLO PM, 1984, J ALLERGY CLIN IMMUN, V74, P494, DOI 10.1016/0091-6749(84)90384-1; Moffitt JE, 1997, ANN ALLERG ASTHMA IM, V79, P125, DOI 10.1016/S1081-1206(10)63098-0; MOTTA P, 1990, Annals of Allergy, V64, P70; MULLER U, 1991, J ALLERGY CLIN IMMUN, V87, P702, DOI 10.1016/0091-6749(91)90392-2; NICKLAS RA, 1998, J ALLERGY CLIN IMMUN, V101, pS465; REISMAN RE, 1994, NEW ENGL J MED, V331, P523, DOI 10.1056/NEJM199408253310808; REISMAN RE, 1982, J ALLERGY CLIN IMMUN, V70, P281, DOI 10.1016/0091-6749(82)90064-1; REISMAN RE, 1993, J ALLERGY CLIN IMMUN, V92, P831, DOI 10.1016/0091-6749(93)90060-S; REISMAN RE, 1984, J ALLERGY CLIN IMMUN, V73, P246, DOI 10.1016/S0091-6749(84)80015-9; REISMAN RE, 1982, J ALLERGY CLIN IMMUN, V69, P268, DOI 10.1016/S0091-6749(82)80003-1; REISMAN RE, 1992, J ALLERGY CLIN IMMUN, V89, P1189, DOI 10.1016/0091-6749(92)90304-K; REISMAN RE, 1989, J ALLERGY CLIN IMMUN, V84, P331, DOI 10.1016/0091-6749(89)90417-X; RHOADES RB, 1977, J FLA MED ASSOC, V64, P247; SETTIPANE G, 1970, ACTA ALLERGOL, V25, P292; Simon P, 1996, NEPHROLOGIE, V17, P163; Stafford CT, 1996, ANN ALLERG ASTHMA IM, V77, P87, DOI 10.1016/S1081-1206(10)63493-X; STROM GJ, 1983, J ALLERGY CLIN IMMUN, V46, P46; TOOGOOD JH, 1988, J ALLERGY CLIN IMMUN, V81, P1, DOI 10.1016/0091-6749(88)90212-6; TRACY J, 1985, J ALLERGY CLIN IMMUN, P824; TRIPLETT RF, 1973, SOUTHERN MED J, V66, P477, DOI 10.1097/00007611-197304000-00019; VALENTINE M, 1990, NEW ENGL J MED, V323, P161; VALENTINE MD, 1990, NEW ENGL J MED, V323, P1601, DOI 10.1056/NEJM199012063232305; VALENTINE MD, 1993, ANN INTERN MED, V118, P225, DOI 10.7326/0003-4819-118-3-199302010-00013; VALENTINE MD, 1993, ANN ALLERGY, V70, P427; VALENTINE MD, 1984, J ALLERGY CLIN IMMUN, V73, P299, DOI 10.1016/0091-6749(84)90397-X; VANDERLINDEN PWG, 1993, ANN INTERN MED, V118, P161, DOI 10.7326/0003-4819-118-3-199302010-00001; Yocum MW, 1996, J ALLERGY CLIN IMMUN, V97, P1424, DOI 10.1016/S0091-6749(96)70217-8	58	8	8	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				963	980						18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP					2022-12-18	WOS:000080470200043
J	Bratton, DL; Fadok, VA				Bratton, DL; Fadok, VA			"Their's but to do and die": Eosinophil longevity in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							COLONY-STIMULATING FACTOR; APOPTOTIC CELLS; IN-VITRO; ATOPIC-DERMATITIS; FAS RECEPTOR; SURVIVAL; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; RECOGNITION; MACROPHAGES		Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA	National Jewish Health	Bratton, DL (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, 1400 Jackson St,D506, Denver, CO 80206 USA.							ALAM R, 1994, J EXP MED, V179, P1041, DOI 10.1084/jem.179.3.1041; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; BRATTON DL, 1995, J CLIN INVEST, V95, P211, DOI 10.1172/JCI117642; Cohen JJ, 1999, J ALLERGY CLIN IMMUN, V103, P548, DOI 10.1016/S0091-6749(99)70222-8; Dibbert B, 1998, BLOOD, V92, P778, DOI 10.1182/blood.V92.3.778.415k38_778_783; Druilhe A, 1998, AM J RESP CELL MOL, V19, P747, DOI 10.1165/ajrcmb.19.5.3166; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, BIOCHEM SOC T, V26, P653, DOI 10.1042/bst0260653; Hebestreit H, 1998, J EXP MED, V187, P415, DOI 10.1084/jem.187.3.415; Hebestreit H, 1996, EUR J IMMUNOL, V26, P1775, DOI 10.1002/eji.1830260817; Iversen PO, 1997, AM J RESP CRIT CARE, V156, P1628, DOI 10.1164/ajrccm.156.5.9612097; MATSUMOTO K, 1995, BLOOD, V86, P1437, DOI 10.1182/blood.V86.4.1437.bloodjournal8641437; MEAGHER LC, 1992, J LEUKOCYTE BIOL, V52, P269, DOI 10.1002/jlb.52.3.269; Persson CGA, 1997, THORAX, V52, P569, DOI 10.1136/thx.52.6.569; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Simon HU, 1997, J IMMUNOL, V158, P3902; Stern M, 1996, AM J PATHOL, V149, P911; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Walsh GM, 1997, J ALLERGY CLIN IMMUN, V100, P208, DOI 10.1016/S0091-6749(97)70226-4; Walsh GM, 1997, CLIN EXP ALLERGY, V27, P482, DOI 10.1111/j.1365-2222.1997.tb00735.x; Wedi B, 1997, J ALLERGY CLIN IMMUN, V100, P536, DOI 10.1016/S0091-6749(97)70147-7; Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237, DOI 10.1164/ajrccm.154.1.8680686; Ying S, 1997, P ASSOC AM PHYSICIAN, V109, P42	25	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1999	103	4					555	558		10.1016/S0091-6749(99)70223-X	http://dx.doi.org/10.1016/S0091-6749(99)70223-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	186HY	10200000				2022-12-18	WOS:000079723900003
J	Fox, DES; Gaughan, MA; Britto, J; Nadel, S; Habibi, P; Marriage, S; Lack, G				Fox, DES; Gaughan, MA; Britto, J; Nadel, S; Habibi, P; Marriage, S; Lack, G			Newly identified co-factors for life-threatening episodes in children with food allergy.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		124	S32	S32						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000126
J	Kalberg, CJ; Yancey, S; Emmett, AH; Rickard, K				Kalberg, CJ; Yancey, S; Emmett, AH; Rickard, K			A comparison of salmeterol versus zafirlukast in patients using inhaled corticosteroids.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline									0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		881	S229	S229						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000883
J	Nickel, R; Barnes, KC; Sengler, CA; Casolaro, V; Freidhoff, LR; Weber, P; Naidu, RP; Caraballo, L; Ehrlich, E; Plitt, J; Schleimer, RP; Huang, SK; Beaty, T				Nickel, R; Barnes, KC; Sengler, CA; Casolaro, V; Freidhoff, LR; Weber, P; Naidu, RP; Caraballo, L; Ehrlich, E; Plitt, J; Schleimer, RP; Huang, SK; Beaty, T		CSGA	Evidence for linkage of chemokine polymorphisms to asthma in populations of African descent.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									JHU, Baltimore, MD USA; NHLBI, Bethesda, MD USA; Univ Cartagena, Cartagena, Colombia; Univ W Indies, Bridgetown, Barbados	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universidad de Cartagena; University West Indies Mona Jamaica; University of the West Indies Open Campus			Casolaro, Vincenzo/E-9144-2010	Casolaro, Vincenzo/0000-0001-9810-0488					0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		667	S174	S174						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000670
J	Roux, K; Sathe, SK; Peterson, WR; Teuber, SS				Roux, K; Sathe, SK; Peterson, WR; Teuber, SS			The major seed storage protein of almond (almond major protein AMP) is an allergen.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Florida State Univ, Tallahassee, FL 32306 USA; Univ Calif Davis, Davis, CA USA	State University System of Florida; Florida State University; University of California System; University of California Davis									0	8	8	0	8	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		255	S66	S67						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000262
J	Santos, ABR; Tobias, KR; Ferriani, VPL; Rizzo, MC; Naspitz, CK; Pomes, A; Vailes, LD; Chapman, MC; Arruda, LK				Santos, ABR; Tobias, KR; Ferriani, VPL; Rizzo, MC; Naspitz, CK; Pomes, A; Vailes, LD; Chapman, MC; Arruda, LK			Identification of tropomyosin from Periplaneta americana as a major cockroach allergen.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									USP, Sch Med, BR-09500900 Sao Paulo, Brazil; UNIFESP, Sao Paulo, Brazil; Univ Virginia, Charlottesville, VA USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Virginia			Arruda, L. Karla/D-5845-2013; Ferriani, Virginia PL/E-2209-2012; Rizzo, Maria/HGD-6576-2022; Pomés, Anna/H-7010-2019	Arruda, L. Karla/0000-0002-7505-210X; Pomés, Anna/0000-0002-8729-1829					0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		467	S122	S122						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000472
J	Bernstein, DI; Cohen, R; Ginchansky, E; Pedinoff, AJ; Tinkelman, DG; Winder, JA				Bernstein, DI; Cohen, R; Ginchansky, E; Pedinoff, AJ; Tinkelman, DG; Winder, JA			A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 mu g per day) for the treatment of patients with mild-to-moderate asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						triamcinolone; asthma; inhaled corticosteroid	NEWLY DIAGNOSED ASTHMA; CLINICAL-TRIAL; BUDESONIDE; AEROSOL; BETA-2-AGONIST; INFLAMMATION; TERBUTALINE; MEDICATIONS; EFFICACY; THERAPY	Background: National and international guidelines recommend the use of inhaled antiinflammatory medications in patients with all but the mildest forms of asthma. Twice daily dosing may increase compliance with therapy. Objective: We sought to evaluate the safety and efficacy of 400 mu g twice daily triamcinolone acetonide (TAA) compared with placebo in adult patients with mild-to-moderate asthma who were poorly controlled by beta(2)-agonist therapy. Methods: We performed a multicenter, randomized, double-blind, placebo-controlled study, including a screening visit, a 7- to 21-day pretreatment baseline phase, and a 6-week double-blind treatment phase. Efficacy was measured by weekly spirometry and daily diary recordings of peak flow rates, asthma symptom scores, and albuterol use. Eligible patients used albuterol four or more times per day, had total asthma symptom scores of 15 or greater (possible total, 60) over 5 of 7 baseline days, and had FEV1 measurements of 60% of predicted value or greater. Results: One hundred twenty-one patients were randomized to treatment. TAA was superior to placebo for all efficacy measures, with significant improvements in asthma symptoms, albuterol use, morning and evening peak flow rates, and forced vital capacity evident at Treatment Week 1. Significant improvements in other pulmonary function measurements were observed after 2 or more weeks. All efficacy variables improved progressively throughout the study. Conclusions: Twice daily TAA (400 mu g) decreased asthma symptoms and improved lung function in patients with mild-to-moderate asthma compared with placebo. Therapeutic benefit was evident within 1 week and increased throughout treatment.	Bernstein Clin Res Ctr, Cincinnati, OH USA; Ctr Asthma & Allergy, Lawrenceville, NJ USA; Ctr Asthma & Allergy, Dallas, TX USA; Princeton Allergy & Asthma Associates, Princeton, NJ USA; Atlanta Asthma & Allergy Res, Atlanta, GA USA; Allergy & Asthma Res Ctr Toledo, Sylvania, OH USA		Bernstein, DI (corresponding author), Div Immunol, ML563,231 Bethesda Ave, Cincinnati, OH 45267 USA.							[Anonymous], 1993, BMJ, V306, P776; BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307; Barnes PJ, 1996, J ALLERGY CLIN IMMUN, V97, P159, DOI 10.1016/S0091-6749(96)80216-8; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BERNSTEIN IL, 1982, CHEST, V81, P20, DOI 10.1378/chest.81.1.20; BUSSE W, 1994, J ALLERGY CLIN IMMUN, V93, P186; CHERVINSKY P, 1994, J ALLERGY CLIN IMMUN, V94, P676, DOI 10.1016/0091-6749(94)90174-0; CHMELIK F, 1994, ANN ALLERGY, V73, P527; DUKES MNG, 1994, CLIN EXP ALLERGY, V24, P160, DOI 10.1111/j.1365-2222.1994.tb00214.x; FALLIERS CJ, 1982, J ASTHMA, V19, P241, DOI 10.3109/02770908209104767; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; *JOINT TASK FORC P, 1995, J ALLERGY CLIN IMM S, V96, P797; LAITINEN A, 1994, AM J RESP CRIT CARE, V150, pS14, DOI 10.1164/ajrccm/150.5_Pt_2.S14; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; MANN MC, 1992, CHEST, V102, P1342, DOI 10.1378/chest.102.5.1342; MAWHINNEY H, 1991, ANN ALLERGY, V66, P294; *NIH NAT HEART LUN, 1995, NIH PUBL; RAND CS, 1992, AM REV RESPIR DIS, V146, P1559, DOI 10.1164/ajrccm/146.6.1559; SBARBARO JA, 1991, ANN ALLERGY, V66, P273; Simmons MS, 1996, CHEST, V109, P963, DOI 10.1378/chest.109.4.963; TINKELMAN DG, 1993, PEDIATRICS, V92, P64; TOOGOOD JH, 1982, J ALLERGY CLIN IMMUN, V70, P288, DOI 10.1016/0091-6749(82)90065-3; WILLIAMS MH, 1974, AM REV RESPIR DIS, V109, P538; ZORA JA, 1989, ANN ALLERGY, V62, P406	26	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1998	101	4	1				433	438		10.1016/S0091-6749(98)70349-5	http://dx.doi.org/10.1016/S0091-6749(98)70349-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZH469	9564793				2022-12-18	WOS:000073113500001
J	MacKenzie, C				MacKenzie, C			Effects of inhaled corticosteroids on growth	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						inhaled corticosteroids; childhood asthma; growth; knemometry; stadiometry	SHORT-TERM GROWTH; LOWER LEG LENGTH; ASTHMATIC-CHILDREN; LINEAR GROWTH; FLUTICASONE PROPIONATE; SYSTEMIC ACTIVITY; CHILDHOOD ASTHMA; CONTROLLED TRIAL; DOUBLE-BLIND; MILD ASTHMA	Inhaled corticosteroids are an established treatment for asthma in childhood. The risk of adverse events associated with conventional doses of inhaled corticosteroids is low, but in children with asthma concern remains about the potential effects of these compounds on growth. Short-term growth in children can he measured with knemometry. This technique measures changes in lower leg length that can be detected over periods as short as days or even intradaily. However, nonlinearity of lower leg growth and the complexity of statural growth confound any attempts to derive a predicted height from short-term measurements of the lower leg. Knemometry is better at detecting growth suppression than growth promotion. With knemometry, inhaled fluticasone propionate 200 mu g/day had no effect on lower leg growth, but beclomethasone propionate 100 mu g/day significantly reduced lower leg growth. Inhaled budesonide also caused a dose-dependent reduction in lower leg growth, but this only reached significance at the 800 mu g/day dose. Long-term growth in children is measured with stadiometry. Growth velocity can only be determined from measurements of height taken over a period of at least 1 year. There is no evidence that inhaled corticosteroids at conventional doses have an adverse effect on the final height of children, but it is important to be aware of the growth-impairing effect of poorly controlled asthma. All children with asthma receiving inhaled corticosteroids should have their growth monitored, and any deviation from the expected pattern should be investigated. The effect of early intervention with inhaled steroids in childhood warrants further investigation.	Sheffield Childrens Hosp, Western Bank, Sheffield S10 2TH, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	MacKenzie, C (corresponding author), Sheffield Childrens Hosp, Western Bank, Sheffield S10 2TH, S Yorkshire, England.							AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; BISGAARD H, 1993, ACTA PAEDIATR, V82, P1066, DOI 10.1111/j.1651-2227.1993.tb12814.x; Davies HA, 1996, ANN HUM BIOL, V23, P149, DOI 10.1080/03014469600004362; DEAN HJ, 1990, ACTA PAEDIATR SCAND, V79, P57, DOI 10.1111/j.1651-2227.1990.tb11331.x; GIBSON AT, 1993, ARCH DIS CHILD-FETAL, V69, P498, DOI 10.1136/adc.69.5_Spec_No.498; GIBSON AT, 1993, ARCH DIS CHILD-FETAL, V69, P505, DOI 10.1136/adc.69.5_Spec_No.505; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1992, EUR RESPIR J S15, V5, pS13; HARRIS DM, 1980, TOPICAL STEROID TREA, P34; HERMANUSSEN M, 1988, ANN HUM BIOL, V15, P1, DOI 10.1080/03014468800009411; HERMANUSSEN M, 1988, ANN HUM BIOL, V15, P103, DOI 10.1080/03014468800009521; HERMANUSSEN M, 1988, EUR J PEDIATR, V147, P350, DOI 10.1007/BF00496409; HERMANUSSEN M, 1989, ARCH DIS CHILD, V64, P259, DOI 10.1136/adc.64.2.259; HUGHES IA, 1987, BMJ-BRIT MED J, V295, P683, DOI 10.1136/bmj.295.6600.683-a; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; Konig P., 1996, European Respiratory Journal Supplement, V9, p294S; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; LOZEWICS S, 1988, AM REV RESPIR DIS, V137, pS212; MACKENZIE CA, 1993, EUR J PEDIATR, V152, P856, DOI 10.1007/BF02073387; MACKENZIE CA, 1991, BRIT MED J, V303, P416; MACKENZIE CA, 1993, EUR RESP J S17, V6, pS262; MARTIN AJ, 1982, BMJ-BRIT MED J, V248, P380; MICHAELSEN KF, 1991, PEDIATR RES, V30, P464, DOI 10.1203/00006450-199111000-00013; NINAN TK, 1992, ARCH DIS CHILD, V67, P703, DOI 10.1136/adc.67.6.703; PRICE JF, 1996, AM J RESP CRIT CARE, V153, pA27; Salter HH, 1868, ASTHMA ITS PATHOLOGY; Scammon RE, 1927, AM J PHYS ANTHROPOL, V10, P329, DOI 10.1002/ajpa.1330100303; SHOHAT M, 1987, ARCH DIS CHILD, V62, P63, DOI 10.1136/adc.62.1.63; VALK IM, 1983, GROWTH, V47, P397; VATHENEN AS, 1991, AM REV RESPIR DIS, V143, P1317, DOI 10.1164/ajrccm/143.6.1317; VOSS LD, 1990, ARCH DIS CHILD, V65, P1340, DOI 10.1136/adc.65.12.1340; WALES JKH, 1987, ARCH DIS CHILD, V62, P166, DOI 10.1136/adc.62.2.166; WALES JKH, 1989, ARCH DIS CHILD, V64, P1708, DOI 10.1136/adc.64.12.1708; WALES JKH, 1987, ACTA PAEDIATR SCAND, P37; WALES JKH, 1988, ARCH DIS CHILD, V63, P981, DOI 10.1136/adc.63.8.981; WALES JKH, 1990, ACTA PAEDIATR SC   S, V367, P155; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; Wasse, 1724, PHILOS T R SOC LOND, V33, P87, DOI 10.1098/rstl.1724.0017; WIT JM, 1987, ACTA PAEDIATR SCAND, V76, P974, DOI 10.1111/j.1651-2227.1987.tb17274.x; WOLTHERS OD, 1992, HORM RES, V37, P156, DOI 10.1159/000182301; WOLTHERS OD, 1993, ARCH DIS CHILD, V68, P673, DOI 10.1136/adc.68.5.673; WOLTHERS OD, 1992, PEDIATRICS, V89, P839; WOLTHERS OD, 1991, BMJ-BRIT MED J, V303, P163, DOI 10.1136/bmj.303.6795.163; WOLTHERS OD, 1990, BRIT MED J, V301, P145, DOI 10.1136/bmj.301.6744.145; WOLTHERS OD, 1994, ALLERGY, V49, P96, DOI 10.1111/j.1398-9995.1994.tb00807.x	45	8	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1998	101	4	2	S			S451	S455		10.1016/S0091-6749(98)70158-7	http://dx.doi.org/10.1016/S0091-6749(98)70158-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZK101	9563371				2022-12-18	WOS:000073285000005
J	Smith, L				Smith, L			Special considerations for the child with airway disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, ILLINOIS				ASTHMA; DIAGNOSIS		Walter Reed Army Med Ctr, Allergy Immunol Dept, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Smith, L (corresponding author), Walter Reed Army Med Ctr, Allergy Immunol Dept, Washington, DC 20307 USA.							AGERTOFT LA, 1995, RESP MED, V88, P373; BERMAN S, 1995, NEW ENGL J MED, V332, P1560, DOI 10.1056/NEJM199506083322307; BRUGMAN SM, 1995, CLIN CHEST MED, V16, P637; CLARK NM, 1993, J ASTHMA, V30, P241, DOI 10.3109/02770909309054524; Creer TL, 1996, J ASTHMA, V33, P203, DOI 10.3109/02770909609055361; FOWLER MG, 1992, PEDIATRICS, V90, P939; GUSTADT LB, 1989, AM J DIS CHILD, V143, P471; HILL RA, 1989, ARCH DIS CHILD, V64, P246, DOI 10.1136/adc.64.2.246; LENNEY W, 1996, J ASTHMA, V6, P208; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MENARDO JL, 1985, J ALLERGY CLIN IMMUN, V75, P646, DOI 10.1016/0091-6749(85)90088-0; NORMAN PS, 1987, J ALLERGY CLIN IMMUN, V79, P572, DOI 10.1016/S0091-6749(87)80150-1; OWNBY DR, 1990, J ALLERGY CLIN IMMUN, V86, P279, DOI 10.1016/S0091-6749(05)80088-0; OWNBY DR, 1994, J ALLERGY CLIN IMMUN, V94, P662, DOI 10.1016/0091-6749(94)90171-6; PEDERSEN S, 1986, ALLERGY, V41, P1118; Price JF, 1996, THORAX, V51, pS13, DOI 10.1136/thx.51.Suppl_1.S13; SPEIGHT ANP, 1983, BRIT MED J, V286, P1253, DOI 10.1136/bmj.286.6373.1253; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; TINKELMAN D, 1994, J ASTHMA, V31, P419, DOI 10.3109/02770909409089483; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9	20	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S370	S372		10.1016/S0091-6749(98)70223-4	http://dx.doi.org/10.1016/S0091-6749(98)70223-4			3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZA245	9500731				2022-12-18	WOS:000072343900007
J	Sampson, HA; Buckley, N; Huang, SK; Burks, AW; Bannon, GA				Sampson, HA; Buckley, N; Huang, SK; Burks, AW; Bannon, GA			Characterization of major peanut allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Arkansas, Little Rock, AR 72204 USA; Johns Hopkins Univ, Baltimore, MD USA; Mt Sinai Sch Med, New York, NY USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Johns Hopkins University; Icahn School of Medicine at Mount Sinai									0	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			993	S240	S240						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800989
J	Warrington, RJ; McPhillips, S				Warrington, RJ; McPhillips, S			Allergic reaction to local anesthetic agents of the amide group	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Manitoba, Allergy & Clin Immunol Sect, Winnipeg, MB R3A 1R9, Canada; Hlth Sci Ctr, Winnipeg, MB R3A 1R9, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Warrington, RJ (corresponding author), Univ Manitoba, Allergy & Clin Immunol Sect, Winnipeg, MB R3A 1R9, Canada.							CuestaHerranz J, 1997, J ALLERGY CLIN IMMUN, V99, P427, DOI 10.1016/S0091-6749(97)70064-2	1	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1997	100	6	1				855	855						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YQ151	9438501				2022-12-18	WOS:000071353600025
J	Ohashi, Y; Nakai, Y; Morimoto, K; Tanaka, A; Kakinoki, Y; Ohno, Y; Masamoto, T; Kato, A				Ohashi, Y; Nakai, Y; Morimoto, K; Tanaka, A; Kakinoki, Y; Ohno, Y; Masamoto, T; Kato, A			Platelet activating factor compromises airway epithelial defense functions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						epithelial permeability; ciliary activity; mucociliary clearance; trachea; platelet activating factor	BRONCHIAL EPITHELIUM; MILD ASTHMA; PERMEABILITY; RESPONSIVENESS; PEROXIDASE; RESPONSES; INVITRO; DAMAGE	Background: The mechanism of disruption of the epithelial defense function observed in asthmatic airways is considered to be largely the result of mediators involved in allergic responses. Platelet activating factor (PAF) might be a key mediator involved in this mechanism. Objective: This study was designed to determine whether PAF is capable of compromising the epithelial defense functions, such as tight junctional barriers and the mucociliary system, Methods: A total of 120 healthy rabbits were used. Twenty of them were used as normal controls, Eighty rabbits were treated with inhalation of 10 ml of PAF (200 mu g/ml), and 20 animals were used for the examination of epithelial defense functions of the trachea at 1, 10, 20, and 30 days after inhalation of PAF, Epithelial defense functions of the trachea were evaluated by ciliary activity, mucociliary transport velocity, epithelial permeability to fluorescein isothiocyanate dextrans (70,000 d), and electron microscopy of the epithelial structure. Results: PAF inhalation induced a significant decrease in ciliary activity and mucociliary transport velocity, which persisted for up to 20 days. PAF inhalation also caused a significant 7.4-fold increase in epithelial permeability to fluorescein isothiocyanate dextrans at 1 and 10 days. This increased epithelial permeability returned to the normal level 20 days after PAF inhalation. However, electron microscopy-demonstrated no apparent evidence of epithelial shedding. Conclusions: PAF-induced prolonged dysfunction of both the epithelial junctional barrier and the mucociliary system may allow enhanced entry of allergen molecules, as well as bronchoactive agonists to the airway parenchyma and may also significantly contribute to an increased airway responsiveness.	OSAKA UNIV PHARMACEUT SCI,DEPT PHARMACEUT,OSAKA 580,JAPAN	Osaka University of Pharmaceutical Sciences	Ohashi, Y (corresponding author), OSAKA CITY UNIV,SCH MED,DEPT OTOLARYNGOL,1-5-7 ASAHIMACHI,OSAKA 545,JAPAN.							BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BOUCHER RC, 1977, J ALLERGY CLIN IMMUN, V60, P134, DOI 10.1016/0091-6749(77)90039-2; CERRINA J, 1986, AM REV RESPIR DIS, V134, P57; CHUNG KF, 1986, J PHARMACOL EXP THER, V236, P580; CUSS FM, 1986, LANCET, V2, P189; ELIA C, 1988, J SUBMICR CYTOL PATH, V20, P509; HULBERT WC, 1981, AM REV RESPIR DIS, V123, P320; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; KROEGEL C, 1988, IMMUNOLOGY, V64, P559; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LOZEWICZ S, 1990, THORAX, V45, P12, DOI 10.1136/thx.45.1.12; MONTEFORT S, 1992, CLIN EXP ALLERGY, V22, P511, DOI 10.1111/j.1365-2222.1992.tb00159.x; MONTEFORT S, 1993, CLIN EXP ALLERGY, V23, P185, DOI 10.1111/j.1365-2222.1993.tb00880.x; MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519; OHASHI Y, 1987, ACTA OTO-LARYNGOL, V104, P495, DOI 10.3109/00016488709128280; OHASHI Y, 1994, AUDITORY SYSTEM, P15; OHASHI Y, 1994, INT ARCH ALLERGY IMM, V104, P302, DOI 10.1159/000236681; OHASHI Y, 1983, ACTA OTOLARYNGOL S S, V397, P3; PAGE CP, 1988, J ALLERGY CLIN IMMUN, V81, P144, DOI 10.1016/0091-6749(88)90233-3; PATTERSON R, 1984, J LAB CLIN MED, V104, P340; RANGA V, 1983, AM REV RESPIR DIS, V128, P1065; RICHARDSON J, 1976, LAB INVEST, V35, P307; SAKAMOTO H, IN PRESS ROXYTHROMYC; SPARROW MP, 1995, CAN J PHYSIOL PHARM, V73, P180, DOI 10.1139/y95-027; WANGENSTEEN OD, 1993, J APPL PHYSIOL, V75, P1009, DOI 10.1152/jappl.1993.75.2.1009; WANNER A, 1983, J ALLERGY CLIN IMMUN, V72, P347, DOI 10.1016/0091-6749(83)90498-0; WARDLAW AJ, 1986, J CLIN INVEST, V78, P170	27	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1997	100	4					520	526						7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YA529	9338547				2022-12-18	WOS:A1997YA52900016
J	Ford, JL; Dolen, WK; Feger, TA; Hoffman, DR; Stafford, CT				Ford, JL; Dolen, WK; Feger, TA; Hoffman, DR; Stafford, CT			Evaluation of an in vitro assay for fire ant venom-specific IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMMUNOASSAY		MED COLL GEORGIA,ALLERGY IMMUNOL SECT,AUGUSTA,GA 30912; E CAROLINA UNIV,SCH MED,DEPT PATHOL,GREENVILLE,NC 27858	University System of Georgia; Augusta University; University of North Carolina; East Carolina University								DOLEN WK, 1992, ANN ALLERGY, V69, P151; FEGER TA, 1995, J ALLERGY CLIN IMMUN, V96, P182, DOI 10.1016/S0091-6749(95)70006-4; PONDER RD, 1994, ANN ALLERGY, V72, P329	3	8	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1997	100	3					425	427		10.1016/S0091-6749(97)70259-8	http://dx.doi.org/10.1016/S0091-6749(97)70259-8			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XX479	9314358				2022-12-18	WOS:A1997XX47900023
J	Sestini, P; Refini, RM; Pieroni, MG; Vaghi, A; Robuschi, M; Bianco, S				Sestini, P; Refini, RM; Pieroni, MG; Vaghi, A; Robuschi, M; Bianco, S			Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bronchial asthma; allergen challenge; bronchial hyperreactivity; lysine acetylsalicylate; aspirin; nonsteroidal antiinflammatory drugs	ANTIINFLAMMATORY DRUGS; ASPIRIN; INDOMETHACIN; ACID	Conflicting results have been reported on the effect of nonsteroidal antiinflammatory drugs on allergen-induced asthmatic responses. The aim of this study was to investigate the effect of inhaled lysine acetylsalicylate (LASA) on the early and late allergen-induced responses. We studied 16 patients with mild, stable asthma who had an early asthmatic response and 10 patients with a dual (early and late) response. Each patient underwent two challenges with a single dose of allergen assessed in a preliminary test, after inhalation of either 720 mg of LASA in 4 ml of saline solution or placebo, according to a randomized, double-blind protocol. Allergen-induced hyperreactivity to methacholine was measured in six patients from each of the early and the dual response groups 2 hours and 24 hours after the challenge, respectively. In the patients with early response, the maximum fall in FEV1 after challenge was 24% +/- 1% after inhalation of placebo and 14% +/- 2% after inhalation of LASA (p < 0.005). No protection was observed in four patients who received the drug orally instead of by inhalation. In the patients with a dual response, the maximum FEV1 decrease during the early response was 27% +/- 2% after placebo and 21% +/- 2% after LASA (p < 0.025). During the late response (between 3 and 8 hours), the maximum decrease in FEV1 was 28% +/- 4% after placebo and 16% +/- 4% after LASA (p < 0.005). In both groups allergen challenge caused a significant reduction in methacholine PD20 after treatment with placebo but not with LASA. Without allergen challenge, LASA had no effect on methacholine reactivity. We conclude that inhaled LASA significantly reduces both the early and the late asthmatic response to allergen challenge and that it prevents the allergen-induced airway hyperresponsiveness that follows these responses.	HOSP GARBAGNATE, PNEUMOL UNIT, MILAN, ITALY; UNIV MILAN, HOSP SAN RAFFAELE, INST CARDIOVASC & RESP DIS, I-20122 MILAN, ITALY	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Sestini, P (corresponding author), UNIV SIENA, INST RESP DIS, VIALE BRACCI 3, I-53100 SIENA, ITALY.		Sestini, Piersante/AAF-8570-2019	Sestini, Piersante/0000-0002-8195-0811				ABRAMSON SB, 1989, ARTHRITIS RHEUM, V32, P1, DOI 10.1002/anr.1780320102; ADAMS GK, 1985, AM REV RESPIR DIS, V131, P8; BIANCO S, 1994, DRUGS, V48, P9, DOI 10.2165/00003495-199448010-00002; BIANCO S, 1995, J ALLERGY CLIN IMMUN, V95, P937, DOI 10.1016/S0091-6749(95)70092-7; BIANCO S, 1993, INT CONGR SER, V1007, P261; BOMALASKI JS, 1986, BIOCHEM BIOPH RES CO, V139, P115, DOI 10.1016/S0006-291X(86)80087-0; *BRIT THOR SOC, 1993, THORAX, V48, pS1; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; FAIRFAX AJ, 1983, CLIN EXP IMMUNOL, V52, P393; ISEL PA, 1991, GOODMAN GILMANS PHAR, P638; LITTNER MR, 1986, J APPL PHYSIOL, V1, P988; PASARGIKLIAN M, 1977, RESPIRATION, V34, P79, DOI 10.1159/000193780; PAVORD ID, 1993, AM REV RESPIR DIS, V148, P87, DOI 10.1164/ajrccm/148.1.87; SESTINI P, 1995, AM J RESP CRIT CARE, V151, P387; SHEFFER AL, 1992, EUR RESPIR J, V5, P601; SMITH AP, 1975, LANCET, V1, P39; TOIVANEN J, 1985, THROMB RES, V37, P493, DOI 10.1016/0049-3848(85)90095-7; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; WEBER C, 1995, CIRCULATION, V91, P1914, DOI 10.1161/01.CIR.91.7.1914	19	8	10	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1997	100	1					71	77		10.1016/S0091-6749(97)70197-0	http://dx.doi.org/10.1016/S0091-6749(97)70197-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XP428	9257790	Bronze			2022-12-18	WOS:A1997XP42800012
J	Kaliner, M				Kaliner, M			Allergy care in the next millennium: Guidelines for the specialty	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ASTHMA; RHINITIS				Kaliner, M (corresponding author), WASHINGTON HOSP CTR, INST ASTHMA & ALLERGY, 106 IRVING ST NW, SUITE 108, WASHINGTON, DC 20010 USA.							*AM COLL ALL ASTHM, 1995, ROL ALL COST EFF TRE; BOUSQUET J, 1994, J ALLERGY CLIN IMMUN, V94, P182, DOI 10.1016/0091-6749(94)90038-8; *JOINT TASK FORC P, IN PRESS J ALLERGY C; KALINER M, 1992, JAMA-J AM MED ASSOC, V268, P2807, DOI 10.1001/jama.268.20.2807; Kaliner M. A., 1996, Journal of Allergy and Clinical Immunology, V97, P190, DOI 10.1016/S0091-6749(96)80247-8; KALINER MA, IN PRESS J ALLERGY C; MCMENAMIN P, 1994, ANN ALLERGY, V73, P35; McNally P. A., 1996, Journal of Allergy and Clinical Immunology, V97, P189, DOI 10.1016/S0091-6749(96)80245-4; MCNALLY PA, IN PRESS ALLERGY P; Nicklas RA, 1996, J ALLERGY CLIN IMMUN, V98, P1001, DOI 10.1016/S0091-6749(96)80183-7; ROSS RN, 1995, DIS MANAGEMENT FORUM, P144; SPECTOR SL, 1995, J ALLERGY CLIN IMMUN, V96, P707; STEINWACHS DM, 1995, ASTHMA PATIENT OUTCO; *US DEP HHS, 1995, NIH PUBL; *US DEP HHS, 1991, NIH PUBL; *US DEP HHS, 1993, NIH PUBL; ZEIGER RS, 1991, J ALLERGY CLIN IMMUN, V87, P1160, DOI 10.1016/0091-6749(91)92162-T	17	8	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				729	734		10.1016/S0091-6749(97)80003-6	http://dx.doi.org/10.1016/S0091-6749(97)80003-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215237				2022-12-18	WOS:A1997XH19300002
J	Lin, RY; Clarin, E; Lee, M; Menikoff, H				Lin, RY; Clarin, E; Lee, M; Menikoff, H			Decreased nasal goblet cells in patients reporting topical corticosteroid use	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NEW YORK MED COLL,ST VINCENTS HOSP & MED CTR,DEPT PATHOL,NEW YORK,NY 10011	New York Medical College; Saint Vincents Hospital Manhattan	Lin, RY (corresponding author), NEW YORK MED COLL,ST VINCENTS HOSP & MED CTR,DEPT MED,ROOM CR104,153 W 11TH ST,NEW YORK,NY 10011, USA.							BECKER S, 1993, AM J RESP CELL MOL, V8, P20, DOI 10.1165/ajrcmb/8.1.20; Clarin E., 1996, Journal of Allergy and Clinical Immunology, V97, P405, DOI 10.1016/S0091-6749(96)81108-0; Laitinen LA, 1996, J ALLERGY CLIN IMMUN, V97, P153, DOI 10.1016/S0091-6749(96)80215-6; MELZER EO, 1994, J ALLERGY CLIN IMMUN, V94, P708; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403	5	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1997	99	2					265	266		10.1016/S0091-6749(97)70109-X	http://dx.doi.org/10.1016/S0091-6749(97)70109-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH831	9042058				2022-12-18	WOS:A1997WH83100021
J	Newman, KB; Mason, UG; Buchmeier, A; Schmaling, KB; Corsello, P; Nelson, HS				Newman, KB; Mason, UG; Buchmeier, A; Schmaling, KB; Corsello, P; Nelson, HS			Failure of colchicine to reduce inhaled triamcinolone dose in patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED, DIV PULM MED, DENVER, CO 80206 USA; NATL JEWISH CTR IMMUNOL & RESP MED, DIV CLIN IMMUNOL & ALLERGY, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, BOULDER, CO 80309 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder			Schmaling, Karen B/F-5217-2011	Schmaling, Karen B/0000-0003-2085-134X				ADALIOGLU G, 1994, J ASTHMA, V31, P361, DOI 10.3109/02770909409061315; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; CALLEN JP, 1985, J AM ACAD DERMATOL, V13, P193, DOI 10.1016/S0190-9622(85)70158-2; ILFELD DN, 1986, CLIN ALLERGY, V16, P407, DOI 10.1111/j.1365-2222.1986.tb01975.x; KELLY SJ, 1995, CHEST, V107, P985, DOI 10.1378/chest.107.4.985; RENNARD SI, 1988, AM REV RESPIR DIS, V137, P181, DOI 10.1164/ajrccm/137.1.181; RUDOLPH SA, 1977, P NATL ACAD SCI USA, V74, P3404, DOI 10.1073/pnas.74.8.3404; SCHWARZ YA, 1990, J ALLERGY CLIN IMMUN, V85, P578, DOI 10.1016/0091-6749(90)90096-M; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601	9	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1997	99	2					176	178		10.1016/S0091-6749(97)70092-7	http://dx.doi.org/10.1016/S0091-6749(97)70092-7			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH831	9042041				2022-12-18	WOS:A1997WH83100004
J	Konig, P				Konig, P			Clinical effects of nedocromil sodium on challenges invoking neuronal mechanisms and on virally induced symptoms	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bronchoconstriction; cough; nedocromil sodium; neuronal stimuli; viral-induced symptoms	DIOXIDE-INDUCED BRONCHOCONSTRICTION; SULFUR-DIOXIDE; NEUROGENIC INFLAMMATION; ASTHMATIC SUBJECTS; HUMAN AIRWAYS; NEUROKININ-A; CROMOGLYCATE; CHILDREN; INHIBITION; METABISULFITE	Although sensory nerve activity may be important to the human airway in numerous possible ways, the relevance of ''neurogenic inflammation'' to the onset and development of asthma is unknown. However several of the symptoms of asthma (bronchoconstriction, cough, and dyspnea) have a neuronal component that can be modeled in the laboratory by various stimuli that are thought to invoke sensory nerve activation. Nedocromil sodium is highly effective against bronchoconstriction induced by bradykinin, the tachykinins substance P and neurokinin A, and sulfur dioxide and metabisulfite. The results for induced cough in healthy subjects are equivocal, although the drug is effective on spontaneously occurring cough in patients with asthma. Nedocromil sodium had a modest but significant effect on symptoms associated with episodes of viral infection.			Konig, P (corresponding author), UNIV MISSOURI,HLTH SCI CTR,DEPT CHILD HLTH,SCH MED,N708 HLTH SCI CTR,1 HOSP DR,COLUMBIA,MO 65212, USA.							ALTOUNYAN REC, 1986, EUR J RESPIR DIS, V69, P274; BALLERIN L, 1991, American Review of Respiratory Disease, V143, pA758; BARNES PJ, 1988, PHARMACOL REV, V40, P49; BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; BARNES PJ, 1991, INT ARCH ALLER A IMM, V94, P303, DOI 10.1159/000235392; BIGBY B, 1993, J ALLERGY CLIN IMMUN, V92, P195, DOI 10.1016/0091-6749(93)90106-P; CHERNIACK R M, 1990, Chest, V97, P1299; CHOUDRY NB, 1992, EUR RESPIR J, V5, P296; COGSWELL JJ, 1985, ARCH DIS CHILD, V60, P736, DOI 10.1136/adc.60.8.736; CONNETT G, 1993, ARCH DIS CHILD, V68, P85, DOI 10.1136/adc.68.1.85; CRIMI N, 1988, CLIN ALLERGY, V18, P375, DOI 10.1111/j.1365-2222.1988.tb02885.x; CRIMI N, 1992, CLIN EXP ALLERGY, V22, P75, DOI 10.1111/j.1365-2222.1992.tb00117.x; DIXON CMS, 1987, THORAX, V42, P462, DOI 10.1136/thx.42.6.462; DIXON CMS, 1989, BRIT J CLIN PHARMACO, V27, P831, DOI 10.1111/j.1365-2125.1989.tb03446.x; DIXON CMS, 1990, BRIT J CLIN PHARMACO, V30, P371, DOI 10.1111/j.1365-2125.1990.tb03786.x; EDWARDS AM, 1993, EUR RESPIR J, V6, P35; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; FYANS PG, 1986, CLIN ALLERGY, V16, P505, DOI 10.1111/j.1365-2222.1986.tb01988.x; HANSSON L, 1988, THORAX, V43, P935, DOI 10.1136/thx.43.11.935; JOOS GF, 1989, J ALLERGY CLIN IMMUN, V83, P663, DOI 10.1016/0091-6749(89)90080-8; JOOS GF, 1995, THORAX, V50, P217, DOI 10.1136/thx.50.3.217; JOOS GF, 1990, ARCH INT PHARMACOD T, V303, P132; KONIG P, 1995, AM J RESP CRIT CARE, V152, P1879; LAVORINI F, 1993, EUR RESPIR J S17, V6, pS198; LOWRY RH, 1988, THORAX, V43, pP256; LOWRY RH, 1989, CLIN SCI         S20, V76, pP5; MITCHELL I, 1978, ARCH DIS CHILD, V53, P106, DOI 10.1136/adc.53.2.106; NICHOL GM, 1988, THORAX, V43, pP836; REES PJ, 1991, THORAX, V46, pP761; ROLDAAN AC, 1982, EUR J RESPIR DIS, V63, P140; VLASTOS F D, 1989, American Review of Respiratory Disease, V139, pA107; WOOD R, 1994, J ALLERGY CLIN IMMUN, V93, P260; WRIGHT W, 1990, AM REV RESPIR DIS, V141, P1400, DOI 10.1164/ajrccm/141.6.1400	33	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S135	S140		10.1016/S0091-6749(96)80141-2	http://dx.doi.org/10.1016/S0091-6749(96)80141-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939189				2022-12-18	WOS:A1996VW14000029
J	Konig, P; Lalloo, U; Mapp, CE; Widdicombe, JG; FitzGerald, JM; Holgate, ST; Bleecker, ER; Rodwell, LT				Konig, P; Lalloo, U; Mapp, CE; Widdicombe, JG; FitzGerald, JM; Holgate, ST; Bleecker, ER; Rodwell, LT			Pathophysiology and clinical presentations of cough - Discussion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material														Barnes, Peter/0000-0002-5122-4018					0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S96	S97						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140					2022-12-18	WOS:A1996VW14000020
J	Raby, R; Blaiss, M; Gross, S; Herrod, HG				Raby, R; Blaiss, M; Gross, S; Herrod, HG			Antibody response to unconjugated Haemophilus influenzae b and pneumococcal polysaccharide vaccines in children with recurrent infections	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						unconjugated H-influenzae b vaccine; pneumococcal polysaccharide vaccine; recurrent infection; antibody response	PROTEIN CONJUGATE VACCINE; IGG SUBCLASS; DEFICIENCY; IMMUNIZATION; INFANTS; DEFECT; AGE	Background: Increasingly, antibody testing is being used to evaluate the status of humoral immunity in patients with recurrent infection and suspected immunodeficiency. In the past, we had been impressed that immunization with unconjugated Haemophilus influenzae b (uHib) vaccine provide useful information about the ability to produce antibody to polysaccharides and that the use of pneumococcal polysaccharide (PPS) vaccine frequently produced results that were difficult to interpret. Objective: The study was carried out to compare antibody responsiveness to vaccination with uHib with the response seen after PPS vaccination. Methods: Twenty children (ages, 2 to 13 years; 11 male) who were referred to our immunology clinic because of recurrent infections were immunized with both uHib vaccine and PPS vaccine. Nine children had previously received conjugated Hib vaccine. Results: All 20 children either responded with a twofold or greater increase in antibody titer after uHib vaccine or had preimmunization antibody concentrations of greater than 400 nanograms antibody per milliliter (ng Ab N/ml). All of the children responded to PPS-3 with postimmunization antibody concentrations greater than 400 ng Ab N/ml. Three children had an increase in titer to PPS-7 of less than twofold, seven did not have a twofold increase in titer to PPS-9, and 15 had an increase in titer to PPS-14 of less than twofold. Conclusion: Unconjugated Hib vaccine is a potent immunogen in children over 2 years of age. Prior immunization with the conjugate vaccine did not prevent a response to unconjugated vaccine. Unconjugated Hib vaccine appears to be at least as immunogenic as PPS-3 when used as an assessment vaccine of evaluating antibody responsiveness.	LEBONHEUR CHILDRENS HOSP & MED CTR,CRIPPLED CHILDRENS FDN RES CTR,MEMPHIS,TN 38103; UNIV TENNESSEE,DEPT PEDIAT,MEMPHIS,TN	University of Tennessee System; University of Tennessee Health Science Center								AMBROSINO DM, 1987, NEW ENGL J MED, V316, P790, DOI 10.1056/NEJM198703263161306; AMBROSINO DM, 1988, J ALLERGY CLIN IMMUN, V81, P1175, DOI 10.1016/0091-6749(88)90887-1; ANDERSON P, 1985, J PEDIATR-US, V107, P346, DOI 10.1016/S0022-3476(85)80504-7; ANDERSON P, 1987, J PEDIATR-US, V111, P644, DOI 10.1016/S0022-3476(87)80237-8; BLECHER T. E., 1968, CLIN EXP IMMUNOL, V3, P47; DAVIS SD, 1973, IMMUNOLOGIC DISORDER, P193; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; GIGLIOTTI F, 1988, PEDIATR INFECT DIS J, V7, P417, DOI 10.1097/00006454-198806000-00010; GRANOFF DM, 1989, J PEDIATR-US, V114, P925, DOI 10.1016/S0022-3476(89)80432-9; GROSS S, 1992, J PEDIATR-US, V121, P516, DOI 10.1016/S0022-3476(05)81137-0; HERROD HG, 1989, J CLIN IMMUNOL, V9, P429, DOI 10.1007/BF00917109; INSEL RA, 1986, NEW ENGL J MED, V315, P499, DOI 10.1056/NEJM198608213150807; KNUTSEN AP, 1989, J ALLERGY CLIN IMMUN, V84, P640, DOI 10.1016/0091-6749(89)90203-0; LAWRENCE EM, 1983, AM J DIS CHILD, V137, P846, DOI 10.1001/archpedi.1983.02140350024007; MADORE DV, 1990, PEDIATRICS, V85, P331; PELTOLA H, 1984, NEW ENGL J MED, V310, P1561, DOI 10.1056/NEJM198406143102404; PELTOLA H, 1977, PEDIATRICS, V60, P730; ROTHBACH C, 1979, J PEDIATR-US, V94, P250, DOI 10.1016/S0022-3476(79)80836-7; SANDERS LAM, 1995, PEDIATR RES, V37, P812, DOI 10.1203/00006450-199506000-00023; SCHNEIDER LC, 1990, J ALLERGY CLIN IMMUN, V85, P948, DOI 10.1016/0091-6749(90)90082-F; SHAPIRO GG, 1991, PEDIATRICS, V87, P311; SILK HJ, 1994, J ALLERGY CLIN IMMUN, V93, P274	22	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1996	98	2					451	459		10.1016/S0091-6749(96)70170-7	http://dx.doi.org/10.1016/S0091-6749(96)70170-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VC995	8757223				2022-12-18	WOS:A1996VC99500025
J	deBoer, R; vanderHoeven, WAD; Kuller, K				deBoer, R; vanderHoeven, WAD; Kuller, K			The control of house dust mites in rugs through wet cleaning	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						house dust mites; house dust allergy; dermatophagoides; rugs	CONTROLLED TRIAL; CHILDREN; ASTHMA; AVOIDANCE; ALLERGENS	Nine rugs from the bedrooms of seven private homes were cut into strips. Half of the strips were wet-cleaned according to a commercial procedure, and the others were kept as controls. Subsequently the cleaned and noncleaned strips were stitched together again and returned to their respective bedrooms. After 0, 1, and 3 months, parts of the strips were taken to the laboratory for tests. The tests were designed to measure the suitability of the rugs as a habitat for house dust mites. To do this, a number of house dust mites were introduced into fragments of the rugs, and the number of survivors and offspring after 4 weeks was determined. Immediately after cleaning, the habitat was markedly less suitable than before. After 1 month, the habitat suitability was partly but not totally recovered. After 3 months, no effect of cleaning could be discerned.			deBoer, R (corresponding author), UNIV AMSTERDAM,DEPT PURE & APPL ECOL,KRUISLAAN 320,NL-1098 SM AMSTERDAM,NETHERLANDS.							BISCHOFF ERC, 1992, EXP APPL ACAROL, V16, P1, DOI 10.1007/BF01201489; DEBOER R, 1990, EXP APPL ACAROL, V9, P113, DOI 10.1007/BF01198989; DEBOER R, 1990, J ALLERGY CLIN IMMUN, V86, P808, DOI 10.1016/S0091-6749(05)80187-3; DEBOER R, 1995, P EXP APPL ENTOMOL, V6, P47; DORWARD AJ, 1988, THORAX, V43, P98, DOI 10.1136/thx.43.2.98; DUSBABEK F, 1975, Folia Parasitologica (Ceske Budejovice), V22, P219; EHNERT B, 1992, J ALLERGY CLIN IMMUN, V90, P135, DOI 10.1016/S0091-6749(06)80024-2; GILLIES DRN, 1987, CLIN ALLERGY, V17, P105, DOI 10.1111/j.1365-2222.1987.tb02327.x; HUGHES A M, 1973, Clinical Allergy, V3, P127, DOI 10.1111/j.1365-2222.1973.tb01316.x; LINTNER TJ, 1993, J ALLERGY CLIN IMMUN, V91, P862, DOI 10.1016/0091-6749(93)90343-E; MASSEY J E, 1984, Hawaii Medical Journal, V43, P406; MURRAY AB, 1983, PEDIATRICS, V71, P418; VANLEEUWEN J, 1991, ANTIGENEN HUISSTOF; WALSHAW MJ, 1986, Q J MED, V58, P89; WASSENAAR DPJ, 1988, EXP APPL ACAROL, V4, P53, DOI 10.1007/BF01213841	15	8	8	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1214	1217		10.1016/S0091-6749(96)70187-2	http://dx.doi.org/10.1016/S0091-6749(96)70187-2			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648015	Green Published			2022-12-18	WOS:A1996VD60700007
J	Corren, J; Froehlich, J; Schoenhoff, M; Spector, S; Rachelefsky, G; Schanker, H; Patnaik, M; Siegel, S				Corren, J; Froehlich, J; Schoenhoff, M; Spector, S; Rachelefsky, G; Schanker, H; Patnaik, M; Siegel, S			Phase I study of anti-IgE recombinant humanized monoclonal antibody rhuMAB-E25 (E25) in adults with moderate to severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	1	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				251	251						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600251
J	Skodasmith, S; Mullen, GR; Oi, F; Atkinson, TP				Skodasmith, S; Mullen, GR; Oi, F; Atkinson, TP			Angioedema following dust mite exposure presenting as suspected food allergy.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				182	182						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600182
J	DOOPER, MWSM; TIMMERMANS, A; WEERSINK, EJM; DEMONCHY, JGR; KAUFFMAN, KF				DOOPER, MWSM; TIMMERMANS, A; WEERSINK, EJM; DEMONCHY, JGR; KAUFFMAN, KF			DEFECT IN POTENTIATION OF ADENYLYL-CYCLASE CORRELATES WITH BRONCHIAL HYPERREACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; ADENYLYL CYCLASE; BRONCHIAL HYPERREACTIVITY; POTENTIATION	CYCLIC ADENOSINE-MONOPHOSPHATE; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; POLYMORPHONUCLEAR LEUKOCYTES; BRONCHOALVEOLAR LAVAGE; AMP ACCUMULATION; T-CELLS; ASTHMA; LYMPHOCYTES; ACTIVATION	Background: Adenylyl cyclase is a transmembrane signaling system involved in the inhibition of cellular responses. Recently, we showed that the activity of adenylyl cyclase may be potentiated by stimuli that induce an increase of cellular responses but that do not activate adenylyl cyclase. This is probably an important physiologic feedback mechanism that prevents cells from becoming ''overstimulated.'' Objective: Because increased cellular activities are frequently observed in persons with asthma, we hypothesized that a defect in potentiation of adenylyl cyclase might be involved. Methods: Potentiation of isoprenaline-induced adenosine cyclic monophosphate (cAMP) production with the mitogen phytohemagglutinin (PHA; 45 mu g/ml) or the calcium ionophore A23187 (1 mu mol/L) was studied in peripheral blood mononuclear cells taken from patients with asthma (n = 8) and healthy control subjects (n = 11). Results: Isoprenaline-induced cAMP production was potentiated significantly in the healthy control subjects (PHA, 110% +/- 15%; A23187, 92% +/- 25%). In contrast, potentiation was not seen with PHA ol A23187 in the total group of patients with asthma. However; some patients showed weak potentiation, whereas in others PHA decreased isoprenaline-induced CAMP production. Moreover, the effect of PHA isoprenaline-induced cAMP production correlated significantly with the degree of bronchial hyperreactivity in patients with asthma (r = 0.96; p = 0.0001). Conclusions: The observed defect in signal transduction could play an important part in bronchial hyperresponsiveness.	UNIV GRONINGEN HOSP, DEPT ALLERGOL, INTERNAL MED CLIN, 9713 EZ GRONINGEN, NETHERLANDS; UNIV GRONINGEN HOSP, INTERNAL MED CLIN, DEPT PULM, 9713 EZ GRONINGEN, NETHERLANDS	University of Groningen; University of Groningen								ANNESI I, 1988, J ALLERGY CLIN IMMUN, V82, P1006, DOI 10.1016/0091-6749(88)90137-6; BETZ M, 1991, J IMMUNOL, V146, P108; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BUSSE WW, 1977, AM REV RESPIR DIS, V115, P783; COCKCROFT DW, 1977, CLIN ALLERGY, V72, P35; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V143, P538, DOI 10.1164/ajrccm/143.3.538; DOOPER MWSM, 1994, BIOCHEM PHARMACOL, V47, P289, DOI 10.1016/0006-2952(94)90019-1; DOOPER MWSM, 1993, J ALLERGY CLIN IMMUN, V92, P559, DOI 10.1016/0091-6749(93)90080-Y; ENDRES S, 1991, IMMUNOLOGY, V72, P56; FALUS A, 1992, IMMUNOL TODAY, V13, P154; JOHNSON RA, 1991, MOL PHARMACOL, V39, P399; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; KVANTA A, 1990, CELL SIGNAL, V2, P461, DOI 10.1016/0898-6568(90)90042-9; LEFKOWITZ RJ, 1983, ANNU REV BIOCHEM, V52, P159, DOI 10.1146/annurev.bi.52.070183.001111; LINGK DS, 1990, J IMMUNOL, V145, P449; MELTZER S, 1989, J ALLERGY CLIN IMMUN, V83, P960, DOI 10.1016/0091-6749(89)90112-7; MEURS H, 1980, CLIN CHIM ACTA, V106, P91, DOI 10.1016/0009-8981(80)90378-2; MEURS H, 1993, INT ARCH ALLERGY IMM, V100, P19, DOI 10.1159/000236382; MEURS H, 1987, J ALLERGY CLIN IMMUN, V80, P326, DOI 10.1016/0091-6749(87)90039-X; MINAKUCHI R, 1990, J IMMUNOL, V145, P2616; NIELSON CP, 1992, J ALLERGY CLIN IMMUN, V90, P825, DOI 10.1016/0091-6749(92)90108-E; NOVAK TJ, 1990, P NATL ACAD SCI USA, V87, P9353, DOI 10.1073/pnas.87.23.9353; RAVID A, 1990, J ALLERGY CLIN IMMUN, V86, P881, DOI 10.1016/S0091-6749(05)80150-2; REBUTBONNETON C, 1990, HORM METAB RES, V22, P175, DOI 10.1055/s-2007-1004877; SATO T, 1990, J ALLERGY CLIN IMMUN, V86, P839, DOI 10.1016/S0091-6749(05)80144-7; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WIERENGA EA, 1990, J IMMUNOL, V144, P4651; WILSON JW, 1992, AM REV RESPIR DIS, V145, P958, DOI 10.1164/ajrccm/145.4_Pt_1.958; YAGISAWA H, 1990, IMMUNOLOGY, V71, P242	31	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1995	96	5	1				628	634		10.1016/S0091-6749(95)70261-X	http://dx.doi.org/10.1016/S0091-6749(95)70261-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TG528	7499679				2022-12-18	WOS:A1995TG52800008
J	SULLIVAN, TJ; MAGERA, BE				SULLIVAN, TJ; MAGERA, BE			RECURRENT ALLERGIC REACTIONS TO LATEX IN A HOSPITALIZED PEDIATRIC-PATIENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									EMORY UNIV,DIV ALLERGY & IMMUNOL,ATLANTA,GA 30322	Emory University								IDSOE O, 1968, B WORLD HEALTH ORGAN, V38, P159; MAKINENKILJUNEN S, 1992, LANCET, V339, P1608, DOI 10.1016/0140-6736(92)91872-6; MAKINENKILJUNEN S, 1994, J ALLERGY CLIN IMMUN, V93, P990, DOI 10.1016/S0091-6749(94)70046-X; PLATT MS, 1994, J ALLERGY CLIN IMMUN, V94, P250, DOI 10.1016/0091-6749(94)90047-7; THARP MD, 1983, J IMMUNOL, V150, P1896; YUNGINGER JW, 1994, J ALLERGY CLIN IMMUN, V93, P836, DOI 10.1016/0091-6749(94)90374-3	6	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1995	96	3					423	425		10.1016/S0091-6749(95)70063-3	http://dx.doi.org/10.1016/S0091-6749(95)70063-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RU660	7560646				2022-12-18	WOS:A1995RU66000016
J	RICHERSON, HB; COON, JD; LUBAROFF, D				RICHERSON, HB; COON, JD; LUBAROFF, D			SELECTIVE EARLY INCREASES OF BRONCHOALVEOLAR CD8(+) LYMPHOCYTES IN A LEW RAT MODEL OF HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						RAT; LUNG HYPERSENSITIVITY; PNEUMONITIS; T LYMPHOCYTES; CD4; CD8	T-CELLS; LAVAGE FLUID; MONOCLONAL-ANTIBODIES; LUNG-TISSUE; ANTIGEN; POPULATIONS; PHENOTYPE; RESPONSES; DISEASE; RECRUITMENT	Background: The pathogenesis of hypersensitivity pneumonitis (HP) involves cell-mediated hypersensitivity; various bronchoalveolar T-cell subsets with uncertain roles in disease have been reported and implicated in the pathogenesis. Objectives: Previous studies at 72 hours after initial antigen challenges showed proportionate increases in T-cell phenotypes. Therefore we tested the hypothesis that early events in response to inhaled antigen in a LEW rat model of HP would include a disproportionate appearance in bronchoalveolar lavage fluid (BALF) and lung parenchyma of a specific T-effector cell responsible for subsequent inflammation and that these events could be identified by phenotyping. Methods: We double labeled BALF and parenchymal lung lymphocytes with monoclonal antibodies and used flow cytometry to quantitate CD4(+) and CD8(+) phenotypic subsets 4 and 24 hours after inhalation of antigen. Results: We found disproportionate increases in BALF CD8(+) phenotypes. The strongest correlation with pathologic findings was for a putative cytotoxic effector (CD8(+)CD45R(-)) T lymphocyte. Conclusion: Meaningful interpretation of lung T-cell phenotype quantitation requires studies of kinetics of cellular influxes, timing after antigen challenge, and relative comparison with increases in other phenotypes. Any pathogenetic role assigned to a phenotype must also await functional studies, including cytokine generation and secretion and cell-cell interactions in situ.	UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA; UNIV IOWA,COLL MED,DEPT UROL,IOWA CITY,IA; UNIV IOWA,COLL MED,DEPT MICROBIOL,IOWA CITY,IA	University of Iowa; University of Iowa; University of Iowa					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL037121] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37121] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARTHUR RP, 1986, J EXP MED, V163, P774, DOI 10.1084/jem.163.4.774; BERMAN JS, 1990, AM REV RESPIR DIS, V142, P238, DOI 10.1164/ajrccm/142.1.238; BERNARDO J, 1979, AM REV RESPIR DIS, V120, P985; COSTABEL U, 1984, CHEST, V85, P514, DOI 10.1378/chest.85.4.514; DUARTE AJS, 1981, J IMMUNOL, V128, P580; ELY JM, 1983, J IMMUNOL, V130, P2798; ERNST DN, 1984, CELL IMMUNOL, V88, P436, DOI 10.1016/0008-8749(84)90176-X; HUNTSBERGER D, 1970, STATISTICAL INFERENC, P213; INOUE T, 1993, J IMMUNOL, V150, P2121; KELLER RH, 1984, AM REV RESPIR DIS, V130, P766; KOULOVA L, 1990, J IMMUNOL, V145, P2035; LEATHERMAN JW, 1984, ANN INTERN MED, V100, P390, DOI 10.7326/0003-4819-100-3-390; LEFEVER AV, 1984, EXP LUNG RES, V7, P23, DOI 10.3109/01902148409087906; LIPSCOMB MF, 1982, J IMMUNOL, V128, P111; MASON DW, 1983, IMMUNOL REV, V74, P57, DOI 10.1111/j.1600-065X.1983.tb01084.x; MCDERMOTT MR, 1987, AM REV RESPIR DIS, V135, P245; Merkenschlager M, 1989, Int Immunol, V1, P450, DOI 10.1093/intimm/1.4.450; MOORE VL, 1980, J ALLERGY CLIN IMMUN, V65, P365, DOI 10.1016/0091-6749(80)90214-6; MORNEX JF, 1984, J ALLERGY CLIN IMMUN, V74, P719, DOI 10.1016/0091-6749(84)90236-7; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OKUMURA M, 1993, J IMMUNOL, V150, P429; POWRIE F, 1989, J EXP MED, V169, P653, DOI 10.1084/jem.169.3.653; RATAJCZAK HV, 1980, AM REV RESPIR DIS, V122, P761, DOI 10.1164/arrd.1980.122.5.761; RICHERSON HB, 1981, J ALLERGY CLIN IMMUN, V68, P226, DOI 10.1016/0091-6749(81)90188-3; RICHERSON HB, 1991, AM J RESP CELL MOL, V5, P451, DOI 10.1165/ajrcmb/5.5.451; RICHERSON HB, 1982, AM J PATHOL, V106, P409; RICHERSON HB, 1983, CLIN REV ALLERG, V1, P469; ROSE C, 1992, AM REV RESPIR DIS, V145, P1; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SEMENZATO G, 1984, AM REV RESIR DIS, V137, P70; STRUHAR D, 1989, AM REV RESPIR DIS, V139, P28, DOI 10.1164/ajrccm/139.1.28; THRALL RS, 1984, AM REV RESPIR DIS, V129, P279; TRENTIN L, 1990, J IMMUNOL, V145, P2147; TRENTIN L, 1988, J ALLERGY CLIN IMMUN, V82, P577, DOI 10.1016/0091-6749(88)90967-0; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; WOOLLETT GR, 1985, EUR J IMMUNOL, V15, P168, DOI 10.1002/eji.1830150211; ZHANG YH, 1986, INFLAMMATION, V10, P9; 1982, SAS USERS GUIDE STAT, P169	38	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1995	96	1					113	121		10.1016/S0091-6749(95)70040-4	http://dx.doi.org/10.1016/S0091-6749(95)70040-4			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RK383	7622753	Bronze			2022-12-18	WOS:A1995RK38300015
J	FOSSO, CK; MILLER, MJ; SOLOMON, WR; BAKER, JR				FOSSO, CK; MILLER, MJ; SOLOMON, WR; BAKER, JR			ADVERSE-EFFECTS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS ASSOCIATED WITH ELEVATED SERUM IGE AND EOSINOPHILIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							CHOLESTEROL; LOVASTATIN; MEVINOLIN; EFFICACY		UNIV MICHIGAN,DEPT INTERNAL MED,DIV ALLERGY,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan								BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; SMELLIE WAS, 1992, ADVERSE DRUG REACT T, V11, P71; TOBERT JA, 1988, AM J CARDIOL, V62, pJ28, DOI 10.1016/0002-9149(88)90004-5; TOBERT JA, 1982, ATHEROSCLEROSIS, V41, P61, DOI 10.1016/0021-9150(82)90070-3; TOBERT JA, 1982, J CLIN INVEST, V69, P913, DOI 10.1172/JCI110530	5	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				1053	1055		10.1016/S0091-6749(95)70109-5	http://dx.doi.org/10.1016/S0091-6749(95)70109-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7751504				2022-12-18	WOS:A1995QY91700020
J	LONNEUX, M; NOLARD, N; PHILIPPART, I; HENKINBRANT, A; HAMELS, J; FASTREZ, J; DODEMONT, JP				LONNEUX, M; NOLARD, N; PHILIPPART, I; HENKINBRANT, A; HAMELS, J; FASTREZ, J; DODEMONT, JP			A CASE OF LYMPHOCYTIC PNEUMONITIS, MYOSITIS, AND ARTHRITIS-ASSOCIATED WITH EXPOSURE TO ASPERGILLUS-NIGER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							DERMATOMYOSITIS; DISEASE		CLIN ST JOSEPH,DEPT MED,B-7000 MONS,BELGIUM; INST HGY & EPIDEMIOL,BRUSSELS,BELGIUM; CLIN ST JOSEPH,DEPT BIOL CLIN,MONS,BELGIUM; INST MORPHOL PATHOL,GERPINNES,BELGIUM; CLIN ST JOSEPH,DEPT THORAC SURG,MONS,BELGIUM									KIMMERLING EA, 1992, CHEST, V101, P870, DOI 10.1378/chest.101.3.870; NOLARD F, 1994, IN PRESS HLTH IMPLIC; RICHERSON HB, 1989, J ALLERGY CLIN IMMUN, V84, P839, DOI 10.1016/0091-6749(89)90349-7; SEMENZATO G, 1992, EUR RESPIR REV, V8, P69; TAZELAAR HD, 1990, AM REV RESPIR DIS, V141, P727, DOI 10.1164/ajrccm/141.3.727; TOPPING MD, 1985, BRIT J IND MED, V42, P312; WALLAERT B, 1986, PRESSE MED, V15, P1247; WIGGINS J, 1989, THORAX, V44, P440, DOI 10.1136/thx.44.5.440	8	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				1047	1049		10.1016/S0091-6749(95)70107-9	http://dx.doi.org/10.1016/S0091-6749(95)70107-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7751502				2022-12-18	WOS:A1995QY91700018
J	BOUTIN, Y; HEBERT, J				BOUTIN, Y; HEBERT, J			SUPPRESSION OF IMMUNE-RESPONSE TO LOL-P-I BY ADMINISTRATION OF IDIOTYPE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ANTIIDIOTYPIC; DOWN-REGULATION; IGE; LOL P I; PRETREATMENT	MURINE MONOCLONAL-ANTIBODIES; BALB-C MICE; T-CELL; ACTIVE IMMUNIZATION; ALLERGIC PATIENTS; IGE ANTIBODIES; IMMUNOTHERAPY; IMMUNOGLOBULIN; AUTOANTIBODIES; GENERATION	Background: Allergic diseases are characterized by an increased production of specific IgE antibodies. Suppression of IgE antibody production may be accomplished through idiotypic manipulation. Objective: Using an animal model, we explored the effects of anti-Lol p I monoclonal antibody administration on the subsequent IgE and IgG antibody response against Lol p I. Methods: Mice were treated with an anti-Lol p I monoclonal antibody (290A-167), which resulted in the production of anti-idiotypic antibodies as evidenced by their ability to bind to the Fab fraction of 290A-167 and to inhibit the binding of rabbit polyclonal anti-idiotypic antibodies to 290A-167. The animals were then immunized with Lol p I absorbed onto alum, and the immune response to the protein was analyzed. Results: Antigen-specific IgG(1) and IgE responses were strongly suppressed as determined by immunoassay. Suppression of anti-Lol p I IgE antibodies was confirmed by a reduction of end-point titers measured by passive cutaneous anaphylaxis. The suppression of antigen-specific antibody was accompanied by a reduction of anti-Lol p I antibody-producing spleen cells. Conclusion: These data indicate that pretreatment with 290A-167 can strongly downregulate the IgE response to the main allergen of ryegrass pollen, which is associated with an increase in anti-idiotypic antibodies. This approach could provide rapid, long-term hyposensitization in patients with grass pollen allergy.	CHU LAVAL, CTR RECH INFLAMMAT IMMUNOL RHUMATOL, Ste Foy, PQ G1V 4G2, CANADA; CHU LAVAL, CTR RECH, Ste Foy, PQ G1V 4G2, CANADA	Laval University; Laval University								AXELROD O, 1985, IMMUNOL LETT, V10, P347, DOI 10.1016/0165-2478(85)90130-0; BLASER K, 1982, PROG ALLERGY, V32, P203; BLASER K, 1980, J IMMUNOL, V125, P24; BLASER K, 1979, EUR J IMMUNOL, V9, P1017, DOI 10.1002/eji.1830091218; BOSE R, 1986, CLIN EXP IMMUNOL, V66, P231; BOSE R, 1984, J IMMUNOL, V133, P2474; BOUSQUET J, 1987, J ALLERGY CLIN IMMUN, V79, P947, DOI 10.1016/0091-6749(87)90245-4; BOUTIN Y, 1994, J ALLERGY CLIN IMMUN, V93, P1039, DOI 10.1016/S0091-6749(94)70053-2; BROWN CA, 1979, J IMMUNOL, V123, P2102; CASTRACANE JM, 1988, INT ARCH ALLER A IMM, V86, P288, DOI 10.1159/000234586; DEKOZAK Y, 1987, EUR J IMMUNOL, V17, P541, DOI 10.1002/eji.1830170417; DIETRICH G, 1990, J CLIN INVEST, V85, P620, DOI 10.1172/JCI114483; DOHI Y, 1979, J EXP MED, V150, P909, DOI 10.1084/jem.150.4.909; DWYER JM, 1992, NEW ENGL J MED, V326, P107; EDDY NK, 1987, J IMMUNOL, V138, P1693; FORD SA, 1986, INT ARCH ALLER A IMM, V81, P193, DOI 10.1159/000234134; FREIDHOFF LR, 1986, J ALLERGY CLIN IMMUN, V78, P1190, DOI 10.1016/0091-6749(86)90271-X; GEHA RS, 1986, ADV IMMUNOL, V39, P255; GEHA RS, 1983, J IMMUNOL, V130, P1634; HAHN BH, 1984, J IMMUNOL, V132, P187; HEBERT J, 1990, CLIN EXP IMMUNOL, V80, P413; HEYMAN B, 1990, IMMUNOL TODAY, V11, P310, DOI 10.1016/0167-5699(90)90126-T; HEYMAN B, 1982, J EXP MED, V155, P994, DOI 10.1084/jem.155.4.994; HORSFALL AC, 1988, CLIN EXP IMMUNOL, V71, P62; MACHIELS JJ, 1990, J CLIN INVEST, V85, P1024, DOI 10.1172/JCI114532; MAZER BD, 1991, J ALLERGY CLIN IMMUN, V87, P976, DOI 10.1016/0091-6749(91)90420-S; MECHERI S, 1988, IMMUNOLOGY, V64, P11; MOURAD W, 1986, IMMUNOL INVEST, V15, P801, DOI 10.3109/08820138609036364; MOURAD W, 1988, MOL IMMUNOL, V25, P899, DOI 10.1016/0161-5890(88)90127-7; MOURAD W, 1989, MOL IMMUNOL, V26, P1051, DOI 10.1016/0161-5890(89)90069-2; MOURAD W, 1986, J IMMUNOL METHODS, V89, P53, DOI 10.1016/0022-1759(86)90031-1; MOURAD W, 1988, J IMMUNOL, V141, P3486; NEILSON EG, 1982, J EXP MED, V155, P179, DOI 10.1084/jem.155.1.179; NYDEGGER UE, 1984, VOX SANG, V47, P92, DOI 10.1111/j.1423-0410.1984.tb01567.x; NYDEGGER UE, 1989, CLIN IMMUNOL IMMUNOP, V53, pS72, DOI 10.1016/0090-1229(89)90072-X; SAEKI Y, 1989, J IMMUNOL, V142, P1046; SAINTREMY JMR, 1988, EUR J IMMUNOL, V18, P83, DOI 10.1002/eji.1830180113; SULTAN Y, 1987, P NATL ACAD SCI USA, V84, P828, DOI 10.1073/pnas.84.3.828; TARKOWSKI A, 1984, J IMMUNOL METHODS, V72, P451, DOI 10.1016/0022-1759(84)90013-9; VELGEROUSSEL F, 1991, J IMMUNOL, V147, P3960; WEAVER M, 1983, J EXP MED, V157, P285, DOI 10.1084/jem.157.1.285; ZANETTI M, 1981, EUR J IMMUNOL, V11, P187, DOI 10.1002/eji.1830110306; ZANETTI M, 1986, J IMMUNOL, V137, P3140	43	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1995	95	3					751	758		10.1016/S0091-6749(95)70182-6	http://dx.doi.org/10.1016/S0091-6749(95)70182-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QM017	7897160				2022-12-18	WOS:A1995QM01700017
J	KUNA, P; REDDIGARI, SR; RUCINSKI, D; SCHALL, TJ; KAPLAN, AP				KUNA, P; REDDIGARI, SR; RUCINSKI, D; SCHALL, TJ; KAPLAN, AP			CHEMOKINES OF THE ALPHA,BETA-SUBCLASS INHIBIT HUMAN BASOPHILS RESPONSIVENESS TO MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR MONOCYTE CHEMOATTRACTANT PROTEIN-1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CHEMOKINES; CYTOKINES; HISTAMINE RELEASE; BASOPHILS	HISTAMINE-RELEASING-FACTOR; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; HUMAN INTERLEUKIN-8 RECEPTOR; INTERCRINE CYTOKINE FAMILY; HUMAN MONONUCLEAR-CELLS; MAST-CELLS; PEPTIDE-III; BIOCHEMICAL-CHARACTERIZATION; FUNCTIONAL EXPRESSION; RHEUMATOID-ARTHRITIS	Monocyte chemotactic and activating factor (MCAF) is the most potent cytokine that activates basophils to release histamine. The response of human basophils to either simultaneous or sequential addition of the chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta platelet factor (PF)4, connective tissue activating peptide III (CTAP-III), interleukin (IL)-8, and inflammatory protein (IP)-10 on MCAF-induced histamine release was studied Simultaneous addition of MCAF and any of the chemokines studied evoked an augmented response as measured by histamine release, whereas preincubation of leukocytes or purified basophils (80%) with these chemokines decreased MCAF-incduced histamine release in a dose-dependent manner. Histamine release by anti-IgE remained unchanged. When tested at 5 X 10(-9) mol/L, the decrease in histamine release by RANTES was 69.2% +/- 3.5%, by MIP-1 alpha 48.8% +/- 3.1%, by MIP-1 beta 42.9% +/- 3.1%, by PF4 56.5% +/- 2.9%, by IL-8 41.2% +/- 2.2 by CTAP III 27% +/- 4.4%, and by IP-10 15.3% +/- 2.6%. The peak inhibition of histamine release by the chemokines was reached within 10 minutes of preincubation with basophils and remained unchanged thereafter Washing basophils after preincubation with chemokines abolished the inhibition, with the exception of desensitization by low concentrations of MCAF. With the exclusion of MCAF and RANTES, none of the chemokines (at the concentration range of 5 X 10(-8) to 5 X 10(-11)) induced significant (>10% above spontaneous) histamine release from basophils. Preincubation of basophils with C5a (5 x 10(-10) mol/L) did not affect histamine release, whereas preincubation with granulocyte-macrophage colony-stimulating factor (10 ng/ml) or IL-5 (10 ng/ml) enhanced MCAF-induced histamine release by 121.8% +/- 10.1% and 108% +/- 20.8%, respectively. We have therefore characterized RANTES, MIP-1 alpha, MIP-1 beta CTAP III, PF4, IL-8, and IP-10 as inhibitors of MCAF-induced histamine release. Although the results are consistent with receptor blockade, the alpha and beta chemokines appear to interact with separate receptors linked to G proteins; thus a mechanism of receptor class desensitization is proposed Interaction of this group of cytokines at the site of allergic inflammation may modulate a function of basophils to initiate, augment, or inhibit histamine release.	SUNY STONY BROOK, HLTH SCI CTR T16, DEPT MED, DIV RHEUMATOL ALLERGY & CLIN IMMUNOL, STONY BROOK, NY 11794 USA; GENENTECH INC, SAN FRANCISCO, CA 94080 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Roche Holding; Genentech				Kuna, Piotr/0000-0003-2401-0070				ALAM R, 1992, J CLIN INVEST, V89, P723, DOI 10.1172/JCI115648; ALAM R, 1992, J EXP MED, V176, P781, DOI 10.1084/jem.176.3.781; ALAM R, 1992, AM J RESP CELL MOL, V7, P427, DOI 10.1165/ajrcmb/7.4.427; ALAM R, 1987, J ALLERGY CLIN IMMUN, V79, P103, DOI 10.1016/S0091-6749(87)80023-4; ALAM R, 1988, J CLIN INVEST, V82, P2056, DOI 10.1172/JCI113826; BAEZA ML, 1990, J CLIN INVEST, V85, P1516, DOI 10.1172/JCI114598; BEAVEN MA, 1972, CLIN CHIM ACTA, V37, P91, DOI 10.1016/0009-8981(72)90419-6; BISCHOFF SC, 1992, J EXP MED, V175, P1271, DOI 10.1084/jem.175.5.1271; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; CASTOR CW, 1983, P NATL ACAD SCI-BIOL, V80, P765, DOI 10.1073/pnas.80.3.765; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; DAHINDEN CA, 1989, J EXP MED, V170, P1787, DOI 10.1084/jem.170.5.1787; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; DUNLOP DJ, 1992, BLOOD, V79, P2221; DVORAK AM, 1984, CLIN IMMUNOL IMMUNOP, V32, P142, DOI 10.1016/0090-1229(84)90116-8; DVORAK HF, 1972, J EXP MED, V135, P235, DOI 10.1084/jem.135.2.235; DVORAK HF, 1971, J IMMUNOL, V106, P279; ELIAS J, 1986, J ALLERGY CLIN IMMUN, V78, P914, DOI 10.1016/0091-6749(86)90240-X; GRUBER B, 1986, ARTHRITIS RHEUM, V29, P944, DOI 10.1002/art.1780290802; HAAKFRENDSCHO M, 1988, J CLIN INVEST, V82, P17, DOI 10.1172/JCI113567; HIRAI K, 1988, J IMMUNOL, V141, P3958; HIRAI K, 1990, J EXP MED, V172, P1525, DOI 10.1084/jem.172.5.1525; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; KAPLAN AP, 1991, ADV IMMUNOL, V50, P237; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; KNAUER KA, 1981, NEW ENGL J MED, V304, P1404, DOI 10.1056/NEJM198106043042307; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; KOCH AE, 1993, CLIN RES, V41, pA316; KUNA P, 1992, J EXP MED, V175, P489, DOI 10.1084/jem.175.2.489; KUNA P, 1992, J IMMUNOL, V149, P636; KUNA P, 1993, J IMMUNOL, V150, P1932; KUNA P, 1991, J IMMUNOL, V147, P1920; KUNA P, 1992, CLIN RES, V40, pA228; KUNA P, 1989, J ALLERGY CLIN IMMUN, V83, P816, DOI 10.1016/0091-6749(89)90020-1; LEE J, 1992, J BIOL CHEM, V267, P16283; LEONARD EJ, 1991, ADV EXP MED BIOL, V305, P57; LEONARD EJ, 1984, J LEUKOCYTE BIOL, V35, P169; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; MACDONALD SM, 1989, J IMMUNOL, V142, P3527; MCLAREN KM, 1980, THROMB RES, V19, P293, DOI 10.1016/0049-3848(80)90431-4; MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427; MOSER B, 1991, J BIOL CHEM, V266, P10666; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PEICHL P, 1991, SCAND J IMMUNOL, V34, P333, DOI 10.1111/j.1365-3083.1991.tb01554.x; REDDIGARI SR, 1992, J ALLERGY CLIN IMMUN, V89, P666, DOI 10.1016/0091-6749(92)90372-9; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; SNYDERMAN R, 1992, INFLAMMATION BASIC P, P421; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; THUESON DO, 1979, J IMMUNOL, V123, P626; WANG JM, 1993, J EXP MED, V177, P699, DOI 10.1084/jem.177.3.699; WANG JM, 1993, J IMMUNOL, V150, P3022; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; ZACHARIAE COC, 1990, J EXP MED, V171, P2177, DOI 10.1084/jem.171.6.2177	65	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1995	95	2					574	586		10.1016/S0091-6749(95)70320-9	http://dx.doi.org/10.1016/S0091-6749(95)70320-9			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH697	7531729				2022-12-18	WOS:A1995QH69700010
J	DEBLAY, F; KOPFERSCHMITT, MC; GRIESS, P; LINDER, J; MAHR, L; VEROT, A; PAULI, G				DEBLAY, F; KOPFERSCHMITT, MC; GRIESS, P; LINDER, J; MAHR, L; VEROT, A; PAULI, G			COMPARISON BETWEEN FEL-D-I LEVELS PROVOKING RESPIRATORY SYMPTOMS AT HOME AND DURING BRONCHIAL CHALLENGE TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				262	262						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400484
J	SEMINARIO, MC; SQUILLACE, D; BARDIN, PG; FRAENKEL, DJ; GLEICH, GJ; JOHNSTON, SL				SEMINARIO, MC; SQUILLACE, D; BARDIN, PG; FRAENKEL, DJ; GLEICH, GJ; JOHNSTON, SL			INCREASED LEVELS OF EOSINOPHIL MAJOR BASIC-PROTEIN IN NASAL SECRETIONS IN RHINOVIRUS INFECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Johnston, Sebastian Lennox/I-2423-2012	Johnston, Sebastian Lennox/0000-0003-3009-9200					0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				259	259						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400472
J	HODGSON, M; STOREY, E				HODGSON, M; STOREY, E			PATIENTS AND THE SICK BUILDING SYNDROME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SICK BUILDING SYNDROME; OCCUPATIONAL DISEASE	VOLATILE ORGANIC-COMPOUNDS; OFFICE EYE SYNDROME; WORKERS; IRRITATION; SYMPTOMS	Physicians encounter patients who have complaints related to indoor environments with increasing frequency. Physicians must distinguish between approaches to identify disease in individual patients, characterization of group effects, and analysis of environmental exposure characteristics. Simultaneously they must consider the influence of illness behavior, work stress, and organization function on the presentation of complaints. They must distinguish discomfort and irritation from disabling disease and communicate the implications of pathophysiology and the limits of knowledge to patients. Joint teams with engineers and industrial hygienists, and at times, organizational analysis is an approach to problem solving for indoor environmental problems.			HODGSON, M (corresponding author), UNIV CONNECTICUT, SCH MED, DEPT MED, ENVIRONM & OCCUPAT MED SECT, STORRS, CT 06269 USA.							APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; BAKER EL, 1986, J OCCUP ENVIRON MED, V28, P126; BASCOM R, 1991, J PHARMACOL EXP THER, V259, P1323; BASCOM R, 1991, ENVIRON HEALTH PERSP, V95, P39, DOI 10.2307/3431104; BAUER RM, 1992, J CONSULT CLIN PSYCH, V60, P213, DOI 10.1037/0022-006X.60.2.213; BOLLA KI, 1991, ENVIRON HEALTH PERSP, V95, P93, DOI 10.2307/3431113; BREYSSE PA, 1993, 1992 P ENV PEOPL C I, P13; BURGE PS, 1990, P INDOOR AIR 90, V5, P1; BURGE PS, 1990, P INDOOR AIR, V1, P575; BURGE S, 1987, ANN OCCUP HYG, V31, P493, DOI 10.1093/annhyg/31.4A.493; COMETTOMUNIZ JE, 1992, ANN NY ACAD SCI, V641, P137, DOI 10.1111/j.1749-6632.1992.tb16539.x; DALES RE, 1989, AM REV RESPIR DIS, V139, P1459, DOI 10.1164/ajrccm/139.6.1459; FANGER PO, 1988, ENERG BUILDINGS, V12, P7, DOI 10.1016/0378-7788(88)90052-7; FINNEGAN MJ, 1984, BRIT MED J, V289, P1573, DOI 10.1136/bmj.289.6458.1573; FRANCK C, 1991, ACTA OPHTHALMOL, V69, P737; FRANCK C, 1986, ACTA OPHTHALMOL, V64, P306; FRANCK C, 1989, ACTA OPHTHALMOL, V67, P61; FRANCK C, 1991, INDOOR AIR, V1, P5; HANSEN LF, 1991, INDOOR AIR, V2, P95; HODGSON M, 1993, J OCCUP ENVIRON MED, V35, P375; HODGSON M, 1994, IN PRESS J ALLERGY C; HODGSON MJ, 1989, OCCUP MED, V4, P593; HODGSON MJ, 1986, 1986 P IND AIR QUALA, P1; HODGSON MJ, 1993, 1992 P ENV PEOPL C I, P47; HODGSON MJ, 1990, P INDOOR AIR, V1, P737; HOFFMAN RE, 1993, AM J PUBLIC HEALTH, V83, P89, DOI 10.2105/AJPH.83.1.89; HOUSE JS, 1986, J HEALTH SOC BEHAV, V27, P62, DOI 10.2307/2136503; KJAERGAARD SK, 1991, ATMOS ENVIRON A-GEN, V25, P1417; MIDDAUGH DA, 1992, J OCCUP ENVIRON MED, V34, P1197; MOLHAVE L, 1986, Environment International, V12, P167, DOI 10.1016/0160-4120(86)90027-9; MOLHAVE L, 1987, P INDOOR AIR 87, V2, P469; NIELSEN GD, 1991, CRIT REV TOXICOL, V21, P183, DOI 10.3109/10408449109089879; NORBACK D, 1990, SCAND J WORK ENV HEA, V16, P121, DOI 10.5271/sjweh.1808; OHM M, 1993, 1992 P ENV PEOPL C I, P41; RAFFERTY E, 1993, IN PRESS 1992 P ENVP; Rylander R, 1992, INDOOR ENVIRON, V1, P263; SKONER DP, 1990, NEW ENGL J MED, V322, P1323; SKOV P, 1989, SCAND J WORK ENV HEA, V15, P286, DOI 10.5271/sjweh.1851; Stolwijk J.A.J., 1992, ENV HLTH PERSPECT, V95, P99; Wolkoff P, 1992, J EXPOS ANAL ENV S1, P1; WOODS JE, 1989, OCCUP MED, V4, P753; 1993, IN PRESS AM IND HYG; [No title captured]	43	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				335	343		10.1053/ai.1994.v94.a56014	http://dx.doi.org/10.1053/ai.1994.v94.a56014			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG770	8077587	Bronze			2022-12-18	WOS:A1994PG77000009
J	TRUDEAU, WL; FERNANDEZCALDAS, E				TRUDEAU, WL; FERNANDEZCALDAS, E			IDENTIFYING AND MEASURING INDOOR BIOLOGIC AGENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Symposium on Building-Related and Home-Related Complaints and Illnesses: Sick Building Syndrome	DEC 03-05, 1992	LAKE BUENA VISTA, FL								TRUDEAU, WL (corresponding author), VET ADM MED CTR,UNIV S FLORIDA,COLL MED,DIV ALLERGY & IMMUNOL,111D,13000 BRUCE B DOWNS BLVD,TAMPA,FL 33612, USA.							BURGE HA, 1985, CLIN REV ALLERG, V3, P319, DOI 10.1007/BF02992998; HAMILTON S, 1992, NEW ENGL REV-MIDDLEB, V14, P96; HARRISON J, 1992, RESP MED, V86, P225, DOI 10.1016/S0954-6111(06)80060-0; HIRSCH DJ, 1978, J ALLERGY CLIN IMMUN, V62, P22, DOI 10.1016/0091-6749(78)90067-2; MACHER JM, 1991, ARCH ENVIRON HEALTH, V46, P25, DOI 10.1080/00039896.1991.9937425; MICHEL O, 1991, CLIN EXP ALLERGY, V21, P441, DOI 10.1111/j.1365-2222.1991.tb01684.x; MOREY PR, 1984, AM C GOVT IND HYGIEN, P121; MUILENBERG ML, 1989, IMMUNOL ALLERGY CLIN, V9, P245; SCHROBER G, 1991, ALLERGY, V46, P639; STROM G, 1990, INDOOR AIR 90, V1, P173; VERHOEFF AP, 1990, ALLERGY, V45, P275, DOI 10.1111/j.1398-9995.1990.tb00496.x	11	8	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1994	94	2	2				393	400		10.1016/0091-6749(94)90104-X	http://dx.doi.org/10.1016/0091-6749(94)90104-X			8	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG770	8077597				2022-12-18	WOS:A1994PG77000019
J	FRITSCHE, R; BOREL, Y				FRITSCHE, R; BOREL, Y			PREVENTION OF ALLERGIC SENSITIZATION TO BETA-LACTOGLOBULIN WITH CONJUGATES MADE OF BETA-LACTOGLOBULIN COUPLED TO ISOLOGOUS IMMUNOGLOBULIN-G	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ALLERGY PREVENTION; BETA-LACTOGLOBULIN; ISOLOGOUS IGG; TOLEROGEN	GAMMA-GLOBULIN; MILK; PROTEINS; SUPPRESSION; RESPONSES; COMPLEXES; CHILDREN; ASTHMA; CELLS; MICE	We have shown that, under certain conditions, a single dose of a conjugate of beta-lactoglobulin linked to isologous IgG suppresses specific antibody responses (IgE, IgG, and IgA) in rats immunized with beta-lactoglobulin. This suppression is allergen specific. If also appears to be effective when animals are first immunized and then tolerized. In addition, administration of the beta-lactoglobulin-IgG tolerogen abolishes mast cell mediator release. This has been shown both in vivo and with passively sensitized mast cells in vitro. We propose that the construction of a tolerogen made of whole protein allergen linked to IgG could provide a novel specific therapy for allergic reactions.	NESTEC LTD,NESTLE RES CTR,CH-1000 LAUSANNE 26,SWITZERLAND	Nestle SA								BOREL H, 1990, J IMMUNOL METHODS, V126, P159, DOI 10.1016/0022-1759(90)90146-M; BOREL Y, 1980, IMMUNOL REV, V50, P71, DOI 10.1111/j.1600-065X.1980.tb00308.x; BOREL Y, 1976, NATURE, V261, P49, DOI 10.1038/261049a0; BOREL Y, 1988, J CLIN INVEST, V82, P1901, DOI 10.1172/JCI113808; BOREL Y, 1975, J EXP MED, V142, P1254, DOI 10.1084/jem.142.5.1254; BRUNNER JR, 1981, J DAIRY SCI, V64, P1038, DOI 10.3168/jds.S0022-0302(81)82682-3; DEWIT D, 1992, J EXP MED, V175, P9, DOI 10.1084/jem.175.1.9; DINER UE, 1979, J IMMUNOL, V122, P1886; FRITSCHE R, 1990, INT ARCH ALLER A IMM, V93, P289, DOI 10.1159/000235256; GEHA RS, 1980, J CLIN INVEST, V65, P1509, DOI 10.1172/JCI109816; HAYGLASS KT, 1990, CLIN EXP IMMUNOL, V82, P429; HUSBY S, 1990, ALLERGY, V45, P547, DOI 10.1111/j.1398-9995.1990.tb00530.x; KATZ DH, 1971, J EXP MED, V134, P201, DOI 10.1084/jem.134.1.201; KILSHAW PJ, 1984, INT ARCH ALLER A IMM, V75, P8, DOI 10.1159/000233582; LIFSCHITZ CH, 1988, J PEDIATR GASTR NUTR, V7, P141, DOI 10.1097/00005176-198801000-00026; MACHIELS JJ, 1990, J CLIN INVEST, V85, P1024, DOI 10.1172/JCI114532; MORIMOTO C, 1983, J CLIN INVEST, V71, P1402, DOI 10.1172/JCI110893; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MUCKERHEIDE A, 1977, J IMMUNOL, V119, P1340; PESCE AJ, 1990, INT ARCH ALLER A IMM, V92, P88, DOI 10.1159/000235230; POULSEN LK, 1989, ALLERGY, V44, P132, DOI 10.1111/j.1398-9995.1989.tb02236.x; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; SEHON AH, 1991, INT ARCH ALLER A IMM, V94, P11, DOI 10.1159/000235318; TAYLOR SL, 1986, J FOOD PROTECT, V49, P239, DOI 10.4315/0362-028X-49.3.239	24	8	11	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1994	93	4					778	786		10.1016/0091-6749(94)90258-5	http://dx.doi.org/10.1016/0091-6749(94)90258-5			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NH497	8163787				2022-12-18	WOS:A1994NH49700011
J	HARTMAN, CT; FREDERICKS, GL; KATZ, ES; BROWN, CA				HARTMAN, CT; FREDERICKS, GL; KATZ, ES; BROWN, CA			PREVALENCE OF SYMPTOMATIC FORMULA INTOLERANCE AND ALLERGY IN A GENERAL INFANT POPULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				210	210						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700285
J	HOVANECBURNS, D; JAGGI, K; CORRAO, M; ORDONEZ, M; BRAGG, A; UNVER, E				HOVANECBURNS, D; JAGGI, K; CORRAO, M; ORDONEZ, M; BRAGG, A; UNVER, E			CROSS-REACTIVITY BETWEEN LATEX AND FICUS ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ünver, Edhem/ABF-8926-2020						0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				283	283						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700724
J	LEE, BJ; NACLERIO, RM; BOCHNER, BS; BAROODY, FM				LEE, BJ; NACLERIO, RM; BOCHNER, BS; BAROODY, FM			UP-REGULATION OF VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) AFTER NASAL ALLERGEN (AG) CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				183	183						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700123
J	MACDONALD, SM; NACLERIO, RM; HAMILTON, RG; LANGDON, JM; WHITE, JM; LICHTENSTEIN, LM				MACDONALD, SM; NACLERIO, RM; HAMILTON, RG; LANGDON, JM; WHITE, JM; LICHTENSTEIN, LM			CYTOKINE MEASUREMENTS IN PATIENTS RECEIVING STANDARD IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1993, JCI, V92, P644	1	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				230	230						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700407
J	MELTZER, SS; JOHNS, MA; RECHSTEINER, EA; JUNGERWIRTH, S; DAMICO, JM; BLEECKER, ER				MELTZER, SS; JOHNS, MA; RECHSTEINER, EA; JUNGERWIRTH, S; DAMICO, JM; BLEECKER, ER			BRONCHODILATORY EFFECTS OF BAY1005, A 5-LIPOXYGENASE INHIBITOR, IN MILD-TO-MODERATE ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV MARYLAND,DEPT MED,BALTIMORE,MD 21201; MILES INC,DIV PHARMACEUT,W HAVEN,CT	University System of Maryland; University of Maryland Baltimore									0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				294	294						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700791
J	SHINOMIYA, N; KUMAI, M; MARSH, DG; HUANG, SK				SHINOMIYA, N; KUMAI, M; MARSH, DG; HUANG, SK			DETECTION OF SPECIFIC IGE-SECRETING CELLS WITH AN ENZYME-LINKED IMMUNOSPOT ASSAY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ALLERGEN-SPECIFIC IGE PRODUCTION; ENZYME-LINKED IMMUNOSPOT ASSAY; RAGWEED	HELPER T-CELLS; HUMAN B-CELLS; COGNATE INTERACTIONS; RAGWEED POLLEN; ELISPOT ASSAY; INTERLEUKIN-4; INVITRO; INDUCTION; CLONES; GAMMA	Background: An in vitro assay system for monitoring the induction of human allergen-specific IgE synthesis with an enzyme-linked immunospot assay is described. Methods: IgE-secreting cells, responding specifically to short ragweed pollen allergens. Amb a V and Amb a VI, were directly enumerated after the coculture of high-density, resting B cells with either autologous T cells or allergen-specific T-cell clones from the peripheral blood of two ragweed-allergic individuals. Both T-cell clones were type 2-like T helper cells (T(H2)) as determined by reverse transcription polymerase chain reaction. The IgE-producing cells were detected on a nitrocellulose-based paper disc coated with antigen after treatment with biotinylated, anti-human IgE and avidin-peroxidase conjugate. Results: We demonstrated the induction of Amb a V- or Amb a VI-specific IgE synthesis from either peripheral blood B cells or purified resting B cells. Specific IgE-secreting B cells could be detected only when T cells were present in the culture, providing that they were not separated by a membrane. The addition of interleukin-4 had an enhancing effect on the overall numbers of IgE-secreting cells and allergen-specific T cells and a synergistic effect in the coculture of B cells and an autoreactive T-cell line. Conclusions: These results suggest that cognate interaction T and B cells is required for the de novo induction of IgE responses. This in vitro system could thus provide a useful model for analysis of the molecular and cellular mechanisms that regulate the allergen-specific IgE responses in human beings.	JOHNS HOPKINS UNIV,SCH MED,JOHNS HOPKINS ASTHMA & ALLERGY CTR,5501 HOPKINS BAYVIEW CIRCLE,BALTIMORE,MD 21224	Johns Hopkins University; Johns Hopkins Medicine			Huang, Shau-Ku/F-5509-2010		NIAID NIH HHS [AI20059] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020059] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARTLETT WC, 1990, J IMMUNOL, V145, P3956; BRENNER CA, 1989, BIOTECHNIQUES, V7, P1096; BRIAN AA, 1988, P NATL ACAD SCI USA, V85, P564, DOI 10.1073/pnas.85.2.564; CHEN SS, 1990, J IMMUNOL METHODS, V135, P129, DOI 10.1016/0022-1759(90)90265-W; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; CZERKINSKY C, 1988, J IMMUNOL METHODS, V110, P29, DOI 10.1016/0022-1759(88)90079-8; DELPRETE G, 1988, J IMMUNOL, V140, P4193; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; HUANG SK, 1991, EUR J IMMUNOL, V21, P1469, DOI 10.1002/eji.1830210621; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; LANZAVECCHIA A, 1984, CLIN EXP IMMUNOL, V55, P197; NOELLE RJ, 1991, J IMMUNOL, V146, P1118; PARRONCHI P, 1990, J IMMUNOL, V144, P2102; RICCI M, 1985, INT ARCH ALLER A IMM, V77, P32, DOI 10.1159/000233749; ROEBBER M, 1985, J IMMUNOL, V134, P3062; ROEBBER M, 1983, J IMMUNOL, V131, P706; ROMAGNANI S, 1987, J IMMUNOL, V138, P1744; Sambrook J., 1989, MOL CLONING LAB MANU; SEKITA K, 1988, EUR J IMMUNOL, V18, P1405, DOI 10.1002/eji.1830180916; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7; UMETSU DT, 1985, J EXP MED, V162, P202, DOI 10.1084/jem.162.1.202; VERCELLI D, 1989, J EXP MED, V169, P1295, DOI 10.1084/jem.169.4.1295	24	8	8	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1993	92	3					479	487		10.1016/0091-6749(93)90127-2	http://dx.doi.org/10.1016/0091-6749(93)90127-2			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LX309	7689603				2022-12-18	WOS:A1993LX30900014
J	KALINER, MA				KALINER, MA			HOW THE CURRENT UNDERSTANDING OF THE PATHOPHYSIOLOGY OF ASTHMA INFLUENCES OUR APPROACH TO THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BRONCHIAL HYPERRESPONSIVENESS; BECLOMETHASONE DIPROPIONATE; IMMUNOTHERAPY; SODIUM; RESPONSIVENESS; PATHOGENESIS; RESPONSES; RHINITIS; ADHESION; TRIAL	Asthma can no longer be equated with bronchospasm; instead, we know now that this disease is due to combinations of mucosal edema and inflammation, increased secretions, and muscle contraction. The appreciation of the contribution of these various causes of airflow obstruction and the role that inflammation plays in asthma dictates that we approach treatment using two parallel modalities: (1) symptomatic drugs that act to relieve the airflow obstruction but have no effects on the underlying causes of the disease (e.g., bronchodilators such as beta-adrenergic agonists, theophylline, and anticholinergic compounds) and (2) specific treatment aimed at preventing or reversing the underlying causes responsible for the disease. Four specific treatments are available today. allergen avoidance, immunotherapy, cromolyn sodium, and inhaled corticosteroids. Management of asthma in the 1990s requires that all patients receive specific treatments intended to reduce the disease processes and that symptomatic treatment be used only as necessary.			KALINER, MA (corresponding author), NIAID,ALLERG DIS SECT,BETHESDA,MD 20892, USA.							BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BEL EH, 1990, AM REV RESPIR DIS, V141, P21, DOI 10.1164/ajrccm/141.1.21; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; FURAKAWA CT, 1988, J ALLERGY CLIN IMMUN, V81, P83; KALINER M, 1987, JAMA-J AM MED ASSOC, V258, P2851, DOI 10.1001/jama.258.20.2851; KALINER M, 1976, TXB IMMUNOPATHOLOGY, P387; KLEIN LM, 1989, P NATL ACAD SCI USA, V86, P8972, DOI 10.1073/pnas.86.22.8972; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LEMANSKE RF, 1988, ALLERGY PRINCIPLES P, P224; MURRAY AB, 1983, PEDIATRICS, V71, P418; OHMAN JL, 1984, J ALLERGY CLIN IMMUN, V74, P230, DOI 10.1016/0091-6749(84)90251-3; PEDEN DB, IN PRESS IMMUNOL ALL; PETTY TL, 1989, AM REV RESPIR DIS, V139, P694, DOI 10.1164/ajrccm/139.3.694; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; PLATTSMILLS TAE, 1982, LANCET, V2, P675; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; RAK S, 1988, J ALLERGY CLIN IMMUN, V82, P470, DOI 10.1016/0091-6749(88)90021-8; RANKIN JA, 1989, J ALLERGY CLIN IMMUN, V83, P722, DOI 10.1016/0091-6749(89)90005-5; VANMETRE TE, 1988, J ALLERGY CLIN IMMUN, V82, P1055, DOI 10.1016/0091-6749(88)90144-3; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; WEINBERGER M, 1984, J ALLERGY CLIN IMMUN, V73, P525, DOI 10.1016/0091-6749(84)90505-0	23	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	2				144	147		10.1016/0091-6749(93)90096-X	http://dx.doi.org/10.1016/0091-6749(93)90096-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ354	8335861	Bronze			2022-12-18	WOS:A1993LQ35400002
J	SONENTHAL, KR; GRAMMER, LC; PATTERSON, R				SONENTHAL, KR; GRAMMER, LC; PATTERSON, R			DO SOME PATIENTS WITH ATOPIC-DERMATITIS REQUIRE LONG-TERM ORAL STEROID-THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							PERCUTANEOUS-ABSORPTION; HYDROCORTISONE; CHILDREN		NORTHWESTERN UNIV, SCH MED,DEPT MED,DIV ALLERGY IMMUNOL, 303 E CHICAGO,TARRY 3-711, CHICAGO, IL 60611 USA	Northwestern University				Grammer, Leslie/0000-0001-6860-2014				AKERS WA, 1980, ARCH DERMATOL, V116, P786, DOI 10.1001/archderm.116.7.786; BUSINCO L, 1989, ALLERGY, V44, P70, DOI 10.1111/j.1398-9995.1989.tb04320.x; CARRUTHERS JA, 1975, BMJ-BRIT MED J, V4, P203, DOI 10.1136/bmj.4.5990.203; DAVID TJ, 1987, ARCH DIS CHILD, V62, P876, DOI 10.1136/adc.62.9.876; HANIFIN JM, 1989, ALLERGY PROC, V10, P397, DOI 10.2500/108854189778935827; HANIFIN JM, 1988, ALLERGY PRINCIPLES P, P1403; HARTER JG, 1963, NEW ENGL J MED, V269, P591, DOI 10.1056/NEJM196309192691201; KAPLAN AP, 1987, JAMA-J AM MED ASSOC, V258, P2900, DOI 10.1001/jama.258.20.2900; MACGREGO.RR, 1969, NEW ENGL J MED, V280, P1427, DOI 10.1056/NEJM196906262802601; RASMUSSEN JE, 1978, ARCH DERMATOL, V114, P1165, DOI 10.1001/archderm.114.8.1165; RASMUSSEN JE, 1989, ALLERGY, V44, P108; THIERS BH, 1989, ALLERGY PROC, V10, P413, DOI 10.2500/108854189778935809; TRUHAN AP, 1989, ANN ALLERGY, V62, P375; TURPEINEN M, 1986, BRIT J DERMATOL, V115, P475, DOI 10.1111/j.1365-2133.1986.tb06242.x; TURPEINEN M, 1988, BRIT J DERMATOL, V118, P517, DOI 10.1111/j.1365-2133.1988.tb02461.x; VICKERS CF, 1989, ACTA DERM-VENEREOL, P23	16	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1993	91	5					971	973		10.1016/0091-6749(93)90208-W	http://dx.doi.org/10.1016/0091-6749(93)90208-W			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LC978	8491946				2022-12-18	WOS:A1993LC97800002
J	ATKINS, PC; VONALLMEN, C; MOSKOVITZ, A; VALENZANO, M; ZWEIMAN, B				ATKINS, PC; VONALLMEN, C; MOSKOVITZ, A; VALENZANO, M; ZWEIMAN, B			FIBRIN FORMATION DURING ONGOING CUTANEOUS ALLERGIC REACTIONS - COMPARISON OF RESPONSES TO ANTIGEN AND CODEINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						COAGULATION; FIBRIN; FIBRINOPEPTIDE-A; ANTIGEN; CODEINE; SKIN CHAMBER; LATE PHASE RESPONSES; MAST CELLS; BASOPHILS; HISTAMINE; IGG	MEDIATOR RELEASE; HAGEMAN-FACTOR; HUMAN-LUNG; ACTIVATION; HISTAMINE; SKIN; CHALLENGE	Background: Fibrin formation, assessed by fibrinopeptide A levels, was evaluated over a 5-hour period al skin chamber sites challenged continuously with pollen antigen or codeine in 10 reactive individuals. Methods: The levels of fibrinopeptide A at antigen sites were compared with those at sites challenged with buffer diluent alone or with codeine for the first 3 hours, followed by antigen challenge during the subsequent 2 hours. Results: Findings showed: (1) fibrinopeptide A levels were higher at antigen challenge sites than at codeine challenge sites by the third hour, with these levels at both sites greater than those at buffer sites; (2) antigen challenge of the previous codeine sites during the third to fifth hours led to a further increase in fibrinopeptide A levels; (3) fibrinopeptide A levels correlated with chamber fluid immunoglobulin G levels but not with chamber fluid histamine levels. Conclusions: Because antigen and codeine both activate mast cells prominently, these findings suggest that other factors play a role in the persistent fibrin formation at allergic skin reaction sites. Because antigen activates both basophils and mast cells and codeine only activates mast cells, we conclude that both basophils and mast cells contribute to the persistent fibrin formation at sites of allergic reactions.	UNIV PENN,SCH MED,DEPT MED,DIV ALLERGY & IMMUNOL,PHILADELPHIA,PA 19104	University of Pennsylvania					NIAID NIH HHS [AI-14332] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATKINS PC, 1982, J ALLERGY CLIN IMMUN, V69, P39, DOI 10.1016/0091-6749(82)90085-9; ATKINS PC, 1987, J IMMUNOL, V139, P2744; ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P360, DOI 10.1016/S0091-6749(05)80099-5; ATKINS PC, 1992, J ALLERGY CLIN IMMUN, V89, P552, DOI 10.1016/0091-6749(92)90322-S; DESHAZO RD, 1979, J IMMUNOL, V122, P692; MEIER HL, 1983, J CLIN INVEST, V72, P574, DOI 10.1172/JCI111005; NEWBALL HH, 1981, T ASSOC AM PHYSICIAN, V94, P126; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V83, P691, DOI 10.1016/0091-6749(89)90084-5; TALBOT SF, 1984, J ALLERGY CLIN IMMUN, V74, P819, DOI 10.1016/0091-6749(84)90185-4	9	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1993	91	4					956	960		10.1016/0091-6749(93)90354-I	http://dx.doi.org/10.1016/0091-6749(93)90354-I			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KY251	7682581				2022-12-18	WOS:A1993KY25100017
J	RAO, PVS; SHANTI, KN; MARTIN, B; VEKATRAMAN, G; NAGPAL, S; METCALFE, DD				RAO, PVS; SHANTI, KN; MARTIN, B; VEKATRAMAN, G; NAGPAL, S; METCALFE, DD			TROPOMYOSIN IS THE MAJOR SHRIMP ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Srinivasa Rao, Prof. P/ABG-1688-2021	Srinivasa Rao, Prof. P/0000-0003-1379-4906					0	8	8	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				341	341						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100799
J	WALLS, AF; HE, SH; TERAN, LM; HOLGATE, ST				WALLS, AF; HE, SH; TERAN, LM; HOLGATE, ST			MAST-CELL PROTEASES AS MEDIATORS OF VASCULAR LEAKAGE AND CELL ACCUMULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Teran, Luis/AAI-9815-2021						0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				256	256						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100462
J	COCKCROFT, DW				COCKCROFT, DW			BETA-AGONISTS, AIRWAY HYPERRESPONSIVENESS, AND ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							HISTAMINE-INDUCED ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; SODIUM CROMOGLYCATE; INDUCED BRONCHOCONSTRICTION; PRESCRIBED FENOTEROL; INHALED SALBUTAMOL; RESPONSIVENESS; HYPERREACTIVITY; METHACHOLINE; CHILDREN				COCKCROFT, DW (corresponding author), UNIV SASKATCHEWAN,DEPT MED,DIV RESP MED,ELLIS HALL,5TH FLOOR,SASKATOON S7N OXO,SASKATCHEWAN,CANADA.							AHRENS RC, 1984, AM REV RESPIR DIS, V129, P903; BANDOUVAKIS J, 1981, BRIT J DIS CHEST, V75, P295, DOI 10.1016/0007-0971(81)90009-7; CASTERLINE CL, 1977, J ALLERGY CLIN IMMUN, V59, P420, DOI 10.1016/0091-6749(77)90004-5; COCKCROFT DW, 1991, J ALLERGY CLIN IMMUN, V87, P914, DOI 10.1016/0091-6749(91)90412-H; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; COCKCROFT DW, 1977, THORAX, V32, P429, DOI 10.1136/thx.32.4.429; COCKCROFT DW, 1991, ASTHMA ITS PATHOLOGY, P51; CRANE J, 1989, LANCET, V1, P917; DAVIES SE, 1968, BRIT MED J, V3, P593, DOI 10.1136/bmj.3.5618.593; GRAINGER J, 1991, THORAX, V46, P105, DOI 10.1136/thx.46.2.105; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; JUNIPER EF, 1981, THORAX, V36, P575, DOI 10.1136/thx.36.8.575; JUNIPER EF, 1987, CLIN ALLERGY, V17, P523, DOI 10.1111/j.1365-2222.1987.tb02048.x; KEIGHLEY JF, 1966, ANN INTERN MED, V65, P985, DOI 10.7326/0003-4819-65-5-985; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; KIRBY JG, 1987, AM REV RESPIR DIS, V136, P379, DOI 10.1164/ajrccm/136.2.379; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; LOWHAGEN O, 1985, J ALLERGY CLIN IMMUN, V75, P460, DOI 10.1016/S0091-6749(85)80018-X; MAGNUSSEN H, 1992, J ALLERGY CLIN IMMUN, V90, P816; MITCHELL EA, 1989, THORAX, V44, P81, DOI 10.1136/thx.44.2.81; MURRAY AB, 1983, PEDIATRICS, V71, P418; MURRAY AB, 1981, J ALLERGY CLIN IMMUN, V68, P119, DOI 10.1016/0091-6749(81)90169-X; PAUWELS R, 1988, CLIN ALLERGY, V18, P317, DOI 10.1111/j.1365-2222.1988.tb02878.x; PEARCE N, 1990, THORAX, V45, P170, DOI 10.1136/thx.45.3.170; PEEL ET, 1980, AM REV RESPIR DIS, V121, P973; PLATTSMILLS TAE, 1982, LANCET, V2, P675; RAES M, 1989, J ALLERGY CLIN IMMUN, V84, P874, DOI 10.1016/0091-6749(89)90382-5; RAMSDALE EH, 1991, AM REV RESPIR DIS, V143, P998, DOI 10.1164/ajrccm/143.5_Pt_1.998; REISMAN RE, 1970, J ALLERGY, V46, P162, DOI 10.1016/0021-8707(70)90095-X; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SIMONS FER, 1992, J ALLERGY CLIN IMMUN, V90, P810; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; TWENTYMAN OP, 1990, LANCET, V336, P1338, DOI 10.1016/0140-6736(90)92894-N; VANSCHAYCK CP, 1990, J ALLERGY CLIN IMMUN, V86, P793, DOI 10.1016/S0091-6749(05)80185-X; VATHENEN AS, 1988, LANCET, V1, P554; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WHITELAW WA, 1991, CHEST, V99, P1507, DOI 10.1378/chest.99.6.1507; WOOLCOCK AJ, 1988, CLIN ALLERGY, V18, P165, DOI 10.1111/j.1365-2222.1988.tb02856.x	38	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1992	90	5					739	741		10.1016/0091-6749(92)90096-K	http://dx.doi.org/10.1016/0091-6749(92)90096-K			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JZ319	1358931				2022-12-18	WOS:A1992JZ31900002
J	ROHR, AS; PAPPANO, JE				ROHR, AS; PAPPANO, JE			PROPHYLAXIS AGAINST FLUORESCEIN-INDUCED ANAPHYLACTOID REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							INTRAVENOUS FLUORESCEIN				ROHR, AS (corresponding author), BRYN MAWR HOSP,BRYN MAWR MED BLDG S,SUITE 107,BRYN MAWR,PA 19010, USA.							ELLIS PP, 1980, T AM OPHTHAL SOC, V38, P191; KWITEROVICH KA, 1991, OPHTHALMOLOGY, V98, P1139; LIEBERMAN P, 1991, ANN ALLERGY, V67, P91; LIPSON BK, 1989, INT OPHTHALMOL CLIN, V29, P200, DOI 10.1097/00004397-198902930-00011; MARSHALL GD, 1991, ANN ALLERGY, V67, P70; STEIN MR, 1971, AM J OPHTHALMOL, V72, P861, DOI 10.1016/0002-9394(71)91681-3	6	8	10	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1992	90	3	1				407	408		10.1016/S0091-6749(05)80022-3	http://dx.doi.org/10.1016/S0091-6749(05)80022-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JP520	1527324				2022-12-18	WOS:A1992JP52000020
J	SAFF, RH; FINK, JN				SAFF, RH; FINK, JN			ANAPHYLAXIS TO CHICKEN SOUP - A CASE-REPORT AND A BRIEF-HISTORY OF THE CHICKEN IN MEDICINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									MED COLL WISCONSIN,DIV ALLERGY IMMUNOL,MILWAUKEE,WI 53226	Medical College of Wisconsin								ANDERSON JA, 1987, JAMA-J AM MED ASSOC, V258, P2891, DOI 10.1001/jama.258.20.2891; CAROLINE NL, 1975, CHEST, V67, P215, DOI 10.1378/chest.67.2.215; SAXON A, 1987, ANN INTERN MED, V107, P204, DOI 10.7326/0003-4819-107-2-204; SMITH P, 1975, CHICKEN BOOK, P1	4	8	10	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1992	89	5					1061	1062		10.1016/0091-6749(92)90229-U	http://dx.doi.org/10.1016/0091-6749(92)90229-U			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HU542	1583247				2022-12-18	WOS:A1992HU54200017
J	SMITH, CH; SOH, C; LEE, TH				SMITH, CH; SOH, C; LEE, TH			CUTANEOUS HISTAMINE-METABOLISM IN CHRONIC URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SKIN; URTICARIA; HISTAMINE; METABOLISM	CHRONIC IDIOPATHIC URTICARIA; SKIN HISTAMINE; COLD URTICARIA; RELEASE	Impaired metabolism of histamine in the skin of patients with chronic idiopathic urticaria (CIU) might explain the observed enhanced 1 and prolonged 2 skin responses to intradermal histamine. Histamine metabolism was measured in homogenates from unaffected forearm skin in nine patients with CIU and in skin of age- and sex-matched control subjects with a radiochromatographic assay, and the results are expressed as nanograms of histamine metabolized per milligram of protein per hour. Endogenous histamine content was determined by RIA. There was a highly significant increase in endogenous histamine content in the skin of patients with urticaria (407.8 +/- 188.3 ng/mg of protein) compared with that in skin of control subjects (240.0 +/- 73.0 ng/mg of protein) (mean +/- 1 SD; p < 0.02), which suggests either an increase in mast cell number or histamine concentration per cell. No significant difference was observed in the metabolism of histamine between patient and control group; therefore, an alternative mechanism may underlie differences in skin reactivity to histamine.	GUYS HOSP, DEPT ALLERGY & ALLIED RESP DISORDERS, ST THOMAS ST, LONDON SE1 9RT, ENGLAND	Guy's & St Thomas' NHS Foundation Trust			Lee, Tak/AAA-9526-2020; Smith, Catherine H./G-5268-2012	Lee, Tak/0000-0002-7554-4059; Smith, Catherine H./0000-0001-9918-1144				BEDARD PM, 1986, J ALLERGY CLIN IMMUN, V78, P1121, DOI 10.1016/0091-6749(86)90260-5; BRUNET C, 1988, J ALLERGY CLIN IMMUN, V82, P398, DOI 10.1016/0091-6749(88)90011-5; CHAMPION RH, 1990, CLIN EXP ALLERGY, V20, P221, DOI 10.1111/j.1365-2222.1990.tb02671.x; COHEN RW, 1986, J ALLERGY CLIN IMMUN, V77, P802, DOI 10.1016/0091-6749(86)90377-5; EADY RAJ, 1979, BRIT J DERMATOL, V100, P623, DOI 10.1111/j.1365-2133.1979.tb08065.x; FRANCIS D, 1977, BRIT J PHARMACOL, V60, P583, DOI 10.1111/j.1476-5381.1977.tb07538.x; FRANCIS DM, 1980, BIOCHEM J, V187, P819, DOI 10.1042/bj1870819; HADDOCK RC, 1987, J BIOL CHEM, V262, P10220; HERMAN JJ, 1982, AGENTS ACTIONS, V12, P46, DOI 10.1007/BF01965105; HESTERBERG R, 1984, AGENTS ACTIONS, V14, P324, DOI 10.1007/BF01973821; IMAMURA S, 1985, Journal of Dermatology (Tokyo), V12, P308; JUHLIN L, 1979, MAST CELL ITS ROLE H, P613; KAPLAN AP, 1978, J ALLERGY CLIN IMMUN, V61, P350, DOI 10.1016/0091-6749(78)90113-6; KEAHEY TM, 1980, ARCH DERMATOL, V116, P174, DOI 10.1001/archderm.116.2.174; KRAUSE LB, 1985, BRIT J CLIN PHARMACO, V20, P486, DOI 10.1111/j.1365-2125.1985.tb05103.x; LESSOF MH, 1990, CLIN EXP ALLERGY, V20, P373, DOI 10.1111/j.1365-2222.1990.tb02796.x; MAXWELL DL, 1990, J ALLERGY CLIN IMMUN, V86, P759, DOI 10.1016/S0091-6749(05)80180-0; MONROE EW, 1985, URTICARIAS, P205; NATBONY SF, 1983, J ALLERGY CLIN IMMUN, V71, P177, DOI 10.1016/0091-6749(83)90096-9; ORMEROD AD, 1988, J ALLERGY CLIN IMMUN, V82, P586, DOI 10.1016/0091-6749(88)90968-2; PHANUPHAK P, 1980, J ALLERGY CLIN IMMUN, V65, P371, DOI 10.1016/0091-6749(80)90215-8; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; SMITH CH, IN PRESS POLYAMINES; SNYDER SH, 1965, BIOCHIM BIOPHYS ACTA, V111, P416, DOI 10.1016/0304-4165(65)90051-6; ZEIGER RS, 1976, J LAB CLIN MED, V87, P1065; ZEIGER RS, 1976, J ALLERGY CLIN IMMUN, V58, P172, DOI 10.1016/0091-6749(76)90152-4	26	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1992	89	5					944	950		10.1016/0091-6749(92)90216-O	http://dx.doi.org/10.1016/0091-6749(92)90216-O			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HU542	1374771				2022-12-18	WOS:A1992HU54200004
J	SMITH, TF; SANCHEZLEGRAND, F; MCKEAN, LP; KUTNER, MH; CRAGOE, EJ; EATON, DC				SMITH, TF; SANCHEZLEGRAND, F; MCKEAN, LP; KUTNER, MH; CRAGOE, EJ; EATON, DC			ROLE OF SODIUM IN MEDIATOR RELEASE FROM HUMAN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HISTAMINE RELEASE; BASOPHILS; SODIUM	METHACHOLINE-INDUCED BRONCHOCONSTRICTION; PROTEIN-KINASE C; RAT MAST-CELLS; CYSTIC-FIBROSIS; INHALED FUROSEMIDE; HISTAMINE-RELEASE; ARACHIDONIC-ACID; RBL-2H3 CELLS; LUNG-DISEASE; AMILORIDE	We studied the effect of extracellular sodium concentration on histamine release (HR) from human basophils initiated by immunologic and nonimmunologic stimuli. We found that lowering extracellular sodium markedly enhances HR induced by an immunologic stimulus from these cells. In buffer in which sodium had been replaced with univalent ions of strong bases, enhancement of HR increased as extracellular sodium decreased. Enhancement was the result of increased duration of release. When sucrose was used for replacement of sodium, we also observed that enhancement of HR increased as extracellular sodium decreased, but there was some lessening of enhancement at [Na+], between 5 and 10 mmol/L. Ouabain, which is an inhibitor of the Na+/K+ adenosine triphosphatase, and bumetanide and furosemide, which are inhibitors of Cl--dependent Na+-K+ cotransport, caused small increases in enhancement of HR by sodium-deficient buffers; 4,4'-diisothiocyanostilbene-2-2'-disulfonic acid, an anion transport inhibitor, caused some inhibition of enhancement of HR. Analogues of amiloride, such as 5-(N-N-hexamethylene) amiloride (HMA) and 5-(N-4-chlorobenzyl)-2'4'dimethylbenzamil (CBDMB), inhibit Na+/H+ exchange, Na+/Ca++ exchange, and Na+ channels. Interestingly, at higher doses, HMA and CBDMB caused marked enhancement of HR in both normal and sodium-deficient buffers. These results suggest that several cellular regulatory mechanisms potentially are important for normal basophil secretion. The most likely are pH regulatory mechanisms that include Na+/H+ exchange and anion exchangers that transport alkaline equivalents. Our finding enhancement of basophil HR by HMA and CBDMB is particularly noteworthy in light of the recent interest in use of amiloride by inhalation for therapy of lung disease in patients with cystic fibrosis.	EMORY UNIV,SCH MED,DIV ALLERGY IMMUNOL & RESP MED,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,DIV CYST FIBROSIS,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOSTAT,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PHYSIOL,ATLANTA,GA 30322	Emory University; Emory University; Emory University; Emory University				Eaton, Douglas/0000-0002-2686-6692	NCRR NIH HHS [SO7RRO5364] Funding Source: Medline; NIAID NIH HHS [AI21072] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R23AI021072] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMELLAL M, 1985, BRIT J PHARMACOL, V85, P819, DOI 10.1111/j.1476-5381.1985.tb11080.x; APP EM, 1990, AM REV RESPIR DIS, V141, P605, DOI 10.1164/ajrccm/141.3.605; ATKINSON TP, 1988, J IMMUNOL, V141, P1307; BEAVEN MA, 1987, AGENTS ACTIONS, V20, P137, DOI 10.1007/BF02074652; BIANCO S, 1988, LANCET, V2, P252; BIANCO S, 1989, NEW ENGL J MED, V321, P1069, DOI 10.1056/NEJM198910193211602; BINCK M, 1985, AGENTS ACTIONS, V16, P118, DOI 10.1007/BF01983116; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; COCHRANE DE, 1976, J PHYSIOL-LONDON, V257, P433, DOI 10.1113/jphysiol.1976.sp011377; CUTHBERT AW, 1990, BRIT J CLIN PHARMACO, V29, P227, DOI 10.1111/j.1365-2125.1990.tb03624.x; FROUSSARD N, 1983, BIOCHEM PHARMACOL, V32, P3259; GRUBBE RE, 1990, J ALLERGY CLIN IMMUN, V85, P881, DOI 10.1016/0091-6749(90)90072-C; HOOK WA, 1981, IMMUNOLOGY, V43, P723; KANNER BI, 1984, J BIOL CHEM, V259, P188; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; KNOWLES MR, 1990, NEW ENGL J MED, V322, P1189, DOI 10.1056/NEJM199004263221704; LASTOWECKA A, 1974, J PHYSIOL-LONDON, V236, P681, DOI 10.1113/jphysiol.1974.sp010460; LINNEBJERG H, 1989, AGENTS ACTIONS, V27, P39, DOI 10.1007/BF02222192; LINNEBJERG H, 1988, FEBS LETT, V240, P167, DOI 10.1016/0014-5793(88)80361-2; MAGRO AM, 1977, CLIN EXP IMMUNOL, V29, P436; MIROLI AA, 1986, J IMMUNOL METHODS, V88, P91, DOI 10.1016/0022-1759(86)90055-4; NICHOL GM, 1990, AM REV RESPIR DIS, V142, P576, DOI 10.1164/ajrccm/142.3.576; PEARCE FL, 1982, PROGR MED CHEM, V19, P59, DOI 10.1016/S0079-6468(08)70328-X; POLOSA R, 1990, EUR RESPIR J, V3, P665; REDDY MM, 1989, AM J PHYSIOL, V257, pC727, DOI 10.1152/ajpcell.1989.257.4.C727; ROBUSCHI M, 1990, J ALLERGY CLIN IMMUN, V85, P10, DOI 10.1016/0091-6749(90)90215-P; SIRAGANIAN RP, 1975, J IMMUNOL METHODS, V7, P283, DOI 10.1016/0022-1759(75)90025-3; STUMP RF, 1987, J IMMUNOL, V139, P881; SUSSMAN Y, 1986, IMMUNOL LETT, V13, P215, DOI 10.1016/0165-2478(86)90058-1; VERBEEK E, 1990, PFLUG ARCH EUR J PHY, V415, P540, DOI 10.1007/BF02583504; VERDIANI P, 1990, THORAX, V45, P377, DOI 10.1136/thx.45.5.377; VIGNE P, 1988, J BIOL CHEM, V263, P8073	32	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1992	89	5					978	986		10.1016/0091-6749(92)90220-V	http://dx.doi.org/10.1016/0091-6749(92)90220-V			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HU542	1374773				2022-12-18	WOS:A1992HU54200008
J	TUNONDELARA, JM; RIO, P; MARTHAN, R; VUILLEMIN, L; DUCASSOU, D; TAYTARD, A				TUNONDELARA, JM; RIO, P; MARTHAN, R; VUILLEMIN, L; DUCASSOU, D; TAYTARD, A			THE EFFECT OF SODIUM CROMOGLYCATE ON PLATELETS - AN INVIVO AND INVITRO APPROACH	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; IGE; PLATELET; CROMOGLYCATE; MONOAMINE	DISODIUM-CROMOGLYCATE; ASTHMATIC-PATIENTS; BRONCHOCONSTRICTION	Platelet functions are altered in patients suffering from atopic diseases, including asthma. Such alterations might be related to IgE since platelets bear a specific IgE receptor termed Fc(epsilon) receptor II, and there is some evidence that IgE alone, that is, in the absence of antigen, could modify platelet functions, such as monoamine uptake. Although disodium cromoglycate (DSCG) has been demonstrated to interfere with IgE-mediated activation of human platelets, its effect in the absence of antigen remains unknown. We examined the DSCG effect on IgE-induced alterations both in vivo and in vitro. The effect, in vivo, of a daily intake of 40 mg of DSCG for 4 weeks was assessed on platelet kinetics, studied by a labeling technique on four patients with stable asthma. The effect, in vitro, of DSCG was assessed on IgE-induced alteration in monoamine uptake in platelets from 12 healthy subjects. DSCG significantly increased, in vivo, the mean time constant of platelet-survival curves from 234 +/- 40 to 463 +/- 150 hours (p < 0.01). The amplitude of this effect increased with the patient's serum IgE concentration. DSCG, in vitro, reduced the inhibitory effect of IgE on monoamine uptake by 82%. This effect was concentration dependent and not related to IgE binding. It is concluded that DSCG alters both the survival time of platelets from allergic patients in vivo and the IgE-dependent monoamine uptake in platelets from normal subjects in vitro. These effects are likely to be related to the direct action of DSCG on cells bearing the Fc(epsilon) receptor II and might be independent of the specific trigger.	UNIV BORDEAUX 2,PHYSIOL LAB,F-33076 BORDEAUX,FRANCE; HOP HAUT LEVEQUE,SERV MED NUCL,PESSAC,FRANCE	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	TUNONDELARA, JM (corresponding author), CHU BORDEAUX,HOP HAUT LEVEQUE,SERV MALADIES RESP,F-33604 PESSAC,FRANCE.			Marthan, Roger/0000-0001-5412-5712				ADVENIER C, 1983, BRIT J PHARMACOL, V78, P301, DOI 10.1111/j.1476-5381.1983.tb09395.x; [Anonymous], 1977, BLOOD, V50, P1137; CAPRON A, 1985, INT ARCH ALLER A IMM, V77, P107, DOI 10.1159/000233762; CAPRON A, 1991, ASTHMA ITS PATHOLOGY, P231; COX JSG, 1967, NATURE, V216, P1328, DOI 10.1038/2161328a0; DAVIES SE, 1968, BRIT MED J, V3, P593, DOI 10.1136/bmj.3.5618.593; DELARA JMT, 1991, CLIN EXP ALLERGY, V21, P109; DIXON M, 1980, BRIT J PHARMACOL, V70, P11, DOI 10.1111/j.1476-5381.1980.tb10898.x; FANTA CH, 1981, AM REV RESPIR DIS, V123, P161; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GALLAGHER JS, 1978, J ALLERGY CLIN IMMUN, V62, P229, DOI 10.1016/0091-6749(78)90212-9; GUILLOTEAU D, 1988, EUR J NUCL MED, V14, P341; HEMMENDINGER S, 1989, J ALLERGY CLIN IMMUN, V83, P990, DOI 10.1016/0091-6749(89)90117-6; KAY AB, 1987, J ALLERGY CLIN IMMUN, V80, P1, DOI 10.1016/S0091-6749(87)80183-5; LAITINEN LA, 1991, ASTHMA ITS PATHOLOGY, P103; MACCIA CA, 1977, J ALLERGY CLIN IMMUN, V59, P101, DOI 10.1016/0091-6749(77)90210-X; PEPYS J, 1968, LANCET, V2, P134; SHEPPARD D, 1981, AM REV RESPIR DIS, V124, P257; TAYTARD A, 1986, AM REV RESPIR DIS, V134, P983, DOI 10.1164/arrd.1986.134.5.983; TSICOPOULOS A, 1988, INT J IMMUNOPHARMACO, V10, P227, DOI 10.1016/0192-0561(88)90053-7; VANREENEN O, 1982, EUR J NUCL MED, V7, P80, DOI 10.1007/BF00251649; 1987, AM REV RESPIR DIS, V136, P225	22	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1992	89	5					994	1000		10.1016/0091-6749(92)90222-N	http://dx.doi.org/10.1016/0091-6749(92)90222-N			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HU542	1583254				2022-12-18	WOS:A1992HU54200010
J	MOHAPATRA, SS				MOHAPATRA, SS			RECOMBINANT ALLERGENS AND ALLERGEN STANDARDIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CDNA CLONING; PROTEIN; POLLEN; IGE				MOHAPATRA, SS (corresponding author), UNIV MANITOBA,DEPT IMMUNOL,WINNIPEG R3T 2N2,MANITOBA,CANADA.							BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; CHUA KY, 1988, J EXP MED, V167, P275; FANG KSY, 1988, P NATL ACAD SCI USA, V85, P895, DOI 10.1073/pnas.85.3.895; GHOSH B, 1991, GENE, V101, P231, DOI 10.1016/0378-1119(91)90416-9; GRIFFITH IJ, 1991, FEBS LETT, V279, P210, DOI 10.1016/0014-5793(91)80151-R; MOHAPATRA SS, 1990, INT ARCH ALLER A IMM, V91, P362, DOI 10.1159/000235142; MOHAPATRA SS, 1990, AEROBIOLOGIA, V6, P205; MORGENSTERN JP, 1991, P NATL ACAD SCI USA, V88, P9690, DOI 10.1073/pnas.88.21.9690; PEREZ M, 1990, J BIOL CHEM, V265, P16210; PLATTSMILLS TAE, 1991, J ALLERGY CLIN IMMUN, V87, P621, DOI 10.1016/0091-6749(91)90379-3; RAFNAR T, 1991, J BIOL CHEM, V266, P1229; ROGERS BL, 1991, J IMMUNOL, V147, P2547; SILVANOVICH A, 1991, J BIOL CHEM, V266, P1204; THOMAS WR, 1988, INT ARCH ALLER A IMM, V85, P127, DOI 10.1159/000234488; TOVEY ER, 1989, J EXP MED, V170, P1457, DOI 10.1084/jem.170.4.1457; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985	16	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1992	89	4					921	921		10.1016/0091-6749(92)90451-7	http://dx.doi.org/10.1016/0091-6749(92)90451-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN860	1560174				2022-12-18	WOS:A1992HN86000020
J	CRESPO, JF; BLANCO, C; CONTRERAS, J; PASCUAL, C; ESTEBAN, MM				CRESPO, JF; BLANCO, C; CONTRERAS, J; PASCUAL, C; ESTEBAN, MM			FOOD ALLERGY - A CLINICAL AND EPIDEMIOLOGIC-STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				192	192						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000141
J	GOLDEN, DBK; ADDISON, BI; KWITEROVICH, KA; FREIDHOFF, LR; KAGEYSOBOTKA, A; MARSH, DG; LICHTENSTEIN, LM				GOLDEN, DBK; ADDISON, BI; KWITEROVICH, KA; FREIDHOFF, LR; KAGEYSOBOTKA, A; MARSH, DG; LICHTENSTEIN, LM			NATURAL-HISTORY OF HYMENOPTERA VENOM ALLERGY (HVA) IN ADULTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				291	291						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000538
J	HOWARTH, PH; LUNN, A; TOMKINS, S				HOWARTH, PH; LUNN, A; TOMKINS, S			A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF INTERVENT BEDDING SYSTEM IN PERENNIAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									SOUTHAMPTON GEN HOSP,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND	University of Southampton									0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				305	305						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000593
J	SOOLTANGOS, S; KHODABOCCUS, F; BALIGADOO, S; LEYNADIER, F; FADEL, R				SOOLTANGOS, S; KHODABOCCUS, F; BALIGADOO, S; LEYNADIER, F; FADEL, R			EFFECT OF HOUSE DUST MITES (HDM) AVOIDANCE MEASURES ON SYMPTOMS OF ASTHMATIC-PATIENTS IN ISLAND OF MAURITIUS, (INDIAN-OCEAN)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				259	259						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000411
J	WARDLAW, AJ; BENTLEY, AM; MENZ, G; STORZ, C; DURHAM, SR; KAY, AB				WARDLAW, AJ; BENTLEY, AM; MENZ, G; STORZ, C; DURHAM, SR; KAY, AB			EXPRESSION OF THE ADHESION MOLECULES ICAM-1 AND ELAM-1 IN THE BRONCHIAL-MUCOSA IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851	1	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				164	164						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000080
J	WERFEL, S; COOKE, S; SAMPSON, HA				WERFEL, S; COOKE, S; SAMPSON, HA			CLINICAL REACTIVITY TO BEEF IN COW MILK ALLERGIC [CMA] CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				228	228						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000288
J	KNIGHT, A; DROUIN, MA; YANG, WH; ALEXANDER, M; DELCARPIO, J; ARNOTT, WS				KNIGHT, A; DROUIN, MA; YANG, WH; ALEXANDER, M; DELCARPIO, J; ARNOTT, WS			CLINICAL-EVALUATION OF THE EFFICACY AND SAFETY OF NOBERASTINE, A NEW H1 ANTAGONIST, IN SEASONAL ALLERGIC RHINITIS - A PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						H1 ANTAGONIST; SEASONAL ALLERGIC RHINITIS; DOSE RESPONSE; RHINORRHEA; LACRIMATION; NASAL CONGESTION		Noberastine (NOB), a new histamine H-1 antagonist, has potent and specific peripheral antihistaminic activity. To evaluate the efficacy and safety of NOB in ragweed seasonal allergic rhinitis, 250 eligible patients were randomized to one of four parallel, double-blind treatment groups: NOB, 10, 20, and 30 mg, or placebo, each administered once daily for 3 weeks. Rescue medication was prohibited. Efficacy parameters included global response rate (percentage of responders), physician visit, patient-diary symptom scores, and onset of action. Efficacy analyses used alpha = 0.0167 (adjusted for multiple comparisons). Efficacy parameters demonstrated universal superiority of NOB therapy over placebo therapy with statistical significance achieved frequently; no statistically or clinically significant separation was demonstrated among NOB-treated groups. Global-response rates for all active-treatment groups (range, 62.7% to 71.1%) were statistically significantly greater than rates for the placebo-treated group (39.6%). Median time to first relief of symptoms was within 2 to 4 hours for NOB-treated groups versus 72 hours for the placebo-treated group. No significant abnormalities in safety parameters were ascribed to NOB treatment. Incidence and severity of adverse experiences of NOB-treated groups were comparable in incidence and severity to placebo treatment. NOB treatment did not appear to cause weight gain or sedation. Once-daily NOB, 10, 20, and 30 mg, is equally and highly effective and safe in the symptomatic management of seasonal allergic rhinitis compared to placebo.	OTTAWA CIVIC HOSP, DEPT MED, OTTAWA K1Y 4E9, ONTARIO, CANADA; ROYAL VICTORIA HOSP, DEPT MED, MONTREAL H3A 1A1, QUEBEC, CANADA; JANSSEN PHARMACEUT INC, DEPT MED, MISSISSAUGA, ONTARIO, CANADA	University of Ottawa; Ottawa Hospital Research Institute; McGill University; Royal Victoria Hospital; Johnson & Johnson; Janssen Pharmaceuticals	KNIGHT, A (corresponding author), SUNNYBROOK HLTH SCI CTR, DEPT MED, ROOM HG40, 2075 BAYVIEW AVE, TORONTO M4N 3M5, ONTARIO, CANADA.							DOBBINS DE, 1981, MICROVASC RES, V21, P343, DOI 10.1016/0026-2862(81)90017-0; JOHNSON RW, 1990, INVESTIGATOR BROCHUR; KAISER HB, 1990, J ALLERGY CLIN IMMUN, V86, P1000, DOI 10.1016/S0091-6749(05)80243-X; KAMALI F, 1990, BRIT J CLIN PHARMACO, V29, pP607; MADSEN F, 1989, ALLERGOLOGIE, V12, P126; SNOECK E, 1988, PHARM WEEKBLAD SCI, V10, P229	6	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1991	88	6					926	934		10.1016/0091-6749(91)90250-R	http://dx.doi.org/10.1016/0091-6749(91)90250-R			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GW262	1683882				2022-12-18	WOS:A1991GW26200014
J	VALACER, DJ; OREILLY, ME; ILOWITE, NT; BONAGURA, VR				VALACER, DJ; OREILLY, ME; ILOWITE, NT; BONAGURA, VR			IDENTIFICATION OF ANTIIDIOTYPIC ANTIBODIES IN THE SERA OF RYEGRASS-ALLERGIC AND NONALLERGIC INDIVIDUALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ANTIIDIOTYPIC ANTIBODIES; IDIOTYPIC NETWORK; RYEGRASS ALLERGY	IMMUNE NETWORK; IMMUNOTHERAPY; IGE; AUTOANTIBODIES; MURINE	Anti-idiotypic (Id) antibodies (Abs) are generated in the humoral response to antigen (Ag). Some of these anti-Id Abs are capable of binding to the combining site or paratope of Abs that bind Ag. These Ab2 can competitively inhibit the binding of Ab1 to Ag and may trigger an Ab1 response similar to the response induced by Ag. To determine if specific Ab2 that inhibit the binding of IgE Abs to ryegrass (RG)-pollen allergens are present in the sera of RG-allergic (RGA) individuals before the initiation of allergen-specific hyposensitization with RG-pollen extract, we studied sera from five RGA and four nonallergic (NA) subjects in an IgE anti-RG RAST-inhibition assay. Ab2-enriched serum fractions were prepared from these study subjects by exhaustive mixed grass-pollen affinity chromatography to remove IgE and IgG anti-RG Ab1 from whole serum aliquots containing Ab1. Unabsorbed, twice-concentrated sera were diluted to one-time concentrated sera with equal volumes of either Ab2-enriched sera without Ab1 or borate-buffered saline absorbed by mixed grass-pollen affinity chromatography. IgE anti-RG Ab1 was determined by a standard RG RAST assay. We have detected Ab2 in the sera of the RGA patients, which inhibit the binding of autologous and allogeneic IgE anti-RG to RG Ags in solid phase. Parallel RG RAST assays with sera from NA subjects demonstrated no significant inhibition. Ab2-enriched sera from some grass-allergic and some NA subjects inhibited IgE anti-RG binding found in some RGA patients' sera. We conclude that anti-Id Abs, Ab2, specific for IgE anti-RG, Ab1, are present in some RGA patients and NA individuals.			VALACER, DJ (corresponding author), LONG ISL JEWISH MED CTR, SCHNEIDER CHILDRENS HOSP, DIV PEDIAT ALLERGY & IMMUNOL, ROOM 235, NEW HYDE PK, NY 11042 USA.			Bonagura, Vincent/0000-0002-0681-2099				AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0; BONAGURA VR, 1987, CELL IMMUNOL, V108, P356, DOI 10.1016/0008-8749(87)90219-X; BONAGURA VR, 1986, HUM IMMUNOL, V15, P211, DOI 10.1016/0198-8859(86)90027-3; BONILLA FA, 1986, IDIOTYPES, P229; BOSE R, 1986, CLIN EXP IMMUNOL, V66, P231; BOSE R, 1984, J IMMUNOL, V133, P2474; CASTRACANE JM, 1988, INT ARCH ALLER A IMM, V86, P288, DOI 10.1159/000234586; GEHA RS, 1983, J IMMUNOL, V130, P1634; GEHA RS, 1983, J CLIN INVEST, V71, P46, DOI 10.1172/JCI110750; GEHA RS, 1986, ADV IMMUNOL, V39, P255; HEBERT J, 1990, CLIN EXP IMMUNOL, V80, P413; HOFFMAN DR, 1980, ANN ALLERGY, V45, P343; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KOHLER H, 1989, CLIN IMMUNOL IMMUNOP, V52, P104, DOI 10.1016/0090-1229(89)90197-9; MOURAD W, 1988, IMMUNOLOGY, V63, P397; OGAWA M, 1971, AM J MED, V51, P193, DOI 10.1016/0002-9343(71)90238-5; QUINTI I, 1986, J ALLERGY CLIN IMMUN, V77, P586, DOI 10.1016/0091-6749(86)90350-7	17	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1991	88	3	1				349	355		10.1016/0091-6749(91)90096-7	http://dx.doi.org/10.1016/0091-6749(91)90096-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GG126	1890262				2022-12-18	WOS:A1991GG12600028
J	YEN, A; GIGLI, I; BARRETT, KE				YEN, A; GIGLI, I; BARRETT, KE			MODULATION OF HUMAN CUTANEOUS MAST-CELL RESPONSIVENESS BY A SINGLE, LOW-DOSE, PUVA TREATMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MAST CELL; PUVA; HISTAMINE; CODEINE; HUMAN SKIN; ULTRAVIOLET LIGHT; WHEAL; FLARE; DEGRANULATION; VASCULATURE	HUMAN-SKIN; URTICARIA PIGMENTOSA; ULTRAVIOLET-LIGHT; DE-GRANULATION; COMPOUND 48/80; HISTAMINE-RELEASE; RAT PERITONEAL; PROTOPORPHYRIN; RADIATION	The present study was conducted to investigate whether a single administration of a relatively low dose of 8-methoxypsoralen (8-MP) with long-wave ultraviolet A (UVA) irradiation alters human skin test responses to a mast cell secretagogue, codeine, and to a vasodilator, histamine. Administration of 8-MP at a dose of 10 mg followed by UVA irradiation (1 joule/cm2) suppressed the skin flare-and-wheal response to codeine and decreased the number of visible degranulated mast cells in biopsy specimens examined histologically. UVA irradiation alone enhanced the skin wheal-and-flare response to either codeine or histamine. The inhibitory effect of 8-MP plus UVA irradiation on both wheal-and-flare responses to codeine tended to decrease, and an increasing enhancement of the skin response to histamine could be observed as the dose of 8-MP was increased from 10 to 30 mg. We postulate that (1) a single 8-MP plus UVA irradiation treatment at appropriate doses could be a potential approach to modulate the mediator-releasing properties of mast cells resident in the skin and (2) the underlying mechanisms of this inhibition is complex, probably reflecting a balance between the inhibitory effect of 8-MP plus UVA irradiation on mast cell-mediator release, enhancement of the vascular response to histamine, and direct photoactivation of resident mast cells.	UNIV CALIF SAN DIEGO,MED CTR,SCH MED,DEPT MED,DIV DERMATOL H811J,225 DICKINSON ST,SAN DIEGO,CA 92103; UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,DIV ALLERGY,SAN DIEGO,CA 92103	University of California System; University of California San Diego; University of California System; University of California San Diego			Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019	Barrett, Kim Elaine/0000-0002-6704-998X	NIAID NIH HHS [AI20476, AI24992] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI024992, P50AI020476] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENYON RC, 1989, CLIN EXP ALLERGY, V19, P375, DOI 10.1111/j.1365-2222.1989.tb02402.x; CHRISTOPHERS E, 1978, BRIT J DERMATOL, V98, P701, DOI 10.1111/j.1365-2133.1978.tb03592.x; DANNO K, 1985, J INVEST DERMATOL, V85, P110, DOI 10.1111/1523-1747.ep12276497; FJELLNER B, 1982, ACTA DERM-VENEREOL, V62, P137; GLOVER RA, 1990, BRIT J DERMATOL, V122, P501, DOI 10.1111/j.1365-2133.1990.tb14727.x; GRANERUS G, 1981, J INVEST DERMATOL, V76, P1, DOI 10.1111/1523-1747.ep12524417; KALIMO K, 1983, ARCH DERMATOL RES, V275, P374, DOI 10.1007/BF00417336; KUMAKIRI M, 1977, J INVEST DERMATOL, V69, P392, DOI 10.1111/1523-1747.ep12510322; KUMAKIRI M, 1978, BRIT J DERMATOL, V99, P65, DOI 10.1111/j.1365-2133.1978.tb01963.x; PLATSHON LF, 1978, J CLIN INVEST, V62, P1113, DOI 10.1172/JCI109230; SHALIT M, 1987, ANN ALLERGY, V59, P461; STUTTGEN G, 1979, ARCH DERMATOL RES, V264, P29, DOI 10.1007/BF00417276; THORVALDSEN J, 1980, CLIN EXP DERMATOL, V5, P43, DOI 10.1111/j.1365-2230.1980.tb01663.x; TODA K, 1986, J INVEST DERMATOL, V87, P113, DOI 10.1111/1523-1747.ep12523611; TOLMAN EL, 1985, DERMATOLOGIC IMMUNOL, P53; WASSERMAN SI, 1985, DERMATOLOGIC IMMUNOL, P187; YEN A, 1990, J IMMUNOL, V144, P4327	18	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1991	88	3	1				395	401		10.1016/0091-6749(91)90103-U	http://dx.doi.org/10.1016/0091-6749(91)90103-U			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GG126	1890269				2022-12-18	WOS:A1991GG12600035
J	CALDERON, E; COFFEY, RG; LOCKEY, RF				CALDERON, E; COFFEY, RG; LOCKEY, RF			METHOTREXATE IN BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							NEUTROPHIL CHEMOTAXIS		JAMES A HALEY VET ADM HOSP,ALLERGY & IMMUNOL SECT,RES SERV 151,BLDG 2,RM 208,TAMPA,FL 33612; UNIV S FLORIDA,COLL MED,DEPT INTERNAL MED,DIV ALLERGY & IMMUNOL,TAMPA,FL 33612; COLL MED TAMPA,DEPT PHARMACOL & THERAPEUT,TAMPA,FL	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida								BUCKLEY LM, 1988, ARTHRITIS RHEUM, V31, pR3; CALABRESI P, 1985, GOODMAN GILMANS PHAR, P1264; MIZEL SB, 1989, FASEB J, V3, P2379, DOI 10.1096/fasebj.3.12.2676681; NOLTE H, 1988, AGENTS ACTIONS, V23, P173, DOI 10.1007/BF02142532; OCALLAGHAN JW, 1988, RHEUMATOL INT, V8, P41, DOI 10.1007/BF00541349; SEGAL R, 1989, ARTHRITIS RHEUM, V32, P370, DOI 10.1002/anr.1780320403; SUAREZ CR, 1987, J RHEUMATOL, V14, P9; TERNOWITZ T, 1985, ACTA DERM-VENER    S, V120, P23; VANDEKERKHOF PCM, 1985, BRIT J DERMATOL, V113, pA251; WALSDORFER U, 1983, BRIT J DERMATOL, V108, P451, DOI 10.1111/j.1365-2133.1983.tb04598.x; WHITE A, 1973, PRINCIPLES BIOCH, P876	11	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1991	88	2					274	276		10.1016/0091-6749(91)90339-P	http://dx.doi.org/10.1016/0091-6749(91)90339-P			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB225	1715352				2022-12-18	WOS:A1991GB22500018
J	PIACENTINI, GL; PERONI, DG; SETTE, L; BONIZZATO, C; BENEDETTI, M; BONER, AL				PIACENTINI, GL; PERONI, DG; SETTE, L; BONIZZATO, C; BENEDETTI, M; BONER, AL			INHIBITION OF DIFFERENT DOSAGES OF OXATOMIDE OR PLACEBO ON SKIN PRICK TEST AND NASAL ALLERGEN PROVOCATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						OXATOMIDE; ANTIHISTAMINES; CHILDREN; RHINITIS; PRICK TEST; NASAL CHALLENGE	PHARMACODYNAMIC PROPERTIES; THERAPEUTIC EFFICACY; POLLEN GRAINS; HAY-FEVER; CHILDREN; PHARMACOKINETICS; CHALLENGE; SUBSENSITIVITY; TERFENADINE; RHINITIS	In this two-stage, double-blind study, we evaluated the effects of different dosages of oxatomide (1 and 2 mg/kg/day) on nasal provocation and skin reaction wheal induced by grass-pollen challenge. Children with a positive history of allergic rhinoconjunctivitis and positive responses to skin prick test and nasal provocation test to grass pollen were studied out of season. The results obtained with 1 mg/kg/day of oxatomide demonstrated no significant difference in wheal areas and nasal secretion induced by allergen challenge between treated and untreated patients. The administration of 2 mg/kg/day demonstrated a significant suppression in wheal reaction and nasal secretion induced by specific challenge.	UNIV VERONA, POLICLIN B ROMA, DEPT PEDIAT, PEDIAT CLIN, I-37134 VERONA, ITALY; IST PIO 12, MISURINA, ITALY	University of Verona			Peroni, Diego G/K-4002-2018; Peroni, Diego/K-8795-2016	Peroni, Diego/0000-0002-0234-1373				BOUSQUET J, 1987, CLIN ALLERGY, V17, P529, DOI 10.1111/j.1365-2222.1987.tb02049.x; BOUSQUET J, 1988, J ALLERGY CLIN IMMUN, V82, P881, DOI 10.1016/0091-6749(88)90094-2; CASTEELSVANDAELE M, 1986, LANCET, V1, P1204; CHURCH MK, 1980, AGENTS ACTIONS, V10, P4, DOI 10.1007/BF02024171; DEBEULE R, 1977, ACTA ALLERGOL, V32, P278; DRUCE HM, 1988, JAMA-J AM MED ASSOC, V259, P260, DOI 10.1001/jama.259.2.260; LEBEL B, 1988, J ALLERGY CLIN IMMUN, V82, P869, DOI 10.1016/0091-6749(88)90092-9; LONG WF, 1985, J ALLERGY CLIN IMMUN, V76, P113, DOI 10.1016/0091-6749(85)90813-9; MOLLER C, 1980, ALLERGY, V35, P319, DOI 10.1111/j.1398-9995.1980.tb01773.x; NACLERIO RM, 1983, EUR J RESPIR DIS, V64, P26; RICHARDS DM, 1984, DRUGS, V27, P210, DOI 10.2165/00003495-198427030-00003; SIMONS FER, 1987, J ALLERGY CLIN IMMUN, V80, P884; SIMONS FER, 1988, J ALLERGY CLIN IMMUN, V82, P1068; SIMONS KJ, 1986, J ALLERGY CLIN IMMUN, V77, P326, DOI 10.1016/S0091-6749(86)80112-9; TASAKA K, 1987, INT ARCH ALLER A IMM, V83, P348, DOI 10.1159/000234367; THOMPSON JA, 1981, J PHARM SCI-US, V70, P1284, DOI 10.1002/jps.2600701127; VANDERBIJL WJF, 1980, LARYNGOSCOPE, V90, P145, DOI 10.1288/00005537-198001000-00015; WATSON WTA, 1989, J ALLERGY CLIN IMMUN, V84, P457, DOI 10.1016/0091-6749(89)90358-8	18	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1991	88	2					218	225		10.1016/0091-6749(91)90332-I	http://dx.doi.org/10.1016/0091-6749(91)90332-I			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB225	1679065	Bronze			2022-12-18	WOS:A1991GB22500011
J	JYONOUCHI, H; VOSS, RM; KRISHNA, S; URVAL, K; SJAHLI, H; WELTY, PB; GOOD, RA				JYONOUCHI, H; VOSS, RM; KRISHNA, S; URVAL, K; SJAHLI, H; WELTY, PB; GOOD, RA			SOLUBLE FC-EPSILON-R II LEVELS IN NORMAL-CHILDREN AND PATIENTS WITH IMMUNODEFICIENCY DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HUMAN RECOMBINANT INTERLEUKIN-4; HUMAN-LYMPHOCYTE RECEPTOR; LOW-AFFINITY RECEPTOR; CELL-LINE RPMI-8866; IGE-BINDING FACTORS; B-CELL; NONALLERGIC CHILDREN; IMMUNOGLOBULIN-E; T-CELL; CD23	CD23 is expressed on mature B cells and is identical to a low-affinity IgE Fc-epsilon receptor type II (Fc-epsilon-R II). The C terminal portion of CD23 is released to the serum as soluble Fc-epsilon-R II (sFc-epsilon-R II), which may be involved in regulation of IgE synthesis. We studied sFc-epsilon-R II levels in normal children and in patients with immunodeficiencies, including common variable immunodeficiency (CVI), partial DiGeorge syndrome, and immunodeficiency associated with ectodermal dysplasia to examine the relationship of sFc-epsilon-R II levels to B cell numbers and other immunoparameters. Serum Fc-epsilon-R II levels are higher in younger children (younger than 3 years) and decline gradually with age. In 11 patients with CVI with normal numbers of B cells (> 6%), sFc-epsilon-R II levels were comparable to that of control subjects. Five patients with CVI with deficiencies of peripheral B cells had levels of sFc-epsilon-R II similar to levels of control subjects. In all but one patient with partial DiGeorge syndrome, sFc-epsilon-R II levels were not significantly elevated, despite the presence of elevated peripheral B cell numbers. Of six patients with ectodermal dysplasia, four demonstrated increased Fc-epsilon-R II levels, a finding not correlated with serum IgE levels or with peripheral eosinophil or B cell numbers.			JYONOUCHI, H (corresponding author), UNIV S FLORIDA,ALL CHILDRENS HOSP,DEPT PEDIAT,801 6TH ST S,SUITE 707,ST PETERSBURG,FL 33701, USA.				NIAID NIH HHS [AI25062] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI025062] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENGTSSON M, 1989, BLOOD, V73, P2139; BIEBER T, 1989, J EXP MED, V170, P309, DOI 10.1084/jem.170.1.309; BONNEFOY JY, 1987, J IMMUNOL, V138, P2970; BUJANOWSKIWEBER J, 1988, IMMUNOLOGY, V65, P53; BUJANOWSKIWEBER J, 1989, IMMUNOLOGY, V66, P505; CONRAD DH, 1988, J IMMUNOL, V141, P1091; DEFRANCE T, 1987, J EXP MED, V165, P1459, DOI 10.1084/jem.165.6.1459; DELESPESSE G, 1989, J IMMUNOL, V142, P134; GALIZZI JP, 1988, J IMMUNOL, V141, P1982; HUFF TF, 1984, P NATL ACAD SCI-BIOL, V81, P1514, DOI 10.1073/pnas.81.5.1514; IKUTA K, 1987, P NATL ACAD SCI USA, V84, P819, DOI 10.1073/pnas.84.3.819; JENSEN JR, 1984, IMMUNOLOGY, V53, P1; JOSEPH M, 1986, EUR J IMMUNOL, V16, P306, DOI 10.1002/eji.1830160318; KIKUTANI H, 1986, J EXP MED, V164, P1455, DOI 10.1084/jem.164.5.1455; KIKUTANI H, 1986, CELL, V47, P657, DOI 10.1016/0092-8674(86)90508-8; KIM KM, 1988, PEDIATR RES, V24, P254, DOI 10.1203/00006450-198808000-00023; KIM KM, 1989, PEDIATR RES, V26, P49, DOI 10.1203/00006450-198907000-00015; LEE BW, 1988, PEDIATR CLIN N AM, V35, P953; LEUNG DYM, 1986, J CLIN INVEST, V77, P952, DOI 10.1172/JCI112395; LUDIN C, 1987, EMBO J, V6, P109, DOI 10.1002/j.1460-2075.1987.tb04726.x; MATSUMOTO T, 1987, ANN ALLERGY, V18, P261; Opitz J M, 1988, Birth Defects Orig Artic Ser, V24, P75; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; PRINZ JC, 1987, EUR J IMMUNOL, V17, P757, DOI 10.1002/eji.1830170604; SAFATI M, 1986, IMMUNOLOGY, V59, P569; SARFATI M, 1988, J IMMUNOL, V141, P2195; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; SUEMURA M, 1986, J IMMUNOL, V137, P1214; VERCELLI D, 1988, J EXP MED, V167, P1406, DOI 10.1084/jem.167.4.1406; YOKOTA A, 1988, CELL, V55, P611, DOI 10.1016/0092-8674(88)90219-X; YUKAWA K, 1987, J IMMUNOL, V138, P2576; 1989, PRIMARY IMMUNODEFICI, V2, P173	32	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1991	87	5					965	970		10.1016/0091-6749(91)90418-N	http://dx.doi.org/10.1016/0091-6749(91)90418-N			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FM095	1827480				2022-12-18	WOS:A1991FM09500008
J	CONROY, MC; KENNEDY, JA; CHESTNUT, JC; WRIGHT, CD; ADOLPHSON, RL; THUESON, DO				CONROY, MC; KENNEDY, JA; CHESTNUT, JC; WRIGHT, CD; ADOLPHSON, RL; THUESON, DO			INHIBITION OF HISTAMINE, LEUKOTRIENE-C4/D4, AND THROMBOXANE-B2 RELEASE FROM HUMAN-LEUKOCYTES AND HUMAN CHOPPED LUNG MAST-CELLS BY THE ALLERGIC MEDIATOR RELEASE INHIBITOR, CI-949	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ARACHIDONIC-ACID METABOLISM; HUMAN BASOPHILS; ANTI-IGE; ACTIVATION; ASTHMA; BRONCHOCONSTRICTION; MONONUCLEAR; PRODUCTS; PROTEIN; SYSTEM	The novel antiallergy compound, 5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H-indole-2-carboxamide, L-arginine salt (CI-949), inhibited mediator release from human basophilic leukocytes and from human chopped lung mast cells challenged with anti-IgE. In leukocytes, CI-949 was a more potent inhibitor of leukotriene C4/D4 and thromboxane B2 release (concentration of drug that inhibits mediator release by 50% [IC50] 0.5 and 0.1-mu-mol/L, respectively) than of histamine (IC50, 11.4-mu-mol/L) when anti-IgE was the challenging stimulus. In human lung, inhibition of release of all three mediators occurred at approximately equal concentrations (IC50s for histamine, 16.6-mu-mol/L; for leukotriene C4/D4, 7.1-mu-mol/L; and for thromboxane B2, 6.2-mu-mol/L). The inhibition of histamine release from basophils by CI-949 was further characterized using a variety of stimuli. Challenge with anti-IgE, histamine-releasing factor derived from lymphocytes, N-formyl-L-methionyl-L-leucyl-L-phenylalanine, and concanavalin A revealed potent inhibition (IC50, 10 to 15-mu-mol/L). CI-949 was less potent versus calcium ionophore A23187, phorbol myristate acetate (12-o-tetradecanoylphorbol-13-acetate), and C5a (IC50s, 30, 54, and 60-mu-mol/L, respectively). These results suggest that diverse pathways of cell activation-excitation coupling exist for different stimuli in basophils. Furthermore, the activity and potency of CI-949 in inhibiting release of histamine, leukotrienes, and thromboxane from both human basophils and mast cells suggest that the compound will be effective clinically for indications in which these mediators are implicated, including asthma and allergic rhinitis.			CONROY, MC (corresponding author), PARKE DAVIS PHARMACEUT RES, DEPT EXPTL THERAPY, IMMUNOPHARMACOL SECT, 2800 PLYMOUTH RD, ANN ARBOR, MI 48105 USA.							ARM JP, 1988, J ALLERGY CLIN IMMUN, V82, P654, DOI 10.1016/0091-6749(88)90979-7; BARNES NC, 1984, THORAX, V39, P500, DOI 10.1136/thx.39.7.500; BROOKS CD, 1988, J ALLERGY CLIN IMMUN, V81, P1110, DOI 10.1016/0091-6749(88)90877-9; COBLE BI, 1984, INT ARCH ALLER A IMM, V75, P32, DOI 10.1159/000233586; CONROY MC, 1985, INT ARCH ALLER A IMM, V77, P222, DOI 10.1159/000233793; FERNANDEZ HN, 1978, J BIOL CHEM, V253, P6955; FERRANTE A, 1978, J IMMUNOL METHODS, V24, P389, DOI 10.1016/0022-1759(78)90143-6; FINDLAY SR, 1981, J CLIN INVEST, V67, P1604, DOI 10.1172/JCI110195; FINKEL MP, 1988, J ALLERGY CLIN IMMUN, V81, P313, DOI 10.1016/0091-6749(88)90816-0; GARCIAGIL M, 1986, J IMMUNOL, V136, P3825; GRIFFIN M, 1983, NEW ENGL J MED, V308, P436, DOI 10.1056/NEJM198302243080807; HARDY CC, 1984, NEW ENGL J MED, V311, P209, DOI 10.1056/NEJM198407263110401; HOLROYDE MC, 1981, AGENTS ACTIONS, V11, P573, DOI 10.1007/BF01978746; IMAI A, 1984, ARCH BIOCHEM BIOPHYS, V232, P259, DOI 10.1016/0003-9861(84)90542-3; ISHIZAKA T, 1987, INT ARCH ALLER A IMM, V82, P327, DOI 10.1159/000234218; IZHIZAKA T, 1972, J IMMUNOL, V108, P1000; KAY AB, 1987, ANN ALLERGY, V59, P35; Lichtenstein LM., 1979, MAST CELL ITS ROLE H, P83; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; NACLERIO RM, 1988, IMMUNOL INVEST, V16, P649; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NAKAMURA T, 1985, J BIOL CHEM, V260, P3584; PETERS SP, 1984, ADV INFLAMMAT RES, V8, P227; PHILLIPS GD, 1989, J APPL PHYSIOL, V66, P304, DOI 10.1152/jappl.1989.66.1.304; RICHARDS IM, 1988, J PHARMACOL EXP THER, V245, P735; SCHELLENBERG RR, 1985, J ALLERGY CLIN IMMUN, V75, P126, DOI 10.1016/0091-6749(85)90223-4; SCHULMAN ES, 1983, EUR J RESPIR DIS, V64, P53; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; SMITH AP, 1975, CLIN SCI MOL MED, V48, P421, DOI 10.1042/cs0480421; THUESON DO, 1987, BIOCHEM BIOPH RES CO, V144, P732, DOI 10.1016/S0006-291X(87)80026-8; THUESON DO, 1979, J IMMUNOL, V123, P626; UNANGST PC, 1989, J MED CHEM, V32, P1360, DOI 10.1021/jm00126a036; VARDEY CJ, 1984, PROSTAGLANDINS, V28, P637, DOI 10.1016/0090-6980(84)90141-2; WARNER JA, 1989, J LEUKOCYTE BIOL, V45, P558, DOI 10.1002/jlb.45.6.558; WARNER JA, 1988, J ALLERGY CLIN IMMUN, V82, P432, DOI 10.1016/0091-6749(88)90016-4; WEISS JW, 1983, JAMA-J AM MED ASSOC, V249, P2814, DOI 10.1001/jama.249.20.2814; WRIGHT CD, IN PRESS J LEUKOCYTE	37	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1990	86	6	1				902	908		10.1016/S0091-6749(05)80153-8	http://dx.doi.org/10.1016/S0091-6749(05)80153-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EQ045	1702129				2022-12-18	WOS:A1990EQ04500011
J	EICHLER, HG; BLOCHLDAUM, B; EICHLER, I; WOLZT, M; KORN, A; GOTZ, M				EICHLER, HG; BLOCHLDAUM, B; EICHLER, I; WOLZT, M; KORN, A; GOTZ, M			NORMAL RESPONSIVENESS OF SUPERFICIAL HAND VEINS TO ALPHA-ADRENERGIC AND BETA-ADRENERGIC STIMULI IN ALLERGIC-ASTHMA - EFFECTS OF TERBUTALINE AND PREDNISOLONE ON BETA-ADRENERGIC RESPONSIVENESS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VIENNA UNIV HOSP,DEPT MED 1,DIV CLIN PHARMACOL,VIENNA,AUSTRIA; VIENNA UNIV HOSP,DEPT PEDIAT,VIENNA,AUSTRIA	University Hospital Vienna; University Hospital Vienna				Wolzt, Michael/0000-0001-6049-1890				AARONS RD, 1983, J PHARMACOL EXP THER, V224, P1; AELLIG WH, 1981, BRIT J CLIN PHARMACO, V11, P237, DOI 10.1111/j.1365-2125.1981.tb00527.x; ALRADI AO, 1985, CLIN PHARMACOL THER, V38, P495, DOI 10.1038/clpt.1985.214; BARNES PJ, 1987, CHEST, V91, pS45, DOI 10.1378/chest.91.5.45S; BARNES PJ, 1981, THORAX, V36, P378, DOI 10.1136/thx.36.5.378; BRODDE OE, 1985, J CLIN INVEST, V76, P1096, DOI 10.1172/JCI112063; BROOKS SM, 1979, J ALLERGY CLIN IMMUN, V63, P401, DOI 10.1016/0091-6749(79)90213-6; BRUIJNZEEL PLB, 1979, ANN ALLERGY, V43, P105; BRUYNZEEL PLB, 1985, B EUR PHYSIOPATH RES, V21, pS45; BULBRING E, 1987, PHARMACOL REV, V39, P49; CASALE TB, 1987, ANN ALLERGY, V59, P391; CONOLLY ME, 1976, J CLIN INVEST, V58, P1307, DOI 10.1172/JCI108586; DAVIES AO, 1983, J CLIN INVEST, V71, P565, DOI 10.1172/JCI110801; DAVIES AO, 1980, J CLIN ENDOCR METAB, V51, P599, DOI 10.1210/jcem-51-3-599; DAVIS PB, 1986, J ALLERGY CLIN IMMUN, V77, P871, DOI 10.1016/0091-6749(86)90386-6; DAVIS PB, 1986, J ALLERGY CLIN IMMUN, V77, P662; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; EICHLER HG, 1989, CLIN SCI, V76, P283, DOI 10.1042/cs0760283; EICHLER HG, 1987, CLIN PHARMACOL THER, V42, P521, DOI 10.1038/clpt.1987.191; EICHLER HG, 1989, J CLIN INVEST, V83, P108, DOI 10.1172/JCI113845; GALANT SP, 1980, J CLIN INVEST, V65, P577, DOI 10.1172/JCI109702; HOFFMAN BB, 1983, CLIN ENDOCRINOL META, V12, P1, DOI 10.1016/S0300-595X(83)80026-7; HOLFORD NHG, 1985, PROPHET PUBLIC PROCE; HOLMBERG E, 1981, CLIN EXP PHARMACOL P, V8, P49, DOI 10.1111/j.1440-1681.1981.tb00133.x; JAZAYERI A, 1988, HYPERTENSION, V12, P393, DOI 10.1161/01.HYP.12.4.393; KALINER M, 1985, J ALLERGY CLIN IMMUN, V76, P321, DOI 10.1016/0091-6749(85)90648-7; KARIMAN K, 1980, LUNG, V158, P41, DOI 10.1007/BF02713701; KUNOS G, 1985, J ALLERGY CLIN IMMUN, V76, P346, DOI 10.1016/0091-6749(85)90652-9; LEE TP, 1977, J ALLERGY CLIN IMMUN, V59, P408, DOI 10.1016/0091-6749(77)90002-1; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; MARTIN SA, 1986, CLIN PHARMACOL THER, V40, P257, DOI 10.1038/clpt.1986.172; MARTINSSON A, 1985, CHEST, V88, P594, DOI 10.1378/chest.88.4.594; MARTINSSON A, 1987, CLIN SCI, V72, P47, DOI 10.1042/cs0720047; MCEWAN JR, 1988, CIRCULATION, V77, P1072, DOI 10.1161/01.CIR.77.5.1072; MCFADDEN ER, 1985, J ALLERGY CLIN IMMUN, V76, P352, DOI 10.1016/0091-6749(85)90653-0; MORRIS HG, 1977, CLIN PHARMACOL THER, V22, P352; MOSES LE, 1986, THINK EXPLAIN STATIS; NYBERG L, 1984, EUR J RESP DIS S134, V65, P1349; PAN HYM, 1986, J PHARMACOL EXP THER, V239, P802; PARKER CW, 1973, J CLIN INVEST, V52, P1342, DOI 10.1172/JCI107306; SANDSTROM T, 1988, EUR J CLIN PHARMACOL, V33, P557, DOI 10.1007/BF00542486; SANDSTROM T, 1988, ALLERGY, V43, P49, DOI 10.1111/j.1398-9995.1988.tb02043.x; SHELHAMER JH, 1980, J ALLERGY CLIN IMMUN, V66, P52, DOI 10.1016/0091-6749(80)90138-4; STOLLEY PD, 1986, CLIN PHARMACOL THER, V39, P489, DOI 10.1038/clpt.1986.85; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TASHKIN DP, 1982, AM REV RESPIR DIS, V125, P185; TATTERSFIELD AE, 1982, PHARMACOL THERAPEUT, V17, P299, DOI 10.1016/0163-7258(82)90019-5; VANDENBERG W, 1982, J ALLERGY CLIN IMMUN, V69, P410, DOI 10.1016/0091-6749(82)90115-4; WEINER N, 1985, PHARMACOL BASIS THER, P66	49	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1990	86	5					714	725		10.1016/S0091-6749(05)80175-7	http://dx.doi.org/10.1016/S0091-6749(05)80175-7			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EJ631	1977786				2022-12-18	WOS:A1990EJ63100003
J	TAYLOR, MB; ZWEIMAN, B; MOSKOVITZ, AR; VONALLMEN, C; ATKINS, PC				TAYLOR, MB; ZWEIMAN, B; MOSKOVITZ, AR; VONALLMEN, C; ATKINS, PC			PLATELET-ACTIVATING-FACTOR AND LEUKOTRIENE-B4-INDUCED RELEASE OF LACTOFERRIN FROM BLOOD NEUTROPHILS OF ATOPIC AND NONATOPIC INDIVIDUALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											TAYLOR, MB (corresponding author), UNIV PENN,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,512 JOHNSON PAVILION,PHILADELPHIA,PA 19104, USA.				NIAID NIH HHS [R01 AI-14332] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADLER KB, 1987, EXP LUNG RES, V13, P25, DOI 10.3109/01902148709064307; AMBRUSO DR, 1986, CLIN RES, V34, pA512; AMBRUSO PR, 1982, J CLIN IMMUNOL, V67, P352; ARCHER CB, 1986, LANCET, V1, P1378; ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; BARNES PJ, 1988, J ALLERGY CLIN IMMUN, V81, P919, DOI 10.1016/0091-6749(88)90952-9; BENVENISTE J, 1987, AM REV RESPIR DIS, V135, P82; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BRAQUET P, 1979, ADV PROSTAGLANDIN TH, V16, P1; BRETONGORIUS J, 1980, AM J PATHOL, V99, P413; BULLIN JJ, 1979, IMMUNOLOGY, V36, P381; CAMP RDR, 1983, BRIT J PHARMACOL, V80, P497, DOI 10.1111/j.1476-5381.1983.tb10721.x; DOWD PM, 1987, ARCH DERMATOL RES, V279, P427, DOI 10.1007/BF00412586; FALLOON J, 1986, J ALLERGY CLIN IMMUN, V77, P653, DOI 10.1016/0091-6749(86)90404-5; FLEEKOP PD, 1987, J ALLERGY CLIN IMMUN, V80, P140, DOI 10.1016/0091-6749(87)90122-9; FUJITA J, 1987, CLIN RES, V35, pA855; GALLIN JI, 1982, BLOOD, V59, P1317; GANZ T, 1988, J CLIN INVEST, V82, P552, DOI 10.1172/JCI113631; GIFFORD LA, 1987, J IMMUNOL, V138, P1184; GOLDMAN DW, 1987, FASEB J, V46, P200; HAFSTROM I, 1981, FEBS LETT, V130, P146, DOI 10.1016/0014-5793(81)80684-9; HENOCQ E, 1986, LANCET, V1, P1378; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; INGRAHAM LM, 1987, BRIT J HAEMATOL, V66, P219, DOI 10.1111/j.1365-2141.1987.tb01302.x; KLINE B. S., 1932, JOUR ALLERGY, V3, P531, DOI 10.1016/S0021-8707(32)90148-8; KURIHARA K, 1989, J ALLERGY CLIN IMMUN, V83, P83, DOI 10.1016/0091-6749(89)90480-6; LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127; LILES WC, 1987, J IMMUNOL, V138, P3396; LYNCH JM, 1986, J IMMUNOL, V137, P2653; MCGOWAN SE, 1987, AM REV RESPIR DIS, V135, P1286; MICHEL L, 1988, LANCET, V2, P404; MICHEL L, 1987, J INVEST DERMATOL, V88, P675, DOI 10.1111/1523-1747.ep12470331; MIYAUCHI J, 1987, CELL TISSUE RES, V247, P249; OFLAHERTY JT, 1986, J CLIN INVEST, V78, P381, DOI 10.1172/JCI112588; OFLAHERTY JT, 1985, J CELL PHYSIOL, V122, P229, DOI 10.1002/jcp.1041220211; SERHAN CN, 1982, BIOCHEM BIOPH RES CO, V107, P1006, DOI 10.1016/0006-291X(82)90622-2; SHALIT M, 1987, J ALLERGY CLIN IMMUN, V80, P87, DOI 10.1016/S0091-6749(87)80196-3; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V83, P691, DOI 10.1016/0091-6749(89)90084-5; SHAW JO, 1981, J IMMUNOL, V127, P1250; SOLLY GO, 1985, J CLIN INVEST, V80, P497; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P381, DOI 10.1016/S0025-6196(12)64861-7; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; STYRT B, 1988, J ALLERGY CLIN IMMUN, V81, P20, DOI 10.1016/0091-6749(88)90215-1; VALONE FH, 1983, IMMUNOLOGY, V48, P141; VERCELLOTTI G, 1987, BLOOD CELLS, V13, P199; WARDLAW AJ, 1986, J CLIN INVEST, V78, P1701, DOI 10.1172/JCI112765; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WHITE MV, 1987, J IMMUNOL, V139, P1624; WINKELMANN RK, 1986, ACTA DERM-VENEREOL, V66, P340; WOLFSON M, 1985, J IMMUNOL, V135, P2057; ZWEIMAN B, 1989, J ALLERGY CLIN IMMUN, V83, P209; ZWEIMAN B, 1976, J ALLERGY CLIN IMMUN, V58, P657, DOI 10.1016/0091-6749(76)90177-9; ZWEIMAN B, 1990, J IMMUNOL, V144, P3953	54	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1990	86	5					740	748		10.1016/S0091-6749(05)80178-2	http://dx.doi.org/10.1016/S0091-6749(05)80178-2			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EJ631	2172350				2022-12-18	WOS:A1990EJ63100006
J	AIZAWA, H; INOUE, H; MIYAZAKI, N; IKEDA, T; SHIGEMATSU, N; ITO, Y				AIZAWA, H; INOUE, H; MIYAZAKI, N; IKEDA, T; SHIGEMATSU, N; ITO, Y			EFFECTS OF AZELASTINE ON VAGAL NEUROEFFECTOR TRANSMISSION IN CANINE AND HUMAN AIRWAY SMOOTH-MUSCLE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									KYUSHU UNIV,FAC MED,DEPT PHARMACOL,HIGASHI KU,FUKUOKA 812,JAPAN	Kyushu University	AIZAWA, H (corresponding author), KYUSHU UNIV,FAC MED,DIS CHEST RES INST,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN.		Shigematsu, Naoyuki/B-9374-2014					ATKINS P, 1984, J ALLERGY CLIN IMMUN, V75, P167; CHAND N, 1986, ALLERGY, V41, P473, DOI 10.1111/j.1398-9995.1986.tb00331.x; CHAND N, 1986, BRIT J PHARMACOL, V87, P443, DOI 10.1111/j.1476-5381.1986.tb10835.x; CHAND N, 1983, EUR J PHARMACOL, V96, P227, DOI 10.1016/0014-2999(83)90311-4; DANSER AHJ, 1987, J APPL PHYSIOL, V62, P785, DOI 10.1152/jappl.1987.62.2.785; DIAMANTIS W, 1982, PHARMACOLOGIST, V24, P200; Diamantis W., 1981, PHARMACOLOGIST, V23, P149; FIELDS DAS, 1981, PHARMACOLOGIST, V23, P161; FISCHER B, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1193; INOUE T, 1984, J PHYSIOL-LONDON, V349, P553, DOI 10.1113/jphysiol.1984.sp015173; INOUE T, 1986, J PHYSIOL-LONDON, V370, P551, DOI 10.1113/jphysiol.1986.sp015950; ITO Y, 1988, BRIT J PHARMACOL, V93, P636, DOI 10.1111/j.1476-5381.1988.tb10321.x; ITO Y, 1988, BRIT J PHARMACOL, V95, P268, DOI 10.1111/j.1476-5381.1988.tb16573.x; ITO Y, 1981, BRIT J PHARMACOL, V73, P563, DOI 10.1111/j.1476-5381.1981.tb10456.x; ITO Y, 1981, J PHYSIOL-LONDON, V319, P379, DOI 10.1113/jphysiol.1981.sp013915; ITO Y, 1979, J PHYSIOL-LONDON, V297, P521, DOI 10.1113/jphysiol.1979.sp013054; ITO Y, 1989, BRIT J PHARMACOL, V98, P1249, DOI 10.1111/j.1476-5381.1989.tb12671.x; KATAYAMA S, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1196; KEMP JP, 1987, J ALLERGY CLIN IMMUN, V79, P893, DOI 10.1016/0091-6749(87)90238-7; MAGNUSSEN H, 1987, CHEST, V91, P855, DOI 10.1378/chest.91.6.855; MANDI A, 1981, B EUR PHYSIOPATHOL R, V17, P5; OLLIER S, 1986, J ALLERGY CLIN IMMUN, V78, P358, DOI 10.1016/S0091-6749(86)80090-2; REICHARDT LF, 1983, ANNU REV BIOCHEM, V52, P871, DOI 10.1146/annurev.bi.52.070183.004255; RUSSELL JA, 1980, J APPL PHYSIOL, V48, P16, DOI 10.1152/jappl.1980.48.1.16; SHORE S, 1987, J APPL PHYSIOL, V62, P1837, DOI 10.1152/jappl.1987.62.5.1837; SIMONSSON BG, 1967, J CLIN INVEST, V46, P1812, DOI 10.1172/JCI105671; STORMS W, 1985, J ALLERGY CLIN IMMUN, V75, P167, DOI 10.1016/0091-6749(85)90386-0; WALTERS EH, 1984, J APPL PHYSIOL, V57, P129, DOI 10.1152/jappl.1984.57.1.129; YAMANAKA T, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1203; ZECHEL HJ, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1184	30	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1990	86	2					171	176		10.1016/S0091-6749(05)80062-4	http://dx.doi.org/10.1016/S0091-6749(05)80062-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DV316	1974560				2022-12-18	WOS:A1990DV31600005
J	MATTSBYBALTZER, I; EDEBO, L; JARVHOLM, B; LAVENIUS, B; SODERSTROM, T				MATTSBYBALTZER, I; EDEBO, L; JARVHOLM, B; LAVENIUS, B; SODERSTROM, T			SUBCLASS DISTRIBUTION OF IGG AND IGA ANTIBODY-RESPONSE TO PSEUDOMONAS-PSEUDOALCALIGENES IN HUMANS EXPOSED TO INFECTED METAL-WORKING FLUID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									GOTHENBURG UNIV, DEPT IMMUNOL, S-41346 GOTHENBURG, SWEDEN; SAHLGRENS UNIV HOSP, DEPT OCCUPAT MED, S-41345 GOTHENBURG, SWEDEN; SKF SWEDEN, CTR HLTH, GOTHENBURG, SWEDEN	University of Gothenburg; Sahlgrenska University Hospital; SKF Group	MATTSBYBALTZER, I (corresponding author), GOTHENBURG UNIV, DEPT CLIN BACTERIOL, GULDHEDSGATAN 10, S-41346 GOTHENBURG, SWEDEN.							ANDERSEN P, 1983, ACTA MED SCAND, V213, P191; BICE DE, 1985, AM REV RESPIR DIS, V132, P661; CAMNER P, 1971, ARCH ENVIRON HEALTH, V23, P421, DOI 10.1080/00039896.1971.10666030; COHEN AB, 1971, J CLIN INVEST, V50, P1390, DOI 10.1172/JCI106622; FICK RB, 1986, AM REV RESPIR DIS, V133, P418; FINKLEA JF, 1971, AM REV RESPIR DIS, V104, P368, DOI 10.1164/arrd.1971.104.3.368; HAMMARSTROM L, 1985, IMMUNOLOGY, V54, P821; HAMMARSTROM L, 1983, CLIN EXP IMMUNOL, V51, P600; HAMMARSTROM L, 1984, CLIN EXP IMMUNOL, V55, P593; HARRIS JO, 1970, J CLIN INVEST, V49, P2086, DOI 10.1172/JCI106426; HAY FC, 1972, EUR J IMMUNOL, V2, P257, DOI 10.1002/eji.1830020312; HORNICK DB, 1986, AM REV RESPIR DIS, V133, pA8; HUGHES DA, 1985, CLIN EXP IMMUNOL, V61, P459; KARCH H, 1983, INFECT IMMUN, V40, P157, DOI 10.1128/IAI.40.1.157-165.1983; LAUGHTER AH, 1977, J LAB CLIN MED, V89, P1326; MAKELA O, 1987, J IMMUNOL, V139, P1999; Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4; MATTSBYBALTZER I, 1989, APPL ENVIRON MICROB, V55, P2681, DOI 10.1128/AEM.55.10.2681-2689.1989; MATTSBYBALTZER I, 1989, INT ARCH ALLER A IMM, V88, P304, DOI 10.1159/000234816; MCSHARRY C, 1985, CLIN ALLERGY, V15, P487, DOI 10.1111/j.1365-2222.1985.tb02299.x; Miller Jr R. G, 1981, SIMULTANEOUS STAT IN, P67; MILLER LG, 1982, CHEST, V82, P526, DOI 10.1378/chest.82.5.526; NAEGEL GP, 1984, AM REV RESPIR DIS, V129, P413; PERSSON MAA, 1986, INFECT IMMUN, V52, P834, DOI 10.1128/IAI.52.3.834-839.1986; PRATT SA, 1971, LAB INVEST, V24, P331; SCHENCK K, 1987, ACTA PATH MICRO IM C, V95, P41; SCHUMAKER VN, 1976, BIOCHEMISTRY-US, V15, P5175, DOI 10.1021/bi00668a035; SHAKIE F, 1980, RES CLIN LAB, V10, P561; THOMAS W, 1973, NATURE, V243, P240, DOI 10.1038/243240a0; WARREN CPW, 1977, THORAX, V32, P567, DOI 10.1136/thx.32.5.567; WEDEGE E, 1987, J CLIN MICROBIOL, V25, P1349, DOI 10.1128/JCM.25.8.1349-1353.1987; Westphal O., 1965, METHODS CARBOHYDRATE, V5, DOI DOI 10.1016/J.WATRES.2010.04.030	32	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1990	86	2					231	238		10.1016/S0091-6749(05)80070-3	http://dx.doi.org/10.1016/S0091-6749(05)80070-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DV316	2384650				2022-12-18	WOS:A1990DV31600013
J	KWASELOW, A; ROWE, M; SEARSEWALD, D; OWNBY, D				KWASELOW, A; ROWE, M; SEARSEWALD, D; OWNBY, D			ROSE HIPS - A NEW OCCUPATIONAL ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HENRY FORD HOSP,DIV ALLERGY & CLIN IMMUNOL,2799 W GRAND BLVD,DETROIT,MI 48202; HARPER GRACE HOSP,DIV ALLERGY & CLIN IMMUNOL,DETROIT,MI 48201	Henry Ford Health System; Henry Ford Hospital								HORIAGON TM, 1985, CHEST, V88, pS8; ROWE MS, 1986, J ALLERGY CLIN IMMUN, V77, P714, DOI 10.1016/0091-6749(86)90416-1; SPECTOR SL, 1983, PROVOCATIVE CHALLENG, V2, P97; Tukey J. W., 1977, EXPLORATORY DATA ANA; TYLER VE, 1988, PHARMACOGNOSY, P485; WALLIS TE, 1960, TXB PHARMACOGNOSY, P275; ZUSKIN E, 1984, BRIT J IND MED, V41, P88	7	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					704	708		10.1016/0091-6749(90)90187-9	http://dx.doi.org/10.1016/0091-6749(90)90187-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2324410				2022-12-18	WOS:A1990DA43700004
J	LAMMERS, JWJ; KIOUMIS, I; MCCUSKER, M; NICHOL, GM; BARNES, PJ; CHUNG, KF				LAMMERS, JWJ; KIOUMIS, I; MCCUSKER, M; NICHOL, GM; BARNES, PJ; CHUNG, KF			EFFECTS OF PROSTACYCLIN ON BRONCHOCONSTRICTION AND NEUTROPENIA INDUCED BY INHALED PLATELET-ACTIVATING FACTOR IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BROMPTON HOSP,NATL HEART & LUNG INST,DEPT THORAC MED,DOVEHOUSE ST,LONDON SW3 6LY,ENGLAND	Imperial College London; Royal Brompton Hospital			Chung, Kian Fan/I-8456-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Barnes, Peter/0000-0002-5122-4018				BARNES PJ, 1988, J ALLERGY CLIN IMMUN, V81, P919, DOI 10.1016/0091-6749(88)90952-9; BIANCO S, 1978, PHARMACOL RES COMMUN, V10, P657, DOI 10.1016/S0031-6989(78)80009-5; BUSH A, 1987, AM REV RESPIR DIS, V136, P767, DOI 10.1164/ajrccm/136.3.767; CHRISTMAN BW, 1988, J APPL PHYSIOL, V64, P2033, DOI 10.1152/jappl.1988.64.5.2033; CHUNG KF, 1988, J ALLERGY CLIN IMMUN, V81, P1192, DOI 10.1016/0091-6749(88)90890-1; CUSS FM, 1986, LANCET, V2, P1019; EVANS TW, 1987, J APPL PHYSIOL, V63, P479, DOI 10.1152/jappl.1987.63.2.479; GARCIA JGN, 1988, THROMB RES, V51, P83, DOI 10.1016/0049-3848(88)90285-X; GATEAU O, 1984, AM REV RESPIR DIS S, V129, P3; HALONEN M, 1985, AM REV RESPIR DIS, V131, P11; HALONEN M, 1981, AM REV RESPIR DIS, V124, P416; HARDY C, 1985, AM REV RESPIR DIS, V131, P18; HARDY CC, 1988, J APPL PHYSIOL, V64, P1567, DOI 10.1152/jappl.1988.64.4.1567; KIOUMIS I, 1988, PROSTAGLANDINS, V36, P343, DOI 10.1016/0090-6980(88)90075-5; LEFORT J, 1984, BRIT J PHARMACOL, V82, P565, DOI 10.1111/j.1476-5381.1984.tb10795.x; LELLOUCHTUBIANA A, 1988, AM REV RESPIR DIS, V137, P940; LONG WA, 1987, AM REV RESPIR DIS, V136, P773, DOI 10.1164/ajrccm/136.3.773; OGRADY J, 1980, PROSTAGLANDINS, V19, P319, DOI 10.1016/0090-6980(80)90030-1; RUBIN AHE, 1987, AM REV RESPIR DIS, V136, P1145, DOI 10.1164/ajrccm/136.5.1145; RUBIN LJ, 1987, AM REV RESPIR DIS, V135, pA176; SCHELLENBERG RR, 1987, AM REV RESPIR DIS, V136, P528; SCHULMAN ES, 1981, AM REV RESPIR DIS, V124, P402; SHEPHARD EG, 1985, BRIT J CLIN PHARMACO, V19, P459, DOI 10.1111/j.1365-2125.1985.tb02671.x; SZCZEKLIK A, 1978, PHARMACOL RES COMMUN, V10, P545, DOI 10.1016/S0031-6989(78)80053-8; VARGAFTIG BB, 1980, EUR J PHARMACOL, V65, P185, DOI 10.1016/0014-2999(80)90391-X; WARRINGTON SJ, 1988, EUR J CARDIOL, V12, P73	26	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					763	768		10.1016/0091-6749(90)90196-B	http://dx.doi.org/10.1016/0091-6749(90)90196-B			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2109002				2022-12-18	WOS:A1990DA43700013
J	TINKELMAN, DG; GARCHA, BS; LUTZ, CN				TINKELMAN, DG; GARCHA, BS; LUTZ, CN			RELATIONSHIP OF DIFFERENT SERUM LEVELS OF THEOPHYLLINE ON METHACHOLINE SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											TINKELMAN, DG (corresponding author), ATLANTA ALLERGY & IMMUNOL RES FDN,ATLANTA ALLERGY CLIN,6667 VERNON WOODS DR,ATLANTA,GA 30328, USA.							BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CARTIER A, 1986, J ALLERGY CLIN IMMUN, V77, P570, DOI 10.1016/0091-6749(86)90347-7; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; COCKCROFT DW, 1989, J ALLERGY CLIN IMMUN, V83, P913, DOI 10.1016/0091-6749(89)90105-X; COCKCROFT DW, 1977, THORAX, V32, P429, DOI 10.1136/thx.32.4.429; DANIEL WW, 1987, BIOSTATISTICS F ANAL; DANIEL WW, 1978, APPLIED NONPARAMETRI; DUTOIT JI, 1987, AM REV RESPIR DIS, V136, P1174, DOI 10.1164/ajrccm/136.5.1174; FURUKAWA CT, 1984, PEDIATRICS, V74, P453; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HENDELES L, 1973, PHARMACOL THERAPEUT, V3, P2; MAGNUSSEN H, 1987, AM REV RESPIR DIS, V136, P1163, DOI 10.1164/ajrccm/136.5.1163; REED C, 1908, ALLERGY PRINCIPLES P, P811; WEINBERGER M, 1984, J ALLERGY CLIN IMMUN, V73, P525, DOI 10.1016/0091-6749(84)90505-0	14	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1990	85	4					750	755		10.1016/0091-6749(90)90194-9	http://dx.doi.org/10.1016/0091-6749(90)90194-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DA437	2182696				2022-12-18	WOS:A1990DA43700011
J	BERNSTEIN, DI; COHN, JR				BERNSTEIN, DI; COHN, JR			GUIDELINES FOR THE DIAGNOSIS AND EVALUATION OF OCCUPATIONAL IMMUNOLOGICAL LUNG-DISEASE - PREFACE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material																		BERNSTEIN DI, GUIDELINES PREPARATI; BERNSTEIN IL, 1981, CLIN CHEST MED, V2, P255; BERNSTEIN IL, 1982, J ALLERGY CLIN IMMUN, V70, P24, DOI 10.1016/0091-6749(82)90197-X; BERNSTEIN KDI, 1988, ALLERGY PRINCIPLES P, P1197; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; BUSH RK, GUIDELINES PREPARATI; BUTCHER BT, GUIDELINES CLIN EVAL; CARTIER A, 1986, J ALLERGY CLIN IMMUN, V78, P1185, DOI 10.1016/0091-6749(86)90270-8; CARTIER A, GUIDELINES BRONCHOPR; GRAMMER L, GUIDELINES IMMUNOLOG; LISS GM, 1988, J ALLERGY CLIN IMMUN, V82, P55, DOI 10.1016/0091-6749(88)90051-6; NOVEY HS, GUIDELINES CLIN EVAL; RICHERSON HB, GUIDELINES DIAGNOSIS; SMITH AB, GUIDELINES EPIDEMIOL	14	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1989	84	5	2	S			791	793		10.1016/0091-6749(89)90341-2	http://dx.doi.org/10.1016/0091-6749(89)90341-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CC527	2809027				2022-12-18	WOS:A1989CC52700001
J	ROSE, MH				ROSE, MH			VIBRATORY URTICARIA ASSOCIATED WITH BLADDER-WALL INFECTION WITH THE YEAST TORULOPSIS-GLABRATA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																			0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1989	84	3					408	408		10.1016/0091-6749(89)90432-6	http://dx.doi.org/10.1016/0091-6749(89)90432-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AR199	2778247				2022-12-18	WOS:A1989AR19900025
J	FRIBERG, S; BEVEGARD, S; GRAFFLONNEVIG, V; HALLBACK, I				FRIBERG, S; BEVEGARD, S; GRAFFLONNEVIG, V; HALLBACK, I			ASTHMA FROM CHILDHOOD TO ADULTHOOD - A FOLLOW-UP-STUDY OF 20 SUBJECTS WITH SPECIAL REFERENCE TO WORK CAPACITY AND PULMONARY GAS-EXCHANGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									KAROLINSKA INST, SODER HOSP, DEPT CLIN PHYSIOL, S-10401 STOCKHOLM 60, SWEDEN	Karolinska Institutet	FRIBERG, S (corresponding author), SACHS CHILDRENS HOSP, S-11669 STOCKHOLM, SWEDEN.							ANDERSON SD, 1972, THORAX, V27, P718, DOI 10.1136/thx.27.6.718; ASTRAND PO, 1964, OXYGEN ANIMAL ORGANI, P295; BALFOURLYNN L, 1981, ARCH DIS CHILD, V56, P450, DOI 10.1136/adc.56.6.450; BEVEGARD S, 1976, ACTA PAEDIATR SCAND, V65, P289, DOI 10.1111/j.1651-2227.1976.tb04888.x; BLACKHALL MI, 1970, ARCH DIS CHILD, V45, P363, DOI 10.1136/adc.45.241.363; BLAIR H, 1977, ARCH DIS CHILD, V52, P613, DOI 10.1136/adc.52.8.613; DEMPSEY JA, 1987, CAN J SPORT SCI S1, V12, P66; FRIBERG S, 1988, ACTA PAEDIATR SCAND, V77, P424, DOI 10.1111/j.1651-2227.1988.tb10671.x; GRAFFLONNEVIG V, 1980, EUR J RESPIR DIS, V61, P357; GRAFFLONNEVIG V, 1979, SCAND J RESPIR DIS, V60, P36; GRAFFLONNEVIG V, 1980, ACTA PAEDIATR SCAND, V69, P347, DOI 10.1111/j.1651-2227.1980.tb07091.x; HARTLEY LH, 1969, SCAND J CLIN LAB INV, V24, P335, DOI 10.3109/00365516909080170; HILL DJ, 1972, ARCH DIS CHILD, V47, P874, DOI 10.1136/adc.47.256.874; JONES RHT, 1966, BMJ-BRIT MED J, V2, P976, DOI 10.1136/bmj.2.5520.976; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; LUNDHOLM L, 1963, ACTA PHYSIOL SCAND, V58, P243, DOI 10.1111/j.1748-1716.1963.tb02645.x; MARTIN A, 1980, BRIT MED J, P1397; MARTIN AJ, 1980, AM REV RESPIR DIS, V122, P609; SCHOLANDER PF, 1947, J BIOL CHEM, V167, P235; Vankampen E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0; Winfield C R, 1985, J R Army Med Corps, V131, P21	21	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1989	84	2					183	190		10.1016/0091-6749(89)90323-0	http://dx.doi.org/10.1016/0091-6749(89)90323-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL836	2760360				2022-12-18	WOS:A1989AL83600008
J	CRETICOS, PS; BODENHEIMER, S; ALBRIGHT, A; LICHTENSTEIN, LM; NORMAN, PS				CRETICOS, PS; BODENHEIMER, S; ALBRIGHT, A; LICHTENSTEIN, LM; NORMAN, PS			EFFECTS OF AN INHALED LEUKOTRIENE ANTAGONIST ON BRONCHIAL CHALLENGE WITH ANTIGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					187	187						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900084
J	FRICK, OL; BARKER, S				FRICK, OL; BARKER, S			ALLERGENICITY AMONG DIFFERENT FOOD FISH SPECIES STUDIED BY WESTERN BLOTTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					295	295						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900516
J	KEMP, JP; MELTZER, EO; ORGEL, HA; WELCH, MJ; OSTROM, NK; GOWARTY, NA; COCCHETTO, DM				KEMP, JP; MELTZER, EO; ORGEL, HA; WELCH, MJ; OSTROM, NK; GOWARTY, NA; COCCHETTO, DM			A COMPARATIVE-STUDY OF SALMETEROL, ALBUTEROL, AND PLACEBO VIA MDI IN ASTHMATIC ADULTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					186	186						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900080
J	KUNZ, B; RING, J; BRAUNFALCO, O				KUNZ, B; RING, J; BRAUNFALCO, O			EICOSAPENTAENOIC ACID (EPA) TREATMENT IN ATOPIC ECZEMA (AE) - A PROSPECTIVE DOUBLE-BLIND TRIAL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152					0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					196	196						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900120
J	CANNY, GJ; LEVISON, H				CANNY, GJ; LEVISON, H			PULMONARY-FUNCTION ABNORMALITIES DURING APPARENT CLINICAL REMISSION IN CHILDHOOD ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											CANNY, GJ (corresponding author), HOSP SICK CHILDREN,DEPT PEDIAT,DIV CHEST DIS,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							ARETAEUS, 1856, EXTANT WORKS ARETAEU, P255; BLACKHALL MI, 1970, ARCH DIS CHILD, V45, P363, DOI 10.1136/adc.45.241.363; BROWN PJ, 1984, THORAX, V39, P131, DOI 10.1136/thx.39.2.131; BURROWS B, 1977, AM REV RESPIR DIS, V115, P751; CADE JF, 1973, AUST NZ J MED, V3, P545, DOI 10.1111/j.1445-5994.1973.tb04293.x; CANNY GJ, 1988, ANN ALLERGY, V60, P11; CARMICHAEL J, 1981, BRIT MED J, V282, P1419, DOI 10.1136/bmj.282.6274.1419; COOPER DM, 1977, CHEST, V71, P361, DOI 10.1378/chest.71.3.361; COOPER DM, 1974, AM REV RESPIR DIS, V109, P519; CUTZ E, 1978, HISTOPATHOLOGY, V2, P407, DOI 10.1111/j.1365-2559.1978.tb01735.x; DEBENEDICTIS FM, 1986, J ASTHMA, V23, P303, DOI 10.3109/02770908609073177; ENGSTROM I, 1959, Acta Paediatr, V48, P114; ERAKER SA, 1984, ANN INTERN MED, V100, P258, DOI 10.7326/0003-4819-100-2-258; FERGUSON AC, 1988, J ALLERGY CLIN IMMUN, V82, P19, DOI 10.1016/0091-6749(88)90045-0; GERGEN PJ, 1988, PEDIATRICS, V81, P1; GOLD WM, 1967, J APPL PHYSIOL, V23, P433, DOI 10.1152/jappl.1967.23.4.433; HAYNES RL, 1976, AM REV RESPIR DIS, V116, P739; HILL DJ, 1972, ARCH DIS CHILD, V47, P874, DOI 10.1136/adc.47.256.874; HILL DJ, 1972, AM REV RESPIR DIS, V106, P873, DOI 10.1164/arrd.1972.106.6.873; JENKINS PF, 1981, THORAX, V36, P835, DOI 10.1136/thx.36.11.835; KATTAN M, 1977, PEDIATRICS, V59, P683; KONIG P, 1982, ANN ALLERGY, V49, P86; KRAEMER R, 1983, J PEDIATR-US, V102, P347, DOI 10.1016/S0022-3476(83)80646-5; KRAEPELIEN S, 1958, Acta Paediatr, V47, P549, DOI 10.1111/j.1651-2227.1958.tb07671.x; KRAEPELIEN S, 1958, Acta Paediatr, V47, P399, DOI 10.1111/j.1651-2227.1958.tb07652.x; KRAEPELIEN S, 1959, Acta Paediatr, V48, P335; LANDAU LI, 1979, THORAX, V34, P217, DOI 10.1136/thx.34.2.217; LEVISON H, 1986, CHILD ASTHMA, P51; LOREN ML, 1978, CHEST, V74, P126, DOI 10.1378/chest.74.2.126; MARTIN AJ, 1980, AM REV RESPIR DIS, V122, P609; MCCARTHY DS, 1980, THORAX, V35, P298, DOI 10.1136/thx.35.4.298; MOK JYQ, 1983, EUR J RESPIR DIS, V64, P487; SHIM CS, 1980, AM J MED, V68, P11, DOI 10.1016/0002-9343(80)90155-2; SLY PD, 1985, AM J DIS CHILD, V139, P479, DOI 10.1001/archpedi.1985.02140070053032; TOOLEY WH, 1965, J PEDIATR-US, V66, P517, DOI 10.1016/S0022-3476(65)80116-0; VEDAL S, 1984, AM REV RESPIR DIS, V130, P187; WENG TR, 1969, AM REV RESPIR DIS, V99, P719	37	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1988	82	1					1	4		10.1016/0091-6749(88)90042-5	http://dx.doi.org/10.1016/0091-6749(88)90042-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P4004	3392360				2022-12-18	WOS:A1988P400400001
J	PEARLMAN, DS				PEARLMAN, DS			CHRONIC RHINITIS IN CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,SCH MED,DENVER,CO 80202; NATL JEWISH CTR IMMUNOL & RESP MED,DENVER,CO	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health								CALDERELLE DD, 1982, PEDIATRIC OTOLARYNGO; JACOBS RL, 1981, J ALLERGY CLIN IMMUN, V67, P253, DOI 10.1016/0091-6749(81)90019-1; JACOBS RL, 1981, J RESPIR DIS, V2, P20; KRAEMER MJ, 1983, JAMA-J AM MED ASSOC, V249, P1022, DOI 10.1001/jama.249.8.1022; MARKS MB, 1963, ANN ALLERGY, V21, P26; MULLARKEY MF, 1980, J ALLERGY CLIN IMMUN, V65, P122, DOI 10.1016/0091-6749(80)90196-7; MYER CM, 1983, PEDIATRICS, V72, P766; Mygind N., 1979, NASAL ALLERGY; RUPP GH, 1982, PEDIATRICS, V70, P437; SETTIPANE GA, 1987, AM J RHINOL, V1, P33; SHWACHMAN H, 1962, PEDIATRICS, V30, P389; SIEGEL SC, 1988, ALLERGIC DISORDERS I, P717; SLAVIN RG, 1982, ANN ALLERGY, V49, P123; ZEIGER RS, 1982, IMMUN ALLERGY PRACTI, V4, P63; ZEIGER RS, 1982, IMMUNOL ALLERGY PRAC, V4, P108; 1979, US NIH79387 DEP HLTH, P22	16	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1988	81	5	2	S			962	966		10.1016/0091-6749(88)90161-3	http://dx.doi.org/10.1016/0091-6749(88)90161-3			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N7037	3286735				2022-12-18	WOS:A1988N703700006
J	ALAM, R; LEWIS, DM; OLENCHOCK, SA				ALAM, R; LEWIS, DM; OLENCHOCK, SA			ACTIVATION OF GUINEA-PIG LYMPHOCYTES AND MAST-CELLS BY GRAIN-DUST EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIOSH, DIV RESP DIS STUDIES, IMMUNOL SECT, MORGANTOWN, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)								ALAM R, 1987, J ALLERGY CLIN IMMUN, V79, P103, DOI 10.1016/S0091-6749(87)80023-4; ALAM R, 1984, ANN ALLERGY, V53, P66; ALAM R, IN PRESS J IMMUNOL; DOPICO GA, 1977, AM REV RESPIR DIS, V115, P915; EZEAMUZIE IC, 1983, AGENTS ACTIONS, V13, P222, DOI 10.1007/BF01967337; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; LETTBROWN MA, 1981, INT ARCH ALLER A IMM, V64, P241, DOI 10.1159/000232700; LEWIS DM, 1986, ENVIRON HEALTH PERSP, V66, P149, DOI 10.2307/3430229; LEWIS DM, 1984, 8TH P COTT DUST RES, P70; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; MOIRA CY, 1986, AM REV RESPIR DIS, V133, P686; OLENCHOCK SA, 1986, ENVIRON HEALTH PERSP, V66, P119, DOI 10.2307/3430225; OLENCHOCK SA, 1980, ANN ALLERGY, V44, P23; PEARCE FL, 1980, AGENTS ACTIONS, V10, P124, DOI 10.1007/BF02024193; SCHULMAN ES, 1985, AM REV RESPIR DIS, V131, P230; SMITH TF, 1985, CLIN IMMUNOL IMMUNOP, V34, P355, DOI 10.1016/0090-1229(85)90184-9; THEOBALD K, 1986, J ALLERGY CLIN IMMUN, V78, P470, DOI 10.1016/0091-6749(86)90035-7; THUESON DO, 1979, J IMMUNOL, V123, P626; TSE KS, 1986, J ALLERGY CLIN IMMUN, V77, P172; UNDEM BJ, 1986, AM REV RESPIR DIS, V133, P763; UNDEM BJ, 1985, J IMMUNOL METHODS, V81, P187, DOI 10.1016/0022-1759(85)90203-0; WARNER JA, 1986, J IMMUNOL, V136, P2583	22	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1988	81	3					580	589		10.1016/0091-6749(88)90200-X	http://dx.doi.org/10.1016/0091-6749(88)90200-X			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M6181					2022-12-18	WOS:A1988M618100016
J	GOTTSCHLICH, GM; GEORGITIS, JW				GOTTSCHLICH, GM; GEORGITIS, JW			PROTAMINE-SPECIFIC IGE, IGG, AND IGG SUBCLASS ANTIBODIES IN PROTAMINE ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					238	238		10.1016/0091-6749(88)90514-3	http://dx.doi.org/10.1016/0091-6749(88)90514-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400301
J	HIRSCH, SR; MELAMED, J; SCHWARTZ, RH				HIRSCH, SR; MELAMED, J; SCHWARTZ, RH			EFFICACY OF NEDOCROMIL SODIUM 2-PERCENT OPHTHALMIC SOLUTION IN THE TREATMENT OF RAGWEED SEASONAL ALLERGIC CONJUNCTIVITIS (SAC)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					173	173		10.1016/0091-6749(88)90257-6	http://dx.doi.org/10.1016/0091-6749(88)90257-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400044
J	JARMOSZUK, I; BLUMENTHAL, M; SILVERS, W; AARONSON, D				JARMOSZUK, I; BLUMENTHAL, M; SILVERS, W; AARONSON, D			NEDOCROMIL SODIUM 2-PERCENT OPHTHALMIC SOLUTION IN THE TREATMENT OF RAGWEED SEASONAL ALLERGIC CONJUNCTIVITIS (SAC)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					174	174		10.1016/0091-6749(88)90258-8	http://dx.doi.org/10.1016/0091-6749(88)90258-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400045
J	KENNEDY, JA; THUESON, DO; CONROY, MC				KENNEDY, JA; THUESON, DO; CONROY, MC			INHIBITION OF HUMAN BASOPHIL HISTAMINE-RELEASE BY A NEW ANTI-ALLERGY COMPOUND, CI-949, FOLLOWING CHALLENGE WITH VARIOUS STIMULI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					233	233		10.1016/0091-6749(88)90495-2	http://dx.doi.org/10.1016/0091-6749(88)90495-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400282
J	MACDONALD, SM; KAGEYSOBOTKA, A; GILLIS, S; LICHTENSTEIN, LM				MACDONALD, SM; KAGEYSOBOTKA, A; GILLIS, S; LICHTENSTEIN, LM			HUMAN RECOMBINANT INTERLEUKIN-3 (IL3) INDUCES HISTAMINE-RELEASE FROM HUMAN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					301	301		10.1016/0091-6749(88)90767-1	http://dx.doi.org/10.1016/0091-6749(88)90767-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400554
J	MOSCICKI, R; RAMADAN, H; CASTRO, O; NADOL, J; BLOCH, KJ				MOSCICKI, R; RAMADAN, H; CASTRO, O; NADOL, J; BLOCH, KJ			CORTICOSTEROID (CS) RESPONSE IN IDIOPATHIC PROGRESSIVE SENSORINEURAL HEARING-LOSS (SNHL)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					217	217		10.1016/0091-6749(88)90432-0	http://dx.doi.org/10.1016/0091-6749(88)90432-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400219
J	WOLF, B; LIEBERMAN, P				WOLF, B; LIEBERMAN, P			RETROSPECTIVE REVIEW OF 89 PATIENTS (P) WITH ANAPHYLAXIS (A)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					238	238		10.1016/0091-6749(88)90516-7	http://dx.doi.org/10.1016/0091-6749(88)90516-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400303
J	WRIGHT, DN; NELSON, RP; LEDFORD, DK; LOCKEY, RF				WRIGHT, DN; NELSON, RP; LEDFORD, DK; LOCKEY, RF			SERUM IGE AND HUMAN IMMUNODEFICIENCY VIRUS (HIV)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					216	216		10.1016/0091-6749(88)90426-5	http://dx.doi.org/10.1016/0091-6749(88)90426-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400213
J	FREIDHOFF, LR; EHRLICHKAUTZKY, E; MEYERS, DA; MARSH, DG				FREIDHOFF, LR; EHRLICHKAUTZKY, E; MEYERS, DA; MARSH, DG			A STUDY OF THE HUMAN IMMUNE-RESPONSE TO LOLIUM-PERENNE (RYE) POLLEN AND ITS COMPONENTS, LOL P-I AND LOL P-II (RYE-I AND RYE-II) .2. LONGITUDINAL VARIATION OF ANTIBODY-LEVELS IN RELATION TO SYMPTOMATOLOGY AND POLLEN EXPOSURE AND CORRECTION OF SEASONALLY ELEVATED ANTIBODY-LEVELS TO BASAL VALUES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											FREIDHOFF, LR (corresponding author), JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,DIV CLIN IMMUNOL,5601 LOCH RAVEN BLVD,BALTIMORE,MD 21239, USA.				NIAID NIH HHS [AI-20059] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020059] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADKINSON NF, 1980, MANUAL CLIN IMMUNOLO, P794; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; FREIDHOFF LR, 1986, J ALLERGY CLIN IMMUN, V78, P1190, DOI 10.1016/0091-6749(86)90271-X; FREIDHOFF LR, 1983, J ALLERGY CLIN IMMUN, V72, P274, DOI 10.1016/0091-6749(83)90032-5; FREIDHOFF LR, 1981, AM J MED GENET, V9, P323, DOI 10.1002/ajmg.1320090409; FREIDHOFF LR, 1984, J ALLERGY CLIN IMMUN, V73, P490, DOI 10.1016/0091-6749(84)90360-9; GLEICH GJ, 1976, J ALLERGY CLIN IMMUN, V57, P203; GLEICH GJ, 1977, J ALLERGY CLIN IMMUN, V60, P188, DOI 10.1016/0091-6749(77)90123-3; JOHANSSON SGO, 1972, PROG CLIN IMMUNOL, V1, P1; JOHNSON P, 1966, IMMUNOCHEMISTRY, V3, P101, DOI 10.1016/0019-2791(66)90291-6; JOHNSON P, 1966, IMMUNOCHEMISTRY, V3, P91, DOI 10.1016/0019-2791(66)90290-4; JOHNSON P, 1965, NATURE, V206, P935, DOI 10.1038/206935b0; JOHNSON P, 1965, EUR POLYM J, V1, P63; KLEINBAUM DJ, 1978, APPLIED REGRESSION A; LICHTENS.LM, 1968, AM J MED, V44, P514, DOI 10.1016/0002-9343(68)90052-1; LICHTENSTEIN LM, 1971, ANN INTERN MED, V75, P663, DOI 10.7326/0003-4819-75-5-663; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; LICHTENSTEIN LM, 1966, J CLIN INVEST, V45, P1126, DOI 10.1172/JCI105419; MARSH DG, 1975, ANTIGENS, V3, P271; MULLIGAN JJ, 1966, J IMMUNOL, V96, P324; NORMAN PS, 1982, J ALLERGY CLIN IMMUN, V70, P248, DOI 10.1016/0091-6749(82)90061-6; NORMAN PS, 1966, CLINICAL PHARMACOLOG, V2, P639; NORMAN PS, 1976, IMMUNOLOGIC INFECTIO, P461; OGDEN EC, 1967, J ALLERGY, V40, P1, DOI 10.1016/0021-8707(67)90053-6; PLATTSMILLS TAE, 1978, J IMMUNOL, V120, P1201; SANTILLI J, 1980, J ALLERGY CLIN IMMUN, V65, P406, DOI 10.1016/0091-6749(80)90232-8; YUNGINGER JW, 1973, J ALLERGY CLIN IMMUN, V51, P174, DOI 10.1016/0091-6749(73)90022-5; YUNGINGER JW, 1973, J CLIN INVEST, V52, P1268, DOI 10.1172/JCI107294; 1982, BMPD STATISTICAL SOF	29	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1987	80	5					646	655		10.1016/0091-6749(87)90283-1	http://dx.doi.org/10.1016/0091-6749(87)90283-1			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K9930	3680810	Bronze			2022-12-18	WOS:A1987K993000003
J	KLEINERMAN, J; ADELSON, L				KLEINERMAN, J; ADELSON, L			A STUDY OF ASTHMA DEATHS IN A CORONERS POPULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106	Case Western Reserve University	KLEINERMAN, J (corresponding author), CLEVELAND METROPOLITAN GEN HOSP,DEPT PATHOL,3395 SCRANTON RD,CLEVELAND,OH 44109, USA.							BURNEY PGJ, 1986, LANCET, V2, P323; Cardell BS, 1959, THORAX, V14, P341; COPELAND AR, 1986, FORENSIC SCI INT, V31, P7, DOI 10.1016/0379-0738(86)90066-6; DOLL R, 1968, BR MED J, V3, P245; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27	5	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			406	409		10.1016/0091-6749(87)90061-3	http://dx.doi.org/10.1016/0091-6749(87)90061-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3624692				2022-12-18	WOS:A1987K103700012
J	LEWIS, CE; LEWIS, MA				LEWIS, CE; LEWIS, MA			EVALUATION AND IMPLEMENTATION OF SELF-MANAGEMENT PROGRAMS FOR CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,SCH NURSING,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH PUBL HLTH,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	LEWIS, CE (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024, USA.							ELINSON J, 1972, HDB MED SOCIOLOGY, P483; JORDAN TE, 1962, MERRILLPALMER Q, V8, P242; LEWIS CE, 1984, PEDIATRICS, V74, P478; MURSTEIN BI, 1960, CHILD DEV, V31, P157, DOI 10.1111/j.1467-8624.1960.tb05793.x	4	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			498	500		10.1016/0091-6749(87)90085-6	http://dx.doi.org/10.1016/0091-6749(87)90085-6			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3624706				2022-12-18	WOS:A1987K103700032
J	RICHARDSON, JB				RICHARDSON, JB			AIRWAYS SMOOTH-MUSCLE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											RICHARDSON, JB (corresponding author), MCGILL UNIV, MONTREAL GEN HOSP, DEPT PATHOL, 1650 CEDAR AVE, MONTREAL H3G 1A4, QUEBEC, CANADA.							AKASAKA K, 1975, TOHOKU J EXP MED, V117, P55, DOI 10.1620/tjem.117.55; ALMY TP, 1980, NEW ENGL J MED, V302, P324, DOI 10.1056/NEJM198002073020605; AMOUR CL, 1984, AM REV RESPIR DIS, V129, P907; ANTHONISEN NR, 1986, AM REV RESPIR DIS, V133, P814; ARMSTRONG PJ, 1986, AM REV RESPIR DIS, V133, P357; BARNES PJ, 1985, BRIT J PHARMACOL, V86, P685, DOI 10.1111/j.1476-5381.1985.tb08946.x; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CERRINA J, 1986, AM REV RESPIR DIS, V134, P57; DANIELS EE, IN PRESS LUNG BIOL H; DOIDGE JM, 1982, J AUTONOM NERV SYST, V5, P83, DOI 10.1016/0165-1838(82)90030-3; DUNNILL MS, 1969, THORAX, V24, P176, DOI 10.1136/thx.24.2.176; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FLAVAHAN NA, 1985, J APPL PHYSIOL, V58, P834, DOI 10.1152/jappl.1985.58.3.834; GOLDEN JA, 1978, AM REV RESPIR DIS, V118, P287; GROSS NJ, 1986, AM REV RESPIR DIS, V133, P725; HAHN HL, 1978, J APPL PHYSIOL, V44, P144, DOI 10.1152/jappl.1978.44.2.144; HEARD BE, 1973, J PATHOL, V110, P319, DOI 10.1002/path.1711100406; HOSSAIN S, 1970, J PATHOL, V101, P171, DOI 10.1002/path.1711010212; IRVIN CG, 1980, SCIENCE, V207, P791, DOI 10.1126/science.7352292; KANNAN MS, 1978, J CELL BIOL, V78, P338, DOI 10.1083/jcb.78.2.338; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LEFF AR, 1983, J APPL PHYSIOL, V55, P113, DOI 10.1152/jappl.1983.55.1.113; MACKLEM PT, 1985, CHEST, V87, pS158, DOI 10.1378/chest.87.5_Supplement.158S; MITCHELL RA, 1985, J APPL PHYSIOL, V58, P911, DOI 10.1152/jappl.1985.58.3.911; MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171; NADEL JA, 1984, ANNU REV MED, V35, P451, DOI 10.1146/annurev.med.35.1.451; ODONNELL SR, 1978, CLIN EXP PHARMACOL P, V5, P325, DOI 10.1111/j.1440-1681.1978.tb00681.x; PACK RJ, 1984, CELL TISSUE RES, V238, P61; RICHARDSON J, 1975, J PEDIATR SURG, V10, P875, DOI 10.1016/S0022-3468(75)80090-X; RICHARDSON JB, 1981, LUNG, V159, P315, DOI 10.1007/BF02713931; SMITH B, 1970, GUT, V11, P388, DOI 10.1136/gut.11.5.388; SNAPPER JR, 1986, AM REV RESPIR DIS, V133, P351; SOUHRADA JF, 1976, RESP PHYSIOL, V27, P241, DOI 10.1016/0034-5687(76)90077-3; STEPHENS NL, 1986, J APPL PHYSIOL, V61, P1492, DOI 10.1152/jappl.1986.61.4.1492; STEPHENS NL, 1985, BRONCHIAL ASTHMA, P96; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TAKIZAWA T, 1971, AM REV RESPIR DIS, V104, P331, DOI 10.1164/arrd.1971.104.3.331; WOOLCOCK AJ, 1984, AM REV RESPIR DIS, V130, P71; ZORYCHTA E, 1980, CLIN RES PROC, V16, P581; ZORYCHTA EA, UNPUB J APPL PHYSL	40	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			409	411		10.1016/0091-6749(87)90062-5	http://dx.doi.org/10.1016/0091-6749(87)90062-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3624693	Bronze			2022-12-18	WOS:A1987K103700013
J	CHANDLER, MJ; ZEISS, CR; LEACH, CL; HATOUM, NS; LEVITZ, D; GARVIN, PJ; PATTERSON, R				CHANDLER, MJ; ZEISS, CR; LEACH, CL; HATOUM, NS; LEVITZ, D; GARVIN, PJ; PATTERSON, R			LEVELS AND SPECIFICITY OF ANTIBODY IN BRONCHOALVEOLAR LAVAGE (BAL) AND SERUM IN AN ANIMAL-MODEL OF TRIMELLITIC ANHYDRIDE INDUCED LUNG INJURY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM LAKESIDE MED CTR,ACOS RES & DEV,400 E ONTARIO,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; AMOCO CORP,DEPT ENVIRONM AFFAIRS & SAFETY,CHICAGO,IL; IIT,LIFE SCI RES RES INST,CHICAGO,IL 60616	Northwestern University; Illinois Institute of Technology					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMAD D, 1979, LANCET, V2, P326; LEACH CL, 1987, TOXICOL APPL PHARM, V87, P67, DOI 10.1016/0041-008X(87)90085-8; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; PATTERSON R, 1981, INT ARCH ALLER A IMM, V66, P332, DOI 10.1159/000232838; PATTERSON R, 1982, J ALLERGY CLIN IMMUN, V70, P19, DOI 10.1016/0091-6749(82)90196-8; PATTERSON R, 1979, AM REV RESPIR DIS, V120, P1259; PATTERSON R, 1980, CLIN IMMUNOL IMMUNOP, V15, P357, DOI 10.1016/0090-1229(80)90047-1; SALE SR, 1981, J ALLERGY CLIN IMMUN, V68, P188, DOI 10.1016/0091-6749(81)90182-2; SALE SR, 1982, INT ARCH ALLER A IMM, V67, P329, DOI 10.1159/000233042; TURNER ES, 1980, CLIN EXP IMMUNOL, V39, P470; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1983, ANN INTERN MED, V98, P8, DOI 10.7326/0003-4819-98-1-8; ZEISS CR, 1980, INT ARCH ALLER A IMM, V61, P380; ZEISS CR, 1987, J ALLERGY CLIN IMMUN, V79, P59, DOI 10.1016/S0091-6749(87)80017-9; ZEISS CR, 1987, J ALLERGY CLIN IMMUN, V79, P245	15	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1987	80	2					223	229		10.1016/0091-6749(87)90133-3	http://dx.doi.org/10.1016/0091-6749(87)90133-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	J6575	3611543				2022-12-18	WOS:A1987J657500015
J	HENDELES, L; HARMAN, E				HENDELES, L; HARMAN, E			SHOULD WE ABANDON THE NOTION THAT CALCIUM-CHANNEL BLOCKERS ARE POTENTIALLY USEFUL FOR ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material															NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031489] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL31489] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADVENIER C, 1983, BRIT J PHARMACOL, V78, P301, DOI 10.1111/j.1476-5381.1983.tb09395.x; AHMED T, 1985, CHEST, V88, P176, DOI 10.1378/chest.88.2.176; AHMED T, 1985, CHEST, V88, pS142; AHRENS RC, 1986, J ALLERGY CLIN IMMUN, V79, P876; ANDERSON SD, 1976, AM REV RESPIR DIS, V114, P493; BARNES PJ, 1985, BRIT J CLIN PHARMACO, V20, pS289, DOI 10.1111/j.1365-2125.1985.tb02815.x; BARNES PJ, 1981, THORAX, V36, P726, DOI 10.1136/thx.36.10.726; BENDOV I, 1986, AM REV RESPIR DIS, V133, P116, DOI 10.1164/arrd.1986.133.1.116; BUNDGAARD A, 1980, ALLERGY, V35, P639, DOI 10.1111/j.1398-9995.1980.tb02016.x; CERRINA J, 1981, AM REV RESPIR DIS, V123, P156; CHRISTOPHER MA, 1987, UNPUB JUL AM COLL CL; CORRIS PA, 1983, AM REV RESPIR DIS, V128, P991; EASTON JG, 1981, J ALLERGY CLIN IMMUN, V67, P388, DOI 10.1016/0091-6749(81)90084-1; FANTA CH, 1982, AM REV RESPIR DIS, V125, P61; FARLEY JM, 1977, J PHARMACOL EXP THER, V201, P199; FRAUNFELDER FT, 1984, NEW ENGL J MED, V311, P1441; GARTY M, 1986, CLIN PHARMACOL THER, V40, P195, DOI 10.1038/clpt.1986.163; GODGRAIND T, 1985, CALCIUM CELL PHYSL, P204; GONZALEZ JM, 1983, AM REV RESPIR DIS, V127, P155; HARMAN E, 1985, American Review of Respiratory Disease, V131, pA50; HARTMANN V, 1985, CHEST, V87, P174, DOI 10.1378/chest.87.2.174; HENDELES L, 1985, J ALLERGY CLIN IMMUN, V75, P173, DOI 10.1016/0091-6749(85)90410-5; HENDELES L, UNPUB DOSE RESPONSE; HENDERSON AF, 1983, THORAX, V38, P512, DOI 10.1136/thx.38.7.512; HILL M, 1985, DRUG INTEL CLIN PHAR, V19, P464; HILL M, 1986, J ALLERGY CLIN IMMUN, V77, P164; JAKSCHIK BA, 1980, BIOCHEM BIOPH RES CO, V95, P103, DOI 10.1016/0006-291X(80)90710-X; LEE VY, 1983, THORAX, V38, P386, DOI 10.1136/thx.38.5.386; LEVER AML, 1984, THORAX, V39, P576, DOI 10.1136/thx.39.8.576; MAGNUSSEN H, 1984, THORAX, V39, P579, DOI 10.1136/thx.39.8.579; MALO PE, 1982, J PHARMACOL EXP THER, V221, P410; MASSEY KL, 1986, J ALLERGY CLIN IMMUN, V77, P152; MIDDLETON E, 1980, J PHARM SCI-US, V69, P243, DOI 10.1002/jps.2600690244; OLIVE SR, 1986, CHEST, V90, P208, DOI 10.1378/chest.90.2.208; OZENNE G, 1985, EUR J RESPIR DIS, V67, P238; PATAKAS D, 1983, J ALLERGY CLIN IMMUN, V72, P269, DOI 10.1016/0091-6749(83)90031-3; PATEL KR, 1982, BRIT MED J, V284, P1916, DOI 10.1136/bmj.284.6333.1916; PATEL KR, 1981, BRIT MED J, V282, P932, DOI 10.1136/bmj.282.6268.932; PATEL KR, 1981, CLIN ALLERGY, V11, P441, DOI 10.1111/j.1365-2222.1981.tb01617.x; PATEL KR, 1983, CLIN ALLERGY, V13, P119, DOI 10.1111/j.1365-2222.1983.tb02578.x; PENNINGTON JE, 1986, J LAB CLIN MED, V108, P44; POLLOCK J, 1977, PEDIATRICS, V60, P840; POPA VT, 1984, AM REV RESPIR DIS, V130, P1006; ROLLA G, 1982, LANCET, V1, P1305; RUSSI EW, 1985, CHEST, V88, P74, DOI 10.1378/chest.88.1.74; RYO UY, 1976, JAMA-J AM MED ASSOC, V236, P927; SO SY, 1982, CLIN ALLERGY, V12, P595, DOI 10.1111/j.1365-2222.1982.tb02558.x; SPEDINI C, 1986, 3 WORLD C CLIN PHARM, P227; WILLIAMS DO, 1981, BRIT MED J, V283, P348, DOI 10.1136/bmj.283.6287.348; YAZIGI R, 1978, ANN ALLERGY, V40, P322	50	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1987	79	6					853	856		10.1016/0091-6749(87)90231-4	http://dx.doi.org/10.1016/0091-6749(87)90231-4			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H9044	3584741	Bronze			2022-12-18	WOS:A1987H904400003
J	CUNNINGTON, AM; LIND, P; SPIEKSMA, FTM				CUNNINGTON, AM; LIND, P; SPIEKSMA, FTM			TAXONOMIC AND IMMUNOCHEMICAL IDENTIFICATION OF 2 HOUSE DUST MITES DERMATOPHAGOIDES-FARINAE AND DERMATOPHAGOIDES-MICROCERAS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									UNIV COPENHAGEN, PROT LAB, DK-1168 COPENHAGEN, DENMARK; STATE UNIV LEIDEN HOSP, DEPT PULM, AEROBIOL LAB, 2333 AA LEIDEN, NETHERLANDS	University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC)	CUNNINGTON, AM (corresponding author), MINIST AGR, SLOUGH LAB, SLOUGH, ENGLAND.							CHAPMAN MD, 1980, J IMMUNOL, V125, P587; CHAPMAN MD, 1985, INT ARCH ALLER A IMM, V77, P166, DOI 10.1159/000233774; CHAPMAN MD, 1984, J IMMUNOL, V133, P2488; CUNNINGTON A M, 1971, Clinical Allergy, V1, P447, DOI 10.1111/j.1365-2222.1971.tb00795.x; Fain A., 1967, Acarologia, V9, P870; GRIFFITHS DA, 1971, J STORED PROD RES, V7, P1, DOI 10.1016/0022-474X(71)90032-4; LIND P, 1985, J ALLERGY CLIN IMMUN, V76, P753, DOI 10.1016/0091-6749(85)90682-7; LIND P, 1986, INT ARCH ALLER A IMM, V79, P60, DOI 10.1159/000233943; LIND P, IN PRESS ALLERGY; LIND P, 1985, INHALATIVE NOXE INHA, P68; LIND P, IN PRESS SCAND J IMM; LIND P, UNPUB PREVALENCE IND; LIND P, 1984, ALLERGY S, V2, P39; MAUNSELL K, 1968, LANCET, V1, P1267; MIYAMOTO T, 1968, J ALLERGY, V42, P14, DOI 10.1016/0021-8707(68)90128-7; Oshima S., 1964, Japanese Journal of Sanitary Zoology, V15, P233; Spieksma F. Th. M., 1967, Acarologia, V9, P226; VOORHORS.R, 1967, J ALLERGY, V39, P325, DOI 10.1016/0021-8707(67)90045-7; Voorhorst R., 1964, Allergie Asthma, V10, P329; VOORHORST R., 1969, House-dust atopy and the house-dust mite Dermatophagoides pteronyssinus (Trouessart 1897).	20	8	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1987	79	2					410	411		10.1016/0091-6749(87)90163-1	http://dx.doi.org/10.1016/0091-6749(87)90163-1			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G1791	3819223				2022-12-18	WOS:A1987G179100018
J	DESAGER, K; VANBEVER, HP; STEVENS, WJ				DESAGER, K; VANBEVER, HP; STEVENS, WJ			CONTACT SENSITIVITY TO AEROALLERGENS IN CHILDREN WITH ATOPIC-DERMATITIS (AD) DEMONSTRATED BY PATCH TEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV INSTELLING ANTWERP,B-2610 WILRIJK,BELGIUM	University of Antwerp									0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					236	236						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000468
J	GAYE, A; LERNER, C				GAYE, A; LERNER, C			REACTIVITY TO PRESERVATIVES IN HEPARIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					238	238						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000476
J	HIGGINS, DA; OBYRNE, PM				HIGGINS, DA; OBYRNE, PM			INHALED LEUKOTRIENE D4 DOES NOT CAUSE A LATE ASTHMATIC RESPONSE IN ATOPIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									MCMASTER UNIV,HAMILTON L8S 4L8,ONTARIO,CANADA	McMaster University									0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					141	141						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000090
J	KASTIN, AJ; GALINA, ZH; HORVATH, A; OLSON, RD				KASTIN, AJ; GALINA, ZH; HORVATH, A; OLSON, RD			SOME PRINCIPLES IN THE PEPTIDE FIELD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TULANE UNIV, SCH MED, NEW ORLEANS, LA 70112 USA; UNIV NEW ORLEANS, NEW ORLEANS, LA 70148 USA	Tulane University; University of Louisiana System; University of New Orleans	KASTIN, AJ (corresponding author), VET ADM MED CTR, 1601 PERDIDO ST, NEW ORLEANS, LA 70146 USA.							ARIMURA A, 1974, CLIN ENDOCRINOL, V3, P421, DOI 10.1111/j.1365-2265.1974.tb02812.x; BANKS WA, 1985, PSYCHONEUROENDOCRINO, V10, P385, DOI 10.1016/0306-4530(85)90079-4; BANKS WA, 1982, PHARMACOL BIOCHEM BE, V17, P1009, DOI 10.1016/0091-3057(82)90486-5; BANKS WA, 1983, LIFE SCI, V33, P1587, DOI 10.1016/0024-3205(83)90700-2; BANKS WA, 1985, BRAIN RES BULL, V15, P287, DOI 10.1016/0361-9230(85)90153-4; BANKS WA, 1984, PHARMACOL BIOCHEM BE, V21, P943, DOI 10.1016/S0091-3057(84)80077-5; BECKWITH BE, 1977, PHYSIOL PSYCHOL, V5, P295, DOI 10.3758/BF03335334; BECKWITH BE, 1977, PHYSIOL BEHAV, V18, P63, DOI 10.1016/0031-9384(77)90095-6; DEWIED D, 1975, BIOCHEM PHARMACOL, V24, P1463, DOI 10.1016/0006-2952(75)90019-2; EHRENSING RH, 1974, ARCH GEN PSYCHIAT, V30, P63; EHRENSING RH, 1982, PHARMACOL BIOCHEM BE, V17, P757, DOI 10.1016/0091-3057(82)90358-6; EHRENSING RH, 1978, AM J PSYCHIAT, V135, P562; GALINA ZH, 1985, PEPTIDES, V6, P1109, DOI 10.1016/0196-9781(85)90435-8; GRAF MV, 1984, P SOC EXP BIOL MED, V177, P197; GRAF MV, 1984, J CLIN ENDOCR METAB, V59, P127, DOI 10.1210/jcem-59-1-127; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; KASTIN AJ, 1984, PHARMACOL BIOCHEM BE, V21, P969, DOI 10.1016/S0091-3057(84)80082-9; KASTIN AJ, 1976, PHARMACOL BIOCHEM BE, V5, P691, DOI 10.1016/0091-3057(76)90313-0; KASTIN AJ, 1985, PHARMACOL BIOCHEM BE, V23, P1045, DOI 10.1016/0091-3057(85)90112-1; KASTIN AJ, 1981, PHARMACOL BIOCHEM BE, V15, P969, DOI 10.1016/0091-3057(81)90064-2; KASTIN AJ, 1976, BRAIN RES BULL, V1, P19, DOI 10.1016/0361-9230(76)90045-9; KASTIN AJ, 1979, PHARMACOL BIOCHEM BE, V11, P721, DOI 10.1016/0091-3057(79)90270-3; KASTIN AJ, 1980, PHARMACOL BIOCHEM BE, V13, P913, DOI 10.1016/0091-3057(80)90228-2; KASTIN AJ, 1978, PHARMACOL BIOCHEM BE, V9, P515, DOI 10.1016/0091-3057(78)90051-5; KASTIN AJ, 1979, LIFE SCI, V25, P401, DOI 10.1016/0024-3205(79)90572-1; KASTIN AJ, 1984, PHARMACOL BIOCHEM BE, V21, P767, DOI 10.1016/S0091-3057(84)80017-9; KASTIN AJ, 1981, ENDOGENOUS PEPTIDES, P563; KASTIN AJ, 1972, INT C SERIES, V263, P159; MICHALS EA, 1986, CLIN RES, V34, pA199; MILLER LH, 1981, PHARMACOL BIOCHEM BE, V15, P845, DOI 10.1016/0091-3057(81)90040-X; MOSS RL, 1973, SCIENCE, V181, P177, DOI 10.1126/science.181.4095.177; PFAFF DW, 1973, SCIENCE, V182, P1148, DOI 10.1126/science.182.4117.1148; PLOTNIKOFF NP, 1971, LIFE SCI, V10, P1279, DOI 10.1016/0024-3205(71)90326-2; REDDING TW, 1974, NEUROENDOCRINOLOGY, V16, P119, DOI 10.1159/000122558; REDDING TW, 1973, NEUROENDOCRINOLOGY, V11, P92, DOI 10.1159/000122121; REDDING TW, 1973, J CLIN ENDOCR METAB, V37, P626, DOI 10.1210/jcem-37-4-626; REDDING TW, 1978, PHARMACOL BIOCHEM BE, V9, P207, DOI 10.1016/0091-3057(78)90166-1; SANDMAN CA, 1979, LIFE SCI, V25, P1755, DOI 10.1016/0024-3205(79)90479-X; SANDMAN CA, 1980, PEPTIDES, V1, P277, DOI 10.1016/0196-9781(80)90002-9; SCHALLY AV, 1970, ADV STEROID BIOCHEM, P41; SHAVIT Y, 1984, SCIENCE, V223, P188, DOI 10.1126/science.6691146; STRATTON LO, 1976, PHARMACOL BIOCHEM BE, V5, P65, DOI 10.1016/0091-3057(76)90330-0; TESKEY GC, 1985, PEPTIDES, V6, P165, DOI 10.1016/0196-9781(85)90034-8; ZADINA JE, 1985, PEPTIDES, V6, P965, DOI 10.1016/0196-9781(85)90329-8; ZADINA JE, 1981, PHARMACOL BIOCHEM BE, V15, P961, DOI 10.1016/0091-3057(81)90062-9; ZADINA JE, 1985, PSYCHONEUROENDOCRINO, V10, P367, DOI 10.1016/0306-4530(85)90078-2; ZADINA JE, BRAIN RES	47	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					6	11		10.1016/S0091-6749(87)80007-6	http://dx.doi.org/10.1016/S0091-6749(87)80007-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810	3805549				2022-12-18	WOS:A1987F881000003
J	ZURAW, B; LAMMLE, B; SUGIMOTO, S; GRIFFIN, J; CURD, J				ZURAW, B; LAMMLE, B; SUGIMOTO, S; GRIFFIN, J; CURD, J			CLEAVAGE OF HIGH-MOLECULAR-WEIGHT KININOGEN (HMWK) IN PLASMA DURING ATTACKS OF ANGIOEDEMA IN HEREDITARY ANGIOEDEMA (HAE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Laemmle, Bernhard/AAJ-1216-2020	Laemmle, Bernhard/0000-0003-4538-5154					0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					177	177						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000233
J	DOR, PJ; AGARWAL, MK; GLEICH, MC; WELSH, PW; DUNNETTE, SL; ADOLPHSON, CR; GLEICH, GJ				DOR, PJ; AGARWAL, MK; GLEICH, MC; WELSH, PW; DUNNETTE, SL; ADOLPHSON, CR; GLEICH, GJ			DETECTION OF ANTIBODIES TO PROTEASES USED IN LAUNDRY DETERGENTS BY THE RADIOALLERGOSORBENT TEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN, DEPT IMMUNOL, ROCHESTER, MN 55905 USA; MAYO CLIN & MAYO FDN, DEPT ALLERG DIS & INTERNAL MED, ROCHESTER, MN 55905 USA	Mayo Clinic; Mayo Clinic								Adolphson C. R., 1986, MANUAL CLIN LABORATO, P652; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Arnon R., 1970, PAPAIN METHODS ENZYM, V19, P226, DOI DOI 10.1016/0076-6879(70)19017-3; BALE WF, 1966, P SOC EXP BIOL MED, V122, P407; BERNSTEIN IL, 1972, J ALLERGY CLIN IMMUN, V49, P219; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FLINDT MLH, 1969, LANCET, V1, P1177; GLEICH GJ, 1980, J ALLERGY CLIN IMMUN, V65, P20, DOI 10.1016/0091-6749(80)90172-4; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P334, DOI 10.1016/0091-6749(75)90005-6; GREENBERG M, 1970, BMJ-BRIT MED J, V2, P629, DOI 10.1136/bmj.2.5710.629; Hales C N, 1980, Methods Enzymol, V70, P334; INOUE M, 1978, BIOCHEM BIOPH RES CO, V82, P1183, DOI 10.1016/0006-291X(78)90311-X; KABAT EA, 1967, EXPT IMMUNOCHEMISTRY, P559; LISS GM, 1984, J ALLERGY CLIN IMMUN, V73, P348, DOI 10.1016/0091-6749(84)90407-X; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NEWHOUSE ML, 1970, LANCET, V1, P689; PEPYS J, 1969, LANCET, V1, P1181; POLGAR L, 1967, BIOCHEMISTRY-US, V6, P610, DOI 10.1021/bi00854a032; SEKAR V, 1979, BIOCHEM BIOPH RES CO, V89, P474, DOI 10.1016/0006-291X(79)90653-3; SHAPIRO RS, 1971, J ALLERGY, V47, P76, DOI 10.1016/S0091-6749(71)80373-1; WEBER K, 1969, J BIOL CHEM, V244, P4406; ZACHARIAE H, 1981, ALLERGY, V36, P513, DOI 10.1111/j.1398-9995.1981.tb01864.x; 1976, THORAX, V31, P621	23	8	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	1				877	886		10.1016/0091-6749(86)90234-4	http://dx.doi.org/10.1016/0091-6749(86)90234-4			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9713	3537081				2022-12-18	WOS:A1986E971300009
J	HILL, DJ; EKERT, H; BRYANT, DH				HILL, DJ; EKERT, H; BRYANT, DH			EPISODIC ANGIOEDEMA AND HYPEREOSINOPHILIA IN CHILDHOOD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									ROYAL CHILDRENS HOSP,HAEMATOL,PARKVILLE,VIC 3052,AUSTRALIA; ST VINCENTS HOSP,SYDNEY,NSW 2010,AUSTRALIA	Royal Children's Hospital Melbourne; St Vincents Hospital Sydney	HILL, DJ (corresponding author), ROYAL CHILDRENS HOSP,ALLERGY CLIN IMMUNOL UNIT,151 FLEMINGTON RD,MELBOURNE 3051,AUSTRALIA.							DESSEIN AJ, 1982, J EXP MED, V156, P90, DOI 10.1084/jem.156.1.90; ELLIS WM, 1980, PATHOLOGY, V12, P587; GLEICH GJ, 1984, NEW ENGL J MED, V310, P1621, DOI 10.1056/NEJM198406213102501; HIRASHIMA M, 1976, IMMUNOLOGY, V30, P203; KATZEN DR, 1986, AM J DIS CHILD, V140, P62, DOI 10.1001/archpedi.1986.02140150064038	5	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	1				122	123		10.1016/0091-6749(86)90124-7	http://dx.doi.org/10.1016/0091-6749(86)90124-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2996	3722632				2022-12-18	WOS:A1986D299600019
J	LOMNITZER, R; RABSON, AR				LOMNITZER, R; RABSON, AR			LACK OF RESPONSIVENESS OF BEEKEEPER MONONUCLEAR-CELLS TO INVITRO STIMULATION WITH PURE BEE VENOM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LOMNITZER, R (corresponding author), S AFRICAN INST MED RES,SCH PATHOL,DEPT IMMUNOL,MRC,HUMAN CELLULAR IMMUNOL RES UNIT,POB 1038,JOHANNESBURG 2000,SOUTH AFRICA.							BAUER JD, 1982, CLIN LABORATORY METH, P1075; Boyum A, 1968, SCAND J CLIN LAB S97, V21, P7; CASE RL, 1981, J ALLERGY CLIN IMMUN, V68, P399, DOI 10.1016/0091-6749(81)90139-1; GATIEN JG, 1975, CLIN IMMUNOL IMMUNOP, V4, P32, DOI 10.1016/0090-1229(75)90036-7; GRIMM EA, 1982, ISOLATION CHARACTERI, P57; GUPTA S, 1977, CLIN EXP IMMUNOL, V30, P222; HIRATANI M, 1981, J ALLERGY CLIN IMMUN, V68, P205, DOI 10.1016/0091-6749(81)90185-8; LOMNITZER R, 1978, CLIN EXP IMMUNOL, V33, P499; MAIZEL AL, 1979, CELL IMMUNOL, V48, P383, DOI 10.1016/0008-8749(79)90133-3; MALKOVSKY M, 1984, IMMUNOL TODAY, V5, P340, DOI 10.1016/0167-5699(84)90074-4; MATLOFF SM, 1983, J ALLERGY CLIN IMMUN, V72, P359, DOI 10.1016/0091-6749(83)90500-6; MORETTA L, 1976, J IMMUNOL, V117, P2171; NATH I, 1980, CLIN EXP IMMUNOL, V42, P203; RAWLE FC, 1985, CLIN EXP IMMUNOL, V59, P101; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; ROCKLIN RE, 1974, J CLIN INVEST, V53, P735, DOI 10.1172/JCI107612; SAXON A, 1984, J CLIN INVEST, V73, P342, DOI 10.1172/JCI111218; SIKORA LKJ, 1984, J IMMUNOL, V133, P2898; STOBO JD, 1977, J IMMUNOL, V119, P918	19	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	1				25	30		10.1016/0091-6749(86)90110-7	http://dx.doi.org/10.1016/0091-6749(86)90110-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2996	3487563				2022-12-18	WOS:A1986D299600005
J	YUNGINGER, JW				YUNGINGER, JW			PROPER APPLICATION OF AVAILABLE LABORATORY TESTS FOR ADVERSE REACTIONS TO FOODS AND FOOD-ADDITIVES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO MED SCH,DEPT PEDIAT,ROCHESTER,MN 55901; MAYO MED SCH,DEPT INTERNAL MED ALLERGY,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic	YUNGINGER, JW (corresponding author), MAYO CLIN & MAYO FDN,ALLERG DIS RES LAB,406 GUGGENHEIM BLDG,ROCHESTER,MN 55905, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI012675] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-12675] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AAS K, 1971, J ALLERGY CLIN IMMUN, V48, P134, DOI 10.1016/0091-6749(71)90008-X; AAS K, 1973, Clinical Allergy, V3, P255, DOI 10.1111/j.1365-2222.1973.tb01331.x; ATKINS FM, 1984, ANNU REV NUTR, V4, P233, DOI 10.1146/annurev.nu.04.070184.001313; BOCK SA, 1978, J ALLERGY CLIN IMMUN, V62, P327, DOI 10.1016/0091-6749(78)90132-X; BOCK SA, 1977, CLIN ALLERGY, V7, P375, DOI 10.1111/j.1365-2222.1977.tb01466.x; BOCK SA, 1983, ALLERGY PRINCIPLES P, P1415; BRENEMAN JC, 1974, ANN ALLERGY, V33, P164; COOK TJ, 1973, J ALLERGY CLIN IMMUN, V51, P71, DOI 10.1016/S0091-6749(73)80002-8; DEFILIPPI I, 1981, ANN ALLERGY, V46, P249; GLEICH GJ, 1983, ALLERGY, P271; KAILIN EW, 1971, J AMER MED ASSOC, V217, P78; LEHMAN CW, 1980, ANN ALLERGY, V45, P144; LIEBERMAN P, 1975, JAMA-J AM MED ASSOC, V231, P728; METCALFE DD, 1983, PROVOCATIVE CHALLENG, V2, P119; NORDLEE JA, 1981, J ALLERGY CLIN IMMUN, V68, P376, DOI 10.1016/0091-6749(81)90136-6; NORMAN PS, 1983, ALLERGY PRINCIPLES P, P295; SAMPSON HA, 1984, J ALLERGY CLIN IMMUN, V74, P26, DOI 10.1016/0091-6749(84)90083-6; SANTRACH PJ, 1981, J ALLERGY CLIN IMMUN, V67, P97, DOI 10.1016/0091-6749(81)90003-8; SIRAGANIAN RP, 1980, MANUAL CLIN IMMUNOLO, P808; YUNGINGER JW, 1983, J FOOD PROTECT, V46, P625, DOI 10.4315/0362-028X-46.7.625; 1981, J ALLERGY CLIN IMMUN, V67, P333	21	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	2	S			220	223		10.1016/0091-6749(86)90015-1	http://dx.doi.org/10.1016/0091-6749(86)90015-1			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2997	3522710				2022-12-18	WOS:A1986D299700015
J	ANDERSON, JA; CHAI, H; CLAMAN, HN; ELLIS, EF; FINK, JN; KAPLAN, AP; LIEBERMAN, PL; PIERSON, WE; SALVAGGIO, JE; SHEFFER, AL; SLAVIN, RG				ANDERSON, JA; CHAI, H; CLAMAN, HN; ELLIS, EF; FINK, JN; KAPLAN, AP; LIEBERMAN, PL; PIERSON, WE; SALVAGGIO, JE; SHEFFER, AL; SLAVIN, RG			THE REMOTE PRACTICE OF ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1986	77	5					651	652		10.1016/0091-6749(86)90403-3	http://dx.doi.org/10.1016/0091-6749(86)90403-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	C3903					2022-12-18	WOS:A1986C390300001
J	GARDINALI, M; CICARDI, M; FRANGI, D; FRANZINELLI, M; GATTONI, F; USLENGHI, C; AGOSTONI, A				GARDINALI, M; CICARDI, M; FRANGI, D; FRANZINELLI, M; GATTONI, F; USLENGHI, C; AGOSTONI, A			INVIVO STUDY OF THE COMPLEMENT-SYSTEM DURING INFUSION OF RADIOGRAPHIC CONTRAST-MEDIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MILANO, OSPED S PAOLO, CATTEDRA CLIN MED 5, VIA RUDINI 8, I-20142 Milan, ITALY; UNIV MILANO, OSPED S PAOLO, CATTEDRA RADIOL, I-20142 Milan, ITALY	University of Milan; University of Milan			cicardi, marco/K-9219-2016	cicardi, marco/0000-0003-1251-225X				ARROYAVE CM, 1979, J ALLERGY CLIN IMMUN, V63, P276, DOI 10.1016/0091-6749(79)90113-1; ARROYAVE CM, 1976, J IMMUNOL, V117, P1866; CHENOWETH DE, 1981, NEW ENGL J MED, V304, P497, DOI 10.1056/NEJM198102263040901; COGEN FC, 1979, J ALLERGY CLIN IMMUN, V64, P299, DOI 10.1016/0091-6749(79)90148-9; DAWSON P, 1983, BRIT J RADIOL, V56, P447, DOI 10.1259/0007-1285-56-667-447; FREYRIA AM, 1982, J ALLERGY CLIN IMMUN, V69, P397, DOI 10.1016/0091-6749(82)90152-X; GONSETTE RE, 1980, INVEST RADIOL, V15, pS26, DOI 10.1097/00004424-198011001-00008; HASSELBACHER P, 1980, J ALLERGY CLIN IMMUN, V66, P217, DOI 10.1016/0091-6749(80)90042-1; LACHMANN PJ, 1973, HDB EXPT IMMUNOLOGY, P1; LASSER EC, 1979, J ALLERGY CLIN IMMUN, V64, P105, DOI 10.1016/0091-6749(79)90043-5; LASSER EC, 1981, CONTRAST MEDIA COMPU, P33; Mayer M.M., 1961, EXPT IMMUNOCHEMISTRY, P133; SIMON RA, 1979, J ALLERGY CLIN IMMUN, V63, P281, DOI 10.1016/0091-6749(79)90114-3; STIMLER NP, 1980, AM J PATHOL, V100, P327; WAGNER JL, 1984, ANAL BIOCHEM, V136, P75, DOI 10.1016/0003-2697(84)90308-7; WILLIAMS TJ, 1981, J EXP MED, V153, P136, DOI 10.1084/jem.153.1.136; ZICCARDI RJ, 1982, J IMMUNOL, V128, P2505	17	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1986	77	5					690	692		10.1016/0091-6749(86)90411-2	http://dx.doi.org/10.1016/0091-6749(86)90411-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	C3903	3700893				2022-12-18	WOS:A1986C390300009
J	PATTERSON, R; GREENBERGER, PA; GRAMMER, LC				PATTERSON, R; GREENBERGER, PA; GRAMMER, LC			SOME INDICATIONS FOR DEPOT METHYLPREDNISOLONE FOR ASTHMA OR OTHER SEVERE ALLERGIC DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611	Northwestern University			Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498; Grammer, Leslie/0000-0001-6860-2014	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		FAUCI AS, 1976, ANN INTERN MED, V84, P304, DOI 10.7326/0003-4819-84-3-304; GREENBERGER PA, 1985, ALLERGIC DISEASES, P304; SONIN L, 1983, ARCH INTERN MED, V144, P554	3	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1986	77	5					686	689		10.1016/0091-6749(86)90410-0	http://dx.doi.org/10.1016/0091-6749(86)90410-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	C3903	3700892				2022-12-18	WOS:A1986C390300008
J	MEYERS, DA; FREIDHOFF, LR; MARSH, DG				MEYERS, DA; FREIDHOFF, LR; MARSH, DG			PREDICTING SKIN-TEST SENSITIVITY AND TOTAL SERUM IGE LEVELS IN FAMILY MEMBERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MEYERS, DA (corresponding author), JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,SCH MED,DEPT MED,DIV CLIN IMMUNOL,5601 LOCH RAVEN BLVD,BALTIMORE,MD 21239, USA.							BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P106, DOI 10.1016/0091-6749(81)90167-6; BAZARAL M, 1971, J IMMUNOL, V107, P794; BLUMENTHAL MN, 1981, AM J MED GENET, V10, P219, DOI 10.1002/ajmg.1320100304; DONNER A, 1980, BIOMETRICS, V39, P599; FREIDHOFF LR, 1983, J ALLERGY CLIN IMMUN, V72, P274, DOI 10.1016/0091-6749(83)90032-5; FREIDHOFF LR, 1981, AM J MED GENET, V9, P323, DOI 10.1002/ajmg.1320090409; FREIDHOFF LR, GENETIC ENV FACTORS; GERRARD JW, 1974, J PEDIATR-US, V85, P660, DOI 10.1016/S0022-3476(74)80510-X; GERRARD JW, 1978, AM J HUM GENET, V30, P46; HASSTEDT SJ, 1983, AM J MED GENET, V14, P61, DOI 10.1002/ajmg.1320140110; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; LEBOWITZ MD, 1984, J ALLERGY CLIN IMMUN, V73, P259, DOI 10.1016/S0091-6749(84)80017-2; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MEYERS DA, 1982, HUM HERED, V32, P15, DOI 10.1159/000153262; ORGEL HA, 1975, PEDIATR CLIN N AM, V22, P17; SANTILLI J, 1980, J ALLERGY CLIN IMMUN, V65, P406, DOI 10.1016/0091-6749(80)90232-8; SCHELLENBERG RR, 1975, J IMMUNOL, V115, P1577; 1982, BMDP STATISTICAL SOF	18	8	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1986	77	4					608	615		10.1016/0091-6749(86)90354-4	http://dx.doi.org/10.1016/0091-6749(86)90354-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A9381	3958390				2022-12-18	WOS:A1986A938100014
J	NEWCOMB, RW; AKHTER, J				NEWCOMB, RW; AKHTER, J			OUTCOMES OF EMERGENCY ROOM VISITS FOR ASTHMA .2. RELATIONSHIP TO ADMISSION CRITERIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CHICAGO,PRITZKER SCH MED,DEPT PEDIAT,65TH ST & LAKE MICHIGAN,CHICAGO,IL 60649; UNIV CHICAGO,LA RABIDA CHILDRENS HOSP & RES CTR,CHICAGO,IL 60649	University of Chicago; University of Chicago								CENTOR RM, 1984, NEW ENGL J MED, V310, P577, DOI 10.1056/NEJM198403013100907; FANTA CH, 1983, AM J MED, V74, P845, DOI 10.1016/0002-9343(83)91076-8; FANTA CH, 1982, AM J MED, V72, P416, DOI 10.1016/0002-9343(82)90498-3; FIEL SB, 1983, AM J MED, V75, P259, DOI 10.1016/0002-9343(83)91202-0; FISCHL MA, 1981, NEW ENGL J MED, V305, P783, DOI 10.1056/NEJM198110013051402; GANDHI M D, 1984, Journal of Allergy and Clinical Immunology, V73, P122; GOLDMAN L, 1982, NEW ENGL J MED, V307, P588, DOI 10.1056/NEJM198209023071004; LEFFERT F, 1980, J PEDIATR-US, V96, P1, DOI 10.1016/S0022-3476(80)80315-5; LULLA S, 1980, J PEDIATR-US, V97, P346, DOI 10.1016/S0022-3476(80)80179-X; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MCFADDEN ER, 1976, AM J MED, V60, P52, DOI 10.1016/0002-9343(76)90533-7; MCFADDEN ER, 1983, ALLERGY PRINCIPLES P, P843; ROSE CC, 1984, NEW ENGL J MED, V310, P573, DOI 10.1056/NEJM198403013100906; ROSSING TH, 1980, AM REV RESPIR DIS, V122, P365; SILVER RB, 1984, CLIN PEDIATR, V23, P81, DOI 10.1177/000992288402300203; SKONER D, 1984, Journal of Allergy and Clinical Immunology, V73, P121; WILLERT C, 1985, J PEDIATR-US, V106, P707, DOI 10.1016/S0022-3476(85)80340-1	17	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1986	77	2					315	321		10.1016/S0091-6749(86)80110-5	http://dx.doi.org/10.1016/S0091-6749(86)80110-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A0899	3944382				2022-12-18	WOS:A1986A089900008
J	COLLINS, JV; WARDLAW, AJ; CROMWELL, O; KAY, AB				COLLINS, JV; WARDLAW, AJ; CROMWELL, O; KAY, AB			MAST-CELLS AND NEUTROPHILS IN BRONCHOALVEOLAR LAVAGE FROM ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									BROMPTON HOSP,INST CARDIOTHORAC,LONDON SW3 6HP,ENGLAND	Royal Brompton Hospital									0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			209	209						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800350
J	MARKHAM, D; CHANG, M; EVANS, R; MULLALLY, D				MARKHAM, D; CHANG, M; EVANS, R; MULLALLY, D			EPIDEMIOLOGIC-STUDY OF DEATHS FROM ASTHMA AMONG CHILDREN IN UNITED-STATES 1965-1983	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			161	161						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800160
J	BLEECKER, ER; WALDEN, SM; BRITT, EJ				BLEECKER, ER; WALDEN, SM; BRITT, EJ			EFFECT OF NEDOCROMIL ON EXERCISE INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									JOHNS HOPKINS UNIV,SCH MED,FRANCIS SCOTT KEY MED CTR,BALTIMORE,MD 21224	Johns Hopkins University									0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					173	173		10.1016/0091-6749(85)90408-7	http://dx.doi.org/10.1016/0091-6749(85)90408-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200273
J	GRANDEL, KE; WARDLOW, ML; FARR, RS				GRANDEL, KE; WARDLOW, ML; FARR, RS			PLATELET ACTIVATING FACTOR IN SPUTUM OF PATIENTS WITH ASTHMA AND COPD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					184	184		10.1016/0091-6749(85)90452-X	http://dx.doi.org/10.1016/0091-6749(85)90452-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200317
J	HINDIALEXANDER, MC; ZIELEZNY, MA; MONTES, N; BULLOUGH, B; MIDDLETON, E; ROSNER, DH; LONDON, WM				HINDIALEXANDER, MC; ZIELEZNY, MA; MONTES, N; BULLOUGH, B; MIDDLETON, E; ROSNER, DH; LONDON, WM			THEOPHYLLINE AND FIBROCYSTIC BREAST DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY BUFFALO,DEPT MED,BUFFALO,NY 14260; SUNY BUFFALO,DEPT SOCIAL & PREVENT MED,BUFFALO,NY 14260; SUNY BUFFALO,SCH NURSING,BUFFALO,NY 14260; SUNY BUFFALO,ROSWELL PK MEM INST,BUFFALO,NY 14260; SUNY BUFFALO,DEPT HLTH BEHAV SCI,BUFFALO,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								BRINTON LA, 1981, CANCER-AM CANCER SOC, V47, P2517, DOI 10.1002/1097-0142(19810515)47:10<2517::AID-CNCR2820471035>3.0.CO;2-L; COLE P, 1978, AM J EPIDEMIOL, V108, P112, DOI 10.1093/oxfordjournals.aje.a112594; DAVIS HH, 1964, CANCER, V17, P957, DOI 10.1002/1097-0142(196408)17:8<957::AID-CNCR2820170802>3.0.CO;2-O; DAY R, 1982, THEOPHYLLINE FIBROCY, P924; ERNSTER VL, 1981, EPIDEMIOL REV, V3, P184, DOI 10.1093/oxfordjournals.epirev.a036233; ERNSTER VL, 1982, SURGERY, V91, P263; FOEKING MK, 1980, MED HYPOTHESES, V6, P659; HAAGENSEN CD, 1981, BREAST CARCINOMA RIS, P51; HARRIS NV, 1982, AM J EPIDEMIOL, V116, P643, DOI 10.1093/oxfordjournals.aje.a113447; HEYDEN S, 1980, SURGERY, V88, P741; HISLOP TG, 1981, CAN MED ASSOC J, V124, P283; HUTCHINSON WB, 1980, J NATL CANCER I, V65, P13; LAWSON DH, 1981, SURGERY, V90, P801; LEIS HP, 1978, BREAST, P208; LOVE SM, 1982, N ENGL J MED, V307, P1011; MARSHALL J, 1982, AM J PUBLIC HEALTH, V72, P610, DOI 10.2105/AJPH.72.6.610; MAY CD, 1974, CLIN ALLERGY, V4, P211, DOI 10.1111/j.1365-2222.1974.tb01377.x; MINTON JP, 1981, SURGERY, V90, P652; MINTON JP, 1979, AM J OBSTET GYNECOL, V135, P157; MINTON JP, 1981, SURGERY, V90, P299; MINTON JP, 1979, SURGERY, V86, P105; MINTON JP, 1981, BREAST DISEASE DIAGN, P143; MONSON RR, 1976, LANCET, V2, P224; MURAD TM, 1968, CANCER-AM CANCER SOC, V22, P587, DOI 10.1002/1097-0142(196809)22:3<587::AID-CNCR2820220315>3.0.CO;2-2; PAGE DL, 1978, J NATL CANCER I, V61, P1055; Papolczay A, 1978, Acta Chir Acad Sci Hung, V19, P349; PILNIK S, 1979, J REPROD MED, V22, P277; ROBERTS MM, 1984, BRIT MED J, V288, P275, DOI 10.1136/bmj.288.6413.275; ROLL TW, 1980, PHARM BASIS THERAPEU, P592; SHERMAN BM, 1974, CANCER, V33, P1306, DOI 10.1002/1097-0142(197405)33:5<1306::AID-CNCR2820330515>3.0.CO;2-#; VORHERR H, 1980, BREAST CANCER EPIDEM	31	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	6					709	715		10.1016/0091-6749(85)90098-3	http://dx.doi.org/10.1016/0091-6749(85)90098-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ALA84	4008800	Bronze			2022-12-18	WOS:A1985ALA8400013
J	HOLLANDER, DI; HALWIG, JM; MCKINNEY, P; PATTERSON, R				HOLLANDER, DI; HALWIG, JM; MCKINNEY, P; PATTERSON, R			ELEPHANTIASIS NOSTRAS 1984	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED & SURG,ALLERGY IMMUNOL SECT,303 E CHICAGO AVE,CHICAGO,IL 60611	Northwestern University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENINSON J, 1971, ANGIOLOGY, V22, P448, DOI 10.1177/000331977102200802; CASTELLA.A, 1969, J TROP MED HYG, V72, P89; CASTELLANI A., 1934, Journal of Tropical Medicine and Hygiene, V37, P257; OOMEN AP, 1969, TROP GEOGR MED, V21, P225; SCHIFF BL, 1980, CUTIS, V25, P88; SOTER NA, 1982, CECIL TXB MED, P1799; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55	7	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	4					450	451		10.1016/S0091-6749(85)80016-6	http://dx.doi.org/10.1016/S0091-6749(85)80016-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AFY44	3980880				2022-12-18	WOS:A1985AFY4400003
J	MOREL, AM; ANFOSSO, FJ; DELAAGE, MA				MOREL, AM; ANFOSSO, FJ; DELAAGE, MA			RADIOIMMUNOASSAY FOR HISTAMINE - APPLICATION TO HISTAMINE-RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					124	124		10.1016/0091-6749(85)90212-X	http://dx.doi.org/10.1016/0091-6749(85)90212-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200077
J	MULLALLY, DI; GRAUMAN, JS; EVANS, R; KASLOW, RA				MULLALLY, DI; GRAUMAN, JS; EVANS, R; KASLOW, RA			HOSPITALIZATIONS OF CHILDREN FOR ASTHMA IN USA 1965-1982	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					197	197		10.1016/0091-6749(85)90505-6	http://dx.doi.org/10.1016/0091-6749(85)90505-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200370
J	PELIKAN, M; PELIKAN, Z				PELIKAN, M; PELIKAN, Z			THE ROLE OF NASAL-MUCOSA IN SOME CASES OF ALLERGIC CONJUNCTIVITIS AND THE EFFECTS OF DISODIUM-CROMOGLYCATE (DSCG)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					186	186		10.1016/0091-6749(85)90462-2	http://dx.doi.org/10.1016/0091-6749(85)90462-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200327
J	SAKAMOTO, Y; KRZANOWSKI, J; LOCKEY, R; MARTIN, DF; DUNCAN, R; POLSON, J; SZENTIVANYI, A				SAKAMOTO, Y; KRZANOWSKI, J; LOCKEY, R; MARTIN, DF; DUNCAN, R; POLSON, J; SZENTIVANYI, A			THE MECHANISM OF PTYCHODISCUS-BREVIS TOXIN-INDUCED RAT VAS-DEFERENS CONTRACTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV S FLORIDA,COLL MED,DEPT INTERNAL MED,DIV ALLERGY & IMMUNOL,TAMPA,FL 33612; JAMES A HALEY VET ADM MED CTR,DEPT INTERNAL MED,DIV ALLERGY & IMMUNOL,TAMPA,FL 33612; UNIV S FLORIDA,COLL NAT SCI,DEPT CHEM,CHEMS CTR,TAMPA,FL 33620	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida	SAKAMOTO, Y (corresponding author), UNIV S FLORIDA,COLL MED,DEPT PHARMACOL & THERAPEUT,12901 N 30TH ST,BOX 9,TAMPA,FL 33612, USA.							ALAM M, 1982, J AM CHEM SOC, V104, P5232, DOI 10.1021/ja00383a043; ASAI S, 1982, J ALLERGY CLIN IMMUN, V69, P418, DOI 10.1016/0091-6749(82)90116-6; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; BADEN DG, 1982, TOXICON, V20, P457, DOI 10.1016/0041-0101(82)90009-5; BADEN DG, 1982, TOXICON, V20, P929, DOI 10.1016/0041-0101(82)90081-2; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; BORISON HL, 1980, BRIT J PHARMACOL, V70, P249, DOI 10.1111/j.1476-5381.1980.tb07930.x; CATTERALL WA, 1982, MOL PHARM, V19, P345; EINHORN VF, 1977, TOXICON, V15, P403, DOI 10.1016/0041-0101(77)90118-0; ELLIS S, 1979, TOXIC DINOFLAGELLATE, P431; GALLAGHER JP, 1980, BRIT J PHARMACOL, V69, P367, DOI 10.1111/j.1476-5381.1980.tb07023.x; GRUNFELD Y, 1974, BR J PHARM, V51, P57; HAY DWP, 1982, BRIT J PHARMACOL, V76, P103, DOI 10.1111/j.1476-5381.1982.tb09195.x; HEMMERT WH, 1975, 1ST P INT C TOX DIN, P489; KAO CY, 1966, PHARMACOL REV, V18, P997; KATZ B, 1967, PROC R SOC SER B-BIO, V167, P8, DOI 10.1098/rspb.1967.0010; MARTIN DF, 1976, J CHEM EDUC, V53, P614, DOI 10.1021/ed053p614; McFARREN E. F., 1965, TOXICON, V3, P111, DOI 10.1016/0041-0101(65)90005-X; NARAHASHI T, 1972, FED PROC, V31, P1124; OHIZUMI Y, 1982, J PHARMACOL EXP THER, V221, P748; OHIZUMI Y, 1981, J PHARMACOL EXP THER, V217, P475; RISK M, 1982, J NEUROCHEM, V39, P1485, DOI 10.1111/j.1471-4159.1982.tb12596.x; Risk M., 1979, P367; ROSS SB, 1976, N-S ARCH PHARMACOL, V295, P183, DOI 10.1007/BF00505085; SASNER JJ, 1972, TOXICON, V10, P163, DOI 10.1016/0041-0101(72)90242-5; SHINNICKGALLAGHER P, 1980, BRIT J PHARMACOL, V69, P373, DOI 10.1111/j.1476-5381.1980.tb07024.x; Steidinger K.A., 1983, Progress phycol. Res., V2, P147	27	8	11	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	1					117	122		10.1016/0091-6749(85)90814-0	http://dx.doi.org/10.1016/0091-6749(85)90814-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AMV84	4040140				2022-12-18	WOS:A1985AMV8400017
J	SCHONFELD, W; KOLLER, M; KNOLLER, J; KONIG, W; MULLER, W; VANDERHARDT, H				SCHONFELD, W; KOLLER, M; KNOLLER, J; KONIG, W; MULLER, W; VANDERHARDT, H			LEUKOTRIENES AND THEIR METABOLISM IN PLASMA AND BRONCHIAL FLUIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					126	126		10.1016/0091-6749(85)90221-0	http://dx.doi.org/10.1016/0091-6749(85)90221-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200086
J	SPECTOR, SL; ROHR, AS; RACHELEFSKY, GS; KATZ, RM; SIEGEL, SC; WO, J; GRACEY, V				SPECTOR, SL; ROHR, AS; RACHELEFSKY, GS; KATZ, RM; SIEGEL, SC; WO, J; GRACEY, V			THE EFFECT OF FOOD ON ONCE DAILY THEO-DUR IN ASTHMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					105	105		10.1016/0091-6749(85)90139-3	http://dx.doi.org/10.1016/0091-6749(85)90139-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200004
J	WEISS, EB; MULLICK, PC				WEISS, EB; MULLICK, PC			TOXIC OXYGEN PRODUCTS ALTER CALCIUM HOMEOSTASIS IN AN ASTHMA MODEL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MASSACHUSETTS, SCH MED, WORCESTER, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	WEISS, EB (corresponding author), ST VINCENT HOSP, DIV RESP DIS, 25 WINTHROP ST, WORCESTER, MA 01604 USA.							ADAMS GK, 1979, J IMMUNOL, V122, P555; BENSON MK, 1975, BRIT J DIS CHEST, V69, P227, DOI 10.1016/0007-0971(75)90090-X; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; COPAS JL, 1982, PROSTA LEUKOTR MED, V8, P105, DOI 10.1016/S0262-1746(82)80002-4; FANTONE JC, 1982, AM J PATHOL, V107, P397; HENDERSON WR, 1982, J IMMUNOL, V128, P2609; HOLTZMAN MJ, 1983, AM REV RESPIR DIS, V127, P686; PARKER JC, 1983, CHEST, V83, pS52, DOI 10.1378/chest.83.5.52S; PATTERSON R, 1976, J LAB CLIN MED, V87, P65; RODGER IW, 1980, FED PROC, V39, P296; SCHULMAN ES, 1981, AM REV RESPIR DIS, V124, P402; SNYDER LM, 1981, BRIT J HAEMATOL, V48, P435, DOI 10.1111/j.1365-2141.1981.tb02735.x; SOUHRADA JF, 1979, RESP PHYSIOL, V36, P231, DOI 10.1016/0034-5687(79)90027-6; TATE RM, 1983, AM REV RESPIR DIS, V128, P552, DOI 10.1164/arrd.1983.128.3.552; VOLPI M, 1980, BIOCHEM BIOPH RES CO, V92, P1231, DOI 10.1016/0006-291X(80)90418-0; WALTERS EH, 1982, THORAX, V37, P438, DOI 10.1136/thx.37.6.438; WEISS EB, 1983, PROSTA LEUKOTR MED, V12, P53, DOI 10.1016/0262-1746(83)90067-7; WEISS EB, 1979, RESPIRATION, V38, P266, DOI 10.1159/000194091; WELTON AF, 1981, BIOCHEM PHARMACOL, V30, P1378, DOI 10.1016/0006-2952(81)90328-2	19	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	6					692	697		10.1016/0091-6749(85)90095-8	http://dx.doi.org/10.1016/0091-6749(85)90095-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ALA84	4008798				2022-12-18	WOS:A1985ALA8400010
J	WHITE, MV; KALINER, MA				WHITE, MV; KALINER, MA			NEUTROPHIL INDUCED MAST-CELL DE-GRANULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					175	175		10.1016/0091-6749(85)90419-1	http://dx.doi.org/10.1016/0091-6749(85)90419-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200284
J	CASALE, TB; SHELHAMER, JH; PARRILLO, JE; KALINER, MA				CASALE, TB; SHELHAMER, JH; PARRILLO, JE; KALINER, MA			DOPAMINE-INHIBITION OF HISTAMINE-MEDIATED CUTANEOUS RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,ALLERG DIS SECT,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	CASALE, TB (corresponding author), NIH,DEPT CRIT CARE MED,BLDG 10,ROOM 11C-207,BETHESDA,MD 20205, USA.		Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377				ALTURA BM, 1982, KLIN WOCHENSCHR, V60, P882, DOI 10.1007/BF01716944; BARBIN G, 1980, MOL PHARMACOL, V18, P1; GRANERUS G, 1967, ACTA MED SCAND, V182, P11; IKEDA K, 1975, PROSTAG OTH LIPID M, V10, P747, DOI 10.1016/0090-6980(75)90003-9; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; Lewis T., 1927, BLOOD VESSELS HUMAN; MAJNO G, 1967, CIRC RES, V21, P833, DOI 10.1161/01.RES.21.6.833; MARKS R, 1977, BRIT J CLIN PHARMACO, V4, P367, DOI 10.1111/j.1365-2125.1977.tb00725.x; MORRISON DC, 1978, IMMEDIATE HYPERSENSI, P431; ROWLEY DA, 1964, BRIT J EXP PATHOL, V45, P56; SAMUELSSON B, 1981, INT ARCH ALLER A IMM, V66, P98, DOI 10.1159/000232880; SOGN DD, 1983, J ALLERGY CLIN IMMUN, V71, P147, DOI 10.1016/0091-6749(83)90358-5; SOLOMON LM, 1968, J INVEST DERMATOL, V51, P280, DOI 10.1038/jid.1968.128; SONDERGAARD J, 1971, BRIT J DERMATOL, V84, P424, DOI 10.1111/j.1365-2133.1971.tb02527.x; STEINSLAND OS, 1978, SCIENCE, V199, P443, DOI 10.1126/science.22933; SUMMERS R, 1981, J ALLERGY CLIN IMMUN, V67, P456, DOI 10.1016/0091-6749(81)90099-3; Summers R J, 1982, Compr Ther, V8, P6; VOORHORST R, 1977, ANN ALLERGY, V38, P255	18	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	6					837	841		10.1016/0091-6749(84)90456-1	http://dx.doi.org/10.1016/0091-6749(84)90456-1			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SV829	6202732	Bronze			2022-12-18	WOS:A1984SV82900012
J	FOWLER, AA; SCHWARTZ, LB				FOWLER, AA; SCHWARTZ, LB			MACROPHAGE-DERIVED CHEMOTACTIC FACTORS AND ALLERGIC-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV CONNECT TISSUE DIS,RICHMOND,VA 23298	Virginia Commonwealth University	FOWLER, AA (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV PULM MED & IMMUNOL,ALLERGY & CLIN IMMUNOL SECT,RICHMOND,VA 23298, USA.							ARNOUX B, 1982, AM REV RESPIR DIS, V125, P70; CAVANAUGH MJ, 1977, J ALLERGY CLIN IMMUN, V59, P41, DOI 10.1016/0091-6749(77)90175-0; COHEN AB, 1971, J CLIN INVEST, V50, P1390, DOI 10.1172/JCI106622; COHN ZA, 1963, J EXP MED, V118, P1009, DOI 10.1084/jem.118.6.1009; CRYSTAL RG, 1981, ANN INTERN MED, V94, P73, DOI 10.7326/0003-4819-94-1-73; DAUGHADAY CC, 1976, J RETICULOENDOTH SOC, V19, P37; DESSAINT JP, 1979, CELL IMMUNOL, V46, P12, DOI 10.1016/0008-8749(79)90241-7; DOLOVICH MB, 1977, AM REV RESPIR DIS, V115, P397; DU JT, 1983, BIOCHIM BIOPHYS ACTA, V753, P159, DOI 10.1016/0005-2760(83)90003-6; FELS AOS, 1982, P NATL ACAD SCI-BIOL, V79, P7866, DOI 10.1073/pnas.79.24.7866; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GADEK JE, 1980, AM REV RESPIR DIS, V121, P723; GLEICH GJ, 1984, ANNU REV IMMUNOL, V2, P429, DOI 10.1146/annurev.immunol.2.1.429; GODARD P, 1982, J ALLERGY CLIN IMMUN, V70, P88, DOI 10.1016/0091-6749(82)90234-2; GODARD P, 1983, CLIN RES, V31, pA548; GUERZON GM, 1979, AM REV RESPIR DIS, V119, P59; HENDRICK DJ, 1975, THORAX, V30, P2, DOI 10.1136/thx.30.1.2; HSUEH W, 1982, BIOCHEM BIOPH RES CO, V106, P1085, DOI 10.1016/0006-291X(82)91223-2; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; HUNNINGHAKE GW, 1981, J CLIN INVEST, V68, P259, DOI 10.1172/JCI110242; HUNNINGHAKE GW, 1980, J CLIN INVEST, V66, P473, DOI 10.1172/JCI109878; ISHIZAKA T, 1979, P NATL ACAD SCI USA, V76, P5858, DOI 10.1073/pnas.76.11.5858; JOSEPH M, 1980, CLIN EXP IMMUNOL, V40, P416; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; MARTIN TR, 1984, AM REV RESPIR DIS, V129, P106; MERRILL WW, 1980, J CLIN INVEST, V65, P268, DOI 10.1172/JCI109668; NAGY L, 1982, CLIN EXP IMMUNOL, V47, P541; OFLAHERTY JT, 1983, CLIN REV ALLERG, V1, P353; RANKIN JA, 1984, J IMMUNOL, V132, P1993; REYNOLDS HY, 1975, J IMMUNOL, V114, P1813; REYNOLDS HY, 1975, J CLIN INVEST, V56, P376, DOI 10.1172/JCI108102; REYNOLDS HY, 1974, J LAB CLIN MED, V84, P559; REYNOLDS HY, 1977, J CLIN INVEST, V59, P165, DOI 10.1172/JCI108615; ROUZER CA, 1982, J EXP MED, V156, P1077, DOI 10.1084/jem.156.4.1077; SCHWARTZ LB, 1983, J IMMUNOL, V130, P1891; SCHWARTZ LB, 1984, PROG ALLERGY, V34, P271; SOLER M, 1982, ALLERGY, V37, P373; WELLER PF, 1983, P NATL ACAD SCI-BIOL, V80, P7626, DOI 10.1073/pnas.80.24.7626; WILLIAMS JD, 1984, J IMMUNOL, V132, P3034; WILSON AF, 1973, NEW ENGL J MED, V288, P1056, DOI 10.1056/NEJM197305172882006	40	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	6					777	780		10.1016/0091-6749(84)90177-5	http://dx.doi.org/10.1016/0091-6749(84)90177-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW418	6501747	Bronze			2022-12-18	WOS:A1984TW41800003
J	GOETZL, EJ; SCOTT, WA				GOETZL, EJ; SCOTT, WA			PROCEEDINGS OF A CONFERENCE ON REGULATION OF CELLULAR ACTIVITIES BY LEUKOTRIENES AND OTHER LIPOXYGENASE PRODUCTS OF ARACHIDONIC-ACID, NOVEMBER 14-18, 1983, SANTA-YNEZ, CALIFORNIA - FOREWORD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									ER SQUIBB & SONS INC, PRINCETON, NJ 08540 USA		GOETZL, EJ (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA.								0	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	3					309	309		10.1016/0091-6749(84)90121-0	http://dx.doi.org/10.1016/0091-6749(84)90121-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TQ633					2022-12-18	WOS:A1984TQ63300001
J	BEDARD, RM; BUSSE, WW				BEDARD, RM; BUSSE, WW			NIFEDIPINE INHIBITION OF HUMAN BASOPHIL HISTAMINE-RELEASE (HR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1981, BIOCH PHARM, V30, P2867	1	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					104	104		10.1016/0091-6749(83)90188-4	http://dx.doi.org/10.1016/0091-6749(83)90188-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200065
J	CHEUNG, NKV; BLESSINGMOORE, J; REID, MJ; LEWISTON, NJ; YANG, G				CHEUNG, NKV; BLESSINGMOORE, J; REID, MJ; LEWISTON, NJ; YANG, G			REDUCTION OF INTERFERENCE BY SPECIFIC IGG WITH A MODIFIED MICROTITER SOLID-PHASE RADIOIMMUNOASSAY TO MEASURE HONEYBEE VENOM IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT PEDIAT,STANFORD,CA 94305; CHILDRENS HOSP STANFORD,DIV HEMATOL ONCOL,DIV ALLERGY & PULM DIS,PALO ALTO,CA 94304; DAVID GRANT USAF MED CTR,ALLERGY CLIN,TRAVIS AFB,CA 94535	Stanford University								AALBERSE RC, 1973, INT ARCH ALLER A IMM, V45, P46, DOI 10.1159/000230999; ADKINSON NF, 1981, J ALLERGY CLIN IMMUN, V67, P87, DOI 10.1016/0091-6749(81)90001-4; ADKINSON NF, 1976, MANUAL CLIN IMMUNOLO, P590; AHLSTEDT S, 1974, CLIN ALLERGY, V4, P131, DOI 10.1111/j.1365-2222.1974.tb01370.x; BLESSING J, 1982, Journal of Allergy and Clinical Immunology, V69, P140; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; CHEUNG NKV, 1981, ANN ALLERGY, V46, P132; CHEUNG NKV, 1983, ANN ALLERGY; Cooke RA, 1935, J EXP MED, V62, P733, DOI 10.1084/jem.62.6.733; FORSTER J, 1979, KLIN WOCHENSCHR, V57, P521; FOUCARD T, 1972, INT ARCH ALLER A IMM, V43, P360, DOI 10.1159/000230851; GLEICH GJ, 1981, J IMMUNOL, V126, P575; GLEICH GJ, 1977, J ALLERGY CLIN IMMUN, V60, P188, DOI 10.1016/0091-6749(77)90123-3; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P334, DOI 10.1016/0091-6749(75)90005-6; GRANT JA, 1981, J ALLERGY CLIN IMMUN, V68, P112, DOI 10.1016/0091-6749(81)90168-8; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HAMILTON R G, 1982, Journal of Allergy and Clinical Immunology, V69, P111; HAMILTON RG, 1981, J ALLERGY CLIN IMMUN, V67, P14, DOI 10.1016/0091-6749(81)90039-7; HAMILTON RG, 1979, J IMMUNOL, V122, P1073; HOFFMAN DR, 1979, ANN ALLERGY, V42, P224; HUGGINS KG, 1979, INT ARCH ALLER A IMM, V58, P241, DOI 10.1159/000232200; JOHANSSON SG, 1971, INT ARCH ALLER A IMM, V41, P443, DOI 10.1159/000230538; JOHANSSON SGO, 1978, IMMUNOL REV, V41, P248, DOI 10.1111/j.1600-065X.1978.tb01467.x; LICHTENSTEIN LM, 1974, NEW ENGL J MED, V290, P1223, DOI 10.1056/NEJM197405302902204; LICHTENSTEIN LM, 1966, J CLIN INVEST, V45, P1126, DOI 10.1172/JCI105419; LOVELESS MH, 1940, J IMMUNOL, V38, P1925; Lowry JOH, 1954, J BIOL CHEM, V193, P265; LYNCH NR, 1975, CLIN EXP IMMUNOL, V22, P35; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P210, DOI 10.1016/0091-6749(73)90059-6; PAULL BR, 1978, J IMMUNOL, V120, P1917; REID MJ, 1982, J ALLERGY CLIN IMMUN, V70, P191, DOI 10.1016/0091-6749(82)90041-0; REID MJ, 1981, J ALLERGY CLIN IMMUN, V67, P263, DOI 10.1016/0091-6749(81)90020-8; REISMAN RE, 1975, J ALLERGY CLIN IMMUN, V56, P443, DOI 10.1016/0091-6749(75)90062-7; SANTRACH PJ, 1980, ANN ALLERGY, V45, P130; SCHELLENBERG RR, 1975, J IMMUNOL, V115, P1577; SCHOPFER K, 1979, NEW ENGL J MED, V300, P835, DOI 10.1056/NEJM197904123001506; SHIMIZU M, 1978, J IMMUNOL METHODS, V19, P317, DOI 10.1016/0022-1759(78)90016-9; SOBOTKA AK, 1978, J IMMUNOL, V121, P2477; SOBOTKA AK, 1976, J IMMUNOL, V117, P84; TYSON CJ, 1981, ANN ALLERGY, V47, P43; VERVLOET D, 1974, Clinical Allergy, V4, P359, DOI 10.1111/j.1365-2222.1974.tb01397.x; WIDE L, 1967, LANCET, V2, P1106; ZEISS CR, 1981, J ALLERGY CLIN IMMUN, V67, P105, DOI 10.1016/0091-6749(81)90004-X; ZEISS CR, 1973, J IMMUNOL, V110, P414; ZIMMERMAN EM, 1980, J ALLERGY CLIN IMMUN, V65, P386; ZOLLINGER WD, 1981, J IMMUNOL METHODS, V46, P129, DOI 10.1016/0022-1759(81)90130-7; ZURAW BL, 1981, J IMMUNOL, V127, P1169	47	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	3					283	293		10.1016/0091-6749(83)90082-9	http://dx.doi.org/10.1016/0091-6749(83)90082-9			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH188	6600761				2022-12-18	WOS:A1983QH18800004
J	GOLDSTEIN, RA; GREEN, LW; PARKER, SR				GOLDSTEIN, RA; GREEN, LW; PARKER, SR			SELF-MANAGEMENT OF CHILDHOOD ASTHMA - PREFACE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									NHLBI,BETHESDA,MD 20205; UNIV TEXAS,HLTH SCI CTR,CTR HLTH PROMOT RES & DEV,HOUSTON,TX 77025	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston	GOLDSTEIN, RA (corresponding author), NIAID,BETHESDA,MD 20205, USA.								0	8	9	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					522	525		10.1016/0091-6749(83)90478-5	http://dx.doi.org/10.1016/0091-6749(83)90478-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RS163	6643863				2022-12-18	WOS:A1983RS16300004
J	HENDERSON, WR; HARLEY, JB; FAUCI, AS; KLEBANOFF, SJ				HENDERSON, WR; HARLEY, JB; FAUCI, AS; KLEBANOFF, SJ			LEUKOTRIENE-B4, LEUKOTRIENE-C4 AND LEUKOTRIENE-D4 GENERATION BY HUMAN EOSINOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		JORG, 1982, J EXP MED, V155, P390	1	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					138	138		10.1016/0091-6749(83)90324-X	http://dx.doi.org/10.1016/0091-6749(83)90324-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200201
J	HIRATANI, M; MUTO, K; OSHIDA, Y; ITO, S; KASEI, M; UEDA, S; SATO, T				HIRATANI, M; MUTO, K; OSHIDA, Y; ITO, S; KASEI, M; UEDA, S; SATO, T			EFFECT OF SUSTAINED-RELEASE THEOPHYLLINE ADMINISTRATION ON PITUITARY-THYROID AXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											HIRATANI, M (corresponding author), KANAZAWA UNIV,SCH MED,DEPT PEDIAT,KANAZAWA,ISHIKAWA 920,JAPAN.							ADAMS EF, 1979, J CLIN ENDOCR METAB, V49, P120, DOI 10.1210/jcem-49-1-120; ARNMAN K, 1975, ACTA MED SCAND, V197, P271; ATUCK NO, 1967, CIRCULATION, V35, P745; ATUK NO, 1974, LANCET, V2, P1056; AUNIS D, 1975, BRIT J PHARMACOL, V53, P425, DOI 10.1111/j.1476-5381.1975.tb07380.x; BROADUS AE, 1970, J CLIN INVEST, V49, P2222, DOI 10.1172/JCI106441; BUSH RK, 1977, J ALLERGY CLIN IMMUN, V59, P398, DOI 10.1016/0091-6749(77)90025-2; CHOPRA IJ, 1976, J CLIN INVEST, V58, P32, DOI 10.1172/JCI108456; Dumont J E, 1978, Adv Cyclic Nucleotide Res, V9, P723; ENSINCK JW, 1970, J CLIN ENDOCR METAB, V31, P153, DOI 10.1210/jcem-31-2-153; FAGLIA G, 1972, J CLIN ENDOCR METAB, V34, P906, DOI 10.1210/jcem-34-5-906; GREENGARD P, 1972, ADV CYCLIC NUCLEOTID, V1; GUSHAW JB, 1977, CLIN CHEM, V23, P1144; HAYNES RC, 1980, PHARMACOL BASIS THER, P1466; HAYNES RC, 1980, PHARMACOL BASIS THER, P1397; HORROBIN DF, 1977, PROSTAGLANDINS, V13, P33, DOI 10.1016/0090-6980(77)90040-5; KOLBECK RC, 1979, LUNG, V156, P173, DOI 10.1007/BF02714008; LOCKHART.RB, 1971, BIOCHEM J, V124, P815; MASUYAMA T, 1978, J JUZEN MED SOC, V87, P387; ORGIAZZI J, 1976, J CLIN ENDOCR METAB, V42, P341, DOI 10.1210/jcem-42-2-341; PERACCHI M, 1974, ACTA ENDOCRINOL-COP, V76, P488, DOI 10.1530/acta.0.0760488; Rall T. W., 1980, PHARMACOL BASIS THER, P592; Robison G.A., 1971, CYCLIC AMP, DOI [10.1146/annurev.bi.37.070168.001053, DOI 10.1146/ANNUREV.BI.37.070168.001053]; TULINSILVER J, 1981, J ALLERGY CLIN IMMUN, V67, P45, DOI 10.1016/0091-6749(81)90044-0; VERNIKOS.J, 1968, P SOC EXP BIOL MED, V128, P1016; WESTGREN U, 1977, ACTA ENDOCRINOL-COP, V84, P281, DOI 10.1530/acta.0.0840281	26	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	6					481	485		10.1016/0091-6749(82)90012-4	http://dx.doi.org/10.1016/0091-6749(82)90012-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PT744	6292280				2022-12-18	WOS:A1982PT74400012
J	KYONG, CU; PONCE, BE; FUDENBERG, HH; GLASSMAN, AB; MOHRMANN, ME				KYONG, CU; PONCE, BE; FUDENBERG, HH; GLASSMAN, AB; MOHRMANN, ME			BACTERICIDAL CAPACITY OF POLYMORPHONUCLEAR LEUKOCYTES FROM PATIENTS RECEIVING THEOPHYLLINE THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED UNIV S CAROLINA,DEPT BASIC & CLIN IMMUNOL & MICROBIOL,CHARLESTON,SC 29425; MED UNIV S CAROLINA,DEPT LAB MED,CHARLESTON,SC 29425	Medical University of South Carolina; Medical University of South Carolina					NCI NIH HHS [CA-25746] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOURNE HR, 1972, J IMMUNOL, V108, P695; BOURNE HR, 1971, J CLIN INVEST, V50, P920, DOI 10.1172/JCI106564; BRYANT RE, 1971, J CLIN INVEST, V50, P920; COX JP, 1973, J CELL BIOL, V59, P480, DOI 10.1083/jcb.59.2.480; Dedman J R, 1979, Adv Cyclic Nucleotide Res, V11, P131; DIPASQUALE AM, 1976, J CELL BIOL, V71, P735, DOI 10.1083/jcb.71.3.735; HIRSCH JG, 1964, J IMMUNOL, V92, P145; ISSEKUTZ AC, 1979, INFECT IMMUN, V24, P434, DOI 10.1128/IAI.24.2.434-440.1979; KELLER HU, 1979, CELL BIOL INT REP, V3, P759, DOI 10.1016/0309-1651(79)90082-1; KOOPMAN WJ, 1973, J IMMUNOL, V110, P1609; LACKIE JM, 1974, J CELL SCI, V16, P167; ORANGE RP, 1971, J EXP MED, V134, P1365; RIVKIN I, 1975, J IMMUNOL, V115, P1126; SPIRER Z, 1973, EXPERIENTIA, V15, P118; THOMPSON RD, 1974, J LAB CLIN MED, V84, P584; TILL G, 1979, CLIN IMMUNOL IMMUNOP, V12, P111, DOI 10.1016/0090-1229(79)90116-8; TSE RL, 1972, J LAB CLIN MED, V80, P264; WEISSMAN.G, 1971, NATURE-NEW BIOL, V231, P131, DOI 10.1038/newbio231131a0; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550	19	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	5					444	447		10.1016/0091-6749(82)90119-1	http://dx.doi.org/10.1016/0091-6749(82)90119-1			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NP934	7076984				2022-12-18	WOS:A1982NP93400006
J	REYES, MA; SARAVIA, NG; WATSON, RR; MCMURRAY, DN				REYES, MA; SARAVIA, NG; WATSON, RR; MCMURRAY, DN			EFFECT OF MODERATE MALNUTRITION ON IMMEDIATE HYPERSENSITIVITY AND IMMUNOGLOBULIN-E LEVELS IN ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TEXAS A&M UNIV,COLL MED,DEPT MED MICROBIOL & IMMUNOL,COLLEGE STN,TX 77843; UNIV VALLE,SCH MED,DEPT PEDIAT,CALI,COLOMBIA; TULANE COLCIENCIAS,INT CTR INFECT DIS RES,CALI,COLOMBIA; PURDUE UNIV,DEPT FOODS & NUTR,W LAFAYETTE,IN 47907	Texas A&M University System; Texas A&M University College Station; Universidad del Valle; Purdue University System; Purdue University; Purdue University West Lafayette Campus					NIAID NIH HHS [AI-10050] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABASSY AS, 1974, J TROP MED HYG, V77, P18; BELL RG, 1976, AM J CLIN NUTR, V29, P392, DOI 10.1093/ajcn/29.4.392; Botero D., 1981, Bulletin of the Pan American Health Organization, V15, P241; BUCKLEY RH, 1978, IMMUNOL REV, V41, P288, DOI 10.1111/j.1600-065X.1978.tb01469.x; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; CHANDRA RK, 1977, MALNUTRITION IMMUNE, P155; CHARLET LD, 1979, J ASTHMA RES, V16, P131, DOI 10.3109/02770907909105660; DOUGLAS SD, 1977, MALNUTRITION IMMUNE, P231; GELLERBERNSTEIN C, 1980, ANN ALLERGY, V44, P29; GODFREY R C, 1975, Clinical Allergy, V5, P201, DOI 10.1111/j.1365-2222.1975.tb01853.x; GOLDSMITH GA, 1974, AM J TROP MED HYG, V23, P756; GOMEZ F, 1955, Adv Pediatr, V7, P131; JOHANSSON SG, 1968, LANCET, V1, P1118; KIKKAWA Y, 1973, PEDIATRICS, V51, P690; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; McFarlane H., 1977, Food and immunology, P23; MCMURRAY DN, 1977, AM J CLIN NUTR, V30, P1944, DOI 10.1093/ajcn/30.12.1944; MCMURRAY DN, 1981, AM J CLIN NUTR, V34, P68, DOI 10.1093/ajcn/34.1.68; NEUMANN CG, 1975, AM J CLIN NUTR, V28, P89, DOI 10.1093/ajcn/28.2.89; PHILLS JA, 1972, NEW ENGL J MED, V286, P965, DOI 10.1056/NEJM197205042861802; PURTILO DT, 1976, AM J TROP MED HYG, V25, P229, DOI 10.4269/ajtmh.1976.25.229; RAPPAPORT I, 1979, ANN ALLERGY, V43, P1; SARSFIELD JK, 1974, ARCH DIS CHILD, V49, P711, DOI 10.1136/adc.49.9.711; STENIUS B, 1971, Clinical Allergy, V1, P37, DOI 10.1111/j.1365-2222.1971.tb02446.x; STIEHM ER, 1980, FED PROC, V39, P3093; SUSKIND R, 1976, AM J CLIN NUTR, V29, P836, DOI 10.1093/ajcn/29.8.836; TAYLOR, 1973, LANCET, V2, P111; WIDE L, 1967, LANCET, V2, P1105; ZIEGLER HD, 1975, JOHNS HOPKINS MED J, V137, P59	29	8	9	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	2					94	100		10.1016/0091-6749(82)90235-4	http://dx.doi.org/10.1016/0091-6749(82)90235-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PB591	6980237				2022-12-18	WOS:A1982PB59100004
J	WOLFE, RN; HUI, KK; CONOLLY, ME; TASHKIN, DP; FISHER, HK				WOLFE, RN; HUI, KK; CONOLLY, ME; TASHKIN, DP; FISHER, HK			A STUDY OF BETA-ADRENERGIC AND PROSTAGLANDIN RECEPTORS IN PATIENTS WITH ASPIRIN-INDUCED BRONCHOSPASM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF LOS ANGELES,SCH MED,DIV CLIN PHARMACOL,LOS ANGELES,CA 90024; VET ADM WADSWORTH MED CTR,PULM DIS SECT,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT MED,DIV CLIN PHARMACOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT PHARMACOL,DIV PULM MED,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles								BARNETT DB, 1977, ASTHMA PHYSL IMMUNOP, P181; BURNET FM, 1965, J PATHOL BACTERIOL, V89, P271, DOI 10.1002/path.1700890128; BURNET FM, 1975, MED HYPOTHESES, V1, P3; CABEZAS GA, 1971, J APPL PHYSIOL, V31, P651, DOI 10.1152/jappl.1971.31.5.651; CONOLLY ME, 1976, J CLIN INVEST, V58, P1307, DOI 10.1172/JCI108586; CONOLLY ME, 1977, BRIT J PHARMACOL, V59, P17, DOI 10.1111/j.1476-5381.1977.tb06971.x; Cooke RA, 1919, J AMER MED ASSOC, V73, P759, DOI 10.1001/jama.1919.02610360029008; FARR RS, 1970, J ALLERGY, V45, P321, DOI 10.1016/0021-8707(70)90040-7; FEIN BT, 1971, ANN ALLERGY, V29, P598; FEINBERG SM, 1946, ALLERGY PRACTICE, P330; GIRALDO B, 1969, ANN INTERN MED, V71, P479, DOI 10.7326/0003-4819-71-3-479; GIRARD JP, 1969, HELV MED ACTA, V35, P86; GRYGLEWSKI RJ, 1977, LIFE SCI, V13, P191; HEDQVIST P, 1977, ASTHMA PHYSL IMMUNOP, P131; HORTON EW, 1969, PHYSIOL REV, V49, P122, DOI 10.1152/physrev.1969.49.1.122; HUI KK, 1981, LIFE SCI, V29, P523, DOI 10.1016/0024-3205(81)90220-4; MATTHEWS KP, 1950, J LAB CLIN MED, V36, P416; NAKANO J, 1976, BRONCHIAL ASTHMA MEC, P191; ORANGE RP, 1971, FED PROC, V30, P1725; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; PARKER CW, 1973, J CLIN INVEST, V52, P1336, DOI 10.1172/JCI107305; Prickman LE, 1937, J AMER MED ASSOC, V108, P445, DOI 10.1001/jama.1937.02780060011004; RACHELEFSKY GS, 1975, PEDIATRICS, V56, P443; RICHARDSON JB, 1977, ASTHMA PHYSL IMMUNOP, P237; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHLUMBERGER HD, 1974, ACTA MED SCAND, V196, P451; SMITH AP, 1971, BRIT MED J, V2, P494, DOI 10.1136/bmj.2.5760.494; STEINER AL, 1972, J BIOL CHEM, V247, P1106; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TAUBER AI, 1973, J IMMUNOL, V111, P27; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; WEISS HJ, 1974, JAMA-J AM MED ASSOC, V229, P1221, DOI 10.1001/jama.229.9.1221; YURCHAK AM, 1970, J ALLERGY, V46, P245, DOI 10.1016/0021-8707(70)90028-6	35	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	1					46	50		10.1016/0091-6749(82)90086-0	http://dx.doi.org/10.1016/0091-6749(82)90086-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ377	6274937				2022-12-18	WOS:A1982MZ37700008
J	RANSOM, JH; SCHUSTER, M				RANSOM, JH; SCHUSTER, M			ALLERGIC REACTIONS TO ENZYMES USED IN PLANT CLONING EXPERIMENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TOPEKA ALLERGY CLIN,TOPEKA,KS									AAS K, 1972, ACTA ALLERGOL, V27, P439; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; OTSUKI Y, 1969, PLANT CELL PHYSIOL, V10, P917, DOI 10.1093/oxfordjournals.pcp.a074476; PEPYS J, 1978, ALLERGY PRINCIPLES P, P812; SOLLEY GO, 1975, J ALLERGY CLIN IMMUN, V55, P112; Suzuki H., 1967, J FERMENT TECHNOL, V45, P73; TOMITA Y, 1968, J FERMENT TECHNOL, V46, P701	7	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	5					412	415		10.1016/0091-6749(81)90088-9	http://dx.doi.org/10.1016/0091-6749(81)90088-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ563	7229229				2022-12-18	WOS:A1981LQ56300013
J	AKHTER, J; MERKER, RI; RIEGER, CHL; ROTHBERG, RM				AKHTER, J; MERKER, RI; RIEGER, CHL; ROTHBERG, RM			EFFECT OF THYMOSIN ON LYMPHOCYTES FROM PATIENTS WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS AND ENDOCRINOPATHIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CHICAGO,DEPT PATHOL,CHICAGO,IL 60637	University of Chicago	AKHTER, J (corresponding author), UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60637, USA.							ALFORD RH, 1973, P SOC EXP BIOL MED, V144, P826, DOI 10.3181/00379727-144-37691; BALLOW M, 1977, CLIN IMMUNOL IMMUNOP, V8, P504, DOI 10.1016/0090-1229(77)90014-9; DiGeorge A. M., 1968, BIRTH DEFECTS OAS, V4, P116; FISCHER A, 1978, J CLIN INVEST, V62, P1005, DOI 10.1172/JCI109204; KIRKPATRICK CH, 1978, CELL IMMUNOL, V41, P62, DOI 10.1016/S0008-8749(78)80028-8; KIRKPATRICK CH, 1970, CLIN EXP IMMUNOL, V6, P375; KIRKPATRICK CH, 1971, ANN INTERN MED, V74, P955, DOI 10.7326/0003-4819-74-6-955; KIRKPATRICK CH, 1976, CLIN EXP IMMUNOL, V23, P414; KIRKPATRICK CH, 1978, CLIN EXP IMMUNOL, V34, P311; KIRKPATRICK CH, 1974, ANN INTERN MED, V80, P310, DOI 10.7326/0003-4819-80-3-310; KRETSCHM.R, 1968, NEW ENGL J MED, V279, P1295, DOI 10.1056/NEJM196812122792401; MILLER JFAP, 1975, ANN NY ACAD SCI, V249, P9, DOI 10.1111/j.1749-6632.1975.tb29052.x; MILLER ME, 1967, AM J MED SCI, V253, P741, DOI 10.1097/00000441-196706000-00012; MONTES LF, 1972, J AMER MED ASSOC, V222, P1619, DOI 10.1001/jama.222.13.1619; NEZELOF C, 1968, BIRTH DEFECTS OAS, V4, P104; RIEGER CHL, 1975, J ALLERGY CLIN IMMUN, V56, P273, DOI 10.1016/0091-6749(75)90101-3; SNYDERMAN R, 1973, ANN INTERN MED, V78, P509, DOI 10.7326/0003-4819-78-4-509; TOURAINE JL, 1975, ANN NY ACAD SCI, V249, P335, DOI 10.1111/j.1749-6632.1975.tb29081.x; VALDIMARSSON H, 1973, CELL IMMUNOL, V6, P348, DOI 10.1016/0008-8749(73)90035-X; WARA DW, 1975, ANN NY ACAD SCI, V249, P308, DOI 10.1111/j.1749-6632.1975.tb29078.x	20	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	1					34	40		10.1016/0091-6749(80)90174-8	http://dx.doi.org/10.1016/0091-6749(80)90174-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB459	6985631				2022-12-18	WOS:A1980JB45900006
J	CATES, KL; GRADY, PG; SHAPIRA, E; DAVIS, AT				CATES, KL; GRADY, PG; SHAPIRA, E; DAVIS, AT			CELL-DIRECTED INHIBITION OF POLYMORPHONUCLEAR LEUKOCYTE CHEMOTAXIS IN A PATIENT WITH MUCOCUTANEOUS CANDIDIASIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS MEM HOSP,DIV INFECT DIS,CHICAGO,IL 60614; CHILDRENS MEM HOSP,DIV GENET,CHICAGO,IL 60614	Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago								ALPER CA, 1970, NEW ENGL J MED, V282, P349, DOI 10.1056/NEJM197002122820701; BERENBERG JL, 1973, J CLIN INVEST, V52, P1200, DOI 10.1172/JCI107287; CLARK RA, 1973, ANN INTERN MED, V78, P515, DOI 10.7326/0003-4819-78-4-515; DAVIS AT, 1977, J PEDIATR-US, V90, P225, DOI 10.1016/S0022-3476(77)80634-3; DEMEO AN, 1972, NEW ENGL J MED, V286, P735, DOI 10.1056/NEJM197204062861401; HILL HR, 1974, LANCET, V1, P183; HILL HR, 1975, METABOLISM, V24, P447, DOI 10.1016/0026-0495(75)90124-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADERAZO EG, 1979, CLIN IMMUNOL IMMUNOP, V12, P382, DOI 10.1016/0090-1229(79)90043-6; MADERAZO EG, 1977, J LAB CLIN MED, V89, P190; MILLER ME, 1975, SEMIN HEMATOL, V12, P59; MILLER ME, 1971, PEDIATR RES, V5, P487, DOI 10.1203/00006450-197109000-00007; REBUCK JW, 1955, ANN NY ACAD SCI, V59, P757, DOI 10.1111/j.1749-6632.1955.tb45983.x; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; SHANNON DC, 1966, NEW ENGL J MED, V275, P690, DOI 10.1056/NEJM196609292751302; SMITH CW, 1972, J LAB CLIN MED, V79, P878; SNYDERMAN R, 1973, ANN INTERN MED, V78, P509, DOI 10.7326/0003-4819-78-4-509; SORIANO RB, 1973, J PEDIATR-US, V83, P951, DOI 10.1016/S0022-3476(73)80528-1; VANEPPS DE, 1974, J IMMUNOL, V113, P189; VANSCOY RE, 1975, ANN INTERN MED, V82, P766, DOI 10.7326/0003-4819-82-6-766; WARD PA, 1969, LANCET, V2, P344; WARD PA, 1974, NEW ENGL J MED, V290, P76, DOI 10.1056/NEJM197401102900203	22	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	6					431	435		10.1016/0091-6749(80)90235-3	http://dx.doi.org/10.1016/0091-6749(80)90235-3			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV764					2022-12-18	WOS:A1980JV76400005
J	COHEN, SH; MONROE, EW				COHEN, SH; MONROE, EW			COMBINED H-1 AND H-2 ANTIHISTAMINE TREATMENT FOR CHRONIC URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					189	190						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000086
J	DOLL, NJ; HUGHES, J; WEILL, H; SALVAGGIO, JE				DOLL, NJ; HUGHES, J; WEILL, H; SALVAGGIO, JE			AUTOANTIBODIES IN SILICOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					170	170						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000024
J	FRIGAS, E; REED, CE				FRIGAS, E; REED, CE			EFFECT OF IODOXAMIDE ETHYL ON ALLERGY SKIN-TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,DIV INTERNAL MED & ALLERG DIS,ROCHESTER,MN 55901	Mayo Clinic								COX JSG, 1976, BRONCHIAL ASTHMA MEC, P805; FORD L, 1979, J ALLERGY CLIN IMMUN, V63, P160; FOREMAN JC, 1975, BIOCHEM PHARMACOL, V24, P538, DOI 10.1016/0006-2952(75)90142-2; FOREMAN JC, 1976, BRIT MED J, V1, P820, DOI 10.1136/bmj.1.6013.820; JOHNSON HG, 1978, INT ARCH ALLER A IMM, V56, P416, DOI 10.1159/000232051; KATCHER ML, 1979, J ALLERGY CLIN IMMUN, V63, P161; NETER J, 1974, APPLIED LINEAR STATI, P732; PATTERSON R, 1971, INT ARCH ALLER A IMM, V41, P592, DOI 10.1159/000230552	8	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	4					257	262		10.1016/0091-6749(80)90152-9	http://dx.doi.org/10.1016/0091-6749(80)90152-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JN548	7358942	Bronze			2022-12-18	WOS:A1980JN54800003
J	FROMER, JM; ANDERSON, JA; YANARI, S; BAILEY, JA				FROMER, JM; ANDERSON, JA; YANARI, S; BAILEY, JA			COCKROACH SENSITIVITY AMONG CHILDREN - EXPOSURE HISTORY, SKIN-TEST, AND IGE-RADIOALLERGOSORBENT TEST (RAST) REACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					203	203						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000129
J	SCHUMACHER, MJ				SCHUMACHER, MJ			EFFECT OF A BETA-ADRENERGIC AGONIST, FENOTEROL, ON NASAL SENSITIVITY TO ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,CLIN RES UNIT,MELBOURNE,VIC 3050,AUSTRALIA; ROYAL MELBOURNE HOSP,MELBOURNE,VIC 3050,AUSTRALIA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital								FUGNER A, 1977, INT ARCH ALLER A IMM, V54, P78, DOI 10.1159/000231810; JORDE W, 1975, MED KLIN, V70, P1314; LICHTENS.LM, 1968, SCIENCE, V161, P902, DOI 10.1126/science.161.3844.902; MCLEAN JA, 1976, J ALLERGY CLIN IMMUN, V58, P563, DOI 10.1016/0091-6749(76)90202-5; MCLEAN JA, 1976, J ALLERGY CLIN IMMUN, V57, P153, DOI 10.1016/0091-6749(76)90034-8; ODONNELL SR, 1970, EUR J PHARMACOL, V12, P35, DOI 10.1016/0014-2999(70)90026-9; ORANGE RP, 1971, J EXP MED, V134, pS136; RUFFIN RE, 1978, J ALLERGY CLIN IMMUN, V61, P42, DOI 10.1016/0091-6749(78)90472-4; SCHILD H., 1936, QUART JOUR EXP PHYSIOL, V26, P165; SCHUMACHER MJ, 1979, J ALLERGY CLIN IMMUN, V64, P202, DOI 10.1016/0091-6749(79)90096-4; SOLOMON WR, 1965, J ALLERGY, V36, P62, DOI 10.1016/0021-8707(65)90033-X	11	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	1					33	36		10.1016/0091-6749(80)90135-9	http://dx.doi.org/10.1016/0091-6749(80)90135-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JZ541	6103906				2022-12-18	WOS:A1980JZ54100005
J	SOLOMON, WR; BURGE, HA; BOISE, JR				SOLOMON, WR; BURGE, HA; BOISE, JR			PERFORMANCE OF ADHESIVES FOR ROTATING-ARM IMPACTORS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,DIV ALLERGY,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan								DZUBAY TG, 1976, ATMOS ENVIRON, V10, P229, DOI 10.1016/0004-6981(76)90095-0; LUNDGREN DALE A., 1967, J AIR POLLUT CONTR ASS, V17, P225; MARPLE VA, 1976, FINE PARTICLES; OGDEN EC, 1968, 8 NY STAT MUS SCI SE; OGDEN EC, 1969, 9 NY STAT MUS SCI SE; RAYNOR GS, 1970, J ALLERGY, V45, P329, DOI 10.1016/0021-8707(70)90041-9; WESOLOWSKI JJ, 1977, XRAY FLUORESCENCE AN	7	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	6					467	470		10.1016/0091-6749(80)90241-9	http://dx.doi.org/10.1016/0091-6749(80)90241-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV764	6989880				2022-12-18	WOS:A1980JV76400011
J	TING, S; DUNSKY, EH; ZWEIMAN, B				TING, S; DUNSKY, EH; ZWEIMAN, B			HISTAMINE SUPPRESSION OF EOSINOPHILOTAXIS AND HISTAMINE-RELEASE INVIVO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					196	197						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000108
J	ANKIN, MG; PETERMAN, VI; FISH, JE				ANKIN, MG; PETERMAN, VI; FISH, JE			PHYSIOLOGIC RESPONSES TO INHALED ANTIGEN IN SUBJECTS WITH HAY-FEVER AND ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					149	150						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400049
J	BROOKS, CD; MAILE, MH; WILDER, MA				BROOKS, CD; MAILE, MH; WILDER, MA			ATTENUATION OF EXERCISE-INDUCED ASTHMA BY INHALED LODOXAMIDE TROMETHAMINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					161	161						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400087
J	CHRYSSANTHOPOULOS, C; MAKSUD, MG; FUNAHASHI, A; HOFFMANN, RG; BARBORIAK, JJ				CHRYSSANTHOPOULOS, C; MAKSUD, MG; FUNAHASHI, A; HOFFMANN, RG; BARBORIAK, JJ			ASSESSMENT OF CARDIORESPIRATORY ADJUSTMENTS OF ASTHMATIC ADULTS TO EXERCISE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN,DEPT PREVENT MED,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT PEDIAT,MILWAUKEE,WI 53233; MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53233; UNIV WISCONSIN,MADISON,WI 53706; VET ADM CTR,RES SERV,WOOD,WI 53193	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison	CHRYSSANTHOPOULOS, C (corresponding author), MED COLL WISCONSIN,MILWAUKEE CHILDRENS HOSP,DEPT PEDIAT,MILWAUKEE,WI 53233, USA.							BEVEGARD S, 1976, ACTA PAEDIATR SCAND, V65, P289, DOI 10.1111/j.1651-2227.1976.tb04888.x; BUCKLEY JM, 1975, PEDIATRICS, V56, P883; BYRNEQUINN E, 1971, J APPL PHYSIOL, V30, P91, DOI 10.1152/jappl.1971.30.1.91; CHERNIACK RM, 1977, PULMONARY FUNCTION T, P56; CHRYSSANTHOPOULOS C, 1978, J ALLERGY CLIN IMMUN, V61, P17, DOI 10.1016/0091-6749(78)90468-2; Consolazio CF., 1963, HDB PHYSL, P313; CROPP GJA, 1975, PEDIATRICS, V56, P860; CROPP GJA, 1977, MUSCULAR EXERCISE LU, P265; DAVIES SE, 1968, BRIT MED J, V3, P593, DOI 10.1136/bmj.3.5618.593; EGGLESTON PA, 1975, PEDIATRICS, V56, P856; EGGLESTON PA, 1976, J ALLERGY CLIN IMMUN, V58, P414, DOI 10.1016/0091-6749(76)90122-6; GODFREY S, 1975, PEDIATRICS, V56, P851; GODFREY S, 1974, EXERCISE TESTING CHI, P102; HAYNES RL, 1976, AM REV RESPIR DIS, V114, P739; IRNELL L, 1966, SCAND J RESPIR DIS, V47, P103; ITKIN IH, 1966, J ALLERGY, V37, P253, DOI 10.1016/S0021-8707(96)90009-X; JONES RS, 1966, BRIT MED J, V2, P972, DOI 10.1136/bmj.2.5520.972; KAWABORI I, 1976, J ALLERGY CLIN IMMUN, V58, P447, DOI 10.1016/0091-6749(76)90188-3; MOREHOUSE L, 1976, PHYSL EXERCISE, P89; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; PIERSON WE, 1970, J ALLERGY, V45, P119; SILVERMAN M, 1972, ARCH DIS CHILD, V47, P882, DOI 10.1136/adc.47.256.882; SLY RM, 1967, J ALLERGY, V40, P93, DOI 10.1016/0021-8707(67)90102-5; Snedecor G. W., 1967, STATISTICAL METHODS, P325; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; WEIL JV, 1971, J CLIN INVEST, V50, P186, DOI 10.1172/JCI106472; Yuhasz MS, 1962, THESIS U ILLINOIS; 1970, TXB WORK PHYSL; 1960, ACTA PHYSL SCAN S169, V49, P45	29	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	5					321	327		10.1016/0091-6749(79)90126-X	http://dx.doi.org/10.1016/0091-6749(79)90126-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GU943	429711				2022-12-18	WOS:A1979GU94300005
J	DAHLEM, NW; KINSMAN, RA; HORTON, DJ				DAHLEM, NW; KINSMAN, RA; HORTON, DJ			REQUESTS FOR AS-NEEDED MEDICATIONS BY ASTHMATIC-PATIENTS - RELATIONSHIPS TO PRESCRIBED ORAL CORTICOSTEROID REGIMENS AND LENGTH OF HOSPITALIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH HOSP & RES CTR,DEPT MED,DENVER,CO 80206; UNIV COLORADO,SCH MED,DEPT MED,BOULDER,CO 80302; UNIV COLORADO,SCH MED,DEPT PSYCHIAT,BOULDER,CO 80302	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder	DAHLEM, NW (corresponding author), NATL JEWISH HOSP & RES CTR,DEPT BEHAV SCI,PSYCHOPHYSIOL RES LABS,3800 E COLFAX AVE,DENVER,CO 80206, USA.							CHAI H, 1973, AM J DIS CHILD, V125, P757, DOI 10.1001/archpedi.1973.04160050095021; COMROE JH, 1962, LUNG, P325; DAHLEM NW, 1977, J ALLERGY CLIN IMMUN, V60, P295, DOI 10.1016/0091-6749(77)90108-7; DIRKS JF, 1977, J ASTHMA RES, V14, P61, DOI 10.3109/02770907709098953; DIRKS JF, 1978, PSYCHOSOM MED, V40, P5, DOI 10.1097/00006842-197802000-00003; DIRKS JF, 1977, PSYCHOSOM MED, V39, P120, DOI 10.1097/00006842-197703000-00006; KINSMAN R A, 1978, Psychosomatic Medicine, V40, P87; KINSMAN RA, 1977, PSYCHOSOM MED, V39, P102, DOI 10.1097/00006842-197703000-00005; KINSMAN RA, 1974, PSYCHOSOM MED, V36, P129, DOI 10.1097/00006842-197403000-00005; KINSMAN RA, 1973, J ALLERGY CLIN IMMUN, V52, P284, DOI 10.1016/0091-6749(73)90047-X; KINSMAN RA, 1976, 24 NAT JEW HOSP RES; Siegel S., 1956, NONPARAMETRIC STAT B; TOOGOOD JH, 1971, AM REV RESPIR DIS, V104, P323, DOI 10.1164/arrd.1971.104.3.323; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed	14	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	1					23	27		10.1016/0091-6749(79)90157-X	http://dx.doi.org/10.1016/0091-6749(79)90157-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	GE110	758338				2022-12-18	WOS:A1979GE11000003
J	DORVAL, G; YANG, WH; OSTERLAND, CK; JENNINGS, B; TOOGOOD, JH				DORVAL, G; YANG, WH; OSTERLAND, CK; JENNINGS, B; TOOGOOD, JH			CIRCULATING IMMUNE-COMPLEXES IN HYPERSENSITIVITY PNEUMONITIS AND BRONCHOPULMONARY ASPERGILLOSIS - LONGITUDINAL-STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					204	204						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400238
J	FRIEDLAENDER, MH				FRIEDLAENDER, MH			OCULAR ALLERGY AND IMMUNOLOGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											FRIEDLAENDER, MH (corresponding author), UNIV CALIF SAN FRANCISCO,FRANCIS I PROCTOR FDN,SAN FRANCISCO,CA 94143, USA.							ALLANSMITH MR, 1976, AM J OPHTHALMOL, V81, P506, DOI 10.1016/0002-9394(76)90310-X; AMON RB, 1975, ARCH DERMATOL, V111, P1581, DOI 10.1001/archderm.111.12.1581; ARSTIKAITIS MJ, 1973, ARCH OPHTHALMOL-CHIC, V90, P376, DOI 10.1001/archopht.1973.01000050378008; Beetham WP, 1940, ARCH OPHTHALMOL-CHIC, V24, P21; BORGES JS, 1975, J EXP MED, V141, P483, DOI 10.1084/jem.141.2.483; BREWERTON DA, 1973, LANCET, V1, P904; CHAR DH, 1974, INVEST OPHTH VISUAL, V13, P198; COLLIN HB, 1977, INVEST OPHTH VIS SCI, V16, P858; COPEMAN PWM, 1965, BRIT MED J, V2, P977, DOI 10.1136/bmj.2.5468.977; CRAM DL, 1974, ARCH DERMATOL, V109, P235, DOI 10.1001/archderm.109.2.235; DOLBY AE, 1969, IMMUNOLOGY, V17, P709; EASTY D, 1971, T OPHTHALMOL SOC UK, V41, P491; FESSEL WJ, 1962, AM J OPHTHALMOL, V53, P640, DOI 10.1016/0002-9394(62)91986-4; FRENKEL JK, 1967, J IMMUNOL, V98, P1309; FUREY N, 1975, AM J OPHTHALMOL, V80, P825, DOI 10.1016/0002-9394(75)90278-0; GANLEY J P, 1975, International Ophthalmology Clinics, V15, P83, DOI 10.1097/00004397-197501530-00013; HAIM S, 1976, BRIT J DERMATOL, V95, P631, DOI 10.1111/j.1365-2133.1976.tb07036.x; HAMMER H, 1974, BRIT J OPHTHALMOL, V58, P773, DOI 10.1136/bjo.58.9.773; HAMMER H, 1971, BRIT J OPHTHALMOL, V55, P850, DOI 10.1136/bjo.55.12.850; INOMATA H, 1970, INVEST OPHTH VISUAL, V9, P263; JAMES DG, 1975, AM J MED, V59, P388, DOI 10.1016/0002-9343(75)90397-6; KAHAN A, 1964, Albrecht Von Graefes Arch Ophthalmol, V167, P246, DOI 10.1007/BF00689778; KARSERAS AG, 1976, BRIT J OPHTHALMOL, V60, P522, DOI 10.1136/bjo.60.7.522; KOGURE M, 1971, ACTA SOC OPHTH JAPON, V75, P1260; LEHNER T, 1967, IMMUNOLOGY, V13, P159; LEHNER T, 1967, BRIT MED J, V1, P465, DOI 10.1136/bmj.1.5538.465; MARAK GE, 1976, OPHTHALMIC RES, V8, P117; MCGREADY SJ, 1975, J ALLERGY CLIN IMMUN, V56, P393; MCPHERSON SD, 1948, AM J OPHTHALMOL, V31, P35, DOI 10.1016/S0002-9394(48)92309-5; METCALF JF, 1976, AM J OPHTHALMOL, V82, P827, DOI 10.1016/0002-9394(76)90057-X; NORN MS, 1977, AM J OPHTHALMOL, V83, P138; OSTLER HB, 1977, S OCULAR THERAPY, V10, P99; PATTEN JT, 1976, AM J OPHTHALMOL, V82, P272, DOI 10.1016/0002-9394(76)90433-5; PEDERSEN NB, 1976, LANCET, V2, P1363; PERSON JR, 1977, MAYO CLIN PROC, V52, P54; POLACK FM, 1962, J EXP MED, V116, P709, DOI 10.1084/jem.116.5.709; RAHI AHS, 1973, BRIT J OPHTHALMOL, V57, P904, DOI 10.1136/bjo.57.12.904; SCHLAEGEL TF, 1969, ESSENTIALS UVEITIS, P123; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; SHEARN M A, 1972, Seminars in Arthritis and Rheumatism, V2, P165, DOI 10.1016/0049-0172(72)90008-X; SHIMADA K, 1974, ARCH OPHTHALMOL-CHIC, V92, P496, DOI 10.1001/archopht.1974.01010010510010; SILVERSTEIN AM, 1973, CORNEAL GRAFT FAILUR, P105; SMOLIN G, 1978, ARCH OPHTHALMOL-CHIC, V96, P1078; SPENCER WH, 1959, AM J OPHTHALMOL, V47, P322; TABBARA KF, 1977, ARCH OPHTHALMOL-CHIC, V95, P2184; THYGESON P, 1976, Survey of Ophthalmology, V21, P82, DOI 10.1016/0039-6257(76)90084-9; THYGESON P, 1954, Trans Am Acad Ophthalmol Otolaryngol, V58, P128; UHLENHUTH P, 1903, FESTSCHRIFT SECHZIGS, P49; WALTMAN SR, 1974, AM J OPHTHALMOL, V77, P891, DOI 10.1016/0002-9394(74)90394-8; WEBER JC, 1969, AM J OPHTHALMOL, V67, P732, DOI 10.1016/S0002-9394(69)90999-4; WILLIAMS LE, 1965, ARCH OPHTHALMOL-CHIC, V73, P112; Wilson P, 1962, Br J Ophthalmol, V46, P626, DOI 10.1136/bjo.46.10.626; WONG VG, 1971, AM J OPHTHALMOL, V72, P960, DOI 10.1016/0002-9394(71)91697-7; Woods AC, 1921, J AMER MED ASSOC, V77, P1317; WRIGHT P, 1975, BRIT MED J, V1, P595, DOI 10.1136/bmj.1.5958.595; 1976, LANCET, V2, P79	56	8	9	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	1					51	60		10.1016/0091-6749(79)90162-3	http://dx.doi.org/10.1016/0091-6749(79)90162-3			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GE110	363772				2022-12-18	WOS:A1979GE11000008
J	HULL, WM; WELSH, PW; ADOLPHSON, CR; GLEICH, GJ				HULL, WM; WELSH, PW; ADOLPHSON, CR; GLEICH, GJ			REACTIVITY OF PURIFIED RYE GRASS-POLLEN ANTIGENS - ANTIGENIC AND ALLERGENIC CROSS-REACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					193	193						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400199
J	HUNJAN, BS; CRONHOLM, LS				HUNJAN, BS; CRONHOLM, LS			ANIMAL-MODEL FOR CELL-MEDIATED IMMUNE-RESPONSES TO DERMATOPHYTES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV LOUISVILLE,DEPT BIOCHEM,LOUISVILLE,KY 40208; INST POSTGRAD MED EDUC & RES,CHANDIGARH,INDIA	University of Louisville; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh								BLOCH B, 1909, Z HYG INFEKTIONSKR, V63, P68; Chase Merrill W., 1946, JOUR BACT, V51, P643; CRUICKSHANK CND, 1960, J INVEST DERMATOL, V35, P219, DOI 10.1038/jid.1960.107; DAVID JR, 1964, J IMMUNOL, V93, P264; DELAMATER ED, 1938, J INVEST DERMATOL, V1, P469; GRAPPEL SF, 1974, BACTERIOL REV, V38, P222, DOI 10.1128/MMBR.38.2.222-250.1974; HAXTHAUSEN H, 1952, J INVEST DERMATOL, V19, P293, DOI 10.1038/jid.1952.99; HOWARD DH, 1973, INFECT IMMUN, V8, P412, DOI 10.1128/IAI.8.3.412-419.1973; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; JONES HE, 1974, ARCH DERMATOL, V110, P369, DOI 10.1001/archderm.110.3.369; JONES HE, 1974, ARCH DERMATOL, V109, P840, DOI 10.1001/archderm.109.6.840; KABAT EH, 1948, EXPTL IMMUNOCHEMISTR; Neisser A, 1902, ARCH DERMATOL SYPH-G, V60, P63, DOI 10.1007/BF01986861; SLOPER JC, 1955, J INVEST DERMATOL, V25, P21, DOI 10.1038/jid.1955.90; VALENTINE F, 1971, INVITRO METHODS CELL	15	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	5					361	369		10.1016/0091-6749(79)90132-5	http://dx.doi.org/10.1016/0091-6749(79)90132-5			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GU943	429716				2022-12-18	WOS:A1979GU94300011
J	LEIFERMAN, KM; YUNGINGER, JW; GLEICH, GJ				LEIFERMAN, KM; YUNGINGER, JW; GLEICH, GJ			MEASUREMENT OF THE POTENCY OF POLLEN EXTRACT BY RADIOIMMUNOPRECIPITATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ALLERG DIS RES LAB,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,DEPT MED,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,DEPT PEDIAT,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic; Mayo Clinic								ARBESMAN CE, 1977, INT ARCH ALLER A IMM, V53, P310, DOI 10.1159/000231767; ARMITAGE P, 1971, STATISTICAL METHODS, P281; AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0; BENTON AW, 1963, SCIENCE, V142, P228, DOI 10.1126/science.142.3589.228; DIXON WJ, 1969, INTRO STATISTICAL AN, P222; FOUCARD T, 1976, CLIN ALLERGY, V6, P429, DOI 10.1111/j.1365-2222.1976.tb01927.x; GLEICH GJ, 1976, J ALLERGY CLIN IMMUN, V58, P31, DOI 10.1016/0091-6749(76)90104-4; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; GLEICH GJ, 1976, MANUAL CLIN IMMUNOLO, P575; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; ISHIZAKA K, 1967, J IMMUNOL, V98, P490; ISHIZAKA K, 1970, IMMUNOCHEMISTRY, V7, P687, DOI 10.1016/0019-2791(70)90175-8; KABAT EA, 1961, EXPERIMENTAL IMMUNOC, P871; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P129, DOI 10.1016/0091-6749(76)90148-2; LEWIS DM, 1978, J CELL BIOL, V77, P702, DOI 10.1083/jcb.77.3.702; PAULL BR, 1978, J IMMUNOL, V120, P1971; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; STEFANI DV, 1973, YU IMMUNOCHEMISTRY, V10, P559; YUNGINGER JW, 1976, J ALLERGY CLIN IMMUN, V58, P405, DOI 10.1016/0091-6749(76)90121-4; YUNGINGER JW, 1979, J ALLERGY CLIN IMMUN, V63, P340, DOI 10.1016/0091-6749(79)90129-5; YUNGINGER JW, 1972, J ALLERGY CLIN IMMUN, V50, P109, DOI 10.1016/0091-6749(72)90006-1; ZEISS CR, 1973, J IMMUNOL, V110, P414; 1976, B WHO, V54, P129	25	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	3					173	181		10.1016/0091-6749(79)90092-7	http://dx.doi.org/10.1016/0091-6749(79)90092-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HL221	469117				2022-12-18	WOS:A1979HL22100004
J	SCHELLENBERG, RR; ADKINSON, NF				SCHELLENBERG, RR; ADKINSON, NF			ASSESSMENT OF THE INFLUENCE OF IRRELEVANT IGE ON ALLERGIC SENSITIVITY TO 2 INDEPENDENT ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV CLIN IMMUNOL,BALTIMORE,MD 21218	Johns Hopkins University								AAS K, 1971, J ALLERGY CLIN IMMUN, V48, P134, DOI 10.1016/0091-6749(71)90008-X; ADKINSON NF, 1976, MANUAL CLIN IMMUNOLO, P590; BAZARAL M, 1973, CLIN EXP IMMUNOL, V14, P117; BERG T, 1971, INT ARCH ALLER A IMM, V40, P770, DOI 10.1159/000230461; CONROY MC, 1977, J IMMUNOL, V118, P1317; EVANS R, 1975, ADV DIAGNOSIS ALLERG; GLEICH GJ, 1975, SCIENCE, V190, P1106, DOI 10.1126/science.1188389; GODFREY R C, 1975, Clinical Allergy, V5, P201, DOI 10.1111/j.1365-2222.1975.tb01853.x; GODFREY RC, 1976, NATURE, V259, P484, DOI 10.1038/259484a0; ISHIZAKA T, 1973, J IMMUNOL, V111, P500; JARRETT EEE, 1971, CLIN EXP IMMUNOL, V9, P585; MALVEAUX FJ, 1978, J CLIN INVEST, V62, P176, DOI 10.1172/JCI109103; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P210, DOI 10.1016/0091-6749(73)90059-6; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P94, DOI 10.1016/0091-6749(73)90081-X; NORMAN PS, 1973, MECHANISMS ALLERGY R, P151; SCHELLENBERG RR, 1975, J IMMUNOL, V115, P1577; SCHELLENBERG RR, 1976, J IMMUNOL, V117, P355; WIDE L, 1967, LANCET, V2, P1105; ZEISS CR, 1973, J IMMUNOL, V110, P414; 1976, LANCET, V1, P894	20	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	1					15	22		10.1016/0091-6749(79)90156-8	http://dx.doi.org/10.1016/0091-6749(79)90156-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GE110	82565				2022-12-18	WOS:A1979GE11000002
J	SHAPRIO, GG; FURUKAWA, CT; PIERSON, WE; BIERMAN, CW				SHAPRIO, GG; FURUKAWA, CT; PIERSON, WE; BIERMAN, CW			DOUBLE-BLIND CONTROLLED-STUDY OF FLUNISOLIDE AEROSOL IN STEROID-DEPENDENT ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					163	163						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400094
J	WEILL, H				WEILL, H			EPIDEMIOLOGIC AND MEDICAL-LEGAL ASPECTS OF OCCUPATIONAL ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											WEILL, H (corresponding author), TULANE UNIV,SCH MED,DEPT MED,NEW ORLEANS,LA 70112, USA.								0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					662	664		10.1016/0091-6749(79)90033-2	http://dx.doi.org/10.1016/0091-6749(79)90033-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	HX843		Bronze			2022-12-18	WOS:A1979HX84300021
J	FINDLAY, SR; LICHTENSTEIN, LM				FINDLAY, SR; LICHTENSTEIN, LM			BASOPHIL RELEASABILITY IN PATIENTS WITH INTRINSIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					157	158		10.1016/0091-6749(78)90337-8	http://dx.doi.org/10.1016/0091-6749(78)90337-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300098
J	JACKSON, CE; SWEET, LC; HAYASHI, H; PAUL, TD				JACKSON, CE; SWEET, LC; HAYASHI, H; PAUL, TD			EVIDENCE FOR NONLINKAGE OF GENES FOR HLA AND HEREDITARY ANGIOEDEMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HENRY FORD HOSP,DEPT MED,DIV ALLERGY & CLIN IMMUNOL,DETROIT,MI 48202; HENRY FORD HOSP,DEPT PATHOL,DETROIT,MI 48202; INDIANA UNIV,DEPT MED GENET,BLOOMINGTON,IN 47401	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Indiana University System; Indiana University Bloomington	JACKSON, CE (corresponding author), HENRY FORD HOSP,DIV CLIN GENET,DETROIT,MI 48202, USA.							FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; GADEK JE, 1977, CLIN RES, V25, P357; GELFAND JA, 1976, NEW ENGL J MED, V295, P1444, DOI 10.1056/NEJM197612232952602; Giblett ER., 1969, GENETIC MARKERS HUMA; GIGLI I, 1968, J IMMUNOL, V100, P1154; JERSILD C, 1976, TRANSPLANT REV-DENMA, V32, P43; MORTON NE, 1957, AM J HUM GENET, V9, P55; OHELA K, 1977, TISSUE ANTIGENS, V9, P90; OTT J, 1974, AM J HUM GENET, V26, P588; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0	10	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	5					331	333		10.1016/0091-6749(78)90055-6	http://dx.doi.org/10.1016/0091-6749(78)90055-6			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EY714	641267				2022-12-18	WOS:A1978EY71400009
J	MAGILAVY, DB; CASSIDY, JT; TUBERGEN, DG; PETTY, RE; CHISHOLM, R; MCCALL, K				MAGILAVY, DB; CASSIDY, JT; TUBERGEN, DG; PETTY, RE; CHISHOLM, R; MCCALL, K			INTRAVENOUS GAMMA-GLOBULIN IN MANAGEMENT OF PATIENTS WITH HYPOGAMMAGLOBULINEMIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MICHIGAN, DEPT PEDIAT & COMMUNICABLE DIS, DIV IMMUNOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT PEDIAT & COMMUNICABLE DIS, DIV HEMATOL, ANN ARBOR, MI 48109 USA; MICHIGAN DEPT HLTH, LANSING, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; MDHHS - Michigan Department of Health & Human Services	MAGILAVY, DB (corresponding author), UNIV MICHIGAN, DEPT PEDIAT & COMMUNICABLE DIS, DIV RHEUMATOL, ANN ARBOR, MI 48109 USA.		Chisholm, Rex/B-3418-2009	Chisholm, Rex/0000-0002-5638-3990				BARANDUN S, 1975, VOX SANG, V28, P157, DOI 10.1111/j.1423-0410.1975.tb02755.x; BARANDUN S, 1962, VOX SANG, V7, P157, DOI 10.1111/j.1423-0410.1962.tb03240.x; BARANDUN SILVIO, 1964, BIBLIOTHECA HAEMATOL, V17, P1; BLACK FL, 1974, MANUAL CLIN MICROBIO, P709; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; FAHEY JL, 1963, J EXP MED, V118, P845, DOI 10.1084/jem.118.5.845; FAHEY JL, 1965, J IMMUNOL, V94, P84; JANEWAY CA, 1968, NEW ENGL J MED, V278, P919, DOI 10.1056/NEJM196804252781701; JANEWAY CA, 1967, GAMMA GLOBULINS, P103; KENT JF, 1963, AM J TROP MED HYG, V12, P103, DOI 10.4269/ajtmh.1963.12.103; LENNETTE EH, 1969, DIAGNOSTIC PROCEDURE, P61; ONCLEY JL, 1949, J AM CHEM SOC, V71, P541, DOI 10.1021/ja01170a048; OSLER A G, 1952, Am J Syph Gonorrhea Vener Dis, V36, P140; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; SCHULTZE HE, 1962, DEUT MED WOCHENSCHR, V87, P1643, DOI 10.1055/s-0028-1113997; SGOURIS J. T., 1960, VOX SANGUINIS, V5, P357; SGOURIS JT, 1967, VOX SANG, V13, P71; STEINBUCH M, 1967, VOX SANG, V13, P103; STEPHAN W, 1969, Z KLIN CHEM KLIN BIO, V7, P282; 1953, IMMUNE SERUM GLOBULI	20	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	6					378	383		10.1016/0091-6749(78)90117-3	http://dx.doi.org/10.1016/0091-6749(78)90117-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC593	77867				2022-12-18	WOS:A1978FC59300006
J	MARONE, G; LICHTENSTEIN, LM				MARONE, G; LICHTENSTEIN, LM			ADENOSINE-ADENOSINE DEAMINASE MODULATION OF HISTAMINE-RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					131	131		10.1016/0091-6749(78)90247-6	http://dx.doi.org/10.1016/0091-6749(78)90247-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300008
J	METZGER, WJ; FISH, J; KELLY, JF; ROSENBERG, M; PATTERSON, R				METZGER, WJ; FISH, J; KELLY, JF; ROSENBERG, M; PATTERSON, R			HYPERSENSITIVITY LUNG-DISEASE - EARLY DIAGNOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT MED,PULM DIS SECT,CHICAGO,IL 60611	Northwestern University; Northwestern University								BANASZAK EF, 1970, NEW ENGL J MED, V283, P271, DOI 10.1056/NEJM197008062830601; EDWARDS C, 1974, BRIT J DIS CHEST, V68, P57, DOI 10.1016/0007-0971(74)90010-2; FAUCI AS, 1976, ANN INTERN MED, V84, P304, DOI 10.7326/0003-4819-84-3-304; FINK J, COMMUNICATION; FINK JN, 1971, J ALLERGY CLIN IMMUN, V48, P179, DOI 10.1016/0091-6749(71)90014-5; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; MARX J J JR, 1976, American Review of Respiratory Disease, V113, P128; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; OGILVIE CM, 1957, J CLIN INVEST, V36, P1, DOI 10.1172/JCI103402; OUCHTERLONY O, 1962, PROG ALLERGY, V6, P30, DOI 10.1159/000313795; PATTERSON R, 1976, AM J MED, V60, P144, DOI 10.1016/0002-9343(76)90543-X; PEPYS J, 1969, MONOGRAPH ALLERGY, V4; REED CE, 1965, J AMER MED ASSOC, V193, P261, DOI 10.1001/jama.1965.03090040005001; SCHATZ M, 1976, CLIN EXP IMMUNOL, V24, P33	14	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	2					67	72		10.1016/0091-6749(78)90227-0	http://dx.doi.org/10.1016/0091-6749(78)90227-0			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EL413	637907				2022-12-18	WOS:A1978EL41300001
J	NEWBALL, HH; ADKINSON, NF; ADAMS, GK; FINDLAY, SR; LICHTENSTEIN, LM				NEWBALL, HH; ADKINSON, NF; ADAMS, GK; FINDLAY, SR; LICHTENSTEIN, LM			MECHANISM OF ANAPHYLACTIC RELEASE OF PROSTAGLANDINS (PGS) FROM HUMAN LUNG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					148	148		10.1016/0091-6749(78)90304-4	http://dx.doi.org/10.1016/0091-6749(78)90304-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300065
J	SOBOTKA, AK; VALENTINE, MD; LICHTENSTEIN, LM				SOBOTKA, AK; VALENTINE, MD; LICHTENSTEIN, LM			IMMUNE-RESPONSE TO HYMENOPTERA VENOMS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					136	136		10.1016/0091-6749(78)90263-4	http://dx.doi.org/10.1016/0091-6749(78)90263-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300024
J	GARRA, B; SHAPIRO, GG; DORSETT, CS; SIMONS, FER; PIERSON, WE; BIERMAN, CW				GARRA, B; SHAPIRO, GG; DORSETT, CS; SIMONS, FER; PIERSON, WE; BIERMAN, CW			DOUBLE-BLIND EVALUATION OF USE OF NEBULIZED METAPROTERENOL AND ISOPROTERENOL IN HOSPITALIZED ASTHMATIC-CHILDREN AND ADOLESCENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; CHILDRENS ORTHOPED HOSP & MED CTR,DIV ALLERGY,SEATTLE,WA 98105; UNIV MANITOBA,DEPT PEDIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA	University of Washington; University of Washington Seattle; University of Manitoba								BIERMAN CW, 1974, PEDIATRICS, V54, P245; BILODEAU M, 1968, CAN MED ASSOC J, V99, P585; CHOOKANG YF, 1969, BMJ-BRIT MED J, V2, P287, DOI 10.1136/bmj.2.5652.287; DICKMAN ML, 1971, AM REV RESPIR DIS, V104, P680; ENGELHARDT A, 1961, DRUGS MADE GERMANY, V4, P123; FALLERONI AE, 1972, ALLERGIC DISEASES DI, P281; FREEDMAN GB, 1971, THORAX, V26, P46; HOLMES TH, 1968, CLIN PHARMACOL THER, V9, P615; MCEVOY JDS, 1973, AM REV RESPIR DIS, V108, P490; MILNER AD, 1971, ARCH DIS CHILD, V46, P502, DOI 10.1136/adc.46.248.502; PELZ HH, 1967, AM J MED SCI, V253, P321, DOI 10.1097/00000441-196703000-00009; REILLY EB, 1974, CURR THER RES CLIN E, V16, P759; SHANKS RG, 1967, BMJ-BRIT MED J, V1, P610, DOI 10.1136/bmj.1.5540.610; SPITZBATH H, 1961, DRUGS MADE GERMANY, V4, P136; STAMM SJ, 1957, DIS CHEST, V52, P1919	15	8	8	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	60	1					63	68		10.1016/0091-6749(77)90084-7	http://dx.doi.org/10.1016/0091-6749(77)90084-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DN224	326847				2022-12-18	WOS:A1977DN22400009
J	GERRITZ, G; PIROFSKY, B; NOLTE, M				GERRITZ, G; PIROFSKY, B; NOLTE, M			VASOMOTOR SYNDROME INDUCED BY INTRAVENOUS (IV) SERUM IMMUNE GLOBULIN (SIG)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					253	253						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000156
J	GUIRGIS, HM; TOWNLEY, RG				GUIRGIS, HM; TOWNLEY, RG			EFFECT OF PERTUSSIS AND BETA ADRENERGIC-BLOCKING AGENTS ON MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CREIGHTON UNIV,SCH MED,DEPT MED,OMAHA,NB 68131	Creighton University								BERGMAN RK, 1968, NATURE, V217, P1173, DOI 10.1038/2171173a0; GILLESPIE E, 1974, J ALLERGY CLIN IMMUN, V53, P27, DOI 10.1016/0091-6749(74)90096-7; GUIRGIS HM, 1975, J ALLERGY CLIN IMMUN, V55, P110; GUIRGIS HM, 1973, J ALLERGY CLIN IMMUN, V51, P91, DOI 10.1016/S0091-6749(73)80030-2; KOOPMAN WJ, 1970, J IMMUNOL, V105, P1096; LECKS HI, 1969, J ALLERGY, V44, P261, DOI 10.1016/0021-8707(69)90031-8; MORSE HC, 1969, J IMMUNOL, V102, P327; MORSE SI, 1965, J EXP MED, V121, P49, DOI 10.1084/jem.121.1.49; MUNOZ J, 1968, BACTERIOL REV, V32, P103, DOI 10.1128/MMBR.32.2.103-126.1968; MURMANN W, 1969, J PHARM PHARMACOL, V21, P478, DOI 10.1111/j.2042-7158.1969.tb08297.x; ORANGE RP, 1971, INT ARCH ALLER A IMM, V41, P79, DOI 10.1159/000230490; OREHEK J, 1975, J ALLERGY CLIN IMMUN, V55, P164, DOI 10.1016/0091-6749(75)90012-3; PERELMUT.L, 1971, INT ARCH ALLER A IMM, V40, P675, DOI 10.1159/000230449; PERELMUTTER L, 1971, INT ARCH ALLER A IMM, V40, P481, DOI 10.1159/000230432; Shanks R G, 1969, Ir J Med Sci, V2, P351, DOI 10.1007/BF02959306; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TOWNLEY RG, 1967, J ALLERGY, V39, P177, DOI 10.1016/0021-8707(67)90036-6	17	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	2					241	249		10.1016/0091-6749(76)90129-9	http://dx.doi.org/10.1016/0091-6749(76)90129-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA661	7584				2022-12-18	WOS:A1976CA66100001
J	NELSON, HS; RAINE, D; BRANCH, B; KALISKER, A				NELSON, HS; RAINE, D; BRANCH, B; KALISKER, A			ADRENERGIC SUBSENSITIVITY INDUCED BY CHRONIC ADMINISTRATION OF TERBUTALINE AND ALBUTEROL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					259	260						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000171
J	ANDRASCH, RH; KOSTER, F; LAWSON, WH; BARDANA, EJ				ANDRASCH, RH; KOSTER, F; LAWSON, WH; BARDANA, EJ			MEATWRAPPERS ASTHMA - APPRAISAL OF A NEW OCCUPATIONAL SYNDROME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					130	130						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800150
J	COLEMAN, M; BARNARD, JH; BARR, SE; BROWN, H; LEVINE, MI; MUELLER, HL				COLEMAN, M; BARNARD, JH; BARR, SE; BROWN, H; LEVINE, MI; MUELLER, HL			PROLONGED INTERVAL HYPOSENSITIZATION THERAPY IN HYMENOPTERA-SENSITIVE PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BARR SE, 1974, JAMA, V228, P6; MUELLER H, COMMUNICATION; MUELLER HL, 1959, NEW ENGL J MED, V261, P374, DOI 10.1056/NEJM195908202610803; 1965, JAMA, V193, P115	4	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	3					222	225		10.1016/0091-6749(75)90093-7	http://dx.doi.org/10.1016/0091-6749(75)90093-7			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AQ290	1151015				2022-12-18	WOS:A1975AQ29000007
J	GUPTA, S; GRIECO, MH				GUPTA, S; GRIECO, MH			T-LYMPHOCYTE AND B-LYMPHOCYTE ROSETTES IN BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					99	100						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800077
J	ILEA, V; OKAZAKI, T; WYPYCH, JI; REISMAN, RE; ARBESMAN, CE				ILEA, V; OKAZAKI, T; WYPYCH, JI; REISMAN, RE; ARBESMAN, CE			COMPARISON OF ANTIGENIC PROPERTIES OF BEE VENOM AND PHOSPHOLIPASE-A	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					74	74						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800014
J	MINARS, N; FU, YS; ESCOBAR, MR				MINARS, N; FU, YS; ESCOBAR, MR			BIPHASIC LOCAL REACTION TO A NEW INSULIN (U-100)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									MED COLL VIRGINIA,DEPT DERMATOL,RICHMOND,VA; MED COLL VIRGINIA,DEPT PATHOL,BOX 137,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University								COLEMAN WP, 1971, ANN ALLERGY, V29, P383; DELVIN JG, 1966, DIABETES, V15, P790; DOLOVICH J, 1970, J ALLERGY, V46, P127, DOI 10.1016/0021-8707(70)90091-2; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; GALLOWAY JA, 1972, DIABETES, V21, P637, DOI 10.2337/diab.21.2.S637; GELFAND ML, 1954, P SOC EXP BIOL MED, V86, P258; Lawrence RD, 1925, LANCET, V1, P1125; PALEY RG, 1952, DIABETES, V1, P22, DOI 10.2337/diab.1.1.22; PATTERSON R, 1969, J IMMUNOL, V103, P1061	9	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	5					411	415		10.1016/0091-6749(75)90135-9	http://dx.doi.org/10.1016/0091-6749(75)90135-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW330	1181354				2022-12-18	WOS:A1975AW33000011
J	RACHELEFSKY, GS; LAVIN, N; KAPLAN, SA				RACHELEFSKY, GS; LAVIN, N; KAPLAN, SA			ACTION OF CROMOLYN SODIUM (CS) - INHIBITION OF CYCLIC 3',5' ADENOSINE-MONOPHOSPHATE (CAMP) PHOSPHODIESTERASE (PDE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					117	118						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800121
J	REISMAN, RE; LIGHT, WC; OKAZAKI, T; ILEA, V; ARBESMAN, CE				REISMAN, RE; LIGHT, WC; OKAZAKI, T; ILEA, V; ARBESMAN, CE			STINGING INSECT ALLERGY .4. COMPARISON OF BEE VENOM AND WHOLE BEE BODY EXTRACT IN HUMAN INSECT HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					79	79						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800026
J	STEVENSON, DD; MATHISON, DA				STEVENSON, DD; MATHISON, DA			AEROALLERGEN INHALATION CHALLENGES IN ASPIRIN-INTOLERANT ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					127	128						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800144
J	CHANG, EB; MARSH, DG				CHANG, EB; MARSH, DG			IMMUNE RESPONSIVENESS OF INBRED MICE TO POLLEN ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					65	66						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000002
J	CHANG, IC; GOTTSHALL, RY				CHANG, IC; GOTTSHALL, RY			SENSITIZATION TO RAGWEED POLLEN IN BORDETELLA-PERTUSSIS-INFECTED OR VACCINE-INJECTED MICE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MICHIGAN DEPT PUBL HLTH LABS, 3500 N LOGAN ST, LANSING, MI 48914 USA									ABRAMSON HA, 1951, TREATMENT ASTHMA; CHANG IC, 1972, INFECT IMMUN, V6, P92, DOI 10.1128/IAI.6.1.92-94.1972; DURHAM OC, 1946, J ALLERGY, V17, P79, DOI 10.1016/0021-8707(46)90025-1; GUYTON AC, 1947, AM J PHYSIOL, V150, P78, DOI 10.1152/ajplegacy.1947.150.1.78; KIND LS, 1959, P SOC EXP BIOL MED, V100, P808, DOI 10.3181/00379727-100-24785; STEVENET P., 1961, Revue d'Hygiene et de Medecine Sociale, V9, P147	6	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	1					20	24		10.1016/S0091-6749(74)80004-7	http://dx.doi.org/10.1016/S0091-6749(74)80004-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T5232	4365297				2022-12-18	WOS:A1974T523200003
J	POLSON, JB; KRZANOWS.JJ; SZENTIVA.A				POLSON, JB; KRZANOWS.JJ; SZENTIVA.A			EFFECT OF HISTAMINE (H) ON PULMONARY LEVELS OF CYCLIC NUCLEOTIDES IN NORMAL MICE AND UNDER CONDITIONS OF PHARMACOLOGIC OR BACTERIAL SENSITIZATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					100	100						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000088
J	ROSENTHA.RR; SUMMER, WR; PERMUTT, S; NORMAN, PS				ROSENTHA.RR; SUMMER, WR; PERMUTT, S; NORMAN, PS			EFFECT OF ATROPINE ON ANTIGEN-MEDIATED BRONCHOSPASM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					73	73						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000020
J	WOODIEL, NL; BENNETT, SE; HORNSBY, RP; DANIEL, JC				WOODIEL, NL; BENNETT, SE; HORNSBY, RP; DANIEL, JC			ALLERGENIC ACTIVITY OF SOLUBLE FRACTIONS OF DERMATOPHAGOIDES-FARINAE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV FLORIDA, AGR RES CTR, FT LAUDERDALE, FL USA; UNIV TENNESSEE, MEM RES CTR & HOSP, KNOXVILLE, TN USA; UNIV TENNESSEE, DEPT ZOOL & ENTOMOL, KNOXVILLE, TN 37901 USA; UNIV TENNESSEE, COLL AGR, DEPT AGR BIOL, KNOXVILLE, TN 37901 USA	State University System of Florida; University of Florida; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville								BERRENS L, 1967, ACTA ALLERGOL, V22, P347, DOI 10.1111/j.1398-9995.1967.tb03238.x; Cooke RA, 1922, J IMMUNOL, V7, P147; DASGUPTA A, 1970, CLIN EXP IMMUNOL, V6, P891; EBELING W, 1970, PEST CONTROL OPER NE, V30, P22; KERN A, 1921, MED CLIN N AM, V5, P751; MAUNSELL K, 1968, LANCET, V1, P1267; MITCHELL WF, 1969, ANN ALLERGY, V27, P93; MIYAMOTO T, 1968, J ALLERGY, V42, P14, DOI 10.1016/0021-8707(68)90128-7; MIYAMOTO T, 1969, J ALLERGY, V44, P282, DOI 10.1016/0021-8707(69)90033-1; PEPYS J, 1968, LANCET, V1, P1270; SPIEKSMA FTM, 1969, ACTA ALLERGOL, V42, P124; VANLEEUWEN W, 1972, BRIT MED J       AUG; Voorhorst R., 1964, Allergie Asthma, V10, P329	13	8	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	5					278	282		10.1016/0091-6749(74)90106-7	http://dx.doi.org/10.1016/0091-6749(74)90106-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S9114	4822488	Bronze			2022-12-18	WOS:A1974S911400004
J	MADDISON, SE; HICKLIN, MD; KAGAN, IG				MADDISON, SE; HICKLIN, MD; KAGAN, IG			IMMEDIATE, ARTHUS, AND DELAYED-TYPE SKIN REACTIONS IN RHESUS-MONKEYS INFECTED WITH SCHISTOSOMA-MANSONI OR MYCOBACTERIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									US DEPT HEW,HLTH SERV & MENTAL HLTH ADM,PHS,CTR DIS CONTROL,PARASITOL BRANCH,ATLANTA,GA 30333; US DEPT HEW,HLTH SERV & MENTAL HLTH ADM,PHS,CTR DIS CONTROL,PATHOL SECT,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA								BARAM P, 1971, LAB ANIM SCI, V21, P727; FLAX MH, 1962, J IMMUNOL, V89, P496; GERSHON RK, 1970, 2 INT CONV IMM BUFF, P207; GOOD RC, 1968, ANN NY ACAD SCI, V154, P200, DOI 10.1111/j.1749-6632.1968.tb16710.x; KAGAN IG, 1961, AM J TROP MED HYG, V10, P200, DOI 10.4269/ajtmh.1961.10.200; KEELING ME, 1969, LAB ANIM CARE, V19, P629; MACKLERB, 1971, INT ARCH ALLERGY, V41, P765; MADDISON SE, 1972, SCIENCE, V178, P757, DOI 10.1126/science.178.4062.757; MADDISON SE, 1971, EXP PARASITOL, V29, P463, DOI 10.1016/0014-4894(71)90056-7; MALLEY A, 1972, J ALLERGY CLIN IMMUN, V49, P36, DOI 10.1016/0091-6749(72)90121-2; MALLEY A, 1968, J IMMUNOL, V101, P292; Melcher LR, 1943, J INFECT DIS, V73, P31, DOI 10.1093/infdis/73.1.31; MONTAGNA W, 1972, AM ZOOL, V12, P109; PATTERSON R, 1969, J LAB CLIN MED, V73, P924; SCHMIDT LH, 1957, AM REV TUBERC PULM, V75, P169; SIBINOVIC S, 1969, LAB ANIM CARE, V19, P621; STUCKI WP, 1968, J PARASITOL, V54, P174, DOI 10.2307/3276901; WOLFSON RL, 1969, J PARASITOL, V55, P1175	18	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	3					131	140		10.1016/0091-6749(73)90029-8	http://dx.doi.org/10.1016/0091-6749(73)90029-8			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q7045	4269339				2022-12-18	WOS:A1973Q704500001
J	DEARAUJO, G; DUDLEY, DL; VANARSDE.PP				DEARAUJO, G; DUDLEY, DL; VANARSDE.PP			PSYCHOSOCIAL ASSETS AND SEVERITY OF CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BERLE BB, 1952, JAMA-J AM MED ASSOC, V149, P1624, DOI 10.1001/jama.1952.02930350012004; DEARAUJO G, 1971, PSYCHOSOM MED, V33, P473; DUDLEY DL, 1969, PSYCHOSOM MED, V31, P310, DOI 10.1097/00006842-196907000-00004; GIRSH LS, 1967, J ALLERGY, V39, P347, DOI 10.1016/0021-8707(67)90047-0; HAWKINS NG, 1957, AM REV TUBERC PULM, V75, P768; HOLMES TH, 1961, J PSYCHOSOM RES, V5, P235, DOI 10.1016/0022-3999(61)90001-0; KLEEMAN ST, 1967, ANN ALLERGY, V25, P611; RAHE RH, 1964, J PSYCHOSOM RES, V8, P35, DOI 10.1016/0022-3999(64)90020-0; REES L, 1964, J PSYCHOSOM RES, V7, P253, DOI 10.1016/0022-3999(64)90003-0; WRIGHT G L, 1965, Med J Aust, V1, P961	10	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	50	5					257	&		10.1016/0091-6749(72)90024-3	http://dx.doi.org/10.1016/0091-6749(72)90024-3			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	N9856	5076352				2022-12-18	WOS:A1972N985600001
J	HAMBURGER, RN; BAZARAL, M				HAMBURGER, RN; BAZARAL, M			IGE LEVELS IN TWINS CONFIRM GENETIC-CONTROL IN HUMAN BEINGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1971, J IMMUNOL, V107, P794	1	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					91	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700013
J	MARSH, DG; BIAS, WB; HSU, SH				MARSH, DG; BIAS, WB; HSU, SH			TESTS OF ASSOCIATION BETWEEN HL-A HISTOCOMPATIBILITY ANTIGENS AND IMMEDIATE HYPERSENSITIVITY REACTIONS TO HIGHLY PURIFIED ALLERGENS IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					124	&						0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700084
J	SPECTOR, SL; FARR, RS				SPECTOR, SL; FARR, RS			COMMENTS ON BRONCHIAL INHALATION PROVOCATIVE TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																		BRONSKY EA, 1969, PEDIATR CLIN N AM, V16, P85; CONNELL JT, 1969, J ALLERGY, V43, P33, DOI 10.1016/0021-8707(69)90018-5; FARR RS, 1960, J IMMUNOL, V85, P250; HERXHEIMER H, 1951, INT ARCH ALLER A IMM, V2, P40, DOI 10.1159/000227899; JOHANSSO.SG, 1967, LANCET, V2, P951; JOHANSSON SG, 1968, IMMUNOLOGY, V14, P265; LEVINE BB, 1970, INT ARCH ALLER A IMM, V39, P156, DOI 10.1159/000230343; LINDBLAD JH, 1961, J ALLERGY, V32, P392, DOI 10.1016/0021-8707(61)90016-8; SALVAGGIO JE, 1964, J ALLERGY, V35, P62, DOI 10.1016/0021-8707(64)90050-4; TIFFENEAU R, 1960, INT ARCH ALLER A IMM, V17, P193, DOI 10.1159/000229128; TOWNLEY RG, 1965, J ALLERGY, V36, P121, DOI 10.1016/0021-8707(65)90161-9	11	8	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	2					120	&		10.1016/0091-6749(71)90093-5	http://dx.doi.org/10.1016/0091-6749(71)90093-5			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K0446					2022-12-18	WOS:A1971K044600006
J	Lechner, A; Henkel, FDR; Hartung, F; Bohnacker, S; Alessandrini, F; Gubernatorova, EO; Drutskaya, MS; Angioni, C; Schreiber, Y; Haimerl, P; Ge, Y; Thomas, D; Kabat, AM; Pearce, EJ; Ohnmacht, C; Nedospasov, SA; Murray, PJ; Chaker, AM; Schmidt-Weber, CB; Esser-von Bieren, J				Lechner, Antonie; Henkel, Fiona D. R.; Hartung, Franziska; Bohnacker, Sina; Alessandrini, Francesca; Gubernatorova, Ekaterina O.; Drutskaya, Marina S.; Angioni, Carlo; Schreiber, Yannick; Haimerl, Pascal; Ge, Yan; Thomas, Dominique; Kabat, Agnieszka M.; Pearce, Edward J.; Ohnmacht, Caspar; Nedospasov, Sergei A.; Murray, Peter J.; Chaker, Adam M.; Schmidt-Weber, Carsten B.; Esser-von Bieren, Julia			Macrophages acquire a TNF-dependent inflammatory memory in allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CCL17; chemokines; eicosanoids; lipid mediators; macrophages; trained immunity; type 2 inflammation	ACTIVATION-REGULATED CHEMOKINE; HOUSE-DUST MITE; RESIDENT ALVEOLAR MACROPHAGES; CELLS; THYMUS; GENE; TRANSCRIPTION; LEUKOTRIENES; EXPRESSION; PROTECTION	Background: Infectious agents can reprogram or "train "macrophages and their progenitors to respond more readily to subsequent insults. However, whether such an inflammatory memory exists in type 2 inflammatory conditions such as allergic asthma was not known. Objective: We sought to decipher macrophage-trained immunity in allergic asthma. Methods: We used a combination of clinical sampling of house dust mite (HDM)-allergic patients, HDM-induced allergic airway inflammation in mice, and an in vitro training setup to analyze persistent changes in macrophage eicosanoid, cytokine, and chemokine production as well as the underlying metabolicand epigenetic mechanisms. Transcriptional and metabolic profiles of patient-derived and in vitro trained macrophages were assessed by RNA sequencing or metabolic flux analysis and liquid chromatography-tandem mass spectrometry analysis,respectively. Results: We found that macrophages differentiated from bone marrow or blood monocyte progenitors of HDM-allergic mice or asthma patients show inflammatory transcriptional reprogramming and excessive mediator (TNF-alpha, CCL17, leukotriene, PGE2, IL-6) responses upon stimulation. Macrophages from HDM-allergic mice initially exhibited a type 2 imprint, which shifted toward a classical inflammatory training over time. HDM-induced allergic airway inflammation elicited a metabolically activated macrophage phenotype,producing high amounts of 2-hydroxyglutarate (2-HG). HDM-induced macrophage training in vitro was mediated by a formyl peptide receptor 2-TNF-2-HG-PGE(2)/PGE(2) receptor 2 axis,resulting in an M2-like macrophage phenotype with high CCL17 production. TNF blockade by etanercept or genetic ablation of Tnfin myeloid cells prevented the inflammatory imprinting of bone marrow-derived macrophages from HDM-allergic mice. Conclusion: Allergen-triggered inflammation drives a TNF-dependent innate memory, which may perpetuate and exacerbate chronic type 2 airway inflammation and thus represents a target for asthma therapy.	[Lechner, Antonie; Henkel, Fiona D. R.; Hartung, Franziska; Bohnacker, Sina; Alessandrini, Francesca; Haimerl, Pascal; Ohnmacht, Caspar; Chaker, Adam M.; Schmidt-Weber, Carsten B.; Esser-von Bieren, Julia] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Munich, Germany; [Lechner, Antonie; Henkel, Fiona D. R.; Hartung, Franziska; Bohnacker, Sina; Alessandrini, Francesca; Haimerl, Pascal; Ohnmacht, Caspar; Chaker, Adam M.; Schmidt-Weber, Carsten B.; Esser-von Bieren, Julia] Helmholtz Ctr Munich, Munich, Germany; [Gubernatorova, Ekaterina O.; Drutskaya, Marina S.; Nedospasov, Sergei A.] Sirius Univ Sci & Technol, Engelhardt Inst Mol Biol, Ctr Precis Genome Editing & Genet Technol Biomed, Moscow, Russia; [Gubernatorova, Ekaterina O.; Drutskaya, Marina S.; Nedospasov, Sergei A.] Sirius Univ Sci & Technol, Soci, Russia; [Angioni, Carlo; Thomas, Dominique] Goethe Univ Frankfurt, Inst Clin Pharmacol, Frankfurt, Germany; [Schreiber, Yannick] Fraunhofer Inst Translat Med & Pharmacol ITMP, Frankfurt, Germany; [Ge, Yan] Univ Dresden, Hosp Carl Gustav Carus, Dept Immunobiol, Dresden, Germany; [Kabat, Agnieszka M.; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Murray, Peter J.] Max Planck Inst Biochem, Munich, Germany; [Chaker, Adam M.] Tech Univ Munich, TUM Med Sch, Dept Otorhinolaryngol & Head & Neck Surg, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Goethe University Frankfurt; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Max Planck Society; Technical University of Munich	Esser-von Bieren, J (corresponding author), Zentrum Fuer Allergie & Umwelt ZAUM, Biedersteiner Str 29, D-80802 Munich, Germany.	julia.esser@tum.de	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802; Chaker, Adam/0000-0002-5117-4073; Lechner, Antonie/0000-0002-1636-3354; Bohnacker, Sina/0000-0002-8804-7238	German Research Foundation (DFG) [FOR2599, ES 471/3-1, ES 471/2-3]; Fritz Thyssen Stiftung [Az. 10.17.2.017MN]; Helmholtz Young Investigator grant [VH-NG-1331]; European Research Council [716718]; DFG [FOR2599, 395357507-SFB1371, OH 282/1-1]; German Center for Lung Research (DZL) [82DZL00302]; Ministry of Science and Higher Education of the Russian Federation [075-15-2019-1660]	German Research Foundation (DFG)(German Research Foundation (DFG)); Fritz Thyssen Stiftung; Helmholtz Young Investigator grant; European Research Council(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); German Center for Lung Research (DZL); Ministry of Science and Higher Education of the Russian Federation	This study was supported by the German Research Foundation (DFG) (FOR2599, ES 471/3-1; ES 471/2-3) , the Fritz Thyssen Stiftung (grant Az. 10.17.2.017MN) , and a Helmholtz Young Investigator grant (VH-NG-1331) to J.E.v.B. C.O. is supported by the European Research Council (ERC starting grant project 716718) and the DFG (project 395357507-SFB1371 and grant OH 282/1-1 within FOR2599) . C.S.W. receives grant support by the German Center for Lung Research (DZL; 82DZL00302) . G.E.O., S.A.N., and M.S.D. are supported by grant 075-15-2019-1660 from the Ministry of Science and Higher Education of the Russian Federation.	Alvarez-Errico D, 2011, J IMMUNOL, V187, P5577, DOI 10.4049/jimmunol.1101626; Backman H, 2017, CLIN EXP ALLERGY, V47, P1426, DOI 10.1111/cea.12963; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Bhavsar PK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-71; Bucchioni E, 2004, RESP MED, V98, P651, DOI 10.1016/j.rmed.2003.12.011; Cai B, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar3721; Calderon MA, 2015, J ALLERGY CLIN IMMUN, V136, P38, DOI 10.1016/j.jaci.2014.10.012; Cartland SP, 2019, ISCIENCE, V12, P41, DOI 10.1016/j.isci.2018.12.037; Cartwright JA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00055; Chen PC, 2021, CELL MOL IMMUNOL, V18, P472, DOI 10.1038/s41423-020-00621-4; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Clarke DL, 2014, MUCOSAL IMMUNOL, V7, P558, DOI 10.1038/mi.2013.74; Cook AD, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99249; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Draijer C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/632049; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haimerl P, 2021, J ALLERGY CLIN IMMUN, V147, P587, DOI 10.1016/j.jaci.2020.04.064; Henkel FDR, 2019, ALLERGY, V74, P1090, DOI 10.1111/all.13700; Holgate ST, 2011, EUR RESPIR J, V37, P1352, DOI 10.1183/09031936.00063510; Hsu AT, 2018, J BIOL CHEM, V293, P11415, DOI 10.1074/jbc.RA118.002416; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Jimenez MD, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay0605; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Kusnadi A, 2019, IMMUNITY, V51, P241, DOI 10.1016/j.immuni.2019.06.005; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Maeda K, 2019, ALLERGY, V74, P1660, DOI 10.1111/all.13788; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Melgert BN, 2011, J ALLERGY CLIN IMMUN, V127, P831, DOI 10.1016/j.jaci.2010.10.045; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Ohlmann A, 2016, HISTOCHEM CELL BIOL, V146, P769, DOI 10.1007/s00418-016-1461-4; Onishi H, 2019, ANTICANCER RES, V39, P1179, DOI 10.21873/anticanres.13227; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Richgels PK, 2017, J ALLERGY CLIN IMMUN, V140, P1404, DOI 10.1016/j.jaci.2016.12.972; Ricklefs I, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93534; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schleicher U, 2016, CELL REP, V15, P1062, DOI 10.1016/j.celrep.2016.04.001; Sekiya T, 2002, ALLERGY, V57, P173, DOI 10.1034/j.1398-9995.2002.1s3256.x; Shen HJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.57; Shen YF, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00288; Smole U, 2020, NAT IMMUNOL, V21, P756, DOI 10.1038/s41590-020-0698-1; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Sundelin JP, 2013, BIOCHEM BIOPH RES CO, V437, P274, DOI 10.1016/j.bbrc.2013.06.066; Thinnes CC, 2014, BBA-GENE REGUL MECH, V1839, P1416, DOI 10.1016/j.bbagrm.2014.05.009; Waisberg M, 2012, P NATL ACAD SCI USA, V109, P5429, DOI 10.1073/pnas.1202689109; Weathington NM, 2017, AM J RESP CELL MOL, V57, P346, DOI 10.1165/rcmb.2016-0316OC; Wojno EDT, 2019, IMMUNITY, V50, P851, DOI 10.1016/j.immuni.2019.03.011; Xu M, 2017, IMMUNOL REV, V278, P185, DOI 10.1111/imr.12558; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yahia SA, 2014, AM J RESP CRIT CARE, V189, P899, DOI 10.1164/rccm.201310-1827OC; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580	64	7	7	9	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					2078	2090		10.1016/j.jaci.2021.11.026	http://dx.doi.org/10.1016/j.jaci.2021.11.026			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2E6QP	34974067	hybrid			2022-12-18	WOS:000812351900003
J	Bachert, C; Sousa, AR; Han, JK; Schlosser, RJ; Sowerby, LJ; Hopkins, C; Maspero, JF; Smith, SG; Kante, O; Karidi-Andrioti, DE; Mayer, B; Chan, RH; Yancey, SW; Chaker, AM				Bachert, Claus; Sousa, Ana R.; Han, Joseph K.; Schlosser, Rodney J.; Sowerby, Leigh J.; Hopkins, Claire; Maspero, Jorge F.; Smith, Steven G.; Kante, Oliver; Karidi-Andrioti, Despina E.; Mayer, Bhabita; Chan, Robert H.; Yancey, Steve W.; Chaker, Adam M.			Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; blood eosinophils; chronic rhinosinusitis; biologic therapy; mepolizumab; nasal polyps; AERD; type 2 inflammation; sinus surgery	ASTHMA; PREVALENCE; SURGERY	Background: In the phase III SYNAPSE study, mepolizumab reduced nasal polyp (NP) size and nasal obstruction in chronic rhinosinusitis with NP. Objective: We sought to assess the efficacy of mepolizumab in patients from SYNAPSE grouped by comorbid asthma, aspirin-exacerbated respiratory disease (AERD), and baseline blood eosinophil count (BEC). Methods: SYNAPSE, a randomized, double-blind, 52-week study (NCT03085797), included patients with severe bilateral chronic rhinosinusitis with NP eligible for surgery despite intranasal corticosteroid treatment. Patients received 4-weekly subcutaneous mepolizumab 100 mg or placebo plus standard of care for 52 weeks. Coprimary end points were change in total endoscopic NP score (week 52) and nasal obstruction visual analog scale score (weeks 49-52). Subgroup analyses by comorbid asthma and AERD status, and post hoc by BEC, were exploratory. Results: Analyses included 407 patients (289 with asthma; 108 with AERD; 371 and 278 with BEC counts >150 or >300 cells/mL, respectively). The proportion of patients with greater than or equal to 1-point improvement from baseline in NP score was higher with mepolizumab versus placebo across comorbid diseases (asthma: 52.9% vs 29.5%; AERD: 51.1% vs 20.6%) and baseline BEC subgroups (<150 cells/mL: 55.0% vs 31.3%; >150 cells/mL: 49.5% vs 28.1%; <300 cells/mL: 50.7% vs 29.0%; >300 cells/mL: 50.4% vs 28.1%). A similar trend was observed in patients without comorbid asthma or AERD. More patients had more than 3-point improvement in nasal obstruction VAS score with mepolizumab versus placebo across comorbid subgroups. Conclusions: Mepolizumab reduced polyp size and nasal obstruction in chronic rhinosinusitis with NP regardless of the presence of comorbid asthma or AERD.	[Bachert, Claus] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium; [Bachert, Claus] Univ Ghent, Dept Otorhinolaryngol, Ghent, Belgium; [Bachert, Claus] Ghent Univ Hosp, Ghent, Belgium; [Bachert, Claus] Univ Stockholm, Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden; [Bachert, Claus] Sun Yat Sen Univ, Affiliated Hosp 1, Int Airway Res Ctr, Guangzhou, Peoples R China; [Sousa, Ana R.; Chan, Robert H.] GlaxoSmithKline Res & Dev Ltd, Clin Sci, Brentford, England; [Han, Joseph K.] Eastern Virginia Med Sch, Dept Otolaryngol Head & Neck Surg, Norfolk, VA 23501 USA; [Schlosser, Rodney J.] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC USA; [Sowerby, Leigh J.] Western Univ, Dept Otolaryngol Head & Neck Surg, London, ON, Canada; [Hopkins, Claire] Guys & St Thomas Hosp, ENT Dept, London, England; [Hopkins, Claire] Kings Coll London, London, England; [Maspero, Jorge F.] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina; [Smith, Steven G.] GSK, Resp Therapeut Area Unit, Res Triangle Pk, NC USA; [Kante, Oliver] GSK, Global Clin Sci & Delivery, Munich, Germany; [Karidi-Andrioti, Despina E.] GSK, Global Clin Sci & Delivery, Brentford, England; [Mayer, Bhabita; Yancey, Steve W.] GSK, Clin Stat, Brentford, England; [Chaker, Adam M.] Tech Univ Munich, TUM Sch Med, Klinikum Rechts Isar, Dept Otolaryngol, Ismaninger Str 22, Munich, Germany; [Chaker, Adam M.] Tech Univ Munich, Ctr Allergy & Environm, Munich, Germany	Ghent University; Ghent University; Ghent University; Ghent University Hospital; Karolinska Institutet; Stockholm University; Sun Yat Sen University; GlaxoSmithKline; Eastern Virginia Medical School; Medical University of South Carolina; Western University (University of Western Ontario); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Technical University of Munich; Technical University of Munich	Chaker, AM (corresponding author), Tech Univ Munich, TUM Sch Med, Klinikum Rechts Isar, Dept Otolaryngol, Ismaninger Str 22, Munich, Germany.; Chaker, AM (corresponding author), Tech Univ Munich, Ctr Allergy & Environm ZAUM, Ismaninger Str 22, Munich, Germany.	adam.chaker@tum.de	Smith, Steven/HDM-9496-2022	Sowerby, Leigh/0000-0002-5825-2759; Chaker, Adam/0000-0002-5117-4073	GlaxoSmithKline (GSK) [205687]; GSK	GlaxoSmithKline (GSK)(GlaxoSmithKline); GSK(GlaxoSmithKline)	This study was funded by GlaxoSmithKline (GSK ID: 205687; ClinicalTrials.gov: NCT03085797). A.R.S., S.G.S., O.K., D.E.K.-A., B.M., R.H.C., and S.W.Y. are employees of GSK and contributed to the design of the study, the analysis and interpretation of data, writing the manuscript, and the decision to submit the manuscript for publication. Editorial support (in the form of writing assistance, including preparation of the draft manuscript under the direction and guidance of the authors, collating and incorporating authors' comments for each draft, assembling tables and figures, grammatical editing, and referencing) was provided by Katie Crossland, PhD, and Ciara Keogh, PhD, at Fishawack Indicia Ltd, part of Fishawack Health, UK, and was funded by GSK.	[Anonymous], 2021, NUCALA US PRESCRIBIN; [Anonymous], 2020, NUCALA SUMMARY PRODU; Bachert C, 2020, J ALLERGY CLIN IMMUN, V147, P1981; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bousquet PJ, 2009, J ALLERGY CLIN IMMUN, V123, P1349, DOI 10.1016/j.jaci.2009.02.033; Chowdhury NI, 2017, INT FORUM ALLERGY RH, V7, P1149, DOI 10.1002/alr.22028; Dalal Anand A, 2016, J Manag Care Spec Pharm, V22, P833, DOI 10.18553/jmcp.2016.22.7.833; Davide R, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2019.102286; DeConde AS, 2017, LARYNGOSCOPE, V127, P550, DOI 10.1002/lary.26391; Emma R, 2018, THER ADV RESPIR DIS, V12, DOI 10.1177/1753466618808490; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032; Han JK, 2021, LANCET RESP MED, V9, P1141, DOI 10.1016/S2213-2600(21)00097-7; Hox V, 2012, ALLERGY, V67, P560, DOI 10.1111/j.1398-9995.2011.02779.x; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Khan A, 2019, RHINOLOGY, V57, P32, DOI 10.4193/Rhin17.255; Kim J, 2020, THER CLIN RISK MANAG, V16, P31, DOI 10.2147/TCRM.S210648; Klossek JM, 2005, ALLERGY, V60, P233, DOI 10.1111/j.1398-9995.2005.00688.x; Lange B, 2013, CLIN OTOLARYNGOL, V38, P474, DOI 10.1111/coa.12189; Llanos JP, 2020, J ASTHMA ALLERGY, V13, P77, DOI 10.2147/JAA.S236609; Loftus CA, 2020, INT FORUM ALLERGY RH, V10, P199, DOI 10.1002/alr.22487; McHugh T, 2018, INT FORUM ALLERGY RH, V8, P1421, DOI 10.1002/alr.22194; Ortega H, 2015, J ALLERGY CLIN IMMUN, V136, P825, DOI 10.1016/j.jaci.2015.05.039; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Passali D, 2016, EUR ARCH OTO-RHINO-L, V273, P2097, DOI 10.1007/s00405-015-3880-6; Pavord ID, 2017, NEW ENGL J MED, V377, P1613, DOI 10.1056/NEJMoa1708208; Philpott CM, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0823-y; Radabaugh JP, 2019, AM J RHINOL ALLERGY, V33, P507, DOI 10.1177/1945892419846263; Schleich F, 2020, CLIN EXP ALLERGY, V50, P687, DOI 10.1111/cea.13601; Seybt MW, 2007, ENT-EAR NOSE THROAT, V86, P409, DOI 10.1177/014556130708600719; Stevens WW, 2017, J ALLER CL IMM-PRACT, V5, P1061, DOI 10.1016/j.jaip.2016.12.027; Stevens WW, 2016, J ALLER CL IMM-PRACT, V4, P565, DOI 10.1016/j.jaip.2016.04.012; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Vennik J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022643; Vlaminck S, 2014, AM J RHINOL ALLERGY, V28, P260, DOI 10.2500/ajra.2014.28.4024; Wang KH, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100052	36	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2022	149	5					1711	+		10.1016/j.jaci.2021.10.040	http://dx.doi.org/10.1016/j.jaci.2021.10.040			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3I4PN	35007624				2022-12-18	WOS:000832701000003
J	Barbieux, C; des Claustres, MB; Fahrner, M; Petrova, E; Tsoi, LC; Gouin, O; Leturcq, F; Nicaise-Roland, P; Bole, C; Beziat, V; Bourrat, E; Schilling, O; Gudjonsson, JE; Hovnanian, A				Barbieux, Claire; des Claustres, Mathilde Bonnet; Fahrner, Matthias; Petrova, Evgeniya; Tsoi, Lam C.; Gouin, Olivier; Leturcq, Florent; Nicaise-Roland, Pascale; Bole, Christine; Beziat, Vivien; Bourrat, Emmanuelle; Schilling, Oliver; Gudjonsson, Johann E.; Hovnanian, Alain			Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-alpha and allergic responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Netherton syndrome; IL-36; ichthyosis linearis circumflexa; scaly erythroderma; type I IFN; T(H)2; T(H)9	SERINE-PROTEASE INHIBITOR; SKIN INFLAMMATION; KERATINOCYTE DIFFERENTIATION; SIGNALING PATHWAY; ATOPIC-DERMATITIS; ACTIVATION; LEKTI; EXPRESSION; PSORIASIS; CELLS	Background: Netherton syndrome (NS) is a rare recessive skin disorder caused by loss-of-function mutations in SPINK5 encoding the protease inhibitor LEKTI (lymphoepithelial Kazal-type-related inhibitor). NS patients experience severe skin barrier defects, display inflammatory skin lesions, and have superficial scaling with atopic manifestations. They present with typical ichthyosis linearis circumflexa (NS-ILC) or scaly erythroderma (NS-SE). Objective: We used a combination of several molecular profiling methods to comprehensively characterize the skin, immune cells, and allergic phenotypes of NS-ILC and NS-SE patients. Methods: We studied a cohort of 13 patients comprising 9 NS-ILC and 4 NS-SE. Results: Integrated multiomics revealed abnormal epidermal proliferation and differentiation and IL-17/IL-36 signatures in lesion skin and in blood in both NS endotypes. Although the molecular profiles of NS-ILC and NS-SE lesion skin were very similar, nonlesion skin of each disease subtype displayed distinctive molecular features. Nonlesion and lesion NS-SE epidermis showed activation of the type I IFN signaling pathway, while lesion NS-ILC skin differed from nonlesion NS-ILC skin by increased complement activation and neutrophil infiltration. Serum cytokine profiling and immunophenotyping of circulating lymphocytes showed a TH2-driven allergic response in NS-ILC, whereas NS-SE patients displayed mainly a TH9 axis with increased CCL22/MDC and CCL17/TARC serum levels. Conclusions: This study confirms IL-17/IL-36 as the predominant signaling axes in both NS endotypes and unveils molecular features distinguishing NS-ILC and NS-SE. These results identify new therapeutic targets and could pave the way for precision medicine of NS.	[Barbieux, Claire; des Claustres, Mathilde Bonnet; Petrova, Evgeniya; Tsoi, Lam C.; Gouin, Olivier; Leturcq, Florent] Hop Xavier Bichat, AP HP Nord, INSERM UMR 1163, Imagine Inst,Lab Genet Skin Dis, Paris, France; [Nicaise-Roland, Pascale] Hop Xavier Bichat, AP HP Nord, Dept Immunol, Paris, France; [Nicaise-Roland, Pascale] St Louis Hosp, INSERM UMR 1152, Paris, France; [Bole, Christine] St Louis Hosp, INSERM UMR 1163, Imagine Inst, Paris, France; [Beziat, Vivien] St Louis Hosp, INSERM UMR 1163, Lab Human Genet Infect Dis, Imagine Inst, Paris, France; [Bourrat, Emmanuelle] St Louis Hosp, Dept Dermatol, Paris, France; [Hovnanian, Alain] Univ Paris, Paris, France; [Hovnanian, Alain] Necker Hosp Sick Children, AP HP, Dept Genet, Paris, France; [Fahrner, Matthias; Schilling, Oliver] Univ Freiburg, Fac Med, Med Ctr, Inst Surg Pathol, Freiburg, Germany; [Fahrner, Matthias] Albert Ludwigs Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Fahrner, Matthias] Albert Ludwigs Univ Freiburg, Fac Biol, Freiburg, Germany; [Gudjonsson, Johann E.; Hovnanian, Alain] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Freiburg; University of Freiburg; University of Michigan System; University of Michigan	Hovnanian, A (corresponding author), Imagine Inst, INSERM UMR 1163, Genet Skin Dis Dis Mech Therapies, 24 Blvd Montparnasse, F-75015 Paris, France.	alain.hovnanian@inserm.fr	Béziat, Vivien/G-2971-2011; Béziat, Vivien/AAT-4097-2021; Fahrner, Matthias/ABE-3484-2021	Béziat, Vivien/0000-0002-4020-824X; Béziat, Vivien/0000-0002-4020-824X; Fahrner, Matthias/0000-0001-7955-2518; Petrova, Evgeniya/0000-0002-7060-1114; Barbieux, Claire/0000-0003-1292-588X	French National Research Agency [ANR-17-CE14-0025, ANR-19-CE17-0017]; Imagine Institute with Cross-Lab program; Association Ichtyose France; European Union's Horizon 2020 research and innovation program under the ERA-NET Cofund action [643578]; NIH [P30-AR075043, AI130025]	French National Research Agency(French National Research Agency (ANR)); Imagine Institute with Cross-Lab program; Association Ichtyose France; European Union's Horizon 2020 research and innovation program under the ERA-NET Cofund action; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by the French National Research Agency ANR-17-CE14-0025 Tfh Atopy (A.H.), ANR-19-CE17-0017 Target-NS (A.H.), the Imagine Institute with Cross-Lab program, and Association Ichtyose France (A.H.). A.H. and O.S. were supported by the European Union's Horizon 2020 research and innovation program under the ERA-NET Cofund action 643578 (KLKIN project); J.E.G. and L.C.T. are supported by NIH P30-AR075043 and AI130025.	Bachelez H, 2019, NEW ENGL J MED, V380, P981, DOI 10.1056/NEJMc1811317; Barbieux C, J AM ACAD DERMATOL, V84, P1476; Bielenberg DR, 1999, J INVEST DERMATOL, V112, P802, DOI 10.1046/j.1523-1747.1999.00566.x; Bitoun E, 2003, HUM MOL GENET, V12, P2417, DOI 10.1093/hmg/ddg247; Blanchard Sarah K, 2020, JAAD Case Rep, V6, P577, DOI 10.1016/j.jdcr.2020.04.025; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Bridgewood C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00200; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Catapano M, 2020, J INVEST DERMATOL, V140, P816, DOI 10.1016/j.jid.2019.08.444; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen L, 2006, INT IMMUNOL, V18, P1233, DOI 10.1093/intimm/dxl054; Chi HH, 2017, J AM SOC NEPHROL, V28, P2022, DOI 10.1681/ASN.2016080840; Conrad C, 2012, J INVEST DERMATOL, V132, P1759, DOI 10.1038/jid.2012.149; Czarnowicki T, 2018, J INVEST DERMATOL, V138, P2157, DOI 10.1016/j.jid.2018.03.1523; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Fontao L, 2011, J INVEST DERMATOL, V131, P1947, DOI 10.1038/jid.2011.124; Fortugno P, 2011, J INVEST DERMATOL, V131, P2223, DOI 10.1038/jid.2011.174; Furio L, 2014, BIOL CHEM, V395, P945, DOI 10.1515/hsz-2014-0137; German B, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123390; Giacomassi C, 2017, J INVEST DERMATOL, V137, P760, DOI 10.1016/j.jid.2016.11.011; Giang J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00639; Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051; Hannula-Jouppi K, 2014, J ALLERGY CLIN IMMUN, V134, P985, DOI 10.1016/j.jaci.2014.07.008; Harusato A, 2017, MUCOSAL IMMUNOL, V10, P1455, DOI 10.1038/mi.2017.21; Hernandez-Santana YE, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900586; Hovnanian A., 2012, EXP REV DERMATOL, V7, P81; Hovnanian A, 2013, CELL TISSUE RES, V351, P289, DOI 10.1007/s00441-013-1558-1; Howell MD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02342; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Jiang ZW, 2017, J INVEST DERMATOL, V137, P2620, DOI 10.1016/j.jid.2017.07.820; Kolbinger F, 2017, J ALLERGY CLIN IMMUN, V139, P923, DOI 10.1016/j.jaci.2016.06.038; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Leclerc-Mercier S, 2016, AM J DERMATOPATH, V38, P83, DOI 10.1097/DAD.0000000000000425; Liu HY, 2017, CELL HOST MICROBE, V22, P653, DOI 10.1016/j.chom.2017.10.006; Luchsinger I, 2020, JAMA DERMATOL, V156, P907, DOI 10.1001/jamadermatol.2020.1019; Mahil SK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2514; Malik K, 2019, J ALLERGY CLIN IMMUN, V143, P604, DOI 10.1016/j.jaci.2018.03.021; Mallbris L, 2002, EXP DERMATOL, V11, P584, DOI 10.1034/j.1600-0625.2002.110611.x; Muller A, 2018, P NATL ACAD SCI USA, V115, P10088, DOI 10.1073/pnas.1801377115; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pajulas A, 2020, J IMMUNOL, V204; Paller AS, 2017, J ALLERGY CLIN IMMUN, V139, P152, DOI 10.1016/j.jaci.2016.07.019; Patrick GJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143334; Pfaff CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15892-7; Renner ED, 2009, J ALLERGY CLIN IMMUN, V124, P536, DOI 10.1016/j.jaci.2009.06.009; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; Sehra S, 2015, J ALLERGY CLIN IMMUN, V136, P433, DOI 10.1016/j.jaci.2015.01.021; Solimani F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02847; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Steuer AB, 2020, JAMA DERMATOL, V156, P350, DOI 10.1001/jamadermatol.2019.4608; Stuvel K, 2020, ALLERGY, V75, P1710, DOI 10.1111/all.14197; Swindell WR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00080; Todorovic V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45626-w; Tsoi LC, 2020, J ALLERGY CLIN IMMUN, V145, P1406, DOI 10.1016/j.jaci.2019.11.047; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; van Smeden J, 2020, J LIPID RES, V61, P859, DOI 10.1194/jlr.RA120000639; van Smeden J, 2014, J INVEST DERMATOL, V134, P1238, DOI 10.1038/jid.2013.517; Volc S, 2020, BRIT J DERMATOL, V183, P165, DOI 10.1111/bjd.18892; Wang WM, 2017, INT J MED SCI, V14, P1002, DOI 10.7150/ijms.20809; Williams MR, 2020, CELL REP, V30, P2923, DOI 10.1016/j.celrep.2020.02.021; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Wu L, 2015, J EXP MED, V212, P1571, DOI 10.1084/jem.20150204; Zhang LJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01440	70	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1358	1372		10.1016/j.jaci.2021.08.024	http://dx.doi.org/10.1016/j.jaci.2021.08.024			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34543653	hybrid, Green Published			2022-12-18	WOS:000820784100003
J	Nakayama, T; Lee, IT; Le, W; Tsunemi, Y; Borchard, NA; Zarabanda, D; Dholakia, SS; Gall, PA; Yang, A; Kim, D; Akutsu, M; Kashiwagi, T; Patel, ZM; Hwang, PH; Frank, DN; Haruna, S; Ramakrishnan, VR; Nolan, GP; Jiang, SZ; Nayak, JV				Nakayama, Tsuguhisa; Lee, Ivan T.; Le, Wei; Tsunemi, Yasuhiro; Borchard, Nicole A.; Zarabanda, David; Dholakia, Sachi S.; Gall, Philip A.; Yang, Angela; Kim, Dayoung; Akutsu, Makoto; Kashiwagi, Takashi; Patel, Zara M.; Hwang, Peter H.; Frank, Daniel N.; Haruna, Shin-ichi; Ramakrishnan, Vijay R.; Nolan, Garry P.; Jiang, Sizun; Nayak, Jayakar, V			Inflammatory molecular endotypes of nasal polyps derived from White and Japanese populations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; nasal polyps; CRSwNP; endotype; type 2 inflammation; single-cell RNA sequencing; transcriptome; gene profiling	CHRONIC RHINOSINUSITIS; CC-CHEMOKINE; EXPRESSION; PROTEIN; EOSINOPHILIA; CELLS; DIFFERENTIATION; IDENTIFICATION; EOTAXIN-3; FEATURES	Background: Emerging evidence suggests that chronic rhinosinusitis with nasal polyps (CRSwNP) is a highly heterogeneous disease with disparate inflammatory characteristics between different racial groups and geographies. Currently, little is known about possible underlying distinguishing factors between these inflammatory differences. Objective: Our aim was to interrogate differences in CRSwNP disease between White/non-Asian patients and Japanese patients by using whole transcriptome and single-cell RNA gene expression profiling of nasal polyps (NPs). Methods: We performed whole transcriptome RNA sequencing with endotype stratification of NPs from 8 White patients (residing in the United States) and 9 Japanese patients (residing in Japan). Reproducibility was confirmed by quantitative PCR in an independent validation set of 46 White and 31 Japanese patients. Single-cell RNA sequencing (scRNAseq) was used to stratify key cell types for contributory transcriptional signatures. Results: Unsupervised clustering analysis identified 2 major endotypes that were present within both cohorts of patients with NPs and had previously been reported at the cytokine level: (1) type 2 endotype and (2) non-type 2 endotype. Importantly, there was a statistically significant difference in the proportion of these endotypes between these geographically distinct subgroups with NPs (P = .03). Droplet-based single-cell RNA sequencing further identified prominent type 2 inflammatory transcript expression: C-C motif chemokine ligand 13 (CCL13) and CCL18 in M2 macrophages, as well as cystatin SN (CST1) and CCL26 in basal, suprabasal, and secretory epithelial cells. Conclusion: NPs from both racial groups harbor the same 2 major endotypes, which we have determined to be present in differing ratios between each cohort with CRSwNP disease. Distinct inflammatory and epithelial cells contribute to the type 2 inflammatory profiles observed.	[Nakayama, Tsuguhisa; Lee, Ivan T.; Le, Wei; Borchard, Nicole A.; Zarabanda, David; Dholakia, Sachi S.; Gall, Philip A.; Yang, Angela; Kim, Dayoung; Patel, Zara M.; Hwang, Peter H.; Nayak, Jayakar, V] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 801 Welch Rd, Stanford, CA 94305 USA; [Lee, Ivan T.; Nolan, Garry P.; Jiang, Sizun] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Lee, Ivan T.] Stanford Univ, Sch Med, Div Allergy Immunol & Rheumatol, Dept Pediat, Stanford, CA 94305 USA; [Nakayama, Tsuguhisa] Jikei Univ, Dept Otorhinolaryngol, Sch Med, Tokyo, Japan; [Tsunemi, Yasuhiro; Akutsu, Makoto; Kashiwagi, Takashi; Haruna, Shin-ichi] Dokkyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Mibu, Tochigi, Japan; [Frank, Daniel N.] Univ Colorado, Div Infect Dis, Aurora, CO USA; [Ramakrishnan, Vijay R.] Univ Colorado, Dept Otolaryngol Head & Neck Surg, Aurora, CO USA; [Jiang, Sizun] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, 3 Blackfan Circle, Boston, MA 02115 USA; [Nayak, Jayakar, V] Vet Affairs Palo Alto Hlth Care Syst, Dept Otolaryngol Head & Neck Surg, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Jikei University; Dokkyo Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Nayak, JV (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 801 Welch Rd, Stanford, CA 94305 USA.; Jiang, SZ (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, 3 Blackfan Circle, Boston, MA 02115 USA.	sjiang3@bidmc.harvard.edu; jnayak@stanford.edu		Nolan, Garry/0000-0002-8862-9043; Hwang, Peter/0000-0002-0786-4675; Patel, Zara/0000-0003-2072-982X; Salvi, Nicole Borchard/0000-0002-4383-1619	California Institute for Regenerative Medicine [DISC2-09637]; Defense Advanced Research Projects Agency [HR001118S0037-PREPARE-FP-001]; PDev Foundation; Bill and Melinda Gates Foundation [INV002704]; Leukemia and Lymphoma Society Career Development Program; Stanford Dean's Fellowship; Stanford Translational Research and Applied Medicine Pilot Grant; Thrasher Research Fund Early Career Award; Stanford Maternal and Child Health Research Institute Clinical (MD) Trainee Support Award Ernest and Amelia Gallo Endowed Postdoctoral Fellowship	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); PDev Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Leukemia and Lymphoma Society Career Development Program(Leukemia and Lymphoma Society); Stanford Dean's Fellowship; Stanford Translational Research and Applied Medicine Pilot Grant; Thrasher Research Fund Early Career Award; Stanford Maternal and Child Health Research Institute Clinical (MD) Trainee Support Award Ernest and Amelia Gallo Endowed Postdoctoral Fellowship	Supported by the California Institute for Regenerative Medicine (DISC2-09637), the Defense Advanced Research Projects Agency (HR001118S0037-PREPARE-FP-001), the PDev Foundation (to J.V.N.), the Bill and Melinda Gates Foundation (INV002704), the Leukemia and Lymphoma Society Career Development Program and the Stanford Dean's Fellowship (to S.J.), the Stanford Translational Research and Applied Medicine Pilot Grant, and the Thrasher Research Fund Early Career Award and the Stanford Maternal and Child Health Research Institute Clinical (MD) Trainee Support Award Ernest and Amelia Gallo Endowed Postdoctoral Fellowship (to I.T.L.).	Abrial C, 2015, BRIT J PHARMACOL, V172, P4319, DOI 10.1111/bph.13210; Agache I, 2019, J CLIN INVEST, V129, P1493, DOI 10.1172/JCI124611; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bachert C, 2020, J ALLER CL IMM-PRACT, V8, P1514, DOI 10.1016/j.jaip.2020.03.007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bujko M, 2015, ONCOL LETT, V9, P2463, DOI 10.3892/ol.2015.3107; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Charrad M, 2014, J STAT SOFTW, V61, P1; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; DAVIDSSON A, 1993, ORL J OTO-RHINO-LARY, V55, P30, DOI 10.1159/000276349; Delemarre T, 2021, J ALLERGY CLIN IMMUN, V147, P179, DOI 10.1016/j.jaci.2020.08.036; Derycke L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097581; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI [10.4193/Rhino12.000, 10.4193/Rhino50E2]; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Grgic MV, 2015, EUR ARCH OTO-RHINO-L, V272, P3735, DOI 10.1007/s00405-015-3519-7; He HL, 2020, J ALLERGY CLIN IMMUN, V145, P1615, DOI 10.1016/j.jaci.2020.01.042; Islam SA, 2013, J EXP MED, V210, P1889, DOI 10.1084/jem.20130240; Jankowski R, 2002, RHINOLOGY, V40, P173; Kato A, 2015, ALLERGOL INT, V64, P121, DOI 10.1016/j.alit.2014.12.006; Kato Y, 2018, AM J RESP CELL MOL, V59, P448, DOI 10.1165/rcmb.2017-0325OC; Katotomichelakis M, 2013, AM J RHINOL ALLERGY, V27, P354, DOI 10.2500/ajra.2013.27.3922; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Kim SY, 2013, AM J RHINOL ALLERGY, V27, pE166, DOI 10.2500/ajra.2013.27.3959; Kim SJ, 2013, OTOLARYNG HEAD NECK, V149, P431, DOI 10.1177/0194599813495363; Komiya A, 2003, CELL IMMUNOL, V225, P91, DOI 10.1016/j.cellimm.2003.10.001; Li ZP, 2019, J ALLERGY CLIN IMMUN, V144, P1228, DOI 10.1016/j.jaci.2019.06.037; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahdavinia M, 2015, J ALLERGY CLIN IMMUN, V135, P576, DOI 10.1016/j.jaci.2014.08.031; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Nakayama T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19834-9; Nakayama T, 2011, RHINOLOGY, V49, P392, DOI 10.4193/Rhino10.261; Okada N, 2018, INT FORUM ALLERGY RH, V8, P592, DOI 10.1002/alr.22083; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Orlandi RR, 2021, INT FORUM ALLERGY RH, V11, P213, DOI 10.1002/alr.22741; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; Peng Y, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00732-2019; Peterson S, 2012, J ALLERGY CLIN IMMUN, V129, P119, DOI 10.1016/j.jaci.2011.08.021; Plager DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011450; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Seshadri S, 2012, ALLERGY, V67, P920, DOI 10.1111/j.1398-9995.2012.02848.x; Shi LL, 2014, AM J RESP CRIT CARE, V190, P628, DOI 10.1164/rccm.201402-0234OC; Shin SH, 2014, AM J RHINOL ALLERGY, V28, P95, DOI 10.2500/ajra.2014.28.4003; Shinkai A, 1999, J IMMUNOL, V163, P1602; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Soler ZM, 2010, OTOLARYNG HEAD NECK, V142, P64, DOI 10.1016/j.otohns.2009.10.005; Stevens WW, 2019, J ALLER CL IMM-PRACT, V7, P2812, DOI 10.1016/j.jaip.2019.05.009; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Turner JH, 2018, J ALLERGY CLIN IMMUN, V141, P1895, DOI 10.1016/j.jaci.2018.02.002; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; Uguccioni M, 1996, J EXP MED, V183, P2379, DOI 10.1084/jem.183.5.2379; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Vlaminck S, 2014, AM J RHINOL ALLERGY, V28, P260, DOI 10.2500/ajra.2014.28.4024; Wang WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26604; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Wei B, 2018, RHINOLOGY, V56, P216, DOI 10.4193/Rhin17.240; Wei Y, 2014, J ALLERGY CLIN IMMUN, V133, P420, DOI 10.1016/j.jaci.2013.09.052; Wen WP, 2012, J ALLERGY CLIN IMMUN, V129, P1522, DOI 10.1016/j.jaci.2012.01.079; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Yan B, 2019, J ALLERGY CLIN IMMUN, V144, P455, DOI 10.1016/j.jaci.2019.03.026; Yao T, 2009, LARYNGOSCOPE, V119, P1053, DOI 10.1002/lary.20191; Yao Y, 2019, AM J OTOLARYNG, V40, P191, DOI 10.1016/j.amjoto.2018.12.002; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	70	7	7	3	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1296	+		10.1016/j.jaci.2021.11.017	http://dx.doi.org/10.1016/j.jaci.2021.11.017			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3T5RO	34863854				2022-12-18	WOS:000840331500022
J	Park, CW; Kim, BJ; Lee, YW; Won, C; Park, CO; Chung, BY; Lee, DH; Jung, K; Nam, HJ; Choi, G; Park, YH; Kim, KH; Park, M				Park, Chun Wook; Kim, Beom Joon; Lee, Yang Won; Won, Chonghyun; Park, Chang Ook; Chung, Bo Young; Lee, Dong Hun; Jung, Kyoungmi; Nam, Hyun-Jin; Choi, Gyeyoung; Park, Young-Ho; Kim, Kyu Han; Park, Miyoung			Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: Phase 3, randomized, vehicle-controlled study (CAPTAIN-AD)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; asivatrep; transient receptor potential vanilloid subfamily member 1 (TRPV1); pruritus	BARRIER; GUIDELINES; ITCH; INVOLVEMENT; MANAGEMENT; ACTIVATION; PRURITUS	Background: Asivatrep is a potent and selective antagonist of transient receptor potential vanilloid subfamily V member 1 (TRPV1), which plays an important role in itch and inflammation in atopic dermatitis (AD). Objective: This current study aimed to evaluate the efficacy and safety of asivatrep cream in patients with AD. Methods: For this phase 3 double-blind, vehicle-controlled study, patients aged >= 12 years with mild to moderate AD were enrolled and randomly assigned 2:1 to the 1.0% asivatrep or vehicle group for 8 weeks of twice-daily application (n = 240). The primary end point was the proportion of patients with an Investigator's Global Assessment score (IGA) of 0 or 1 at week 8. Standard safety assessments were conducted. Results: At week 8, significantly more patients in the asivatrep group (36.0%) than in the vehicle group (12.8%) had IGA scores of 0 or 1 (P < .001); significantly more had >= 2 points of improvement on the IGA from baseline score (20.3% vs 7.7%; P = .01). The mean percentage reduction in the Eczema Area and Severity Index (EASI) score was 44.3% for the asivatrep group and 21.4% for the vehicle group at week 8 (P <.001). Significantly more asivatrep-treated patients experienced an improvement of at least 50%, 75%, and 90% on the EASI than the vehicle group. The mean +/- SD change in the pruritus visual analog scale score at week 8 was -2.3 +/- 2.4 for the asivatrep group and 21.5 +/- 2.4 for the vehicle group (P = .02). No significant safety issues were reported. Conclusion: Asivatrep improved clinical signs and symptoms of AD and was well tolerated.	[Park, Chun Wook; Chung, Bo Young] Hallym Univ, Coll Med, Dept Dermatol, Kangnam Sacred Heart Hosp, Chunchon, South Korea; [Kim, Beom Joon] Chung Ang Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Lee, Yang Won] Konkuk Univ, Sch Med, Dept Dermatol, Seoul, South Korea; [Won, Chonghyun] Ulsan Univ, Dept Dermatol, Sch Med, Ulsan, South Korea; [Park, Chang Ook] Yonsei Univ, Dept Dermatol, Coll Med, Seoul, South Korea; [Park, Chang Ook] Yonsei Univ, Cutaneous Biol Res Inst, Coll Med, Seoul, South Korea; [Lee, Dong Hun; Kim, Kyu Han] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Dermatol, Coll Med, Seoul, South Korea; [Jung, Kyoungmi; Nam, Hyun-Jin; Choi, Gyeyoung; Park, Young-Ho; Park, Miyoung] AMOREPACIF R&D Ctr, Yongin, South Korea	Hallym University; Chung Ang University; Chung Ang University Hospital; Konkuk University; Konkuk University Medical Center; University of Ulsan; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University Hospital	Park, M (corresponding author), AMOREPACIF R&D Ctr, Healthcare Res Div, 1920 Yonggu Daero, Yongin 17074, South Korea.; Kim, KH (corresponding author), Seoul Natl Univ Hosp, Dept Dermatol, 101 Daehak Ro, Seoul 01080, South Korea.	kyuhkim@snu.ac.kr; mpark0315@gmail.com		Park, Chang Ook/0000-0003-3856-1201	AMOREPACIFIC RD Center	AMOREPACIFIC RD Center	This study was funded by AMOREPACIFIC R&D Center. The funders contributed to the conception and design of the study; the collection, analysis, and interpretation of the data; the drafting and critical revision of the report; and provided approval for submission.	Aubdool AA, 2011, J INVEST DERM SYMP P, V15, P33, DOI 10.1038/jidsymp.2011.8; Bartolucci S, 2019, J CUTAN MED SURG, V23, P551, DOI 10.1177/1203475419860501; Brunner PM, 2018, ANN ALLERG ASTHMA IM, V120, P34, DOI 10.1016/j.anai.2017.09.055; Brunner PM, 2017, J ALLERGY CLIN IMMUN, V139, pS65, DOI 10.1016/j.jaci.2017.01.011; Caterina MJ, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040077; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Choi JK, 2020, REGUL TOXICOL PHARM, V112, DOI 10.1016/j.yrtph.2020.104613; Czarnowicki T, 2017, J ALLERGY CLIN IMMUN, V139, P1723, DOI 10.1016/j.jaci.2017.04.004; Dainichi T, 2018, NAT IMMUNOL, V19, P1286, DOI 10.1038/s41590-018-0256-2; Egawa G, 2016, J ALLERGY CLIN IMMUN, V138, P350, DOI 10.1016/j.jaci.2016.06.002; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Hutter MM, 2005, PANCREAS, V30, P260, DOI 10.1097/01.mpa.0000153616.63384.24; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kittaka H, 2017, ALLERGOL INT, V66, P22, DOI 10.1016/j.alit.2016.10.003; Lee JH, 2018, J DERMATOL SCI, V91, P184, DOI 10.1016/j.jdermsci.2018.04.017; Lee YW, 2019, BRIT J DERMATOL, V180, P1030, DOI 10.1111/bjd.17455; Mollanazar NK, 2016, CLIN REV ALLERG IMMU, V51, P263, DOI 10.1007/s12016-015-8488-5; Park M, 2018, CELL BIOL TOXICOL, V34, P143, DOI 10.1007/s10565-017-9407-8; Perner C, 2020, IMMUNITY, V53, P1063, DOI 10.1016/j.immuni.2020.10.001; Saeki H, 2016, J DERMATOL, V43, P1117, DOI 10.1111/1346-8138.13392; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Song PI, 2019, BRIT J DERMATOL, V180, P971, DOI 10.1111/bjd.17777; Stander S, 2004, EXP DERMATOL, V13, P129, DOI 10.1111/j.0906-6705.2004.0178.x; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P657, DOI 10.1111/jdv.14891; Woo Taylor Evart, 2019, Skin Therapy Lett, V24, P4; Yun JW, 2011, J DERMATOL SCI, V62, P8, DOI 10.1016/j.jdermsci.2010.10.014	29	7	7	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1340	+		10.1016/j.jaci.2021.09.024	http://dx.doi.org/10.1016/j.jaci.2021.09.024			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	2R0DI	34606832	hybrid			2022-12-18	WOS:000820784100001
J	Shimizu, K; Tanabe, N; Oguma, A; Kimura, H; Suzuki, M; Yokota, I; Makita, H; Sato, S; Hirai, T; Nishimura, M; Konno, S				Shimizu, Kaoruko; Tanabe, Naoya; Oguma, Akira; Kimura, Hirokazu; Suzuki, Masaru; Yokota, Isao; Makita, Hironi; Sato, Susumu; Hirai, Toyohiro; Nishimura, Masaharu; Konno, Satoshi		Hi-CARAT Investigators	Parenchymal destruction in asthma: Fixed airflow obstruction and lung function trajectory	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; computed tomography; fractal; low-attenuation area; nonsmokers; parenchyma	COMPUTED-TOMOGRAPHY; PULMONARY-DISEASE; FUNCTION DECLINE; EMPHYSEMA; SMOKERS; DIMENSIONS; COMPLEXITY; DENSITY; IMPACT; RISK	Background: Fixed airflow obstruction (FAO) in asthma, particularly in nonsmokers, is generally believed to be caused by airway remodeling. However, parenchymal destruction may also contribute to FAO and longitudinal decline in forced expiratory volume in 1 second (FEV1). Objectives: To evaluate parenchymal destruction, we used emphysema indices, exponent D, and low-attenuation area percentage (LAA%) on computed tomography (CT), and test whether the parenchymal destruction and airway disease are independently associated with FAO and FEV1 decline in both smoking and nonsmoking asthma. Methods: Exponent D, LAA%, wall area percentage at segmental airways, and airway fractal dimension (AFD) in those with asthma were measured on inspiratory CT and compared to those in patients with chronic obstructive pulmonary disease (COPD). Results: Exponent D was lower and LAA% was higher in COPD (n = 42) and asthma with FAO (n = 101) than in asthma without FAO (n = 88). The decreased exponent D and increased LAA% were associated with FAO regardless of smoking status or asthma severity. In multivariable analysis, decreased exponent D and increased LAA% were associated with an increased odds ratio of FAO and decreased FEV1, irrespective of wall area percentage and airway fractal dimension. Moreover, decreased exponent D affected the longitudinal decline in FEV1 in those with severe asthma, independent of smoking status. Conclusions: Patients with asthma with FAO showed parenchymal destruction regardless of smoking status and asthma severity. Parenchymal destruction was associated with an accelerated FEV1 decline, suggesting the involvements of both airway and parenchyma in the pathophysiology of a subgroup of asthma.	[Shimizu, Kaoruko; Oguma, Akira; Kimura, Hirokazu; Suzuki, Masaru; Makita, Hironi; Nishimura, Masaharu; Konno, Satoshi] Hokkaido Univ, Fac Med, Dept Resp Med, Sapporo, Hokkaido, Japan; [Tanabe, Naoya; Sato, Susumu; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Yokota, Isao] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan; [Makita, Hironi; Nishimura, Masaharu] Hokkaido Inst Resp Dis, Sapporo, Hokkaido, Japan	Hokkaido University; Kyoto University; Hokkaido University	Shimizu, K (corresponding author), Hokkaido Univ, Fac Med, Dept Resp Med, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	okaoru@med.hokudai.ac.jp	Yokota, Isao/AAB-2910-2021; Suzuki, Masaru/H-2087-2012; shimizu, kaoruko/G-1947-2012	Yokota, Isao/0000-0001-6254-2225; Suzuki, Masaru/0000-0002-2124-6793; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24249049, 26461151]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Hokkaido-based Investigative Cohort Analysis for Refractory Asthma (Hi-CARAT) study is supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24249049 to M.N., 26461151 to S.K.).	[Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; Apostol GG, 2002, AM J RESP CRIT CARE, V166, P166, DOI 10.1164/rccm.2007035; Bhatt SP, 2017, AM J RESP CRIT CARE, V196, P569, DOI 10.1164/rccm.201701-0050OC; Bhatt SP, 2016, ACAD RADIOL, V23, P1255, DOI 10.1016/j.acra.2016.02.002; Biernacki W, 1997, EUR RESPIR J, V10, P2455, DOI 10.1183/09031936.97.10112455; Bodduluri S, 2018, J CLIN INVEST, V128, P5374, DOI 10.1172/JCI120693; Bodduluri S, 2017, AM J RESP CRIT CARE, V196, P1404, DOI 10.1164/rccm.201705-0855OC; Diaz Alejandro A, 2014, Ann Am Thorac Soc, V11, P1371, DOI 10.1513/AnnalsATS.201403-095OC; Gelb AF, 2015, CHEST, V148, P313, DOI 10.1378/chest.14-2483; Global Initiative for Asthma (GINA), 2021 GINA REP GLOB S; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; Hancox RJ, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02536-2017; Hastie AT, 2021, AM J RESP CRIT CARE, V203, P882, DOI 10.1164/rccm.202009-3713OC; Kimura H, 2017, ANN AM THORAC SOC, V14, P332, DOI 10.1513/AnnalsATS.201606-463OC; Krings JG, 2021, J ALLERGY CLIN IMMUN, V148, P752, DOI 10.1016/j.jaci.2021.01.029; Mauad T, 2004, AM J RESP CRIT CARE, V170, P857, DOI 10.1164/rccm.200403-305OC; Mauad T, 2007, J ALLERGY CLIN IMMUN, V120, P997, DOI 10.1016/j.jaci.2007.06.031; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Mitsunobu F, 2003, AM J RESP CRIT CARE, V167, P411, DOI 10.1164/rccm.2112070; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Newby C, 2014, J ALLERGY CLIN IMMUN, V134, P287, DOI 10.1016/j.jaci.2014.04.005; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Oguma T, 2015, THORAX, V70, P719, DOI 10.1136/thoraxjnl-2014-206651; Postma DS, 2019, LANCET RESP MED, V7, P402, DOI 10.1016/S2213-2600(19)30049-9; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Semprini R, 2018, J ALLER CL IMM-PRACT, V6, P1982, DOI 10.1016/j.jaip.2018.03.004; Shimizu K, 2020, THORAX, V75, P116, DOI 10.1136/thoraxjnl-2019-213525; Shimizu K, 2018, J APPL PHYSIOL, V125, P183, DOI 10.1152/japplphysiol.01062.2017; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Suzuki M, 2016, AM J RESP CRIT CARE, V194, P1358, DOI 10.1164/rccm.201602-0353OC; Tanabe N, 2021, J THORAC IMAG, V36, P224, DOI 10.1097/RTI.0000000000000568; Tanabe N, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.603197; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Tonga KO, 2020, RESPIROLOGY, V25, P613, DOI 10.1111/resp.13688; Tuder RM, 2018, ANN AM THORAC SOC, V15, pS227, DOI 10.1513/AnnalsATS.201808-583MG; Yuan R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-153	37	7	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					934	+		10.1016/j.jaci.2021.07.042	http://dx.doi.org/10.1016/j.jaci.2021.07.042			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34437923				2022-12-18	WOS:000765938100023
J	Maurer, M; Aygoren-Pursun, E; Banerji, A; Bernstein, JA; Boysen, HB; Busse, PJ; Bygum, A; Caballero, T; Castaldo, AJ; Christiansen, SC; Craig, T; Farkas, H; Grumach, AS; Hide, M; Katelaris, CH; Li, HH; Longhurst, H; Lumry, WR; Magerl, M; Martinez-Saguer, I; Riedl, MA; Zhi, YX; Zuraw, B				Maurer, Marcus; Aygoren-Pursun, Emel; Banerji, Aleena; Bernstein, Jonathan A.; Boysen, Henrik Balle; Busse, Paula J.; Bygum, Anette; Caballero, Teresa; Castaldo, Anthony J.; Christiansen, Sandra C.; Craig, Timothy; Farkas, Henriette; Grumach, Anete S.; Hide, Michihiro; Katelaris, Constance H.; Li, H. Henry; Longhurst, Hilary; Lumry, William R.; Magerl, Markus; Martinez-Saguer, Inmaculada; Riedl, Marc A.; Zhi, Yuxiang; Zuraw, Bruce			Consensus on treatment goals in hereditary angioedema: A global Delphi initiative	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hereditary angioedema; C1-INH deficiency; treatment goals; quality of life; acute treatment; prophylaxis	TRANEXAMIC ACID; VALIDATION; ATTACKS; LANADELUMAB; PREVENTION; MANAGEMENT; THERAPIES; C1-INH	Background: Hereditary angioedema (HAE) is a rare, life-threatening genetic disorder characterized by recurrent episodes of subcutaneous or submucosal angioedema. The ultimate goals of treatment for HAE remain ill-defined. Objectives: The aim of this Delphi process was to define the goals of HAE treatment and to examine which factors should be considered when assessing disease control and normalization of the patient's life. Methods: The Delphi panel comprised 23 participants who were selected based on involvement with scientific research on HAE or coauthorship of the most recent update and revision of the World Allergy Organization/European Academy of Allergy and Clinical Immunology guideline on HAE. The process comprised 3 rounds of voting. The final round aimed to aggregate the opinions of the expert panel and to achieve consensus. Results: Two direct consensus questions were posed in round 2, based on the responses received in round 1, and the panel agreed that the goals of treatment are to achieve total control of the disease and to normalize the patient's life. For the third round of voting, 21 statements were considered, with the participants reaching consensus on 18. It is clear from the wide-ranging consensus statements that the burdens of disease and treatment should be considered when assessing disease control and normalization of patients' lives. Conclusions: The ultimate goal for HAE treatment is to achieve no angioedema attacks. The availability of improved treatments and disease management over the last decade now makes complete control of HAE a realistic possibility for most patients. (J Allergy Clin Immunol 2021;148:1526-32.)	[Maurer, Marcus; Magerl, Markus] Charite Univ Med Berlin, Angioedema Ctr Reference & Excellence Dermatol Al, Allergie Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany; [Aygoren-Pursun, Emel] Univ Hosp Frankfurt, Dept Children & Adolescents, Frankfurt, Germany; [Banerji, Aleena] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Bernstein, Jonathan A.] Univ Cincinnati, Dept Med, Div Immunol, Allergy Sect, Cincinnati, OH USA; [Boysen, Henrik Balle] HAE Hereditary Angioedema Int HAEi, Horsens, Denmark; [Busse, Paula J.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Bygum, Anette] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Bygum, Anette] Univ Southern Denmark, Clin Inst, Odense, Denmark; [Caballero, Teresa] Hosp Univ La Paz, Hosp La Paz Inst Hlth Res, Ctr Biomed Network Res Rare Dis, Allergy Dept, Madrid, Spain; [Castaldo, Anthony J.] US HAE Assoc, Fairfax, VA USA; [Christiansen, Sandra C.; Riedl, Marc A.; Zuraw, Bruce] Univ Calif San Diego, Dept Med, US HAE Assoc Angioedema Ctr, La Jolla, CA 92093 USA; [Craig, Timothy] Penn State Univ, Dept Med Pediat & Grad Studies, Hershey, PA USA; [Farkas, Henriette] Semmelweis Univ, Hungarian Angioedema Ctr Reference & Excellence, Dept Internal Med & Haematol, Budapest, Hungary; [Grumach, Anete S.] Ctr Univ Saude ABC, Fac Med, Dept Clin Immunol, Santo Andre, SP, Brazil; [Hide, Michihiro] Hiroshima Univ, Dept Dermatol, Hiroshima, Japan; [Katelaris, Constance H.] Campbelltown Hosp, Dept Med, Campbelltown, NSW, Australia; [Katelaris, Constance H.] Western Sydney Univ, Campbelltown, NSW, Australia; [Li, H. Henry] Inst Asthma & Allergy, Chevy Chase, MD USA; [Longhurst, Hilary] Auckland City Hosp, Auckland, New Zealand; [Longhurst, Hilary] Univ Coll Hosp, Dept Immunol, London, England; [Lumry, William R.] Univ Texas Dallas, Southwestern Med Sch, Dept Internal Med, Allergy Immunol Div, Richardson, TX 75083 USA; [Lumry, William R.] Allergy & Asthma Res Assoc Res Ctr, Dallas, TX USA; [Martinez-Saguer, Inmaculada] Hemophilia Ctr Rhine Main, Morfelden Walldorf, Germany; [Zhi, Yuxiang] Peking Union Med Coll Hosp & Chinese Acad Med Sci, Natl Clin Res Ctr Immunol Dis, Dept Allergy & Clin Immunol, Beijing, Peoples R China; [Zuraw, Bruce] San Diego Vet Affairs Healthcare, San Diego, CA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Semmelweis University; Hiroshima University; University of Sydney; Western Sydney University; Auckland City Hospital; University of London; University College London; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Maurer, M (corresponding author), Charite Univ Med Berlin, Angioedema Ctr Reference & Excellence Dermatol Al, Allergie Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany.	marcus.maurer@charite.de	Magerl, Markus/ABI-5335-2020; Maurer, Marcus/ABG-2174-2020	Magerl, Markus/0000-0001-9218-5468; Maurer, Marcus/0000-0002-4121-481X; Bygum, Anette/0000-0002-3004-0180	Global Allergy and Asthma European Network (GA2 LEN) - Takeda Pharmaceuticals International [IIR-DEU002394]	Global Allergy and Asthma European Network (GA2 LEN) - Takeda Pharmaceuticals International	This consensus was supported and facilitated by the Global Allergy and Asthma European Network (GA2 LEN), which received an Investigator-initiated research grant (IIR-DEU002394) from Takeda Pharmaceuticals International. The funding body had no input into the development of the voting statements, the analysis or interpretation of the results, or the decision to submit the manuscript for publication.	Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; Banerji A, 2017, ANN ALLERG ASTHMA IM, V119, pS5; Banerji A, 2015, ALLERGY ASTHMA PROC, V36, P213, DOI 10.2500/aap.2015.36.3824; Betschel S, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0376-8; Blaiss MS, 2019, ANN ALLERG ASTHMA IM, V122, P463, DOI 10.1016/j.anai.2018.08.019; BLOHME G, 1972, ACTA MED SCAND, V192, P293; Bork K, 2017, ALLERGY, V72, P320, DOI 10.1111/all.13076; Bork K, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01570-x; Bork K, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-1334-8; Bork K, 2012, J ALLERGY CLIN IMMUN, V130, P692, DOI 10.1016/j.jaci.2012.05.055; Burnette AF, 2021, INT FORUM ALLERGY RH, V11, P965, DOI 10.1002/alr.22764; Busse PJ, 2020, NEW ENGL J MED, V382, P1136, DOI 10.1056/NEJMra1808012; Busse PJ, 2019, J ALLER CL IMM-PRACT, V7, P1679, DOI 10.1016/j.jaip.2018.11.042; Bygum A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00212; Caballero T, 2017, IMMUNOL ALLERGY CLIN, V37, P597, DOI 10.1016/j.iac.2017.04.005; Chen M, 2017, IMMUNOL ALLERGY CLIN, V37, P585, DOI 10.1016/j.iac.2017.03.003; Craig T, 2019, J ALLER CL IMM-PRACT, V7, P1793, DOI 10.1016/j.jaip.2019.01.054; Craig T, 2018, ANN ALLERG ASTHMA IM, V121, P673, DOI 10.1016/j.anai.2018.07.025; DALKEY N, 1969, FUTURES, V1, P408, DOI 10.1016/S0016-3287(69)80025-X; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Elwyn G, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0480-9; Farkas H, 2019, EXPERT OPIN THER TAR, V23, P457, DOI 10.1080/14728222.2019.1608949; Horiuchi T, 2018, J CUTAN IMMUNOL ALL, V1, DOI 10.1002/cia2.12029; Jindal NL, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-016-0176-3; Joao Forjaz M, 2020, J INVESTIG ALLERGOL; Kulthanan K, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9157895; Longhurst H, 2017, NEW ENGL J MED, V376, P1131, DOI 10.1056/NEJMoa1613627; Magerl M, 2017, IMMUNOL ALLERGY CLIN, V37, P571, DOI 10.1016/j.iac.2017.04.004; Maurer M, 2018, ALLERGY, V73, P1575, DOI 10.1111/all.13384; Prior N, 2016, J ALLER CL IMM-PRACT, V4, P464, DOI 10.1016/j.jaip.2015.12.010; Prior N, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-82; Riedl M, 2019, ANN ALLERG ASTHMA IM, V123, pS30, DOI 10.1016/j.anai.2019.08.263; SHEFFER AL, 1972, NEW ENGL J MED, V287, P452, DOI 10.1056/NEJM197208312870907; Valerieva A, 2020, J ALLER CL IMM-PRACT, V8, P799, DOI 10.1016/j.jaip.2019.08.011; Weller K, 2016, ALLERGY, V71, P1203, DOI 10.1111/all.12900; Weller K, 2013, ALLERGY, V68, P1185, DOI 10.1111/all.12209; Weller K, 2012, ALLERGY, V67, P1289, DOI 10.1111/all.12007; Weller K, 2020, J ALLER CL IMM-PRACT, V8, P2050, DOI 10.1016/j.jaip.2020.02.038; Weller K, 2020, ALLERGY, V75, P1165, DOI 10.1111/all.14144; Zuraw BL, 2013, J ALLER CL IMM-PRACT, V1, P458, DOI 10.1016/j.jaip.2013.07.002	40	7	7	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1526	1532		10.1016/j.jaci.2021.05.016	http://dx.doi.org/10.1016/j.jaci.2021.05.016		DEC 2021	7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM7UO	34048855	Green Published, hybrid			2022-12-18	WOS:000729027300001
J	Bryant-Stephens, TC; Strane, D; Robinson, EK; Bhambhani, S; Kenyon, CC				Bryant-Stephens, Tyra C.; Strane, Douglas; Robinson, Elizabeth K.; Bhambhani, Sanya; Kenyon, Chen C.			Housing and asthma disparities	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; housing; disparities; structural racism; social determinants of health	ENVIRONMENTAL INTERVENTION; COCKROACH ALLERGEN; CHILDREN; HOME; MORBIDITY; HEALTH; SENSITIZATION; ASSOCIATION; EXPOSURES; OUTCOMES	The burden of asthma disproportionately affects minority and low-income communities, resulting in racial and socioeconomic disparities in asthma prevalence, asthma exacerbations, and asthma-related death. Social determinants of health are increasingly implicated as root causes of disparities, and healthy housing is perhaps the most critical social determinant in asthma health disparities. In many minority communities, poor housing conditions and value are a legacy of historical policies and practices imbued with structural racism, including redlining, displacement, and exclusionary zoning. As a result, poor-quality, substandard housing is a characteristic feature of many underrepresented minority communities. Consequently, structurally deficient housing stock cultivates home environments rife with indoor asthma triggers. In this review we consider the historical context of urban housing policies and practices and how these policies and practices have contributed to the substandard housing conditions for many minoritized children in the present day. We describe the impact of poor housing quality on asthma and interventions that have attempted to mitigate its influence on asthma symptoms and health care utilization. We discuss the need to promote asthma health equity by reinvesting in these neighborhoods and communities to provide healthy housing. (J Allergy Clin Immunol 2021;148:1 121-9.)	[Bryant-Stephens, Tyra C.; Strane, Douglas; Robinson, Elizabeth K.; Bhambhani, Sanya; Kenyon, Chen C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bryant-Stephens, Tyra C.; Kenyon, Chen C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Bryant-Stephens, TC (corresponding author), CHOP Roberts Bldg,2716 South St, Philadelphia, PA 19146 USA.	stephenst@chop.edu			BUILD Health Challenge 2.0, Children's Hospital of Philadelphia (CHOP) matching funds; CHOP PolicyLab, National Institutes of Health [K23HL136842, U01HL138687]; Pennsylvania Department of Health [9239140621]	BUILD Health Challenge 2.0, Children's Hospital of Philadelphia (CHOP) matching funds; CHOP PolicyLab, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health	Supported by the BUILD Health Challenge 2.0, Children's Hospital of Philadelphia (CHOP) matching funds, CHOP PolicyLab, National Institutes of Health (grant K23HL136842 [to C.C.K.] and grant U01HL138687 [to T.C.B-S.]), and the Pennsylvania Department of Health (grant 9239140621).	Akinbami LJ, 2014, J ALLERGY CLIN IMMUN, V134, P547, DOI 10.1016/j.jaci.2014.05.037; [Anonymous], 2021, US CTR DIS CONTR PRE; Blake K, 2007, MEASURING OVERCROWDI; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Carr J.H., 2008, SEGREGATION RISING C; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; Crocker DD, 2011, AM J PREV MED, V41, pS5, DOI [10.1016/j.amepre.2011.04.011, 10.1016/j.amepre.2011.05.012]; Desmond M, 2018, INT J URBAN REGIONAL, V42, P160, DOI 10.1111/1468-2427.12529; Elliott L, 2007, ENVIRON HEALTH PERSP, V115, P215, DOI 10.1289/ehp.9412; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Grineski SE, 2010, LOCAL ENVIRON, V15, P199, DOI 10.1080/13549830903575562; Gruber KJ, 2016, ANN ALLERG ASTHMA IM, V116, P408, DOI 10.1016/j.anai.2016.03.025; Gupta RS, 2006, J ALLERGY CLIN IMMUN, V117, P351, DOI 10.1016/j.jaci.2005.11.047; Hirt S, 2015, PLAN PERSPECT, V30, P367, DOI 10.1080/02665433.2014.985602; Howden-Chapman P, 2007, BMJ-BRIT MED J, V334, P460, DOI 10.1136/bmj.39070.573032.80; Howden-Chapman P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1411; Institute of Medicine, 2000, CLEAR AIR ASTHM IND, P105; Institute of Medicine (US) Committee on the Assessment of Asthma and Indoor Air, 2000, CLEAR AIR ASTHM IND; Kercsmar CM, 2006, ENVIRON HEALTH PERSP, V114, P1574, DOI 10.1289/ehp.8742; Leas BF, 2018, J ALLERGY CLIN IMMUN, V141, P1854, DOI 10.1016/j.jaci.2018.02.001; Massey D, 1993, AM APARTHEID; Matsui EC, 2014, ALLERGY, V69, P553, DOI 10.1111/all.12361; Matsui EC, 2006, ANN ALLERG ASTHMA IM, V97, P514, DOI 10.1016/S1081-1206(10)60943-X; Matsui EC, 2017, JAMA-J AM MED ASSOC, V317, P1027, DOI 10.1001/jama.2016.21048; McGovern L, 2014, RELATIVE CONTRIBUTIO, DOI [10.1377/hpb20140821.404487/full/, DOI 10.1377/HPB20140821.404487/FULL]; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Northridge J, 2010, J URBAN HEALTH, V87, P211, DOI 10.1007/s11524-009-9404-1; Nurmagambetov TA, 2011, AM J PREV MED, V41, pS33, DOI 10.1016/j.amepre.2011.05.011; Perzanowski MS, 2013, J ALLERGY CLIN IMMUN, V131, P886, DOI 10.1016/j.jaci.2012.12.666; Peters JL, 2007, J URBAN HEALTH, V84, P185, DOI 10.1007/s11524-006-9146-2; Phipatanakul W, 2004, ANN ALLERG ASTHMA IM, V92, P420, DOI 10.1016/S1081-1206(10)61777-2; Poowuttikul P, 2019, CLIN REV ALLERG IMMU, V56, P248, DOI 10.1007/s12016-019-08728-x; Rauh VA, 2008, ANN NY ACAD SCI, V1136, P276, DOI 10.1196/annals.1425.032; Reponen T, 2012, J ALLERGY CLIN IMMUN, V130, P639, DOI 10.1016/j.jaci.2012.05.030; Rodems R, 2020, CHILD YOUTH SERV REV, V112, DOI 10.1016/j.childyouth.2020.104767; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Rothstein R., 2017, COLOR LAW FORGOTTEN; SCHWARTZ J, 1990, AM REV RESPIR DIS, V142, P555, DOI 10.1164/ajrccm/142.3.555; Somerville M, 2000, PUBLIC HEALTH, V114, P434, DOI 10.1038/sj.ph.1900687; Swope CB, 2019, SOC SCI MED, V243, DOI 10.1016/j.socscimed.2019.112571; Takaro TK, 2011, AM J PUBLIC HEALTH, V101, P55, DOI 10.2105/AJPH.2010.300008; Turcotte DA, 2014, AM J PUBLIC HEALTH, V104, P665, DOI 10.2105/AJPH.2013.301695; Ulrich L, 2021, PEDIATR PULM, V56, P1951, DOI 10.1002/ppul.25406; Wang J, 2009, CLIN EXP ALLERGY, V39, P1381, DOI 10.1111/j.1365-2222.2009.03225.x; Wilson JM, 2018, J ALLER CL IMM-PRACT, V6, P1, DOI 10.1016/j.jaip.2017.10.003; Wilson J, 2010, ENVIRON RES, V110, P189, DOI 10.1016/j.envres.2009.10.007; Woodfine L, 2011, BRIT J GEN PRACT, V61, P674, DOI 10.3399/bjgp11X606636; Woods LL, 2014, HEALTH PROMOT PRACT, V15, P476, DOI 10.1177/1524839914533568	48	7	7	3	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1121	1129		10.1016/j.jaci.2021.09.023	http://dx.doi.org/10.1016/j.jaci.2021.09.023		NOV 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	WV7LX	34599980				2022-12-18	WOS:000717415000004
J	Croce, EA; Levy, ML; Adamson, AS; Matsui, EC				Croce, Emily A.; Levy, Moise L.; Adamson, Adewole S.; Matsui, Elizabeth C.			Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Atopic dermatitis; eczema; disparities; race; ethnicity; racism; social determinants of health	STRUCTURAL RACISM; ECZEMA PREVALENCE; HEALTH INEQUITIES; CHILDHOOD ECZEMA; SKIN PROPERTIES; AIR-POLLUTION; UNITED-STATES; EXPOSURE; CHILDREN; ASSOCIATIONS	Black people in the United States experience greater atopic dermatitis (AD) prevalence, severity, and persistence when compared with White people. Although very little published literature describes AD in the Latinx population, additional differences in severity, persistence, and age of onset exist in contrast to White people. Thus far, genetic polymorphisms associated with increased risk and/or severity of AD are less common among Black people, so should confer reduced, rather than the observed increased, AD risk among Black people. Little is known regarding genetic risk factors in Latinx people. In contrast, there is consistent evidence that socioeconomic, environmental, and health care factors influence AD prevalence, severity, and/or persistence, and these same risk factors are more common among racial and ethnic minority populations as a result of racism. Researchers too often pursue genetic explanations for racial and ethnic AD disparities when the evidence points to the importance of contextual, rather than genetic, causes of these disparities. Reframing the prevailing view that innate differences among racial and ethnic groups are responsible for these disparities by emphasizing the role of racism and its downstream effects on contextual factors will be a critical first step toward shrinking these disparities.	[Croce, Emily A.] Univ Texas Austin, Sch Nursing, Austin, TX USA; [Croce, Emily A.; Levy, Moise L.; Matsui, Elizabeth C.] Dell Childrens Med Grp, Austin, TX USA; [Levy, Moise L.; Adamson, Adewole S.; Matsui, Elizabeth C.] Univ Texas Austin, Dell Med Sch, 1601 Trinity St,Bldg B, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Matsui, EC (corresponding author), Univ Texas Austin, Dell Med Sch, 1601 Trinity St,Bldg B, Austin, TX 78712 USA.	elizabeth.matsui@austin.utexas.edu			National Institute of Nursing Research of the National Institutes of Health [T32NR019035]; Pfizer Dermatology Research Fellowship; Dermatology Foundation; National Institutes of Health [UL1 TR002645, K24AI114769, R01ES023447, R01ES026170]; American Cancer Society; Robert Wood Johnson Foundation	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Pfizer Dermatology Research Fellowship; Dermatology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	E.C. is supported by the National Institute of Nursing Research of the National Institutes of Health (grant no. T32NR019035) and a Pfizer Dermatology Research Fellowship. A.S.A. is supported by the Dermatology Foundation, the National Institutes of Health (grant no. UL1 TR002645), the American Cancer Society, and the RobertWood Johnson Foundation. E.C.M. is supported by the National Institutes of Health (grant nos. K24AI114769, R01ES023447, and R01ES026170). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abuabara K, 2020, J ALLERGY CLIN IMMUN, V145, P192, DOI 10.1016/j.jaci.2019.06.044; Ahluwalia SK, 2013, J ALLERGY CLIN IMMUN, V132, P830, DOI 10.1016/j.jaci.2013.05.005; Ahluwalia SK, 2011, CURR OPIN ALLERGY CL, V11, P137, DOI 10.1097/ACI.0b013e3283445921; Alexis A, 2014, SKIN COLOR PRACTICAL; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Barilla S, 2017, ADV EXP MED BIOL, V1027, P71, DOI 10.1007/978-3-319-64804-0_7; Bonham VL, 2018, JAMA-J AM MED ASSOC, V320, P1533, DOI 10.1001/jama.2018.13609; Boothe WD, 2017, ADV EXP MED BIOL, V1027, P21, DOI 10.1007/978-3-319-64804-0_3; Briscoe CC, 2019, PEDIATR DERMATOL, V36, P482, DOI 10.1111/pde.13867; Brunner PM, 2019, ANN ALLERG ASTHMA IM, V122, P449, DOI 10.1016/j.anai.2018.11.015; Bufford JD, 2007, CURR ALLERGY ASTHM R, V7, P375, DOI 10.1007/s11882-007-0057-4; Chung J, 2019, ANN ALLERG ASTHMA IM, V122, P360, DOI 10.1016/j.anai.2018.12.017; Clark LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094431; Dave ND, 2011, IMMUNOL ALLERGY CLIN, V31, P55, DOI 10.1016/j.iac.2010.09.009; Davis MF, 2018, J ALLERGY CLIN IMMUN, V141, P402, DOI 10.1016/j.jaci.2017.06.031; Daya M, 2019, ANN ALLERG ASTHMA IM, V122, P456, DOI 10.1016/j.anai.2019.02.009; Dey T, 2021, CHEM RES TOXICOL, V34, P669, DOI 10.1021/acs.chemrestox.0c00432; Di Q, 2017, NEW ENGL J MED, V376, P2513, DOI 10.1056/NEJMoa1702747; Diao JA, 2022, J AM ACAD DERMATOL, V86, P950, DOI 10.1016/j.jaad.2021.03.088; Dougherty GB, 2020, AM J PREV MED, V59, P530, DOI 10.1016/j.amepre.2020.05.019; Drislane C, 2020, ANN ALLERG ASTHMA IM, V124, P36, DOI 10.1016/j.anai.2019.10.008; du Plessis J, 2013, SKIN RES TECHNOL, V19, P265, DOI 10.1111/srt.12037; Fadadu RP, 2021, JAMA DERMATOL, V157, P658, DOI 10.1001/jamadermatol.2021.0179; Fischer AH, 2017, J AM ACAD DERMATOL, V77, P1060, DOI 10.1016/j.jaad.2017.08.035; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Gupta J, 2008, J ALLERGY CLIN IMMUN, V121, P725, DOI 10.1016/j.jaci.2007.12.1161; Gupta J, 2016, J ALLERGY CLIN IMMUN, V138, P676, DOI 10.1016/j.jaci.2016.02.045; Horii KA, 2007, PEDIATRICS, V120, pE527, DOI 10.1542/peds.2007-0289; Jackson-Cowan L, 2021, ANN ALLERG ASTHMA IM, V126, P661, DOI 10.1016/j.anai.2020.11.008; Kantor R, 2017, EXPERT REV CLIN IMMU, V13, P15, DOI 10.1080/1744666X.2016.1212660; Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538; Kaufman BP, 2018, EXP DERMATOL, V27, P340, DOI 10.1111/exd.13514; Kelly APTS, 2015, TAYLOR KELLYS DERMAT, V2nd; Kim HJ, 2015, CLIN IMMUNOL, V161, P384, DOI 10.1016/j.clim.2015.07.007; Kim Y, 2019, J INVEST DERMATOL, V139, P827, DOI 10.1016/j.jid.2018.10.029; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Kumar R, 2020, J ALLERGY CLIN IMMUN, V145, P108, DOI 10.1016/j.jaci.2019.11.008; Landor AM, 2013, J FAM PSYCHOL, V27, P817, DOI 10.1037/a0033883; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; Lee E, 2020, J PEDIAT-BRAZIL, V96, P125, DOI 10.1016/j.jped.2018.07.012; Leung DYM, 2019, ANN ALLERG ASTHMA IM, V122, P1, DOI 10.1016/j.anai.2018.09.454; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Levin ME, 2020, J ALLERGY CLIN IMMUN, V145, P415, DOI 10.1016/j.jaci.2019.07.048; Liang YS, 2016, CLIN REV ALLERG IMMU, V51, P315, DOI 10.1007/s12016-015-8508-5; Liu LF, 2019, ARTIF CELL NANOMED B, V47, P3540, DOI 10.1080/21691401.2019.1640709; Malina D, 2021, NEW ENGL J MED, V384, P1861, DOI 10.1056/NEJMms2035717; Margolis DJ, 2014, J ALLERGY CLIN IMMUN, V133, P784, DOI 10.1016/j.jaci.2013.09.015; Margolis DJ, 2012, J ALLERGY CLIN IMMUN, V130, P912, DOI 10.1016/j.jaci.2012.07.008; Mathyer ME, 2018, EXP DERMATOL, V27, P989, DOI 10.1111/exd.13691; Matsui EC, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-018572; Matsui EC, 2019, J ALLERGY CLIN IMMUN, V143, P2024, DOI 10.1016/j.jaci.2019.03.015; Maymi Maria A, 2007, P R Health Sci J, V26, P127; McKenzie C, 2019, ANN ALLERG ASTHMA IM, V123, P173, DOI 10.1016/j.anai.2019.05.014; McKenzie C, 2019, ANN ALLERG ASTHMA IM, V122, P198, DOI 10.1016/j.anai.2018.10.022; Miller JD, 2019, CLIN REV ALLERG IMMU, V57, P312, DOI 10.1007/s12016-018-8693-0; Narla S, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00971-z; Pelucchi C, 2013, J ALLERGY CLIN IMMUN, V132, P616, DOI 10.1016/j.jaci.2013.04.009; Penard-Morand C, 2005, CLIN EXP ALLERGY, V35, P1279, DOI 10.1111/j.1365-2222.2005.02336.x; Polcari I, 2014, PEDIATR DERMATOL, V31, P489, DOI 10.1111/pde.12355; Raley E, 2021, J ALLER CL IMM-PRACT, V9, P3290, DOI 10.1016/j.jaip.2021.04.063; Ramírez-Soto Martín, 2018, Rev. alerg. Méx., V65, P372, DOI 10.29262/ram.v65i4.527; Roul S, 2001, ANN DERMATOL VENER, V128, P115; Roux AVD, 2012, ANNU REV PUBL HEALTH, V33, P41, DOI 10.1146/annurev-publhealth-031811-124534; Sacotte R, 2018, CLIN DERMATOL, V36, P595, DOI 10.1016/j.clindermatol.2018.05.007; Sanyal RD, 2019, ANN ALLERG ASTHMA IM, V122, P99, DOI 10.1016/j.anai.2018.08.024; Schmidt SAJ, 2021, JAMA DERMATOL, V157, P667, DOI 10.1001/jamadermatol.2021.0009; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Siegfried EC, 2020, BMC DERMATOL, V20, DOI 10.1186/s12895-020-00114-x; Silverberg JI, 2020, J AM ACAD DERMATOL, V83, P1349, DOI 10.1016/j.jaad.2020.05.041; Silverberg JI, 2014, DERMATITIS, V25, P107, DOI 10.1097/DER.0000000000000034; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Silverberg JI, 2013, JAMA PEDIATR, V167, P554, DOI 10.1001/jamapediatrics.2013.1319; Silverberg NB., 2015, PEDIAT SKIN COLOR; Simpson EL, 2018, J INVEST DERMATOL, V138, P2224, DOI 10.1016/j.jid.2018.03.1517; Stefanovic N, 2020, ALLERGY, V75, P63, DOI 10.1111/all.13946; Sullivan K, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-0899-6; Tackett KJ, 2020, PEDIATR DERMATOL, V37, P142, DOI 10.1111/pde.14058; Teteh DK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237041; Tollefson MM, 2014, PEDIATRICS, V134, pE1735, DOI 10.1542/peds.2014-2812; Vachiramon V, 2012, PEDIATR DERMATOL, V29, P395, DOI 10.1111/j.1525-1470.2012.01740.x; Nguyen VK, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2020.105496; Wan J, 2021, JAMA DERMATOL, V157, P651, DOI 10.1001/jamadermatol.2021.0008; Wan J, 2019, JAMA DERMATOL, V155, P973, DOI 10.1001/jamadermatol.2019.0597; Wan J, 2019, J INVEST DERMATOL, V139, P1906, DOI 10.1016/j.jid.2019.02.024; Wesley NO, 2003, AM J CLIN DERMATOL, V4, P843, DOI 10.2165/00128071-200304120-00004; Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Yang EJ, 2019, PEDIATR DERMATOL, V36, P66, DOI 10.1111/pde.13727; Yudell M, 2016, SCIENCE, V351, P564, DOI 10.1126/science.aac4951; Zeiser K, 2021, J EUR ACAD DERMATOL, V35, P835, DOI 10.1111/jdv.16950	91	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1104	1111		10.1016/j.jaci.2021.09.015	http://dx.doi.org/10.1016/j.jaci.2021.09.015		NOV 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	WV7LX	34600773	Green Accepted			2022-12-18	WOS:000717415000002
J	Tanaka, N; Koido, M; Suzuki, A; Otomo, N; Suetsugu, H; Kochi, Y; Tomizuka, K; Momozawa, Y; Kamatani, Y; Ikegawa, S; Yamamoto, K; Terao, C				Tanaka, Nao; Koido, Masaru; Suzuki, Akari; Otomo, Nao; Suetsugu, Hiroyuki; Kochi, Yuta; Tomizuka, Kouhei; Momozawa, Yukihide; Kamatani, Yoichiro; Ikegawa, Shiro; Yamamoto, Kazuhiko; Terao, Chikashi		Biobank Japan Project	Eight novel susceptibility loci and putative causal variants in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; genetic study; immune cells; gene expression	GENOME-WIDE ASSOCIATION; T-CELLS; RISK LOCI; NLRP10; METAANALYSIS; INDUCTION; ASTHMA; IL-18	Background: Atopic dermatitis (AD) is the most common allergic disease in the world. While genetic components play critical roles in its pathophysiology, a large proportion of its genetic background is still unexplored. Objectives: This study sought to illuminate the genetic associations with AD using genome-wide association study (GWAS) and its downstream analyses. Methods: This study conducted a GWAS for AD comprising 2,639 cases and 115,648 controls in the Japanese population, followed by a trans-ethnic meta-analysis with UK Biobank data and downstream analyses including partitioning heritability analysis by linkage disequilibrium score regression. Results: This study identified 17 significant susceptibility loci, among which 4 loci-AFF1, ITGB8, EHMT1, and EGR2-were novel in the Japanese GWAS. The trans-ethnic meta-analysis revealed 4 additional novel loci, namely-ZBTB38, LOC105755953/LOC101928272, TRAF3, and IQGAP1. This study found a missense variant (R243W) with a deleterious functional effect in NLRP10 and a variant altering expression of CCDC80 via enhancer expression as highly likely causal variants. These 2 regions were Asian-specific, and these population-specific associations could be explained by the frequency of causal variants. The gene-based test showed SMAD4 as an additional novel significant locus. Downstream analyses revealed substantial overlap of GWAS significant signals in enhancers of skin cells and immune cells, especially CD4 T cells. A highly shared polygenic architecture of AD between Europeans and Asians was also found. Conclusions: This study identified Japanese-specific loci and novel significant loci shared by different populations. Two putative causal variants were illuminated in Japanese-specific loci. Trans ethnic analyses revealed strong heritability enrichment in immune related pathways, and relevant cell types shared among populations. (J Allergy Clin Immunol 2021;148:1293-306.)	[Tanaka, Nao; Koido, Masaru; Otomo, Nao; Suetsugu, Hiroyuki; Tomizuka, Kouhei; Kamatani, Yoichiro; Ikegawa, Shiro; Terao, Chikashi] RIKEN, Ctr Integrat Med Sci, Lab Stat & Translat Genet, Yokohama, Kanagawa, Japan; [Suzuki, Akari; Kochi, Yuta; Yamamoto, Kazuhiko] RIKEN, Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan; [Momozawa, Yukihide] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Tanaka, Nao] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Rheumatol, Tokyo, Japan; [Kochi, Yuta] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Funct & Divers, Tokyo, Japan; [Koido, Masaru] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Mol Pathol, Tokyo, Japan; [Kamatani, Yoichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Complex Trait Genom, Tokyo, Japan; [Biobank Japan Project] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Otomo, Nao; Suetsugu, Hiroyuki; Ikegawa, Shiro] RIKEN, Ctr Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Otomo, Nao] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Suetsugu, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Orthoped Surg, Fukuoka, Japan; [Terao, Chikashi] Univ Shizuoka, Shizuoka Gen Hosp, Clin Res Ctr, Shizuoka, Japan; [Terao, Chikashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Appl Genet, Shizuoka, Japan	RIKEN; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo; RIKEN; Keio University; Kyushu University; Shizuoka General Hospital; University of Shizuoka; University of Shizuoka	Terao, C (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Stat & Translat Genet, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	chikashi.terao@riken.jp	Koido, Masaru/I-2930-2019	Koido, Masaru/0000-0002-0348-0666	BioBank Japan Project - Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese Government; Japan Agency for Medical Research and Development [17km0305002, 18km0605001]	BioBank Japan Project - Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was funded by the BioBank Japan Project, which was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese Government and The Japan Agency for Medical Research and Development (grants 17km0305002 and 18km0605001).	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Baurecht H, 2015, AM J HUM GENET, V96, P104, DOI 10.1016/j.ajhg.2014.12.004; Brown BC, 2016, AM J HUM GENET, V99, P76, DOI 10.1016/j.ajhg.2016.05.001; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Damm A, 2016, EUR J IMMUNOL, V46, P1959, DOI 10.1002/eji.201646401; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Eisenbarth SC, 2012, NATURE, V484, P510, DOI 10.1038/nature11012; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Elmose Camilla, 2015, J Allergy (Cairo), V2015, P902359, DOI 10.1155/2015/902359; Esparza-Gordillo J, 2013, J ALLERGY CLIN IMMUN, V132, P371, DOI 10.1016/j.jaci.2013.01.057; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Ferreira MAR, 2019, AM J HUM GENET, V104, P665, DOI 10.1016/j.ajhg.2019.02.022; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hait TA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1432-2; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hirata M, 2017, J EPIDEMIOL, V27, pS9, DOI 10.1016/j.je.2016.12.003; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Honda T, 2020, J ALLERGY CLIN IMMUN, V145, P1136, DOI 10.1016/j.jaci.2020.02.008; Hoshino T, 1999, J IMMUNOL, V162, P5070; Ishigaki K, 2020, NAT GENET, V52, P669, DOI 10.1038/s41588-020-0640-3; Ishigaki K, 2017, NAT GENET, V49, P1120, DOI 10.1038/ng.3885; Jung K, 2011, J ALLERGY CLIN IMMUN, V127, P420, DOI 10.1016/j.jaci.2010.10.043; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Katoh N, 2019, J DERMATOL, V46, P1053, DOI 10.1111/1346-8138.15090; Kawaji H, 2020, 011205 BIORXIV; Kichaev G, 2019, AM J HUM GENET, V104, P65, DOI 10.1016/j.ajhg.2018.11.008; Kim KW, 2015, J ALLERGY CLIN IMMUN, V136, P678, DOI 10.1016/j.jaci.2015.03.030; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Lamparter D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004714; Li WY, 2020, BIOCHEM BIOPH RES CO, V526, P813, DOI 10.1016/j.bbrc.2020.03.121; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Myouzen K, 2010, HUM MOL GENET, V19, P2313, DOI 10.1093/hmg/ddq092; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schaarschmidt H, 2015, J ALLERGY CLIN IMMUN, V136, P802, DOI 10.1016/j.jaci.2015.01.047; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; Vacca M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01462; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Xu H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17097-5; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yasuda K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030649; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Yu Q, 2008, J IMMUNOL, V181, P3346, DOI 10.4049/jimmunol.181.5.3346; Zheng Y, 2019, BRAIN, V142, P787, DOI 10.1093/brain/awy354; Zhu ZZ, 2018, NAT GENET, V50, P857, DOI 10.1038/s41588-018-0121-0	59	7	7	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1293	1306		10.1016/j.jaci.2021.04.019	http://dx.doi.org/10.1016/j.jaci.2021.04.019		NOV 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	34116867				2022-12-18	WOS:000717415000027
J	Wohlford, EM; Huang, PF; Elhawary, JR; Millette, LA; Contreras, MG; Witonsky, J; Holweg, CTJ; Oh, SS; Lee, C; Merenda, C; Rabin, RL; Araojo, R; Mak, ACY; Eng, CS; Hu, DL; Huntsman, S; LeNoir, MA; Rodriguez-Santana, JR; Borrell, LN; Burchard, EG				Wohlford, Eric M.; Huang, Peter F.; Elhawary, Jennifer R.; Millette, Lauren A.; Contreras, Maria G.; Witonsky, Jonathan; Holweg, Cecile T. J.; Oh, Sam S.; Lee, Christine; Merenda, Christine; Rabin, Ronald L.; Araojo, Richardae; Mak, Angel C. Y.; Eng, Celeste S.; Hu, Donglei; Huntsman, Scott; LeNoir, Michael A.; Rodriguez-Santana, Jose R.; Borrell, Luisa N.; Burchard, Esteban G.			Racial/ethnic differences in eligibility for asthma biologics among pediatric populations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; pediatric asthma; biomarker-driven asthma therapeutics; asthma subtypes; peripheral blood parameters; white blood cell count; total IgE; minority pediatric populations	ALLERGIC-ASTHMA; BRONCHODILATOR RESPONSIVENESS; AFRICAN-AMERICANS; GENETIC ANCESTRY; ANTI-IGE; COUNT; VALIDATION; BIOMARKER; TRIALS; TESTS	Background: Asthma is a heterogeneous disease. Clinical blood parameters differ by race/ethnicity and are used to distinguish asthma subtypes and inform therapies. Differences in subtypes may explain population-specific trends in asthma outcomes. However, these differences in racial/ethnic minority pediatric populations are unclear. Objective: We investigated the association of blood parameters and asthma subtypes with asthma outcomes and examined population-specific eligibility for biologic therapies in minority pediatric populations. Methods: Using data from 2 asthma case-control studies of pediatric minority populations, we performed case-control (N = 3738) and case-only (N = 2743) logistic regressions to quantify the association of blood parameters and asthma subtypes with asthma outcomes. Heterogeneity of these associations was tested using an interaction term between race/ethnicity and each exposure. Differences in therapeutic eligibility were investigated using chi-square tests. Results: Race/ethnicity modified the association between total IgE and asthma exacerbations. Elevated IgE level was associated with worse asthma outcomes in Puerto Ricans. Allergic asthma was associated with worse outcomes in Mexican Americans, whereas eosinophilic asthma was associated with worse outcomes in Puerto Ricans. A lower proportion of Puerto Ricans met dosing criteria for allergic asthma-directed biologic therapy than other groups. A higher proportion of Puerto Ricans qualified for eosinophilic asthma-directed biologic therapy than African Americans. Conclusions: We found population-specific associations between blood parameters and asthma subtypes with asthma outcomes. Our findings suggest that eligibility for asthma biologic therapies differs across pediatric racial/ethnic populations. These findings call for more studies in diverse populations for equitable treatment of minority patients with asthma.	[Wohlford, Eric M.; Witonsky, Jonathan] Univ Calif San Francisco, Div Pediat Allergy & Immunol, San Francisco, CA 94143 USA; [Wohlford, Eric M.; Huang, Peter F.; Elhawary, Jennifer R.; Contreras, Maria G.; Witonsky, Jonathan; Oh, Sam S.; Mak, Angel C. Y.; Eng, Celeste S.; Hu, Donglei; Huntsman, Scott; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Millette, Lauren A.; Holweg, Cecile T. J.] Genentech Inc, San Francisco, CA 94080 USA; [Lee, Christine; Merenda, Christine; Araojo, Richardae] US FDA, Off Minor Hlth & Hlth Equ, Silver Spring, MD USA; [Rabin, Ronald L.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [LeNoir, Michael A.] Bay Area Pediat, Oakland, CA USA; [Rodriguez-Santana, Jose R.] Ctr Neumol Pediat, Caguas, PR USA; [Borrell, Luisa N.] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); City University of New York (CUNY) System; University of California System; University of California San Francisco	Elhawary, JR (corresponding author), Rock Hall,1550 4th St,Rm 582,Box 2911, San Francisco, CA 94158 USA.	jennifer.elhawary@ucsf.edu			Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; National Institute of General Medical Sciences [T32GM007546]; Na-tional Institute of Environmental Health Sciences [R01ES015794]; Na-tional Heart, Lung, and Blood Institute [2R01HL117004-05, R01HL155024]; National Heart, Lung, and Blood Institute TOPMed grant [1X01HL134589]; Tobacco-Related Disease Research Program [27IR-0030]; Food and Drug Administration (FDA) of the US Department of Health and Human Services (HHS) [U01FD005978]; Genentech Inc; FDA/HHS; Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II	Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Na-tional Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Na-tional Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute TOPMed grant; Tobacco-Related Disease Research Program(University of California System); Food and Drug Administration (FDA) of the US Department of Health and Human Services (HHS)(United States Department of Health & Human Services); Genentech Inc(Roche HoldingGenentech); FDA/HHS; Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II	This work was supported in part by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II, the National Institute of General Medical Sciences (grant no. T32GM007546) , the Na-tional Institute of Environmental Health Sciences (grant no. R01ES015794) , the Na-tional Heart, Lung, and Blood Institute (grant nos. 2R01HL117004-05 and R01HL155024) , the National Heart, Lung, and Blood Institute TOPMed grant (grant no. 1X01HL134589) , and the Tobacco-Related Disease Research Program (grant no. 27IR-0030) . This publication was supported by the Food and Drug Administration (FDA) of the US Department of Health and Human Services (HHS) as part of a finan-cial assistance award (grant no. U01FD005978) totaling $50,000, with 16% funded by the FDA/HHS, and $245,000 amount, with 80% funded by nongovernment source (s) . The contents are those of the author (s) and do not necessarily represent the officialviews of, nor an endorsement, by the FDA/HHS, or the US government. These com-ments do not bind or obligate the FDA. Funding for the work was also provided by Genentech Inc, a member of the Roche Group.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Al Obaidi AHA, 2008, J ASTHMA, V45, P654, DOI 10.1080/02770900802126958; [Anonymous], 2020, PUERTO RICO US CLIN; [Anonymous], 2020, NUCALA MEPOLIZUMAB I; [Anonymous], 2020, XOLAIR; [Anonymous], 2019, TABL 2 1 LIF ASTHM P; [Anonymous], 2021, PATIENT INFORM DUPIX; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Borish L, 2005, ANN ALLERG ASTHMA IM, V95, P247, DOI 10.1016/S1081-1206(10)61221-5; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Buhl R, 2007, EUR RESPIR REV, V16, P73, DOI 10.1183/09059180.00010403; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Burchard EG, 2015, AM J RESP CRIT CARE, V191, P514, DOI 10.1164/rccm.201410-1944PP; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Cardet JC, 2015, EXPERT OPIN BIOL TH, V15, P1531, DOI 10.1517/14712598.2015.1090972; Casciano J, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0271-8; Chapman Kenneth R, 2006, Can Respir J, V13 Suppl B, p1B; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Davila I, 2015, J INVEST ALLERG CLIN, V25, P120; Dixon AE, 2011, AM J RESP CRIT CARE, V184, P1220, DOI 10.1164/rccm.201109-1683ED; Emma R, 2018, THER ADV RESPIR DIS, V12, DOI 10.1177/1753466618808490; Ferrante G, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00186; Finan C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1166; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Fundora-Hernandez H, 2014, TROP MED INT HEALTH, V19, P545, DOI 10.1111/tmi.12293; Institute of Medicine, 2000, CLEAR AIR ASTHM IND; Jain D, 2017, HUM MOL GENET, V26, P1193, DOI 10.1093/hmg/ddx024; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Katz Lynn E, 2014, Ann Am Thorac Soc, V11, P531, DOI 10.1513/AnnalsATS.201310-354OC; Kawalcami T, 2016, J IMMUNOL, V197, P4187, DOI 10.4049/jimmunol.1601476; Kostikas K, 2018, CURR DRUG TARGETS, V19, P1882, DOI 10.2174/1389450119666180212120012; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Mensinga Tjeert T., 1994, Annals of Epidemiology, V4, P382; Naqvi M, 2007, J ASTHMA, V44, P639, DOI 10.1080/02770900701554441; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Painter JE, 2015, MMWR SURVEILL SUMM, V64, P15; Palmer LJ, 2000, AM J RESP CRIT CARE, V161, P1836, DOI 10.1164/ajrccm.161.6.9805104; Peralta CA, 2010, CIRC-CARDIOVASC GENE, V3, P240, DOI 10.1161/CIRCGENETICS.109.914499; Rappoport N, 2018, J APPL LAB MED, V3, P366, DOI 10.1373/jalm.2018.026492; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; The Annie E. Casey Foundation, CHILD POP RAC US; Tschopp JM, 1998, ALLERGY, V53, P608, DOI 10.1111/j.1398-9995.1998.tb03937.x; Wechsler ME, 2011, AM J RESP CRIT CARE, V184, P1247, DOI 10.1164/rccm.201103-0514OC; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Zhang XY, 2014, CLIN EXP ALLERGY, V44, P1137, DOI 10.1111/cea.12345	49	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1324	+		10.1016/j.jaci.2021.09.005	http://dx.doi.org/10.1016/j.jaci.2021.09.005		NOV 2021	20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV8FQ	34536416	Green Accepted, hybrid			2022-12-18	WOS:000717466600003
J	Crow, YJ; Neven, B; Fremond, ML				Crow, Yanick J.; Neven, Benedicte; Fremond, Marie-Louise			JAK inhibition in the type I interferonopathies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Type I interferonopathies; JAK inhibition			[Crow, Yanick J.] Univ Edinburgh, Inst Genet & Canc, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Crow, Yanick J.; Fremond, Marie-Louise] Univ Paris, Imagine Inst, Lab Neurogenet & Neuroinflammat, Gif Sur Yvette, France; [Neven, Benedicte] Univ Paris, Gif Sur Yvette, France; [Neven, Benedicte; Fremond, Marie-Louise] Univ Paris, Hop Necker Enfants Malades, APHP, Pediat Hematol Immunol & Rheumatol Dept, Gif Sur Yvette, France; [Neven, Benedicte] INSERM UMR 1163, Lab Immunogenet Pediat Autoimmun, Imagine Inst, Paris, France	University of Edinburgh; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Crow, YJ (corresponding author), Univ Edinburgh, Inst Genet & Canc, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	yanickcrow@mac.com	Frémond, Marie-Louise/AAH-4266-2019	Frémond, Marie-Louise/0000-0002-2798-9141				Alsohime F, 2020, NEW ENGL J MED, V382, P256, DOI 10.1056/NEJMoa1905633; Forbes LR, 2018, J ALLERGY CLIN IMMUN, V142, P1665, DOI 10.1016/j.jaci.2018.07.020; Fremond ML, 2021, J ALLER CL IMM-PRACT, V9, P803, DOI 10.1016/j.jaip.2020.11.007; Fremond ML, 2016, J ALLERGY CLIN IMMUN, V138, P1752, DOI 10.1016/j.jaci.2016.07.015; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Neven B, 2020, NEW ENGL J MED, V383, P2190, DOI 10.1056/NEJMc2031081; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Uggenti C, 2019, ANNU REV IMMUNOL, V37, P247, DOI 10.1146/annurev-immunol-042718-041257; Vanderver A, 2020, NEW ENGL J MED, V383, P986, DOI 10.1056/NEJMc2001362	10	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					991	993		10.1016/j.jaci.2021.07.028	http://dx.doi.org/10.1016/j.jaci.2021.07.028		OCT 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	34375617				2022-12-18	WOS:000705023300008
J	Georas, SN; Donohue, P; Connolly, M; Wechsler, ME				Georas, Steve N.; Donohue, Patrick; Connolly, Margaret; Wechsler, Michael E.			JAK inhibitors for asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Asthma; severe asthma; Janus kinase; JAK; STAT pathway; JAK Inhibitor	JANUS KINASE INHIBITOR; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; BARRIER FUNCTION; SAFETY PROFILE; T(H)17 CELLS; IFN-GAMMA; TOFACITINIB; INFLAMMATION	Asthma is an inflammatory disease of the airways characterized by intermittent episodes of wheezing, chest tightness, and cough. Many of the inflammatory pathways implicated in asthma involve cytokines and growth factors that activate Janus kinases (JAKs). The discovery of the JAK/signal transducer and activator of transcription (STAT) signaling pathway was a major breakthrough that revolutionized our understanding of cell growth and differentiation. JAK inhibitors are under active investigation for immune and inflammatory diseases, and they have demonstrated clinical efficacy in diseases such as rheumatoid arthritis and atopic dermatitis. Substantial preclinical data support the idea that inhibiting JAKs will ameliorate airway inflammation and hyperreactivity in asthma. Here, we review the rationale for use of JAK inhibitors in different asthma endotypes as well as the preclinical and early clinical evidence supporting such use. We review preclinical data from the use of systemic and inhaled JAK inhibitors in animal models of asthma and safety data based on the use of JAK inhibitors in other diseases. We conclude that JAK inhibitors have the potential to usher in a new era of antiinflammatory treatment for asthma. (J Allergy Clin Immunol 2021;148:953-63.)	[Georas, Steve N.; Connolly, Margaret] Univ Rochester, Med Ctr, Div Pulm & Crit Care Med, 601 Elmwood Ave, Rochester, NY 14642 USA; [Donohue, Patrick; Wechsler, Michael E.] Natl Jewish Med Ctr, Denver, CO USA	University of Rochester; National Jewish Health	Georas, SN (corresponding author), Univ Rochester, Med Ctr, Div Pulm & Crit Care Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	Steve_Georas@urmc.rochester.edu			NIH [R01 AI144241, U24 HL138998, T32 HL066988, UG1 HL139123]; Jin Hua Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jin Hua Foundation	S.N.G. was supported by grants from the NIH including R01 AI144241 and U24 HL138998. P.D. and M.C. were supported by NIH T32 HL066988. M.E.W. was supported by NIH UG1 HL139123 and the Jin Hua Foundation. The authors gratefully acknowledge helpful discussion with the PrecISE Asthma Network Jak Inhibitor Working Group (Praveen Akuthota, Anastasia Ivanova, Jonathan M. Gaffin, James Moy, Sally J. Wenzel).	Aguilar-Pimentel A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178563; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Akdis CA, 2021, NAT REV IMMUNOL, V21, P739, DOI 10.1038/s41577-021-00538-7; Al-Salama ZT, 2018, DRUGS, V78, P761, DOI 10.1007/s40265-018-0908-4; Amano W, 2015, J ALLERGY CLIN IMMUN, V136, P667, DOI 10.1016/j.jaci.2015.03.051; Amrani Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-104; Ashino S, 2014, J ALLERGY CLIN IMMUN, V133, P1162, DOI 10.1016/j.jaci.2013.10.036; Babina M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010102; Bach J, 2019, J MED CHEM, V62, P9045, DOI 10.1021/acs.jmedchem.9b00533; Bleecker ER, 2020, AM J RESP CRIT CARE, V201, P276, DOI 10.1164/rccm.201904-0903SO; Bloechliger M, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0742-y; Braithwaite IE, J ALLERGY CLIN IMMUN, P2021; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Calama E, 2017, PULM PHARMACOL THER, V43, P60, DOI 10.1016/j.pupt.2017.01.002; Calbet M, 2019, J PHARMACOL EXP THER, V370, P137, DOI 10.1124/jpet.119.256263; Camiolo MJ, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108974; Caniga M, 2019, J AEROSOL MED PULM D, V32, P251, DOI 10.1089/jamp.2018.1492; Chen CX, 2021, LEUKEMIA, V35, P2616, DOI 10.1038/s41375-021-01266-6; Cohen Stanley B, 2020, RMD Open, V6, DOI 10.1136/rmdopen-2020-001395; Conaghan PG, 2021, DRUG SAFETY, V44, P515, DOI 10.1007/s40264-020-01036-w; Corren J, 2020, J ALLER CL IMM-PRACT, V8, P516, DOI 10.1016/j.jaip.2019.08.050; Del Bel KL, 2017, J ALLERGY CLIN IMMUN, V139, P2016, DOI 10.1016/j.jaci.2016.12.957; Dengler HS, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2151; Ekstrom M, 2019, ALLERGY, V74, P2181, DOI 10.1111/all.13874; Eum SY, 2005, AM J PHYSIOL-LUNG C, V288, pL576, DOI 10.1152/ajplung.00380.2003; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Farne HA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010834.pub3; Gadina M, 2018, J LEUKOCYTE BIOL, V104, P499, DOI 10.1002/JLB.5RI0218-084R; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gladman DD, 2019, ARTHRIT CARE RES, V71, P1387, DOI 10.1002/acr.23930; Grunstein MM, 2002, AM J PHYSIOL-LUNG C, V282, pL520, DOI 10.1152/ajplung.00343.2001; Heller NM, 2004, CLIN EXP ALLERGY, V34, P1690, DOI 10.1111/j.1365-2222.2004.02091.x; Hermans MAW, 2018, CLIN EXP ALLERGY, V48, P1412, DOI 10.1111/cea.13217; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Howell MD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02342; Howell MD, 2018, ANN ALLERG ASTHMA IM, V120, P367, DOI 10.1016/j.anai.2018.02.012; Israel E, 2021, J ALLERGY CLIN IMMUN, V147, P1594, DOI 10.1016/j.jaci.2021.01.037; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; Jevnikar Z, 2019, J ALLERGY CLIN IMMUN, V143, P577, DOI 10.1016/j.jaci.2018.05.026; Jones P, 2017, J MED CHEM, V60, P767, DOI 10.1021/acs.jmedchem.6b01634; Joo YH, 2021, LARYNGOSCOPE, V131, pE1400, DOI 10.1002/lary.29129; Kay J, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2020-001370; Keystone EC, 2015, ANN RHEUM DIS, V74, P333, DOI 10.1136/annrheumdis-2014-206478; King B, 2017, J INVEST DERMATOL, V137, P951, DOI 10.1016/j.jid.2016.10.044; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Li RF, 2018, EUR REV MED PHARMACO, V22, P835, DOI 10.26355/eurrev_201802_14320; Li XX, 2019, NAT IMMUNOL, V20, P1594, DOI 10.1038/s41590-019-0514-y; Li XN, 2020, J ALLERGY CLIN IMMUN, V145, P430, DOI 10.1016/j.jaci.2019.08.031; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Linnekin D, 1999, INT J BIOCHEM CELL B, V31, P1053, DOI 10.1016/S1357-2725(99)00078-3; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Manson ML, 2020, J ALLERGY CLIN IMMUN, V145, P808, DOI 10.1016/j.jaci.2019.10.037; Alvaro-Gracia JM, 2021, RHEUMATOL THER, V8, P17, DOI 10.1007/s40744-020-00258-9; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; Matsunaga K, 2020, NPJ PRIM CARE RESP M, V30, DOI 10.1038/s41533-020-00192-x; Matsunaga Y, 2011, BIOCHEM BIOPH RES CO, V404, P261, DOI 10.1016/j.bbrc.2010.11.104; McInnes IB, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1964-1; McKnight CG, 2020, MUCOSAL IMMUNOL, V13, P283, DOI 10.1038/s41385-019-0232-7; Menson KE, 2020, AM J PHYSIOL-LUNG C, V319, pL693, DOI 10.1152/ajplung.00204.2020; Moore PE, 2002, AM J PHYSIOL-LUNG C, V282, pL847, DOI 10.1152/ajplung.00245.2001; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Permaul P, 2021, J ALLER CL IMM-PRACT, V9, P2916, DOI 10.1016/j.jaip.2021.02.047; Peters MC, 2019, J ALLERGY CLIN IMMUN, V143, P104, DOI 10.1016/j.jaci.2017.12.1009; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Pruner KB, 2021, J EXP MED, V218, DOI 10.1084/jem.20201733; Pullen NA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00117; Rahimi R, 2020, J EXP MED, V217, DOI 10.1084/jem.20190865; Maneiro JR, 2017, SEMIN ARTHRITIS RHEU, V47, P149, DOI 10.1016/j.semarthrit.2017.02.007; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Ray A, 2016, J CLIN INVEST, V126, P2394, DOI 10.1172/JCI84144; Ross SH, 2018, ANNU REV IMMUNOL, V36, P411, DOI 10.1146/annurev-immunol-042617-053352; Ruterbusch M, 2020, ANNU REV IMMUNOL, V38, P705, DOI 10.1146/annurev-immunol-103019-085803; Saatian B, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24333; Sada M, 2021, IMMUN INFLAMM DIS, V9, P363, DOI 10.1002/iid3.397; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Sewgobind VDKD, 2010, AM J TRANSPLANT, V10, P1785, DOI 10.1111/j.1600-6143.2010.03200.x; Sohn SJ, 2013, J IMMUNOL, V191, P2205, DOI 10.4049/jimmunol.1202859; Stenova E, 2020, CLIN RHEUMATOL, V39, P3507, DOI 10.1007/s10067-020-05134-z; Strober B, 2013, BRIT J DERMATOL, V169, P992, DOI 10.1111/bjd.12517; van der Ploeg EK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd3489; Verma M, 2021, J EXP MED, V218, DOI 10.1084/jem.20201354; Vian L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02972; Waljee AK, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1415; Wang WW, 2018, RHINOLOGY, V56, DOI 10.4193/Rhin17.045; Wenzel SE, 2021, AM J RESP CRIT CARE, V203, P809, DOI 10.1164/rccm.202009-3631CI; Winthrop KL, 2017, ARTHRITIS RHEUMATOL, V69, P1960, DOI 10.1002/art.40189; Winthrop KL, 2017, NAT REV RHEUMATOL, V13, P234, DOI 10.1038/nrrheum.2017.23; Wolk R, 2017, J CLIN LIPIDOL, V11, P1243, DOI 10.1016/j.jacl.2017.06.012; Woo A, 2021, J ALLERGY CLIN IMMUN, V147, P135, DOI 10.1016/j.jaci.2020.04.041; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yates M, 2021, ARTHRITIS RHEUMATOL, V73, P779, DOI 10.1002/art.41580; Yi CA, 2015, FUTURE ONCOL, V11, P719, DOI [10.2217/FON.14.272, 10.2217/fon.14.272]; Younis US, 2019, AAPS PHARMSCITECH, V20, DOI 10.1208/s12249-019-1377-0; Zak M, 2019, BIOORG MED CHEM LETT, V29, DOI 10.1016/j.bmcl.2019.126658; Zak M, 2019, BIOORG MED CHEM LETT, V29, P1522, DOI 10.1016/j.bmcl.2019.04.008; Zand MS, 2013, TRANSPLANT REV-ORLAN, V27, P85, DOI 10.1016/j.trre.2013.04.001; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	102	7	7	4	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					953	963		10.1016/j.jaci.2021.08.013	http://dx.doi.org/10.1016/j.jaci.2021.08.013		OCT 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	34625142	Green Accepted			2022-12-18	WOS:000705023300004
J	Pennington, LF; Gasser, P; Brigger, D; Guntern, P; Eggel, A; Jardetzky, TS				Pennington, Luke F.; Gasser, Pascal; Brigger, Daniel; Guntern, Pascal; Eggel, Alexander; Jardetzky, Theodore S.			Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Active desensitization; affinity maturation; allergies; anaphylaxis; DARPins; disruptive IgE inhibitors; Fc fusion; IgE; knobs in holes; yeast display	FC-FUSION PROTEINS; HISTAMINE-RELEASE; MAST-CELLS; HALF-LIFE; ANAPHYLAXIS; AFFINITY; OMALIZUMAB; MOUSE; IL-4; COMPLEXES	Background: Anaphylaxis represents one of the most severe and fatal forms of allergic reactions. Like most other allergies, it is caused by activation of basophils and mast cells by allergen-mediated cross-linking of IgE bound to its high-affinity receptor, Fc epsilon RI, on the cell surface. The systemic release of soluble mediators induces an inflammatory cascade, rapidly causing symptoms with peak severity in minutes to hours after allergen exposure. Primary treatment for anaphylaxis consists of immediate intramuscular administration of adrenaline. Objective: While adrenaline alleviates life-threatening symptoms of an anaphylactic reaction, there are currently no disease-modifying interventions available. We sought to develop potent and fast-acting IgE inhibitors with the potential to rapidly terminate acute allergic reactions. Methods: Using affinity maturation by yeast display and structure-guided molecular engineering, we generated 3 optimized disruptive IgE inhibitors based on designed ankyrin repeat proteins and assessed their ability to actively remove IgE from allergic effector cells in vitro as well as in vivo in mice. Results: The engineered IgE inhibitors rapidly dissociate preformed IgE:Fc epsilon RI complexes, terminate IgE-mediated signaling in preactivated human blood basophils in vitro, and shut down preinitiated allergic reactions and anaphylaxis in mice in vivo. Conclusions: Fast-acting disruptive IgE inhibitors demonstrate the feasibility of developing kinetically optimized inhibitors for the treatment of anaphylaxis and the rapid desensitization of allergic individuals.	[Pennington, Luke F.; Jardetzky, Theodore S.] Stanford Univ, Dept Struct Biol, Sch Med, Fairchild Bldg,Room 309, Stanford, CA 94305 USA; [Pennington, Luke F.; Jardetzky, Theodore S.] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Pennington, Luke F.; Jardetzky, Theodore S.] Stanford Univ, Sean N Parker Ctr Allergy Res, Stanford, CA 94305 USA; [Gasser, Pascal; Brigger, Daniel; Guntern, Pascal; Eggel, Alexander] Bern Univ Hosp, Dept Rheumatol & Immunol, Bern, Switzerland; [Gasser, Pascal; Brigger, Daniel; Guntern, Pascal; Eggel, Alexander] Univ Bern, Dept BioMed Res, Sahlihaus 2,Room 108, CH-3010 Bern, Switzerland	Stanford University; Stanford University; Stanford University; University of Bern; University Hospital of Bern; University of Bern	Jardetzky, TS (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, Fairchild Bldg,Room 309, Stanford, CA 94305 USA.; Eggel, A (corresponding author), Univ Bern, Dept BioMed Res, Sahlihaus 2,Room 108, CH-3010 Bern, Switzerland.	alexander.eggel@dbmr.unibe.ch; tjardetzky@stanford.edu		Pennington, Luke/0000-0002-7947-8714; Eggel, Alexander/0000-0001-8746-3339	Fondation Acteria; Swiss Lung Association, Bern; Uniscientia Foundation; National Institutes of Health [AI115469, HL141493]	Fondation Acteria; Swiss Lung Association, Bern; Uniscientia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a grant from the Fondation Acteria (to A.E.), the Research Fund of the Swiss Lung Association, Bern, and the Uniscientia Foundation (to A.E.), and National Institutes of Health grants AI115469 (to T.S.J.) and HL141493 (to T.S.J. and A.E.).	Asrat S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aav8402; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Borthakur S, 2012, J BIOL CHEM, V287, P31457, DOI 10.1074/jbc.C112.397059; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Chang TW, 2015, J ALLERGY CLIN IMMUN, V135, P337, DOI 10.1016/j.jaci.2014.04.036; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Eggel A, 2011, ALLERGY, V66, P961, DOI 10.1111/j.1398-9995.2011.02546.x; Eggel A, 2014, J ALLERGY CLIN IMMUN, V133, P1709, DOI 10.1016/j.jaci.2014.02.005; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Gasser P, 2018, CURR OPIN IMMUNOL, V54, P86, DOI 10.1016/j.coi.2018.05.015; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Gibbs BF, 1996, EUR J IMMUNOL, V26, P2493, DOI 10.1002/eji.1830261033; Holgate S, 2009, RESP MED, V103, P1098, DOI 10.1016/j.rmed.2009.03.008; HUTCHINSON LE, 1995, J BIOL CHEM, V270, P16333, DOI 10.1074/jbc.270.27.16333; Kemp SF, 2002, J ALLERGY CLIN IMMUN, V110, P341, DOI 10.1067/mai.2002.126811; Kim B, 2012, NATURE, V491, P613, DOI 10.1038/nature11546; Kunimoto D, 2020, OPHTHALMOLOGY, V127, P1331, DOI 10.1016/j.ophtha.2020.03.035; Lorentz A, 2000, J IMMUNOL, V164, P43, DOI 10.4049/jimmunol.164.1.43; Malbec O, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aag1401; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Metz M, 2014, J DERMATOL SCI, V73, P57, DOI 10.1016/j.jdermsci.2013.08.011; Miura K, 1999, J IMMUNOL, V162, P4198; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Reber LL, 2017, J ALLERGY CLIN IMMUN, V140, P335, DOI 10.1016/j.jaci.2017.06.003; Redrup AC, 1998, J IMMUNOL, V160, P1957; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1; Steiner D, 2017, PROTEIN ENG DES SEL, V30, P583, DOI 10.1093/protein/gzx022; Stumpp MT, 2020, BIODRUGS, V34, P423, DOI 10.1007/s40259-020-00429-8; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Turner PJ, 2017, J ALLER CL IMM-PRACT, V5, P1169, DOI 10.1016/j.jaip.2017.06.031; Unverdorben F, 2016, MABS-AUSTIN, V8, P120, DOI 10.1080/19420862.2015.1113360; Walser M, 2020, BIORXIV PREPRINT, V2021, DOI 10.1101/2020.08.25.256339; White M, 1999, J ALLERGY CLIN IMMUN, V103, pS378, DOI 10.1016/S0091-6749(99)70215-0; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2012, J BIOL CHEM, V287, P36251, DOI 10.1074/jbc.M112.407502; Yu JE, 2018, CLIN REV ALLERG IMMU, V54, P366, DOI 10.1007/s12016-015-8503-x; Zellweger F, 2017, ALLERGY, V72, P1174, DOI 10.1111/all.13109; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106	45	7	7	4	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					1049	1060		10.1016/j.jaci.2021.03.050	http://dx.doi.org/10.1016/j.jaci.2021.03.050		OCT 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	33991582	Green Accepted			2022-12-18	WOS:000705023300015
J	Calise, J; Garabatos, N; Bajzik, V; Farrington, M; Robinson, D; Jeong, D; Londei, M; Wambre, E				Calise, Justine; Garabatos, Nahir; Bajzik, Veronique; Farrington, Mary; Robinson, David; Jeong, David; Londei, Marco; Wambre, Erik			Optimal human pathogenic T(H)2 cell effector function requires local epithelial cytokine signaling	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T cell; ST2; T(H)2A cell; IL-33; CD154; allergy; epithelial cytokine; pMHCII tetramer	T-CELLS; IL-33; DIFFERENTIATION; TYPE-2; RECEPTOR; ROLES	Background: IL-33 is an emerging key factor in development of allergic diseases. The IL-33 receptor (suppressor of tumorigenicity [ST2]) is a differentially expressed gene in pathogenic TH2 cells, but its role in T-cell effector function has not been elucidated. Objective: We investigated the role of IL-33 in modulating circulating allergen-specific T-cell responses. We hypothesized that selective ST2 expression on allergen-specific CD4(+) T cells would confer susceptibility to the effects of IL-33. Methods: PBMCs from subjects with food allergy, inhalant allergy, and no allergy were obtained on the basis of clinical history and serum IgE level. A T-cell receptor-dependent CD154 upregulation assay and direct peptide major histocompatibility complex class II tetramer staining were used to profile allergen-specific CD4(+) T cells by flow cytometry. Allergen-specific CD4(+) T cell cytokine production was evaluated during IL-33 exposure. ST2 expression was also tracked by using a 2-color flow-based assay. Results: ST2 expression on peripheral allergen-specific CD4(+) T cells was confined to subjects with allergy and restricted to T(H)2A cells. Comparison between direct peptide major histocompatibility complex class II tetramer staining and the CD154 functional assay identified ST2 as a marker of T(H)2A cell activation. IL-33 exposure enhanced IL-4 and IL-5 secretion in allergen-reactive T(H)2A cells. Allergen induced ST2 expression on peripheral CD4(+) T cells can be used to track allergen-reactive T(H)2A cells from donors with allergy. Conclusion: ST2 expression on circulating CD41 T cells represents a transient phenotype associated with T(H)2A cell activation, allowing these cells to sense locally elicited tissue cytokines. IL-33 selectively amplifies pathogenic T(H)2 cell effector functions, suggesting a tissue checkpoint that may regulate adaptive allergic immunity.	[Calise, Justine; Garabatos, Nahir; Bajzik, Veronique; Wambre, Erik] Benaroya Res Inst Virginia Mason, Translat Res Program, Seattle, WA USA; [Farrington, Mary; Robinson, David; Jeong, David] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Londei, Marco] AnaptysBio Inc, San Diego, CA USA	Benaroya Research Institute; Virginia Mason Medical Center; Virginia Mason Medical Center	Wambre, E (corresponding author), Benaroya Res Inst Virginia Mason, 1201 9th Ave, Seattle, WA 98101 USA.	ewambre@benaroyaresearch.org			National Institute of Allergy and Infectious Diseases, United States [U19 AI125378-01, R01AI108839]; Food Allergy Research Education, United States; AnaptysBio Inc, United States	National Institute of Allergy and Infectious Diseases, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Food Allergy Research Education, United States; AnaptysBio Inc, United States	Supported by the National Institute of Allergy and Infectious Diseases, United States (grants U19 AI125378-01 and R01AI108839); the Food Allergy Research Education, United States, and AnaptysBio Inc, United States (all to E.W.).	Alvarez F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00522; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cerosaletti K, 2020, J ALLERGY CLIN IMMUN, V145, pAB88, DOI 10.1016/j.jaci.2019.12.048; Chinthrajah S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131347; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Griesenauer B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00475; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kwok WW, 2010, J ALLERGY CLIN IMMUN, V125, P1407, DOI 10.1016/j.jaci.2010.03.037; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Lombardi V, 2016, J ALLERGY CLIN IMMUN, V138, P305, DOI 10.1016/j.jaci.2015.12.1325; Lott JM, 2015, J LEUKOCYTE BIOL, V97, P1037, DOI 10.1189/jlb.3RI1214-595R; Murdaca G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235856; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Pusceddu I, 2019, CLIN CHIM ACTA, V495, P493, DOI 10.1016/j.cca.2019.05.023; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Ruiter B, 2020, J ALLERGY CLIN IMMUN, V145, P270, DOI 10.1016/j.jaci.2019.09.033; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Tu AA, 2019, NAT IMMUNOL, V20, P1692, DOI 10.1038/s41590-019-0544-5; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Wambre E, 2012, CURR OPIN IMMUNOL, V24, P700, DOI 10.1016/j.coi.2012.07.009; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Wen T, 2019, J CLIN INVEST, V129, P2014, DOI 10.1172/JCI125917; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yamamoto T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06468-8; Zhang JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0166	29	7	7	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					867	+		10.1016/j.jaci.2021.02.019	http://dx.doi.org/10.1016/j.jaci.2021.02.019		SEP 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR		Green Accepted			2022-12-18	WOS:000695242900035
J	Suarez-Farinas, M; Suprun, M; Bahnson, HT; Raghunathan, R; Getts, R; duToit, G; Lack, G; Sampson, HA				Suarez-Farinas, Mayte; Suprun, Maria; Bahnson, Henry T.; Raghunathan, Rohit; Getts, Robert; duToit, George; Lack, Gideon; Sampson, Hugh A.			Evolution of epitope-specific IgE and IgG(4) antibodies in children enrolled in the LEAP trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Peanut allergy; biomarkers; sequential epitope; antibody; IgE; IgG(4); bead-based epitope assay	MICROARRAY IMMUNOASSAY; PEANUT CONSUMPTION	Background: In the LEAP (Learning Early About Peanut Allergy) trial, early consumption of peanut in high-risk infants was found to decrease the rate of peanut allergy at 5 years of age. Sequential epitope-specific (ses-)IgE is a promising biomarker of clinical peanut reactivity. Objective: We sought to compare the evolution of ses-IgE and ses-IgG4 in children who developed (or not) peanut allergy and to evaluate the immunomodulatory effects of early peanut consumption on these antibodies. Methods: Sera from 341 children (LEAP cohort) were assayed at baseline, 1, 2.5, and 5 years of age, with allergy status determined by oral food challenge at 5 years. A bead-based epitope assay was used to quantitate ses-IgE and ses-IgG4 to 64 sequential epitopes fromAra h 1 to Ara h 3 and was analyzed using linear mixed-effect models. Results: In children avoiding peanut who became peanut allergic, the bulk of peanut ses-IgE did not develop until after 2.5 years. Minimal increases of ses-IgE occurred after 1 year in consumers, but not to the same epitopes as those in children developing peanut allergy. No major changes in ses-IgE were seen in nonallergic or sensitized children. IgE in sensitized consumers was detected against peanut proteins. ses-IgG4 increased over time in most children regardless of consumption or allergy status. Conclusions: Early peanut consumption in infants at high risk of developing peanut allergy appears to divert the immunologic response to a presumably "protective'' effect. In general, consumers tend to generate ses-IgG4 earlier and in greater quantities than nonconsumers do, whereas only avoiders tend to generate significant quantities of ses-IgE.	[Suarez-Farinas, Mayte] Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Suarez-Farinas, Mayte; Raghunathan, Rohit] Icahn Sch Med Mt Sinai, Ctr Biostat, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Suprun, Maria; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Div Pediat Allergy & Immunol, 1425 Madison Ave, New York, NY 10029 USA; [Raghunathan, Rohit; Getts, Robert] AllerGenis LLC, Hatfield, Herts, England; [Bahnson, Henry T.] Benaroya Res Inst, Seattle, WA USA; [Bahnson, Henry T.] Immune Tolerance Network, Seattle, WA USA; [duToit, George; Lack, Gideon] St Thomas Hosp, Dept Pediat, London, England; [duToit, George; Lack, Gideon] Kings Coll London, London, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Benaroya Research Institute; Immune Tolerance Network; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Sampson, HA (corresponding author), Icahn Sch Med Mt Sinai, Div Pediat Allergy & Immunol, 1425 Madison Ave, New York, NY 10029 USA.	hugh.sampson@mssm.edu	Suprun, Maria/AAE-5507-2022		National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1AI109565, NO1-AI-15416, HHSN272200800029C, UM2AI117870]; David H. and Julia Koch Research Program in Food Allergy Therapeutics; AllerGenis LLC; Integrated Pharmacological Sciences Training Program grant from the National Institute of General Medical Sciences [T32GM062754]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); David H. and Julia Koch Research Program in Food Allergy Therapeutics; AllerGenis LLC; Integrated Pharmacological Sciences Training Program grant from the National Institute of General Medical Sciences	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (awards UM1AI109565, NO1-AI-15416, UM1AI109565, HHSN272200800029C, and UM2AI117870); the David H. and Julia Koch Research Program in Food Allergy Therapeutics; and AllerGenis LLC. M.S. was funded by the Integrated Pharmacological Sciences Training Program grant from the National Institute of General Medical Sciences (T32GM062754). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beyer K, 2003, J ALLERGY CLIN IMMUN, V112, P202, DOI 10.1067/mai.2003.1621; Bogh KL, 2012, MOL IMMUNOL, V51, P337, DOI 10.1016/j.molimm.2012.04.002; Cicchetti D.V., 1994, PSYCHOL ASSESSMENTS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; du Toit G, 2018, J ALLERGY CLIN IMMUN, V141, P1343, DOI 10.1016/j.jaci.2017.09.034; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Feeney M, 2016, J ALLERGY CLIN IMMUN, V138, P1108, DOI 10.1016/j.jaci.2016.04.016; Flinterman AE, 2008, J ALLERGY CLIN IMMUN, V121, P737, DOI 10.1016/j.jaci.2007.11.039; Otsu K, 2015, CLIN EXP ALLERGY, V45, P471, DOI 10.1111/cea.12407; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P1249, DOI 10.1016/j.jaci.2015.01.012; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Shreffler WG, 2004, J ALLERGY CLIN IMMUN, V113, P776, DOI 10.1016/j.jaci.2003.12.588; Suprun M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54868-7	14	7	7	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					835	842		10.1016/j.jaci.2021.01.030	http://dx.doi.org/10.1016/j.jaci.2021.01.030		SEP 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	33592205	Green Accepted			2022-12-18	WOS:000695242900032
J	Delgado-Eckert, E; James, A; Meier-Girard, D; Kupczyk, M; Andersson, LI; Bossios, A; Mikus, M; Ono, J; Izuhara, K; Middelveld, R; Dahlen, B; Gaga, M; Siafakas, NM; Papi, A; Beghe, B; Joos, G; Rabe, KF; Sterk, PJ; Bel, EH; Johnston, SL; Chanez, P; Gjomarkaj, M; Howarth, PH; Nizankowska-Mogilnicka, E; Dahlen, SE; Frey, U				Delgado-Eckert, Edgar; James, Anna; Meier-Girard, Delphine; Kupczyk, Maciej; Andersson, Lars I.; Bossios, Apostolos; Mikus, Maria; Ono, Junya; Izuhara, Kenji; Middelveld, Roelinde; Dahlen, Barbro; Gaga, Mina; Siafakas, Nikos M.; Papi, Alberto; Beghe, Bianca; Joos, Guy; Rabe, Klaus F.; Sterk, Peter J.; Bel, Elisabeth H.; Johnston, Sebastian L.; Chanez, Pascal; Gjomarkaj, Mark; Howarth, Peter H.; Nizankowska-Mogilnicka, Ewa; Dahlen, Sven-Erik; Frey, Urs			Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; chronic obstructive pulmonary disease; cluster analysis; phenotyping; remodeling	OBSTRUCTIVE PULMONARY-DISEASE; PEAK EXPIRATORY FLOW; PROTEIN; METALLOPROTEINASES; COMPLEXITY; SEVERITY; ADULTS; RISK	Background: In all chronic airway diseases, the dynamics of airway function are influenced by underlying airway inflammation and bronchial hyperresponsiveness along with limitations in reversibility owing to airway and lung remodeling as well as mucous plugging. The relative contribution of each component translates into specific clinical patterns of symptoms, quality of life, exacerbation risk, and treatment success. Objective: We aimed to evaluate whether subgrouping of patients with obstructive airway diseases according to patterns of fluctuation in lung function allows identification of specific phenotypes with distinct clinical characteristics. Methods: We applied the novel method of fluctuation-based clustering (FBC) to twice-daily FEV1 measurements recorded over a 1-year period in a mixed group of 134 adults with mild to-moderate asthma, severe asthma, or chronic obstructive pulmonary disease from the European BIOAIR cohort. Results: Independently of clinical diagnosis, FBC divided patients into 4 fluctuation-based clusters with progressively increasing alterations in lung function that corresponded to patterns of increasing clinical severity, risk of exacerbation, and lower quality of life. Clusters of patients with airway disease with significantly elevated levels of biomarkers relating to remodeling (osteonectin) and cellular senescence (plasminogen activator inhibitor-1), accompanied by a loss of airway reversibility, pulmonary hyperinflation, and loss of diffusion capacity, were identified. The 4 clusters generated were stable over time and revealed no differences in levels of markers of type 2 inflammation (blood eosinophils and periostin). Conclusion: FBC-based phenotyping provides another level of information that is complementary to clinical diagnosis and unrelated to eosinophilic inflammation, which could identify patients who may benefit from specific treatment strategies or closer monitoring.	[Delgado-Eckert, Edgar; Meier-Girard, Delphine; Frey, Urs] Univ Basel, Univ Childrens Hosp, Basel, Switzerland; [James, Anna; Kupczyk, Maciej; Andersson, Lars I.; Bossios, Apostolos; Mikus, Maria; Middelveld, Roelinde; Dahlen, Barbro; Dahlen, Sven-Erik] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Kupczyk, Maciej] Univ Lodz, Dept Internal Med Asthma & Allergy, Lodz, Poland; [Bossios, Apostolos; Dahlen, Barbro] Karolinska Univ Hosp, Dept Resp Med & Allergy, Huddinge, Sweden; [Bossios, Apostolos; Dahlen, Barbro] Karolinska Inst, Dept Med, Stockholm, Sweden; [Ono, Junya] Shino Test Corp Ltd, Sagamihara, Kanagawa, Japan; [Izuhara, Kenji] Saga Med Sch, Div Med Biochem, Dept Biomol Sci, Saga, Japan; [Gaga, Mina] Univ Athens, Athens, Greece; [Siafakas, Nikos M.] Univ Crete, Iraklion, Greece; [Papi, Alberto] Univ Ferrara, Ferrara, Italy; [Beghe, Bianca] Univ Modena & Reggio Emilia, Modena, Italy; [Joos, Guy] Univ Ghent, Ghent, Belgium; [Rabe, Klaus F.] Christian Albrechts Univ Kiel, Kiel, Germany; [Sterk, Peter J.; Bel, Elisabeth H.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands; [Johnston, Sebastian L.] Imperial Coll Sci & Technol, London, England; [Chanez, Pascal] Univ Marseilles, Marseille, France; [Gjomarkaj, Mark] Italian Res Council, Palermo, Italy; [Howarth, Peter H.] Univ Southampton, Southampton, Hants, England; [Nizankowska-Mogilnicka, Ewa] Jagellonian Univ, Krakow, Poland	University of Basel; Karolinska Institutet; University of Lodz; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Shino Test Corporation; Saga University; National & Kapodistrian University of Athens; University of Crete; University of Ferrara; Universita di Modena e Reggio Emilia; Ghent University; University of Kiel; University of Amsterdam; Imperial College London; UDICE-French Research Universities; Aix-Marseille Universite; University of Southampton; Jagiellonian University	Dahlen, SE (corresponding author), Karolinska Inst, Unit Asthma & Allergy Res, Inst Environm Med, S-17177 Stockholm, Sweden.	Sven-Erik.Dahlen@ki.se	Rabe, Klaus F./AAW-6296-2021; James, Anna/AAY-9937-2021	Rabe, Klaus F./0000-0002-7020-1401; Kupczyk, Maciej/0000-0003-0800-7867; Mikus, Maria/0000-0001-6560-6124; Andersson, Lars I./0000-0002-5257-4052; Bossios, Apostolos/0000-0002-0494-2690; Howarth, Peter/0000-0003-0619-7927; chanez, pascal/0000-0003-4059-0917; Frey, Urs/0000-0003-3773-2822	Swiss National Science Foundation [3200B0112099]; European Union [QLG1-CT-2000-01185]; Swedish Heart-Lung Foundation; Asthma and Allergy Foundation; Stockholm County Council; Vitalograph; Swedish Strategic Research Foundation; AstraZeneca; Bernard Osher Initiative for Se-vere Asthma Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Asthma and Allergy Foundation; Stockholm County Council(Stockholm County Council); Vitalograph; Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); AstraZeneca(AstraZeneca); Bernard Osher Initiative for Se-vere Asthma Research	Funding for this project was provided by the Swiss National Science Foundation (grant 3200B0112099) . The Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease (BIOAIR) study was supported by The Fifth Frame-work Programme of the European Union (contract number QLG1-CT-2000-01185) and several national funding bodies (the Swedish Heart-Lung Foundation, Asthma and Allergy Foundation and the Stockholm County Council) , and it received uncondi-tional support from Vitalograph. The ChAMP (the Centre for Allergy Research High-lights Asthma Markers of Phenotype) consortium is supported by the Swedish Strategic Research Foundation and an unconditional and competitive grant donated by AstraZeneca. M.K. and A.J. were supported by the Bernard Osher Initiative for Se-vere Asthma Research.	Agassandian M, 2014, INT J BIOCHEM CELL B, V53, P77, DOI 10.1016/j.biocel.2014.05.016; Agresti A., 1992, STAT SCI, V7, P131, DOI 10.1214/ss/1177011454; Barnes PJ, 2017, ANNU REV PHYSIOL, V79, P517, DOI 10.1146/annurev-physiol-022516-034314; Carolan BJ, 2013, J ALLERGY CLIN IMMUN, V131, P627, DOI 10.1016/j.jaci.2013.01.010; Choi S, 2017, J ALLERGY CLIN IMMUN, V140, P690, DOI 10.1016/j.jaci.2016.11.053; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; COLLINS LC, 1995, CHEST, V107, P1298, DOI 10.1378/chest.107.5.1298; Delgado-Eckert E, 2018, THORAX, V73, P107, DOI 10.1136/thoraxjnl-2016-209919; Diba C, 2007, J APPL PHYSIOL, V103, P296, DOI 10.1152/japplphysiol.00420.2006; Donaldson GC, 2012, EUR RESPIR J, V40, P1123, DOI 10.1183/09031936.00180811; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Eger KAB, 2019, CURR OPIN PHARMACOL, V46, P108, DOI 10.1016/j.coph.2019.05.005; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Frey U, 2011, J APPL PHYSIOL, V110, P1723, DOI 10.1152/japplphysiol.01297.2010; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Hathout Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31727; Hinks TSC, 2016, J ALLERGY CLIN IMMUN, V138, P61, DOI 10.1016/j.jaci.2015.11.020; Ilmarinen P, 2019, J ALLER CL IMM-PRACT, V7, P2466, DOI 10.1016/j.jaip.2019.03.043; Kalsheker NA, 1996, INT J BIOCHEM CELL B, V28, P961, DOI 10.1016/1357-2725(96)00032-5; Kaminsky DA, 2017, AM J RESP CRIT CARE, V195, P993, DOI 10.1164/rccm.201601-0076OC; Konstantellou E, 2015, RESP MED, V109, P1404, DOI 10.1016/j.rmed.2015.09.009; Kowal K, 2006, J THROMB HAEMOST, V4, P2718, DOI 10.1111/j.1538-7836.2006.02206.x; Kupczyk M, 2014, ALLERGY, V69, P1198, DOI 10.1111/all.12445; Kupczyk M, 2013, RESP MED, V107, P1521, DOI 10.1016/j.rmed.2013.07.014; Kupczyk M, 2013, THORAX, V68, P611, DOI 10.1136/thoraxjnl-2012-201815; Ma Z, 2009, CLIN EXP ALLERGY, V39, P1136, DOI 10.1111/j.1365-2222.2009.03272.x; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Phipatanakul W, 2017, AM J RESP CRIT CARE, V195, P1439, DOI 10.1164/rccm.201607-1453OC; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Schwenk JM, 2008, J PROTEOME RES, V7, P3168, DOI 10.1021/pr700890b; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; Thamrin C, 2016, AM J RESP CRIT CARE, V194, P1053, DOI 10.1164/rccm.201511-2288PP; Thamrin C, 2011, THORAX, V66, P1036, DOI 10.1136/thx.2010.156489; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Ye Q, 2018, EXPERT REV RESP MED, V12, P265, DOI 10.1080/17476348.2018.1439741; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84	40	7	7	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					407	419		10.1016/j.jaci.2020.12.652	http://dx.doi.org/10.1016/j.jaci.2020.12.652		AUG 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	33548398				2022-12-18	WOS:000684625700018
J	Ho, HE; Chun, Y; Jeong, S; Jumreornvong, O; Sicherer, SH; Bunyavanich, S				Ho, Hsi-en; Chun, Yoojin; Jeong, Stephanie; Jumreornvong, Oranicha; Sicherer, Scott H.; Bunyavanich, Supinda			Multidimensional study of the oral microbiome, metabolite, and immunologic environment in peanut allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; peanut allergy; microbiome; metabolome; short-chain fatty acids; mucosal immunity; cytokine; T(H)2 immunity	FOOD ALLERGY; SENSITIZATION; PROTECT; UPDATE	Background: The oral mucosa is the initial interface between food antigens, microbiota, and mucosal immunity, yet, little is known about oral host- environment dynamics in food allergy. Objective: Our aim was to determine oral microbial, metabolic, and immunologic profiles associated with peanut allergy. Methods: We recruited 105 subjects (56 with peanut allergy and 49 healthy subjects) for salivary microbiome profiling using 16S ribosomal RNA sequencing, short-chain fatty acid (SCFA) metabolite assays using liquid chromatography/mass spectrometry, and measurement of oral secreted cytokines using multiplex assays. Analyses within and across data types were performed. Results: The oral microbiome of individuals with peanut allergy was characterized by reduced species in the orders Lactobacillales, Bacteroidales (Prevotella spp), and Bacillales, and increased Neisseriales spp. The distinct oral microbiome of subjects with peanut allergy was accompanied by significant reductions in oral SCFA levels, including acetate, butyrate, and propionate, and significant elevation of IL-4 secretion. Decreased abundances of oral Prevotella spp and Veillonella spp in subjects with peanut allergy were significantly correlated with reduced oral SCFA levels (false discovery rate < 0.05), and increased oral Neisseria spp was correlated with lower oral SCFA levels (false discovery rate < 0.05). Additionally, oral Prevotella spp abundances were correlated with decreased local secretion of T(H)2-stimulating epithelial factors (IL-33 and thymic stromal lymphopoietin) and T(H)2 cytokines (IL-4, IL-5, and IL-13), whereas oral Neisseria spp abundance was positively associated with a T(H)2-skewed oral immune milieu. Conclusion: Our novel multidimensional analysis of the oral environment revealed distinct microbial and metabolic profiles associated with mucosal immune disturbances in peanut allergy. Our findings highlight the oral environment as an anatomic site of interest to examine host-microbiome dynamics in food allergy.	[Ho, Hsi-en; Jeong, Stephanie; Jumreornvong, Oranicha; Sicherer, Scott H.; Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Dept Pediat, Div Allergy & Immunol, New York, NY 10029 USA; [Ho, Hsi-en] Icahn Sch Med Mt Sinai, Dept Med, Div Clin Immunol, New York, NY 10029 USA; [Chun, Yoojin; Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genome Technol, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bunyavanich, S (corresponding author), 1425 Madison Ave,Box 1498, New York, NY 10029 USA.	supinda@post.harvard.edu			National Institutes of Health [R01 AI 147028]; Mount Sinai Food Allergy Treatment and Research Center; American Academy of Allergy Asthma and Immunology/Elliot and Roslyn Jaffe Third Year Fellowship in Food Allergy Research Award; Mount Sinai Pediatric Scholars Program; Mindich Child Health and Development Institute Trainee Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai Food Allergy Treatment and Research Center; American Academy of Allergy Asthma and Immunology/Elliot and Roslyn Jaffe Third Year Fellowship in Food Allergy Research Award; Mount Sinai Pediatric Scholars Program; Mindich Child Health and Development Institute Trainee Award	Funded by the National Institutes of Health (grant R01 AI 147028), the Mount Sinai Food Allergy Treatment and Research Center, the American Academy of Allergy Asthma and Immunology/Elliot and Roslyn Jaffe Third Year Fellowship in Food Allergy Research Award, the Mount Sinai Pediatric Scholars Program, and the Mindich Child Health and Development Institute Trainee Award.	Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Allam JP, 2011, ALLERGY, V66, P532, DOI 10.1111/j.1398-9995.2010.02510.x; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Bunyavanich S, 2019, J ALLERGY CLIN IMMUN, V144, P1468, DOI 10.1016/j.jaci.2019.10.019; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V138, P1122, DOI 10.1016/j.jaci.2016.03.041; Chen CC, 2016, PEDIAT ALLERG IMM-UK, V27, P254, DOI 10.1111/pai.12522; Chen TT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02995-4; Chu DK, 2014, MUCOSAL IMMUNOL, V7, P1395, DOI 10.1038/mi.2014.29; D'Argenio V, 2016, AM J GASTROENTEROL, V111, P879, DOI 10.1038/ajg.2016.95; Fazlollahi M, 2018, ALLERGY, V73, P1515, DOI 10.1111/all.13389; Han H, 2018, MUCOSAL IMMUNOL, V11, P394, DOI 10.1038/mi.2017.61; Ho HE, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0780-z; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iaffaldano L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29443-1; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Moingeon P, 2013, J ALLER CL IMM-PRACT, V1, P228, DOI 10.1016/j.jaip.2013.03.013; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Roduit C, 2019, ALLERGY, V74, P799, DOI 10.1111/all.13660; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Xiao J, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0082-x	25	7	7	3	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					627	+		10.1016/j.jaci.2021.03.028	http://dx.doi.org/10.1016/j.jaci.2021.03.028		AUG 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW		Green Accepted			2022-12-18	WOS:000687104900014
J	Xu, HD; Ohgami, N; Sakashita, M; Ogi, K; Hashimoto, K; Tazaki, A; Tong, KM; Aoki, M; Fujieda, S; Kato, M				Xu, Huadong; Ohgami, Nobutaka; Sakashita, Masafumi; Ogi, Kazuhiro; Hashimoto, Kazunori; Tazaki, Akira; Tong, Keming; Aoki, Masayo; Fujieda, Shigeharu; Kato, Masashi			Intranasal levels of lead as an exacerbation factor for allergic rhinitis in humans and mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Air pollutant; seasonal allergic rhinitis; exacerbation factor; intranasal exposure; lead; Japanese cedar pollen	JAPANESE CEDAR POLLINOSIS; SOLUBLE FAS LEVELS; SIGNAL-TRANSDUCTION; LOCAL-LEVELS; TOTAL IGE; POLLEN; PROTEIN; ASTHMA; NASAL; POLLUTION	Background: Air pollutants are suspected to affect pathological conditions of allergic rhinitis (AR). Objectives: After detecting Pb (375 mg/kg) in Japanese cedar pollen, the effects of intranasal exposure to Pb on symptoms of AR were investigated. Methods: Pollen counts, subjective symptoms, and Pb levels in nasal epithelial lining fluid (ELF) were investigated in 44 patients with Japanese cedar pollinosis and 57 controls from preseason to season. Effects of intranasal exposure to Pb on symptoms were confirmed by using a mouse model of AR. Results: Pb levels in ELF from patients were >40% higher than those in ELF from control subjects during the pollen season but not before the pollen season. Pb level in ELF was positively associated with pollen counts for the latest 4 days before visiting a hospital as well as scores of subjective symptoms. Intranasal exposure to Pb exacerbated symptoms in allergic mice, suggesting Pb as an exacerbation factor. Pb levels in ELF and nasal mucosa in Pb-exposed allergic mice were higher than those in Pb-exposed nonallergic mice, despite intranasally challenging the same amount of Pb. Because the increased Pb level in the nasal mucosa of Pb-exposed allergic mice was decreased after washing the nasal cavity, Pb on the surface of but not inside the nasal mucosa may have been a source of increased Pb level in ELF of allergic mice. Conclusions: Increased nasal Pb level partially derived from pollen could exacerbate subjective symptoms of AR, indicating Pb as a novel hazardous air pollutant for AR.	[Xu, Huadong; Ohgami, Nobutaka; Hashimoto, Kazunori; Tazaki, Akira; Tong, Keming; Aoki, Masayo; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi, Japan; [Xu, Huadong; Ohgami, Nobutaka; Hashimoto, Kazunori; Tazaki, Akira; Tong, Keming; Aoki, Masayo; Kato, Masashi] Voluntary Body Int Healthcare Univ, Nagoya, Aichi, Japan; [Sakashita, Masafumi; Ogi, Kazuhiro; Fujieda, Shigeharu] Univ Fukui, Div Otolaryngol Head & Neck Surg, Dept Sensory & Locomotor Med, Fukui, Japan	Nagoya University; University of Fukui	Kato, M (corresponding author), Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	katomasa@med.nagoya-u.ac.jp	KATO, Masashi/I-7250-2014; Kato, Masashi/AAG-3755-2021	Kato, Masashi/0000-0002-8951-3640; Xu, Huadong/0000-0003-2698-1807; Tazaki, Akira/0000-0002-7151-0089	Ministry of Education, Culture, Sports, Science and Technology [15H01743, 15H02588, 19H01147, 17KT0033, 20H03929, 16K08343, 20K21708]; Mirai-Program Small Start Type from the Japan Science and Technology Agency; Kobayashi International Scholarship Foundation; AEON Environmental Foundation; CSC (Chinese Scholarship Council) Scholarship [201706010346]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mirai-Program Small Start Type from the Japan Science and Technology Agency; Kobayashi International Scholarship Foundation; AEON Environmental Foundation; CSC (Chinese Scholarship Council) Scholarship	This study was supported in part by Grants-in-Aid for Scientific Research (A) (15H01743, 15H02588 and 19H01147), (B) (17KT0033 and 20H03929), (C) (16K08343) and Challenging Exploratory Research (20K21708) from the Ministry of Education, Culture, Sports, Science and Technology; Mirai-Program Small Start Type from the Japan Science and Technology Agency; Kobayashi International Scholarship Foundation; AEON Environmental Foundation; and CSC (Chinese Scholarship Council) Scholarship (201706010346). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akhand AA, 1998, J CELL BIOCHEM, V71, P243, DOI 10.1002/(SICI)1097-4644(19981101)71:2<243::AID-JCB9>3.0.CO;2-V; Al Hossain MMA, 2019, CHEMOSPHERE, V229, P611, DOI 10.1016/j.chemosphere.2019.04.112; Behrendt H, 2014, CHEM IMMUNOL ALLERGY, V100, P268, DOI 10.1159/000359918; Bibi S, 2008, PAK J BOT, V40, P507; Charpin D, 2019, CLIN REV ALLERG IMMU, V56, P174, DOI 10.1007/s12016-017-8602-y; Cui XX, 2018, ENVIRON INT, V114, P27, DOI 10.1016/j.envint.2018.02.010; Ghiani A, 2012, ALLERGY, V67, P887, DOI 10.1111/j.1398-9995.2012.02846.x; Gotoh M, 2019, J ALLER CL IMM-PRACT, V7, P1287, DOI 10.1016/j.jaip.2018.11.044; Gotoh M, 2013, ALLERGOL INT, V62, P181, DOI 10.2332/allergolint.12-OA-0498; Hattori Y, 2016, TOXICOL SCI, V152, P181, DOI 10.1093/toxsci/kfw080; Kato M, 1999, J ALLERGY CLIN IMMUN, V103, P1213, DOI 10.1016/S0091-6749(99)70202-2; Kato M, 1999, ALLERGY, V54, P1299, DOI 10.1034/j.1398-9995.1999.00303.x; Kato M, 1999, ALLERGY, V54, P278, DOI 10.1034/j.1398-9995.1999.00942.x; KATO M, 1994, BRIT J CLIN PRACT, V48, P299; Kato M, 2000, ARCH OTOLARYNGOL, V126, P997, DOI 10.1001/archotol.126.8.997; Kato M, 1996, ALLERGY, V51, P128, DOI 10.1111/j.1398-9995.1996.tb00048.x; KATO M, 1995, CLIN EXP ALLERGY, V25, P744, DOI 10.1111/j.1365-2222.1995.tb00012.x; KATO M, 1995, ORL J OTO-RHINO-LARY, V57, P269, DOI 10.1159/000276756; Kato M, 2020, ENVIRON HEALTH PREV, V25, DOI 10.1186/s12199-020-00855-8; KAULBACH HC, 1993, J ALLERGY CLIN IMMUN, V92, P457, DOI 10.1016/0091-6749(93)90125-Y; Kim EH, 2016, ALLERGY, V71, P629, DOI 10.1111/all.12839; Koh HY, 2019, J ALLER CL IMM-PRACT, V7, P2912, DOI 10.1016/j.jaip.2019.05.015; Li CH, 2020, J ASTHMA ALLERGY, V13, P285, DOI 10.2147/JAA.S237758; Lim MS, 2017, YONSEI MED J, V58, P1040, DOI 10.3349/ymj.2017.58.5.1040; Maspero JF, 2010, ALLERGY ASTHMA PROC, V31, P483, DOI 10.2500/aap.2010.31.3397; Mo JH, 2011, ALLERGY, V66, P279, DOI 10.1111/j.1398-9995.2010.02476.x; Nakamura H, 2003, J ALLERGY CLIN IMMUN, V112, P1127, DOI 10.1016/j.jaci.2003.08.051; Nakashima I, 2002, ANTIOXID REDOX SIGN, V4, P517, DOI 10.1089/15230860260196326; Ninomiya H, 2020, CHEMOSPHERE, V250, DOI 10.1016/j.chemosphere.2020.126124; Ohgami N, 2015, ENVIRON POLLUT, V206, P456, DOI 10.1016/j.envpol.2015.07.041; Omata Y, 2018, CHEMOSPHERE, V210, P384, DOI 10.1016/j.chemosphere.2018.07.022; Park S, 2016, J ALLERGY CLIN IMMUN, V138, P1701, DOI 10.1016/j.jaci.2016.04.030; Patelis A, 2016, UPSALA J MED SCI, V121, P25, DOI 10.3109/03009734.2015.1109569; Pu MY, 1996, J CELL BIOCHEM, V63, P104; Roberts G, 2004, THORAX, V59, P752, DOI 10.1136/thx.2003.008722; Rouadi PW, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100467; RoweJones JM, 1997, ALLERGY, V52, P20, DOI 10.1111/j.1398-9995.1997.tb04818.x; Schmidt CW, 2016, ENVIRON HEALTH PERSP, V124, pA70, DOI 10.1289/ehp.124-A70; Schober W, 2006, TOXICOL SCI, V90, P377, DOI 10.1093/toxsci/kfj092; Sedghy F, 2017, INT J BIOMETEOROL, V61, P1, DOI 10.1007/s00484-016-1186-z; Smith KE, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2021.110800; Sudo M, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.140830; Suzuki Toshihiro, 2018, Mass Spectrom (Tokyo), V7, pA0065, DOI 10.5702/massspectrometry.A0065; Tsuchiyama T, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109770; Urashima M, 2018, ALLERGY, V73, P2395, DOI 10.1111/all.13575; Weidinger S, 2004, J ALLERGY CLIN IMMUN, V114, P457, DOI 10.1016/j.jaci.2004.04.011; Xu HD, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115094; Xu HD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35244-3; Yajima I, 2017, ARCH TOXICOL, V91, P3507, DOI 10.1007/s00204-017-1975-0; Yajima I, 2015, J INVEST DERMATOL, V135, P1147, DOI 10.1038/jid.2014.514; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002	51	7	8	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					139	+		10.1016/j.jaci.2021.03.019	http://dx.doi.org/10.1016/j.jaci.2021.03.019		JUL 2021	19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	33766551				2022-12-18	WOS:000669906700022
J	Nobs, SP; Pohlmeier, L; Li, FQ; Kayhan, M; Becher, B; Kopf, M				Nobs, Samuel Philip; Pohlmeier, Lea; Li, Fengqi; Kayhan, Merve; Becher, Burkhard; Kopf, Manfred			GM-CSF instigates a dendritic cell-T-cell inflammatory circuit that drives chronic asthma development	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Neutrophils; asthma; chronic airway inflammation; GM-CSF; dendritic cell	COLONY-STIMULATING FACTOR; AIRWAY INFLAMMATION; NULL MUTATION; MICE; DIFFERENTIATION; SENSITIZATION; DEFICIENCY; MONOCYTES; RESPONSES; RELEASE	Background: Steroid-resistant asthma is often characterized by high levels of neutrophils and mixed TH2/TH17 immune profiles. Indeed, neutrophils are key drivers of chronic lung inflammation in multiple respiratory diseases. Their numbers correlate strongly with disease severity, and their presence is often associated with exacerbation of chronic lung inflammation. Objective: What factors drive development of neutrophil-mediated chronic lung disease remains largely unknown, and we sought to study the role of GM-CSF as a potential regulator in chronic asthma. Methods: Different experimental animal models of chronic asthma were used in combination with alveolar macrophage- reconstitution of global GM-CSF receptor knockout mice as well as cell-type-specific knockout animals to elucidate the role of GM-CSF signaling in chronic airway inflammation. Results: We identify GM-CSF signaling as a critical factor regulating pulmonary accumulation of neutrophils. We show that although being not required for intrinsically regulating neutrophil migration, GM-CSF controls lung dendritic cell function, which in turn promotes T-cell-dependent recruitment of neutrophils to the airways. We demonstrate that GM-CSF regulates lung dendritic cell antigen uptake, transport, and T(H)2/T(H)17 cell priming in an intrinsic fashion, which in turn drives pulmonary granulocyte recruitment and contributes to development of airway hyperresponsiveness in chronic disease. Conclusions: We identify GM-CSF as a potentially novel therapeutic target in chronic lung inflammation, describing a GM-CSF-dependent lung conventional dendritic cell-T-cellneutrophil axis that drives chronic lung disease.	[Nobs, Samuel Philip; Pohlmeier, Lea; Li, Fengqi; Kayhan, Merve; Kopf, Manfred] Swiss Fed Inst Technol, Dept Biol, Inst Mol Hlth Sci, Mol Biomed, Zurich, Switzerland; [Nobs, Samuel Philip] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Weizmann Institute of Science; University of Zurich	Kopf, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Otto Stern Weg 7, CH-8093 Zurich, Switzerland.	manfred.kopf@ethz.ch	Nobs, Samuel Philip/N-4819-2019; Kopf, Manfred/B-6907-2009	Nobs, Samuel Philip/0000-0003-0627-892X; Kopf, Manfred/0000-0002-0628-7140; Pohlmeier, Lea/0000-0001-5066-6941	Swiss National Science Foundation; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This study was funded by Swiss National Science Foundation and ETH Zurich.	Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Byrne AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069246; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; De Luca G, 2020, LANCET RHEUMATOL, V2, pE465, DOI 10.1016/S2665-9913(20)30170-3; Gorska MM, 2018, METHODS MOL BIOL, V1809, P351, DOI 10.1007/978-1-4939-8570-8_23; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huang G, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/7915975; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Krishnamoorthy N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4747; Leslie J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.125937; Molfino NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007709; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nobs SP, 2019, J ALLERGY CLIN IMMUN, V143, P1513, DOI 10.1016/j.jaci.2018.08.044; Nobs SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005508; Nobs SP, 2015, IMMUNITY, V43, P674, DOI 10.1016/j.immuni.2015.09.006; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Scherzer R, 2018, ANN ALLERG ASTHMA IM, V121, P400, DOI 10.1016/j.anai.2018.06.009; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schneider C, 2017, J LEUKOCYTE BIOL, V101, P367, DOI 10.1189/jlb.4HI0316-157R; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Su YC, 2008, J IMMUNOL, V180, P2600, DOI 10.4049/jimmunol.180.4.2600; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76	32	7	7	4	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2118	+		10.1016/j.jaci.2020.12.638	http://dx.doi.org/10.1016/j.jaci.2020.12.638		JUN 2021	19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33440200	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000657814800017
J	Williams, EJ; Negewo, NA; Baines, KJ				Williams, Evan J.; Negewo, Netsanet A.; Baines, Katherine J.			Role of the NLRP3 inflammasome in asthma: Relationship with neutrophilic inflammation, obesity, and therapeutic options	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; NLRP3 inflammasome; neutrophils; neutrophil extracellular traps; obesity	EXPRESSION		[Williams, Evan J.; Negewo, Netsanet A.; Baines, Katherine J.] Univ Newcastle, Prior Res Ctr Hlth Lungs, Hunter Med Res Inst, Callaghan, NSW, Australia	Hunter Medical Research Institute; University of Newcastle	Baines, KJ (corresponding author), Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Resp & Sleep Med, HMRI, Level 2 West,Lot 1 Kookaburra Circuit, New Lambton Hts, NSW 2305, Australia.	katherine.baines@newcastle.edu.au	Williams, Evan/ABC-2165-2021	Williams, Evan/0000-0003-0532-2060				Baines KJ, 2014, J ALLERGY CLIN IMMUN, V133, P997, DOI 10.1016/j.jaci.2013.12.1091; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Lachowicz-Scroggins ME, 2019, AM J RESP CRIT CARE, V199, P1076, DOI 10.1164/rccm.201810-1869OC; Rheinheimer J, 2017, METABOLISM, V74, P1, DOI 10.1016/j.metabol.2017.06.002; Shukla SD, 2021, THORAX, V76, P733, DOI 10.1136/thoraxjnl-2020-216331; Simpson JL, 2014, EUR RESPIR J, V43, P1067, DOI 10.1183/09031936.00105013; Theofani E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101615; Wood LG, 2019, J ALLERGY CLIN IMMUN, V143, P305, DOI 10.1016/j.jaci.2018.04.037; Wright TK, 2016, RESPIROLOGY, V21, P467, DOI 10.1111/resp.12730	10	7	7	2	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2060	2062		10.1016/j.jaci.2021.04.022	http://dx.doi.org/10.1016/j.jaci.2021.04.022		JUN 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33932467	Bronze			2022-12-18	WOS:000657814800008
J	Branchett, WJ; Cook, J; Oliver, RA; Bruno, N; Walker, SA; Stolting, H; Mack, M; O'Garra, A; Saglani, S; Lloyd, CM				Branchett, William J.; Cook, James; Oliver, Robert A.; Bruno, Nicoletta; Walker, Simone A.; Stoelting, Helen; Mack, Matthias; O'Garra, Anne; Saglani, Sejal; Lloyd, Clare M.			Airway macrophage-intrinsic TGF-beta 1 regulates pulmonary immunity during early-life allergen exposure	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; type 2 immunity; neonate; TGF-beta; lung immunity; macrophage; monocyte; chemokine	ALVEOLAR MACROPHAGES; TISSUE MACROPHAGES; FETAL MONOCYTES; DENDRITIC CELLS; 1ST WEEK; INFLAMMATION; MOUSE; HOMEOSTASIS; EXPRESSION; INFECTION	Background: Early life represents a major risk window for asthma development. However, the mechanisms controlling the threshold for establishment of allergic airway inflammation in early life are incompletely understood. Airway macrophages (AMs) regulate pulmonary allergic responses and undergo TGF-beta-dependent postnatal development, but the role of AM maturation factors such as TGF-beta in controlling the threshold for pathogenic immune responses to inhaled allergens remains unclear. Objective: Our aim was to test the hypothesis that AM-derived TGF-beta 1 regulates pathogenic immunity to inhaled allergen in early life. Methods: Conditional knockout (Tgfb1(Delta CD11c)) mice, with TGF-beta 1 deficiency in AMs and other CD11c(+) cells, were analyzed throughout early life and following neonatal house dust mite (HDM) inhalation. The roles of specific chemokine receptors were determined by using in vivo blocking antibodies. Results: AM-intrinsic TGF-beta 1 was redundant for initial population of the neonatal lung with AMs, but AMs from Tgfb1(Delta CD11c) mice failed to adopt a mature homeostatic AM phenotype in the first weeks of life. Evidence of constitutive TGF-beta 1 signaling was also observed in pediatric human AMs. TGF-beta 1-deficient AMs expressed enhanced levels of monocyte-attractant chemokines, and accordingly, Tgfb1(Delta DC11c) mice exposed to HDM throughout early life accumulated CCR2-dependent inflammatory CD11c(+) mononuclear phagocytes into the airway niche that expressed the proallergic chemokine CCL8. Tgfb1(Delta CD11c) mice displayed augmented T(H)2, group 2 innate lymphoid cell, and airway remodeling responses to HDM, which were ameliorated by blockade of the CCL8 receptor CCR8. Conclusion: Our results highlight a causal relationship between AM maturity, chemokines, and pathogenic immunity to environmental stimuli in early life and identify TGF-beta 1 as a key regulator of this.	[Branchett, William J.; Cook, James; Oliver, Robert A.; Bruno, Nicoletta; Walker, Simone A.; Stoelting, Helen; O'Garra, Anne; Saglani, Sejal; Lloyd, Clare M.] Imperial Coll London, Fac Med, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg, London SW7 2AZ, England; [Cook, James; Saglani, Sejal] Royal Brompton Hosp, Dept Paediat Resp Med, London, England; [Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med Nephrol 2, Regensburg, Germany; [O'Garra, Anne] Francis Crick Inst, Lab Immunoregulat & Infect, London, England	Imperial College London; Royal Brompton Hospital; University of Regensburg; Francis Crick Institute	Lloyd, CM (corresponding author), Imperial Coll London, Fac Med, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	c.lloyd@imperial.ac.uk	Stoelting, Helen/GPS-8154-2022	Stoelting, Helen/0000-0002-7830-2776; Lloyd, Clare/0000-0001-8977-6726	Wellcome Trust Senior Fellowship [107059/Z/15/Z]; Cancer Research UK [FC001126]; UK Medical Research Council [FC001126]; Wellcome Trust [FC001126]	Wellcome Trust Senior Fellowship(Wellcome Trust); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a Wellcome Trust Senior Fellowship 107059/Z/15/Z (to C.M.L.) . In addition, A.O.G. is employed by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001126) , the UK Medical Research Council (FC001126) , and the Wellcome Trust (FC001126) .	Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Bachus H, 2019, IMMUNITY, V50, P225, DOI 10.1016/j.immuni.2018.11.012; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Branchett William J, 2020, Wellcome Open Res, V5, P101, DOI 10.12688/wellcomeopenres.15875.1; Branchett WJ, 2020, J ALLERGY CLIN IMMUN, V145, P666, DOI 10.1016/j.jaci.2019.08.006; Byrne AJ, 2017, MUCOSAL IMMUNOL, V10, P716, DOI 10.1038/mi.2016.92; Byrne AJ, 2015, THORAX, V70, P1189, DOI 10.1136/thoraxjnl-2015-207020; Byrneee AJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20191236; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Draijer C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/632049; Duan M, 2016, MUCOSAL IMMUNOL, V9, P550, DOI 10.1038/mi.2015.84; Ducreux J, 2009, IMMUNOL LETT, V124, P77, DOI 10.1016/j.imlet.2009.04.006; Dyer DP, 2019, IMMUNITY, V50, P378, DOI 10.1016/j.immuni.2019.01.009; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Knipfer L, 2019, J EXP MED, V216, P2763, DOI 10.1084/jem.20182111; Lambert L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01570; Lee AH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08794-x; Lee YG, 2015, AM J RESP CELL MOL, V52, P772, DOI 10.1165/rcmb.2014-0255OC; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Lloyd CM, 2019, TRENDS IMMUNOL, V40, P786, DOI 10.1016/j.it.2019.07.004; Lloyd CM, 2017, IMMUNOL REV, V278, P101, DOI 10.1111/imr.12562; Ma B, 2004, J IMMUNOL, V172, P1872, DOI 10.4049/jimmunol.172.3.1872; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mathie SA, 2015, ALLERGY, V70, P80, DOI 10.1111/all.12536; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Puttur F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav7638; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Saglani S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan4128; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580; Zhang Y, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1134	46	7	7	1	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1892	1906		10.1016/j.jaci.2021.01.026	http://dx.doi.org/10.1016/j.jaci.2021.01.026		MAY 2021	15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33571538	Green Published, hybrid			2022-12-18	WOS:000651594300009
J	Li, H; Ryu, MH; Rider, CF; Tse, W; Clifford, RL; Aristizabal, MJ; Wen, WP; Carlsten, C				Li, Hang; Ryu, Min Hyung; Rider, Christopher F.; Tse, Wayne; Clifford, Rachel L.; Aristizabal, Maria J.; Wen, Weiping; Carlsten, Chris			Predominant DNMT and TET mediate effects of allergen on the human bronchial epithelium in a controlled air pollution exposure study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Controlled human exposure crossover study; ten-eleven translocation (TET); DNA methylation (DNAm); asthma; allergen; diesel exhaust (DE)	COLONY-STIMULATING FACTOR; DNA-BASE 5-HYDROXYMETHYLCYTOSINE; INHALED DIESEL EXHAUST; DENDRITIC CELLS; T-CELLS; METHYLATION; 5-METHYLCYTOSINE; PROTEINS; METHYLTRANSFERASE; DIFFERENTIATION	Background: Epidemiological data show that traffic-related air pollution contributes to the increasing prevalence and severity of asthma. DNA methylation (DNAm) changes may elucidate adverse health effects of environmental exposures. Objectives: We sought to assess the effects of allergen and diesel exhaust (DE) exposures on global DNAm and its regulation enzymes in human airway epithelium. Methods: A total of 11 participants, including 7 with and 4 without airway hyperresponsiveness, were recruited for a randomized, double-blind crossover study. Each participant had 3 exposures: filtered air + saline, filtered air + allergen, and DE + allergen. Forty-eight hours postexposure, endobronchial biopsies and bronchoalveolar lavages were collected. Levels of DNA methyltransferases (DNMTs) and ten-eleven translocation (TET) enzymes, 5-methylcytosine, and 5-hydroxymethylcytosine were determined by immunohistochemistry. Cytokines and chemokines in bronchoalveolar lavages were measured by electrochemiluminescence multiplex assays. Results: Predominant DNMT (the most abundant among DNMT1, DNMT3A, and DNMT3B) and predominant TET (the most abundant among TET1, TET2, and TET3) were participant-dependent. 5-Methylcytosine and its regulation enzymes differed between participants with and without airway hyperresponsiveness at baseline (filtered air + saline) and in response to allergen challenge (regardless of DE exposure). Predominant DNMT and predominant TET correlated with lung function. Allergen challenge effect on IL-8 in bronchoalveolar lavages was modified by TET2 baseline levels in the epithelium. Conclusions: Response to allergen challenge is associated with key DNAm regulation enzymes. This relationship is generally unaltered by DE coexposure but is rather dependent on airway hyperresponsiveness status. These enzymes therefore warranted further inquiry regarding their potential in diagnosis, prognosis, and treatment of asthma. (J Allergy Clin Immunol 2021;147:1671-82.)	[Li, Hang; Wen, Weiping] Sun Yat Sen Univ, Dept Otolaryngol, Affiliated Hosp 1, 58,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Li, Hang; Ryu, Min Hyung; Rider, Christopher F.; Tse, Wayne; Carlsten, Chris] Univ British Columbia, Dept Med, Div Resp Med, Air Pollut Exposure Lab, Vancouver, BC, Canada; [Clifford, Rachel L.] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham NIHR Biomed Res Ctr, Nottingham, England; [Aristizabal, Maria J.] Univ British Columbia, BC Childrens Hosp Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC, Canada; [Aristizabal, Maria J.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Aristizabal, Maria J.] Canadian Inst Adv Res CIFAR, Child & Brain Dev Program, Toronto, ON, Canada	Sun Yat Sen University; University of British Columbia; Nottingham University Hospital NHS Trust; University of Nottingham; University of British Columbia; University of Toronto; Canadian Institute for Advanced Research (CIFAR)	Wen, WP (corresponding author), Sun Yat Sen Univ, Dept Otolaryngol, Affiliated Hosp 1, 58,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Carlsten, C (corresponding author), Lung Ctr, Vancouver Gen Hosp, Gordon & Leslie Diamond Hlth Care Ctr, 2775 Laurel St,7th Floor, Vancouver, BC V5Z 1M9, Canada.	wenwp@mail.sysu.edu.cn; carlsten@mail.ubc.ca	温, 家琦/GYV-3177-2022	Ryu, Min Hyung/0000-0003-3071-7363; Aristizabal, Maria/0000-0002-4491-6147	Canadian Institutes of Health Research [MOP 123319]; WorkSafe BC [RG2011OG07]; AllerGen National Centre for Excellence [GxE4]; International Program Fund for doctoral students from Sun Yatsen University; program of China Scholarships Council; WorkSafe BC Research Training Award [RS2016-TG08]; NSERC Alexander Graham Bell Scholarship CGS-D; BC Lung Association; MITACS Accelerate; Michael Smith Foundation for Health Research; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); WorkSafe BC; AllerGen National Centre for Excellence; International Program Fund for doctoral students from Sun Yatsen University; program of China Scholarships Council; WorkSafe BC Research Training Award; NSERC Alexander Graham Bell Scholarship CGS-D; BC Lung Association; MITACS Accelerate; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chairs program(Canada Research Chairs)	This study was supported by Canadian Institutes of Health Research (grant no. MOP 123319) , WorkSafe BC (grant no. RG2011OG07) , AllerGen National Centre for Excellence (grant no. GxE4) , the International Program Fund for doctoral students from Sun Yatsen University and the program of China Scholarships Council (to H.L.) , WorkSafe BC Research Training Award RS2016-TG08 and an NSERC Alexander Graham Bell Scholarship CGS-D (to M.H.R.) , fellowships from the BC Lung Association, MITACS Accelerate, and the Michael Smith Foundation for Health Research (to C.F.R.) , and the Canada Research Chairs program (to C.C.) .	ADAMS RLP, 1990, BIOCHEM J, V265, P309, DOI 10.1042/bj2650309; Akiyama N, 2019, HISTOL HISTOPATHOL, P18147; Begin P, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-27; BRITTEN KM, 1993, BIOTECH HISTOCHEM, V68, P271, DOI 10.3109/10520299309105629; Burleson JD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43767-6; Cardenas A, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1467; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Clifford RL, 2017, J ALLERGY CLIN IMMUN, V139, P112, DOI 10.1016/j.jaci.2016.03.046; Cockcroft DW, 2005, ALLERGY, V60, P56, DOI 10.1111/j.1398-9995.2004.00612.x; Collignon E, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap7309; Collins JE, 2011, METHODS MOL BIOL, V762, P371, DOI 10.1007/978-1-61779-185-7_27; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Francisco-Cruz A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0774-6; Garlisi CG, 1999, EUR J IMMUNOL, V29, P3210, DOI 10.1002/(SICI)1521-4141(199910)29:10<3210::AID-IMMU3210>3.0.CO;2-W; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Hosseini A, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0114-z; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang RW, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0071-3; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; KARASUYAMA H, 1988, J EXP MED, V167, P1377, DOI 10.1084/jem.167.4.1377; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lardenoije R, 2015, NEUROBIOL AGING, V36, P3079, DOI 10.1016/j.neurobiolaging.2015.08.001; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Li H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02271; Liu J, 2008, TOXICOL SCI, V102, P76, DOI 10.1093/toxsci/kfm290; LOPEZ AF, 1986, J EXP MED, V163, P1085, DOI 10.1084/jem.163.5.1085; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moen EL, 2015, IMMUNOL REV, V263, P36, DOI 10.1111/imr.12242; Perez L, 2013, EUR RESPIR J, V42, P594, DOI 10.1183/09031936.00031112; Rider CF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0713-2; Root RK, 1999, J INFECT DIS, V179, pS342, DOI 10.1086/513857; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Ryu MH, 2020, THORAX, V75, P640, DOI 10.1136/thoraxjnl-2020-214561; Shukla A, 2019, SCI TOTAL ENVIRON, V656, P760, DOI 10.1016/j.scitotenv.2018.11.381; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Somineni HK, 2016, J ALLERGY CLIN IMMUN, V137, P797, DOI 10.1016/j.jaci.2015.10.021; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stancheva I, 2000, GENE DEV, V14, P313; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200; White GP, 2006, PEDIAT ALLERG IMM-UK, V17, P557, DOI 10.1111/j.1399-3038.2006.00465.x; Wilson SJ, 2000, METH MOLEC MED, V44, P227, DOI 10.1385/1-59259-072-1:227; Wooding DJ, 2019, AM J RESP CRIT CARE, V200, P565, DOI 10.1164/rccm.201809-1657OC; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Zhang LT, 2013, BIOANALYSIS, V5, P839, DOI [10.4155/BIO.13.28, 10.4155/bio.13.28]; Zhang X, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy020	58	7	7	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1671	1682		10.1016/j.jaci.2020.08.044	http://dx.doi.org/10.1016/j.jaci.2020.08.044		MAY 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33069714	Green Accepted			2022-12-18	WOS:000647680800017
J	Toyoshima, S; Sakamoto-Sasaki, T; Kurosawa, Y; Hayama, K; Matsuda, A; Watanabe, Y; Terui, T; Gon, Y; Matsumoto, K; Okayama, Y				Toyoshima, Shota; Sakamoto-Sasaki, Tomomi; Kurosawa, Yusuke; Hayama, Koremasa; Matsuda, Akira; Watanabe, Yasuo; Terui, Tadashi; Gon, Yasuhiro; Matsumoto, Kenji; Okayama, Yoshimichi			miR103a-3p in extracellular vesicles from Fc epsilon RI- aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Extracellular vesicles; human mast cells; group 2 innate lymphoid cells; IL-5; miRNA103a-3p; methylated arginine residue; protein arginine methyltransferase 5	REGULATORY T-CELLS; GENE-EXPRESSION; EXOSOMES; INFLAMMATION; IGE; MICRORNAS; PROTEIN; METHYLATION; INHIBITION; INDUCTION	Background: Mast cells (MCs) are key regulators of IgE-mediated allergic inflammation. Cell-derived extracellular vesicles (EVs) contain bioactive compounds such as microRNAs. EVs can transfer signals to recipient cells, thus using a novel mechanism of cell-to-cell communication. However, whether MC-derived EVs are involved in Fc epsilon RI-mediated allergic inflammation is unclear. Objective: We sought to investigate the effect of EVs derived from Fc epsilon RI-aggregated human MCs on the function of human group 2 innate lymphoid cells (ILC2s). Methods: Human cultured MCs were sensitized with and without IgE for 1 hour and then incubated with anti-IgE antibody, IL-33, or medium alone for 24 hours. EVs in the MC supernatant were isolated by using ExoQuick-TC. Results: Coculture of ILC2s with EVs derived from the Fc epsilon RI-aggregated MCs significantly enhanced IL-5 production and sustained upregulation of IL-5 mRNA expression in IL-33-stimulated ILC2s, but IL-13 production and IL-13 mRNA expression were unchanged. miR103a-3p expression was upregulated in IL-33-stimulated ILC2s that had been cocultured with EVs derived from anti-IgE antibody-stimulated MCs.Transduction of an miR103a-3p mimic to ILC2s significantly enhanced IL-5 production by IL-33-stimulated ILC2s. miR103a3p promoted demethylation of an arginine residue of GATA3 by downregulating protein arginine methyltransferase 5 (PRMT5) mRNA. Reduction of protein arginine methyltransferase 5 expression in ILC2s by using a small interfering RNA technique resulted in upregulation of IL-5 production by IL-33-stimulated ILC2s. Furthermore, the level of miR103a-3p expression was significantly higher in EVs from sera of patients with atopic dermatitis than in EVs from nonatopic healthy control subjects. Conclusion: Eosinophilic allergic inflammation may be exacerbated owing to ILC2 activation by MC-derived miR103a-3p.	[Toyoshima, Shota; Sakamoto-Sasaki, Tomomi; Kurosawa, Yusuke; Okayama, Yoshimichi] Nihon Univ, Sch Med, Allergy & Immunol Res Project Team, Res Inst Med Sci, Tokyo, Japan; [Toyoshima, Shota; Sakamoto-Sasaki, Tomomi; Okayama, Yoshimichi] Nihon Univ, Sch Med, Ctr Med Educ, Tokyo, Japan; [Kurosawa, Yusuke; Gon, Yasuhiro] Nihon Univ, Sch Med, Div Resp Med, Dept Internal Med, Tokyo, Japan; [Hayama, Koremasa; Terui, Tadashi] Nihon Univ, Sch Med, Divison Cutaneous Sci, Dept Dermatol, Tokyo, Japan; [Toyoshima, Shota; Sakamoto-Sasaki, Tomomi; Kurosawa, Yusuke; Hayama, Koremasa; Terui, Tadashi; Gon, Yasuhiro; Okayama, Yoshimichi] Nihon Univ, Itabashi Hosp, Ctr Allergy, Tokyo, Japan; [Matsuda, Akira; Watanabe, Yasuo] Juntendo Univ, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan	Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Juntendo University; National Center for Child Health & Development - Japan	Okayama, Y (corresponding author), Nihon Univ, Sch Med, Ctr Med Educ,Itabashi Ku, Ctr Allergy,Res Inst Med Sci,Allergy & Immunol Re, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	okayama.yoshimichi@nihon.u.ac.jp	Matsuda, Akira/A-9981-2010	Matsuda, Akira/0000-0002-0792-3663	MEXT of the Japanese Government [19K17687, 20K08811]; Nihon University Research Grant for Social Implementation [Sya201201]; MEXT [S1511014]	MEXT of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University Research Grant for Social Implementation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported in part by a GrantinAid for EarlyCareer Scientists (19K17687 [to S.T.] ) and a GrantinAid for Scientific Research from the MEXT of the Japanese Government (20K08811 [to Y.O.] ) , the Nihon University Research Grant for Social Implementation for 2020 (project No. Sya201201 [to Y.O.] ) , and the MEXTSupported Program for the Strategic Research Foundation at Private Universities, 2015-2019 (project No. S1511014 [to Y.O., T.T., and Y.G.) .	Abels ER, 2016, CELL MOL NEUROBIOL, V36, P301, DOI 10.1007/s10571-016-0366-z; Akdis CA, 2020, ALLERGY, V75, P1582, DOI 10.1111/all.14318; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boothe WD, 2017, ADV EXP MED BIOL, V1027, P21, DOI 10.1007/978-3-319-64804-0_3; Bryniarski K, 2013, J ALLERGY CLIN IMMUN, V132, P170, DOI 10.1016/j.jaci.2013.04.048; Burton OT, 2018, CLIN EXP ALLERGY, V48, P288, DOI 10.1111/cea.13075; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Busse W, 2019, J ALLERGY CLIN IMMUN, V143, P190, DOI 10.1016/j.jaci.2018.08.031; Chen Z, 2018, J IMMUNOL, V201, P2472, DOI 10.4049/jimmunol.1800304; Cheung KL, 2016, J EXP MED, V213, P2399, DOI 10.1084/jem.20160258; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Fujisawa D, 2014, J ALLERGY CLIN IMMUN, V134, P622, DOI 10.1016/j.jaci.2014.05.004; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gonda A, 2019, MOL CANCER RES, V17, P337, DOI 10.1158/1541-7786.MCR-18-0891; Gyles SL, 2006, IMMUNOLOGY, V119, P362, DOI 10.1111/j.1365-2567.2006.02440.x; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hosokawa H, 2015, J BIOL CHEM, V290, P13095, DOI 10.1074/jbc.M114.621524; Igarashi H, 2009, MOL IMMUNOL, V46, P1031, DOI 10.1016/j.molimm.2008.08.272; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Inoue M, 2018, NAT IMMUNOL, V19, P1265, DOI 10.1038/s41590-018-0222-z; Ito R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121580; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Katoh N, 2020, ALLERGOL INT, V69, P356, DOI 10.1016/j.alit.2020.02.006; Kim DK, 2018, P NATL ACAD SCI USA, V115, pE10692, DOI 10.1073/pnas.1809938115; Kimura K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02406-2; Lee H, 2013, ARTHRITIS RHEUM-US, V65, P109, DOI 10.1002/art.37741; Lee JB, 2016, J ALLERGY CLIN IMMUN, V137, P1216, DOI 10.1016/j.jaci.2015.09.019; Li F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3623898; Li SH, 2018, CELL REP, V23, P389, DOI 10.1016/j.celrep.2018.03.051; Lianga YT, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1697583; Litzler LC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07884-6; Liu FT, 2011, CLIN REV ALLERG IMMU, V41, P298, DOI 10.1007/s12016-011-8252-4; Lu XQ, 2018, BLOOD, V132, P2026, DOI 10.1182/blood-2018-02-831438; Luo X, 2015, SCI REP-UK, V5, DOI 10.1038/srep15937; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Matsuno T, 2018, ALLERGOL INT, V67, pS18, DOI 10.1016/j.alit.2018.05.001; Men YQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11534-w; Mjosberg J, 2016, J ALLERGY CLIN IMMUN, V138, P1265, DOI 10.1016/j.jaci.2016.09.009; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Nagai Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00174; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Nazimek K, 2019, CLIN EXP ALLERGY, V49, P1487, DOI 10.1111/cea.13475; Qiao YM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00217; Real JM, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2003-3; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Ronnberg E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01361; Saha B, 2016, J BIOL CHEM, V291, P149, DOI 10.1074/jbc.M115.694133; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Skokos D, 2003, J IMMUNOL, V170, P3037, DOI 10.4049/jimmunol.170.6.3037; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Truong G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174514; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Webb LM, 2017, J IMMUNOL, V198, P1439, DOI 10.4049/jimmunol.1601702; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Zhang BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049767; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zheng YX, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00596	65	7	7	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1878	1891		10.1016/j.jaci.2021.01.002	http://dx.doi.org/10.1016/j.jaci.2021.01.002		MAY 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33465368	Bronze			2022-12-18	WOS:000651594300008
J	van der Ploeg, EK; Hermans, MAW; van der Velden, VHJ; Dik, WA; van Daele, PLA; Stadhouders, R				van der Ploeg, Esmee K.; Hermans, Maud A. W.; van der Velden, Vincent H. J.; Dik, Willem A.; van Daele, Paul L. A.; Stadhouders, Ralph			Increased group 2 innate lymphoid cells in peripheral blood of adults with mastocytosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mastocytosis; mast cell; innate lymphoid cell; ILC2; KIT; itch; maculopapular cutaneous mastocytosis	SYSTEMIC MASTOCYTOSIS; MAST-CELLS	Background: Systemic mastocytosis is a hematological disease in which aberrant mast cells accumulate because of gain-of-function mutations in the KIT receptor. Group 2 innate lymphoid cells (ILC2s) are effector cells of type 2 immune responses that also express KIT and colocalize with mast cells at barrier tissue sites. In mouse models, mast cell-ILC2 crosstalk can drive local inflammation. However, a possible role for ILC2s in the pathophysiology of mastocytosis remains unexplored. Objective: We sought to characterize circulating ILC2s in a clinically diverse cohort of patients with mastocytosis. Methods: We included 21 adults with systemic mastocytosis and 18 healthy controls. Peripheral blood ILC2 abundance and phenotype were analyzed by flow cytometry and correlated to clinical characteristics, including the presence of the D816V KIT mutation. Results: ILC2 levels were significantly higher in D816V1 patients with mastocytosis compared with D816V- patients or healthy controls. We observed increased proportions of KIT1 ILC2s among patients with mastocytosis, regardless of D816V status. Patients with skin involvement and itch showed the highest levels of ILC2s, which was independent from atopy or serum tryptase levels. Allele-specific quantitative PCR showed that the vast majority of ILC2s did not carry the D816V mutation. Conclusions: Our findings suggest a role for ILC2s and pathogenic ILC2-mast cell crosstalk in mastocytosis. We hypothesize that a high cutaneous D816V1 mast cell burden alters the skin microenvironment to induce chronic local ILC2 activation and their dissemination into the circulation. Activated ILC2s could contribute to skin symptoms by producing inflammatory mediators and by further augmenting mast cell mediator release.	[van der Ploeg, Esmee K.; Stadhouders, Ralph] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [van der Ploeg, Esmee K.; Stadhouders, Ralph] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Hermans, Maud A. W.; van Daele, Paul L. A.] Erasmus MC, Dept Internal Med, Clin Immunol Sect, Rotterdam, Netherlands; [Hermans, Maud A. W.; van Daele, Paul L. A.] Erasmus MC, Dept Internal Med, Sect Allergy, Rotterdam, Netherlands; [van der Velden, Vincent H. J.; Dik, Willem A.; van Daele, Paul L. A.] Erasmus MC, Dept Immunol, Lab Med Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Stadhouders, R (corresponding author), Erasmus MC, Dept Pulm Med, Dept Cell Biol, Room Ee2253a,S Gravendijkwal 230, NL-3015 CD Rotterdam, Netherlands.	r.stadhouders@erasmusmc.nl	Stadhouders, Ralph/J-8663-2015	Stadhouders, Ralph/0000-0002-1060-5607	Netherlands Organisation for Scientific Research (Veni fellowship) [91617114]; Erasmus MC	Netherlands Organisation for Scientific Research (Veni fellowship); Erasmus MC	This study is supported by the Netherlands Organisation for Scientific Research (Veni fellowship no. 91617114 to R.S.) and the Erasmus MC (internal fellowship to R.S.).	Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0; Chatterjee A, 2015, ONCOTARGET, V6, P18250, DOI 10.18632/oncotarget.4213; Doherty TA, 2015, J LEUKOCYTE BIOL, V97, P455, DOI 10.1189/jlb.5BT0814-374R; HAMANN K, 1995, BRIT J DERMATOL, V133, P203, DOI 10.1111/j.1365-2133.1995.tb02616.x; Hochdorfer T, 2019, EUR J IMMUNOL, V49, P884, DOI 10.1002/eji.201848006; Kristensen T, 2011, J MOL DIAGN, V13, P180, DOI 10.1016/j.jmoldx.2010.10.004; Mukai K, 2018, IMMUNOL REV, V282, P121, DOI 10.1111/imr.12634; Pardanani A, 2019, AM J HEMATOL, V94, P363, DOI 10.1002/ajh.25371; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Roediger B, 2014, CURR OPIN IMMUNOL, V31, P108, DOI 10.1016/j.coi.2014.10.008; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893; van Daele PLA, 2009, NETH J MED, V67, P142; van Doormaal JJ, 2012, ALLERGY, V67, P683, DOI 10.1111/j.1398-9995.2012.02809.x; Vermeiren MR, 2020, ANN ALLERG ASTHMA IM, V124, P373, DOI 10.1016/j.anai.2019.12.020; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056	16	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1490	+		10.1016/j.jaci.2020.09.037	http://dx.doi.org/10.1016/j.jaci.2020.09.037		APR 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RX3VK	33091410	Green Published, hybrid			2022-12-18	WOS:000647154500013
J	Yoneyama, T; Nakano, N; Hara, M; Yamada, H; Izawa, K; Uchida, K; Kaitani, A; Ando, T; Kitaura, J; Ohtsuka, Y; Ogawa, H; Okumura, K; Shimizu, T				Yoneyama, Toshiyuki; Nakano, Nobuhiro; Hara, Mutsuko; Yamada, Hiromichi; Izawa, Kumi; Uchida, Koichiro; Kaitani, Ayako; Ando, Tomoaki; Kitaura, Jiro; Ohtsuka, Yoshikazu; Ogawa, Hideoki; Okumura, Ko; Shimizu, Toshiaki			Notch signaling contributes to the establishment of sustained unresponsiveness to food allergens by oral immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; oral immunotherapy; Notch signaling; myeloid-derived suppressor cell; sustained unresponsiveness	REGULATORY T-CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; MECHANISMS; GENERATION; INDUCTION; TOLERANCE; DEPLETION; IMMUNITY; INNATE	Background: Oral immunotherapy (OIT) aims to establish desensitization and sustained unresponsiveness (SU) in patients with food allergy by ingestion of gradually increasing doses of specific food allergens. However, little is known about the mechanisms by which OIT induces SU to specific allergens. Objectives: We investigated the role of Notch signaling, which controls cell fate decisions in many types of immune cells in the induction of SU by OIT treatment. Methods: Two types of mouse models, ovalbumin-induced food allergy and OIT, were generated. To elucidate the role of Notch signaling in OIT-induced SU, mice were intraperitoneally injected with the Notch signaling inhibitor N-[(3,5- difluorophenyl)acetyl]-L-alanyl-2-phenylglycine-1,1-dimethylethyl ester during the OIT treatment period. Results: Ovalbumin-sensitized mice were desensitized and also had SU induced by OIT treatment, whereas repeated challenges with ovalbumin caused the development of severe allergic reactions in ovalbumin-sensitized mice. Administration of N- [(3,5-difluorophenyl)acetyl]-L-alanyl-2-phenylglycine-1,1- dimethylethylester to mice during the OIT treatment period inhibited the establishment of SU to ovalbumin but did not affect the induction of desensitization. OIT induced a systemic expansion of IL-10-producing CD41 T cells, including TH2 cells, and myeloid-derived suppressor cells (MDSCs), particularly the monocytic MDSC subpopulation. Inhibition of Notch signaling prevented the OIT-induced expansion of those cells. In vitro cultures of bone marrow cells showed that Notch signaling directly promoted the generation of monocytic MDSCs. In addition, the contribution of MDSCs to OIT-induced SU was confirmed by MDSC depletion with the anti-Gr1 antibody. Conclusion: Notch signaling contributes to the establishment of SU induced by OIT through systemic expansion of immunosuppressive cells, such as IL-10-producing CD41 T cells and MDSCs. (J Allergy Clin Immunol 2021;147:1063-76.) <comment>Superscript/Subscript Available</comment	[Yoneyama, Toshiyuki; Yamada, Hiromichi; Ohtsuka, Yoshikazu; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo, Japan; [Nakano, Nobuhiro; Hara, Mutsuko; Izawa, Kumi; Kaitani, Ayako; Ando, Tomoaki; Kitaura, Jiro; Ogawa, Hideoki; Okumura, Ko] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan; [Uchida, Koichiro] Juntendo Univ, Adv Res Inst Hlth Sci, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University	Nakano, N (corresponding author), Juntendo Univ, Atopy Allergy Res Ctr, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nbnakano@juntendo.ac.jp		Nakano, Nobuhiro/0000-0002-5317-5950	Ministry of Education, Culture, Sports, Science and Technology [18K08416]; Foundation for Dietary Scientific Research	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Dietary Scientific Research	Supported in part by the Ministry of Education, Culture, Sports, Science and Technology GrantsinAid for Scientific Research program (grant 18K08416) and Research Grant 2018 from the Foundation for Dietary Scientific Research.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cheng PY, 2014, CANCER RES, V74, P141, DOI 10.1158/0008-5472.CAN-13-1686; Chinthrajah RS, 2016, J ALLERGY CLIN IMMUN, V137, P984, DOI 10.1016/j.jaci.2016.02.004; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Dorhoi A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01895; Fang DF, 2020, CELL MOL LIFE SCI, V77, P289, DOI 10.1007/s00018-019-03277-0; Freeland DMH, 2017, SEMIN IMMUNOL, V30, P36, DOI 10.1016/j.smim.2017.08.008; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goldberg MR, 2017, J ALLERGY CLIN IMMUN, V139, P1388, DOI 10.1016/j.jaci.2016.09.053; Grazioli P, 2017, J LEUKOCYTE BIOL, V102, P361, DOI 10.1189/jlb.1VMR1216-505R; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Honjo A, 2017, J ALLERGY CLIN IMMUN, V139, P987, DOI 10.1016/j.jaci.2016.05.046; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Ma C, 2012, J LEUKOCYTE BIOL, V92, P1199, DOI 10.1189/jlb.0212059; Mao L, 2018, INT J CANCER, V142, P999, DOI 10.1002/ijc.31115; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Ochi H, 2017, J INVEST DERMATOL, V137, P1578, DOI 10.1016/j.jid.2017.02.970; Oka T, 2013, J ALLERGY CLIN IMMUN, V132, P922, DOI 10.1016/j.jaci.2013.05.004; Peters RL, 2016, PEDIAT ALLERG IMM-UK, V27, P784, DOI 10.1111/pai.12620; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Sato S, 2014, INT ARCH ALLERGY IMM, V164, P1, DOI 10.1159/000361025; Savilahti EM, 2010, J ALLERGY CLIN IMMUN, V125, P1315, DOI 10.1016/j.jaci.2010.03.025; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shi MH, 2014, J ALLERGY CLIN IMMUN, V134, P1163, DOI 10.1016/j.jaci.2014.04.035; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Skabytska Y, 2014, IMMUNITY, V41, P762, DOI 10.1016/j.immuni.2014.10.009; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Uttarkar S, 2019, J ALLERGY CLIN IMMUN, V143, P1302, DOI 10.1016/j.jaci.2018.12.1011; Wang SH, 2016, EUR J CANCER, V68, P90, DOI 10.1016/j.ejca.2016.08.019; Wawrzyniak M, 2017, ALLERGY ASTHMA IMMUN, V9, P107, DOI 10.4168/aair.2017.9.2.107; Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P973, DOI 10.1016/j.jaci.2016.01.001; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	44	7	7	9	23	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1063	+		10.1016/j.jaci.2020.07.011	http://dx.doi.org/10.1016/j.jaci.2020.07.011		MAR 2021	23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	32717254				2022-12-18	WOS:000635524300011
J	Mandola, AB; Sharfe, N; Nagdi, Z; Dadi, H; Vong, L; Merico, D; Ngan, B; Reid, B; Roifman, CM				Mandola, Amarilla B.; Sharfe, Nigel; Nagdi, Zahra; Dadi, Harjit; Vong, Linda; Merico, Daniele; Ngan, Bo; Reid, Brenda; Roifman, Chaim M.			Combined immunodeficiency caused by a novel homozygous NFKB1 mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NFKB1; common variable immunodeficiency; combined immunodeficiency; hypogammaglobulinemia; autoimmunity; B-cell repertoire	NF-KAPPA-B; ECTODERMAL DYSPLASIA; NF-KAPPA-B1 P105; P50; DEFICIENCY; HAPLOINSUFFICIENCY; SUBUNIT; BETA	Background: Genetic faults in several components of the nuclear factor-kappa B pathway cause immunodeficiency. Most defects lead to combined immunodeficiency with a range of severity. Heterozygous mutations in NFKB1 were associated with common variable immunodeficiency, however, homozygous mutations have not been described. Objective: We studied the molecular basis of combined immunodeficiency in a patient who presented with failure to thrive, persistent EBV viremia and hepatitis, pneumocystis jirovecii pneumonitis, and generalized lymphadenopathy. Methods: Whole genome and exome sequencing followed by Sanger confirmation were performed to identify the genetic defect. Molecular and cellular techniques were used to assess the variant impact on the nuclear factor-kappa B pathway and lymphocyte function. Results: Genetic analysis revealed a novel homozygous mutation in NFKB1, c.2878G>A, p.Gly960Arg (G960R). This affected p105 phosphorylation and p50 formation on antigen and cytokine stimulation, as well as attenuating nuclear signal transmission. As a result, both T- and B-cell maturation and function were perturbed. The number of memory CD4(+) T cells were reduced, while CD8(+) T cells consisted predominately of expanded differentiated populations. The function of T cells were diminished as shown by reduced responses to mitogens as well as diminished cytokine secretion. B-cell maturation was also affected, with decreased IgD(+)CD27(+) memory B cells while transitional B cells were increased, likely contributing to the reduced ability to produce specific antibodies. Conclusion: Homozygous G960R mutation in NFKB1 leads to a severe clinical presentation of combined immunodeficiency. This was associated with blockade of nuclear factor-kappa B pathway signaling, resulting in aberrations in T- and B-cell maturation and function.	[Mandola, Amarilla B.; Sharfe, Nigel; Nagdi, Zahra; Dadi, Harjit; Vong, Linda; Reid, Brenda; Roifman, Chaim M.] Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada; [Mandola, Amarilla B.; Sharfe, Nigel; Nagdi, Zahra; Dadi, Harjit; Vong, Linda; Reid, Brenda; Roifman, Chaim M.] Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada; [Mandola, Amarilla B.; Vong, Linda; Reid, Brenda; Roifman, Chaim M.] Hosp Sick Children, Div Immunol & Allergy, Dept Paediat, Toronto, ON, Canada; [Mandola, Amarilla B.; Sharfe, Nigel; Nagdi, Zahra; Dadi, Harjit; Vong, Linda; Roifman, Chaim M.] Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Merico, Daniele] Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada; [Ngan, Bo] Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mandola, Amarilla B.; Sharfe, Nigel; Nagdi, Zahra; Dadi, Harjit; Roifman, Chaim M.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Merico, Daniele] Deep Genom Inc, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Roifman, CM (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	chaim.roifman@sickkids.ca		Merico, Daniele/0000-0002-3728-4401; Mandola, Amarilla/0000-0001-9194-6798	Immunodeficiency Canada's Distinguished Professorship in Immunology; Program for Immunogenomics; Canadian Centre for Primary Immunodeficiency; Jeffrey Modell Foundation; Immunodeficiency Canada	Immunodeficiency Canada's Distinguished Professorship in Immunology; Program for Immunogenomics; Canadian Centre for Primary Immunodeficiency; Jeffrey Modell Foundation; Immunodeficiency Canada	This work was supported by Immunodeficiency Canada's Distinguished Professorship in Immunology (C.M.R.), the Program for Immunogenomics and the Canadian Centre for Primary Immunodeficiency (C.M.R.), and the Jeffrey Modell Foundation and Immunodeficiency Canada (C.M.R.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Beinke S, 2002, J BIOL CHEM, V277, P24162, DOI 10.1074/jbc.M201576200; Boztug H, 2016, J CLIN IMMUNOL, V36, P533, DOI 10.1007/s10875-016-0306-1; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; Fliegauf M, 2015, AM J HUM GENET, V97, P389, DOI 10.1016/j.ajhg.2015.07.008; Fusco F, 2015, INT REV IMMUNOL, V34, P445, DOI 10.3109/08830185.2015.1055331; Heron E, 1995, GENOMICS, V30, P493, DOI 10.1006/geno.1995.1270; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Legarda-Addison D, 2007, J IMMUNOL, V178, P7767, DOI 10.4049/jimmunol.178.12.7767; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Lorenzini T, 2020, J CLIN IMMUNOL, V40, pS57; Lupino E, 2012, J IMMUNOL, V188, P2545, DOI 10.4049/jimmunol.1102938; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Merico D, 2016, LYMPHOSIGN J, V3, P135, DOI DOI 10.14785/LYMPH0SIGN-2016-0011; Merico D, 2015, LYMPHOSIGN J, V2, P147, DOI DOI 10.14785/LPSN-2015-0005; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nielsen C, 2014, J CLIN IMMUNOL, V34, P916, DOI 10.1007/s10875-014-0097-1; Ozkinay F, 2007, J CHILD NEUROL, V22, P741, DOI 10.1177/0883073807302617; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Poplin R., 2017, SCALING ACCURATE GEN, DOI [10.1101/201178, DOI 10.1101/201178]; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; Scott O, 2019, J ALLERGY CLIN IMMUN, V143, P1688, DOI 10.1016/j.jaci.2019.03.016; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Trost B, 2018, AM J HUM GENET, V102, P142, DOI 10.1016/j.ajhg.2017.12.007; Tuijnenburg P, 2018, J ALLERGY CLIN IMMUN, V142, P1285, DOI 10.1016/j.jaci.2018.01.039; Vincent Feng-Sheng Shih, 2011, Cell Research, V21, P86; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	39	7	7	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					727	+		10.1016/j.jaci.2020.08.040	http://dx.doi.org/10.1016/j.jaci.2020.08.040		FEB 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32980423				2022-12-18	WOS:000616665800035
J	Sullivan, KE				Sullivan, Kathleen E.			The scary world of variants of uncertain significance (VUS): A hitchhiker's guide to interpretation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Whole-exome sequencing; diagnosis; SCID; NBS; variants of uncertain significance			[Sullivan, Kathleen E.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sullivan, KE (corresponding author), Childrens Hosp Philadelphia, Allergy Immunol, ARC 1216-1,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	sullivank@email.chop.edu			Children's Hospital of Philadelphia	Children's Hospital of Philadelphia	This work was supported by the Children's Hospital of Philadelphia.	Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; Chinn IK, 2020, J ALLERGY CLIN IMMUN, V145, P46, DOI 10.1016/j.jaci.2019.09.009; Heimall J, 2019, IMMUNOL ALLERGY CLIN, V39, P129, DOI 10.1016/j.iac.2018.08.009; Mahlaoui N, 2019, J ALLERGY CLIN IMMUN, V143, P1646, DOI 10.1016/j.jaci.2018.12.994; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Smith LD, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a023168; Stray-Pedersen A, 2017, J ALLERGY CLIN IMMUN, V139, P232, DOI 10.1016/j.jaci.2016.05.042; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Weck KE, 2018, GENET MED, V20, P291, DOI 10.1038/gim.2017.269	10	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					492	494		10.1016/j.jaci.2020.06.011	http://dx.doi.org/10.1016/j.jaci.2020.06.011		FEB 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32598897	Bronze			2022-12-18	WOS:000616665800006
J	Lyles, JL; Martin, LJ; Shoda, T; Collins, MH; Trimarchi, MP; He, H; Kottyan, LC; Mukkada, VA; Rothenberg, ME				Lyles, John L.; Martin, Lisa J.; Shoda, Tetsuo; Collins, Margaret H.; Trimarchi, Michael P.; He, Hua; Kottyan, Leah C.; Mukkada, Vincent A.; Rothenberg, Marc E.			Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Infancy; environment; cesarean delivery; genetics; molecular pathogenesis; EoEHSS; EREFS; EDP; CAPN14; ACTG2		Background: Eosinophilic esophagitis (EoE) is a chronic, food antigen-mediated disease characterized by esophageal dysfunction and intraepithelial eosinophil accumulation. Objective: We hypothesized that very early onset EoE (V-EoE) would be enriched for early-life and genetic factors and have worse presentation and prognosis than later-onset pediatric EoE (L-EoE). Methods: We conducted a single-site, retrospective review comparing patients diagnosed at age 12 months or less (V-EoE, n = 57) and age 14 to 18 years (L-EoE, n = 70). These patients underwent medical record, EoE Histology Scoring System, Endoscopic Reference Score, and EoE Diagnostic Panel assessment when sample availability permitted. Genetic association used 2 EoE genotype repositories. Data were analyzed using chi-square tests, t tests, Wilcoxon rank-sum tests, Spearman correlations, cluster analysis, and logistic regression. Results: Among pediatric patients with EoE, diagnosis most commonly occurred within early life (0-24 months, 17%). V-EoE was more likely to attain histologic remission via dietary restriction (P<.0001). Basal zone hyperplasia and eosinophil inflammation were greater in V-EoE (P<.05). Esophageal strictures more commonly occurred in L-EoE (P=.03). V-EoE had lower endoscopic scores (P<.05). Molecular expression was very similar between groups. Cesarean delivery was more common in patients with V-EoE (P = .03). Patients with V-EoE demonstrated enrichment of CAPN14 common genetic variants. Conclusions: Early-life diagnosis of EoE is a common occurrence. V-EoE responds to standard therapy without early evidence for complications, suggesting a less severe prognosis than hypothesized. Molecular pathogenesis is preserved between V-EoE and L-EoE. Cesarean delivery and CAPN14 genetic variation likely promote earlier disease development.	[Lyles, John L.; Mukkada, Vincent A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Martin, Lisa J.; He, Hua] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Martin, Lisa J.; Collins, Margaret H.; Kottyan, Leah C.; Mukkada, Vincent A.; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Shoda, Tetsuo; Trimarchi, Michael P.; Kottyan, Leah C.; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA; [Collins, Margaret H.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Collins, Margaret H.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH USA; [Kottyan, Leah C.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA.	Marc.Rothenberg@cchmc.org		Shoda, Tetsuo/0000-0001-8337-5438; Kottyan, Leah/0000-0003-3979-2220	National Institutes of Health [K24 DK100303, U19 AI070235, R01 AI124355, R01 DK107502, R37 A1045898, P30 DK078392]; Campaign Urging Research for Eosinophilic Disease; Sunshine Charitable Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campaign Urging Research for Eosinophilic Disease; Sunshine Charitable Foundation	This work was supported in part by the National Institutes of Health (grant no. K24 DK100303 to J.L.L. and grant nos. U19 AI070235, R01 AI124355, R01 DK107502, R37 A1045898, and P30 DK078392 [Gene and Protein Expression Core]); the Campaign Urging Research for Eosinophilic Disease (to M.E.R.); and the Sunshine Charitable Foundation and its supporters, Denise and David Bunning (to M.E.R.).	Aceves S, 2020, J ALLERGY CLIN IMMUN, V145, P28, DOI 10.1016/j.jaci.2019.11.012; Aceves SS, 2018, J ALLERGY CLIN IMMUN, V142, P130, DOI 10.1016/j.jaci.2018.05.014; Alexander ES, 2014, J ALLERGY CLIN IMMUN, V134, P1084, DOI 10.1016/j.jaci.2014.07.021; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Andreae DA, 2016, AM J GASTROENTEROL, V111, P1187, DOI 10.1038/ajg.2016.238; Arias A, 2014, GASTROENTEROLOGY, V146, P1639, DOI 10.1053/j.gastro.2014.02.006; Benitez AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0085-6; Biedermann L, 2018, CURR OPIN PHARMACOL, V43, P139, DOI 10.1016/j.coph.2018.08.013; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Blanchard C, 2006, J ALLERGY CLIN IMMUN, V118, P1054, DOI 10.1016/j.jaci.2006.07.038; Collins MH, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12470; Collins MH, 2020, J PEDIATR GASTR NUTR, V70, P598, DOI 10.1097/MPG.0000000000002637; Crowley E, 2018, GASTROENTEROL CLIN N, V47, P755, DOI 10.1016/j.gtc.2018.07.004; Davis BP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86355; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; Dellon ES, 2018, GASTROENTEROLOGY, V154, P319, DOI 10.1053/j.gastro.2017.06.067; Esposito F, 2001, J CLIN ULTRASOUND, V29, P326, DOI 10.1002/jcu.1043; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fox VL, 2003, GASTROINTEST ENDOSC, V57, P30, DOI 10.1067/mge.2003.33; Harris JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128346; Hommeida S, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/doy062; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V142, P32, DOI 10.1016/j.jaci.2018.04.015; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V141, P632, DOI 10.1016/j.jaci.2017.07.010; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V141, P214, DOI 10.1016/j.jaci.2017.05.018; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Litosh VA, 2017, J ALLERGY CLIN IMMUN, V139, P1762, DOI 10.1016/j.jaci.2016.09.027; Lopes SRM, 2017, LUPUS, V26, P996, DOI 10.1177/0961203317690616; Lyles J, 2019, CURR OPIN IMMUNOL, V60, P46, DOI 10.1016/j.coi.2019.04.004; McCann ME, 2019, LANCET, V393, P664, DOI 10.1016/S0140-6736(18)32485-1; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; O'Shea KM, 2018, GASTROENTEROLOGY, V154, P333, DOI 10.1053/j.gastro.2017.06.065; Palabiyik FB, 2012, J ULTRAS MED, V31, P1375; Pentiuk S, 2009, J PEDIATR GASTR NUTR, V48, P152, DOI 10.1097/MPG.0b013e31817f0197; Purcell S., PLINK VERSION 1 07; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinn M, 2006, J PEDIATR-US, V148, P366, DOI 10.1016/j.jpeds.2005.10.029; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Shaheen NJ, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/doy015; Shoda T, 2018, LANCET GASTROENTEROL, V3, P477, DOI 10.1016/S2468-1253(18)30096-7; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Stucke EM, 2015, J PEDIATR GASTR NUTR, V61, P65, DOI 10.1097/MPG.0000000000000740; Sun RW, 2018, LARYNGOSCOPE, V128, P798, DOI 10.1002/lary.26838; Wangler MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004258; Wechsler JB, 2018, CLIN GASTROENTEROL H, V16, P1056, DOI 10.1016/j.cgh.2017.12.019; Wen T, 2013, GASTROENTEROLOGY, V145, P1289, DOI 10.1053/j.gastro.2013.08.046; Wong CK, 2010, AM J RESP CELL MOL, V43, P305, DOI 10.1165/rcmb.2009-0168OC; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	47	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					244	+		10.1016/j.jaci.2020.10.017	http://dx.doi.org/10.1016/j.jaci.2020.10.017		JAN 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	33446329	Green Accepted			2022-12-18	WOS:000613645900028
J	Okubo, Y; Horimukai, K; Michihata, N; Morita, K; Matsui, H; Fushimi, K; Yasunaga, H				Okubo, Yusuke; Horimukai, Kenta; Michihata, Nobuaki; Morita, Kojiro; Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo			Association between early antibiotic treatment and clinical outcomes in children hospitalized for asthma exacerbation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; antibiotics; children; propensity score matching; inverse probability of treatment weighting; g-computation; instrumental variable		Background: Professional society guidelines recommend against routine early antibiotic use in the treatment of asthma exacerbation without comorbid bacterial infection. However, high antibiotic prescribing rates have been reported in developed countries. Objective: We sought to assess the effectiveness of this strategy in the routine care of children. Methods: Using data on 48,743 children hospitalized for asthma exacerbation with no indication of bacterial infection during the period 2010 to 2018, we conducted a retrospective cohort study to compare clinical outcomes and resource utilization between children who received early antibiotic treatment and those who did not. Results: Overall, 19,866 children (41%) received early antibiotic treatment. According to the propensity score matching analysis, children with early antibiotic treatment had longer hospital stay (mean difference, 0.21 days; 95% CI, 0.18-0.28), higher hospitalization costs (mean difference, $83.5; 95% CI, 62.9104.0), and higher risk of probiotic use (risk ratio, 2.01; 95% CI, 1.81-2.23) than children who did not receive early antibiotic therapy. Similar results were found from inverse probability of treatment weighting, g-computation, and instrumental variable methods and sensitivity analyses. The risks of mechanical ventilation and 30-day readmission were similar between the groups or slightly higher in the treated group, depending on the statistical models. Conclusions: Antibiotic therapy may be associated with prolonged hospital stay, elevated hospitalization costs, and high risk of probiotic use without improving treatment failure and readmission. Our findings highlight the need for reducing inappropriate antibiotic use among children hospitalized for asthma.	[Okubo, Yusuke] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Okubo, Yusuke] Natl Ctr Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Okubo, Yusuke; Morita, Kojiro; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Horimukai, Kenta] Jikei Univ, Dept Pediat, Katsushika Med Ctr, Tokyo, Japan; [Michihata, Nobuaki] Univ Tokyo, Dept Hlth Serv Res, Grad Sch Med, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan	University of California System; University of California Los Angeles; National Center for Child Health & Development - Japan; University of Tokyo; Jikei University; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Okubo, Y (corresponding author), Natl Ctr Child Hlth & Dev, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	sunning_dale@yahoo.co.jp		Morita, Kojiro/0000-0002-2306-0669; Michihata, Nobuaki/0000-0003-3091-114X; Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour, and Welfare, Japan; University of California, Los Angeles, Asia Pacific Center	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); University of California, Los Angeles, Asia Pacific Center(University of California System)	This work was supported by grants from the Ministry of Health, Labour, and Welfare, Japan. Y.O. is supported by theWagatsuma Fellowship from the University of California, Los Angeles, Asia Pacific Center.	Arakawa H, 2017, ALLERGOL INT, V66, P190, DOI 10.1016/j.alit.2016.11.003; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896; British Thoracic Society/Scottish Intercollegiate Guidelines Network, 2016, BRIT GUID MAN ASTHM; Chauhan AJ, 2003, LANCET, V361, P1939, DOI 10.1016/S0140-6736(03)13582-9; Douglas LC, 2020, J ASTHMA, V57, P525, DOI 10.1080/02770903.2019.1590590; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Froidure A, 2016, EUR RESPIR J, V47, P304, DOI 10.1183/13993003.01824-2014; Fujimori K, 2013, ASIAN PACIFIC J DIS, V5, P81; Gibson PG, 2017, LANCET, V390, P659, DOI 10.1016/S0140-6736(17)31281-3; Global Environment Facility, 2018, GLOB AN PARTN 5 STEP, P1; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hsia Y, 2019, LANCET INFECT DIS, V19, P67, DOI 10.1016/S1473-3099(18)30547-4; Johnston SC, 2002, AM J EPIDEMIOL, V156, P753, DOI 10.1093/aje/kwf095; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Koutsoubari I, 2012, PEDIAT ALLERG IMM-UK, V23, P385, DOI 10.1111/j.1399-3038.2012.01280.x; LEWIS-FANING E., 1960, ACTA ALLERGOL, V15, P492, DOI 10.1111/j.1398-9995.1960.tb03682.x; Lindenauer PK, 2016, JAMA INTERN MED, V176, P1397, DOI 10.1001/jamainternmed.2016.4050; Lousdal ML, 2018, EMERG THEMES EPIDEMI, V15, DOI 10.1186/s12982-018-0069-7; Morikawa E, 2020, ALLERGOL INT, V69, P98, DOI 10.1016/j.alit.2019.08.010; Okubo Y, 2019, J PEDIATR GASTR NUTR, V68, P13, DOI 10.1097/MPG.0000000000002115; Okubo Y, 2018, CLIN RESPIR J, V12, P1479, DOI 10.1111/crj.12694; Okubo Y, 2018, J GLOB ANTIMICROB RE, V13, P55, DOI 10.1016/j.jgar.2017.11.004; Okubo Y, 2018, RESPIR INVESTIG, V56, P158, DOI 10.1016/j.resinv.2017.11.005; Okubo Y, 2017, PEDIAT ALLERG IMM-UK, V28, P763, DOI 10.1111/pai.12801; Okubo Y, 2016, J ALLER CL IMM-PRACT, V4, P1227, DOI 10.1016/j.jaip.2016.06.004; Rabe KF, 2000, EUR RESPIR J, V16, P802, DOI 10.1183/09031936.00.16580200; Sasaki M, 2019, ALLERGY, V74, P1572, DOI 10.1111/all.13773; Sasaki M, 2014, PEDIAT ALLERG IMM-UK, V25, P804, DOI 10.1111/pai.12316; Snowden JM, 2011, AM J EPIDEMIOL, V173, P731, DOI 10.1093/aje/kwq472; Stefan MS, 2019, JAMA INTERN MED, V179, P333, DOI 10.1001/jamainternmed.2018.5394; Stokholm J, 2016, LANCET RESP MED, V4, P19, DOI [10.1016/S2213-2600(15)00500-7, 10.1016/S2213-2600(16)00050-3]; Uda K, 2019, J INFECT CHEMOTHER, V25, P758, DOI 10.1016/j.jiac.2019.03.004; Uda K, 2018, PEDIATR PULM, V53, P802, DOI 10.1002/ppul.24021; Wang AL, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-016-0282-4; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; World Health Organization, WHO WHO CHILD GROWTH; Xu S, 2010, VALUE HEALTH, V13, P273, DOI 10.1111/j.1524-4733.2009.00671.x; Yoshida K, 2018, ASIAN PAC J ALLERGY, V36, P16, DOI 10.12932/AP0882	41	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					114	+		10.1016/j.jaci.2020.05.030	http://dx.doi.org/10.1016/j.jaci.2020.05.030		JAN 2021	23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	32504615				2022-12-18	WOS:000613645900016
J	Wolf, C; Bruck, N; Koss, S; Griep, C; Kirschfink, M; Palm-Beden, K; Fang, MY; Rober, N; Winkler, S; Berner, R; Latz, E; Gunther, C; Lee-Kirsch, MA				Wolf, Christine; Bruck, Normi; Koss, Sarah; Griep, Constanze; Kirschfink, Michael; Palm-Beden, Katharina; Fang, Mingyan; Roeber, Nadja; Winkler, Stefan; Berner, Reinhard; Latz, Eike; Guenther, Claudia; Lee-Kirsch, Min Ae			Janus kinase inhibition in complement component 1 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Wolf, Christine; Bruck, Normi; Koss, Sarah; Griep, Constanze; Winkler, Stefan; Berner, Reinhard; Lee-Kirsch, Min Ae] Tech Univ Dresden, Dept Pediat, Med Fak Carl Gustav Carus, Dresden, Germany; [Kirschfink, Michael] Heidelberg Univ, Univ Klinikum Hidelberg, Inst Immunol, Heidelberg, Germany; [Palm-Beden, Katharina] Klin Kinder & Jugendrheumatol, St Josef Stift, Sendenhorst, Germany; [Fang, Mingyan] BGI Shenzhen, Shenzhen, Peoples R China; [Fang, Mingyan] China Natl Genebank, Shenzhen, Peoples R China; [Roeber, Nadja] Tech Univ Dresden, Inst Immunol, Med Fak Carl Gustav Carus, Dresden, Germany; [Latz, Eike] Univ Bonn, Inst Innate Immun, Bonn, Germany; [Guenther, Claudia] Tech Univ Dresden, Med Fak Carl Gustav Carus, Dept Dermatol, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg; Beijing Genomics Institute (BGI); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Bonn; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Lee-Kirsch, MA (corresponding author), Tech Univ Dresden, Dept Pediat, Med Fak Carl Gustav Carus, Dresden, Germany.	minae.lee-kirsch@uniklinikum-dresden.de	Lee-Kirsch, Min Ae/C-5769-2018; Günther, Claudia/AGG-8982-2022	Fang, Mingyan/0000-0001-7185-6445				Albrecht J, 2005, J INVEST DERMATOL, V125, P889, DOI 10.1111/j.0022-202X.2005.23889.x; Chen YX, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix120; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mathsson L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1926; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025	8	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1439	1442		10.1016/j.jaci.2020.04.002	http://dx.doi.org/10.1016/j.jaci.2020.04.002			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32325142	hybrid			2022-12-18	WOS:000596937900026
J	Dai, X; Dharmage, SC; Abramson, MJ; Erbas, B; Bennett, CM; Svanes, C; Hui, JN; Axelrad, C; Lowe, AJ; Lodge, CJ				Dai, Xin; Dharmage, Shyamali C.; Abramson, Michael J.; Erbas, Bircan; Bennett, Catherine M.; Svanes, Cecilie; Hui, Jennie; Axelrad, Christine; Lowe, Adrian J.; Lodge, Caroline J.			Early life acetaminophen exposure, glutathione S-transferase genes, and development of adolescent asthma in a high-risk birth cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; oxidative stress; acetaminophen; glutathione transferase; cohort studies; respiratory function tests	LUNG-FUNCTION; CHILDHOOD ASTHMA; REFERENCE VALUES; PARACETAMOL USE; DISEASE; WHEEZE; T1; P1; M1	Background: Although the impact of early life acetaminophen on asthma risk is still not clear, potential interactions with glutathione S-transferase (GST) genes due to reduced antioxidant function in particular polymorphisms, and possible impact on lung function, have never been investigated in adolescents. Objective: We aimed to investigate associations between early life acetaminophen use and adolescent asthma and lung function and to assess potential interactions by GST polymorphisms. Methods: Acetaminophen use was recorded 18 times up to age 2 years (n = 575 [92.7%]). Participants were genotyped for GST polymorphisms (GSTM1/T1/P1) (n = 429 [69.2%]). Asthma and lung function were measured at 12 (n = 365 [58.9%]) and 18 years (n = 413 [66.6%]). Regression models assessed associations and interactions. Results: Doubling of days of acetaminophen use was associated with reduced prebronchodilator FEV1/forced vital capacity (b coefficient, -0.10; 95% CI, -0.19 to -0.01) and midexpiratory flow (-0.09; 95% CI, -0.18 to 0) at 18 years, but this association was not found when restricted for nonrespiratory reasons, suggesting confounding by indication. However, in children with GSTM1 null and GSTT1 present, increasing acetaminophen use for nonrespiratory reasons was associated with reduced FEV1 and midexpiratory flow at 18 years (interaction between GSTM1/T1 and acetaminophen P < .05). Increased acetaminophen use was associated with asthma at 18 years for children with GSTP1 Ile/Ile (odds ratio, 1.66; 95% CI, 1.07 to 2.57), but not other GSTP1 genotypes. Conclusions: These novel findings need to be investigated for consistency in other studies but suggest that children carrying risk genotypes may be susceptible to respiratory consequences from acetaminophen use.	[Dai, Xin; Dharmage, Shyamali C.; Lowe, Adrian J.; Lodge, Caroline J.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia; [Dharmage, Shyamali C.; Axelrad, Christine; Lowe, Adrian J.] Murdoch Childrens Res Inst, Ctr Food & Allergy Res, Melbourne, Vic, Australia; [Abramson, Michael J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Erbas, Bircan] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Bennett, Catherine M.] Deakin Univ, Inst Hlth Transformat, Melbourne, Vic, Australia; [Svanes, Cecilie] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Hui, Jennie] Pathwest Lab Med West Australia, Perth, WA, Australia; [Hui, Jennie] Univ Western Australia, Sch Populat & Global Hlth, Crawley, Australia; [Hui, Jennie] Univ Western Australia, Sch Pathol & Lab Med, Crawley, Australia	University of Melbourne; Murdoch Children's Research Institute; Monash University; La Trobe University; Deakin University; University of Bergen; University of Bergen; Haukeland University Hospital; University of Western Australia; University of Western Australia	Dharmage, SC (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Level 3,207 Bouverie St, Melbourne, Vic 3010, Australia.	S.dharmage@unimelb.edu.au	DAI, XIN/AAL-3706-2021; Svanes, Cecilie/N-7556-2017	Svanes, Cecilie/0000-0001-8512-5192; Lodge, Caroline/0000-0002-2342-3888; Dai, Xin/0000-0002-0472-700X	Nestec Ltd of Nestle Australia; Asthma Foundation of Victoria; National Health and Medical Research Council of Australia (NHMRC) [APP454856]; NHMRC	Nestec Ltd of Nestle Australia(Nestle SA); Asthma Foundation of Victoria; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The first 6 years of the Melbourne Atopy Cohort Study were funded (study formula and staff) by Nestec Ltd, a subsidiary of Nestle Australia. The 12-year follow-up was funded by a project grant from the Asthma Foundation of Victoria. The National Health and Medical Research Council of Australia (NHMRC) funded the 18-year follow-up (grant no. APP454856). X.D., S.C.D., A.J.L., and C.J.L. are funded by the NHMRC.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Appleton SL, 2005, J ALLERGY CLIN IMMUN, V116, P976, DOI 10.1016/j.jaci.2005.08.034; BAUDOUIN SV, 1995, THORAX, V50, P399, DOI 10.1136/thx.50.4.399; Beasley RW, 2011, AM J RESP CRIT CARE, V183, P171, DOI 10.1164/rccm.201005-0757OC; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Cheelo M, 2015, ARCH DIS CHILD, V100, P81, DOI 10.1136/archdischild-2012-303043; Dai X, 2019, CHEST, V155, P94, DOI 10.1016/j.chest.2018.08.1079; Dai X, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0771-0; Fan G, 2017, ALLERGOL IMMUNOPATH, V45, P528, DOI 10.1016/j.aller.2016.10.014; Farquhar H, 2010, CLIN EXP ALLERGY, V40, P32, DOI 10.1111/j.1365-2222.2009.03378.x; Geisler SA, 2001, AM J EPIDEMIOL, V154, P95, DOI 10.1093/aje/154.2.95; Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P710, DOI 10.1164/rccm.2112065; Hall GL, 2012, RESPIROLOGY, V17, P1150, DOI 10.1111/j.1440-1843.2012.02232.x; Gonzalez-Barcala FJ, 2013, EUR J PUBLIC HEALTH, V23, P706, DOI 10.1093/eurpub/cks061; Kang SH, 2013, ANN ALLERG ASTHMA IM, V110, P364, DOI 10.1016/j.anai.2013.03.008; Lourido-Cebreiro T, 2017, J ASTHMA, V54, P32, DOI 10.1080/02770903.2016.1194431; Lowe AJ, 2017, INT J EPIDEMIOL, V46, P25, DOI 10.1093/ije/dyw011; Lowe AJ, 2011, J ALLERGY CLIN IMMUN, V128, P360, DOI 10.1016/j.jaci.2010.05.006; Lowe AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4616; Magnus MC, 2016, INT J EPIDEMIOL, V45, P512, DOI 10.1093/ije/dyv366; Manuck TA, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2015.4577; Milos J, 2017, FRONT PEDIATR, V5; Minelli C, 2011, AM J EPIDEMIOL, V173, P603, DOI 10.1093/aje/kwq403; Minelli C, 2010, INT J EPIDEMIOL, V39, P539, DOI 10.1093/ije/dyp337; Perzanowski MS, 2010, THORAX, V65, P118, DOI 10.1136/thx.2009.121459; Piler P, 2018, J EPIDEMIOL COMMUN H, V72, P349, DOI 10.1136/jech-2017-209960; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Schnabel E, 2010, J ALLERGY CLIN IMMUN, V126, P1071, DOI 10.1016/j.jaci.2010.08.023; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shaheen SO, 2010, J ALLERGY CLIN IMMUN, V126, P1141, DOI 10.1016/j.jaci.2010.08.047; Smith GD, 2016, INT J EPIDEMIOL, V45, P605, DOI 10.1093/ije/dyw224; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V135, P441, DOI 10.1016/j.jaci.2014.07.065; Weiss ST, 2010, NAT GENET, V42, P14, DOI 10.1038/ng0110-14; Wu WQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01352	36	7	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1035	+		10.1016/j.jaci.2020.03.027	http://dx.doi.org/10.1016/j.jaci.2020.03.027			22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32289338				2022-12-18	WOS:000588153700008
J	Dahlsgaard, KK; Lewis, MO; Spergel, JM				Dahlsgaard, Katherine K.; Lewis, Megan O.; Spergel, Jonathan M.			New issue of food allergy: Phobia of anaphylaxis in pediatric patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food allergy; peanut allergy; anaphylaxis; anxiety; phobia; children; behavioral health; cognitive-behavioral therapy; quality of life	EXPOSURE THERAPY; CHILDREN; CONTACT; PEANUT		[Dahlsgaard, Katherine K.] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USA; [Lewis, Megan O.; Spergel, Jonathan M.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Food Allergy Ctr, Philadelphia, PA 19104 USA; [Spergel, Jonathan M.] Perelman Sch Med, Dept Pediat, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Spergel, JM (corresponding author), Childrens Hosp Philadelphia, Allergy Sect, Wood 3325D,3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	spergel@email.chop.edu			Children's Hospital of Philadelphia	Children's Hospital of Philadelphia	Children's Hospital of Philadelphia funded the work. This article did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.	Becker-Haimes EM, 2017, J ANXIETY DISORD, V49, P88, DOI 10.1016/j.janxdis.2017.04.002; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Craske MG, 2014, BEHAV RES THER, V58, P10, DOI 10.1016/j.brat.2014.04.006; Dinakar C, 2016, ANN ALLERG ASTHMA IM, V117, P135, DOI 10.1016/j.anai.2016.06.015; LeBovidge JS, 2009, J ALLERGY CLIN IMMUN, V124, P1282, DOI 10.1016/j.jaci.2009.08.045; Manassis, 2012, J ALLERGY, V2012, DOI DOI 10.1155/2012/316296; Simonte SJ, 2003, J ALLERGY CLIN IMMUN, V112, P180, DOI 10.1067/mai.2003.1486; Wainstein BK, 2007, CLIN EXP ALLERGY, V37, P839, DOI 10.1111/j.1365-2222.2007.02726.x; Walter HJ, 2020, J AM ACAD CHILD PSY, V59, P1107, DOI 10.1016/j.jaac.2020.05.005; Whiteside SPH, 2020, CLIN CHILD FAM PSYCH, V23, P102, DOI 10.1007/s10567-019-00303-2	10	7	7	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					780	782		10.1016/j.jaci.2020.07.010	http://dx.doi.org/10.1016/j.jaci.2020.07.010			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	OH2JO	32710976	Bronze			2022-12-18	WOS:000582395800006
J	Klocperk, A; Unger, S; Friedmann, D; Seidl, M; Zoldan, K; Pfeiffer, J; Hausmann, O; Benes, V; Andrieux, G; Boettler, T; Sediva, A; Bengsch, B; Warnatz, K				Klocperk, Adam; Unger, Susanne; Friedmann, David; Seidl, Maximilian; Zoldan, Katharina; Pfeiffer, Jens; Hausmann, Oliver; Benes, Vladimir; Andrieux, Geoffroy; Boettler, Tobias; Sediva, Anna; Bengsch, Bertram; Warnatz, Klaus			Exhausted phenotype of follicular CD8 T cells in CVID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Klocperk, Adam; Unger, Susanne; Friedmann, David; Warnatz, Klaus] Univ Freiburg, Dept Rheumatol & Clin Immunol, Div Immunodeficiency, Freiburg, Germany; [Klocperk, Adam; Unger, Susanne; Friedmann, David; Warnatz, Klaus] Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency CCI, Freiburg, Germany; [Klocperk, Adam; Sediva, Anna] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic; [Klocperk, Adam; Sediva, Anna] Univ Hosp Motol, Prague, Czech Republic; [Unger, Susanne] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Friedmann, David] Univ Freiburg, Fac Biol, Freiburg, Germany; [Seidl, Maximilian] Univ Freiburg, Inst Surg Pathol, Freiburg, Germany; [Zoldan, Katharina; Boettler, Tobias; Bengsch, Bertram] Univ Freiburg, Dept Med 2, Freiburg, Germany; [Pfeiffer, Jens] Univ Freiburg, Fac Med, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Freiburg, Germany; [Hausmann, Oliver] Lowenpraxis & Klin St Anna, Luzern, Switzerland; [Benes, Vladimir] EMBL Heidelberg, Genom Core Facil, Heidelberg, Germany; [Andrieux, Geoffroy] Univ Freiburg, Fac Med, Univ Med Ctr Freiburg, Inst Med Bioinformat & Syst Med, Freiburg, Germany; [Andrieux, Geoffroy] German Canc Consortium DKTK, Partner Site Freiburg, Heidelberg, Germany; [Andrieux, Geoffroy] German Canc Res Ctr, Heidelberg, Germany; [Bengsch, Bertram] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Bengsch, Bertram] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany	University of Freiburg; University of Freiburg; Charles University Prague; Motol University Hospital; University of Zurich; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; European Molecular Biology Laboratory (EMBL); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg	Klocperk, A; Warnatz, K (corresponding author), Univ Freiburg, Dept Rheumatol & Clin Immunol, Div Immunodeficiency, Freiburg, Germany.; Klocperk, A; Warnatz, K (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency CCI, Freiburg, Germany.	adam.klocperk@fnmotol.cz; warnatz@uniklinik-freiburg.de	Bengsch, Bertram/ABF-2142-2020; Warnatz, Klaus/AAD-3464-2022; Boettler, Tobias/E-3331-2012; Sediva, Anna/AAE-2774-2019; Seidl, Maxmilian/ABF-3322-2021; Klocperk, Adam/L-6185-2017	Bengsch, Bertram/0000-0003-2552-740X; Boettler, Tobias/0000-0002-1195-055X; Sediva, Anna/0000-0001-7730-2304; Seidl, Maxmilian/0000-0002-5559-4980; Klocperk, Adam/0000-0002-1526-4557; ANDRIEUX, GEOFFROY/0000-0002-5389-9481	Deutsche Forschungsgemeinschaft [SFB 1160]; European Society for Immunodeficiencies; Czech health research council; Ministry of Health, Czech Republic [AZV NV18-05-00162]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Society for Immunodeficiencies; Czech health research council; Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government)	This study was funded by a grant issued by the Deutsche Forschungsgemeinschaft (grant no. SFB 1160 IMPATH; project A04 to K.W. and project A03 to B.B.), a personal grant of the European Society for Immunodeficiencies to A.K., and a grant issued by the Czech health research council and Ministry of Health, Czech Republic (grant no. AZV NV18-05-00162).	Arbore G, 2016, SCIENCE, V352; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Jiang H, 2017, DNA CELL BIOL, V36, P321, DOI 10.1089/dna.2016.3571; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuntz M, 2011, CLIN IMMUNOL, V141, P177, DOI 10.1016/j.clim.2011.07.006; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Muhl H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00018; Petrovas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2285; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Unger S, 2014, J CLIN IMMUNOL, V34, P615, DOI 10.1007/s10875-014-0052-1; Valentine KM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01322; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744	18	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					912	+		10.1016/j.jaci.2020.02.025	http://dx.doi.org/10.1016/j.jaci.2020.02.025			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32169377	Bronze			2022-12-18	WOS:000582395800022
J	Schmitt, MER; Lutz, J; Haase, P; Bosl, MR; Wienands, J; Engels, N; Voehringer, D				Schmitt, Michaela E. R.; Lutz, Johannes; Haase, Paul; Bosl, Michael R.; Wienands, Jurgen; Engels, Niklas; Voehringer, David			The B-cell antigen receptor of IgE-switched plasma cells regulates memory IgE responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; helminths; IgE; plasma cells; B-cell receptor	MEMBRANE-BOUND IGE; IMMUNOGLOBULIN-E; PERSISTENCE; EXPRESSION; ANTIBODIES; TAIL; BCR	Background: Allergic inflammation is driven by IgE-producing plasma cells (PCs), which are required for IgE-mediated activation of mast cells and basophils. Repeated antigen encounter elicits a memory IgE response with elevated serum IgE titers and accumulation of IgE-producing PCs. However, the cellular compartment and molecular signals that underlie the immunologic memory of IgE responses remain unclear. Objective: With this study we aimed at clarifying whether inactivation of the cytoplasmic immunoglobulin tail tyrosine (ITT) motif in transmembrane IgE (mIgE) impairs the memory IgE response in mice. Methods: We generated mice with an inactivated mIgE-ITT motif and analyzed serum IgE levels as well as the generation of IgE-producing germinal center B cells and PCs subsequent to primary and secondary infection with helminths. In vitro cultures were used to study the mIgE-ITT-controlled expression of mIgE on the surface of PCs. Systemic mast cell activation was determined by serum Mcpt1 ELISA in response to ovalbumin challenge. Results: mIgE-ITT-mutant mice showed an impaired memory IgE response subsequent to helminth infection. Furthermore, sensitization and challenge of mIgE-ITT-mutant mice with ovalbumin resulted in diminished serum IgE titers and reduced mast cell activation. The mIgE-ITT motif was required for optimal cell surface expression of mIgE B-cell antigen receptors but not for intracellular IgE expression in PCs. Conclusion: These results indicate that the mIgE B-cell antigen receptor plays a critical role in establishing or maintaining the population of IgE-producing PCs during memory IgE responses.	[Schmitt, Michaela E. R.; Haase, Paul; Voehringer, David] Univ Hosp Erlangen, Dept Infect Biol, Wasserturmstr 3-5, D-91054 Erlangen, Germany; [Lutz, Johannes; Wienands, Jurgen; Engels, Niklas] Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, Humboldtallee 34, D-37073 Gottingen, Germany; [Bosl, Michael R.] Univ Wurzburg, Dept Expt Biomed 1, Univ Hosp, Wurzburg, Germany; [Bosl, Michael R.] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany	University of Erlangen Nuremberg; University of Gottingen; University of Wurzburg; University of Wurzburg	Voehringer, D (corresponding author), Univ Hosp Erlangen, Dept Infect Biol, Wasserturmstr 3-5, D-91054 Erlangen, Germany.; Engels, N (corresponding author), Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, Humboldtallee 34, D-37073 Gottingen, Germany.	nengels@gwdg.de; david.voehringer@uk-erlangen.de		Haase, Paul/0000-0002-2441-4190; Lutz, Johannes/0000-0001-7452-0023	Deutsche Forschungsgemeinschaft [TRR130_TP08, TRR130_TP20]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (grant TRR130_TP08 [to N.E. and J.W.] and grant TRR130_TP20 [to D.V.]).	Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; Blanc P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13600; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Engels N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6456; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Haniuda K, 2016, NAT IMMUNOL, V17, P1109, DOI 10.1038/ni.3508; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; He JS, 2013, J EXP MED, V210, P2755, DOI 10.1084/jem.20131539; HIRANO T, 1983, INT ARCH ALLER A IMM, V71, P182, DOI 10.1159/000233385; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Khodoun MV, 2011, P NATL ACAD SCI USA, V108, P12413, DOI 10.1073/pnas.1105695108; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Laffleur B, 2015, CELL REP, V10, P900, DOI 10.1016/j.celrep.2015.01.023; Lutz J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9575; MANDLER R, 1993, J IMMUNOL, V150, P407; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; MILLS FC, 1995, J IMMUNOL, V155, P3021; Mitre E, 2006, J ALLERGY CLIN IMMUN, V117, P939, DOI 10.1016/j.jaci.2005.12.1341; Oberndorfer I, 2006, J IMMUNOL, V177, P1139, DOI 10.4049/jimmunol.177.2.1139; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; OGILVIE BM, 1966, NATURE, V209, P1221, DOI 10.1038/2091221a0; Otte M, 2016, J ALLERGY CLIN IMMUN, V137, P1884, DOI 10.1016/j.jaci.2015.12.1333; PENG C, 1992, J IMMUNOL, V148, P129; Racine R, 2011, J IMMUNOL, V186, P1011, DOI 10.4049/jimmunol.1002836; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Tong P, 2017, P NATL ACAD SCI USA, V114, pE8411, DOI 10.1073/pnas.1704962114; Turqueti-Neves A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002290; Vanshylla K, 2018, EUR J IMMUNOL, V48, P441, DOI 10.1002/eji.201747196; Vanshylla K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22544-x; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Vigl B, 2017, J IMMUNOL METHODS, V449, P28, DOI 10.1016/j.jim.2017.06.006; Wienands J, 2016, CURR TOP MICROBIOL, V393, P107, DOI 10.1007/82_2015_480; Wolkerstorfer S, 2016, CELL MOL IMMUNOL, V13, P451, DOI 10.1038/cmi.2015.18; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Yang ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.21238; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009; ZHANG K, 1992, J EXP MED, V176, P233, DOI 10.1084/jem.176.1.233	44	7	7	4	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					642	+		10.1016/j.jaci.2020.02.015	http://dx.doi.org/10.1016/j.jaci.2020.02.015			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NN7PN	32113980	Bronze			2022-12-18	WOS:000568978400001
J	Amirav, I; Newhouse, MT				Amirav, Israel; Newhouse, Michael T.			COVID-19: Time to embrace MDI plus valved-holding chambers!	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Amirav, Israel] Univ Alberta, Pediat Dept, Edmonton, AB, Canada; [Newhouse, Michael T.] McMaster Univ, St Josephs Hosp, Firestone Inst Resp Hlth, Hamilton, ON, Canada	University of Alberta; McGill University; McMaster University	Amirav, I (corresponding author), Univ Alberta, Pediat Dept, Edmonton, AB, Canada.	amirav@ualberta.ca		Amirav, Israel/0000-0002-6917-5285				Amirav I, 1997, ARCH PEDIAT ADOL MED, V151, P876, DOI 10.1001/archpedi.1997.02170460014003; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000052.pub3; Global INitiative for Asthma, COVID 19 GINA ANSW F; Lewis D, 2020, NATURE, V580, P175, DOI 10.1038/d41586-020-00974-w; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Spin P, 2017, CAN J EMERG MED, V19, P1, DOI 10.1017/cem.2016.344; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Vincken W, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00065-2018	8	7	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					331	331		10.1016/j.jaci.2020.04.046	http://dx.doi.org/10.1016/j.jaci.2020.04.046			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32482527	Bronze, Green Published			2022-12-18	WOS:000558835000020
J	Prunotto, G; Offor, UT; Samarasinghe, S; Wynn, R; Vora, A; Carpenter, B; Gowdy, C; McHugh, K; Windebank, KP; Rovelli, AM; Slatter, MA; Gennery, AR; Veys, P; Bacon, CM; Bomken, S; Lucchini, G				Prunotto, Giulia; Offor, Ugonna T.; Samarasinghe, Sujith; Wynn, Robert; Vora, Ajay; Carpenter, Ben; Gowdy, Claire; McHugh, Kieran; Windebank, Kevin P.; Rovelli, Attilio Maria; Slatter, Mary A.; Gennery, Andrew R.; Veys, Paul; Bacon, Chris M.; Bomken, Simon; Lucchini, Giovanna			HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Prunotto, Giulia; Rovelli, Attilio Maria] Milano Bicocca Univ, Dept Pediat, Bone Marrow Transplantat Unit, Monza, Italy; [Prunotto, Giulia; Rovelli, Attilio Maria] Brianza Bambino & Mamma Fdn, Monza, Italy; [Offor, Ugonna T.; Bacon, Chris M.; Bomken, Simon] Newcastle Univ, Translat & Clin Res Inst, Ctr Canc, Wolfson Childhood Canc Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Offor, Ugonna T.; Windebank, Kevin P.; Bomken, Simon] Newcastle Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Dept Paediat Haematol & Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Samarasinghe, Sujith; Vora, Ajay] Great Ormond St Hosp NHS Trust, Dept Haematol, London, England; [Wynn, Robert] Royal Manchester Childrens Hosp, Dept Blood & Marrow Transplantat, Manchester, Lancs, England; [Carpenter, Ben] Univ Coll London Hosp, London, England; [Gowdy, Claire] Royal Belfast Hosp Sick Children, Dept Radiol, Belfast, Antrim, North Ireland; [McHugh, Kieran] Great Ormond St Hosp NHS Trust, Dept Radiol, London, England; [Slatter, Mary A.; Gennery, Andrew R.] Newcastle Tyne Hosp NHS Fdn Trust, Dept Paediat Immunol & Haematopoiet Stem Cell Tra, Newcastle Upon Tyne, Tyne & Wear, England; [Gennery, Andrew R.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Veys, Paul; Lucchini, Giovanna] Great Ormond St Hosp NHS Trust, BMT Dept, London, England; [Bacon, Chris M.] Newcastle Tyne Hosp NHS Fdn Trust, Dept Cellular Pathol, Newcastle Upon Tyne, Tyne & Wear, England	University of Milano-Bicocca; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Royal Manchester Children's Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Lucchini, G (corresponding author), Great Ormond St Hosp NHS Trust, BMT Dept, London, England.	Giovanna.lucchini@gosh.nhs.uk		Bomken, Simon/0000-0001-9163-5738	Children's Cancer and Leukaemia Group [CCLGA 2017 16]; Little Princess Trust; MRC [MR/S021590/1] Funding Source: UKRI	Children's Cancer and Leukaemia Group; Little Princess Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was generously supported in part by a research grant (grant no. CCLGA 2017 16) from the Children's Cancer and Leukaemia Group and The Little Princess Trust.	Bomken S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02912; Bousfiha A, 2020, J CLIN IMMUNOL, V40, P66, DOI 10.1007/s10875-020-00758-x; Canioni D, 2001, HISTOPATHOLOGY, V38, P146, DOI 10.1046/j.1365-2559.2001.01039.x; Cohen JM, 2007, BLOOD, V110, P2209, DOI 10.1182/blood-2006-12-062174; Hauck F, 2018, J ALLERGY CLIN IMMUN, V141, P59, DOI 10.1016/j.jaci.2017.06.009; Mayor PC, 2018, J ALLERGY CLIN IMMUN, V141, P1028, DOI 10.1016/j.jaci.2017.05.024; Slatter MA, 2018, EXPERT REV CLIN IMMU, V14, P103, DOI 10.1080/1744666X.2018.1424627; Swerdlow SH, 2017, WHO CLASSIFICATION T; Wolska-Kusnierz B, 2015, J CLIN IMMUNOL, V35, P538, DOI 10.1007/s10875-015-0186-9	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					447	450		10.1016/j.jaci.2020.03.043	http://dx.doi.org/10.1016/j.jaci.2020.03.043			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32371070	Bronze			2022-12-18	WOS:000558835000034
J	Klug, C; Hemmer, W; Roman-Carrasco, P; Focke-Tejkl, M; Quirce, S; Boyano-Martinez, T; Gaubitzer, E; Wank, H; Swoboda, I				Klug, Christoph; Hemmer, Wolfgang; Roman-Carrasco, Patricia; Focke-Tejkl, Margarete; Quirce, Santiago; Boyano-Martinez, Teresa; Gaubitzer, Erwin; Wank, Herbert; Swoboda, Ines			Gal d 7-a major allergen in primary chicken meat allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Poultry meat allergy; major chicken meat allergen; recombinant allergen; Gal d 7; genuine sensitization	FOOD ALLERGY; MUSCLE MYOSIN; POULTRY MEAT; EGG PROTEINS; SENSITIZATION; TRANSCRIPTION; REACTIVITY; CHILDREN; GELS	Background: Poultry meat can induce severe allergic reactions. So far, the molecules causing poultry meat allergy are largely unknown. Objective: Our aim was to identify and characterize poultry meat allergens. Methods: Profiles of patients' IgE reactivity to chicken muscle were analyzed in immunoblots, and proteins recognized by the majority of patients were subjected to peptide mass fingerprinting. A 23-kDa IgE-reactive protein was identified as myosin light chain 1, designated Gallus domesticus 7 (Gal d 7). Recombinant Gal d 7 was produced in Escherichia coli. The protein's IgE reactivity was analyzed in ELISA experiments, and cross-reactivity with allergens of other poultry species was assessed in inhibition immunoblots. Fold and thermal stability were evaluated by circular dichroism analysis, and enzymatic stability was investigated using in vitro gastrointestinal digestion assays. Results: Recombinant Gal d 7 represents a properly folded, predominantly alpha-helical protein and displays IgE-binding activity comparable to that of its natural counterpart. IgE reactivity analysis in 28 patients allergic to chicken meat revealed that Gal d 7 is a major allergen for patients primarily sensitized to chicken meat. Furthermore, Gal d 7-cross-reactive allergens were also detected in other poultry species, suggesting that recombinant Gal d 7 can be used as a diagnostic marker allergen for poultry meat allergy. The high thermal stability, refolding capacity, and resistance to gastrointestinal enzymes might explain why Gal d 7 can act as a potent sensitizing agent. Conclusion: Gal d 7 represents a novel major chicken meat allergen. Recombinant Gal d 7 could be used for diagnosis of genuine poultry meat sensitization.	[Klug, Christoph; Roman-Carrasco, Patricia; Wank, Herbert; Swoboda, Ines] Univ Appl Sci, Biotechnol Sect, Campus Vienna Bioctr, FH Campus Wien,Helmut Qualtinger Gasse 2, A-1030 Vienna, Austria; [Hemmer, Wolfgang] Floridsdorf Allergy Ctr, Vienna, Austria; [Focke-Tejkl, Margarete] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Quirce, Santiago; Boyano-Martinez, Teresa] Hosp La Paz, Inst Hlth Res, Dept Allergy, Madrid, Spain; [Gaubitzer, Erwin] Univ Vienna, Max F Perutz Labs, Dept Struct Biol & Biomol Chem, Vienna, Austria; [Klug, Christoph] MacroArray Diagnost GmbH, Vienna, Austria	Vienna Biocenter (VBC); Medical University of Vienna; Hospital Universitario La Paz; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Swoboda, I (corresponding author), Univ Appl Sci, Biotechnol Sect, Campus Vienna Bioctr, FH Campus Wien,Helmut Qualtinger Gasse 2, A-1030 Vienna, Austria.	ines.swoboda@fh-campuswien.ac.at	Román-Carrasco, Patricia/AAA-2952-2022	Roman Carrasco, Patricia/0000-0001-7301-871X; Swoboda, Ines/0000-0002-9164-1721	Austrian Science Fund Austria [P 25868-B13, P 29991]; Municipal Department 23 for Economic Affairs, Labor and Statistics, Vienna, Austria [15-10]	Austrian Science Fund Austria; Municipal Department 23 for Economic Affairs, Labor and Statistics, Vienna, Austria	This study was supported by research grants P 25868-B13 and P 29991 from the Austrian Science Fund Austria and research grant 15-10 from the Municipal Department 23 for Economic Affairs, Labor and Statistics, Vienna, Austria.	Barnig C, 2012, J INVEST ALLERG CLIN, V22, P439; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cahen YD, 1998, CLIN EXP ALLERGY, V28, P1026, DOI 10.1046/j.1365-2222.1998.00356.x; de Blay F, 2006, ALLERGY ASTHMA PROC, V15, P77; Feuille E, 2018, ALLERGY ASTHMA IMMUN, V10, P189, DOI 10.4168/aair.2018.10.3.189; Gonzalez-Mancebo E, 2011, J INVESTIG ALLERGOL, V21, P317; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Hemmer W, 2010, CLIN EXP ALLERGY, V40, P679, DOI 10.1111/j.1365-2222.2010.03486.x; Hemmer W, 2016, ALLERGO J, V25, P22, DOI 10.1007/s15007-016-1073-2; Hilger C, 2010, INT ARCH ALLERGY IMM, V151, P173, DOI 10.1159/000236008; Kelso JM, 1999, J ALLERGY CLIN IMMUN, V104, P202, DOI 10.1016/S0091-6749(99)70136-3; Kuehn A, 2016, ALLERGY, V71, P1772, DOI 10.1111/all.12968; Kuehn A, 2009, ALLERGY, V64, P1557, DOI 10.1111/j.1398-9995.2009.02094.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liccardi G, 1997, J ALLERGY CLIN IMMUN, V100, P577, DOI 10.1016/S0091-6749(97)70154-4; Lippi G, 2016, CRIT REV ONCOL HEMAT, V97, P1, DOI 10.1016/j.critrevonc.2015.11.008; Marangoni F, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.27606; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Mottet A, 2017, WORLD POULTRY SCI J, V73, P245, DOI [10.1017/S0043933917000071, 10.1017/s0043933917000071]; NABESHIMA YI, 1984, NATURE, V308, P333, DOI 10.1038/308333a0; Pekar J, 2018, MOL IMMUNOL, V100, P14, DOI 10.1016/j.molimm.2018.03.017; PERIASAMY M, 1984, J BIOL CHEM, V259, P3595; Polasani R, 1997, ANN ALLERG ASTHMA IM, V78, P35, DOI 10.1016/S1081-1206(10)63368-6; Quirce S, 2001, ALLERGY, V56, P754, DOI 10.1034/j.1398-9995.2001.056008754.x; Rance F, 1999, PEDIAT ALLERG IMM-UK, V10, P33, DOI 10.1034/j.1399-3038.1999.101008.x; SAMPSON HA, 1984, J ALLERGY CLIN IMMUN, V74, P26, DOI 10.1016/0091-6749(84)90083-6; Sentandreu MA, 2010, J PROTEOME RES, V9, P3374, DOI 10.1021/pr9008942; SHARP A, 1992, J SCI FOOD AGR, V58, P63, DOI 10.1002/jsfa.2740580112; Smyth AB, 1996, J AGR FOOD CHEM, V44, P1005, DOI 10.1021/jf950581p; Sokolova A, 2009, ALLERGOL IMMUNOPATH, V37, P168, DOI 10.1016/S0301-0546(09)71731-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	31	7	7	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					169	+		10.1016/j.jaci.2020.02.033	http://dx.doi.org/10.1016/j.jaci.2020.02.033			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	32194042	hybrid			2022-12-18	WOS:000579170500026
J	Navel, V; Chiambaretta, F; Dutheil, F				Navel, Valentin; Chiambaretta, Frederic; Dutheil, Frederic			Will environmental impacts of social distancing due to the pandemic caused by SARS-CoV-2 decrease allergic disease?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						SARS-CoV-2 pandemic; coronavirus; air pollution; quarantine; allergic diseases			[Navel, Valentin; Chiambaretta, Frederic] Univ Clermont Auvergne, CHU Clermont Ferrand, Univ Hosp Clermont Ferrand,Ophthalmol, CNRS,INSERM,GReD,Translat Approach Epithelial Inj, Clermont Ferrand, France; [Dutheil, Frederic] Univ Clermont Auvergne, CHU Clermont Ferrand, Univ Hosp Clermont Ferrand,Prevent & Occupat Med, CNRS,LaPSCo,Physiol & Psychosocial Stress, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Navel, V (corresponding author), CHU Clermont Ferrand, Univ Hosp Clermont Ferrand, Ophthalmol, F-63000 Clermont Ferrand, France.	valentin.navel@hotmail.fr						Agache I, 2019, ALLERGY, V74, P449, DOI 10.1111/all.13690; D'Amato G, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0036-x; Demain JG, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0777-7; European Space Agency, 2020, NITR DIOX CONC FRANC; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; NASA, 2020, AIRB NITR DIOX PLUMM; Permaul P, 2020, J ALLERGY CLIN IMMUN, V146, P813, DOI 10.1016/j.jaci.2020.03.003; Wuebbles D.J., 2017, CLIMATE SCI SPECIAL, VI, P10, DOI [10.7930/J0DJ5CTG., 10.7930/J0DJ5CTG.U.S]	8	7	7	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					70	71		10.1016/j.jaci.2020.04.026	http://dx.doi.org/10.1016/j.jaci.2020.04.026			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	32348792	Green Published, Bronze			2022-12-18	WOS:000579170500013
J	Pawelec, G				Pawelec, Graham			Aging as an inflammatory disease and possible reversal strategies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Senescence; aging; inflammation; senolytics; biomarker; healthspan; SASP	PHENOTYPE; LIFE		[Pawelec, Graham] Univ Tubingen, Dept Immunol, Tubingen, Germany; [Pawelec, Graham] Hlth Sci North Res Inst, Sudbury, ON, Canada	Eberhard Karls University of Tubingen; Health Sciences North; Northern Ontario School of Medicine	Pawelec, G (corresponding author), Interfac Inst Cell Biol, Dept Immunol, Morgenstelle 15-3-008, D-72076 Tubingen, Germany.	graham.pawelec@uni-tuebingen.de						Calder PC, 2013, BRIT J NUTR, V109, pS1, DOI 10.1017/S0007114512005119; Calimport SRG, 2019, SCIENCE, V366, P576, DOI 10.1126/science.aay7319; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052; Justice JN, 2018, CARDIOVASC ENDOCR ME, V7, P80, DOI 10.1097/XCE.0000000000000159; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Muller L, 2015, AGEING RES REV, V23, P116, DOI 10.1016/j.arr.2015.01.005; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9	10	7	7	5	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1355	1356		10.1016/j.jaci.2020.02.022	http://dx.doi.org/10.1016/j.jaci.2020.02.022			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	32142747	Bronze			2022-12-18	WOS:000531063400005
J	Farrera, C; Melchiotti, R; Petrov, N; Teng, KWW; Wong, MT; Loh, CY; Villanova, F; Tosi, I; Chen, JM; Grys, K; Sreeneebus, H; Chapman, A; Perera, GK; Heck, S; Gracio, F; de Rinaldis, E; Barker, JN; Smith, CH; Nestle, FO; Newell, EW; Di Meglio, P				Farrera, Consol; Melchiotti, Rossella; Petrov, Nedyalko; Teng, Karen Wei Weng; Wong, Michael Thomas; Loh, Chiew Yee; Villanova, Federica; Tosi, Isabella; Chen, Jinmiao; Grys, Katarzyna; Sreeneebus, Hemawtee; Chapman, Anna; Perera, Gayathri K.; Heck, Susanne; Gracio, Filipe; de Rinaldis, Emanuele; Barker, Jonathan N.; Smith, Catherine H.; Nestle, Frank O.; Newell, Evan W.; Di Meglio, Paola			T-cell phenotyping uncovers systemic features of atopic dermatitis and psoriasis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							REVEALS		[Farrera, Consol; Villanova, Federica; Tosi, Isabella; Grys, Katarzyna; Sreeneebus, Hemawtee; Barker, Jonathan N.; Smith, Catherine H.; Nestle, Frank O.; Di Meglio, Paola] Kings Coll London, St Johns Inst Dermatol, London, England; [Farrera, Consol; Melchiotti, Rossella; Petrov, Nedyalko; Villanova, Federica; Tosi, Isabella; Grys, Katarzyna; Sreeneebus, Hemawtee; Heck, Susanne; Gracio, Filipe; de Rinaldis, Emanuele] Guys & St Thomas Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Farrera, Consol; Melchiotti, Rossella; Petrov, Nedyalko; Villanova, Federica; Tosi, Isabella; Grys, Katarzyna; Sreeneebus, Hemawtee; Heck, Susanne; Gracio, Filipe; de Rinaldis, Emanuele] Kings Coll London, London, England; [Teng, Karen Wei Weng; Wong, Michael Thomas; Loh, Chiew Yee; Chen, Jinmiao; Newell, Evan W.] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Chapman, Anna] Queen Elizabeth Hosp, Dermatol Dept, London, England; [Perera, Gayathri K.] Chelsea & Westminster NHS Fdn Trust, West Middlesex Univ Hosp, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Imperial College London	Newell, EW (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	enewell@fredhutch.org; paola.dimeglio@kcl.ac.uk	Newell, Evan W/F-9711-2012; Chen, Jinmiao/ABE-5601-2021; Smith, Catherine/G-5268-2012	Newell, Evan W/0000-0002-2889-243X; Smith, Catherine/0000-0001-9918-1144; Di Meglio, Paola/0000-0002-2066-7780; Farrera, Consol/0000-0002-4214-9597	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London; NIHR Clinical Research Facility; Singapore Immunology Network; Singapore Immunology Network Immune Profiling Platform; New Development grant from the Fred Hutchinson Cancer Research Center	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London; NIHR Clinical Research Facility; Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Singapore Immunology Network Immune Profiling Platform; New Development grant from the Fred Hutchinson Cancer Research Center	This research was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London and/or the NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The authors also acknowledge core funding support (to E.W.N.) from the Singapore Immunology Network and the Singapore Immunology Network Immune Profiling Platform. E.W.N. is currently supported by a New Development grant from the Fred Hutchinson Cancer Research Center.	Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Czarnowicki T, 2017, ALLERGY, V72, P366, DOI 10.1111/all.13080; Czarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P208, DOI 10.1016/j.jaci.2015.03.032; Di Meglio P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015354; Guttman-Yassky E, 2018, J AM ACAD DERMATOL, V78, P872, DOI 10.1016/j.jaad.2018.01.016; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Reefer AJ, 2008, J ALLERGY CLIN IMMUN, V121, P415, DOI 10.1016/j.jaci.2007.11.003; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2898, DOI 10.1038/jid.2014.261; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X	11	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					1021	+		10.1016/j.jaci.2019.11.030	http://dx.doi.org/10.1016/j.jaci.2019.11.030			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31812571	Green Submitted, Bronze			2022-12-18	WOS:000518756700046
J	Villazala-Merino, S; Rodriguez-Dominguez, A; Stanek, V; Campion, NJ; Gattinger, P; Hofer, G; Froeschl, R; Fae, I; Lupinek, C; Vrtala, S; Breiteneder, H; Keller, W; Perkmann, T; Nakamura, R; Pickl, WF; Valenta, R; Eckl-Dorna, J; Niederberger, V				Villazala-Merino, Sergio; Rodriguez-Dominguez, Azahara; Stanek, Victoria; Campion, Nicholas J.; Gattinger, Pia; Hofer, Gerhard; Froeschl, Renate; Fae, Ingrid; Lupinek, Christian; Vrtala, Susanne; Breiteneder, Heimo; Keller, Walter; Perkmann, Thomas; Nakamura, Ryosuke; Pickl, Winfried F.; Valenta, Rudolf; Eckl-Dorna, Julia; Niederberger, Verena			Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen; CD23; Bet v 1; facilitated allergen presentation; IgE; birch pollen allergy; cross-linking; T-cell activation; IgE-allergen complex	BIRCH POLLEN ALLERGEN; GRASS-POLLEN; B-CELLS; BLOCKING ANTIBODIES; MONOCLONAL-ANTIBODY; IMMUNOGLOBULIN-E; DOUBLE-BLIND; HAY-FEVER; BINDING; INHIBITION	Background: CD23 mediates IgE-facilitated allergen presentation and subsequent allergen-specific T-cell activation in allergic patients. Objective: We sought to investigate key factors regulating IgE-facilitated allergen presentation through CD23 and subsequent T-cell activation. Methods: To study T-cell activation by free allergens and different types of IgE-Bet v 1 complexes, we used a molecular model based on monoclonal human Bet v 1-specific IgE, monomeric and oligomeric Bet v 1 allergen, an MHC-matched CD23-expressing B-cell line, and a T-cell line expressing a human Bet v 1-specific T-cell receptor. The ability to cross-link Fc epsilon receptors of complexes consisting of either IgE and monomeric Bet v 1 or IgE and oligomeric Bet v 1 was studied in human Fc epsilon RI-expressing basophils. T-cell proliferation by monomeric or oligomeric Bet v 1, which cross-links Fc epsilon receptors to a different extent, was studied in allergic patients' PBMCs with and without CD23-expressing B cells. Results: In our model non-cross-linking IgE-Bet v 1 monomer complexes, as well as cross-linking IgE-Bet v 1 oligomer complexes, induced T-cell activation, which was dependent on the concentration of specific IgE. However, T-cell activation by cross-linking IgE-Bet v 1 oligomer complexes was approximately 125-fold more efficient. Relevant T-cell proliferation occurred in allergic patients' PBMCs only in the presence of B cells, and its magnitude depended on the ability of IgE-Bet v 1 complexes to cross-link CD23. Conclusion: The extent of CD23-mediated T-cell activation depends on the concentration of allergen-specific IgE and the cross-linking ability of IgE-allergen complexes.	[Villazala-Merino, Sergio; Stanek, Victoria; Campion, Nicholas J.; Eckl-Dorna, Julia; Niederberger, Verena] Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria; [Rodriguez-Dominguez, Azahara; Gattinger, Pia; Lupinek, Christian; Vrtala, Susanne; Valenta, Rudolf] Med Univ Vienna, Div Immunopathol, Vienna, Austria; [Breiteneder, Heimo] Med Univ Vienna, Div Med Biotechnol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Froeschl, Renate; Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Fae, Ingrid] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Pickl, Winfried F.] Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Hofer, Gerhard; Keller, Walter] Karl Franzens Univ Graz, Inst Mol Biosci, BioTechMed Graz, Graz, Austria; [Nakamura, Ryosuke] Natl Inst Hlth Sci, Div Med Safety Sci, Kawasaki, Kanagawa, Japan; [Valenta, Rudolf] Sechenov First Moscow State Med Univ, Immunopathol Lab, Dept Clin Immunol & Allergy, Moscow, Russia; [Valenta, Rudolf] NRC Inst Immunol FMBA Russia, Moscow, Russia	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Graz; National Institute of Health Sciences - Japan; Sechenov First Moscow State Medical University; NRC Institute of Immunology FMBA of Russia	Eckl-Dorna, J (corresponding author), Med Univ Vienna, Dept Otorhinolaryngol, Res Labs 8H, Gen Hosp Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	julia.eckl-dorna@meduniwien.ac.at	Perkmann, Thomas/F-3074-2012; Lupinek, Christian/I-3311-2019; Eckl-Dorna, Julia/AAY-6371-2020; Keller, Walter/AAW-1501-2021	Lupinek, Christian/0000-0002-8612-8245; Keller, Walter/0000-0002-2261-958X; Eckl-Dorna, Julia/0000-0001-5981-1607; Perkmann, Thomas/0000-0002-7976-0285; Valenta, Rudolf/0000-0001-5944-3365; Gattinger, Pia/0000-0001-6724-8543; Villazala Merino, Sergio/0000-0002-6791-3272; Pickl, Winfried F./0000-0003-0430-4952	Austrian Science Fund (FWF) [DK1248-B13, F4604, F4605, F4608, F4609, F4613]; Russian Academic Excellence Project [5-100]; Government of the Russian Federation [14.W03.31.0024]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Russian Academic Excellence Project(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); Government of the Russian Federation	Supported by grants DK1248-B13, F4604, F4605, F4608, F4609, and F4613 from the Austrian Science Fund (FWF) and by the Russian Academic Excellence Project 5-100. R.V. is a recipient of a Megagrant of the Government of the Russian Federation, grant no. 14.W03.31.0024.	BALL T, 1994, J BIOL CHEM, V269, P28323; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Campana R, 2016, J ALLERGY CLIN IMMUN, V137, P601, DOI 10.1016/j.jaci.2015.08.042; Campana R, 2011, MOL IMMUNOL, V48, P431, DOI 10.1016/j.molimm.2010.09.016; CHAKRABARTY S, 1980, INT ARCH ALLER A IMM, V63, P369, DOI 10.1159/000232653; Chevigne A, 2018, J ALLERGY CLIN IMMUN, V142, P398, DOI 10.1016/j.jaci.2018.05.027; Curin M, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0790-x; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Eckl-Dorna J, 2018, ALLERGY, V73, P1003, DOI 10.1111/all.13343; Fae I, 2019, HLA, V93, P89, DOI 10.1111/tan.13439; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; Gieras A, 2007, J ALLERGY CLIN IMMUN, V119, P384, DOI 10.1016/j.jaci.2006.09.034; GRENIERBROSSETTE N, 1992, EUR J IMMUNOL, V22, P1573, DOI 10.1002/eji.1830220634; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; Holm J, 2011, J ALLERGY CLIN IMMUN, V127, P1029, DOI 10.1016/j.jaci.2011.01.062; Laffer S, 1996, J IMMUNOL, V157, P4953; Laffer S, 2001, J ALLERGY CLIN IMMUN, V108, P409, DOI 10.1067/mai.2001.117593; Leb VM, 2008, J ALLERGY CLIN IMMUN, V121, P64, DOI 10.1016/j.jaci.2007.10.006; MALLEY A, 1970, J ALLERGY, V45, P14, DOI 10.1016/0021-8707(70)90013-4; McKenna OE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071433; Nakamura R, 2010, ALLERGY, V65, P1266, DOI 10.1111/j.1398-9995.2010.02363.x; Neunkirchner A, 2011, J IMMUNOL, V187, P4077, DOI 10.4049/jimmunol.1003220; Niederberger V, 2007, INT ARCH ALLERGY IMM, V142, P133, DOI 10.1159/000096439; Orengo JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03636-8; Palaniyandi S, 2011, J IMMUNOL, V186, P3484, DOI 10.4049/jimmunol.1002146; Poole JA, 2005, J ALLERGY CLIN IMMUN, V116, P780, DOI 10.1016/j.jaci.2005.07.007; Pree I, 2010, CLIN EXP ALLERGY, V40, P1346, DOI 10.1111/j.1365-2222.2010.03548.x; Raftery MJ, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-10; Reginald K, 2013, IMMUNOL CELL BIOL, V91, P167, DOI 10.1038/icb.2012.70; Schappi GF, 1999, CLIN EXP ALLERGY, V29, P633, DOI 10.1046/j.1365-2222.1999.00567.x; Selb R, 2017, J ALLERGY CLIN IMMUN, V139, P290, DOI 10.1016/j.jaci.2016.03.042; Selb R, 2017, J ALLERGY CLIN IMMUN, V139, P281, DOI 10.1016/j.jaci.2016.04.015; Sellge G, 2005, CLIN EXP ALLERGY, V35, P774, DOI 10.1111/j.1365-2222.2005.02248.x; Shamji MH, 2006, J IMMUNOL METHODS, V317, P71, DOI 10.1016/j.jim.2006.09.004; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; van Neerven RJ, 2006, INT ARCH ALLERGY IMM, V141, P119, DOI 10.1159/000094714; van Neerven RJJ, 1999, J IMMUNOL, V163, P2944; van Neerven RJJ, 2004, CLIN EXP ALLERGY, V34, P420, DOI 10.1111/j.1365-2222.2004.01899.x; VANDERHEIJDEN FL, 1993, J IMMUNOL, V150, P3643; VANDERHEIJDEN FL, 1995, CLIN EXP IMMUNOL, V99, P289; Vinhas R, 2011, ALLERGY, V66, P1088, DOI 10.1111/j.1398-9995.2011.02598.x; Vrtala S, 2001, FASEB J, V15, P2045, DOI 10.1096/fj.00-0767fje; Wachholz PA, 2003, J ALLERGY CLIN IMMUN, V112, P915, DOI 10.1016/S0091-6749(03)02022-0; Wilcock LK, 2006, IMMUNOL ALLERGY CLIN, V26, P333, DOI 10.1016/j.iac.2006.02.004; Wurtzen PA, 2008, CLIN EXP ALLERGY, V38, P1290, DOI 10.1111/j.1365-2222.2008.03020.x	45	7	7	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					958	+		10.1016/j.jaci.2019.11.019	http://dx.doi.org/10.1016/j.jaci.2019.11.019			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31775017	hybrid, Green Accepted			2022-12-18	WOS:000518756700032
J	Delgado, SJ; Dehmel, S; Twisterling, E; Wichmann, J; Jonigk, D; Warnecke, G; Braubach, P; Fieguth, HG; Wilkens, L; Dahlmann, F; Kaup, FJ; Eggel, A; Knauf, S; Sewald, K; Braun, A				Delgado, Sharon Jimenez; Dehmel, Susann; Twisterling, Elaine; Wichmann, Judy; Jonigk, Danny; Warnecke, Gregor; Braubach, Peter; Fieguth, Hans-Gerd; Wilkens, Ludwig; Dahlmann, Franziska; Kaup, Franz-Josef; Eggel, Alexander; Knauf, Sascha; Sewald, Katherina; Braun, Armin			Disruptive anti-IgE inhibitors prevent mast cell-dependent early airway response in viable atopic lung tissue	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							OMALIZUMAB; COMPLEXES		[Delgado, Sharon Jimenez; Dehmel, Susann; Twisterling, Elaine; Wichmann, Judy; Jonigk, Danny; Warnecke, Gregor; Braubach, Peter; Dahlmann, Franziska; Sewald, Katherina; Braun, Armin] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Delgado, Sharon Jimenez; Dehmel, Susann; Twisterling, Elaine; Wichmann, Judy; Dahlmann, Franziska; Sewald, Katherina; Braun, Armin] German Ctr Lung Res DZL, Hannover, Germany; [Delgado, Sharon Jimenez; Dehmel, Susann; Twisterling, Elaine; Wichmann, Judy; Jonigk, Danny; Warnecke, Gregor; Braubach, Peter; Dahlmann, Franziska; Sewald, Katherina; Braun, Armin] Biomed Res Endstage & Obstruct Lung Dis BREATH Re, Hannover, Germany; [Twisterling, Elaine; Wichmann, Judy; Kaup, Franz-Josef; Knauf, Sascha] Leibniz Inst Primate Res, German Primate Ctr GmbH, Gottingen, Germany; [Jonigk, Danny; Warnecke, Gregor; Braubach, Peter] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Fieguth, Hans-Gerd; Wilkens, Ludwig] Klinikum Reg Hannover KRH, Inst Pathol, Hannover, Germany; [Eggel, Alexander] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland	Fraunhofer Gesellschaft; Deutsches Primatenzentrum (DPZ); Hannover Medical School; University of Bern; University Hospital of Bern	Sewald, K (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany.; Sewald, K (corresponding author), German Ctr Lung Res DZL, Hannover, Germany.; Sewald, K (corresponding author), Biomed Res Endstage & Obstruct Lung Dis BREATH Re, Hannover, Germany.	katherina.sewald@item.fraunhofer.de	Eggel, Alexander/J-8177-2019; Braun, Armin/B-8750-2009; Knauf, Sascha/F-1661-2017	Eggel, Alexander/0000-0001-8746-3339; Braun, Armin/0000-0002-1142-1463; Knauf, Sascha/0000-0001-5744-4946	German Research Foundation (DFG), Bonn, Germany [SPP 1394]; Fondation Acteria; Swiss National Science Foundation Ambizione grant [PZ00P3_148185]; Research Fund of the Swiss Lung Association, Berne, Switzerland; Uniscientia foundationa	German Research Foundation (DFG), Bonn, Germany(German Research Foundation (DFG)); Fondation Acteria; Swiss National Science Foundation Ambizione grant; Research Fund of the Swiss Lung Association, Berne, Switzerland; Uniscientia foundationa	This study was funded by the German Research Foundation (DFG), Bonn, Germany, and part of the programme SPP 1394 "Mast-cells-promoters of health and modulators of disease,'' as well as a grant from Fondation Acteria, a Swiss National Science Foundation Ambizione grant (PZ00P3_148185); the Research Fund of the Swiss Lung Association, Berne, Switzerland and the Uniscientia foundationa (to A.E.).	Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Eggel A, 2014, J ALLERGY CLIN IMMUN, V133, P1709, DOI 10.1016/j.jaci.2014.02.005; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Kim B, 2012, NATURE, V491, P613, DOI 10.1038/nature11546; Kunitomo M, 2005, RHINOLOGY, V43, P199; Neuhaus V, 2018, JOVE-J VIS EXP, DOI 10.3791/57042; Seehase S, 2011, J APPL PHYSIOL, V111, P791, DOI 10.1152/japplphysiol.00162.2011; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					719	+		10.1016/j.jaci.2019.11.002	http://dx.doi.org/10.1016/j.jaci.2019.11.002			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31858993	Bronze			2022-12-18	WOS:000512887400037
J	Ellis, AK; Frankish, CW; Armstrong, K; Steacy, L; Tenn, MW; Pawsey, S; Hafner, RP				Ellis, Anne K.; Frankish, Charles W.; Armstrong, Kristen; Steacy, Lisa; Tenn, Mark W.; Pawsey, Stephen; Hafner, Roderick P.			Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasons	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergic rhinoconjunctivitis; allergen challenge; environmental exposure unit; synthetic peptide immunoregulatory epitope; peptide; immunotherapy; grass; synthetic peptide immunoregulatory epitope; allergic rhinitis	IMMUNO-REGULATORY EPITOPES; ADVERSE SYSTEMIC REACTIONS; SUBLINGUAL IMMUNOTHERAPY; NATIONAL-HEALTH; EUROPEAN SURVEY; EFFICACY; SENSITIZATION; PREVALENCE; CHALLENGE; INDUCTION	Background: Grass allergen peptides are in development for the treatment of grass pollen-induced allergic rhinoconjunctivitis. A previous randomized, placebo-controlled study demonstrated that grass allergen peptides significantly improved total rhinoconjunctivitis symptom scores (TRSSs) after posttreatment challenge (PTC) to rye grass in an environmental exposure unit after 1 intervening grass pollen season (GPS1). Objective: We sought to evaluate the efficacy/safety of 4 dosing regimens of grass allergen peptides after a second (GPS2) and third (GPS3) intervening GPS in the environmental exposure unit. Methods: Eligible subjects who were randomized in the parent study (GPS1) during the first year of recruitment were invited to participate in GPS2 and GPS3, which took place 1 and 2 years after treatment cessation, respectively. Participants were not treated further, and both participants and study personnel remained blinded. The primary efficacy end point was the change in mean TRSS (reported every 30 minutes) from GPS1 baseline to the follow-up PTC calculated across all time points over days 2 to 4 for GPS2 and across hours 1 to 3 over days 2 to 4 for GPS3. Secondary efficacy end points and safety were also assessed. Results: One hundred twenty-two and 85 participants were enrolled in GPS2 and GPS3, respectively. A numerically greater, but not statistically significant improvement from baseline in mean TRSS at PTC was observed in the group receiving one 6-nmol intradermal injection every 2 weeks for 14 weeks group compared with the placebo at GPS2 (-6.0 vs -3.6, P = .0535) and GPS3 (-6.2 vs -3.6, P = .1128). Similar findings were observed for the group receiving one 6-nmol intradermal injection every 2 weeks for 14 weeks at GPS3 (-6.4 vs -3.6, P = .0759). No adverse safety signals were detected. Conclusion: Treatment with grass allergen peptides led to an improvement in allergic rhinoconjunctivitis symptoms after 3 intervening GPSs, corresponding to up to 2 years off treatment.	[Ellis, Anne K.; Tenn, Mark W.] Queens Univ, Dept Med, Kingston, ON, Canada; [Ellis, Anne K.; Tenn, Mark W.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Ellis, Anne K.; Steacy, Lisa; Tenn, Mark W.] Kingston Gen Hlth Res Inst, Allergy Res Unit, Hamilton, ON, Canada; [Frankish, Charles W.] Univ Ottawa, Dept Med, Hamilton, ON, Canada; [Armstrong, Kristen] Adiga Life Sci, Hamilton, ON, Canada; [Pawsey, Stephen; Hafner, Roderick P.] Circassia, Oxford, England	Queens University - Canada; Queens University - Canada; McMaster University; University of Ottawa	Ellis, AK (corresponding author), Kingston Hlth Sci Ctr, Dept Biomed & Mol Sci, Div Allergy & Immunol, Dept Med, Kingston Gen Hosp Site,Watkins 1D,76 Stuart St, Kingston, ON K7L 2V7, Canada.	ellisa@queensu.ca			Adiga Life Sciences, Hamilton, Ontario, Canada	Adiga Life Sciences, Hamilton, Ontario, Canada	This study was funded by Adiga Life Sciences, Hamilton, Ontario, Canada.	Alexander C, 2005, CLIN EXP ALLERGY, V35, P52, DOI 10.1111/j.1365-2222.2005.02143.x; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Calderon MA, 2017, ALLERGY, V72, P462, DOI 10.1111/all.13066; Chan-Yeung M, 2010, ALLERGY, V65, P1404, DOI 10.1111/j.1398-9995.2010.02399.x; Couroux P, 2015, CLIN EXP ALLERGY, V45, P974, DOI 10.1111/cea.12488; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Cox LS, 2006, J ALLERGY CLIN IMMUN, V117, P1021, DOI 10.1016/j.jaci.2006.02.040; Creticos PS, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-30; Demoly P, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0061-z; Didier A, 2013, CLIN EXP ALLERGY, V43, P568, DOI 10.1111/cea.12100; Didier A, 2011, J ALLERGY CLIN IMMUN, V128, P559, DOI 10.1016/j.jaci.2011.06.022; Durham SR, 2016, J ALLERGY CLIN IMMUN, V137, P339, DOI 10.1016/j.jaci.2015.12.1298; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Ellis AK, 2017, J ALLERGY CLIN IMMUN, V140, P486, DOI 10.1016/j.jaci.2016.11.043; Ellis AK, 2013, ANN ALLERG ASTHMA IM, V111, P323, DOI 10.1016/j.anai.2013.07.019; Gliddon DR, 2015, ALLERGY SS101, V70, pA1747; Gunawardana NC, 2018, J ALLERGY CLIN IMMUN, V141, P785, DOI 10.1016/j.jaci.2017.08.016; Hafner RP, 2012, J ALLERGY CLIN IMMUN, V129, pAB144, DOI 10.1016/j.jaci.2011.12.485; Hafner R, 2015, J ALLERGY CLIN IMMUN, V135, pAB142, DOI 10.1016/j.jaci.2014.12.1399; Hafner R, 2014, J ALLERGY CLIN IMMUN, V133, pAB289, DOI 10.1016/j.jaci.2013.12.1023; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Keith PK, 2012, ALLERGY ASTHMA CL IM, V8, DOI 10.1186/1710-1492-8-7; Kettner A, 2018, J ALLERGY CLIN IMMUN, V142, P678, DOI 10.1016/j.jaci.2018.01.052; Kiel MA, 2013, J ALLERGY CLIN IMMUN, V132, P353, DOI 10.1016/j.jaci.2013.03.013; Larche Mark, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS292, DOI 10.1513/AnnalsATS.201402-090AW; Marogna M, 2010, J ALLERGY CLIN IMMUN, V126, P969, DOI 10.1016/j.jaci.2010.08.030; Musa F, 2017, HUM VACC IMMUNOTHER, V13, P514, DOI 10.1080/21645515.2016.1243632; O'Hehir RE, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0587-0; Oldfield WLG, 2001, J IMMUNOL, V167, P1734, DOI 10.4049/jimmunol.167.3.1734; Orengo JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03636-8; Patel D, 2013, J ALLERGY CLIN IMMUN, V131, P103, DOI 10.1016/j.jaci.2012.07.028; Pene J, 1998, J ALLERGY CLIN IMMUN, V102, P571, DOI 10.1016/S0091-6749(98)70294-5; del Rio PR, 2017, PEDIAT ALLERG IMM-UK, V28, P60, DOI 10.1111/pai.12660; Rolland JM, 2009, PHARMACOL THERAPEUT, V121, P273, DOI 10.1016/j.pharmthera.2008.11.007; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Spertini F, 2016, J ALLERGY CLIN IMMUN, V138, P162, DOI 10.1016/j.jaci.2016.02.044; Tarzi M, 2006, CLIN EXP ALLERGY, V36, P465, DOI 10.1111/j.1365-2222.2006.02469.x; Tonti E, 2016, ALLERGY SS102, V71, pA4; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; Worm M, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Zhao DY, 2016, INT ARCH ALLERGY IMM, V169, P113, DOI 10.1159/000444391	44	7	8	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					610	+		10.1016/j.jaci.2019.09.010	http://dx.doi.org/10.1016/j.jaci.2019.09.010			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31568796	Bronze			2022-12-18	WOS:000512887400023
J	Pesek, RD; Rothenberg, ME				Pesek, Robert D.; Rothenberg, Marc E.			Eosinophilic gastrointestinal disease below the belt	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Eosinophilic esophagitis; eosinophilic gastritis; eosinophilic gastroenteritis; eosinophilic colitis; eosinophilic gastrointestinal diseases	GASTRITIS; ADULTS; GASTROENTERITIS; ESOPHAGITIS; VALIDATION; EXPRESSION; PATTERNS; CHILDREN; COLITIS; TRACT	Eosinophilic gastrointestinal diseases (EGIDs) are rare diseases of the gastrointestinal tract caused by allergic inflammation and gastrointestinal dysfunction. Initially described in 1978, recognition of these disorders has greatly increased over the past several decades. Thus far, eosinophilic esophagitis (EoE) has received the most focus, leading to significant advances in understanding of disease mechanisms, widely adopted guidelines for diagnosis and management, and ongoing clinical trials to provide expanded treatment options. EGIDs can affect other parts of the gastrointestinal tract and include eosinophilic gastritis (EG), eosinophilic gastroenteritis (EGE), and eosinophilic colitis (EC), yet these diseases are barely understood compared with EoE. Much of the research to date is limited to case series or single-center experiences, and there are no well-established guidelines for diagnosis or management. In this article the current state of EGIDs will be reviewed.	[Pesek, Robert D.] Univ Arkansas Med Sci, Dept Pediat, Div Allergy Immunol, Little Rock, AR 72205 USA; [Pesek, Robert D.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy Immunol, Cincinnati, OH 45229 USA; [Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Pesek, RD (corresponding author), Arkansas Childrens Hosp, Div Allergy Immunol, 13 Childrens Way,Slot 512-13, Little Rock, AR 72202 USA.	rdpesek@uams.edu			Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Services (NCATS) [U54 AI117804]; National Institute of Allergy and Infectious Diseases (NIAID) [U54 AI117804]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U54 AI117804]; NCATS; American Partnership for Eosinophilic Disorders; Campaign Urging Research for Eosinophilic Disease; Eosinophilic Family Coalition	Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Services (NCATS); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Partnership for Eosinophilic Disorders; Campaign Urging Research for Eosinophilic Disease; Eosinophilic Family Coalition	Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR; U54 AI117804) is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Services (NCATS), and is funded through collaboration between the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and NCATS. CEGIR is also supported by patient advocacy groups, including the American Partnership for Eosinophilic Disorders, the Campaign Urging Research for Eosinophilic Disease, and Eosinophilic Family Coalition.	Caldwell JM, 2014, J ALLERGY CLIN IMMUN, V134, P1114, DOI 10.1016/j.jaci.2014.07.026; Chehade M, 2007, J PEDIATR GASTR NUTR, V45, P354, DOI 10.1097/MPG.0b013e31803219d5; Chernetsova E, 2016, HUM PATHOL, V54, P55, DOI 10.1016/j.humpath.2016.03.004; Collins MH, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12470; DeBrosse CW, 2006, PEDIATR DEVEL PATHOL, V9, P210, DOI 10.2350/11-05-0130.1; Dellon ES, 2018, GASTROENTEROLOGY, V155, P1022, DOI 10.1053/j.gastro.2018.07.009; DiTommaso LA, 2019, J ALLERGY CLIN IMMUN, V143, P1928, DOI 10.1016/j.jaci.2018.12.1002; Egan M, 2018, ANN ALLERG ASTHMA IM, V121, P162, DOI 10.1016/j.anai.2018.06.013; Foroughi S, 2007, J ALLERGY CLIN IMMUN, V120, P594, DOI 10.1016/j.jaci.2007.06.015; Grandinetti T, 2019, DIGEST DIS SCI, V64, P2231, DOI 10.1007/s10620-019-05617-3; Gupta SK, 2019, GASTROENTEROLOGY, V156, P838, DOI 10.1053/j.gastro.2018.10.057; Hirano I, 2013, GUT, V62, P489, DOI 10.1136/gutjnl-2011-301817; Hogan SP, 2001, NAT IMMUNOL, V2, P353, DOI 10.1038/86365; Jensen ET, 2016, J PEDIATR GASTR NUTR, V62, P36, DOI 10.1097/MPG.0000000000000865; Johnsson M, 2011, J INNATE IMMUN, V3, P594, DOI 10.1159/000331326; Kennedy K, 2019, J ALLER CL IMM-PRACT, V7, P2059, DOI 10.1016/j.jaip.2019.01.053; Kim HP, 2018, CLIN GASTROENTEROL H, V16, P1992, DOI 10.1016/j.cgh.2018.03.024; Kuang FL, 2019, NEW ENGL J MED, V380, P1336, DOI 10.1056/NEJMoa1812185; Lucendo AJ, 2015, J PEDIATR GASTR NUTR, V61, P56, DOI 10.1097/MPG.0000000000000766; Lwin T, 2011, MODERN PATHOL, V24, P556, DOI 10.1038/modpathol.2010.221; Moawad FJ, 2019, GASTROINTEST ENDOSC, V28, P15; Muir AB, 2019, J ALLER CL IMM-PRACT, V7, P2434, DOI 10.1016/j.jaip.2019.03.020; O'Shea KM, 2018, GASTROENTEROLOGY, V154, P333, DOI 10.1053/j.gastro.2017.06.065; Prussin C, 2009, J ALLERGY CLIN IMMUN, V124, P1326, DOI 10.1016/j.jaci.2009.09.048; Reed C, 2015, DIGEST LIVER DIS, V47, P197, DOI 10.1016/j.dld.2014.11.009; Saad AG, 2011, PEDIATR DEVEL PATHOL, V14, P294, DOI 10.2350/10-07-0878-OA.1; Safroneeva E, 2019, CURR OPIN ALLERGY CL, V19, P169, DOI 10.1097/ACI.0000000000000514; Sato M, 2017, J ALLER CL IMM-PRACT, V5, P1639, DOI 10.1016/j.jaip.2017.03.030; Schoepfer AM, 2014, GASTROENTEROLOGY, V147, P1255, DOI 10.1053/j.gastro.2014.08.028; Shoda T, 2020, J ALLERGY CLIN IMMUN, V145, P255, DOI 10.1016/j.jaci.2019.11.007; Shoda T, 2018, LANCET GASTROENTEROL, V3, P477, DOI 10.1016/S2468-1253(18)30096-7; Simon D, 2016, ALLERGY, V71, P611, DOI 10.1111/all.12846; Sindher SB, 2016, J ALLERGY CLIN IMMUN, V137, pAB230, DOI 10.1016/j.jaci.2015.12.885; Song DJ, 2017, ALLERGY ASTHMA IMMUN, V9, P360, DOI 10.4168/aair.2017.9.4.360; Torrente F, 2014, J PEDIATR GASTR NUTR, V59, P300, DOI 10.1097/MPG.0000000000000432; Warners MJ, 2017, AM J GASTROENTEROL, V112, P1658, DOI 10.1038/ajg.2017.363; Youngblood BA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126219	37	7	8	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					87	+		10.1016/j.jaci.2019.10.013	http://dx.doi.org/10.1016/j.jaci.2019.10.013			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31669097	Green Accepted, Bronze			2022-12-18	WOS:000505590800008
J	Sbihi, H; Jones, MJ; MacIsaac, JL; Brauer, M; Allen, RW; Sears, MR; Subbarao, P; Mandhane, PJ; Moraes, TJ; Azad, MB; Becker, AB; Brook, JR; Kobor, MS; Turvey, SE				Sbihi, Hind; Jones, Meaghan J.; MacIsaac, Julie L.; Brauer, Michael; Allen, Ryan W.; Sears, Malcolm R.; Subbarao, Padmaja; Mandhane, Piush J.; Moraes, Theo J.; Azad, Meghan B.; Becker, Allan B.; Brook, Jeffrey R.; Kobor, Michael S.; Turvey, Stuart E.			Prenatal exposure to traffic-related air pollution, the gestational epigenetic clock, and risk of early-life allergic sensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LONGITUDINAL DEVELOPMENT CHILD; DNA METHYLATION; BIRTH COHORT		[Sbihi, Hind; Jones, Meaghan J.; MacIsaac, Julie L.; Brauer, Michael; Kobor, Michael S.; Turvey, Stuart E.] Univ British Columbia, Vancouver, BC, Canada; [Sbihi, Hind; Jones, Meaghan J.; MacIsaac, Julie L.; Kobor, Michael S.; Turvey, Stuart E.] British Columbia Childrens Hosp, Vancouver, BC, Canada; [Jones, Meaghan J.; Azad, Meghan B.; Becker, Allan B.] Univ Manitoba, Winnipeg, MB, Canada; [Allen, Ryan W.] Simon Fraser Univ, Burnaby, BC, Canada; [Sears, Malcolm R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Subbarao, Padmaja; Moraes, Theo J.] Hosp Sick Children, Toronto, ON, Canada; [Mandhane, Piush J.] Univ Alberta, Edmonton, AB, Canada; [Brook, Jeffrey R.] Univ Toronto, Toronto, ON, Canada	University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Manitoba; Simon Fraser University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Toronto	Kobor, MS (corresponding author), Univ British Columbia, Vancouver, BC, Canada.; Kobor, MS (corresponding author), British Columbia Childrens Hosp, Vancouver, BC, Canada.	msk@bcchr.ca; sturvey@cw.bc.ca	Azad, Meghan/H-7226-2019; Turvey, Stuart/HGV-1191-2022; Moraes, Theo/CAJ-3254-2022; Jones, Meaghan J/J-7672-2017; Brauer, Michael/Y-2810-2019	Azad, Meghan/0000-0002-5942-4444; Moraes, Theo/0000-0001-9968-6601; Jones, Meaghan J/0000-0003-1593-997X; Brauer, Michael/0000-0002-9103-9343; Turvey, Stuart/0000-0003-1599-1065	Canadian Institutes of Health Research (CIHR); Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence; Health Canada; Environment Canada; Canada Mortgage and Housing Corporation; Sick Children's Hospital Foundation; Silver Thread Foundation; Childhood Asthma Foundation (Canada); BC Children's Hospital Research Institute; BC Children's Hospital Foundation; Genome BC; Genome Canada [274CHI]; Michael Smith Foundation for Health Research; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence; Health Canada; Environment Canada(CGIAR); Canada Mortgage and Housing Corporation; Sick Children's Hospital Foundation; Silver Thread Foundation; Childhood Asthma Foundation (Canada); BC Children's Hospital Research Institute; BC Children's Hospital Foundation; Genome BC; Genome Canada(Genome Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR))	The Canadian Institutes of Health Research (CIHR) and the Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence provided core funding for the Canadian Healthy Infant Longitudinal Development cohort study. Additional support has been provided by Health Canada, Environment Canada, Canada Mortgage and Housing Corporation, the Sick Children's Hospital Foundation, Don & Debbie Morrison, the Silver Thread Foundation, the Childhood Asthma Foundation (Canada), BC Children's Hospital Research Institute and BC Children's Hospital Foundation, Genome BC, and Genome Canada (274CHI). H.S. is supported by Michael Smith Foundation for Health Research Postdoctoral Trainee Fellowship and CIHR Fellowship. M.S.K. is the Sunny Hill BC Leadership Chair in Child Development and the Canada Research Chair in Social Epigenetics. S.E.T. holds the Aubrey J. Tingle Professorship in Pediatric Immunology and Canada Research Chair in Pediatric Precision Health.	Bohlin J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1063-4; Bowatte G, 2015, ALLERGY, V70, P245, DOI 10.1111/all.12561; Cusack L, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0160-x; Esposito EA, 2016, DEV PSYCHOPATHOL, V28, P1385, DOI 10.1017/S0954579416000055; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feinberg AP, 2018, NEW ENGL J MED, V378, P1323, DOI [10.1056/NEJMra1402513, 10.1056/nejmra1402513]; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Khouja JN, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0520-1; Knight AK, 2018, J PEDIATR-US, V198, P168, DOI 10.1016/j.jpeds.2018.02.074; Knight AK, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1068-z; Marioni R. E., 2016, INT J EPIDEMIOL; Moraes TJ, 2015, PAEDIATR PERINAT EP, V29, P84, DOI 10.1111/ppe.12161; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Sbihi H, 2015, ENVIRON HEALTH PERSP, V123, P902, DOI 10.1289/ehp.1408700; Suarez A, 2018, J AM ACAD CHILD PSY, V57, P321, DOI 10.1016/j.jaac.2018.02.011; Subbarao P, 2015, THORAX, V70, P998, DOI 10.1136/thoraxjnl-2015-207246; Takaro TK, 2015, J EXPO SCI ENV EPID, V25, P580, DOI 10.1038/jes.2015.7; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Tingley D, 2014, J STAT SOFTW, V59	20	7	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1729	+		10.1016/j.jaci.2019.07.047	http://dx.doi.org/10.1016/j.jaci.2019.07.047			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31470034	Bronze			2022-12-18	WOS:000500694900032
J	Wooldridge, AL; McMillan, M; Kaur, M; Giles, LC; Marshall, HS; Gatford, KL				Wooldridge, Amy L.; McMillan, Mark; Kaur, Manpreet; Giles, Lynne C.; Marshall, Helen S.; Gatford, Kathryn L.			Relationship between birth weight or fetal growth rate and postnatal allergy: A systematic review	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Birth weight; systematic review; eczema; allergic rhinitis; food allergy; allergic asthma	ATOPIC-DERMATITIS; FOOD ALLERGY; RISK-FACTORS; INTRAUTERINE GROWTH; WORLDWIDE VARIATIONS; GESTATIONAL-AGE; THYMUS SIZE; ASTHMA; ECZEMA; INFANTS	Background: Individual susceptibility to allergic diseases is developmentally programmed by early-life exposures. Evidence frompreclinical studies suggests that intrauterine growth restriction is protective against later inflammatory responses to allergens. Objective: We sought to evaluate whether prenatal growth affects susceptibility to allergy in human subjects. Methods: We systematically searched for relevant studies in 11 databases, including Web of Science, ProQuest, EMBASE, and PubMed. We included only studies that corrected for gestational age or were restricted to full-term infants to separate effects of fetal growth from those of prematurity. Results: The 42 eligible studies included prospective and retrospective cohort, cross-sectional, and case-control studies. Only 2 studies reported allergic asthma. A birth weight increase of 1 kg was associated with a 44% greater risk of food allergy in children (odds ratio [OR], 1.44; 95% CI, 1.04-1.99; P = .001), a 17% greater risk of ever allergic dermatitis in children (OR, 1.17; 95% CI, 1.04-1.32; P = .008), and a 34% greater risk of ever or current allergic dermatitis in infants up to 2 years of age (OR, 1.34; 95% CI, 1.08-1.68; P = .009). Risks of allergic rhinitis were not associated with birth weight. Conclusions: The results of these meta-analyses suggest that intrauterine growth restriction protects against allergic diseases in human subjects consistent with preclinical evidence but that effects might differ between allergic diseases. The strongest evidence is available for infancy and early childhood, and additional studies in older children and adults are needed to determine whether the effects of prenatal growth on each allergic disease persist or differ between those with severe and mild phenotypes.	[Wooldridge, Amy L.; McMillan, Mark; Kaur, Manpreet; Giles, Lynne C.; Marshall, Helen S.; Gatford, Kathryn L.] Univ Adelaide, Robinson Res Inst, Level 6,Adelaide Hlth & Med Sci Bldg, Adelaide, SA 5005, Australia; [Wooldridge, Amy L.; McMillan, Mark; Marshall, Helen S.; Gatford, Kathryn L.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Giles, Lynne C.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Wooldridge, Amy L.] Univ Western Australia, Sch Human Sci, Perth, WA, Australia; [McMillan, Mark; Marshall, Helen S.] Womens & Childrens Hosp, Vaccinol & Immunol Res Trials Unit VIRTU, North Adelaide, SA, Australia; [Kaur, Manpreet] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Adelaide; University of Western Australia; Deakin University	Gatford, KL (corresponding author), Univ Adelaide, Robinson Res Inst, Level 6,Adelaide Hlth & Med Sci Bldg, Adelaide, SA 5005, Australia.	kathy.gatford@adelaide.edu.au		Wooldridge, Amy/0000-0002-2914-7693; McMillan, Mark/0000-0002-6490-7707	Australian Postgraduate Award; Healthy Development Adelaide scholarship; National Health and Medical Research Council of Australia [1155066]	Australian Postgraduate Award(Australian Government); Healthy Development Adelaide scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	During the first part of this work, A.L.W. was supported by an Australian Postgraduate Award and a Healthy Development Adelaide scholarship. H.S.M. is supported by a Practitioner Fellowship (APP ID 1155066) from the National Health and Medical Research Council of Australia.	Agosti M, 2003, ACTA PAEDIATR, V92, P44; AlMakoshi A, 2015, PEDIAT ALLERG IMM-UK, V26, P811, DOI 10.1111/pai.12380; Anderson EL, 2013, PEDIAT ALLERG IMM-UK, V24, P122, DOI 10.1111/pai.12049; Asher MI, 1998, EUR RESPIR J, V12, P315; Bager P, 2003, J ALLERGY CLIN IMMUN, V111, P51, DOI 10.1067/mai.2003.34; Barbarot S, 2013, BRIT J DERMATOL, V169, P1257, DOI 10.1111/bjd.12581; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Belderbos ME, 2012, CLIN EXP ALLERGY, V42, P66, DOI 10.1111/j.1365-2222.2011.03857.x; Benn CS, 2003, ACTA DERM-VENEREOL, V83, P347; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P1355, DOI 10.1016/j.jaci.2009.03.046; Bleker OP, 2006, PLACENTA, V27, P1052, DOI 10.1016/j.placenta.2006.01.001; Braback L, 1998, CLIN EXP ALLERGY, V28, P936; Diemert A, 2016, J REPROD IMMUNOL, V113, P76, DOI 10.1016/j.jri.2015.12.002; Egeberg A, 2016, PEDIAT ALLERG IMM-UK, V27, P368, DOI 10.1111/pai.12560; Ekin A, 2016, J ULTRAS MED, V35, P511, DOI 10.7863/ultra.15.05039; Ergaz Z, 2005, REPROD TOXICOL, V20, P301, DOI 10.1016/j.reprotox.2005.04.007; ERICSSON CH, 1991, ANN ALLERGY, V67, P53; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Gabet S, 2016, INT J HYG ENVIR HEAL, V219, P792, DOI 10.1016/j.ijheh.2016.09.001; Galassi C, 2006, PEDIATRICS, V117, P34, DOI 10.1542/peds.2004-2709; Goksor E, 2013, PEDIAT ALLERG IMM-UK, V24, P339, DOI 10.1111/pai.12078; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Grieger JA, 2016, INT ARCH ALLERGY IMM, V169, P80, DOI 10.1159/000443961; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hesselmar B, 2002, ACTA PAEDIATR, V91, P992, DOI 10.1080/080352502760272713; Hikino S, 2001, ACTA PAEDIATR, V90, P850, DOI 10.1080/08035250152509537; Hinz D, 2012, ALLERGY, V67, P380, DOI 10.1111/j.1398-9995.2011.02767.x; Kramer MS, 2004, CLIN EXP ALLERGY, V34, P753, DOI 10.1111/j.1365-2222.2004.1940.x; Landgraf MA, 2008, NUTRITION, V24, P262, DOI 10.1016/j.nut.2007.12.005; Landgraf MA, 2012, CELL PHYSIOL BIOCHEM, V30, P552, DOI 10.1159/000341437; Lau S, 2019, ANN ALLERG ASTHMA IM, V122, P25, DOI 10.1016/j.anai.2018.05.012; Lin MH, 2015, PAEDIATR PERINAT EP, V29, P472, DOI 10.1111/ppe.12215; Linneberg A, 2006, J ALLERGY CLIN IMMUN, V117, P184, DOI 10.1016/j.jaci.2005.09.042; Loid P, 2015, ACTA PAEDIATR, V104, P707, DOI 10.1111/apa.13015; Lundholm C, 2010, CLIN EXP ALLERGY, V40, P1044, DOI 10.1111/j.1365-2222.2010.03519.x; Marschan E, 2008, PEDIATR ALLERGY IMMU, V19, P132, DOI 10.1111/j.1399-3038.2007.00593.x; Metsala J, 2010, AM J EPIDEMIOL, V171, P1310, DOI 10.1093/aje/kwq074; Mitchell EA, 2014, PEDIAT ALLERG IMM-UK, V25, P264, DOI [10.1111/pai.12210, 10.1111/pai.12233_1]; Miyake Y, 2013, J ASTHMA, V50, P555, DOI 10.3109/02770903.2013.790422; Moola S., 2017, JOANNA BRIGGS I REVI, VVolume 5; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Mullins RJ, 2007, MED J AUSTRALIA, V186, P618, DOI 10.5694/j.1326-5377.2007.tb01077.x; Olesen AB, 1997, BRIT MED J, V314, P1003, DOI 10.1136/bmj.314.7086.1003; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Panduru M, 2014, ACTA DERMATOVENER CR, V22, P91; Pekkanen J, 2001, CLIN EXP ALLERGY, V31, P95, DOI 10.1046/j.1365-2222.2001.00930.x; Poulos LM, 2007, J ALLERGY CLIN IMMUN, V120, P878, DOI 10.1016/j.jaci.2007.07.040; Renz-Polster H, 2005, CLIN EXP ALLERGY, V35, P1466, DOI 10.1111/j.1365-2222.2005.02356.x; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Sanchez-Garcia S, 2015, PEDIAT ALLERG IMM-UK, V26, P711, DOI 10.1111/pai.12514; Sebok B, 2006, J EUR ACAD DERMATOL, V20, P418, DOI 10.1111/j.1468-3083.2006.01490.x; Sevelsted A, 2012, ALLERGY, V67, P670, DOI 10.1111/j.1398-9995.2012.02805.x; Shenkin SD, 2017, J DEV ORIG HLTH DIS, V8, P137, DOI 10.1017/S2040174416000581; Siltanen M, 2011, J ALLERGY CLIN IMMUN, V127, P935, DOI 10.1016/j.jaci.2010.12.1107; Silverberg JI, 2015, BRIT J DERMATOL, V173, P1400, DOI 10.1111/bjd.14031; Spergel JM, 2010, IMMUNOL ALLERGY CLIN, V30, P269, DOI 10.1016/j.iac.2010.06.003; Spracklen CN, 2014, CANCER EPIDEMIOL, V38, P538, DOI 10.1016/j.canep.2014.07.004; Steffensen FH, 2000, EPIDEMIOLOGY, V11, P185, DOI 10.1097/00001648-200003000-00018; Vaughn AR, 2017, DERMATITIS, V28, P241, DOI 10.1097/DER.0000000000000305; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Woods RK, 2002, EUR J CLIN NUTR, V56, P31, DOI 10.1038/sj.ejcn.1601306; Wooldridge Amy L, 2016, JBI Database System Rev Implement Rep, V14, P11; Wooldridge AL, 2014, AM J PHYSIOL-REG I, V306, pR441, DOI 10.1152/ajpregu.00432.2013; World Allergy Organization, 2013, WORLD ALLERGY ORG WA	65	7	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1703	1713		10.1016/j.jaci.2019.08.032	http://dx.doi.org/10.1016/j.jaci.2019.08.032			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31615640	Bronze			2022-12-18	WOS:000500694900027
J	Dolle-Bierke, S; Siebenhaar, F; Burmeister, T; Worm, M				Doelle-Bierke, Sabine; Siebenhaar, Frank; Burmeister, Thomas; Worm, Margitta			Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase-first data from the Anaphylaxis Registry (NORA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MASTOCYTOSIS		[Doelle-Bierke, Sabine; Siebenhaar, Frank; Burmeister, Thomas; Worm, Margitta] Charite Univ Med Berlin, Berlin, Germany; [Doelle-Bierke, Sabine; Siebenhaar, Frank; Burmeister, Thomas; Worm, Margitta] Free Univ Berlin, Berlin, Germany; [Doelle-Bierke, Sabine; Siebenhaar, Frank; Burmeister, Thomas; Worm, Margitta] Humboldt Univ, Berlin, Germany; [Doelle-Bierke, Sabine; Siebenhaar, Frank; Worm, Margitta] Berlin Inst Hlth, Dept Dermatol Venereol & Allergol, Berlin, Germany; [Burmeister, Thomas] Berlin Inst Hlth, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany; [Burmeister, Thomas] Lab Berlin, Hematol Tumor Genet, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health	Worm, M (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Worm, M (corresponding author), Free Univ Berlin, Berlin, Germany.; Worm, M (corresponding author), Humboldt Univ, Berlin, Germany.; Worm, M (corresponding author), Berlin Inst Hlth, Dept Dermatol Venereol & Allergol, Berlin, Germany.	margitta.worm@charite.de		Siebenhaar, Frank/0000-0003-4532-1644; Burmeister, Thomas/0000-0003-4843-2876; Dolle-Bierke, Sabine/0000-0002-3339-0709; Worm, Margitta/0000-0002-3449-1245	Network for Online-Registration of Anaphylaxis NORA; Deutsche Jose Carreras Leuk_amie-Stiftung e. V.	Network for Online-Registration of Anaphylaxis NORA; Deutsche Jose Carreras Leuk_amie-Stiftung e. V.	The Anaphylaxis Registry was supported by the Network for Online-Registration of Anaphylaxis NORA e. V. T.B. was supported by the Deutsche Jose Carreras Leuk_amie-Stiftung e. V.	Brockow Knut, 2017, Curr Opin Allergy Clin Immunol, V17, P356, DOI 10.1097/ACI.0000000000000391; Broesby-Olsen S, 2015, J ALLERGY CLIN IMMUN, V135, P262, DOI 10.1016/j.jaci.2014.06.031; Carter MC, 2018, BRIT J HAEMATOL, V183, P775, DOI 10.1111/bjh.15624; Nassiri M, 2016, J ALLERGY CLIN IMMUN, V137, P312, DOI 10.1016/j.jaci.2015.07.001; Oropeza AR, 2017, ALLERGY, V72, P1944, DOI 10.1111/all.13207; Rueff F, 2009, J ALLERGY CLIN IMMUN, V124, P1047, DOI 10.1016/j.jaci.2009.08.027; Valent P, 2014, ALLERGY, V69, P1267, DOI 10.1111/all.12436; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P1125, DOI 10.1016/j.jaip.2019.01.006; Worm M, 2018, ALLERGY, V73, P1322, DOI 10.1111/all.13380	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1448	+		10.1016/j.jaci.2019.07.037	http://dx.doi.org/10.1016/j.jaci.2019.07.037			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31415784	Bronze			2022-12-18	WOS:000495004700043
J	Allard, B; Panariti, A; Pernet, E; Downey, J; Ano, S; Dembele, M; Nakada, E; Fujii, U; McGovern, TK; Powell, WS; Divangahi, M; Martin, JG				Allard, Benoit; Panariti, Alice; Pernet, Erwan; Downey, Jeffrey; Ano, Satoshi; Dembele, Marieme; Nakada, Emily; Fujii, Utako; McGovern, Toby K.; Powell, William S.; Divangahi, Maziar; Martin, James G.			Tolerogenic signaling of alveolar macrophages induces lung adaptation to oxidative injury	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Lung injury; oxidative stress; disease tolerance; lung function adaptation; forkhead box P3; alveolar macrophages; mucosal immunology	REGULATORY T-CELLS; PROSTAGLANDIN E-2; FOXP3 EXPRESSION; AIR-POLLUTION; RESOLUTION; RECEPTOR; PHAGOCYTOSIS; INFLAMMATION; INHALATION; RESPONSES	Background: Inhaled oxidative toxicants present in ambient air cause airway epithelial injury, inflammation, and airway hyperresponsiveness. Effective adaptation to such environmental insults is essential for the preservation of pulmonary function, whereas failure or incomplete adaptation to oxidative injury can render the host susceptible to the development of airway disease. Objective: We sought to explore the mechanisms of airway adaptation to oxidative injury. Methods: For a model to study pulmonary adaptation to oxidative stress-induced lung injury, we exposed mice to repeated nose-only chlorine gas exposures. Outcome measures were evaluated 24 hours after the last chlorine exposure. Lung mechanics and airway responsiveness to methacholine were assessed by using the flexiVent. Inflammation and antioxidant responses were assessed in both bronchoalveolar lavage fluid and lung tissue. Using both loss or gain of function and genomic approaches, we further dissected the cellular and molecular mechanisms involved in pulmonary adaptation. Results: Repeated exposures to oxidative stress resulted in pulmonary adaptation evidenced by abrogation of neutrophilic inflammation and airway hyperresponsiveness. This adaptation was independent of antioxidant mechanisms and regulatory T cells but dependent on residential alveolar macrophages (AMs). Interestingly, 5% of AMs expressed forkhead box P3, and depletion of these cells abolished adaptation. Results from transcriptomic profiling and loss and gain of function suggest that adaptation might be dependent on TGF-beta and prostaglandin E-2. Conclusion: Pulmonary adaptation during oxidative stress-induced lung injury is mediated by a novel subset of forkhead box P3-positive AMs that limits inflammation, favoring airway adaptation and host fitness through TGF-beta and prostaglandin E-2.	[Allard, Benoit; Panariti, Alice; Pernet, Erwan; Downey, Jeffrey; Ano, Satoshi; Dembele, Marieme; Nakada, Emily; Fujii, Utako; McGovern, Toby K.; Powell, William S.; Divangahi, Maziar; Martin, James G.] McGill Univ, Res Inst, Meakins Christie Labs, Hlth Ctr, Block E,Rm EM3-2379,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada; [Allard, Benoit; Panariti, Alice; Pernet, Erwan; Downey, Jeffrey; Ano, Satoshi; Dembele, Marieme; Nakada, Emily; Fujii, Utako; McGovern, Toby K.; Powell, William S.; Divangahi, Maziar; Martin, James G.] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University	Martin, JG (corresponding author), McGill Univ, Res Inst, Meakins Christie Labs, Hlth Ctr, Block E,Rm EM3-2379,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	james.martin@mcgill.ca	Powell, William/AAE-9000-2020	Allard, Benoit/0000-0002-7093-5851; Martin, James/0000-0001-7574-5363; Pernet, Erwan/0000-0003-3595-4755	Canadian Institutes of Health Research [MOP-126131]; Richard and Edith Strauss Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Richard and Edith Strauss Foundation	Supported by an operating grant from the Canadian Institutes of Health Research (MOP-126131) and the Richard and Edith Strauss Foundation.	Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Ano S, 2017, FREE RADICAL BIO MED, V102, P1, DOI 10.1016/j.freeradbiomed.2016.11.017; Arjomandi M, 2005, AM J RESP CRIT CARE, V172, P427, DOI 10.1164/rccm.200502-272OC; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bates JHT, 2009, IEEE ENG MED BIO, P170, DOI 10.1109/IEMBS.2009.5333302; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bowatte G, 2017, J ALLERGY CLIN IMMUN, V139, P122, DOI 10.1016/j.jaci.2016.05.008; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Careau E, 2004, AM J RESP CELL MOL, V31, P22, DOI 10.1165/rcmb.2003-0229OC; Clark KA, 2016, ANN AM THORAC SOC, V13, P356, DOI 10.1513/AnnalsATS.201508-525OC; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; Degrossoli A, 2018, ELIFE, V7, DOI 10.7554/eLife.32288; Devaud C, 2014, CANCER IMMUNOL IMMUN, V63, P869, DOI 10.1007/s00262-014-1581-4; FARRELL BP, 1979, AM REV RESPIR DIS, V119, P725; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Holguin Fernando, 2013, Ann Am Thorac Soc, V10 Suppl, pS150, DOI 10.1513/AnnalsATS.201305-116AW; Hoyle GW, 2016, ANN NY ACAD SCI, V1378, P33, DOI 10.1111/nyas.13139; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-035OC; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ivanova V, 2013, EUR J PHARM BIOPHARM, V84, P335, DOI 10.1016/j.ejpb.2012.11.023; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lakey PSJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32916; Lewkowicz N, 2013, IMMUNOBIOLOGY, V218, P455, DOI 10.1016/j.imbio.2012.05.029; Lewkowicz P, 2006, J IMMUNOL, V177, P7155, DOI 10.4049/jimmunol.177.10.7155; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martin JG, 2003, AM J RESP CRIT CARE, V168, P568, DOI 10.1164/rccm.200201-021OC; Martin JG, 2002, J IMMUNOL, V169, P3963, DOI 10.4049/jimmunol.169.7.3963; McCaslin CA, 2015, J CYST FIBROS, V14, P70, DOI 10.1016/j.jcf.2014.06.009; McGovern T, 2016, J IMMUNOL, V197, P266, DOI 10.4049/jimmunol.1501084; McGovern T, 2011, FREE RADICAL BIO MED, V50, P602, DOI 10.1016/j.freeradbiomed.2010.12.001; McGovern TK, 2015, AM J RESP CELL MOL, V52, P513, DOI 10.1165/rcmb.2013-0430OC; McGovern TK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-138; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morimoto K, 2012, RESP MED, V106, P1800, DOI 10.1016/j.rmed.2012.08.020; O'Koren EG, 2013, AM J RESP CELL MOL, V49, P788, DOI 10.1165/rcmb.2012-0369OC; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Parmentier C, 1998, J CHROMATOGR B, V719, P37, DOI 10.1016/S0378-4347(98)00414-9; Porto BN, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00311; Pyle CJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006640; Richards H, 2010, IMMUNOLOGY, V131, P583, DOI 10.1111/j.1365-2567.2010.03333.x; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; Tuck SA, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-61; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; White Carl W, 2010, Proc Am Thorac Soc, V7, P257, DOI 10.1513/pats.201001-008SM; Zarogiannis SG, 2011, AM J RESP CELL MOL, V45, P386, DOI 10.1165/rcmb.2010-0432OC	61	7	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					945	+		10.1016/j.jaci.2019.07.015	http://dx.doi.org/10.1016/j.jaci.2019.07.015			26	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31356919				2022-12-18	WOS:000488803900011
J	Bacharier, LB; Mori, A; Kita, H				Bacharier, Leonard B.; Mori, Akio; Kita, Hirohito			Advances in asthma, asthma-COPD overlap, and related biologics in 2018	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; asthma-COPD overlap; biologics	INNATE LYMPHOID-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; BUDESONIDE-FORMOTEROL; RISK; EXPRESSION; IL-33; PREDISPOSES; MICROBIOTA; CHILDHOOD; DIVERSITY	Over the past year, numerous important advances in our understanding of multiple aspects of asthma, ranging from disease pathogenesis to epidemiology to therapeutics, have been reported. This review is a compilation of highlights from articles published largely in the Journal of Allergy and Clinical Immunology and supplemented by articles published elsewhere that have substantially advanced the fields of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap and biologic therapies for these disorders. The intention of this article is not to provide a comprehensive review but rather to focus on several areas that have developed quickly and/or received extensive attention from our readers.	[Bacharier, Leonard B.] Washington Univ, Dept Pediat, Div Pediat Allergy Immunol & Pulm Med, St Louis, MO 63110 USA; [Bacharier, Leonard B.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Mori, Akio] Natl Hosp Org Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Dept Adv Med, Sagamihara, Kanagawa, Japan; [Kita, Hirohito] Mayo Clin, Div Allerg Dis, Dept Med & Dept Immunol, Rochester, MN USA; [Kita, Hirohito] Mayo Clin, Dept Med, Div Allerg Dis, Scottsdale, AZ USA; [Kita, Hirohito] Mayo Clin, Dept Immunol, Scottsdale, AZ USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Bacharier, LB (corresponding author), Washington Univ, Sch Med, 425 S Euclid Ave, St Louis, MO 63110 USA.	Bacharier_L@wustl.edu		Bacharier, Leonard/0000-0003-0432-2704				Agache I, 2018, J ALLERGY CLIN IMMUN, V141, P442, DOI 10.1016/j.jaci.2017.08.027; Ali Z, 2018, J ALLERGY CLIN IMMUN, V141, P761, DOI 10.1016/j.jaci.2017.03.040; Altman MC, 2018, J ALLERGY CLIN IMMUN, V142, P1856, DOI 10.1016/j.jaci.2018.02.019; Basu T, 2018, J ALLERGY CLIN IMMUN, V141, P423, DOI 10.1016/j.jaci.2017.07.034; Bateman ED, 2018, NEW ENGL J MED, V378, P1877, DOI 10.1056/NEJMoa1715275; Bourdin A, 2018, J ALLERGY CLIN IMMUN, V141, P1516, DOI 10.1016/j.jaci.2017.11.049; Busse WW, 2018, NEW ENGL J MED, V378, P2497, DOI 10.1056/NEJMoa1716868; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Chairakaki AD, 2018, J ALLERGY CLIN IMMUN, V142, P542, DOI 10.1016/j.jaci.2017.08.032; Chapman KR, 2018, AM J RESP CRIT CARE, V198, P329, DOI 10.1164/rccm.201803-0405OC; Chen J, 2018, J ALLERGY CLIN IMMUN, V142, P207, DOI 10.1016/j.jaci.2017.08.015; Chuang YT, 2019, J ALLERGY CLIN IMMUN, V143, P565, DOI 10.1016/j.jaci.2018.03.022; Coverstone AM, 2018, J ALLERGY CLIN IMMUN, V142, P297, DOI 10.1016/j.jaci.2018.02.008; Dai YR, 2018, J ALLERGY CLIN IMMUN, V141, P1532, DOI 10.1016/j.jaci.2018.01.006; Dicker AJ, 2018, J ALLERGY CLIN IMMUN, V141, P117, DOI 10.1016/j.jaci.2017.04.022; Ek WE, 2018, J ALLERGY CLIN IMMUN, V141, P1157, DOI 10.1016/j.jaci.2017.10.022; Eldeirawi K, 2018, J ALLERGY CLIN IMMUN, V141, P2306, DOI 10.1016/j.jaci.2018.02.012; Evans MD, 2018, J ALLERGY CLIN IMMUN, V142, P415, DOI 10.1016/j.jaci.2017.09.035; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Farahi N, 2018, J ALLERGY CLIN IMMUN, V142, P1659, DOI 10.1016/j.jaci.2018.07.011; Fazlollahi M, 2018, J ALLERGY CLIN IMMUN, V142, P834, DOI 10.1016/j.jaci.2018.02.020; Gaffin JM, 2018, J ALLERGY CLIN IMMUN, V141, P2249, DOI 10.1016/j.jaci.2017.08.028; Gerald JK, 2019, J ALLERGY CLIN IMMUN, V143, P755, DOI 10.1016/j.jaci.2018.06.048; Ghebre MA, 2018, J ALLERGY CLIN IMMUN, V141, P2027, DOI 10.1016/j.jaci.2018.04.013; Gill MA, 2018, J ALLERGY CLIN IMMUN, V141, P1735, DOI 10.1016/j.jaci.2017.07.035; Goldman DL, 2018, J ALLERGY CLIN IMMUN, V141, P808, DOI 10.1016/j.jaci.2017.09.018; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Hanania NA, 2019, J ALLERGY CLIN IMMUN, V143, P1629, DOI 10.1016/j.jaci.2018.11.032; Happle C, 2018, J ALLERGY CLIN IMMUN, V141, P685, DOI 10.1016/j.jaci.2017.03.051; Hekking PP, 2018, J ALLERGY CLIN IMMUN, V141, P1280, DOI 10.1016/j.jaci.2017.06.037; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Jackson DJ, 2018, NEW ENGL J MED, V378, P891, DOI 10.1056/NEJMoa1710988; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jevnikar Z, 2019, J ALLERGY CLIN IMMUN, V143, P577, DOI 10.1016/j.jaci.2018.05.026; Khatri S, 2019, J ALLERGY CLIN IMMUN, V143, P1742, DOI 10.1016/j.jaci.2018.09.033; Kuschnir FC, 2018, J ALLERGY CLIN IMMUN, V141, P1947, DOI 10.1016/j.jaci.2018.01.026; Kyburz A, 2019, J ALLERGY CLIN IMMUN, V143, P1496, DOI 10.1016/j.jaci.2018.07.046; Lai PS, 2018, J ALLERGY CLIN IMMUN, V141, P2311, DOI 10.1016/j.jaci.2018.02.022; Lang JE, 2018, J ALLERGY CLIN IMMUN, V141, P1459, DOI 10.1016/j.jaci.2017.09.043; Ta LDH, 2018, J ALLERGY CLIN IMMUN, V142, P86, DOI 10.1016/j.jaci.2018.01.032; Lee A, 2018, J ALLERGY CLIN IMMUN, V141, P1880, DOI 10.1016/j.jaci.2017.07.017; Leffler J, 2018, J ALLERGY CLIN IMMUN, V142, P1639, DOI 10.1016/j.jaci.2018.07.003; Lenberg J, 2018, J ALLERGY CLIN IMMUN, V141, P1118, DOI 10.1016/j.jaci.2017.09.002; Leyva-Castillo JM, 2019, J ALLERGY CLIN IMMUN, V143, P619, DOI 10.1016/j.jaci.2018.05.032; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Liu XQ, 2018, J ALLERGY CLIN IMMUN, V141, P886, DOI 10.1016/j.jaci.2017.05.016; Ludka-Gaulke T, 2018, J ALLERGY CLIN IMMUN, V141, P454, DOI 10.1016/j.jaci.2017.07.032; Lugogo N, 2018, J ALLERGY CLIN IMMUN, V141, P1096, DOI 10.1016/j.jaci.2017.04.047; Maazi H, 2018, J ALLERGY CLIN IMMUN, V141, P893, DOI 10.1016/j.jaci.2017.04.043; Mallia P, 2018, J ALLERGY CLIN IMMUN, V142, P815, DOI 10.1016/j.jaci.2017.10.017; Martinez CH, 2018, J ALLERGY CLIN IMMUN, V141, P429, DOI 10.1016/j.jaci.2017.07.039; Martinez FJ, 2018, AM J RESP CRIT CARE, V198, P1268, DOI 10.1164/rccm.201712-2493OC; McCleary N, 2018, J ALLERGY CLIN IMMUN, V141, P1510, DOI 10.1016/j.jaci.2017.11.034; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; McKeever T, 2018, NEW ENGL J MED, V378, P902, DOI 10.1056/NEJMoa1714257; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morgan BW, 2019, J ALLERGY CLIN IMMUN, V143, P1598, DOI 10.1016/j.jaci.2018.06.052; Morten M, 2018, J ALLERGY CLIN IMMUN, V142, P1765, DOI 10.1016/j.jaci.2018.02.039; Nobs SP, 2019, J ALLERGY CLIN IMMUN, V143, P1513, DOI 10.1016/j.jaci.2018.08.044; Nunes JOF, 2018, J ALLERGY CLIN IMMUN, V141, P1018, DOI 10.1016/j.jaci.2017.06.025; O'Byrne PM, 2018, NEW ENGL J MED, V378, P1865, DOI 10.1056/NEJMoa1715274; O'Connor GT, 2018, J ALLERGY CLIN IMMUN, V141, P1468, DOI 10.1016/j.jaci.2017.06.040; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Panganiban RA, 2018, J ALLERGY CLIN IMMUN, V142, P1469, DOI 10.1016/j.jaci.2017.11.040; Pavord ID, 2018, J ALLERGY CLIN IMMUN, V141, P1983, DOI 10.1016/j.jaci.2018.04.020; Peters U, 2018, J ALLERGY CLIN IMMUN, V141, P1169, DOI 10.1016/j.jaci.2018.02.004; Qiu WL, 2018, J ALLERGY CLIN IMMUN, V141, P1250, DOI 10.1016/j.jaci.2017.05.052; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Ramirez LP, 2018, J ALLERGY CLIN IMMUN, V141, P1921, DOI 10.1016/j.jaci.2017.11.058; Ravanetti L, 2019, J ALLERGY CLIN IMMUN, V143, P1355, DOI 10.1016/j.jaci.2018.08.051; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Rice MB, 2018, J ALLERGY CLIN IMMUN, V141, P1932, DOI 10.1016/j.jaci.2017.11.062; Roche N, 2017, AM J RESP CRIT CARE, V195, P1189, DOI 10.1164/rccm.201701-0193OC; Rosas-Salazar C, 2018, J ALLERGY CLIN IMMUN, V142, P1447, DOI 10.1016/j.jaci.2017.10.049; Rossios C, 2018, J ALLERGY CLIN IMMUN, V141, P560, DOI 10.1016/j.jaci.2017.02.045; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Schleimer RP, 2017, J ALLERGY CLIN IMMUN, V139, P1752, DOI 10.1016/j.jaci.2017.04.010; Segal LN, 2018, J ALLERGY CLIN IMMUN, V141, P1961, DOI 10.1016/j.jaci.2018.02.035; Sehmi R, 2018, J ALLERGY CLIN IMMUN, V141, P1529, DOI 10.1016/j.jaci.2018.01.008; Shen XF, 2018, J ALLERGY CLIN IMMUN, V141, P1929, DOI 10.1016/j.jaci.2018.01.005; Shirai T, 2019, J ALLER CL IMM-PRACT, V7, P134, DOI 10.1016/j.jaip.2018.06.015; Siddiqui S, 2018, J ALLERGY CLIN IMMUN, V142, P1457, DOI 10.1016/j.jaci.2017.12.982; Sobieraj DM, 2018, JAMA-J AM MED ASSOC, V320, P934, DOI 10.1001/jama.2018.8577; Sobieraj DM, 2018, JAMA-J AM MED ASSOC, V319, P1473, DOI 10.1001/jama.2018.2757; Soffer N, 2018, J ALLERGY CLIN IMMUN, V142, P1366, DOI 10.1016/j.jaci.2018.04.043; Sorkness RL, 2018, J ALLERGY CLIN IMMUN, V142, P1090, DOI 10.1016/j.jaci.2017.09.047; Stadhouders R, 2018, J ALLERGY CLIN IMMUN, V142, P1793, DOI 10.1016/j.jaci.2017.12.1006; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Sugita K, 2018, J ALLERGY CLIN IMMUN, V141, P300, DOI 10.1016/j.jaci.2017.02.038; Sullivan PW, 2018, J ALLERGY CLIN IMMUN, V141, P110, DOI 10.1016/j.jaci.2017.04.009; Taylor SL, 2018, J ALLERGY CLIN IMMUN, V141, P94, DOI 10.1016/j.jaci.2017.03.044; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Teufelberger AR, 2018, J ALLERGY CLIN IMMUN, V141, P549, DOI 10.1016/j.jaci.2017.05.004; Thio CLP, 2018, J ALLERGY CLIN IMMUN, V142, P1867, DOI 10.1016/j.jaci.2018.02.032; Toki S, 2018, J ALLERGY CLIN IMMUN, V142, P1515, DOI 10.1016/j.jaci.2017.11.043; Tran MM, 2018, J ALLERGY CLIN IMMUN, V141, P601, DOI 10.1016/j.jaci.2017.08.024; Turato G, 2018, AM J RESP CRIT CARE, V197, P1216, DOI 10.1164/rccm.201708-1684LE; Venkateshaiah SU, 2018, J ALLERGY CLIN IMMUN, V141, P906, DOI 10.1016/j.jaci.2017.05.025; Verma M, 2018, J ALLERGY CLIN IMMUN, V142, P793, DOI 10.1016/j.jaci.2017.10.020; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang M, 2019, J ALLERGY CLIN IMMUN, V143, P1892, DOI 10.1016/j.jaci.2018.11.016; Wang W, 2018, J IMMUNOL, V201, P2221, DOI 10.4049/jimmunol.1800709; Weinstein SF, 2018, J ALLERGY CLIN IMMUN, V142, P171, DOI 10.1016/j.jaci.2017.11.051; Werder RB, 2018, J ALLERGY CLIN IMMUN, V141, P1607, DOI 10.1016/j.jaci.2017.07.051; Westerhof GA, 2018, J ALLERGY CLIN IMMUN, V141, P104, DOI 10.1016/j.jaci.2017.03.034; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wisniewski JA, 2018, J ALLERGY CLIN IMMUN, V141, P2048, DOI 10.1016/j.jaci.2017.08.020; Wypych TP, 2018, J ALLERGY CLIN IMMUN, V141, P1395, DOI 10.1016/j.jaci.2017.09.001; Yun JH, 2018, J ALLERGY CLIN IMMUN, V141, P2037, DOI 10.1016/j.jaci.2018.04.010; Zeiger RS, 2018, J ALLER CL IMM-PRACT, V6, P944, DOI 10.1016/j.jaip.2017.10.004; Zhang YM, 2019, AM J RESP CRIT CARE, V199, P478, DOI 10.1164/rccm.201803-0438OC	113	7	7	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					906	919		10.1016/j.jaci.2019.08.021	http://dx.doi.org/10.1016/j.jaci.2019.08.021			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31476323	Bronze			2022-12-18	WOS:000488803900004
J	Bucci, T; Parente, R; De Feo, G; Cardamone, C; Triggiani, M				Bucci, Tommaso; Parente, Roberta; De Feo, Giulia; Cardamone, Chiara; Triggiani, Massimo			Flow-mediated dilation shows impaired endothelial function in patients with mastocytosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Endothelial cells; endothelial function; flow-mediated dilation; mast cells; mastocytosis; mediators; tryptase	MAST-CELLS; SYSTEMIC MASTOCYTOSIS; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; BRACHIAL-ARTERY; CLASSIFICATION; ACTIVATION	Background: Mastocytosis is a rare disease characterized by clonal proliferation of mast cells (MCs) in different organs. Clinical manifestations of mastocytosis are mostly due to release of mediators from MCs and, in many cases, such as urticaria, flushing, angioedema, and anaphylaxis, are an expression of the biological effects of mediators on endothelial cells. Chronic secretion of mediators in patients with mastocytosis can lead to alteration of endothelial function. Objective: We sought to investigate endothelial function in patients with mastocytosis using a noninvasive technique of flow-mediated dilation (FMD). Methods: Twenty-five adult patients with indolent and advanced forms of mastocytosis and 20 healthy control subjects were enrolled in the study. Ultrasound assessment of FMD was performed by measuring changes in the diameter of the brachial artery after 5 minutes of arterial occlusion. Changes in FMD were correlated with clinical parameters and serum tryptase levels. Results: Patients with mastocytosis had lower FMD compared with healthy control subjects (P < .001). Advanced and smoldering forms showed a lower FMD compared with indolent forms (P < .001). FMD inversely correlated with age and serum tryptase levels and directly with median arterial pressure and recurrent flushing episodes. No correlation was found between FMD and osteoporosis, recurrent anaphylaxis, presence of skin lesions, and long-term antihistamine treatment. Conclusions: Endothelial dysfunction, as demonstrated by FMD reduction, is detectable in patients with mastocytosis and is more severe in patients with high tryptase levels and advanced disease. Endothelial function appears to be negatively influenced by MC proliferation rather than by the severity of mediator-related symptoms.	[Bucci, Tommaso; Parente, Roberta; De Feo, Giulia; Cardamone, Chiara; Triggiani, Massimo] Univ Salerno, Dept Med, Div Allergy & Clin Immunol, Via S Allende 34, I-84081 Salerno, Italy	University of Salerno	Triggiani, M (corresponding author), Univ Salerno, Dept Med, Div Allergy & Clin Immunol, Via S Allende 34, I-84081 Salerno, Italy.	mtriggiani@unisa.it	Bucci, Tommaso/ABA-4162-2021	Bucci, Tommaso/0000-0003-2895-6234; Cardamone, Chiara/0000-0002-5713-3993	Italian Association of Patients with Mastocytosis (ASIMAS)	Italian Association of Patients with Mastocytosis (ASIMAS)	Supported in part by the Italian Association of Patients with Mastocytosis (ASIMAS).	Akin C, 2017, J ALLERGY CLIN IMMUN, V140, P349, DOI 10.1016/j.jaci.2017.06.007; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Broesby-Olsen S, 2016, AM J HEMATOL, V91, P1069, DOI 10.1002/ajh.24490; Butterfield JH, 2018, IMMUNOL ALLERGY CLIN, V38, P397, DOI 10.1016/j.iac.2018.04.011; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Daiber A, 2017, BRIT J PHARMACOL, V174, P1591, DOI 10.1111/bph.13517; Divekar R, 2015, ALLERGY, V70, P1230, DOI 10.1111/all.12668; Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8; Gangemi S, 2015, ALLERGY, V70, P436, DOI 10.1111/all.12571; Godo S, 2017, ARTERIOSCL THROM VAS, V37, pE108, DOI 10.1161/ATVBAHA.117.309813; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Indhirajanti S, 2018, ATHEROSCLEROSIS, V268, P152, DOI 10.1016/j.atherosclerosis.2017.11.030; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kim DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162831; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Li ZY, 2015, PHOTOCH PHOTOBIO SCI, V14, P414, DOI 10.1039/c4pp00304g; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Metcalfe DD, 2017, ANNU REV PATHOL-MECH, V12, P487, DOI 10.1146/annurev-pathol-052016-100312; Metcalfe DD, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0094-3; Olivera A, 2018, J ALLERGY CLIN IMMUN, V142, P381, DOI 10.1016/j.jaci.2018.01.034; Pardanani A, 2016, AM J HEMATOL, V91, P1147, DOI 10.1002/ajh.24553; PATELLA V, 1995, J IMMUNOL, V154, P2855; Poredos P, 2013, J ATHEROSCLER THROMB, V20, P1; Raitakari OT, 2000, BRIT J CLIN PHARMACO, V50, P397, DOI 10.1046/j.1365-2125.2000.00277.x; Ras RT, 2013, INT J CARDIOL, V168, P344, DOI 10.1016/j.ijcard.2012.09.047; RILEY JF, 1953, J PATHOL BACTERIOL, V65, P461, DOI 10.1002/path.1700650218; Self TJ, 2005, BRIT J PHARMACOL, V146, P612, DOI 10.1038/sj.bjp.0706337; Sokol H, 2013, J ALLERGY CLIN IMMUN, V132, P866, DOI 10.1016/j.jaci.2013.05.026; SORENSEN KE, 1995, BRIT HEART J, V74, P247; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Suzuki H, 2009, HYPERTENSION, V53, P182, DOI 10.1161/HYPERTENSIONAHA.108.125229; Suzuki Y, 2005, CHEM IMMUNOL ALLERGY, V87, P32, DOI 10.1159/000087569; Theoharides TC, 2015, NEW ENGL J MED, V373, P163, DOI 10.1056/NEJMra1409760; Thurston RC, 2008, CIRCULATION, V118, P1234, DOI 10.1161/CIRCULATIONAHA.108.776823; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893; Valent P, 2017, CANCER RES, V77, P1261, DOI 10.1158/0008-5472.CAN-16-2234; Vergnolle N, 1999, J IMMUNOL, V163, P5064	40	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					1106	1111		10.1016/j.jaci.2019.05.037	http://dx.doi.org/10.1016/j.jaci.2019.05.037			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31211959	Bronze			2022-12-18	WOS:000488803900024
J	Tufvesson, E; Jogdand, P; Che, KF; Levanen, B; Erjefalt, JS; Bjermer, L; Linden, A				Tufvesson, Ellen; Jogdand, Prajakta; Che, Karlhans Fru; Levanen, Bettina; Erjefalt, Jonas S.; Bjermer, Leif; Linden, Anders			Enhanced local production of IL-26 in uncontrolled compared with controlled adult asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INTERLEUKIN-26; CELLS		[Tufvesson, Ellen; Bjermer, Leif] Lund Univ, Dept Clin Sci Lund Resp Med & Allergol, Lund, Sweden; [Jogdand, Prajakta; Erjefalt, Jonas S.] Lund Univ, Dept Expt Med Sci, Airway Inflammat, Lund, Sweden; [Che, Karlhans Fru; Levanen, Bettina; Linden, Anders] Karolinska Inst, Inst Environm Med, Unit Lung & Airway Res, Stockholm, Sweden; [Linden, Anders] Karolinska Univ Hosp Solna, Dept Resp Med & Allergy, Stockholm, Sweden	Lund University; Lund University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Linden, A (corresponding author), Karolinska Inst, Inst Environm Med, Unit Lung & Airway Res, Stockholm, Sweden.; Linden, A (corresponding author), Karolinska Univ Hosp Solna, Dept Resp Med & Allergy, Stockholm, Sweden.	anders.linden@ki.se		Tufvesson, Ellen/0000-0002-4941-332X; Linden, Anders/0000-0003-1258-2928	Swedish Heart-Lung Foundation [2016-0322, 2018-0315]; Swedish Research Council [2016-01563]; Swedish Association for Respiratory Medicine; Swedish Asthma and Allergy Foundation [F2017-0041]; Crafoord Foundation [2016-0954]; Alfred Osterlund Foundation; Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association for Respiratory Medicine; Swedish Asthma and Allergy Foundation; Crafoord Foundation; Alfred Osterlund Foundation; Karolinska Institutet(Karolinska Institutet)	This work was supported by independent research grants from the Swedish Heart-Lung Foundation (E.T. #2016-0322 and A.L. #2018-0315), the Swedish Research Council (A.L. #2016-01563), the Swedish Association for Respiratory Medicine (A.L. no number), the Swedish Asthma and Allergy Foundation (E.T. #F2017-0041), Crafoord Foundation (E.T. #2016-0954), Alfred Osterlund Foundation (E.T. no number), and Karolinska Institutet (A.L. no number). No funding was obtained from the tobacco industry.	Bao AH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188909; Bousquet J, 2007, ALLERGY, V62, P102, DOI 10.1111/j.1398-9995.2006.01305.x; Che KF, 2014, AM J RESP CRIT CARE, V190, P1022, DOI 10.1164/rccm.201404-0689OC; Che KF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00956; Che KF, 2017, MOL MED, V23, P247, DOI 10.2119/molmed.2016.00064; Konradsen JR, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0351-6; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; Olin JT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5517	8	7	7	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					1134	1136		10.1016/j.jaci.2019.06.035	http://dx.doi.org/10.1016/j.jaci.2019.06.035			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31288043	hybrid			2022-12-18	WOS:000488803900032
J	Wang, P; Xu, YN; Zhang, JY; Shi, L; Lei, T; Hou, YX; Lu, ZB; Zhao, Y				Wang, Peng; Xu, Yana; Zhang, Jiayu; Shi, Lu; Lei, Tong; Hou, Yangxiao; Lu, Zhongbing; Zhao, Yong			The amino acid sensor general control nonderepressible 2 (GCN2) controls T(H)9 cells and allergic airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						GCN2; T(H)9 cell; allergic airway inflammation; metabolism	FACTOR-KAPPA-B; T-CELLS; EIF2-ALPHA KINASES; TH9 CELLS; DIFFERENTIATION; INDUCTION; TRANSCRIPTION; PATHWAY; INTERLEUKIN-9; STARVATION	Background: T(H)9 cells have emerged as important mediators of allergic airway inflammation. There is evidence that general control nonderepressible 2 (GCN2) affects the immune response under some stress conditions. However, whether GCN2 regulates CD4(+) T-cell differentiation during allergic inflammation remains unknown. Objective: We sought to clarify the regulatory roles of GCN2 in CD4(+) T-cell subset differentiation and its significance in patients with allergic airway inflammation. Methods: The effects of GCN2 in differentiation of T-H cell subsets were detected by using the in vitro induction system. GCN2 knockout mice, ovalbumin-induced allergic airway inflammation, and adoptive transfer mouse models were used to determine the significance of GCN2 in T(H)9 differentiation and allergic airway inflammation in vivo. RNA sequencing, real-time PCR, Western blotting, and other molecular approaches were used to identify the molecular mechanisms relevant to regulation of GCN2 in T(H)9 cell differentiation. Results: GCN2 deficiency significantly inhibited differentiation of T(H)9 cells but not T(H)1, T(H)2, and regulatory T cells. GCN2 knockout mice and recombination-activating gene 2 knockout (Rag2KO) mice that received adoptively transferred GCN2-deficient CD4(+) T cells exhibited reduced T(H)9 differentiation and less severe allergic airway inflammation. Furthermore, the isolated GCN2-deficient T(H)9 cells also mediated less severe allergic airway inflammation on adoptive transfer. Mechanistically, GCN2 deficiency inhibits T(H)9 cell differentiation through a hypoxia-inducible factor 1 alpha-dependent glycolytic pathway. Conclusion: Our results reveal a novel role of GCN2 in T(H)9 cell differentiation. Our findings indicate that new strategies to inhibit GCN2 activity might provide novel approaches to attenuate allergic airway inflammation.	[Wang, Peng; Xu, Yana; Zhang, Jiayu; Shi, Lu; Hou, Yangxiao; Zhao, Yong] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China; [Zhao, Yong] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Wang, Peng; Xu, Yana; Zhang, Jiayu; Lei, Tong; Hou, Yangxiao; Lu, Zhongbing; Zhao, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Peng] Zhengzhou Univ, Sch Basic Med Sci, Dept Immunol, Zhengzhou, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhengzhou University	Zhao, Y (corresponding author), Chinese Acad Sci, Inst Zool, Transplantat Biol Res Div, State Key Lab Membrane Biol, Beichen West Rd 1-5, Beijing 100101, Peoples R China.; Lu, ZB (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, 19A Yuquanlu, Beijing 100049, Peoples R China.	luzhongbing@ucas.ac.cn; zhaoy@ioz.ac.cn		wang, peng/0000-0003-1845-7589	National Key Research and Development Program of China [2017YFA0104401]; Chinese Academy of Sciences [XDA16030301]; National Natural Science Foundation [81530049, U1738111]; China Manned Space Flight Technology Project [TZ-1]	National Key Research and Development Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Manned Space Flight Technology Project	Supported by grants from the National Key Research and Development Program of China (2017YFA0104401 to Y.Z.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16030301 to Y.Z.), the National Natural Science Foundation for General and Key Programs (81530049, U1738111 to Y.Z.), and the China Manned Space Flight Technology Project (TZ-1 to Y.Z.).	Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Battu S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01719; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chen H, 2017, ALLERGY, V72, P1510, DOI 10.1111/all.13152; Chiang CY, 2017, CELL MOL IMMUNOL; Choi BK, 2017, CELL MOL IMMUNOL, V14, P748, DOI 10.1038/cmi.2016.02; Chung KF, 2015, LANCET, V386, P1086, DOI 10.1016/S0140-6736(15)00157-9; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Eleftheriadis T, 2016, INT J MOL MED, V37, P1412, DOI 10.3892/ijmm.2016.2547; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Grallert B, 2013, BIOCHEM SOC T, V41, P1687, DOI 10.1042/BST20130210; Guo YT, 2018, PROTEIN CELL, V9, P966, DOI 10.1007/s13238-018-0504-0; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hou YZ, 2018, PROTEIN CELL, V9, P1027, DOI 10.1007/s13238-018-0505-z; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Kabata H, 2015, ALLERGOL INT, V64, P227, DOI 10.1016/j.alit.2015.03.004; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Keil M, 2016, J NEUROIMMUNOL, V297, P117, DOI 10.1016/j.jneuroim.2016.05.014; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Li Y, 2018, CELL MOL IMMUNOL, V15, P518, DOI 10.1038/cmi.2017.39; Liang ZF, 2018, AUTOPHAGY, V14, P505, DOI 10.1080/15548627.2017.1376161; Liu HY, 2014, MOL CELL BIOL, V34, P428, DOI 10.1128/MCB.00946-13; Martin R, 2013, J CELL SCI, V126, P3010, DOI 10.1242/jcs.118067; McKenzie Andrew N J, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS263, DOI 10.1513/AnnalsATS.201403-097AW; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Niedbala W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5575; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Qiao Q, 2017, CANCER SCI, V108, P1421, DOI 10.1111/cas.13260; Qiao QA, 2010, EXP HEMATOL, V38, P1199, DOI 10.1016/j.exphem.2010.08.007; Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186; Ravishankar B, 2015, P NATL ACAD SCI USA, V112, P10774, DOI 10.1073/pnas.1504276112; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Sehra S, 2015, J ALLERGY CLIN IMMUN, V136, P433, DOI 10.1016/j.jaci.2015.01.021; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sun B, 2018, CELL MOL IMMUNOL, V15, P782, DOI 10.1038/cmi.2017.163; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wang P, 2018, J ALLERGY CLIN IMMUN, V141, P2168, DOI 10.1016/j.jaci.2017.06.026; Wang Y, 2016, IMMUNITY, V44, P1337, DOI 10.1016/j.immuni.2016.05.009; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wu TT, 2016, SCI REP-UK, V6, DOI [10.1038/srep20250, 10.1038/srep35230]; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yao WG, 2013, IMMUNITY, V38, P360, DOI 10.1016/j.immuni.2013.01.007; Yao WG, 2011, J ALLERGY CLIN IMMUN, V128, P1357, DOI 10.1016/j.jaci.2011.06.019; Zhao Y, 2018, BLOOD, V131, P1587, DOI 10.1182/blood-2017-04-777128; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	59	7	7	4	18	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					1091	1105		10.1016/j.jaci.2019.04.028	http://dx.doi.org/10.1016/j.jaci.2019.04.028			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31121187	Bronze			2022-12-18	WOS:000488803900023
J	Dijk, EN; Folkersma, C; Gruzieva, O; Kumar, A; Wijga, AH; Gehring, U; Kull, I; Postma, DS; Vonk, JM; Melen, E; Koppelman, GH				Dijk, E. Nicole; Folkersma, Charlotte; Gruzieva, Olena; Kumar, Ashish; Wijga, Alet H.; Gehring, Ulrike; Kull, Inger; Postma, Dirkje S.; Vonk, Judith M.; Melen, Erik; Koppelman, Gerard H.			Genetic risk scores do not improve asthma prediction in childhood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							VIRUS		[Dijk, E. Nicole; Folkersma, Charlotte; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol, Groningen, Netherlands; [Dijk, E. Nicole; Folkersma, Charlotte; Vonk, Judith M.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Gruzieva, Olena; Kumar, Ashish; Melen, Erik] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Gruzieva, Olena] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Kumar, Ashish] Swiss Trop & Publ Hlth Inst, Dept Publ Hlth Epidemiol, Basel, Switzerland; [Kumar, Ashish] Univ Basel, Basel, Switzerland; [Wijga, Alet H.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Gehring, Ulrike] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Kull, Inger; Melen, Erik] Soder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden; [Kull, Inger] Soder Sjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Kull, Inger] Karolinska Inst, Stockholm, Sweden	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Karolinska Institutet; Stockholm County Council; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Utrecht University; Netherlands National Institute for Public Health & the Environment; Sodersjukhuset Hospital; Sodersjukhuset Hospital; Karolinska Institutet	Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol, Groningen, Netherlands.; Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands.	g.h.koppelman@umcg.nl	Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252; Gehring, Ulrike/0000-0003-3612-5780	Netherlands Lung Foundation [3.2.09.081JU]; Stichting Astma Bestrijding; Ubbo Emmius Foundation; Swedish Research Council; Swedish Heart-Lung Foundation; Stockholm County Council (ALF project); European Commission [018996]	Netherlands Lung Foundation; Stichting Astma Bestrijding; Ubbo Emmius Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF project)(Stockholm County Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	Supported by The Netherlands Lung Foundation (grant no. 3.2.09.081JU), Stichting Astma Bestrijding, and the Ubbo Emmius Foundation. The BAMSE project was supported by the Swedish Research Council, Swedish Heart-Lung Foundation, Stockholm County Council (ALF project), and European Commission (GABRIEL Project: 018996).	Caudri D, 2009, J ALLERGY CLIN IMMUN, V124, P903, DOI 10.1016/j.jaci.2009.06.045; Colicino S, 2019, CLIN EXP ALLERGY, V49, P410, DOI 10.1111/cea.13336; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Gias E, 2008, J VIROL METHODS, V147, P328, DOI 10.1016/j.jviromet.2007.09.013; Hafkamp-de Groen E, 2013, J ALLERGY CLIN IMMUN, V132, P1303, DOI 10.1016/j.jaci.2013.07.007; Kull I, 2010, J ALLERGY CLIN IMMUN, V125, P1013, DOI 10.1016/j.jaci.2010.01.051; Sears MR, 2015, J ALLERGY CLIN IMMUN, V136, P829, DOI 10.1016/j.jaci.2015.04.048; Wijga AH, 2014, INT J EPIDEMIOL, V43, P527, DOI 10.1093/ije/dys231; Yu D, 2010, CLIN MICROBIOL INFEC, V16, P1399, DOI [10.1111/j.1469-0691.2010.03147.x, 10.1111/j.1469-0691.2009.03147.x]; Zhang Y, 2018, NAT GENET, V50, P1318, DOI 10.1038/s41588-018-0193-x	11	7	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					857	+		10.1016/j.jaci.2019.05.017	http://dx.doi.org/10.1016/j.jaci.2019.05.017			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31145937	Bronze, Green Submitted			2022-12-18	WOS:000485222300030
J	Visness, CM; Gebretsadik, T; Jackson, DJ; Myers, JB; Haystad, S; Lemanske, RE; Hartert, TV; Hershey, GKK; Zoratti, EM; Martin, LJ; Miller, R; Gold, DR; Wright, A; Stern, DA; Gem, JE				Visness, Cynthia M.; Gebretsadik, Tebeb; Jackson, Daniel J.; Myers, Jocelyn Biagini; Haystad, Suzanne; Lemanske, Robert E., Jr.; Hartert, Tina V.; Hershey, Gurjit K. Khurana; Zoratti, Edward M.; Martin, Lisa J.; Miller, Rachel; Gold, Diane R.; Wright, Anne; Stern, Debra A.; Gem, James E.		Children's Resp & Environm Workgrp	Asthma as an outcome: Exploring multiple definitions of asthma across birth cohorts in the Environmental influences on Child Health Outcomes Children's Respiratory and Environmental Workgroup	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							AGE; EXPOSURE; LIFE; ALLERGEN; RISK		[Visness, Cynthia M.] Rho Fed Syst Div Inc, Chapel Hill, NC 27713 USA; [Gebretsadik, Tebeb] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Hartert, Tina V.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Jackson, Daniel J.; Lemanske, Robert E., Jr.; Gem, James E.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Jackson, Daniel J.; Lemanske, Robert E., Jr.; Gem, James E.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Myers, Jocelyn Biagini; Hershey, Gurjit K. Khurana; Martin, Lisa J.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myers, Jocelyn Biagini; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Haystad, Suzanne] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Zoratti, Edward M.] Henry Ford Hlth Syst, Dept Med, Detroit, MI USA; [Miller, Rachel] Columbia Univ Coll Phys & Surg, Columbia Univ Mailman Sch Publ Hlth, Dept Med, 630 W 168th St, New York, NY 10032 USA; [Miller, Rachel] Columbia Univ Coll Phys & Surg, Columbia Univ Mailman Sch Publ Hlth, Dept Pediat, 630 W 168th St, New York, NY 10032 USA; [Miller, Rachel] Columbia Univ Coll Phys & Surg, Columbia Univ Mailman Sch Publ Hlth, Dept Environm Hlth, 630 W 168th St, New York, NY 10032 USA; [Gold, Diane R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Gold, Diane R.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wright, Anne; Stern, Debra A.] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA	Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Columbia University; Columbia University; Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Arizona	Visness, CM (corresponding author), Rho Fed Syst Div Inc, Chapel Hill, NC 27713 USA.	cindy_visness@rhoworld.com	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946	Children's Respiratory and Environmental Workgroup (CREW) - US Department of Health and Human Services/National Institutes of Health [5UG3OD023282, 4UH3OD023282, R01 E5008977, P30ES09089, R01 E5013163, R827027]; Tucson Children's Respiratory Study (TCRS)-National Heart, Lung, and Blood Institute [132523, (IIS)-HL-56177, P01 HL070831, U10 HL064305, R01 HL061879, N01-AI-25496, HHSN272200900052C, HHSN272201000052I]; National Center for Research Resources/NIH [RR00052, M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, UL1TR001079, 5UL1RR024992-02]; National Center for Advancing Translational Sciences (NCATS)/NIH [UL1TR000040, R01 ES11170, R01 E5019890, R01 AI035786, R01 AI050681, R56 AI050681, R01 AI061774, K01 AI070606, R21 AI069271, R01 HL113010, P01 AI089473, R21 AI080066, R01 AI110450, R01 HD082147, R01 AI024156, R03 HL067427, RO1 AI051598]; Blue Cross Foundation Johnson; Fund for Henry Ford Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD082147] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089473, R01AI110450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, R01ES019890, R01ES013163] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023282, UH3OD023282] Funding Source: NIH RePORTER	Children's Respiratory and Environmental Workgroup (CREW) - US Department of Health and Human Services/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tucson Children's Respiratory Study (TCRS)-National Heart, Lung, and Blood Institute; National Center for Research Resources/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Blue Cross Foundation Johnson; Fund for Henry Ford Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Children's Respiratory and Environmental Workgroup (CREW) is funded by US Department of Health and Human Services/National Institutes of Health grants 5UG3OD023282 and 4UH3OD023282. Additional support was provided by individual cohorts' grants/contracts: Columbia University-P01ES09600, R01 E5008977, P30ES09089, R01 E5013163, and R827027; Tucson Children's Respiratory Study (TCRS)-National Heart, Lung, and Blood Institute 132523; Infant Immune Study (IIS)-HL-56177; Childhood Origins of Asthma Study (COAST) -P01 HL070831, U10 HL064305, and R01 HL061879; Urban Environment and Childhood Asthma Study (URECA)-N01-AI-25496, NO1-AI-25482, HHSN272200900052C, HHSN272201000052I, National Center for Research Resources/NIH RR00052, M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, UL1TR001079, 5UL1RR024992-02, and National Center for Advancing Translational Sciences (NCATS)/NIH UL1TR000040; Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)-R01 ES11170 and R01 E5019890; Epidemiology of Home Allergens and Asthma Study (EHAAS)-R01 AI035786; Wayne County Health, Environment, Allergy and Asthma Longitudinal Study (WHEALS) -R01 AI050681, R56 AI050681, R01 AI061774, R21 AI059415, K01 AI070606, R21 AI069271, R01 HL113010, R21 E5022321, P01 AI089473, R21 AI080066, R01 AI110450, R01 HD082147, and the Fund for Henry Ford Health System; Childhood Allergy Study (CAS) -R01 AI024156, R03 HL067427, RO1 AI051598, Blue Cross Foundation Johnson, and the Fund for Henry Ford Hospital.	Bousquet J, 2013, INT ARCH ALLERGY IMM, V161, P1, DOI 10.1159/000343018; Carter PM, 2003, ANN ALLERG ASTHMA IM, V90, P41, DOI 10.1016/S1081-1206(10)63612-5; Gern JE, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1088-9; Gold DR, 1999, AM J RESP CRIT CARE, V160, P227, DOI 10.1164/ajrccm.160.1.9807104; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Havstad S, 2014, J ALLERGY CLIN IMMUN, V134, P722, DOI 10.1016/j.jaci.2014.01.022; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Johnson CC, 2004, J ALLERGY CLIN IMMUN, V114, P105, DOI 10.1016/j.jaci.2004.04.007; LeMasters G, 2015, OBESITY, V23, P32, DOI 10.1002/oby.20941; O'Connor GT, 2018, J ALLERGY CLIN IMMUN, V141, P1468, DOI 10.1016/j.jaci.2017.06.040; Omoyinmi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181874; Raby BA, 2004, PEDIATRICS, V114, pE327, DOI 10.1542/peds.2003-0838-L; Rothers J, 2011, J ALLERGY CLIN IMMUN, V128, P397, DOI 10.1016/j.jaci.2011.04.044; van Wonderen KE, 2010, EUR RESPIR J, V36, P48, DOI 10.1183/09031936.00154409; Whyatt RM, 2014, ENVIRON HEALTH PERSP, V122, P1141, DOI 10.1289/ehp.1307670	15	7	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					866	+		10.1016/j.jaci.2019.05.025	http://dx.doi.org/10.1016/j.jaci.2019.05.025			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31163174	Bronze, Green Accepted			2022-12-18	WOS:000485222300033
J	Blumenthal, KG; Topaz, M; Zhou, L; Harkness, T; Sa'adon, R; Bar-Bachar, O; Long, ADA				Blumenthal, Kimberly G.; Topaz, Maxim; Zhou, Li; Harkness, Tyler; Sa'adon, Roee; Bar-Bachar, Ofrit; Long, Aidan A.			Mining social media data to assess the risk of skin and soft tissue infections from allergen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Informatics; NLP; infection; posts; allergen immunotherapy; preparation; aseptic; influenza; vaccination; safely; compounding; shot		Background: Allergen immunotherapy (AIT) treatment for allergic rhinitis and asthma is used by 2.6 million Americans annually. Clinical and sterility testing studies identify no risk of contamination or infection from extracts prepared using recommended aseptic techniques, but regulatory concerns persist. Social media can be used to investigate rare adverse effects not captured by traditional studies. Objective: We sought to investigate large social media databases for suggestion of AIT skin and soft tissue infection (SSTI) risk and compare this risk to a comparator procedure with a sterile pharmaceutical. Methods: We analyzed US-restricted data from more than 10 common text-based social media platforms including Facebook, Twitter, and Reddit between 2012 and 2016. We used natural language processing (NLP) to identify posts related to AIT and, separately, influenza vaccination (comparator procedure). NLP was followed by manual review to identify posts suggesting a possible SSTI associated with either AIT or influenza vaccination. SSTI frequencies with 95% CIs were compared. Results: We identified 25,126 AIT posts, which were matched by social media platform to 25,126 influenza vaccination related posts. NLP identified 4088 (16.3%) AIT posts that required manual review, with 6 posts (0.02%; 95% CI, 0.005%-0.043%) indicative of possible AIT-related SSTI. NLP identified 2689 (10.7%) influenza posts that required manual review, with 7 posts (0.03%; 95% CI, 0.007 %-0.048 %) indicative of possible influenza vaccination related SSTI. Conclusions: Social media data suggest that SSTI from AIT and influenza vaccination are equally rare events. Given that AIT's SSTI risk appears comparable to the risk using a sterile pharmaceutical based on social media data, current aseptic technique procedures seem safe.	[Blumenthal, Kimberly G.; Harkness, Tyler; Long, Aidan A.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Cox 201,55 Fruit St, Boston, MA 02114 USA; [Blumenthal, Kimberly G.; Zhou, Li; Long, Aidan A.] Harvard Med Sch, Boston, MA 02115 USA; [Topaz, Maxim; Bar-Bachar, Ofrit] Univ Haifa, Cheryl Spencer Dept Nursing, Haifa, Israel; [Topaz, Maxim; Zhou, Li] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Sa'adon, Roee] Treato Ltd, Or Yehuda, Israel	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Haifa; Harvard University; Brigham & Women's Hospital	Long, ADA (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Cox 201,55 Fruit St, Boston, MA 02114 USA.	aalong@mgh.harvard.edu	Blumenthal, Kimberly/AAG-8290-2019; Topaz, Maxim/AAQ-7121-2021	Blumenthal, Kimberly/0000-0003-4773-9817; Topaz, Maxim/0000-0002-2358-9837	Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital; National Institutes of Health [K01AI125631]; American Academy of Allergy, Asthma& Immunology Foundation; MGHClaflin Distinguished Scholar Award; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS025375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI125631] Funding Source: NIH RePORTER	Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Allergy, Asthma& Immunology Foundation; MGHClaflin Distinguished Scholar Award; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital. K.G.B. receives career development support from the National Institutes of Health (grant no. K01AI125631), the American Academy of Allergy, Asthma& Immunology Foundation, and theMGHClaflin Distinguished Scholar Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2015, INT C HARM TECHN REQ; Balekian DS, 2016, J ALLERGY CLIN IMMUN, V137, P1887, DOI 10.1016/j.jaci.2016.03.021; Bhattacharyya N, 2011, LARYNGOSCOPE, V121, P1830, DOI 10.1002/lary.22034; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Curtis JR, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1251-y; Duh MS, 2016, PHARMACOEPIDEM DR S, V25, P1425, DOI 10.1002/pds.4090; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Epstein TG, 2013, ANN ALLERG ASTHMA IM, V110, P274, DOI 10.1016/j.anai.2013.01.015; Falagas ME, 2006, MAYO CLIN PROC, V81, P1553, DOI 10.4065/81.12.1553; Gupta N, 2014, CLIN INFECT DIS, V59, P1, DOI 10.1093/cid/ciu218; Hankin CS, 2013, J ALLERGY CLIN IMMUN, V131, P1084, DOI 10.1016/j.jaci.2012.12.662; Hernandez CL, 2017, ANN ALLERG ASTHMA IM, V118, P374, DOI 10.1016/j.anai.2016.12.004; Jurafsky Dan, 2014, SPEECH LANGUAGE PROC, V3; Lay PC, 2007, OTOLARYNG HEAD NECK, V137, P243, DOI 10.1016/j.otohns.2007.02.012; Lay P Chase, 2008, Otolaryngol Head Neck Surg, V139, P364, DOI 10.1016/j.otohns.2008.06.016; Letz AG, 2009, J ALLERGY CLIN IMMUN, V123, P1175, DOI 10.1016/j.jaci.2009.01.048; Lin SY, 2008, OTOLARYNG HEAD NECK, V139, P195, DOI 10.1016/j.otohns.2008.05.013; Liu J, 2018, INT J MED INFORM, V117, P33, DOI 10.1016/j.ijmedinf.2018.06.008; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Powers D., 2008, EVALUATION PRECISION, V2, P37; R Development Core Team, 2018, R LANG ENV STAT COMP; Sarker A, 2015, J BIOMED INFORM, V54, P202, DOI 10.1016/j.jbi.2015.02.004; Staes C, 2013, AM J HEALTH-SYST PH, V70, P1301, DOI 10.2146/ajhp130049; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Topaz M, 2016, DRUG SAFETY, V39, P241, DOI 10.1007/s40264-015-0381-x; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Wong A, 2018, PHARMACOTHERAPY, V38, P822, DOI 10.1002/phar.2151	28	7	8	2	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					129	134		10.1016/j.jaci.2019.01.029	http://dx.doi.org/10.1016/j.jaci.2019.01.029			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30721764	Bronze, Green Accepted			2022-12-18	WOS:000473432800016
J	Cho, SH; Jo, A; Casale, T; Jeong, SJ; Hong, SJ; Cho, JK; Holbrook, JT; Kumar, R; Smith, LJ				Cho, Seong H.; Jo, Ara; Casale, Thomas; Jeong, Su J.; Hong, Seung-Jae; Cho, Joong K.; Holbrook, Janet T.; Kumar, Rajesh; Smith, Lewis J.			Soy isoflavones reduce asthma exacerbation in asthmatic patients with high PAI-1-producing genotypes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Soy isoflavones; genistein; asthma; exacerbation; plasminogen activator inhibitor 1; polymorphisms	PLASMINOGEN-ACTIVATOR INHIBITOR-1; LUNG-FUNCTION; 4G/5G POLYMORPHISM; ALLERGIC-ASTHMA; GENISTEIN; EXPRESSION; AIRWAYS; DIET	Background: The 4G4G genotype of plasminogen activator inhibitor 1 (PAI-1) is associated with increased plasma PAI-1 levels and poor asthma control. Previous studies suggest that soy isoflavones can reduce PAI-1 levels. Objective: We sought to investigate PAI-1 genotype-specific differences of the soy isoflavone response in asthma outcomes. Methods: A PAI-1 functional polymorphism (rs1799768, 4G5G) was characterized in subjects with poorly controlled asthma enrolled in a randomized clinical trial of soy isoflavones (n = 265). Genotype-specific treatment responses on asthma outcomes were compared between soy isoflavones and placebo. Normal human bronchial epithelial cells were cultured with or without TGF-beta 1, genistein, or both, and PAI-1 levels were measured. Results: The 4G4G/4G5G genotype was associated with a greater risk for allergy-related worsened asthma symptoms and eczema at baseline compared with the 5G5G genotype. There was a significant interaction between the genotype and soy isoflavone intervention on oral corticosteroid use for asthma exacerbation (P = .005). In a subgroup analysis soy isoflavones significantly reduced the use of oral corticosteroids (number of events/person-year) by 4-fold compared with placebo in the 4G4G/4G5G genotype (0.2 vs 0.8; relative risk, 0.28; P < .001) but not in the 5G5G genotype. Soy isoflavones reduced plasma PAI-1 levels compared with placebo. Genistein treatment reduced TGF-beta 1-induced PAI-1 production in normal human bronchial epithelial cells. Conclusions: This study demonstrates that soy isoflavone treatment provides a significant benefit in reducing the number of severe asthma exacerbations in asthmatic patients with the high PAI-1 producing genotype. PAI-1 polymorphisms can be used as a genetic biomarker for soy isoflavone-responsive patients with asthma.	[Cho, Seong H.; Jo, Ara; Casale, Thomas; Cho, Joong K.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy Immunol, Tampa, FL USA; [Jeong, Su J.] Kyung Hee Univ, Med Sci Res Inst, Dept Stat Support, Sch Med, Seoul, South Korea; [Cho, Seong H.; Hong, Seung-Jae] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Holbrook, Janet T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Clin Trials & Evidence Synth, Baltimore, MD USA; [Kumar, Rajesh] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Smith, Lewis J.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	State University System of Florida; University of South Florida; Kyung Hee University; Kyung Hee University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Cho, SH (corresponding author), Univ S Florida, Dept Internal Med, Div Allergy Immunol, 13000 Bruce B Downs Blvd 111D, Tampa, FL 33612 USA.	scho2@health.usf.edu		Kumar, Rajesh/0000-0002-1962-7108; Jo, Ara/0000-0002-2781-8529	American Heart Association (AHA) [11SDG7590063]; National Institutes of Health [1K23AI110731, U01HL0088367, U01HL087987]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI110731] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by American Heart Association (AHA) grant 11SDG7590063 and National Institutes of Health grants 1K23AI110731, U01HL0088367, and U01HL087987.	Bime C, 2012, PRIM CARE RESP J, V21, P398, DOI 10.4104/pcrj.2012.00073; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; Cho SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157848; Cho SH, 2015, AM J RESP CELL MOL, V52, P88, DOI 10.1165/rcmb.2013-0399OC; Cho SH, 2014, J ALLERGY CLIN IMMUN, V133, P1465, DOI 10.1016/j.jaci.2013.11.009; Cho SH, 2004, EXP BIOL MED, V229, P138, DOI 10.1177/153537020422900202; Cho SH, 2001, J ALLERGY CLIN IMMUN, V108, P212, DOI 10.1067/mai.2001.117260; Chung HL, 2007, J ALLERGY CLIN IMMUN, V119, P1541, DOI 10.1016/j.jaci.2007.02.040; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; James AL, 2002, AM J RESP CRIT CARE, V166, P1590, DOI 10.1164/rccm.2108069; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; McParland BE, 2003, J APPL PHYSIOL, V95, P426, DOI 10.1152/japplphysiol.00159.2003; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Nagasawa A, 2003, BIOCHEM BIOPH RES CO, V311, P909, DOI 10.1016/j.bbrc.2003.10.087; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; Pampuch A, 2006, ALLERGY, V61, P234, DOI 10.1111/j.1398-9995.2005.00948.x; Pare PD, 2007, CAN J PHYSIOL PHARM, V85, P653, DOI 10.1139/Y07-051; Raviv S, 2010, CURR OPIN PULM MED, V16, P71, DOI 10.1097/MCP.0b013e3283323b73; Rijken DC, 2001, THROMB RES, V103, pS41, DOI 10.1016/S0049-3848(01)00296-1; Royce SG, 2009, ANN ALLERG ASTHMA IM, V102, P238, DOI 10.1016/S1081-1206(10)60087-7; Smith LJ, 2015, JAMA-J AM MED ASSOC, V313, P2033, DOI 10.1001/jama.2015.5024; Smith LJ, 2004, J ASTHMA, V41, P833, DOI 10.1081/JAS-200038447; Tsantes AE, 2008, THROMB RES, V122, P736, DOI 10.1016/j.thromres.2007.09.005; VANHINSBERGH VWM, 1994, BLOOD, V84, P2984	27	7	7	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					109	+		10.1016/j.jaci.2019.01.020	http://dx.doi.org/10.1016/j.jaci.2019.01.020			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30707970	Green Accepted, Bronze			2022-12-18	WOS:000473432800014
J	Burbank, AJ; Vadlamudi, A; Mills, KH; Alt, EM; Wells, H; Zhou, HB; Alexis, N; Hernandez, ML; Peden, DB				Burbank, Allison J.; Vadlamudi, Anusha; Mills, Katherine H.; Alt, Ethan M.; Wells, Heather; Zhou, Haibo; Alexis, Neil; Hernandez, Michelle L.; Peden, David B.			The glutathione-S-transferase mu-1 null genotype increases wood smoke-induced airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LUNG-FUNCTION; EXPOSURE		[Burbank, Allison J.; Hernandez, Michelle L.; Peden, David B.] Univ N Carolina, Dept Pediat, Div Allergy Immunol & Rheumatol, Gillings Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Burbank, Allison J.; Mills, Katherine H.; Wells, Heather; Alexis, Neil; Hernandez, Michelle L.; Peden, David B.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Gillings Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Alt, Ethan M.; Zhou, Haibo] Univ N Carolina, Dept Biostat, Gillings Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Vadlamudi, Anusha] Duke Univ, Sch Med, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Burbank, AJ (corresponding author), Univ N Carolina, Dept Pediat, Div Allergy Immunol & Rheumatol, Gillings Sch Publ Hlth, Chapel Hill, NC 27515 USA.; Burbank, AJ (corresponding author), Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Gillings Sch Publ Hlth, Chapel Hill, NC 27515 USA.	Allison_burbank@med.unc.edu	ZHOU, Haibo/M-7373-2017	Peden, David/0000-0003-4526-4627	National Institute of Environmental Health Sciences of the National Institutes of Health [R01ES025124]; US Environmental Protection Agency (EPA) [83578501-0];  [5T32ES007018-42];  [P30ES010126];  [R01HL135235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, T32ES007018, R01ES025124] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Research reported in this publication was entirely supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under award number R01ES025124 and Assistance Agreement no. 83578501-0 awarded by the US Environmental Protection Agency (EPA) to the University of North Carolina. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Environmental Protection Agency. The EPA does not endorse any products or commercial services mentioned in this publication. E.M.A. is supported by grant 5T32ES007018-42. M.L.H and A.J.B. are supported by grant R01HL135235. H.Z. is supported by grant P30ES010126.	Alexis NE, 2009, J ALLERGY CLIN IMMUN, V124, P1222, DOI 10.1016/j.jaci.2009.07.036; Chen BY, 2016, ENVIRON RES, V149, P145, DOI 10.1016/j.envres.2016.05.007; Dillon MA, 2011, OCCUP ENVIRON MED, V68, P783, DOI 10.1136/oem.2010.061747; Ghio AJ, 2012, OCCUP ENVIRON MED, V69, P170, DOI 10.1136/oem.2011.065276; Hurteau MD, 2014, ENVIRON SCI TECHNOL, V48, P2298, DOI 10.1021/es4050133; LIU D, 1992, AM REV RESPIR DIS, V146, P1469, DOI 10.1164/ajrccm/146.6.1469; Reid CE, 2016, ENVIRON HEALTH PERSP, V124, P1334, DOI 10.1289/ehp.1409277; Swiston JR, 2008, EUR RESPIR J, V32, P129, DOI 10.1183/09031936.00097707; US EPA Air Emissions Inventories, NAT EM INV NEI DAT 2	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2299	+		10.1016/j.jaci.2019.02.006	http://dx.doi.org/10.1016/j.jaci.2019.02.006			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30790595	Green Accepted, Bronze			2022-12-18	WOS:000470113200038
J	Hanif, T; Dhaygude, K; Kankainen, M; Renkonen, J; Mattila, P; Ojala, T; Joenvaara, S; Makela, M; Pelkonen, A; Kauppi, P; Haahtela, T; Renkonen, R; Toppila-Salmi, S				Hanif, Tanzeela; Dhaygude, Kishor; Kankainen, Matti; Renkonen, Jutta; Mattila, Pirkko; Ojala, Teija; Joenvaara, Sakari; Makela, Mika; Pelkonen, Anna; Kauppi, Paula; Haahtela, Tari; Renkonen, Risto; Toppila-Salmi, Sanna			Birch pollen allergen immunotherapy reprograms nasal epithelial transcriptome and recovers microbial diversity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RHINITIS; PACKAGE; ACCURATE; HEALTHY; ASTHMA		[Hanif, Tanzeela; Dhaygude, Kishor; Renkonen, Jutta; Joenvaara, Sakari; Renkonen, Risto; Toppila-Salmi, Sanna] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Kankainen, Matti; Mattila, Pirkko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Kankainen, Matti] Univ Helsinki, Med & Clin Genet, Helsinki, Finland; [Kankainen, Matti; Makela, Mika; Pelkonen, Anna; Kauppi, Paula; Haahtela, Tari; Toppila-Salmi, Sanna] Helsinki Univ Hosp, Helsinki, Finland; [Ojala, Teija] Univ Helsinki, Dept Pharmacol, Helsinki, Finland; [Makela, Mika; Pelkonen, Anna; Kauppi, Paula; Haahtela, Tari; Toppila-Salmi, Sanna] Univ Helsinki, Skin & Allergy Hosp, Helsinki, Finland; [Renkonen, Risto] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Toppila-Salmi, S (corresponding author), Univ Helsinki, Haartman Inst, Helsinki, Finland.; Toppila-Salmi, S (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Toppila-Salmi, S (corresponding author), Univ Helsinki, Skin & Allergy Hosp, Helsinki, Finland.	sanna.salmi@helsinki.fi	Kauppi, Paula/AAX-9525-2020; Toppila-Salmi, Sanna/ABF-5840-2020	Kauppi, Paula/0000-0002-1065-330X; Toppila-Salmi, Sanna/0000-0003-0890-6686; Makela, Mika/0000-0002-2933-3111; Dhaygude, Kishor/0000-0003-4499-6180; Hanif, Tanzeela/0000-0001-9158-6841; Kankainen, Matti/0000-0002-4714-9481; Ojala, Teija/0000-0001-8186-1707	Finnish Association of Otorhinolaryngology and Head and Neck Surgery; Finnish Medical Foundation; Finnish Medical Society Duodecim; Finnish Society of Allergology and Immunology; Jane and Aatos Erkko Foundation; Finnish Cultural Foundation; Paulo Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Vaino and Laina Kivi Foundation; Yrjo Jahnsson Foundation; Academy of Finland [292605, 292635]; Business Finland [Dnro 6113/31/2016];  [TYH2018103]	Finnish Association of Otorhinolaryngology and Head and Neck Surgery; Finnish Medical Foundation; Finnish Medical Society Duodecim; Finnish Society of Allergology and Immunology; Jane and Aatos Erkko Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paulo Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Vaino and Laina Kivi Foundation; Yrjo Jahnsson Foundation; Academy of Finland(Academy of Finland); Business Finland; 	The study was supported in part by research grants from the Finnish Association of Otorhinolaryngology and Head and Neck Surgery, Finnish Medical Foundation, the Finnish Medical Society Duodecim, the Finnish Society of Allergology and Immunology, the Jane and Aatos Erkko Foundation, the Finnish Cultural Foundation, State funding for university-level health research (grant no. TYH2018103), the Paulo Foundation, the Sigrid Juselius Foundation, the Tampere Tuberculosis Foundation, the Vaino and Laina Kivi Foundation, the Yrjo Jahnsson Foundation, the Academy of Finland (grant nos. 292605 and 292635), and Business Finland (grant no. Dnro 6113/31/2016).	Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Arvidsson MB, 2002, J ALLERGY CLIN IMMUN, V109, P777, DOI 10.1067/mai.2002.123868; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Chen H., 2018, VennDiagram: generate High-Resolution Venn and Euler Plots; Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02067-7; Choi CH, 2014, AM J RHINOL ALLERGY, V28, P281, DOI 10.2500/ajra.2014.28.4050; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dufva O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03987-2; Joenvaara S, 2009, J ALLERGY CLIN IMMUN, V124, P135, DOI 10.1016/j.jaci.2008.11.048; Juniper EF, 2000, CLIN EXP ALLERGY, V30, P132; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Kolde R., 2018, PHEATMAP PRETTY HEAT; Kumar A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4039-1; Lal D, 2017, INT FORUM ALLERGY RH, V7, P561, DOI 10.1002/alr.21934; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Mattila P, 2010, ALLERGY, V65, P175, DOI 10.1111/j.1398-9995.2009.02181.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Pawankar R, 2011, ASIA PAC ALLERGY, V1, P157, DOI 10.5415/apallergy.2011.1.3.157; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Toppila-Salmi S, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0495-8; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	32	7	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2293	+		10.1016/j.jaci.2019.02.002	http://dx.doi.org/10.1016/j.jaci.2019.02.002			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30768989	hybrid, Green Accepted			2022-12-18	WOS:000470113200036
J	Bucciol, G; Nicholas, SK; Calvo, PL; Cant, A; Edgar, JDM; Espanol, T; Ferrua, F; Galicchio, M; Gennery, AR; Hadzic, N; Hanson, IC; Kusminsky, G; Lange, A; Lanternier, F; Mahlaoui, N; Moshous, D; Nademi, Z; Neven, B; Oleastro, M; Porta, F; Quarello, P; Silva, M; Slatter, MA; Soncini, E; Stefanowicz, M; Tandoi, F; Teisseyre, M; Torgerson, TR; Veys, P; Weinacht, KG; Wolska-Kusnierz, B; Pirenne, J; de la Morena, MT; Meyts, I				Bucciol, Giorgia; Nicholas, Sarah K.; Calvo, Pier Luigi; Cant, Andrew; Edgar, J. David M.; Espanol, Teresa; Ferrua, Francesca; Galicchio, Miguel; Gennery, Andrew R.; Hadzic, Nedim; Hanson, I. Celine; Kusminsky, Gustavo; Lange, Andrzej; Lanternier, Fanny; Mahlaoui, Nizar; Moshous, Despina; Nademi, Zohreh; Neven, Benedicte; Oleastro, Matias; Porta, Fulvio; Quarello, Paola; Silva, Marcelo; Slatter, Mary A.; Soncini, Elena; Stefanowicz, Marek; Tandoi, Francesco; Teisseyre, Mikolaj; Torgerson, Troy R.; Veys, Paul; Weinacht, Katja G.; Wolska-Kusnierz, Beata; Pirenne, Jacques; de la Morena, M. Teresa; Meyts, Isabelle			Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CD40 LIGAND DEFICIENCY; FEATURES; DISEASE		[Bucciol, Giorgia; Meyts, Isabelle] Katholieke Univ Leuven, Lab Childhood Immunol, Dept Microbiol & Immunol, Leuven, Belgium; [Bucciol, Giorgia; Meyts, Isabelle] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Nicholas, Sarah K.] Baylor Coll Med, Solid Organ Transplant Immunol, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Hanson, I. Celine] Baylor Coll Med, Immunol Allergy & Rheumatol Sect, Houston, TX 77030 USA; [Hanson, I. Celine] Texas Childrens Hosp, Houston, TX 77030 USA; [Calvo, Pier Luigi] Regina Margherita Childrens Hosp, Pediat Gastroenterol, Dept Pediat, Turin, Italy; [Quarello, Paola] Regina Margherita Childrens Hosp, Pediat Oncol Hematol, Stem Cell Transplantat & Cellular Therapy Div, Turin, Italy; [Tandoi, Francesco] AOU Citta Salute & Sci, Liver Transplantat Ctr, Gen Surg 2U, Dept Surg Sci,Molinette Hosp, Turin, Italy; [Cant, Andrew; Gennery, Andrew R.; Slatter, Mary A.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Cant, Andrew; Gennery, Andrew R.; Slatter, Mary A.] Newcastle Upon Tyne Univ, Primary Immunodeficiency Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Edgar, J. David M.] Royal Hosp, Reg Immunol Serv, Belfast, Antrim, North Ireland; [Espanol, Teresa] Vall dHebron Univ Hosp, Immunol Unit, Barcelona, Spain; [Ferrua, Francesca] Great North Childrens Hosp, Dept Pediat Immunol & HSCT, Newcastle Upon Tyne, Tyne & Wear, England; [Ferrua, Francesca] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy SR Tiget, Pediat Immunohematol & Bone Marrow Transplantat U, Milan, Italy; [Ferrua, Francesca] Univ Vita Salute San Raffaele, Milan, Italy; [Galicchio, Miguel] Hosp Ninos VJ Vilela, Allergy & Immnunol Serv, Rosario, Santa Fe, Argentina; [Hadzic, Nedim] Kings Coll Hosp London, Pediat Ctr Hepatol Gastroenterol & Nutr, London, England; [Kusminsky, Gustavo] Austral Univ Hosp, Stem Cell Transplantat Unit, Buenos Aires, DF, Argentina; [Lange, Andrzej] Polish Acad Sci, L Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Lange, Andrzej] Natl Bone Marrow Donor Registry, Lower Silesian Ctr Cellular Transplantat, Wroclaw, Poland; [Lanternier, Fanny] Necker Enfants Malades Univ Hosp, Infectiol Ctr Necker Pasteur, Serv Infects & Trop Dis, Paris, France; [Lanternier, Fanny; Mahlaoui, Nizar] Necker Enfants Malades Univ Hosp, Infectiol Ctr Necker Pasteur, French Natl Reference Ctr Hereditary Immune Defic, Paris, France; [Mahlaoui, Nizar; Moshous, Despina; Neven, Benedicte] Necker Enfants Malades Univ Hosp, Infectiol Ctr Necker Pasteur, Pediat Hematol Immunol & Rheumatol Unit, Paris, France; [Lanternier, Fanny; Mahlaoui, Nizar; Neven, Benedicte] Paris Descartes Univ, Sorbonne Paris Cite, Inst Imagine, Paris, France; [Nademi, Zohreh] Great Ormond St Hosp Sick Children, Dept Immunol, London, England; [Veys, Paul] Great Ormond St Hosp Sick Children, Bone Marrow Transplant Unit, London, England; [Oleastro, Matias] Hosp Nacl Pediat JP Garrahan, Rheumathol & Immunol Serv, Buenos Aires, DF, Argentina; [Porta, Fulvio; Soncini, Elena] Spedali Civil Brescia, Pediat Hematol Oncol & HSCT Unit, Brescia, Italy; [Silva, Marcelo] Austral Hosp, Hepatol Unit, Buenos Aires, DF, Argentina; [Stefanowicz, Marek] Childrens Mem Hlth Inst, Dept Pediat Surg & Organ Transplantat, Warsaw, Poland; [Teisseyre, Mikolaj] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Feeding Disorders & Pe, Warsaw, Poland; [Wolska-Kusnierz, Beata] Childrens Mem Hlth Inst, Dept Immunol, Warsaw, Poland; [Torgerson, Troy R.; de la Morena, M. Teresa] Univ Washington, Dept Pediat Immunol, Seattle, WA 98195 USA; [Torgerson, Troy R.; de la Morena, M. Teresa] Seattle Childrens Res Inst, Seattle, WA USA; [Weinacht, Katja G.] Stanford Sch Med, Dept Pediat, Div Stem Cell Transplantat & Regenerat Med, Stanford, CA USA; [Pirenne, Jacques] Univ Hosp Leuven, Abdominal Transplantat Surg, Lab Abdominal Transplantat, Leuven, Belgium; [Pirenne, Jacques] Katholieke Univ Leuven, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Hospital Universitari Vall d'Hebron; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; King's College Hospital NHS Foundation Trust; King's College Hospital; Austral University; Hospital Universitario Austral; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Hospital Spedali Civili Brescia; Austral University; Hospital Universitario Austral; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Stanford University; KU Leuven; University Hospital Leuven; KU Leuven	Meyts, I (corresponding author), Katholieke Univ Leuven, Lab Childhood Immunol, Dept Microbiol & Immunol, Leuven, Belgium.; Meyts, I (corresponding author), Univ Hosp Leuven, Dept Pediat, Leuven, Belgium.	Isabelle.Meyts@uzleuven.be	Tandoi, Francesco/G-3395-2013; Moshous, Despina/B-7507-2017; MAHLAOUI, Nizar/AAH-6103-2020; Ferrua, Francesca/K-4340-2016; Meyts, Isabelle/Z-3295-2019; Quarello, Paola/AAD-2731-2020; Lanternier, Fanny/AAQ-2815-2021; Pirenne, Jacques/I-3728-2018; Lange, Andrzej/AAR-3247-2021	Tandoi, Francesco/0000-0003-3166-6684; Moshous, Despina/0000-0001-6719-3693; MAHLAOUI, Nizar/0000-0002-0030-8094; Ferrua, Francesca/0000-0002-5695-4490; Pirenne, Jacques/0000-0002-8147-8801; Lange, Andrzej/0000-0003-3544-1853; Edgar, John David Moore/0000-0003-2969-4475; Bucciol, Giorgia/0000-0001-5004-0738; Hanson, Imelda/0000-0001-9457-0757	Research Foundation-Flanders [G0C8517N]; Jeffrey Modell Foundation; Research FoundationFlanders [G0C8517N]	Research Foundation-Flanders(FWO); Jeffrey Modell Foundation; Research FoundationFlanders(FWO)	G.B. is supported by the Research Foundation-Flanders (project G0C8517N). I.M. is supported by the Jeffrey Modell Foundation and by the Research FoundationFlanders (project G0C8517N).	Azzu V, 2018, J ALLERGY CLIN IMMUN, V141, P405, DOI 10.1016/j.jaci.2017.06.036; de la Morena MT, 2017, J ALLERGY CLIN IMMUN, V139, P1282, DOI 10.1016/j.jaci.2016.07.039; de la Morena MT, 2016, J ALLER CL IMM-PRACT, V4, P1023, DOI 10.1016/j.jaip.2016.09.013; KRAAKMAN MEM, 1995, CLIN GENET, V48, P46; Lanternier F, 2017, TRANSPLANTATION, V101, P826, DOI 10.1097/TP.0000000000001503; Leven EA, 2016, J CLIN IMMUNOL, V36, P490, DOI 10.1007/s10875-016-0291-4; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Mitsui-Sekinaka K, 2015, J ALLERGY CLIN IMMUN, V136, P1018, DOI 10.1016/j.jaci.2015.02.020; Qamar N, 2014, CLIN REV ALLERG IMMU, V46, P120, DOI 10.1007/s12016-013-8378-7; Quarello P, 2018, TRANSPLANTATION, V102, P823, DOI [10.1097/tp.0000000000002114, 10.1097/TP.0000000000002114]; Teisseyre M, 2010, TRANSPL P, V42, P4608, DOI 10.1016/j.transproceed.2010.09.170; Van Hoeyveld E, 2007, IMMUNOLOGY, V120, P497, DOI 10.1111/j.1365-2567.2006.02520.x; Venick RS, 2018, J AM COLL SURGEONS, V226, P355, DOI 10.1016/j.jamcollsurg.2017.12.042; Winkelstein JA, 2003, MEDICINE, V82, P373, DOI 10.1097/01.md.0000100046.06009.b0; 1997, TRANSPLANT P, V29, P432; N ENGL J MED, V342, P320	16	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1952	+		10.1016/j.jaci.2018.12.1013	http://dx.doi.org/10.1016/j.jaci.2018.12.1013			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30682461	Green Accepted			2022-12-18	WOS:000466784600037
J	Ben-Ali, M; Ben-Khemis, L; Mekki, N; Yaakoubi, R; Ouni, R; Benabdessalem, C; Ben-Mustapha, I; Barbouche, MR				Ben-Ali, Meriem; Ben-Khemis, Leila; Mekki, Najla; Yaakoubi, Roukaya; Ouni, Rym; Benabdessalem, Chaouki; Ben-Mustapha, Imen; Barbouche, Mohamed-Ridha			Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MUTATIONS; DEFICIENCY		[Ben-Ali, Meriem; Ben-Khemis, Leila; Mekki, Najla; Yaakoubi, Roukaya; Ouni, Rym; Benabdessalem, Chaouki; Ben-Mustapha, Imen; Barbouche, Mohamed-Ridha] Inst Pasteur Tunis, Lab Transmiss Control & Immunobiol Infect LR11IPT, Tunis, Tunisia; [Ben-Ali, Meriem; Mekki, Najla; Yaakoubi, Roukaya; Ouni, Rym; Benabdessalem, Chaouki; Ben-Mustapha, Imen; Barbouche, Mohamed-Ridha] Univ Tunis El Manar, Tunis, Tunisia; [Ben-Khemis, Leila] Univ Carthage, Sidi Bou Said, Carthage, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Universite de Carthage	Barbouche, MR (corresponding author), Inst Pasteur Tunis, Lab Transmiss Control & Immunobiol Infect LR11IPT, Tunis, Tunisia.; Barbouche, MR (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.	ridha.barbouche@pasteur.rns.tn	Benabdessalem, Chaouki/W-7077-2019; mekki, najla/AAA-6564-2019	Benabdessalem, Chaouki/0000-0001-7309-6814; MEKKI, NAJLA/0000-0002-5842-9147	Tunisian Ministry of Higher Education and Research [LR11IPT02]	Tunisian Ministry of Higher Education and Research	This work was supported by the Tunisian Ministry of Higher Education and Research (grant no. LR11IPT02).	Ben-Khemis L, 2017, MOL IMMUNOL, V90, P57, DOI 10.1016/j.molimm.2017.06.248; Greig KT, 2007, MOL CELL BIOL, V27, P5849, DOI 10.1128/MCB.00802-07; Matsuo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111097; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Schwerd T, 2017, J EXP MED, V214, P2547, DOI 10.1084/jem.20161810; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Waetzig GH, 2010, J BIOL CHEM, V285, P1781, DOI 10.1074/jbc.M109.075952; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	9	7	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1638	+		10.1016/j.jaci.2018.12.987	http://dx.doi.org/10.1016/j.jaci.2018.12.987			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30578875	Bronze, Green Submitted			2022-12-18	WOS:000463348900043
J	Dissanayake, E; Inoue, Y; Ochiai, S; Eguchi, A; Nakano, T; Yamaide, F; Hasegawa, S; Kojima, H; Suzuki, H; Mori, C; Kohno, Y; Taniguchi, M; Shimojo, N				Dissanayake, Eishika; Inoue, Yuzaburo; Ochiai, Shingo; Eguchi, Akifumi; Nakano, Taiji; Yamaide, Fumiya; Hasegawa, Satomi; Kojima, Hiroyuki; Suzuki, Hiroko; Mori, Chisato; Kohno, Yoichi; Taniguchi, Masaru; Shimojo, Naoki			Hsa-mir-144-3p expression is increased in umbilical cord serum of infants with atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Dissanayake, Eishika; Nakano, Taiji; Yamaide, Fumiya; Hasegawa, Satomi; Shimojo, Naoki] Chiba Univ, Dept Pediat, Grad Sch Med, Chiba, Japan; [Inoue, Yuzaburo] Chiba Univ, Dept Gen Med Sci, Grad Sch Med, Chiba, Japan; [Ochiai, Shingo; Mori, Chisato] Chiba Univ, Dept Bioenvironm Med, Grad Sch Med, Chiba, Japan; [Dissanayake, Eishika] Chiba Univ, Future Med Educ & Res Org, Chiba, Japan; [Ochiai, Shingo; Eguchi, Akifumi; Mori, Chisato] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Inoue, Yuzaburo] Eastern Chiba Med Ctr, Dept Pediat, Chiba, Japan; [Inoue, Yuzaburo] Chiba Childrens Hosp, Dept Allergy & Rheumatol, Chiba, Japan; [Kojima, Hiroyuki] Higashikoiwa Wanpaku Clin, Tokyo, Japan; [Suzuki, Hiroko] Seikei Kai Chiba Med Ctr, Chiba, Japan; [Kohno, Yoichi] Chiba Rosai Hosp, Chiba, Japan; [Taniguchi, Masaru] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Chiba University; Chiba Children's Hospital; RIKEN	Inoue, Y (corresponding author), Chiba Univ, Dept Gen Med Sci, Grad Sch Med, Chiba, Japan.; Inoue, Y (corresponding author), Eastern Chiba Med Ctr, Dept Pediat, Chiba, Japan.; Inoue, Y (corresponding author), Chiba Childrens Hosp, Dept Allergy & Rheumatol, Chiba, Japan.	yuzaburo@chiba-u.jp	Yamaide, Fumiya/GLU-2426-2022; Eguchi, Akifumi/G-9640-2012; Inoue, Yuzaburo/E-3262-2019	Eguchi, Akifumi/0000-0001-5858-8132; Inoue, Yuzaburo/0000-0001-5904-687X; Nakano, Taiji/0000-0001-7499-1204; YAMAIDE, FUMIYA/0000-0002-2916-9710	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [JP15K09638, JP16H01781, JP16K16198]; Japan Agency for Medical Research and Development (AMED) [J17JK00057]; AMED-Innovative Advanced research and Development Support (AMED-CREST) grant [J17JK00058]; RIKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED-Innovative Advanced research and Development Support (AMED-CREST) grant; RIKEN	Supported by a Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research (C) JP15K09638 (to Y.I.), a Grantin-Aid for Scientific Research (A) JP16H01781 (to C.M.), a Grant-in-Aid for Young Scientists (B) JP16K16198 (to A.E.), Japan Agency for Medical Research and Development (AMED) grant J17JK00057 (to N.S.), and an AMED-Innovative Advanced research and Development Support (AMED-CREST) grant J17JK00058 (to N.S.) and was conducted with funds provided by RIKEN based on the Joint Research Agreement between Chiba University and RIKEN.	Agrawal R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0433-9; Chieosilapatham P, 2017, CLIN EXP IMMUNOL, V190, P155, DOI 10.1111/cei.13013; de Aguiar VT, 2013, CIRC RES, V112, P300648, DOI DOI 10.1161/CIRCRESAHA.112.300648; Malik K, 2017, CLIN EXP ALLERGY, V47, P1648, DOI 10.1111/cea.13040; Nagao M, 2018, J ALLERGY CLIN IMMUN, V141, P1934, DOI 10.1016/j.jaci.2018.01.021; Renz H, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.98; Sivaprasad U, 2015, J INVEST DERMATOL, V135, P160, DOI 10.1038/jid.2014.353; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	9	7	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					447	+		10.1016/j.jaci.2018.09.024	http://dx.doi.org/10.1016/j.jaci.2018.09.024			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30312706	Bronze			2022-12-18	WOS:000454918300059
J	Fokkens, W; Reitsma, S				Fokkens, Wytske; Reitsma, Sietze			New delivery forms of nasal corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Chronic rhinosinusitis with nasal polyps; local corticosteroids; treatment; clinical trial; delivery	SINUS SURGERY; CHRONIC RHINOSINUSITIS		[Fokkens, Wytske; Reitsma, Sietze] Amsterdam Univ Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands		Fokkens, W (corresponding author), Amsterdam Univ Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands.	w.j.fokkens@amc.nl	Fokkens, Wytske WJ/ABF-2185-2020	Reitsma, Sietze/0000-0003-1734-2632				Chong LY, 2016, COCHRANE DB SYST REV, V4; Djupesland PG, 2013, DRUG DELIV TRANSL RE, V3, P42, DOI 10.1007/s13346-012-0108-9; Forwith KD, 2016, INT FORUM ALLERGY RH, V6, P573, DOI 10.1002/alr.21741; Harvey RJ, 2018, INT FORUM ALLERGY RH, V8, P461, DOI 10.1002/alr.22093; Leopold DA, 2019, J ALLERGY CLIN IMMUN, V143, P126, DOI 10.1016/j.jaci.2018.06.010; Pundir V, 2016, RHINOLOGY, V54, P3, DOI [10.4193/Rhin15.079, 10.4193/Rhino15.079]; Snidvongs K, 2013, AM J RHINOL ALLERGY, V27, P221, DOI 10.2500/ajra.2013.27.3880; Taulu R, 2017, RHINOLOGY, V55, P218, DOI [10.4193/Rhino16070, 10.4193/Rhino16.070]; Thomas WW, 2013, INT FORUM ALLERGY RH, V3, P691, DOI 10.1002/alr.21172; van der Veen J, 2017, ALLERGY, V72, P282, DOI 10.1111/all.12983	10	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					87	88		10.1016/j.jaci.2018.10.037	http://dx.doi.org/10.1016/j.jaci.2018.10.037			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30414856				2022-12-18	WOS:000454918300011
J	Patterson, AR; Bolcas, P; Lampe, K; Cantrell, R; Ruff, B; Lewkowich, I; Hogan, SP; Janssen, EM; Bleesing, J; Hershey, GKK; Hoebe, K				Patterson, Andrew R.; Bolcas, Paige; Lampe, Kristin; Cantrell, Rachel; Ruff, Brandy; Lewkowich, Ian; Hogan, Simon P.; Janssen, Edith M.; Bleesing, Jack; Hershey, Gurjit K. Khurana; Hoebe, Kasper			Loss of GTPase of immunity-associated protein 5 (Gimap5) promotes pathogenic CD4(+) T-cell development and allergic airway disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergic airway disease; house dust mite; primary immune deficiency; GIMAP5; T(H)2/T(H)17 cells; TGF-beta; DNA damage response; T-cell polarization; immune homeostasis; lung disease	INNATE LYMPHOID-CELLS; TGF-BETA ACTIVATION; IL-17A; ASTHMA; TH17; PRODUCE; FOXO; POLYMORPHISM; STIMULATION; CONTRIBUTES	Background: GTPase of immunity-associated protein 5 (GIMAP5) is essential for lymphocyte homeostasis and survival. Recently, human GIMAP5 single nucleotide polymorphisms have been linked to an increased risk for asthma, whereas loss of Gimap5 in mice has been associated with severe CD4(+) T cell-driven immune pathology. Objective: We sought to identify the molecular and cellular mechanisms by which Gimap5 deficiency predisposes to allergic airway disease. Methods: CD4(+) T-cell polarization and development of pathogenic CD4(+) T cells were assessed in Gimap5-deficient mice and a human patient with a GIMAP5 loss-of-function (LOF) mutation. House dust mite-induced airway inflammation was assessed by using a complete Gimap5 LOF (Gimap5(sph/sph)) and conditional Gimap5(fl/fl) Cd4(Cre/ert2) mice. Results: GIMAP5 LOF mutations in both mice and human subjects are associated with spontaneous polarization toward pathogenic T(H)17 and T(H)2 cells in vivo. Mechanistic studies in vitro reveal that impairment of Gimap5-deficient T-H cell differentiation is associated with increased DNA damage, particularly during T(H)1-polarizing conditions. DNA damage in Gimap5-deficient CD4(+) T cells could be controlled by TGF-beta T(H)17, and pathogenic T(H)17/T(H)2 cells. Conclusion: Activation of Gimap5-deficient CD4(+) T cells is associated with increased DNA damage and reduced survival that can be overcome by TGF-beta. This leads to selective survival of pathogenic T(H)17 cells but also T(H)2 cells in human subjects and mice, ultimately promoting allergic airway disease.	[Patterson, Andrew R.; Lampe, Kristin; Cantrell, Rachel; Lewkowich, Ian; Hogan, Simon P.; Janssen, Edith M.; Hoebe, Kasper] Cincinnati Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH USA; [Bolcas, Paige; Ruff, Brandy; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Res Fdn, Div Asthma Res, Cincinnati, OH USA; [Bleesing, Jack] Cincinnati Childrens Hosp Res Fdn, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH USA; [Patterson, Andrew R.; Bolcas, Paige; Cantrell, Rachel] Cincinnati Childrens Hosp Med Ctr, Grad Program Immunol, Cincinnati, OH 45229 USA; [Patterson, Andrew R.; Bolcas, Paige; Cantrell, Rachel] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Lewkowich, Ian; Hogan, Simon P.; Janssen, Edith M.; Hershey, Gurjit K. Khurana; Hoebe, Kasper] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Hogan, Simon P.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Hogan, Simon P.] Univ Michigan, Clin Labs, Ann Arbor, MI 48109 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hoebe, K (corresponding author), Cincinnati Childrens Hosp Res Fdn, MLC7021,Rm S5-421,3333 Burnet Ave, Cincinnati, OH 45229 USA.	khoebe@its.jnj.com		Patterson, Andrew/0000-0002-5177-5055; Cantrell, Rachel/0000-0001-8424-2530	Crohn's & Colitis Foundation of America [3793]; National Institutes of Health, PHS Grant [P30 DK078392, R21AI131050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI131050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America; National Institutes of Health, PHS Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Crohn's & Colitis Foundation of America (#3793) and the National Institutes of Health, PHS Grant P30 DK078392 (Integrative Morphology Core of the Cincinnati Digestive Disease Research Core Center) and R21# R21AI131050.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Aksoylar HI, 2012, J IMMUNOL, V188, P146, DOI 10.4049/jimmunol.1101206; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Beurel E, 2013, J IMMUNOL, V190, P5000, DOI 10.4049/jimmunol.1203057; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151837; Chien JW, 2013, CLIN EXP ALLERGY, V43, P1018, DOI 10.1111/cea.12119; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Cousins L, 2006, GASTROENTEROLOGY, V131, P1475, DOI 10.1053/j.gastro.2006.09.023; Fischer HJ, 2016, FASEB J, V30, P1724, DOI 10.1096/fj.15-277384; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hall SL, 2017, J ALLERGY CLIN IMMUN, V139, P462, DOI 10.1016/j.jaci.2016.04.037; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; Heinonen MT, 2015, J IMMUNOL, V194, P5885, DOI 10.4049/jimmunol.1500016; Hekking PP, 2018, J ALLERGY CLIN IMMUN, V141, P1280, DOI 10.1016/j.jaci.2017.06.037; Hekking PPW, 2015, J ALLERGY CLIN IMMUN, V135, P896, DOI 10.1016/j.jaci.2014.08.042; Hellquist A, 2007, J MED GENET, V44, P314, DOI 10.1136/jmg.2006.046185; Herz U, 2004, METHODS, V32, P271, DOI 10.1016/j.ymeth.2003.08.013; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kitamura H., 2011, J CLIN INVEST, V121, P40; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lim MK, 2009, LUPUS, V18, P1045, DOI 10.1177/0961203309106830; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pan MG, 2007, J IMMUNOL, V178, P4315, DOI 10.4049/jimmunol.178.7.4315; Patterson AR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02897-7; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Poussier P, 2005, J IMMUNOL, V174, P4081, DOI 10.4049/jimmunol.174.7.4081; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Shin JH, 2007, GENES IMMUN, V8, P503, DOI 10.1038/sj.gene.6364413; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; van den Brandt J, 2010, J IMMUNOL, V185, P2285, DOI 10.4049/jimmunol.1000462; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Welsh GI, 1996, J BIOL CHEM, V271, P11410, DOI 10.1074/jbc.271.19.11410; Wu CT, 2015, J MOL MED, V93, P73, DOI 10.1007/s00109-014-1206-6; Zhang ZH, 2017, J ALLERGY CLIN IMMUN, V139, P54, DOI 10.1016/j.jaci.2016.02.031; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438	57	7	8	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					245	+		10.1016/j.jaci.2018.10.018	http://dx.doi.org/10.1016/j.jaci.2018.10.018			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30616774	Bronze, Green Accepted			2022-12-18	WOS:000454918300029
J	Woo, YD; Koh, J; Kang, HR; Kim, HY; Chung, DH				Woo, Yeon Duk; Koh, Jaemoon; Kang, Hye-Ryun; Kim, Hye Young; Chung, Doo Hyun			The invariant natural killer T cell-mediated chemokine X-C motif chemokine ligand 1-X-C motif chemokine receptor 1 axis promotes allergic airway hyperresponsiveness by recruiting CD103(+) dendritic cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chemokine X-C motif chemokine ligand 1; X-C motif chemokine receptor 1; invariant natural killer T cells; CD103(+) dendritic cells; lung; asthma	NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; LUNG; MIGRATION; IMMUNITY; INFLAMMATION; METASTASIS; ACTIVATION; EXPRESSION; RESPONSES	Background: The chemokine X-C motif chemokine ligand 1 (XCL1)-X-C motif chemokine receptor 1 (XCR1) axis has been reported to play a role in immune homeostasis and inflammation. However, it is not known whether this axis has a critical function in patients with allergic asthma. Objective: In the present study we explored whether the invariant natural killer T (iNKT) cell-mediated XCL1-XCR1 axis regulated allergic asthma. Methods: Ovalbumin (OVA)- or house dust mite-induced asthma was developed in XCL1 or XCR1 knockout (KO) mice. Results: XCL1 or XCR1 KO mice showed attenuation in airway hyperresponsiveness (AHR), numbers of CD103(+) dendritic cells (DCs), and TH2 responses in the lungs compared with wild-type (WT) mice during OVA-or house dust mite-induced asthma. These effects were reversed by intratracheal administration of recombinant XCL1 or adoptive transfer of CD103(+) DCs but not CD11b(+) DCs into XCL1 KO mice. Moreover, iNKT cells highly expressed XCL1 both in vitro and in vivo. On intranasal alpha-galactosyl ceramide challenge, CD103(+) DC numbers in the lungs were increased in WT but not XCL1 KO mice. Furthermore, adoptive transfer of WT iNKT cells increased AHR, CD103(+) DC recruitment, and T(H)2 responses in the lungs of CD1d KO mice during OVA-induced asthma, whereas adoptive transfer of XCL1-deficient iNKT cells did not. In human patients, percentages and XCL1 production capacity of iNKT cells from PBMCs were greater in patients with asthma than in healthy control subjects. Conclusion: These data demonstrate that the iNKT cell-mediated XCL1-XCR1 axis promotes AHR by recruiting CD103(+) DCs into the lung in patients with allergic asthma.	[Woo, Yeon Duk; Koh, Jaemoon; Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Dept Pathol, 103 Daehak Ro, Seoul 110799, South Korea; [Woo, Yeon Duk; Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Lab Immune Regulat, Seoul, South Korea; [Kim, Hye Young] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Lab Mucosal Immunol, Seoul, South Korea; [Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Hye-Ryun; Kim, Hye Young] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chung, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, 103 Daehak Ro, Seoul 110799, South Korea.	doohyun@snu.ac.kr	Kim, Hye Young/AAF-7609-2020	Kim, Hye Young/0000-0001-5978-512X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014R1A1A3052488, NRF-2017R1A2B2007164]; BK21-plus education program by the National Research Foundation of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; BK21-plus education program by the National Research Foundation of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2014R1A1A3052488 and NRF-2017R1A2B2007164). Y.D.W. received a scholarship from the BK21-plus education program provided by the National Research Foundation of Korea.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bain CC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00658-6; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Burdin N, 1998, J IMMUNOL, V161, P3271; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Dong C, 2005, J IMMUNOL METHODS, V302, P136, DOI 10.1016/j.jim.2005.05.008; Dong GY, 2015, J IMMUNOL, V194, P3745, DOI 10.4049/jimmunol.1401754; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Fergeson JE, 2017, J ALLERGY CLIN IMMUN, V139, P438, DOI 10.1016/j.jaci.2016.06.054; Furuhashi Kazuki, 2012, Am J Respir Cell Mol Biol, V46, P165, DOI 10.1165/rcmb.2011-0070OC; Gorbachev AV, 2006, EUR J IMMUNOL, V36, P2494, DOI 10.1002/eji.200636075; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Huang EY, 2016, BIOCHEM BIOPH RES CO, V474, P252, DOI 10.1016/j.bbrc.2016.04.024; Hwang SJ, 2006, J IMMUNOL, V177, P5258, DOI 10.4049/jimmunol.177.8.5258; Ito T, 2017, J IMMUNOL, V198, P61, DOI 10.4049/jimmunol.1502393; Joyee AG, 2010, J IMMUNOL, V184, P2095, DOI 10.4049/jimmunol.0901348; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Kim HY, 2005, J EXP MED, V201, P41, DOI 10.1084/jem.20041400; Kim JH, 2011, J IMMUNOL, V186, P1432, DOI 10.4049/jimmunol.1003140; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Macho-Fernandez E, 2014, J IMMUNOL, V193, P961, DOI 10.4049/jimmunol.1303029; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; Mayer JU, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15820; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Monteiro M, 2014, CRIT REV IMMUNOL, V34, P81, DOI 10.1615/CritRevImmunol.2014010088; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nguyen KD, 2008, J IMMUNOL, V181, P5386, DOI 10.4049/jimmunol.181.8.5386; Oh Sae Jin, 2011, Immune Netw, V11, P406, DOI 10.4110/in.2011.11.6.406; Ohta T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23505; Park K, 2016, J CLIN INVEST, V126, P4603, DOI 10.1172/JCI87081; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Seo SH, 2018, J ALLERGY CLIN IMMUN, V141, P1382, DOI 10.1016/j.jaci.2017.07.019; Shekhar S, 2018, CELL MOL IMMUNOL, V15, P377, DOI 10.1038/cmi.2016.68; Sinclair C, 2017, SCIENCE, V357, P1014, DOI 10.1126/science.aaj2155; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Thomas SY, 2006, NEW ENGL J MED, V354, P2613; Thomas SY, 2010, J ALLERGY CLIN IMMUN, V125, P980, DOI 10.1016/j.jaci.2010.01.032; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Wang T, 2015, BIOCHEM BIOPH RES CO, V464, P635, DOI 10.1016/j.bbrc.2015.06.175; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Zelante T, 2015, CELL REP, V12, P1789, DOI 10.1016/j.celrep.2015.08.030; Zhuo SM, 2015, CELL BIOCHEM BIOPHYS, V73, P505, DOI 10.1007/s12013-015-0690-9	53	7	7	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1781	+		10.1016/j.jaci.2017.12.1005	http://dx.doi.org/10.1016/j.jaci.2017.12.1005			24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	29474842	Bronze			2022-12-18	WOS:000452315800014
J	Zwicker, C; Sarate, P; Drinic, M; Ambroz, K; Korb, E; Smole, U; Kohler, C; Wilson, MS; Kozakova, H; Sebo, P; Kverka, M; Wiedermann, U; Schabussova, I				Zwicker, Christian; Sarate, Priya; Drinic, Mirjana; Ambroz, Katharina; Korb, Elke; Smole, Ursula; Koehler, Cordula; Wilson, Mark S.; Kozakova, Hana; Sebo, Peter; Kverka, Miloslav; Wiedermann, Ursula; Schabussova, Irma			Prophylactic and therapeutic inhibition of allergic airway inflammation by probiotic Escherichia coli O83	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DELTA T-CELLS		[Zwicker, Christian; Sarate, Priya; Drinic, Mirjana; Ambroz, Katharina; Korb, Elke; Wiedermann, Ursula; Schabussova, Irma] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Smole, Ursula; Koehler, Cordula] Med Univ Vienna, Inst Immunol, Vienna, Austria; [Wilson, Mark S.] Genentech Inc, Immunol Discovery, San Francisco, CA USA; [Kozakova, Hana] Czech Acad Sci, Inst Microbiol, Lab Gnotobiol, Novy Hradek, Czech Republic; [Sebo, Peter; Kverka, Miloslav] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic	Medical University of Vienna; Medical University of Vienna; Roche Holding; Genentech; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Schabussova, I (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	irma.schabussova@meduniwien.ac.at	Kozakova, Hana/I-1153-2014; SEBO, Peter/N-2043-2019; Kverka, Miloslav/H-2507-2014; SEBO, Peter/F-7423-2011	Kozakova, Hana/0000-0001-7352-5922; SEBO, Peter/0000-0002-9755-7715; Kverka, Miloslav/0000-0002-1335-5252; SEBO, Peter/0000-0002-9755-7715; Smole, Ursula/0000-0001-5124-2024; Wiedermann, Ursula/0000-0002-1302-3223; Zwicker, Christian/0000-0001-7724-1361; Schabussova, Irma/0000-0002-2109-2640	Austrian Science Fund (FWF) [SFB 4612, SFB 4609]; OeAD [CZ 15/2015, CZ 13/2016];  [MCCA DK W1248-B13];  [DK W1248]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); OeAD; ; 	Supported by Austrian Science Fund (FWF) grants SFB 4612 (to U.W. and I.S.), SFB 4609 (to U.S. and C.K.), and Doctoral Program MCCA DK W1248-B13 (to C.Z., P.S., U.W. and I.S.) and DK W1248 (to U.S. and C.K.), and OeAD grants CZ 15/2015 (to C.Z., P.S., M.D., H.K., and I.S.) and CZ 13/2016 (to C.Z., P.S., M.D., M.K., and I.S.).	Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; Lodinova-Zadnikova R, 2010, INT ARCH ALLERGY IMM, V153, P201, DOI 10.1159/000312638; Nembrini C, 2011, THORAX, V66, P755, DOI 10.1136/thx.2010.152512; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Sheshko V, 2006, FEMS IMMUNOL MED MIC, V48, P257, DOI 10.1111/j.1574-695X.2006.00140.x; Starkhammar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104114; West CE, 2016, EXPERT REV CLIN IMMU, V12, P625, DOI 10.1586/1744666X.2016.1147955; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	8	7	7	2	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1987	+		10.1016/j.jaci.2018.07.029	http://dx.doi.org/10.1016/j.jaci.2018.07.029			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30125662	hybrid			2022-12-18	WOS:000452315800035
J	Churlaud, G; Abbara, C; Vinot, PA; Fourcade, G; Ritvo, PG; Lorenzon, R; Rosenzwajg, M; Diquet, B; Klatzmann, D				Churlaud, Guillaume; Abbara, Chadi; Vinot, Pierre-Axel; Fourcade, Gwladys; Ritvo, Paul-Gydeon; Lorenzon, Roberta; Rosenzwajg, Michelle; Diquet, Bertrand; Klatzmann, David			Pharmacodynamics of regulatory T cells in mice and humans treated with low-dose IL-2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INTERLEUKIN-2; THERAPY		[Churlaud, Guillaume; Vinot, Pierre-Axel; Lorenzon, Roberta; Rosenzwajg, Michelle; Klatzmann, David] Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi & Inflammat Immunopathol Bioth, Paris, France; [Churlaud, Guillaume; Vinot, Pierre-Axel; Fourcade, Gwladys; Ritvo, Paul-Gydeon; Lorenzon, Roberta; Rosenzwajg, Michelle; Klatzmann, David] UPMC Univ Paris 06, Sorbonne Univ, Immunol Immunopathol Immunotherapy I3, Paris, France; [Abbara, Chadi; Diquet, Bertrand] Univ Angers, Serv Pharmacol, Toxicol, Angers, France; [Abbara, Chadi; Diquet, Bertrand] Univ Angers, CHU Angers, Ctr Pharmacovigilance, Angers, France; [Abbara, Chadi; Diquet, Bertrand] Univ Angers, Fac Sante, Angers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Klatzmann, D (corresponding author), Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi & Inflammat Immunopathol Bioth, Paris, France.; Klatzmann, D (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Immunol Immunopathol Immunotherapy I3, Paris, France.	david.klatzmann@sorbonne-universite.fr	Rosenzwajg, Michelle/AAF-6276-2019	Rosenzwajg, Michelle/0000-0001-5312-6203	LabEx Transimmunom [ANR-11-IDEX-0004-02]; European Research Council Advanced Grant TRiPoD [322856]; Academie Nationale de Medecine	LabEx Transimmunom; European Research Council Advanced Grant TRiPoD; Academie Nationale de Medecine	The project was funded by the LabEx Transimmunom (grant no. ANR-11-IDEX-0004-02) and European Research Council Advanced Grant TRiPoD (322856) to D.K. G.C. was supported by the Academie Nationale de Medecine.	Bonnet B, 2016, J IMMUNOL, V197, P188, DOI 10.4049/jimmunol.1501271; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; KONRAD MW, 1990, CANCER RES, V50, P2009; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Rosenzwajg M, 2015, J AUTOIMMUN, V58, P48, DOI 10.1016/j.jaut.2015.01.001; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Yu AX, 2015, DIABETES, V64, P2172, DOI 10.2337/db14-1322	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1344	1346		10.1016/j.jaci.2018.06.006	http://dx.doi.org/10.1016/j.jaci.2018.06.006			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29920353	Green Published, Bronze			2022-12-18	WOS:000446327300034
J	Jadkauskaite, L; Bahri, R; Farjo, N; Farjo, B; Jenkins, G; Bhogal, R; Haslam, I; Bulfone-Paus, S; Paus, R				Jadkauskaite, Laura; Bahri, Rajia; Farjo, Nilofer; Farjo, Bessam; Jenkins, Gail; Bhogal, Ranjit; Haslam, Iain; Bulfone-Paus, Silvia; Paus, Ralf			Nuclear factor (erythroid-derived 2)-like-2 pathway modulates substance P-induced human mast cell activation and degranulation in the hair follicle	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GROWTH; ALOPECIA; LINES		[Jadkauskaite, Laura; Bahri, Rajia; Haslam, Iain; Bulfone-Paus, Silvia; Paus, Ralf] Univ Manchester, MAHSC, Ctr Dermatol Res, Manchester, Lancs, England; [Jadkauskaite, Laura; Bahri, Rajia; Haslam, Iain; Bulfone-Paus, Silvia; Paus, Ralf] NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Bahri, Rajia; Bulfone-Paus, Silvia] Univ Manchester, MCCIR, Manchester, Lancs, England; [Farjo, Nilofer; Farjo, Bessam] Farjo Med Ctr, Manchester, Lancs, England; [Jenkins, Gail; Bhogal, Ranjit] Unilever R&D Colworth, Colworth Sci Pk, Sharnbrook, Beds, England; [Haslam, Iain] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield, W Yorkshire, England; [Paus, Ralf] Univ Miami, Miller Sch Med, Dept Dermatol, Miami, FL 33136 USA	University of Manchester; University of Manchester; Unilever; University of Huddersfield; University of Miami	Paus, R (corresponding author), Univ Manchester, MAHSC, Ctr Dermatol Res, Manchester, Lancs, England.; Paus, R (corresponding author), NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England.; Paus, R (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol, Miami, FL 33136 USA.	ralf.paus@manchester.ac.uk	Bahri, Rajia/ABE-1725-2021; Haslam, Iain/B-8299-2011	Haslam, Iain/0000-0002-1008-2447	Biotechnology and Biological Sciences Research Council (BBSRC)-Unilever Case studentship; British Skin Foundation (UK); Psoriasis Association	Biotechnology and Biological Sciences Research Council (BBSRC)-Unilever Case studentship; British Skin Foundation (UK); Psoriasis Association	L. Jadkauskaite received funding from Biotechnology and Biological Sciences Research Council (BBSRC)-Unilever Case studentship. S. Bulfone-Paus received funding from British Skin Foundation (UK) and Psoriasis Association. The rest of the authors declare that they have no relevant conflicts of interest.	Bahri R, 2018, J ALLERGY CLIN IMMUN, V142, P485, DOI 10.1016/j.jaci.2018.01.043; Bai Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/407580; Bertolini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094260; Bulfone-Paus S, 2017, TRENDS IMMUNOL, V38, P657, DOI 10.1016/j.it.2017.01.008; Cetin ED, 2009, AM J DERMATOPATH, V31, P53, DOI 10.1097/DAD.0b013e318185a66e; Colombe L, 2008, EXP DERMATOL, V17, P63, DOI 10.1111/j.1600-0625.2007.00639.x; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Diaz-Agustin B, 1999, BRIT J HAEMATOL, V106, P400, DOI 10.1046/j.1365-2141.1999.01572.x; Garza Luis A, 2012, Sci Transl Med, V4, p126ra34, DOI 10.1126/scitranslmed.3003122; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Guhl S, 2010, EXP DERMATOL, V19, P845, DOI 10.1111/j.1600-0625.2010.01103.x; Haslam IS, 2017, J INVEST DERMATOL, V137, P295, DOI 10.1016/j.jid.2016.08.035; Ito N, 2010, J INVEST DERMATOL, V130, P995, DOI 10.1038/jid.2009.387; JAWORSKY C, 1992, BRIT J DERMATOL, V127, P239, DOI 10.1111/j.1365-2133.1992.tb00121.x; Jensen Bettina M, 2006, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0323s74; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Langan EA, 2015, EXP DERMATOL, V24, P903, DOI 10.1111/exd.12836; Larson AR, 2014, J CUTAN PATHOL, V41, P364, DOI 10.1111/cup.12286; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061574; Matsushima M, 2009, INFLAMM RES, V58, P705, DOI 10.1007/s00011-009-0039-1; Moon TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108595; Nieves A, 2014, EXP DERMATOL, V23, P224, DOI 10.1111/exd.12348; Peters EMJ, 2004, AM J PATHOL, V165, P259, DOI 10.1016/S0002-9440(10)63294-4; Peters EMJ, 2007, AM J PATHOL, V171, P1872, DOI 10.2353/ajpath.2007.061206; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009	26	7	8	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1331	+		10.1016/j.jaci.2018.04.039	http://dx.doi.org/10.1016/j.jaci.2018.04.039			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29859202	Bronze, Green Submitted			2022-12-18	WOS:000446327300030
J	Hirai, K; Shirai, T; Suzuki, M; Shimomura, T; Itoh, K				Hirai, Keita; Shirai, Toshihiro; Suzuki, Masayuki; Shimomura, Tatsuki; Itoh, Kunihiko			Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXHALED NITRIC-OXIDE; SYNTHASE GENE; PHENOTYPES		[Hirai, Keita; Suzuki, Masayuki; Shimomura, Tatsuki; Itoh, Kunihiko] Univ Shizuoka, Dept Clin Pharmacol & Genet, Sch Pharmaceut Sci, Shizuoka, Japan; [Hirai, Keita; Itoh, Kunihiko] Shizuoka Prefectural Gen Hosp, Lab Clin Pharmacogen, Shizuoka, Japan; [Shirai, Toshihiro] Shizuoka Prefectural Gen Hosp, Dept Resp Med, Shizuoka, Japan	University of Shizuoka; Shizuoka General Hospital; Shizuoka General Hospital	Itoh, K (corresponding author), Univ Shizuoka, Dept Clin Pharmacol & Genet, Sch Pharmaceut Sci, Shizuoka, Japan.; Itoh, K (corresponding author), Shizuoka Prefectural Gen Hosp, Lab Clin Pharmacogen, Shizuoka, Japan.	itohk@u-shizuoka-ken.ac.jp	Hirai, Keita/K-6290-2014	Hirai, Keita/0000-0001-8027-3508	Japan Society for the Promotion of Science [16K18949]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Young Scientists (B) (grant no. 16K18949) from the Japan Society for the Promotion of Science (to K.H.).	Hirai K, 2017, CLIN EXP ALLERGY, V47, P1374, DOI 10.1111/cea.12970; Konno S, 2001, J ALLERGY CLIN IMMUN, V108, P810, DOI 10.1067/mai.2001.119030; Leung TF, 2006, PEDIATR PULM, V41, P649, DOI 10.1002/ppul.20428; Modena BD, 2014, AM J RESP CRIT CARE, V190, P1363, DOI 10.1164/rccm.201406-1099OC; Pascual M, 2008, J INVEST ALLERG CLIN, V18, P241; Potaczek DP, 2017, EPIGENOMICS-UK, V9, P539, DOI 10.2217/epi-2016-0162; Sarnelli G, 2017, UNITED EUR GASTROENT, V5, P200, DOI 10.1177/2050640616648870; Sato S, 2016, ALLERGOL INT, V65, P300, DOI 10.1016/j.alit.2016.02.007; Warpeha KM, 1999, FASEB J, V13, P1825, DOI 10.1096/fasebj.13.13.1825	9	7	8	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					663	665		10.1016/j.jaci.2018.02.023	http://dx.doi.org/10.1016/j.jaci.2018.02.023			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29518423	Bronze			2022-12-18	WOS:000440664400031
J	Seo, KY; Kitamura, K; Han, SJ; Kelsall, B				Seo, Kyoung Yul; Kitamura, Kazuya; Han, Soo Jung; Kelsall, Brian			T(H)17 cells mediate inflammation in a novel model of spontaneous experimental autoimmune lacrimal keratoconjunctivitis with neural damage	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Autoimmune lacrimal keratoconjunctivitis; T(H)17 cell	DRY EYE DISEASE; OCULAR SURFACE; T-CELLS; INTESTINAL INFLAMMATION; DESICCATING STRESS; INTERFERON-GAMMA; COLITIS; NERVE; TH17	Background: Dry eye disease (DED) affects one third of the population worldwide. In prior studies, experimental autoimmune lacrimal keratoconjunctivitis (EALK) induced by desiccating stress in mice has been used as a model of DED. This model is complicated by a requirement for exogenous epithelial cell injury and administration of anticholinergic agents with broad immunologic effects. Objective: We sought to develop a novel mouse model of EALK and to demonstrate the responsible pathogenic mechanisms. Methods: CD4(+)CD45RB(high) naive T cells with and without CD4(+)CD45RB(low) regulatory T cells were adoptively transferred to C57BL/10 recombination-activating gene 2 (Rag2)(-/-) mice. The eyes, draining lymph nodes, lacrimal glands, and surrounding tissues of mice with and without spontaneous keratoconjunctivitis were evaluated for histopathologic changes, cellular infiltration, and cytokine production in tissues and isolated cells. Furthermore, the integrity of the corneal nerves was evaluated using whole-tissue immunofluorescence imaging. Gene-deficient naive T cells or RAG2-deficient hosts were evaluated to assess the roles of IFN-gamma, IL-17A, and IL-23 in disease pathogenesis. Finally, cytokine levels were determined in the tears of patients with DED. Results: EALK developed spontaneously in C57BL/10 Rag2(-/-) mice after adoptive transfer of CD4(+)CD45RB(high) naive T cells and was characterized by infiltration of CD4(+) T cells, macrophages, and neutrophils. In addition to lacrimal keratoconjunctivitis, mice had damage to the corneal nerve, which connects components of the lacrimal functional unit. Pathogenic T-cell differentiation was dependent on IL-23p40 and controlled by cotransferred CD4(+)CD45RB(low) regulatory T cells. T(H)17 rather than T(H)1 CD4(+) cells were primarily responsible for EALK, even though levels of both IL-17 and IFN-gamma were increased in inflammatory tissues, likely because of their ability to drive expression of CXC chemokines within the cornea and the subsequent influx of myeloid cells. Consistent with the findings of this model, the tears of patients with DED had increased levels of inflammatory cytokines, including IL-17A and TNF-alpha. Conclusion: We describe a novel model of spontaneous EALK that supports a role for T(H)17 cells in disease pathogenesis and that will contribute to our understanding of autoimmune lacrimal keratoconjunctivitis in many human eye diseases, including DED.	[Seo, Kyoung Yul; Kitamura, Kazuya; Kelsall, Brian] NIAID, Mucosal Immunobiol Sect, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Seo, Kyoung Yul; Han, Soo Jung] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Kitamura, Kazuya] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yonsei University; Yonsei University Health System; Kanazawa University	Kelsall, B (corresponding author), NIAID, Lab Mol Immunol, NIH, 10-11N104,10 Ctr Dr, Bethesda, MD 20892 USA.	bkelsall@niaid.nih.gov	Seo, Kyoung Yul/I-5484-2019	Seo, Kyoung Yul/0000-0002-9855-1980	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000833] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bergmanson JPG, 2005, CLIN CONTACT LENS PR, P11; Bouma G, 2002, GASTROENTEROLOGY, V123, P554, DOI 10.1053/gast.2002.34752; Chauhan SK, 2009, MUCOSAL IMMUNOL, V2, P375, DOI 10.1038/mi.2009.21; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen YH, 2011, J LEUKOCYTE BIOL, V89, P965, DOI 10.1189/jlb.1110611; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kim JC, 2002, ADV EXP MED BIOL, V506, P687; Labbe A, 2012, INVEST OPHTH VIS SCI, V53, P4926, DOI 10.1167/iovs.11-8708; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Liu YY, 2015, NEUROMOL MED, V17, P391, DOI 10.1007/s12017-015-8368-4; Mohsenin Amir, 2012, Conn Med, V76, P533; Moynes DM, 2014, BRAIN BEHAV IMMUN, V41, P1, DOI 10.1016/j.bbi.2014.03.004; Muller L, 1996, INVEST OPHTH VIS SCI, V37, P476; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Noma N, 2011, NEUROSCI LETT, V493, P86, DOI 10.1016/j.neulet.2011.01.079; Patel SJ, 2002, AM FAM PHYSICIAN, V66, P991; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Schaumburg CS, 2011, J IMMUNOL, V187, P3653, DOI 10.4049/jimmunol.1101442; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; St Leger AJ, 2017, IMMUNITY, V47, P148, DOI 10.1016/j.immuni.2017.06.014; Stern ME, 2010, MUCOSAL IMMUNOL, V3, P425, DOI 10.1038/mi.2010.26; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Valatas V, 2013, MUCOSAL IMMUNOL, V6, P601, DOI 10.1038/mi.2012.102; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035700, 10.1371/journal.pone.0035991]	30	7	8	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					96	+		10.1016/j.jaci.2017.07.052	http://dx.doi.org/10.1016/j.jaci.2017.07.052			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	28958903	Green Accepted, Bronze			2022-12-18	WOS:000437837500014
J	Spergel, JM; Aceves, SS; Kliewer, K; Gonsalves, N; Chehade, M; Wechsler, JB; Groetch, M; Friedlander, J; Dellon, ES; Book, W; Hirano, I; Muir, AB; Cianferoni, A; Spencer, L; Liacouras, CA; Cheng, E; Kottyan, L; Wen, T; Platts-Mills, T; Rothenberg, ME				Spergel, Jonathan M.; Aceves, Seema S.; Kliewer, Kara; Gonsalves, Nirmala; Chehade, Mirna; Wechsler, Joshua B.; Groetch, Marion; Friedlander, Joshua; Dellon, Evan S.; Book, Wendy; Hirano, Ikuo; Muir, Amanda B.; Cianferoni, Antonella; Spencer, Lisa; Liacouras, Chris A.; Cheng, Edaire; Kottyan, Leah; Wen, Ting; Platts-Mills, Thomas; Rothenberg, Marc E.			New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophilic esophagitis; food allergy; treatment; diagnosis	RESPONSIVE ESOPHAGEAL EOSINOPHILIA; ELIMINATION DIET; UNITED-STATES; CHILDREN; IGE; INFLAMMATION; VARIANTS; THERAPY; CELLS; IDENTIFICATION	The Consortium of Eosinophilic Gastrointestinal Diseases and the International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the recent 2018 Annual Meeting of the American Academy of Allergy, Asthma & Immunology, which was coupled for the first time with the World Allergy Organization meeting to create an international platform. The symposium featured experts in many facets of eosinophilic gastrointestinal diseases, including allergy, immunology, gastroenterology, pathology, and nutrition, and was a well-attended event. The basic science, genetics, cellular immunology, and clinical features of the diseases, with a focus on epithelial, eosinophil, and mast cell responses, as well as current and emerging treatment options, were reviewed. Here we briefly review some of the highlights of the material presented at the meeting.	[Spergel, Jonathan M.; Cianferoni, Antonella] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Muir, Amanda B.; Liacouras, Chris A.] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; [Spergel, Jonathan M.; Muir, Amanda B.; Cianferoni, Antonella; Liacouras, Chris A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Aceves, Seema S.] Univ Calif San Diego, Dept Pediat, Div Allergy, Rady Childrens Hosp,Immunol, La Jolla, CA 92093 USA; [Aceves, Seema S.] Univ Calif San Diego, Dept Med, Div Allergy, Rady Childrens Hosp,Immunol, La Jolla, CA 92093 USA; [Kliewer, Kara; Wen, Ting; Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Kottyan, Leah] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Kottyan, Leah] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Gonsalves, Nirmala; Hirano, Ikuo] Northwestern Univ, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Chehade, Mirna; Groetch, Marion] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Eosinophil Disorders, New York, NY 10029 USA; [Wechsler, Joshua B.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Gastroenterol Hepatol & Nutr, Eosinophil Gastrointestinal Dis Program, Chicago, IL 60611 USA; [Friedlander, Joshua] Childrens Hosp Colorado, Digest Hlth Inst, Aurora, CO USA; [Friedlander, Joshua] Univ Colorado, Sch Med, Aerodigest Program, Aurora, CO USA; [Dellon, Evan S.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC 27515 USA; [Book, Wendy] Amer Partnership Eosinophil Disorders, Atlanta, GA USA; [Spencer, Lisa] Beth Israel Deaconess, Boston, MA USA; [Cheng, Edaire] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Childrens Med Ctr, Dallas, TX USA; [Cheng, Edaire] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Childrens Med Ctr, Dallas, TX USA; [Platts-Mills, Thomas] Univ Virginia, Div Asthma Allergy & Immunol, Charlottesville, VA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai; Ann & Robert H. Lurie Children's Hospital of Chicago; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia	Rothenberg, ME (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, 3333 Burnet Ave,MLC7028, Cincinnati, OH 45229 USA.	Rothenberg@cchmc.org		Kottyan, Leah/0000-0003-3979-2220; Platts-Mills, Thomas/0000-0002-1263-329X	NIH; UCSD; PCORI; Nutricia; Regeneron; Shire; Allakos; Triple Endoscopy; CURED Foundation, OEDIT-STATE of Colorado; Adare; Banner; Celgene/Receptos; Alivio; AstraZeneca; Enumeral; Robarts Clinical Trials; Meritage; Miraca; Holoclara; Receptos; DBV; Abbott Nutrition; NIH, a US-Israel Binational Grant; GlaxoSmithKline; Merck; Celgene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI117804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107502] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; PCORI(Patient-Centered Outcomes Research Institute - PCORI); Nutricia(Danone Nutricia); Regeneron(Regeneron); Shire; Allakos; Triple Endoscopy; CURED Foundation, OEDIT-STATE of Colorado; Adare; Banner; Celgene/Receptos(Bristol-Myers SquibbCelgene Corporation); Alivio; AstraZeneca(AstraZeneca); Enumeral; Robarts Clinical Trials; Meritage; Miraca; Holoclara; Receptos; DBV; Abbott Nutrition(Abbott Laboratories); NIH, a US-Israel Binational Grant(US-Israel Binational Science Foundation); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Celgene(Bristol-Myers SquibbCelgene Corporation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	J.M. Spergel reports grants from the National Institutes of Health (NIH), End Allergy Together, and Aimmune Therapeutics; grants and personal fees from Regeneron, Shire, and DBV Technology; personal fees from UpToDate, Abbott, and the Annals of Allergy Asthma and Immunology outside the submitted work. S.S. Aceves reports a grant from the NIH and a UCSD patented licensed to Shire Pharma. M. Chehade reports receiving grants from NIH, PCORI, Nutricia, Regeneron, and Shire and consulting fees from Allakos and Shire. M. Groetch has received honoraria from Abbott, Nutricia North America and Mead Johnson for educational lectures. J. Friedlander reports personal fees and other from Triple Endoscopy and grants from the CURED Foundation, OEDIT-STATE of Colorado; in addition, J. Friedlander has a patent on Pediatric Nasal Endoscope/Aerodigestive Scope with royalties paid to University of Colorado. E.S. Dellon reports grants and personal fees from Adare, Banner, Celgene/Receptos, Regeneron, and Shire and personal fees from Alivio, Allakos, AstraZeneca, Enumeral, Robarts Clinical Trials; grants from Meritage, Miraca, Nutricia, and Holoclara. I. Hirano reports grants and consultant fees from Adare, Shire, Regeneron, and Receptos. A. Cianferoni reports grants and personal fees from DBV and grants from Shire. E. Cheng reports personal fees from Abbott Nutrition. L. Kottyan reports a pending patent WO2015142739A1. T. Wen and M. E. Rothenberg are co-inventors of issued and pending patents owned by CCHMC. M. E. Rothenberg reports grants from the NIH, a US-Israel Binational Grant, and PCORI; personal fees from Celgene and Genentech; equity in Immune Pharmaceuticals, PulmOne, and Spoon Guru; and personal fees from GlaxoSmithKline, Merck, Allakos, AstraZeneca, Celgene, and Regeneron; in addition, M. E. Rothenberg receives royalties from UpToDate and reslizumab (Teva Pharmaceuticals). The rest of the authors declare that they have no relevant conflicts to disclose.	Abonia JP, 2010, J ALLERGY CLIN IMMUN, V126, P140, DOI 10.1016/j.jaci.2010.04.009; Abu-Sultaneh SMA, 2011, DIGEST DIS SCI, V56, P97, DOI 10.1007/s10620-010-1259-5; Aceves SS, 2010, ALLERGY, V65, P109, DOI 10.1111/j.1398-9995.2009.02142.x; Aceves SS, 2014, DIGEST DIS, V32, P143, DOI 10.1159/000357131; Arias A, 2014, GASTROENTEROLOGY, V146, P1639, DOI 10.1053/j.gastro.2014.02.006; Brennan PJ, 2014, P NATL ACAD SCI USA, V111, P13433, DOI 10.1073/pnas.1415357111; Carlson DA, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.47; Cheng E, 2012, AM J PHYSIOL-GASTR L, V303, pG1175, DOI 10.1152/ajpgi.00313.2012; Cheng Katherine, 2017, Transl Sci Rare Dis, V2, P141, DOI 10.3233/TRD-170016; Cianferoni A, 2018, ANN ALLERG ASTHMA IM, V120; Cianferoni A, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0558-5; Clayton F, 2014, GASTROENTEROLOGY, V147, P602, DOI 10.1053/j.gastro.2014.05.036; Dellon ES, 2018, GASTROENTEROLOGY, V154, P319, DOI 10.1053/j.gastro.2017.06.067; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P589, DOI 10.1016/j.cgh.2013.09.008; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Dohil R, 2010, GASTROENTEROLOGY, V139, P418, DOI 10.1053/j.gastro.2010.05.001; Eluri S, 2017, J PEDIATR GASTR NUTR, V65, P53, DOI 10.1097/MPG.0000000000001415; Eluri S, 2016, GASTROINTEST ENDOSC, V83, P1142, DOI 10.1016/j.gie.2015.11.019; Erwin EA, 2016, J ALLERGY CLIN IMMUN, V138, P625, DOI 10.1016/j.jaci.2016.01.048; Erwin EA, 2015, J ALLER CL IMM-PRACT, V3, P896, DOI 10.1016/j.jaip.2015.05.015; Groetch M, 2017, J ALLER CL IMM-PRACT, V5, P312, DOI 10.1016/j.jaip.2016.12.026; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V141, P632, DOI 10.1016/j.jaci.2017.07.010; Jensen ET, 2016, J PEDIATR GASTR NUTR, V62, P36, DOI 10.1097/MPG.0000000000000865; Jensen ET, 2015, BEST PRACT RES CL GA, V29, P721, DOI 10.1016/j.bpg.2015.06.008; Jensen ET, 2015, AM J GASTROENTEROL, V110, P626, DOI 10.1038/ajg.2014.316; Jyonouchi S, 2014, CLIN EXP ALLERGY, V44, P58, DOI 10.1111/cea.12201; Kagalwalla AF, 2011, J PEDIATR GASTR NUTR, V53, P145, DOI 10.1097/MPG.0b013e31821cf503; Kwiatek MA, 2011, GASTROENTEROLOGY, V140, P82, DOI 10.1053/j.gastro.2010.09.037; Lieberman JA, 2012, ALLERGY, V67, P1299, DOI 10.1111/j.1398-9995.2012.02881.x; Lucendo AJ, 2013, J ALLERGY CLIN IMMUN, V131, P797, DOI 10.1016/j.jaci.2012.12.664; Menard-Katcher C, 2017, AM J GASTROENTEROL, V112, P1466, DOI 10.1038/ajg.2017.131; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Moawad FJ, 2016, CLIN GASTROENTEROL H, V14, P23, DOI 10.1016/j.cgh.2015.08.034; Molina-Infante J, 2016, EXPERT REV CLIN IMMU, V12, P945, DOI 10.1080/1744666X.2016.1178574; Molina-Infante J, 2016, GUT, V65, P524, DOI 10.1136/gutjnl-2015-310991; Muir AB, 2016, J PEDIATR GASTR NUTR, V63, P200, DOI 10.1097/MPG.0000000000001100; Pelz BJ, 2016, CLIN EXP ALLERGY, V46, P1431, DOI 10.1111/cea.12776; Petroni D, 2018, ANN ALLERG ASTHMA IM, V120, P237, DOI 10.1016/j.anai.2017.11.016; Rajan J, 2016, J ALLERGY CLIN IMMUN, V137, P147, DOI 10.1016/j.jaci.2015.05.045; Rayapudi M, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2013.13; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Shoda T, 2018, LANCET GASTROENTEROL, V3, P477, DOI 10.1016/S2468-1253(18)30096-7; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spechler SJ, 2007, AM J GASTROENTEROL, V102, P1301, DOI 10.1111/j.1572-0241.2007.01179.x; Spergel JM, 2007, J ALLERGY CLIN IMMUN, V119, P509, DOI 10.1016/j.jaci.2006.11.016; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V130, P461, DOI 10.1016/j.jaci.2012.05.021; Tkachenko E, 2016, J ALLERGY CLIN IMMUN, V137, P1270, DOI 10.1016/j.jaci.2015.09.020; van Rhijn BD, 2015, J ALLERGY CLIN IMMUN, V136, P1095, DOI 10.1016/j.jaci.2015.02.038; Wang R, 2018, DIG DIS SCI; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043	52	7	7	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					48	53		10.1016/j.jaci.2018.05.005	http://dx.doi.org/10.1016/j.jaci.2018.05.005			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29803797	Green Accepted, Bronze			2022-12-18	WOS:000437837500006
J	DeVries, A; Vercelli, D				DeVries, Avery; Vercelli, Donata			Of pleiotropy and trajectories: Does the TGF-beta pathway link childhood asthma and chronic obstructive pulmonary disease?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Childhood asthma; asthma; chronic obstructive pulmonary disease; TGF-beta; epigenetics; genome-wide association study; pleiotropy	GENOME-WIDE ASSOCIATION; COPD OVERLAP SYNDROME; LUNG-FUNCTION; WEIGHT-GAIN; LARGE-SCALE; FOLLOW-UP; RISK; LOCI; BIRTH; LIFE	The study of developmental trajectories is where epigenetics truly shines. The "epi'' in epigenetics captures the fact that although epigenetic processes also preside over the maintenance and termination of gene expression, the unfolding and remodeling of chromatin architecture are especially critical to prepare genes for regulated transcription. These properties imply being on a path, a trajectory to events that will occur later thanks to epigenetic programming. Thus epigenetics is about timed and timely events. In this article we discuss epigenetic and genetic evidence from several independent studies of asthma, chronic obstructive pulmonary disease, and lung function, which converge to highlight a potential role of the TGF-beta gene pathway in these processes. These results raise the possibility that at least in a subset of subjects, these conditions might be functionally connected in ways that need to be further defined but that likely reflect the uniquely pleiotropic nature of TGF-beta pathway genes, particularly their ability to control both lung development and immune responses essential for regulation and inflammation. Further characterization of this pathway in longitudinally phenotyped populations might unmask novel trajectories to lung disease that begin in utero and unfold into old age.	Univ Arizona, Dept Cellular & Mol Med, Arizona Ctr Biol Complex Dis, Tucson, AZ 85721 USA; Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Vercelli, D (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Inst BIO5, Rm 339,1657 E Helen St, Tucson, AZ 85721 USA.	donata@email.arizona.edu	DeVries, Avery/AAQ-9183-2020		 [HL007249 T32];  [R01HL129735];  [R21AI133765]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129735, T32HL007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI133765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by a Pre-doctoral Fellowship from HL007249 T32 (to A.D.V.), R01HL129735, and R21AI133765 (to D.V.).	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Busch R, 2017, AM J RESP CELL MOL, V57, P35, DOI 10.1165/rcmb.2016-0331OC; Cho MH, 2015, AM J RESP CRIT CARE, V192, P559, DOI 10.1164/rccm.201501-0148OC; DeVries A, 2017, ATS INT C; DeVries A, 2017, J ALLERGY CLIN IMMUN, V140, P534, DOI 10.1016/j.jaci.2016.10.041; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Halonen M, 2013, AM J RESP CRIT CARE, V188, P35, DOI 10.1164/rccm.201207-1265OC; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Harpsoe MC, 2013, J ALLERGY CLIN IMMUN, V131, P1033, DOI 10.1016/j.jaci.2012.09.008; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Leung JM, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3772; Lim RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010134; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P864, DOI 10.1016/j.jaci.2013.09.030; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; McGeachie MJ, 2017, CURR OPIN ALLERGY CL, V17, P104, DOI 10.1097/ACI.0000000000000348; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Neuman A, 2012, AM J RESP CRIT CARE, V186, P1037, DOI 10.1164/rccm.201203-0501OC; Rothers J, 2018, AM J RESP CELL MOL B; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787; Woodruff PG, 2017, AM J RESP CRIT CARE, V196, P375, DOI 10.1164/rccm.201705-0973WS; Yang IV, 2015, J ALLERGY CLIN IMMUN, V136, P69, DOI 10.1016/j.jaci.2015.01.025	30	7	10	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					1992	1996		10.1016/j.jaci.2018.04.012	http://dx.doi.org/10.1016/j.jaci.2018.04.012			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29709672	Green Accepted, Bronze			2022-12-18	WOS:000434701600004
J	Elfeky, R; Furtado-Silva, JM; Chiesa, R; Rao, K; Lucchini, G; Amrolia, P; Worth, A; Gaspar, B; Qasim, W; Veys, P				Elfeky, Reem; Furtado-Silva, Juliana M.; Chiesa, Robert; Rao, Kanchan; Lucchini, Giovanna; Amrolia, Persis; Worth, Austen; Gaspar, Bobby; Qasim, Waseem; Veys, Paul			Umbilical cord blood transplantation without in vivo T-cell depletion for children with MHC class II deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Elfeky, Reem] NHS Fdn Trust, Great Ormond St Hosp Children, Dept Immunol, London, England; NHS Fdn Trust, Great Ormond St Hosp Children, Dept Bone Marrow Transplant, London, England	Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Elfeky, R (corresponding author), NHS Fdn Trust, Great Ormond St Hosp Children, Dept Immunol, London, England.	r.elfeky@ucl.ac.uk		QASIM, WASEEM/0000-0001-8353-4494	National Institute for Health Research; GOSH Biomedical Research Centre; National Institute for Health Research [RP-2014-05-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); GOSH Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the National Institute for Health Research and the GOSH Biomedical Research Centre.	Al-Mousa H, 2010, BIOL BLOOD MARROW TR, V16, P818, DOI 10.1016/j.bbmt.2010.01.002; Bhattacharya A, 2005, BONE MARROW TRANSPL, V36, P295, DOI 10.1038/sj.bmt.1705054; Bonduel M, 1999, BONE MARROW TRANSPL, V24, P437, DOI 10.1038/sj.bmt.1701915; Chiesa R, 2012, BRIT J HAEMATOL, V156, P656, DOI 10.1111/j.1365-2141.2011.08994.x; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; Lane JR, 2014, BIOL BLOOD MARROW TR, V20, P243, DOI 10.1016/j.bbmt.2013.11.005; Ouederni M, 2011, BLOOD, V118, P5108, DOI 10.1182/blood-2011-05-352716; Siepermann M, 2011, PEDIATR TRANSPLANT, V15, pE80, DOI 10.1111/j.1399-3046.2010.01292.x; Small TN, 2013, BONE MARROW TRANSPL, V48, P226, DOI 10.1038/bmt.2012.140	9	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2279	2282		10.1016/j.jaci.2017.10.051	http://dx.doi.org/10.1016/j.jaci.2017.10.051			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29366700	Green Accepted, Bronze			2022-12-18	WOS:000434701600035
J	Kaur, A; Skoner, D; Ibrahim, J; Li, Q; Lockey, RF; Blaiss, M; Bufe, A; Andersen, JS; Canonica, GW; Nolte, H				Kaur, Amarjot; Skoner, David; Ibrahim, Joseph; Li, Qing; Lockey, Richard F.; Blaiss, Michael; Bufe, Albrecht; Andersen, Jens Strodl; Canonica, Giorgio Walter; Nolte, Hendrik			Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trials	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sublingual immunotherapy; children; adults; efficacy; IgG(4); Bayesian framework; frequentist; trial design	ALLERGIC RHINITIS; CLINICAL-TRIALS; EFFICACY; SAFETY	Background: Large sample sizes are needed for sublingual immunotherapy (SLIT) trials because of inherent data variability secondary to inconsistent allergen exposure. Obtaining large sample sizes for pediatric SLIT trials is challenging, but a Bayesian approach using prior adult data can reduce the necessary sample size. Objective: We sought to describe how a Bayesian framework using prior information from adult trials can be used to improve pediatric SLIT clinical development. Methods: Data were compiled by using a frequentist approach (conventional clinical trial approach independent of prior data) from trials conducted during the clinical development of timothy grass SLIT-tablets. Results: The treatment effect of timothy grass SLIT-tablets was considered similar between pediatric (n = 795) and adult (n = 2299) data pools, with relative total combined symptom plus medication score improvement versus placebo of 21% (95% CI, 11.0% to 30.4%) and 20% (95% CI, 14.6% to 24.4%), respectively. Phleum pratense-specific IgG(4) and IgE-blocking factor increased from baseline in both children and adults treated with timothy grass SLIT-tablets. Given the reasonable assumption in similarity of treatment response between adults and children, a Bayesian approach is described to demonstrate rigorous efficacy criteria for pediatric trials incorporating information from prior adult trials and thereby reduce the sample size. Conclusions: Data support the similarity of efficacy and immunologic changes between children and adults treated with SLIT for allergic rhinoconjunctivitis. Therefore it is appropriate to use data from adult trials to design feasible trials in children, which might reduce unsafe off-label use by promoting more quickly proper labeling of approved products.	[Kaur, Amarjot; Li, Qing; Nolte, Hendrik] Merck, Kenilworth, NJ USA; [Skoner, David] West Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV USA; [Ibrahim, Joseph] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Lockey, Richard F.] Univ S Florida, Morsani Coll Med, Div Allergy & Immunol, Tampa, FL USA; [Blaiss, Michael] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Bufe, Albrecht] Ruhr Univ Bochum, Dept Expt Pneumol, Bochum, Germany; [Andersen, Jens Strodl] ALK Abello, Horsholm, Denmark; [Canonica, Giorgio Walter] Humanitas Univ & Res Hosp, Personalized Med Clin Asthma & Allergy, Milan, Italy	Merck & Company; West Virginia University; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of South Florida; University System of Georgia; Augusta University; Ruhr University Bochum; ALK-Abello AS; Humanitas University	Nolte, H (corresponding author), ALK Abello, US Highway 135 Route 202-206, Bedminster, NJ 07921 USA.	Hendrik.nolte@alk.net	canonica, giorgio walter/ABF-2037-2020	canonica, giorgio walter/0000-0001-8467-2557	Merck; Kenilworth, NJ; ALK-Abello; Horsholm, Denmark; Denmark	Merck(Merck & Company); Kenilworth, NJ; ALK-Abello; Horsholm, Denmark; Denmark	Supported by Merck, Kenilworth, NJ, and ALK-Abello, Horsholm, Denmark. Medical writing and editorial assistance was provided by Erin P. Scott, PhD, of Scott Medical Communications; this assistance was funded by Merck.	[Anonymous], 2014, GRAST TIM GRASS POLL; [Anonymous], 2010, GUID IND FDA STAFF G; [Anonymous], 2014, OR SWEET VERN ORCH P; Bagnasco M, 1997, J ALLERGY CLIN IMMUN, V100, P122, DOI 10.1016/S0091-6749(97)70203-3; Blaiss M, 2011, J ALLERGY CLIN IMMUN, V127, P64, DOI 10.1016/j.jaci.2010.11.034; Bufe A, 2009, J ALLERGY CLIN IMMUN, V123, P167, DOI 10.1016/j.jaci.2008.10.044; Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Cox L, 2009, ANN ALLERG ASTHMA IM, V103, P451, DOI 10.1016/S1081-1206(10)60259-1; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; Demoly P, 2016, J ALLERGY CLIN IMMUN, V137, P444, DOI 10.1016/j.jaci.2015.06.036; Didier A, 2007, J ALLERGY CLIN IMMUN, V120, P1338, DOI 10.1016/j.jaci.2007.07.046; Dretzke J, 2013, J ALLERGY CLIN IMMUN, V131, P1361, DOI 10.1016/j.jaci.2013.02.013; Dunne J, 2011, PEDIATRICS, V128, pE1242, DOI 10.1542/peds.2010-3487; European Medicines Agency, 2013, CONC PAP EXTR EFF SA; Food and Drug Administration, SPEC REQ CONT FORM L; Hattevig G, 1993, Pediatr Allergy Immunol, V4, P182, DOI 10.1111/j.1399-3038.1993.tb00089.x; Janiaud P, 2015, J CLIN EPIDEMIOL, V68, P1221, DOI 10.1016/j.jclinepi.2015.06.021; Maloney J, 2014, ANN ALLERG ASTHMA IM, V112, P146, DOI 10.1016/j.anai.2013.11.018; Massie T., STAT CRITERIA ESTABL; Murphy K, 2013, J NEGAT RESULTS BIOM, V12, DOI 10.1186/1477-5751-12-10; Nelson H, 2015, J ALLER CL IMM-PRACT, V3, P256, DOI 10.1016/j.jaip.2014.09.018; Nelson HS, 2015, EXPERT REV CLIN IMMU, V11, P959, DOI 10.1586/1744666X.2015.1062726; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, P72, DOI 10.1016/j.jaci.2010.11.035; Nolte H, 2016, J ALLERGY CLIN IMMUN, V138, P1631, DOI 10.1016/j.jaci.2016.06.044; Radulovic S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002893.pub2; Schoenfeld DA, 2009, CLIN TRIALS, V6, P297, DOI 10.1177/1740774509339238; Sullivan KE, 2008, PEDIAT INFECT DIS RE, P338; VANWILSEM EJG, 1994, IMMUNOLOGY, V83, P128; Viele K, 2014, PHARM STAT, V13, P41, DOI 10.1002/pst.1589; Wahn U, 2009, J ALLERGY CLIN IMMUN, V123, P160, DOI 10.1016/j.jaci.2008.10.009	31	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1744	1749		10.1016/j.jaci.2017.09.051	http://dx.doi.org/10.1016/j.jaci.2017.09.051			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29221713	Bronze, Green Accepted			2022-12-18	WOS:000432148200021
J	Sugier, PE; Brossard, M; Sarnowski, C; Vaysse, A; Morin, A; Pain, L; Margaritte-Jeannin, P; Dizier, MH; Cookson, WOCM; Lathrop, M; Moffatt, MF; Laprise, C; Demenais, F; Bouzigon, E				Sugier, Pierre-Emmanuel; Brossard, Myriam; Sarnowski, Chloe; Vaysse, Amaury; Morin, Andreane; Pain, Lucile; Margaritte-Jeannin, Patricia; Dizier, Marie-Helene; Cookson, William O. C. M.; Lathrop, Mark; Moffatt, Miriam F.; Laprise, Catherine; Demenais, Florence; Bouzigon, Emmanuelle			A novel role for ciliary function in atopy: ADGRV1 and DNAH5 interactions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopy; asthma; genetics; genome-wide association study; gene-gene interaction; text mining; ADGRV1; DNAH5; ciliary function	GENOME-WIDE ASSOCIATION; ASTHMA; GENETICS; IDENTIFICATION; METAANALYSIS; VARIANTS; ALLERGY; LOCI; SENSITIZATION; MUTATIONS	Background: Atopy, an endotype underlying allergic diseases, has a substantial genetic component. Objective: Our goal was to identify novel genes associated with atopy in asthma-ascertained families. Methods: We implemented a 3-step analysis strategy in 3 data sets: the Epidemiological Study on the Genetics and Environment of Asthma (EGEA) data set (1660 subjects), the Saguenay-Lac-Saint-Jean study data set (1138 subjects), and the Medical Research Council (MRC) data set (446 subjects). This strategy included a single nucleotide polymorphism (SNP) genome-wide association study (GWAS), the selection of related gene pairs based on statistical filtering of GWAS results, and text-mining filtering using Gene Relationships Across Implicated Loci and SNP-SNP interaction analysis of selected gene pairs. Results: We identified the 5q14 locus, harboring the adhesion G protein-coupled receptor V1 (ADGRV1) gene, which showed genome-wide significant association with atopy (rs4916831, meta-analysis P value = 6.8 x 10(-9)). Statistical filtering of GWAS results followed by text-mining filtering revealed relationships between ADGRV1 and 3 genes showing suggestive association with atopy (P <= 10(-4)). SNP-SNP interaction analysis between ADGRV1 and these 3 genes showed significant interaction between ADGRV1 rs17554723 and 2 correlated SNPs (rs2134256 and rs1354187) within the dynein axonemal heavy chain 5 (DNAH5) gene (Pmeta-int = 3.6 x 10(-5) and 6.1 x 10(-5), which met the multiple-testing corrected threshold of 7.3 x 10(-5)). Further conditional analysis indicated that rs2134256 alone accounted for the interaction signal with rs17554723. Conclusion: Because both DNAH5 and ADGRV1 contribute to ciliary function, this study suggests that ciliary dysfunction might represent a novel mechanism underlying atopy. Combining GWAS and epistasis analysis driven by statistical and knowledge-based evidence represents a promising approach for identifying new genes involved in complex traits.	[Sugier, Pierre-Emmanuel; Brossard, Myriam; Sarnowski, Chloe; Vaysse, Amaury; Margaritte-Jeannin, Patricia; Dizier, Marie-Helene; Demenais, Florence; Bouzigon, Emmanuelle] Univ Paris Diderot, Univ Sorbonne Paris Cite, Genet Variat & Human Dis Unit, INSERM, Paris, France; [Sugier, Pierre-Emmanuel] Univ Paris 06, Paris, France; [Morin, Andreane; Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Morin, Andreane; Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Morin, Andreane; Pain, Lucile; Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Cookson, William O. C. M.; Moffatt, Miriam F.] Natl Heart & Lung Inst, Sect Genom Med, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; McGill University; University of Quebec; University of Quebec Chicoutimi; Imperial College London	Demenais, F (corresponding author), Univ Paris Diderot, INSERM, UMR 946, 27 Rue Juliette Dodu, F-75010 Paris, France.	florence.demenais@inserm.fr	Demenais, Florence/G-3298-2013; Bouzigon, Emmanuelle/L-2766-2017; Dizier, Marie-Hélène/K-8463-2018; Cookson, William/HHC-1790-2022; Brossard, Myriam/P-2640-2019	Demenais, Florence/0000-0001-8361-0936; Bouzigon, Emmanuelle/0000-0001-5756-4286; Dizier, Marie-Hélène/0000-0001-8460-7667; Sugier, Pierre-Emmanuel/0000-0002-5846-1104; Laprise, Catherine/0000-0001-5526-9945; Sarnowski, Chloe/0000-0002-6090-7099; Vaysse, Amaury/0000-0003-2397-4230	French National Agency for Research [ANR-11-BSV1-027-GWISAM, ANR-USPC-2013-EDAGWAS]; Universite Pierre et Marie Curie doctoral fellowship; Canada Research Chair; Canadian Institutes of Health Research (CIHR); European Commission [LSHB-CT-2006-018996-GABRIEL]; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish	French National Agency for Research(French National Research Agency (ANR)); Universite Pierre et Marie Curie doctoral fellowship; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	Supported by the French National Agency for Research (ANR-11-BSV1-027-GWISAM; ANR-USPC-2013-EDAGWAS), Universite Pierre et Marie Curie doctoral fellowship, and the Canada Research Chair (held by C.L.), and support from the Canadian Institutes of Health Research (CIHR) enabled the maintenance and continuation of the SLSJ asthma study. C.L. is the director of the Asthma Strategic Group of the Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ) and a member of Allergen Network. Genotyping was supported by a grant from the European Commission (no. LSHB-CT-2006-018996-GABRIEL).	Almoguera B, 2017, AM J RESP CRIT CARE, V195, P456, DOI 10.1164/rccm.201604-0861OC; Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Armengot M, 2012, INVEST OPHTH VIS SCI, V53, P2076, DOI 10.1167/iovs.11-8666; Besnard T, 2012, HUM MUTAT, V33, P504, DOI 10.1002/humu.22004; BONNEAU D, 1993, J MED GENET, V30, P253, DOI 10.1136/jmg.30.3.253; Bonnelykke K, 2015, CURR OPIN IMMUNOL, V36, P115, DOI 10.1016/j.coi.2015.08.002; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bouzigon E, 2015, REV MAL RESPIR, V32, P822, DOI 10.1016/j.rmr.2014.12.005; Castro-Giner F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-128; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; Dizier MH, 2016, EUR RESPIR J, V47, P1072, DOI 10.1183/13993003.00849-2015; Dizier MH, 2012, J ALLERGY CLIN IMMUN, V129, P1547, DOI 10.1016/j.jaci.2012.04.010; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Jones AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19837-6; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Kovacic MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023714; Laprise C, 2014, GENES IMMUN, V15, P247, DOI 10.1038/gene.2014.12; Lee JH, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0097-y; Leigh MW, 2009, CURR OPIN PEDIATR, V21, P320, DOI 10.1097/MOP.0b013e328329cddb; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Li ZC, 2016, BIOINFORMATICS, V32, P1057, DOI 10.1093/bioinformatics/btv695; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Los H, 2001, Twin Res, V4, P81, DOI 10.1375/twin.4.2.81; Luo Y, 2014, CANCER INFORM, V13, P69, DOI 10.4137/CIN.S13874; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Olbrich H, 2006, PEDIATR RES, V59, P418, DOI 10.1203/01.pdr.0000200809.21364.e2; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sarnowski C, 2016, J ALLERGY CLIN IMMUN, V138, P1071, DOI 10.1016/j.jaci.2016.03.018; Sun XQ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00106; Thomsen SF, 2006, CLIN EXP ALLERGY, V36, P1382, DOI 10.1111/j.1365-2222.2006.02512.x; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wan YI, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Wan YZI, 2011, J ALLERGY CLIN IMMUN, V127, P223, DOI 10.1016/j.jaci.2010.10.006; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685	46	7	7	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1659	+		10.1016/j.jaci.2017.06.050	http://dx.doi.org/10.1016/j.jaci.2017.06.050			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	28927820	Bronze, Green Submitted			2022-12-18	WOS:000432148200013
J	van der Vlugt, LEPM; Eger, K; Muller, C; Ninaber, DK; Zarcone, MC; Amatngalim, GD; Bracher, F; von Mutius, E; Smits, HH; Hiemstra, PS				van der Vlugt, Lucien E. P. M.; Eger, Katrien; Mueller, Christoph; Ninaber, Dennis K.; Zarcone, Maria C.; Amatngalim, Gimano D.; Bracher, Franz; von Mutius, Erika; Smits, Hermelijn H.; Hiemstra, Pieter S.			Farm dust reduces viral load in human bronchial epithelial cells by increasing barrier function and antiviral responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[van der Vlugt, Lucien E. P. M.; Eger, Katrien; Ninaber, Dennis K.; Zarcone, Maria C.; Amatngalim, Gimano D.; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [van der Vlugt, Lucien E. P. M.; Eger, Katrien; Smits, Hermelijn H.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Mueller, Christoph; Bracher, Franz] Ludwig Maximilians Univ Munchen, Dept Pharm, Ctr Drug Res, Munich, Germany; [von Mutius, Erika] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany; [von Mutius, Erika] German Ctr Lung Res, CPC M, Munich, Germany; [van der Vlugt, Lucien E. P. M.] Univ Michigan, Ann Arbor, MI 48109 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Munich; University of Munich; University of Michigan System; University of Michigan	Hiemstra, PS (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands.	p.s.hiemstra@lumc.nl	/V-8478-2019; Amatngalim, Gimano/AGQ-6886-2022; Smits, Hermelijn/V-4216-2018; Hiemstra, Pieter S/K-8587-2018	Amatngalim, Gimano/0000-0003-3442-1754; Smits, Hermelijn/0000-0001-9279-2890; Hiemstra, Pieter S/0000-0002-0238-5982; Eger, Katrien/0000-0002-9628-2174	Gottfried Wilhelm Leibniz Award of the German Research Foundation	Gottfried Wilhelm Leibniz Award of the German Research Foundation	This work was supported by the Gottfried Wilhelm Leibniz Award 2013 of the German Research Foundation to E.v.M.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Amatngalim GD, 2015, J IMMUNOL, V194, P3340, DOI 10.4049/jimmunol.1402169; Feldman A. S., AM J RESP CRIT CARE; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Kormann M. S., ALLERGY; Mertens TCJ, 2016, PULM PHARMACOL THER, V39, P14, DOI 10.1016/j.pupt.2016.05.005; Moheimani F., RESP RES, P17119; Porter JD, 2016, J ANTIMICROB CHEMOTH, V71, P2767, DOI 10.1093/jac/dkw222; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Smits H. H., CURR OPIN IMMUNOL; von Mutius E, 2016, J ALLERGY CLIN IMMUN, V137, P680, DOI 10.1016/j.jaci.2015.12.1301	12	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1949	+		10.1016/j.jaci.2018.01.025	http://dx.doi.org/10.1016/j.jaci.2018.01.025			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29425849	Bronze			2022-12-18	WOS:000432148200056
J	Wright, BL; Nguyen, N; Shim, KP; Masterson, JC; Jacobsen, EA; Ochkur, SI; Lee, JJ; Furuta, GT				Wright, Benjamin L.; Nguyen, Nathalie; Shim, Kelly P.; Masterson, Joanne C.; Jacobsen, Elizabeth A.; Ochkur, Sergei I.; Lee, James J.; Furuta, Glenn T.			Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CYTOKINE EXPRESSION		[Wright, Benjamin L.; Shim, Kelly P.; Jacobsen, Elizabeth A.; Ochkur, Sergei I.; Lee, James J.] Mayo Clin Arizona, Scottsdale, AZ 85259 USA; [Wright, Benjamin L.; Shim, Kelly P.] Phoenix Childrens Hosp, Phoenix, AZ 85016 USA; [Nguyen, Nathalie; Masterson, Joanne C.; Furuta, Glenn T.] Childrens Hosp Colorado, Digest Hlth Inst, Aurora, CO USA; [Nguyen, Nathalie; Masterson, Joanne C.; Furuta, Glenn T.] Univ Colorado, Gastrointestinal Eosinophil Dis Program, Sch Med, Aurora, CO USA	Mayo Clinic; Mayo Clinic Phoenix; Phoenix Children's Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wright, BL (corresponding author), Mayo Clin Arizona, Scottsdale, AZ 85259 USA.; Wright, BL (corresponding author), Phoenix Childrens Hosp, Phoenix, AZ 85016 USA.	wright.benjamin@mayo.edu		Jacobsen, Elizabeth A./0000-0003-2956-753X	Mayo Clinic; Phoenix Children's Hospital Foundation; Don and Kathy Levin Family Foundation; Consortium of Eosinophilic Gastrointestinal Disease Researchers, Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, National Center for Advancing Translational Sciences (NCATS) [U54AI117804]; National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, NCATS; American Partnership for Eosinophilic Disorders (APFED); Campaign Urging Research for Eosinophilic Disease (CURED); Eosinophilic Family Coalition (EFC); National Institutes of Health [1K24DK100303, T32DK067009-11]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI117804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067009, K24DK100303] Funding Source: NIH RePORTER	Mayo Clinic; Phoenix Children's Hospital Foundation; Don and Kathy Levin Family Foundation; Consortium of Eosinophilic Gastrointestinal Disease Researchers, Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, National Center for Advancing Translational Sciences (NCATS); National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, NCATS; American Partnership for Eosinophilic Disorders (APFED); Campaign Urging Research for Eosinophilic Disease (CURED); Eosinophilic Family Coalition (EFC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Mayo Clinic, Phoenix Children's Hospital Foundation, and Don and Kathy Levin Family Foundation (B.L.W., J.J.L.). This work was also supported by the Consortium of Eosinophilic Gastrointestinal Disease Researchers (grant no. U54AI117804), which is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, National Center for Advancing Translational Sciences (NCATS), and is funded through a collaboration between the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, NCATS, and patient advocacy groups including the American Partnership for Eosinophilic Disorders (APFED), the Campaign Urging Research for Eosinophilic Disease (CURED) and the Eosinophilic Family Coalition (EFC). The National Institutes of Health provided grants 1K24DK100303 (G.T.F.) and T32DK067009-11 (N.N.). This work benefitted from data assembled by the ImmGen consortium.	Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; Gupta SK, 2006, J PEDIATR GASTR NUTR, V42, P22, DOI 10.1097/01.mpg.0000188740.38757.d2; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Nunez-Nateras R, 2014, UROL ONCOL, V32, P23; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053	9	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1919	+		10.1016/j.jaci.2017.12.993	http://dx.doi.org/10.1016/j.jaci.2017.12.993			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29374572	Green Accepted, Bronze			2022-12-18	WOS:000432148200045
J	Saiganesh, A; Hales, BJ; Chen, S; Filipovska-Naumovska, E; Pereira, G; Garand, M; Kollmann, TR; Currie, AJ; Souef, PN; Zhang, GC				Saiganesh, Aarti; Hales, Belinda J.; Chen, Shu; Filipovska-Naumovska, Emilija; Pereira, Gavin; Garand, Mathieu; Kollmann, Tobias R.; Currie, Andrew J.; Le Souef, Peter N.; Zhang, Guicheng			The Western environment reduces innate immune cytokine production in Chinese immigrants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA; PREVALENCE; SYMPTOMS; ALLERGIES; CHILDREN		[Saiganesh, Aarti; Currie, Andrew J.; Le Souef, Peter N.; Zhang, Guicheng] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia; [Saiganesh, Aarti; Hales, Belinda J.; Zhang, Guicheng] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Chen, Shu; Filipovska-Naumovska, Emilija; Pereira, Gavin; Zhang, Guicheng] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Garand, Mathieu; Kollmann, Tobias R.] Univ British Columbia, Dept Paediat, Vancouver, BC, Canada; [Garand, Mathieu] MRC Unit, Vaccine & Immun Theme, Fajara, Gambia; [Currie, Andrew J.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Zhang, Guicheng] Univ Western Australia, Fac Med Dent & Hlth Sci, Ctr Genet Origins Hlth & Dis, Perth, WA, Australia; [Zhang, Guicheng] Curtin Univ, Fac Hlth Sci, Perth, WA, Australia; [Zhang, Guicheng] Curtin Univ, Curtin Hlth Innovat Res Inst Biosci, Perth, WA, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; Curtin University; University of British Columbia; University of London; London School of Hygiene & Tropical Medicine; Murdoch University; University of Western Australia; Curtin University; Curtin University	Zhang, GC (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia.; Zhang, GC (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.; Zhang, GC (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.; Zhang, GC (corresponding author), Univ Western Australia, Fac Med Dent & Hlth Sci, Ctr Genet Origins Hlth & Dis, Perth, WA, Australia.; Zhang, GC (corresponding author), Curtin Univ, Fac Hlth Sci, Perth, WA, Australia.; Zhang, GC (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst Biosci, Perth, WA, Australia.	brad.zhang@curtin.edu.au	Zhang, Brad/AAF-8719-2021; Currie, Andrew/C-2778-2015; Pereira, Gavin/D-7136-2014; Le Souef, Peter N/H-5256-2014; Garand, Mathieu/AAV-3190-2020	Pereira, Gavin/0000-0003-3740-8117; Garand, Mathieu/0000-0003-4243-853X; Zhang, Guicheng/0000-0001-9888-5385; Kollmann, Tobias/0000-0003-2403-9762; Le Souef, Peter/0000-0003-0930-1654; Currie, Andrew/0000-0002-5193-3404	Telethon Perth Children's Hospital Research Funds; National Health and Medical Research Council	Telethon Perth Children's Hospital Research Funds; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	G. Pereira is employed by the National Health and Medical Research Council and his institution received grants for other projects. G. Zhang received grants from Telethon Perth Children's Hospital Research Funds and the National Health and Medical Research Council. The rest of the authors declare that they have no relevant conflicts of interest.	Ait-Khaled N, 2009, ALLERGY, V64, P123, DOI 10.1111/j.1398-9995.2008.01884.x; Laatikainen T, 2011, ALLERGY, V66, P886, DOI 10.1111/j.1398-9995.2010.02533.x; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; LEUNG RC, 1994, MED J AUSTRALIA, V161, P418, DOI 10.5694/j.1326-5377.1994.tb127522.x; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Wang HY, 2008, CAN MED ASSOC J, V179, P1133, DOI 10.1503/cmaj.071797	7	7	7	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1504	+		10.1016/j.jaci.2017.11.031	http://dx.doi.org/10.1016/j.jaci.2017.11.031			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29274412	Green Published, Bronze			2022-12-18	WOS:000429197800042
J	von Mutius, E				von Mutius, Erika			Biodiversity: The new kid on the block?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergens; asthma; environment; cohort study; microbiome	ENVIRONMENTAL INTERVENTION; EARLY-LIFE; ASTHMA; ALLERGY; CHILDREN; TRIAL; HOME		[von Mutius, Erika] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Asthma & Allergiepravent, Ingolstadter Landstr 1, Neuherberg, Germany; [von Mutius, Erika] Ludwig Maximilians Univ Munchen, Dr von Haunersches Kinderspital, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	von Mutius, E (corresponding author), Ludwig Maximilian Univ Muenchen, Dr von Hauner Childrens Hosp, Pneumol Allergol, Lindwurm Str 4, D-80337 Munich, Germany.	erika.von.mutius@med.lmu.de			European Commission; European Research Council; German Federal Ministry of Education and Research; German Research Foundation; HAL Allergie GmbH; Okosoziales Forum Oberosterreich; Mundipharma; American Thoracic Society; AbbVie Deutschland GmbH	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); HAL Allergie GmbH; Okosoziales Forum Oberosterreich; Mundipharma; American Thoracic Society; AbbVie Deutschland GmbH(AbbVie)	E. von Mutius has received grants from the European Commission, the European Research Council, the German Federal Ministry of Education and Research, and the German Research Foundation; has board memberships with the Massachusetts Medical Society and the American Academy of Allergy, Asthma & Immunology; has consultant arrangements with Novartis Pharma SAS, OM Pharma, Decision Resources, and Pharma Ventures; has provided expert testimony for the European Commission, the Chinese University of Hong Kong, the University of Copenhagen, and the University of Tampere; and has received payment for lectures from HAL Allergie GmbH, Okosoziales Forum Oberosterreich, Mundipharma, the American Thoracic Society, and AbbVie Deutschland GmbH.	Crain EF, 2002, ENVIRON HEALTH PERSP, V110, P939, DOI 10.1289/ehp.02110939; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Ege MJ, 2012, ALLERGY, V67, P1565, DOI 10.1111/all.12028; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Marks GB, 2006, J ALLERGY CLIN IMMUN, V118, P53, DOI 10.1016/j.jaci.2006.04.004; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; O'Connor GT, 2018, J ALLERGY CLIN IMMUN, V141, P1468, DOI 10.1016/j.jaci.2017.06.040; Woodcock A, 2004, AM J RESP CRIT CARE, V170, P433, DOI 10.1164/rccm.200401-083OC	10	7	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1215	1216		10.1016/j.jaci.2018.01.036	http://dx.doi.org/10.1016/j.jaci.2018.01.036			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29454002	Bronze			2022-12-18	WOS:000429197800006
J	Persson, C; Ueki, S				Persson, Carl; Ueki, Shigeharu			Lytic eosinophils produce extracellular DNA traps as well as free eosinophil granules	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Persson, Carl; Ueki, Shigeharu] Univ Hosp, Clin Pharmacol, Lab Med, Lund, Sweden	Lund University; Skane University Hospital	Persson, C (corresponding author), Univ Hosp, Clin Pharmacol, Lab Med, Lund, Sweden.	carl.persson@med.lu.se	Ueki, Shigeharu/I-3566-2019	Ueki, Shigeharu/0000-0002-3537-7735	MEXT/JSPS; Research Grant on Allergic Disease and Immunology from the Japan Agency for Medical Research and Development; Charitable Trust Laboratory Medicine Research Foundation of Japan; Novartis Pharma; Japan Allergy Foundation; Phyzer	MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Grant on Allergic Disease and Immunology from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Charitable Trust Laboratory Medicine Research Foundation of Japan; Novartis Pharma; Japan Allergy Foundation; Phyzer	S. Ueki receives grant support from MEXT/JSPS, Research Grant on Allergic Disease and Immunology from the Japan Agency for Medical Research and Development, the Charitable Trust Laboratory Medicine Research Foundation of Japan, Novartis Pharma, the Japan Allergy Foundation, and Phyzer, and serves as a consultant for Boehringer Ingelheim. C. Persson declares no relevant conflicts of interest.	Gevaert E, 2017, J ALLERGY CLIN IMMUN, V139, P1849, DOI 10.1016/j.jaci.2017.01.019; HARLIN SL, 1988, J ALLERGY CLIN IMMUN, V81, P867, DOI 10.1016/0091-6749(88)90944-X; Persson C, 2014, AM J RESP CRIT CARE, V189, P628, DOI 10.1164/rccm.201311-2069OE; Prince LR, 2013, PLOS ONE, V7; Ueki S, 2016, J ALLERGY CLIN IMMUN, V137, P258, DOI 10.1016/j.jaci.2015.04.041; Ueki S, 2013, BLOOD, V121, P2074, DOI 10.1182/blood-2012-05-432088; Uller L, 2004, AM J RESP CRIT CARE, V170, P742, DOI 10.1164/rccm.200402-240OC	7	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1164	1164		10.1016/j.jaci.2017.05.047	http://dx.doi.org/10.1016/j.jaci.2017.05.047			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	28780970	Bronze			2022-12-18	WOS:000426974800048
J	Casale, TB; Teng, MN; Morano, JP; Unnasch, T; Lockwood, CJ				Casale, Thomas B.; Teng, Michael N.; Morano, Jamie P.; Unnasch, Thomas; Lockwood, Charles J.			Zika virus: An emerging infectious disease with serious perinatal and neurologic complications	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Zika; dengue; chikungunya; emerging infectious diseases; Guillain-Barre syndrome; microcephaly; vaccine; flavivirus	MALE SEXUAL TRANSMISSION; CROSS-REACTIVITY; PROTECTIVE EFFICACY; DENGUE VIRUS; VACCINE; RNA; ENHANCEMENT; PROSPECTS; OUTBREAK; AMERICA	Zika virus (ZIKV) is a flavivirus that is primarily transmitted by Aedes aegypti, the mosquito vector also important in transmission of the flaviviruses responsible for dengue fever, yellow fever, and chikungunya. Because of occurrence in the same geographic regions, serologic cross-reactivity, and similar but often less severe clinical manifestations, such as dengue and chikungunya infections, ZIKV infection likely has gone undetected, misdiagnosed, or both for many years. ZIKV is somewhat unique among flaviviruses in its ability to also be transmitted through sexual contact, nonsexual body fluids, and perinatally. The relatively recent detection of the link between ZIKV infection and Guillain-Barre syndrome and fetal neurological defects, including microcephaly, has prompted intense efforts aimed at the development of new and specific diagnostic tests. Infection with ZIKV has been postulated to lead to a more severe clinical course from other structurally related viruses, especially dengue, and vice versa because of a phenomenon termed antibody-dependent enhancement. Inactivated whole virus, DNA, RNA, and vectored vaccine approaches to prevent ZIKV infection are in development, as are treatments for active disease that are safe in pregnant women. Here we summarize the important epidemiologic and clinical features of ZIKV infection, as well as the progress and challenges in developing rapid point-of-care diagnostic tests and vaccines to prevent disease. We used electronic databases to identify relevant published data regarding ZIKV MeSH searches.	[Casale, Thomas B.] Univ S Florida, Dept Internal Med, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA; [Casale, Thomas B.] Univ S Florida, Dept Pediat, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA; [Teng, Michael N.] Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA; [Morano, Jamie P.] Univ S Florida, Div Infect Dis & Int Med, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA; [Unnasch, Thomas] Univ S Florida, Dept Global Hlth, Coll Publ Hlth, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA; [Lockwood, Charles J.] Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Casale, TB (corresponding author), Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA.	tbcasale@health.usf.edu	amsalu, ribka/G-8780-2019		Florida Department of Health Zika Research Grants	Florida Department of Health Zika Research Grants	Supported by Florida Department of Health Zika Research Grants (to T.B.C., M.N.T., and C.J.L.).	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016; Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001; Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333; Andrade D. V., 2017, VIRUS RES; Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158; Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6; Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005; Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046; Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]; Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180; Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2; Bozzo J, 2017, EXPERT REV ANTI-INFE, V15, P585, DOI 10.1080/14787210.2017.1328278; Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2; Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009; CDC, TRIOPL REAL TIM RT P; CDC, 2016, ZIK CAS COUNTS; CDC, 2017, ZIK CAS COUNTS; CDC, GUID US LAB TEST ZIK; Centers for Disease Control and Prevention, 2016, ZIKV CAS COUNTS US; Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dempsey LA, 2017, NAT IMMUNOL, V18, P603, DOI 10.1038/ni.3762; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8; Flores MS, 2016, CLEV CLIN J MED, V83, P1, DOI 10.3949/ccjm.83a.16027; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102; Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036; Hastings AK, 2017, YALE J BIOL MED, V90, P325; Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004; Lindenbach BD, 2013, FIELDS VIROLOGY, P712; Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]; Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016; Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920; Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017; Sanabani SS, 2017, PLOS CURR, V9; Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375; Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018; U.S. Food and Drug Administration Emergency, EM US AUTH; Ulmer JB, 2012, VACCINE, V30, P4414, DOI 10.1016/j.vaccine.2012.04.060; Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899; Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148; Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]; Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004	73	7	7	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					482	490		10.1016/j.jaci.2017.11.029	http://dx.doi.org/10.1016/j.jaci.2017.11.029			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	29273403	Bronze			2022-12-18	WOS:000424410800003
J	Wang, ECE; Dai, ZP; Christiano, AM				Wang, Etienne C. E.; Dai, Zhenpeng; Christiano, Angela M.			Novel therapies for alopecia areata: The era of rational drug development	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Alopecia areata; personalized medicine; therapies	CLOBETASOL PROPIONATE 0.05-PERCENT; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; TRIAMCINOLONE ACETONIDE; TOPICAL LATANOPROST; PLAQUE PSORIASIS; HAIR REGROWTH; C3H/HEJ MICE; TOFACITINIB; UNIVERSALIS	Treatments for alopecia areata (AA) have evolved over the decades from broad and nonspecific therapies to those that are now more targeted and rationally selected. This was achieved by means of close cooperation and communication between clinicians and basic scientists, which resulted in the elucidation and understanding of the unique pathophysiology of AA. In this review we discuss this evolution and how novel therapies for AA have changed over the decades, what we have in our current arsenal of drugs for this potentially devastating disease, and what the future holds.	[Wang, Etienne C. E.; Dai, Zhenpeng; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Wang, Etienne C. E.] Natl Skin Ctr, Singapore, Singapore	Columbia University; National Skin Centre	Christiano, AM (corresponding author), 1150 St Nicholas Ave,Russ Berrie Pavil,Rm 303B, New York, NY 10032 USA.	amc65@cumc.columbia.edu	Lauschner, Flavia H/P-2457-2018		National Institutes of Health (NIH); Pfizer BMS	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer BMS(Pfizer)	E. C. E. Wang is employed by the National Skin Center, Singapore. A. M. Christiano's institution received grants from the National Institutes of Health (NIH), Pfizer BMS, and foundations for this work and from the NIH for other works; personally received honorarium for speaking invitations for this work, as well as travel to speaking events; has board membership with the National Alopecia Areata Foundation, the Dystrophic Epidermolysis Bullosa Research Association, and Douglass College; is employed by Columbia University; has given expert testimony to law firms; and has received payment from advisory boards. Z. Dai declares no relevant conflicts of interest.	Abaci HE, 2017, EXP BIOL MED, V242, P1657, DOI 10.1177/1535370217712690; Al-Mutairi N, 2009, PEDIATR DERMATOL, V26, P547, DOI 10.1111/j.1525-1470.2009.00980.x; Ali A, 2010, J DRUGS DERMATOL, V9, P62; Anzengruber F, 2016, CASE REP DERMATOL, V8, P102, DOI 10.1159/000445182; Beccastrini E, 2010, Dermatol Online J, V16, P15; Betz RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6966; Bianchi B, 2003, J EUR ACAD DERMATOL, V17, P408, DOI 10.1046/j.1468-3083.2003.00758.x; Charuwichitratana S, 2000, ARCH DERMATOL, V136, P1276, DOI 10.1001/archderm.136.10.1276; Craiglow BG, 2017, J AM ACAD DERMATOL, V76, P29, DOI 10.1016/j.jaad.2016.09.006; Craiglow BG, 2016, JAMA DERMATOL, V152, P490, DOI 10.1001/jamadermatol.2015.4445; Craiglow BG, 2014, J INVEST DERMATOL, V134, P2988, DOI 10.1038/jid.2014.260; Crispin MK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89776; Dastgheib L, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/784863; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; de Medeiros AKA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164080; Dhayalan A, 2016, JAMA DERMATOL, V152, P492, DOI 10.1001/jamadermatol.2015.3772; Erduran F, 2017, ACTA DERMATOVEN ALP, V26, P47, DOI 10.15570/actaapa.2017.15; Ettefagh L, 2004, ARCH DERMATOL, V140, P1012, DOI 10.1001/archderm.140.8.1012-a; Fattah NSAA, 2016, INT J DERMATOL, V55, P24, DOI 10.1111/ijd.12769; Ferreira SB, 2016, CASE REP DERMATOL, V8, P262, DOI 10.1159/000450848; Fischer J, 2017, EXP DERMATOL, V26, P536, DOI 10.1111/exd.13123; Freyschmidt-Paul P, 1999, J INVEST DERMATOL, V113, P61, DOI 10.1046/j.1523-1747.1999.00640.x; Ghafoor R, 2017, JCPSP-J COLL PHYSICI, V27, P200, DOI 2589; Ghoreishi M, 2010, BRIT J DERMATOL, V163, P57, DOI 10.1111/j.1365-2133.2010.09775.x; Goh C, 2006, J EUR ACAD DERMATOL, V20, P1055, DOI 10.1111/j.1468-3083.2006.01676.x; Gonul M, 2009, INDIAN J DERMATOL VE, V75, DOI 10.4103/0378-6323.55430; Gupta AK, 2016, J EUR ACAD DERMATOL, V30, P1373, DOI 10.1111/jdv.13598; Guttman-Yassky E, 2016, J ALLERGY CLIN IMMUN, V137, P301, DOI 10.1016/j.jaci.2015.11.001; Harel S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500973; Harris JE, 2016, J AM ACAD DERMATOL, V74, P370, DOI 10.1016/j.jaad.2015.09.073; Hernandez MV, 2009, CLIN EXP RHEUMATOL, V27, P892; Higgins E, 2015, J ALLERGY CLIN IMMUN, V135, P551, DOI 10.1016/j.jaci.2014.12.1867; Ibrahim O, 2017, JAMA DERMATOL, V153, P600, DOI 10.1001/jamadermatol.2017.0001; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; Jabbari A, 2016, EXP DERMATOL, V25, P642, DOI 10.1111/exd.13060; Jabbari A, 2016, EBIOMEDICINE, V7, P240, DOI 10.1016/j.ebiom.2016.03.036; Jabbari A, 2015, EBIOMEDICINE, V2, P351, DOI 10.1016/j.ebiom.2015.02.015; Johnstone MA, 1997, AM J OPHTHALMOL, V124, P544, DOI 10.1016/S0002-9394(14)70870-0; Joly P, 2006, J AM ACAD DERMATOL, V55, P632, DOI 10.1016/j.jaad.2005.09.010; Kassim JM, 2014, BRIT J DERMATOL, V170, P766, DOI 10.1111/bjd.12863; Kelton W, 2017, SCI REP-UK, V7, DOI 10.1038/srep45775; Keren A, 2015, J DERMATOL SCI, V77, P74, DOI 10.1016/j.jdermsci.2014.11.009; Kim BJ, 2008, J DERMATOL TREAT, V19, P216, DOI 10.1080/09546630701846095; King LE, 2014, J INVEST DERMATOL, V134, P264, DOI 10.1038/jid.2013.252; Li AW, 2016, PEDIATR DERMATOL, V33, pE282, DOI 10.1111/pde.12920; Liu LY, 2017, J AM ACAD DERMATOL, V76, P22, DOI 10.1016/j.jaad.2016.09.007; Loi C, 2016, J AM ACAD DERMATOL, V74, pE99, DOI 10.1016/j.jaad.2015.09.071; Mackay-Wiggan J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89790; Megiorni F, 2013, ARCH DERMATOL RES, V305, P665, DOI 10.1007/s00403-013-1348-3; Moftah NH, 2016, ARCH DERMATOL RES, V308, P415, DOI 10.1007/s00403-016-1652-9; Moreira FT, 2014, LIFE SCI, V98, P83, DOI 10.1016/j.lfs.2014.01.001; Mrowietz U, 2017, ACTA DERM-VENEREOL, V97, P283, DOI 10.2340/00015555-2491; NELSON DA, 1985, INT J DERMATOL, V24, P606, DOI 10.1111/j.1365-4362.1985.tb05863.x; Ochoa BE, 2009, J AM ACAD DERMATOL, V61, P530, DOI 10.1016/j.jaad.2009.01.027; Ohtsuki Akiko, 2013, Indian J Dermatol, V58, P326, DOI 10.4103/0019-5154.113954; OLSEN EA, 1992, ARCH DERMATOL, V128, P1467, DOI 10.1001/archderm.128.11.1467; PENDERS AJM, 1968, DERMATOLOGICA, V136, P395, DOI 10.1159/000254125; Petukhova Lynn, 2013, J Investig Dermatol Symp Proc, V16, pS16, DOI 10.1038/jidsymp.2013.5; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Pieri L, 2015, AM J HEMATOL, V90, P82, DOI 10.1002/ajh.23871; Poole RM, 2014, DRUGS, V74, P825, DOI 10.1007/s40265-014-0218-4; PORTER D, 1971, BRIT J DERMATOL, V85, P272, DOI 10.1111/j.1365-2133.1971.tb07230.x; Price VH, 2008, J AM ACAD DERMATOL, V58, P395, DOI 10.1016/j.jaad.2007.10.645; Robins Douglas N, 2007, J Drugs Dermatol, V6, P946; Roseborough I, 2009, J AM ACAD DERMATOL, V60, P705, DOI 10.1016/j.jaad.2008.08.029; Sasaki S, 2005, EXP DERMATOL, V14, P323, DOI 10.1111/j.0906-6705.2005.00270.x; Scheinberg M, 2016, ANN INTERN MED, V165, P750, DOI 10.7326/L16-0125; SCHMOECKEL C, 1979, ARCH DERMATOL, V115, P1254, DOI 10.1001/archderm.115.10.1254; Shapiro J, 1997, J AM ACAD DERMATOL, V36, P114, DOI 10.1016/S0190-9622(97)70342-6; Strober BE, 2005, J AM ACAD DERMATOL, V52, P1082, DOI 10.1016/j.jaad.2005.03.039; Strober BE, 2009, ARCH DERMATOL, V145, P1262, DOI 10.1001/archdermatol.2009.264; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V136, P1277, DOI 10.1016/j.jaci.2015.06.032; Taylor PC, 2017, EXPERT OPIN INV DRUG, V26, P1181, DOI 10.1080/13543784.2017.1372422; Thompson JM, 2017, AM J CLIN DERMATOL; Tosti A, 2003, J AM ACAD DERMATOL, V49, P96, DOI 10.1067/mjd.2003.423; Tosti A, 2006, J EUR ACAD DERMATOL, V20, P1243, DOI 10.1111/j.1468-3083.2006.01781.x; Vandiver A, 2017, INT J DERMATOL, V56, P833, DOI 10.1111/ijd.13598; VANSCOTT EJ, 1958, J INVEST DERMATOL, V31, P35, DOI 10.1038/jid.1958.73; Wikramanayake TC, 2012, LASER MED SCI, V27, P431, DOI 10.1007/s10103-011-0953-7; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Zaher H, 2015, DERMATOLOGY, V230, P308, DOI 10.1159/000371416; Zoller M, 2004, J AUTOIMMUN, V23, P241, DOI 10.1016/j.jaut.2004.08.002	82	7	7	0	21	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					499	504		10.1016/j.jaci.2017.10.028	http://dx.doi.org/10.1016/j.jaci.2017.10.028			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	29155099	Bronze			2022-12-18	WOS:000424410800005
J	Khanolkar, A; Kirschmann, DA; Caparelli, EA; Wilks, JD; Cerullo, JM; Bergerson, JRE; Jennings, LJ; Fuleihan, RL				Khanolkar, Aaruni; Kirschmann, Dawn A.; Caparelli, Edward A.; Wilks, Jeffrey D.; Cerullo, Jillian M.; Bergerson, Jenna R. E.; Jennings, Lawrence J.; Fuleihan, Ramsay L.			CD4 T cell-restricted IL-2 signaling defect in a patient with a novel IFNGR1 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HEALTHY-CHILDREN; SUBSETS; MYCOBACTERIAL		[Khanolkar, Aaruni; Kirschmann, Dawn A.; Caparelli, Edward A.; Wilks, Jeffrey D.; Cerullo, Jillian M.; Jennings, Lawrence J.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pathol, Chicago, IL 60611 USA; [Khanolkar, Aaruni; Jennings, Lawrence J.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Bergerson, Jenna R. E.; Fuleihan, Ramsay L.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Allergy & Immunol, Chicago, IL 60611 USA; [Khanolkar, Aaruni; Bergerson, Jenna R. E.; Fuleihan, Ramsay L.] Ann & Robert H Lurie Childrens Hosp Chicago, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago	Khanolkar, A (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pathol, Chicago, IL 60611 USA.; Khanolkar, A (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	Akhanolkar@luriechildrens.org			Ann and Robert H. Lurie Children's Hospital of Chicago; Jeffrey Modell Foundation	Ann and Robert H. Lurie Children's Hospital of Chicago; Jeffrey Modell Foundation	Supported by the Ann and Robert H. Lurie Children's Hospital of Chicago and the Jeffrey Modell Foundation.	[Anonymous], 2016, ACTIMMUNE INTERFERON; Bogaert DJA, 2017, HAEMATOLOGICA, V102, P192, DOI 10.3324/haematol.2016.149112; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Conti F, 2016, J ALLERGY CLIN IMMUN, V138, P241, DOI 10.1016/j.jaci.2015.11.041; Coppieters F, 2014, GENET MED, V16, P671, DOI 10.1038/gim.2014.24; Doffinger R, 2002, MOL IMMUNOL, V38, P903, DOI 10.1016/S0161-5890(02)00017-2; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Ganapathi KA, 2015, BLOOD, V125, P56, DOI 10.1182/blood-2014-06-580340; Gao L, 2015, J ALLERGY CLIN IMMUN, V136, P1591, DOI 10.1016/j.jaci.2015.06.047; Goldman FD, 2012, PEDIATR BLOOD CANCER, V58, P591, DOI 10.1002/pbc.23160; Hoshino A, 2017, J ALLERGY CLIN IMMUN, V140, P223, DOI 10.1016/j.jaci.2016.09.029; Kreins AY, 2015, J EXP MED, V212, P1641, DOI 10.1084/jem.20140280; Kuehn HS, 2016, NEW ENGL J MED, V374, P1032, DOI 10.1056/NEJMoa1512234; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306	20	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					435	+		10.1016/j.jaci.2017.08.018	http://dx.doi.org/10.1016/j.jaci.2017.08.018			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	28927822	Bronze			2022-12-18	WOS:000419312200057
J	Pichler, WJ; Yerly, D				Pichler, Werner J.; Yerly, Daniel			Drug hypersensitivity: We need to do more	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Human; T cells; drug hypersensitivity	P-I		[Pichler, Werner J.] ADR AC GmbH, Holligenstr 91, CH-3008 Bern, Switzerland; [Yerly, Daniel] Univ Bern, Inselspital, Clin Rheumatol Immunol & Allergol, Bern, Switzerland	University of Bern; University Hospital of Bern	Pichler, WJ (corresponding author), ADR AC GmbH, Holligenstr 91, CH-3008 Bern, Switzerland.	werner.pichler@adr-ac.ch		Yerly, Daniel/0000-0003-2857-0737				Adkinson NF, 2002, J ALLERGY CLIN IMMUN, V109, pS461, DOI 10.1067/mai.2002.122214; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Pichler WJ, 2016, INT ARCH ALLERGY IMM, V171, P166, DOI 10.1159/000453265; Pichler WJ, 2015, INT ARCH ALLERGY IMM, V168, P13, DOI 10.1159/000441280; Sullivan A, 2018, J ALLERGY CLIN IMMUN, V141, P235, DOI 10.1016/j.jaci.2017.01.020; Wheatley LM, 2015, J ALLERGY CLIN IMMUN, V136, P262, DOI 10.1016/j.jaci.2015.05.027; Whitaker P, 2011, J IMMUNOL, V187, P200, DOI 10.4049/jimmunol.1100647; Wuillemin N, 2013, J IMMUNOL, V190, P4956, DOI 10.4049/jimmunol.1202949	10	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					89	91		10.1016/j.jaci.2017.11.002	http://dx.doi.org/10.1016/j.jaci.2017.11.002			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	29155149				2022-12-18	WOS:000419312200013
J	Rajput, S; Sharma, V; Hughes, SM; Ewing, CI; Arkwright, PD				Rajput, Shelly; Sharma, Vibha; Hughes, Stephen M.; Ewing, Carol I.; Arkwright, Peter D.			Allergy testing in predicting outcome of open food challenge to peanut	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ARA H 2; IGE; CHILDREN		[Rajput, Shelly; Hughes, Stephen M.; Arkwright, Peter D.] Univ Manchester, Manchester, Lancs, England; [Sharma, Vibha; Hughes, Stephen M.; Ewing, Carol I.; Arkwright, Peter D.] Royal Manchester Childrens Hosp, Dept Paediat Allergy & Immunol, Manchester, Lancs, England	University of Manchester; Royal Manchester Children's Hospital	Arkwright, PD (corresponding author), Univ Manchester, Manchester, Lancs, England.; Arkwright, PD (corresponding author), Royal Manchester Childrens Hosp, Dept Paediat Allergy & Immunol, Manchester, Lancs, England.	peter.arkwright@nhs.net			University of Manchester	University of Manchester	This study was funded by the University of Manchester.	Keet CA, 2013, J ALLER CL IMM-PRACT, V1, P101, DOI 10.1016/j.jaip.2012.08.007; Klemans RJB, 2015, CLIN EXP ALLERGY, V45, P720, DOI 10.1111/cea.12412; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Kukkonen AK, 2015, ALLERGY, V70, P1239, DOI 10.1111/all.12671; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; van Erp FC, 2017, J ALLERGY CLIN IMMUN, V139, P358, DOI 10.1016/j.jaci.2016.06.041	6	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					457	458		10.1016/j.jaci.2017.05.001	http://dx.doi.org/10.1016/j.jaci.2017.05.001			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	28624349	Bronze			2022-12-18	WOS:000419312200064
J	Thostesen, LM; Stensballe, LG; Pihl, GT; Kjaergaard, J; Birk, NM; Nissen, TN; Jensen, AKG; Aaby, P; Olesen, AW; Jeppesen, DL; Benn, CS; Kofoed, PE				Thostesen, Lisbeth Marianne; Stensballe, Lone Graff; Pihl, Gitte Thybo; Kjaergaard, Jesper; Birk, Nina Marie; Nissen, Thomas Norrelykke; Jensen, Aksel Karl Georg; Aaby, Peter; Olesen, Annette Wind; Jeppesen, Dorthe Lisbeth; Benn, Christine Stabell; Kofoed, Poul-Erik			Neonatal BCG vaccination has no effect on recurrent wheeze in the first year of life: A randomized clinical trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						BCG; vaccination; infant; recurrent wheeze; heterologous immunity; nonspecific effects	CALMETTE-GUERIN VACCINATION; MULTICENTER TRIAL; CHILDHOOD ASTHMA; CHILDREN; BIRTH; PREVALENCE; SURVIVAL	Background: Recurrent wheeze (RW) is frequent in childhood. Studies have suggested that BCG vaccination can have nonspecific effects, reducing general nontuberculosis morbidity, including respiratory tract infections and atopic diseases. The mechanisms behind these nonspecific effects of BCG are not fully understood, but a shift from a T(H)2 to a T(H)1 response has been suggested as a possible explanation. Objective: We hypothesized that BCG at birth would reduce the cumulative incidence of RW during the first year of life. Methods: The Danish Calmette Study is a multicenter randomized trial conducted from 2012-2015 at 3 Danish hospitals. The 4262 newborns of 4184 included mothers were randomized 1: 1 to BCG (SSI strain 1331) or to a no-intervention control group within 7 days of birth; siblings were randomized together as one randomization unit. Exclusion criteria were gestational age of less than 32 weeks, birth weight of less than 1000 g, known immunodeficiency, or no Danish-speaking parent. Information was collected through telephone interviews and clinical examinations at 3 and 13 months of age; data collectors were blind to randomization group. RW was defined in several ways, with the main definition being physician-diagnosed and medically treated RW up to 13 months of age. Results: By 13 months, 211 (10.0%) of 2100 children in the BCG group and 195 (9.4%) of 2071 children in the control group had received a diagnosis of RW from a medical doctor and received antiasthma treatment (relative risk, 1.07; 95% CI, 0.89-1.28). Supplementary analyses were made, including an analysis of baseline risk factors for development of RW. Conclusion: Neonatal BCG had no effect on the development of RW before 13 months of age.	[Thostesen, Lisbeth Marianne; Pihl, Gitte Thybo; Kofoed, Poul-Erik] Kolding Cty Hosp, Dept Pediat, Skovvangen 2-8, DK-6000 Kolding, Denmark; [Thostesen, Lisbeth Marianne; Pihl, Gitte Thybo; Kofoed, Poul-Erik] Univ Southern Denmark, Inst Reg Hlth Res, Kolding, Denmark; [Stensballe, Lone Graff] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Centret, Dept Paediat & Adolescent Med, Copenhagen, Denmark; [Kjaergaard, Jesper] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Centret, Dept Paediat & Adolescent Med,Res Unit Womens & C, Copenhagen, Denmark; [Birk, Nina Marie; Nissen, Thomas Norrelykke; Jeppesen, Dorthe Lisbeth] Copenhagen Univ Hosp, Dept Pediat, Hvidovre, Denmark; [Jensen, Aksel Karl Georg] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, Copenhagen, Denmark; [Jensen, Aksel Karl Georg] Univ Copenhagen, Sect Biostat, Copenhagen, Denmark; [Aaby, Peter] Statens Serum Inst, Bandim Hlth Project, Copenhagen, Denmark; [Olesen, Annette Wind] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Benn, Christine Stabell] Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Copenhagen, Denmark; [Benn, Christine Stabell] Univ Southern Denmark, OPEN, Inst Clin Res, Odense Univ Hosp, Odense, Denmark	Kolding Hospital; University of Southern Denmark; University of Southern Denmark; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Statens Serum Institut; University of Southern Denmark; Odense University Hospital; Statens Serum Institut; University of Southern Denmark; Odense University Hospital	Thostesen, LM (corresponding author), Kolding Cty Hosp, Dept Pediat, Skovvangen 2-8, DK-6000 Kolding, Denmark.; Thostesen, LM (corresponding author), Univ Southern Denmark, Inst Reg Hlth Res, Kolding, Denmark.	lmje@dadlnet.dk	Stensballe, Lone Graff/AAS-4137-2020	Stensballe, Lone Graff/0000-0003-1569-153X; Olesen, Annette Wind/0000-0002-0586-4815; Nissen, Thomas Norrelykke/0000-0001-8565-9629; Pihl, Gitte/0000-0002-2227-5860; Thostesen, Lisbeth Marianne/0000-0003-3231-1260; Aaby, Peter/0000-0001-8331-1389	Danish National Research Foundation [DNRF 108]; involved hospital (Danish National Hospital in Copenhagen); involved hospital (Hvidovre Hospital); involved hospital (Kolding Hospital)	Danish National Research Foundation(Danmarks Grundforskningsfond); involved hospital (Danish National Hospital in Copenhagen); involved hospital (Hvidovre Hospital); involved hospital (Kolding Hospital)	Supported by the Danish National Research Foundation (DNRF 108) and the 3 involved hospitals (Danish National Hospital in Copenhagen, Hvidovre Hospital, and Kolding Hospital). The BCG vaccine was produced by Statens Serum Institute, Copenhagen, Denmark, and bought by the Danish Calmette Study.	Aaby P, 2000, CLIN EXP ALLERGY, V30, P644, DOI 10.1046/j.1365-2222.2000.00803.x; Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Aaby P, 2014, CLIN INFECT DIS, V59, P484, DOI 10.1093/cid/ciu354; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Arnoldussen DL, 2011, J ALLERGY CLIN IMMUN, V127, P246, DOI 10.1016/j.jaci.2010.07.039; Arnoldussen DL, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Chan EY, 2005, PEDIATR PULM, V39, P558, DOI 10.1002/ppul.20227; Kilpelainen M, 2001, ALLERGY, V56, P377, DOI 10.1034/j.1398-9995.2001.056005377.x; Kjaergaard J, 2016, PEDIATR RES, V80, P681, DOI 10.1038/pr.2016.142; Linehan MF, 2007, J ALLERGY CLIN IMMUN, V119, P1079, DOI 10.1016/j.jaci.2006.12.672; Linehan MF, 2014, J ALLERGY CLIN IMMUN, V133, P688, DOI 10.1016/j.jaci.2013.08.007; Linneberg A, 2006, J ALLERGY CLIN IMMUN, V117, P184, DOI 10.1016/j.jaci.2005.09.042; Marchant A, 1999, J IMMUNOL, V163, P2249; Nissen TN, 2016, VACCINE, V34, P2477, DOI 10.1016/j.vaccine.2016.03.100; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rieckmann A, 2017, INT J EPIDEMIOL, V46, P695, DOI 10.1093/ije/dyw120; Roth A, 2006, EXPERT REV VACCINES, V5, P277, DOI 10.1586/14760584.5.2.277; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Steenhuis TJ, 2008, CLIN EXP ALLERGY, V38, P79, DOI 10.1111/j.1365-2222.2007.02859.x; Stensballe LG, 2017, ARCH DIS CHILD, V102, P224, DOI 10.1136/archdischild-2016-310760; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Thostesen LM, 2015, CONTEMP CLIN TRIALS, V42, P213, DOI 10.1016/j.cct.2015.04.006	26	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1616	+		10.1016/j.jaci.2016.12.990	http://dx.doi.org/10.1016/j.jaci.2016.12.990			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28347733	Green Published, hybrid			2022-12-18	WOS:000417206000016
J	Wen, T; Kuhl, J; Putnam, P; Mukkada, V; Farrell, M; Kaul, A; Cole, C; Rothenberg, ME				Wen, Ting; Kuhl, Jonathan; Putnam, Philip; Mukkada, Vincent; Farrell, Michael; Kaul, Ajay; Cole, Conrad; Rothenberg, Marc E.			A flow cytometry-based diagnosis of eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONSENSUS RECOMMENDATIONS; ADULTS; CHILDREN		[Wen, Ting; Kuhl, Jonathan; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45220 USA; [Putnam, Philip; Mukkada, Vincent; Farrell, Michael; Kaul, Ajay; Cole, Conrad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Putnam, Philip; Mukkada, Vincent; Farrell, Michael; Kaul, Ajay; Cole, Conrad; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45220 USA.; Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45220 USA.	Rothenberg@cchmc.org	Mukkada, Vincent/AAF-6995-2019	Mukkada, Vincent/0000-0003-4225-5506; Kaul, Ajay/0000-0002-9706-9113; Cole, Conrad/0000-0001-8478-6343	National Institutes of Health [R37 A1045898, R01 AI083450, P30 DK078392, R01 DK076893, U19 AI070235]; Campaign Urging Research for Eosinophilic Disease (CURED) Foundation; Sunshine Foundation; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083450, R37AI045898, U19AI070235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893, P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campaign Urging Research for Eosinophilic Disease (CURED) Foundation; Sunshine Foundation; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health grants R37 A1045898, R01 AI083450, P30 DK078392, R01 DK076893, and U19 AI070235; the Campaign Urging Research for Eosinophilic Disease (CURED) Foundation; the Sunshine Foundation and its supporter Denise & Dave Bunning; and the Buckeye Foundation.	Abonia JP, 2010, J ALLERGY CLIN IMMUN, V126, P140, DOI 10.1016/j.jaci.2010.04.009; Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Costamagna Guido, 2010, Gastroenterol Hepatol (N Y), V6, P391; Dellon ES, 2011, AM J GASTROENTEROL, V106, P264, DOI 10.1038/ajg.2010.412; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Gonsalves N, 2006, GASTROINTEST ENDOSC, V64, P313, DOI 10.1016/j.gie.2006.04.037; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Ramsay David B, 2010, Gastroenterol Hepatol (N Y), V6, P772; Stucke EM, 2015, J PEDIATR GASTR NUTR, V61, P65, DOI 10.1097/MPG.0000000000000740	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1736	+		10.1016/j.jaci.2017.07.022	http://dx.doi.org/10.1016/j.jaci.2017.07.022			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28826772	Green Accepted, Bronze			2022-12-18	WOS:000417206000039
J	Chand, HS; Mebratu, YA; Kuehl, PJ; Tesfaigzi, Y				Chand, Hitendra S.; Mebratu, Yohannes A.; Kuehl, Philip J.; Tesfaigzi, Yohannes			Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AIRWAY EPITHELIAL-CELLS; GROWTH-FACTOR-I; IFN-GAMMA; EXPRESSION; METAPLASIA; APOPTOSIS; INHIBITOR; POTENT; DEATH; RATS		[Chand, Hitendra S.; Mebratu, Yohannes A.; Tesfaigzi, Yohannes] Lovelace Resp Res Inst, COPD Program, Albuquerque, NM 87108 USA; [Kuehl, Philip J.] Lovelace Resp Res Inst, Chem & Inhalat Exposure Program, Albuquerque, NM USA; [Chand, Hitendra S.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA	Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; State University System of Florida; Florida International University	Tesfaigzi, Y (corresponding author), Lovelace Resp Res Inst, COPD Program, Albuquerque, NM 87108 USA.	ytesfaig@LRRI.org	Chand, Hitendra/AAE-7975-2020	Chand, Hitendra/0000-0002-0574-9307; Mebratu, Yohannes/0000-0002-5360-2158; Kuehl, Philip/0000-0002-7567-3002; Tesfaigzi, Yohannes/0000-0002-3997-5839	National Institutes of Health [HL068111, ES015482, AI115291, AI117560]; American Lung Association [RG306208]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068111, R56HL068111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115291, R21AI117560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health grants to Y.T. (HL068111 and ES015482), Y.A.M. (AI115291), and H.S.C. (AI117560) and by the American Lung Association to H.S.C. (RG306208).	Alexander DJ, 2008, INHAL TOXICOL, V20, P1179, DOI [10.1080/08958370802207318, 10.1080/08958370802207318 ]; Chand HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6567; Chand HS, 2012, AM J RESP CELL MOL, V47, P784, DOI 10.1165/rcmb.2012-0079OC; Chand HS, 2012, J IMMUNOL, V188, P4581, DOI 10.4049/jimmunol.1102673; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Harris JF, 2005, AM J RESP CRIT CARE, V171, P764, DOI 10.1164/rccm.200408-1108OC; Kuehl PJ, 2012, INHAL TOXICOL, V24, P27, DOI 10.3109/08958378.2011.632787; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Mebratu YA, 2011, AM J RESP CRIT CARE, V183, P1531, DOI 10.1164/rccm.201011-1930OC; Schwalm K, 2008, AM J PHYSIOL-LUNG C, V294, pL1102, DOI 10.1152/ajplung.00424.2007; Shi ZOQ, 2002, J IMMUNOL, V168, P4764; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tesfaigzi Y, 2006, AM J RESP CELL MOL, V34, P537, DOI 10.1165/rcmb.2006-0014OC; Tesfaigzi Y, 2004, AM J PHYSIOL-LUNG C, V286, pL268, DOI 10.1152/ajplung.00172.2003; Tesfaigzi Y, 2002, J IMMUNOL, V169, P5919, DOI 10.4049/jimmunol.169.10.5919; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831	18	7	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1456	+		10.1016/j.jaci.2017.05.038	http://dx.doi.org/10.1016/j.jaci.2017.05.038			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28784260	Bronze, Green Accepted			2022-12-18	WOS:000414304300032
J	Nowak-Wegrzyn, A; Spergel, JM				Nowak-Wegrzyn, Anna; Spergel, Jonathan M.			Food protein-induced enterocolitis syndrome: Not so rare after all	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food protein-induced enterocolitis syndrome; prevalence; incidence; epidemiology; food allergy; milk allergy	ALLERGY; POPULATION; INSIGHTS; LIFE		[Nowak-Wegrzyn, Anna] Kravis Childrens Hosp, Jaffe Food Allergy Inst, Dept Pediat, Div Allergy & Immunol,Icahn Sch Med Mt Sinai, New York, NY USA; [Spergel, Jonathan M.] Univ Penn, Childrens Hosp Philadelphia, Div Allergy & Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Childrens Hospital of Philadelphia	Nowak-Wegrzyn, A (corresponding author), Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, One Gustave Levy Pl,Box 1198, New York, NY 10029 USA.	anna.nowak-wegrzyn@mssm.edu		Nowak-Wegrzyn, Anna/0000-0002-0960-9854; Spergel, Jonathan/0000-0002-4658-5353	Immune Tolerance Network/National Institute of Allergy and Infectious Disease and DBV Technology; National Institutes of Health; DBV	Immune Tolerance Network/National Institute of Allergy and Infectious Disease and DBV Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DBV	A. Nowak-Wegrzyn serves on the board for Gerber Advisory Council and Merck, provides expert testimony for Giannone R. Bolton PLC, receives grant support from the Immune Tolerance Network/National Institute of Allergy and Infectious Disease and DBV Technology, receives payment for lectures from Nestle and Nutricia, and receives royalties from UpToDate. J. M. Spergel serves on the board for FARE, iFPIES, and the National Eczema Association; serves as a consultant DBV Technology; receives grant support from the National Institutes of Health and DBV; receives payments for lectures from Nutricia; receives royalties from UpToDate; receives payment for educational presentations from Medscape; and holds stock with DBV Technologies.	Caubet JC, 2014, J ALLERGY CLIN IMMUN, V134, P382, DOI 10.1016/j.jaci.2014.04.008; Greenhawt M, 2016, J ALLERGY CLIN IMMUN, V137, P1251, DOI 10.1016/j.jaci.2015.09.056; Heine RG, 2015, BEST PRACT RES CL GA, V29, P731, DOI 10.1016/j.bpg.2015.09.004; Katz Y, 2011, J ALLERGY CLIN IMMUN, V127, P647, DOI 10.1016/j.jaci.2010.12.1105; Mehr S, 2017, J ALLERGY CLIN IMMUN, V140, P1323, DOI 10.1016/j.jaci.2017.03.027; Nowak-Wegrzyn A, 2017, J ALLERGY CLIN IMMUN, V139, P1111, DOI 10.1016/j.jaci.2016.12.966; Nowak-Wegrzyn A, 2015, J ALLERGY CLIN IMMUN, V135, P1114, DOI 10.1016/j.jaci.2015.03.025; Ponsonby AL, 2009, INFLAMM BOWEL DIS, V15, P858, DOI 10.1002/ibd.20842; Ruffner MA, 2013, J ALLER CL IMM-PRACT, V1, P343, DOI 10.1016/j.jaip.2013.05.011; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013	10	7	7	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1275	1276		10.1016/j.jaci.2017.07.020	http://dx.doi.org/10.1016/j.jaci.2017.07.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28797735	Bronze			2022-12-18	WOS:000414304300007
J	Banoth, B; Cassel, SL				Banoth, Balaji; Cassel, Suzanne L.			Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Nucleotide-binding leucine-rich repeat receptor family pyrin domain containing protein 3; Bruton tyrosine kinase; ibrutinib			[Banoth, Balaji; Cassel, Suzanne L.] Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Cassel, SL (corresponding author), Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA.	suzanne.cassel@cshs.org	Cassel, Suzanne/AAI-3947-2021; Banoth, Balaji/ABF-7350-2020	Cassel, Suzanne/0000-0003-2492-1923; Banoth, Balaji/0000-0002-7467-2198	American Lung Association/American Academy of Allergy, Asthma & Immunology foundation grant; National Institutes of Health grant [AI104706]	American Lung Association/American Academy of Allergy, Asthma & Immunology foundation grant; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by an American Lung Association/American Academy of Allergy, Asthma & Immunology foundation grant and National Institutes of Health grant AI104706 (to S.L.C.).	Brunner C, 2005, HISTOL HISTOPATHOL, V20, P945, DOI 10.14670/HH-20.945; de Jesus AA, 2015, ANNU REV IMMUNOL, V33, P823, DOI 10.1146/annurev-immunol-032414-112227; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Hernandez-Trujillo VP, 2014, J CLIN IMMUNOL, V34, P627, DOI 10.1007/s10875-014-0056-x; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Varma G, 2016, CLIN ADV HEMATOL ONC, V14, P543	10	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					985	987		10.1016/j.jaci.2017.03.041	http://dx.doi.org/10.1016/j.jaci.2017.03.041			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28456622				2022-12-18	WOS:000412172900009
J	Carlson, RJ; Bond, MR; Hutchins, S; Brown, Y; Wolfe, LA; Lam, C; Nelson, C; DiMaggio, T; Jones, N; Rosenzweig, SD; Stone, KD; Freeman, AF; Holland, SM; Hanover, JA; Milner, JD; Lyons, JJ				Carlson, Ryan J.; Bond, Michelle R.; Hutchins, Shermaine; Brown, Yishai; Wolfe, Lynne A.; Lam, Christina; Nelson, Celeste; DiMaggio, Thomas; Jones, Nina; Rosenzweig, Sergio D.; Stone, Kelly D.; Freeman, Alexandra F.; Holland, Steven M.; Hanover, John A.; Milner, Joshua D.; Lyons, Jonathan J.			Detection of phosphoglucomutase-3 deficiency by lectin-based flow cytometry	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GLYCOSYLATION; MUTATIONS; AUTOIMMUNITY		[Carlson, Ryan J.; Hutchins, Shermaine; Brown, Yishai; Nelson, Celeste; DiMaggio, Thomas; Stone, Kelly D.; Milner, Joshua D.; Lyons, Jonathan J.] NIAID, Lab Allerg Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bond, Michelle R.; Hanover, John A.] NIDDK, Lab Cell & Mol Biol, Bethesda, MD 20892 USA; [Wolfe, Lynne A.; Lam, Christina] NIH, Natl Human Genome Res Inst, Bldg 10, Bethesda, MD 20892 USA; [Lam, Christina] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Lam, Christina] Seattle Childrens Hosp, Dept Pediat, Div Med Genet, Seattle, WA USA; [Jones, Nina] Leidos Biomed Res Inc, Clin Res Directorate CMRP, NCI Campus Frederick, Frederick, MD USA; [Rosenzweig, Sergio D.] NIAID, Serv Immunol, Dept Lab Med, Clin Ctr & Primary Immunodeficiency Clin,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Freeman, Alexandra F.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lyons, JJ (corresponding author), NIAID, Lab Allerg Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jonathan.lyons@nih.gov		Carlson, Ryan/0000-0001-8311-481X	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; Intramural Research Program of the National Institute of Allergy and Infectious Diseases; Intramural Research Program of National Institute for Diabetes and Digestive and Kidney Diseases; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001192, ZIAAI001122, ZIAAI001183, ZIAAI001098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060101, ZIADK060103] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of National Institute for Diabetes and Digestive and Kidney Diseases; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	This research was supported by the Intramural Research Programs of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research, of the National Institute of Allergy and Infectious Diseases, and of the National Institute for Diabetes and Digestive and Kidney Diseases. This project has been funded in whole or in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Ben-Ali M, 2016, J CLIN IMMUNOL, V36, P235; Bernth-Jensen JM, 2016, J ALLERGY CLIN IMMUN, V137, P321, DOI 10.1016/j.jaci.2015.07.047; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Greig KT, 2007, MOL CELL BIOL, V27, P5849, DOI 10.1128/MCB.00802-07; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	9	7	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					291	+		10.1016/j.jaci.2016.12.951	http://dx.doi.org/10.1016/j.jaci.2016.12.951			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28063873	Bronze, Green Accepted			2022-12-18	WOS:000404542000036
J	Hosokawa, J; Suzuki, K; Meguro, K; Tanaka, S; Maezawa, Y; Suto, A; Fujimura, L; Sakamoto, A; Clevers, H; Ohara, O; Nakajima, H				Hosokawa, Junichi; Suzuki, Kotaro; Meguro, Kazuyuki; Tanaka, Shigeru; Maezawa, Yuko; Suto, Akira; Fujimura, Lisa; Sakamoto, Akemi; Clevers, Hans; Ohara, Osamu; Nakajima, Hiroshi			I kappa BNS enhances follicular helper T-cell differentiation and function downstream of ASCI2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ROLES		[Hosokawa, Junichi; Suzuki, Kotaro; Meguro, Kazuyuki; Tanaka, Shigeru; Maezawa, Yuko; Suto, Akira; Nakajima, Hiroshi] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan; [Fujimura, Lisa; Sakamoto, Akemi] Chiba Univ, Grad Sch Med, Biomed Res Ctr, Chiba, Japan; [Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Technol Dev, Chiba, Japan	Chiba University; Chiba University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Kazusa DNA Research Institute	Suzuki, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan.	suzuki_k@faculty.chiba-u.jp; nakajimh@faculty.chiba-u.jp	Ohara, Osamu/G-5448-2015; Nakajima, Hiroshi/AFU-9313-2022	Ohara, Osamu/0000-0002-3328-9571; Nakajima, Hiroshi/0000-0001-8595-9381; Tanaka, Shigeru/0000-0002-8466-110X; Suto, Akira/0000-0002-2593-565X	Ministry of Education, Culture, Sports, Science and Technology; Japanese Government; LGS (Leading Graduate School) Program, MEXT, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government; LGS (Leading Graduate School) Program, MEXT, Japan	Supported in part by Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; the Japanese Government; and the LGS (Leading Graduate School) Program, MEXT, Japan.	Arnold CN, 2012, P NATL ACAD SCI USA, V109, P12286, DOI 10.1073/pnas.1209134109; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Touma M, 2011, J IMMUNOL, V187, P3942, DOI 10.4049/jimmunol.1002109; Weinstein JS, 2014, BLOOD, V124, P3719, DOI 10.1182/blood-2014-06-582700	8	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					288	+		10.1016/j.jaci.2016.10.047	http://dx.doi.org/10.1016/j.jaci.2016.10.047			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28040417	Bronze			2022-12-18	WOS:000404542000035
J	Ciprandi, G				Ciprandi, Giorgio			Serum IgE as biomarker for predicting allergen immunotherapy effectiveness	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Ciprandi, Giorgio] IRCCS Azienda Osped Univ San Martino IST, Dept Med, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST	Ciprandi, G (corresponding author), IRCCS Azienda Osped Univ San Martino IST, Dept Med, Genoa, Italy.	gio.cip@libero.it	Ciprandi, Giorgio/G-7462-2012	Ciprandi, Giorgio/0000-0001-7016-8421				Akdis CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7390; Ciprandi G, 2014, J INVEST ALLERG CLIN, V24, P35; Ciprandi G, 2014, ALLERGOL IMMUNOPATH, V42, P369, DOI 10.1016/j.aller.2012.12.004; Di Lorenzo G, 2009, ALLERG CLIN IMMUNOL, V123, P1103; Fujimura T, 2011, CLIN IMMUNOL, V139, P65, DOI 10.1016/j.clim.2010.12.022; Galli SJ, 2016, J ALLERGY CLIN IMMUN, V137, P1289, DOI 10.1016/j.jaci.2016.03.006; Tosca M, 2014, IMMUNOTHERAPY-UK, V6, P29, DOI 10.2217/imt.13.145	7	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					2029	2029		10.1016/j.jaci.2016.12.987	http://dx.doi.org/10.1016/j.jaci.2016.12.987			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	28410740				2022-12-18	WOS:000402724600047
J	Drucker, AM; Li, WQ; Park, MK; Li, T; Qureshi, AA; Cho, E				Drucker, Aaron M.; Li, Wen-Qing; Park, Min Kyung; Li, Tricia; Qureshi, Abrar A.; Cho, Eunyoung			Niacin intake and incident adult-onset atopic dermatitis in women	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FOOD FREQUENCY QUESTIONNAIRE; REPRODUCIBILITY; VALIDITY; ECZEMA		[Drucker, Aaron M.; Li, Wen-Qing; Park, Min Kyung; Qureshi, Abrar A.; Cho, Eunyoung] Rhode Isl Hosp, Warren Alpert Med Sch, Dept Dermatol, Providence, RI USA; [Drucker, Aaron M.; Qureshi, Abrar A.] Rhode Isl Hosp, Dept Dermatol, Providence, RI USA; [Li, Wen-Qing; Qureshi, Abrar A.; Cho, Eunyoung] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Li, Tricia; Qureshi, Abrar A.; Cho, Eunyoung] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Li, Tricia; Qureshi, Abrar A.; Cho, Eunyoung] Harvard Med Sch, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Cho, E (corresponding author), Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA.; Cho, E (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Cho, E (corresponding author), Harvard Med Sch, Boston, MA USA.	eunyoung_cho@brown.edu	Cho, Eunyoung/AAV-4469-2020	Cho, Eunyoung/0000-0001-6594-2582; Li, Wen-Qing/0000-0002-8336-5552	Department of Dermatology, Warren Alpert Medical School of Brown University; National Institutes of Health Nurses' Health Study II grant [UM1 CA176726]; NATIONAL CANCER INSTITUTE [UM1CA176726] Funding Source: NIH RePORTER	Department of Dermatology, Warren Alpert Medical School of Brown University; National Institutes of Health Nurses' Health Study II grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Department of Dermatology, Warren Alpert Medical School of Brown University, and National Institutes of Health Nurses' Health Study II grant (grant no. UM1 CA176726). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Chen AC, 2016, BRIT J DERMATOL, V175, P1363, DOI 10.1111/bjd.14648; El-Heis S, 2016, CLIN EXP ALLERGY, V46, P1337, DOI 10.1111/cea.12782; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Hanifin IM, 2007, DERMATITIS, V18, P82, DOI 10.2310/6620.2007.06034; Holm EA, 2007, BRIT J DERMATOL, V157, P674, DOI 10.1111/j.1365-2133.2007.08101.x; HORWITT MK, 1981, AM J CLIN NUTR, V34, P423, DOI 10.1093/ajcn/34.3.423; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI [DOI 10.1093/OXFORDJOURNALS.AJE.A116211, DOI 10.1093/OXFORDJOUMALS.AJE.A116211]; Silverberg JI, 2015, BRIT J DERMATOL, V173, P1400, DOI 10.1111/bjd.14031	9	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					2020	+		10.1016/j.jaci.2016.12.956	http://dx.doi.org/10.1016/j.jaci.2016.12.956			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	28111310	Green Accepted, Bronze			2022-12-18	WOS:000402724600044
J	Kalhan, TA; Loo, EXL; Kalhan, AC; Kramer, MS; Karunakaran, B; Lam, CU; Van Bever, H; Shek, LPC; Goh, A; Chong, YS; Lee, BW; Gluckman, P; Kwek, K; Saw, SM; Godfrey, K; Hsu, CY				Kalhan, Tosha Ashish; Loo, Evelyn Xiu Ling; Kalhan, Ashish Chetan; Kramer, Michael S.; Karunakaran, Bindu; Lam, Carolina Un; Van Bever, Hugo; Shek, Lynette Pei-Chi; Goh, Anne; Chong, Yap Seng; Lee, Bee Wah; Gluckman, Peter; Kwek, Kenneth; Saw, Seang Mei; Godfrey, Keith; Hsu, Chin-Ying			Atopic dermatitis and early childhood caries: Results of the GUSTO study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Kalhan, Tosha Ashish; Kalhan, Ashish Chetan; Karunakaran, Bindu; Lam, Carolina Un; Hsu, Chin-Ying] Natl Univ Singapore, Fac Dent, Discipline Oral Sci, Singapore, Singapore; [Loo, Evelyn Xiu Ling; Shek, Lynette Pei-Chi] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Kramer, Michael S.] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Kramer, Michael S.] Montreal Childrens Hosp, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Van Bever, Hugo; Shek, Lynette Pei-Chi] Khoo Teck Puat Natl Univ, Childrens Med Inst, Natl Univ Hosp, Singapore, Singapore; [Van Bever, Hugo; Shek, Lynette Pei-Chi; Lee, Bee Wah] Natl Univ Singapore, Dept Paediat, Singapore, Singapore; [Goh, Anne] KK Womens & Childrens Hosp, Dept Paediat, Allergy Serv, Singapore, Singapore; [Chong, Yap Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Lee, Bee Wah] Mt Elizabeth Med Ctr, Singapore, Singapore; [Gluckman, Peter] ASTAR, Singapore Inst Clin Sci, Growth Dev & Metab Programme, Singapore, Singapore; [Gluckman, Peter] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Godfrey, Keith] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Godfrey, Keith] MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); McGill University; McGill University; McGill University; National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; Mount Elizabeth Medical Centre; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Auckland; KK Women's & Children's Hospital; National University of Singapore; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Kalhan, TA (corresponding author), Natl Univ Singapore, Fac Dent, Discipline Oral Sci, Singapore, Singapore.	denhsus@nus.edu.sg	Kalhan, Ashish/AAV-3418-2021	Shek, Lynette/0000-0001-9064-8983; Loo, Evelyn Xiu Ling/0000-0001-7690-3191; Godfrey, Keith/0000-0002-4643-0618; Chong, Yap Seng/0000-0002-7232-8473	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore [NMRC/TCR/004-NUS/2008, NMRC/TCR/012-NUHS/2014]; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; Singapore's NMRC [NMRC/CIRG/1341/2012: R-221-000-059-511, NMRC/CSA/022/2010];  [NRF370062-HUJ-NUS]; Medical Research Council [MC_UU_12011/4] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10042] Funding Source: researchfish; MRC [MC_UU_12011/4] Funding Source: UKRI	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; Singapore's NMRC; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore (grant no. NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014). Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore. This study was also funded by Singapore's NMRC (grant nos. NMRC/CIRG/1341/2012: R-221-000-059-511 and NMRC/CSA/022/2010) and NRF370062-HUJ-NUS.	[Anonymous], 2000, J Calif Dent Assoc, V28, P685; Bertelsen RJ, 2014, J ALLERGY CLIN IMMUN, V133, P165, DOI 10.1016/j.jaci.2013.07.032; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Duverger O, 2014, J CLIN INVEST, V124, P5219, DOI 10.1172/JCI78272; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Vieira AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124236	9	7	8	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					2000	+		10.1016/j.jaci.2016.10.038	http://dx.doi.org/10.1016/j.jaci.2016.10.038			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	28122670				2022-12-18	WOS:000402724600036
J	Mose, AP; Mortz, CG; Eller, E; Sprogoe, U; Barington, T; Bindslev-Jensen, C				Mose, Anja P.; Mortz, Charlotte G.; Eller, Esben; Sprogoe, Ulrik; Barington, Torben; Bindslev-Jensen, Carsten			Dose-time-response relationship in peanut allergy using a human model of passive cutaneous anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ABSORPTION		[Mose, Anja P.; Mortz, Charlotte G.; Eller, Esben; Bindslev-Jensen, Carsten] Odense Univ Hosp, Odense Res Ctr Anaphylaxis ORCA, Odense, Denmark; [Mose, Anja P.; Mortz, Charlotte G.; Eller, Esben; Bindslev-Jensen, Carsten] Odense Univ Hosp, Dept Dermatol & Allergy Ctr, Odense, Denmark; [Sprogoe, Ulrik; Barington, Torben] Odense Univ Hosp, Dept Clin Immunol, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Bindslev-Jensen, C (corresponding author), Odense Univ Hosp, Odense Res Ctr Anaphylaxis ORCA, Odense, Denmark.; Bindslev-Jensen, C (corresponding author), Odense Univ Hosp, Dept Dermatol & Allergy Ctr, Odense, Denmark.	carsten.bindslev-jensen@rsyd.dk	Bindslev-Jensen, Carsten/H-1877-2011; Barington, Torben/C-3922-2009; Barington, Torben/R-6841-2019	Bindslev-Jensen, Carsten/0000-0002-8940-038X; Barington, Torben/0000-0001-6968-148X; Mortz, Charlotte G/0000-0001-8710-0829	Novartis; Sandoz A/S; Odense University Hospital Research Foundation; Hal Allergy; Thermofisher	Novartis(Novartis); Sandoz A/S; Odense University Hospital Research Foundation; Hal Allergy(HAL Allergy Group); Thermofisher	C. G. Mortz has served on a board for Novartis and has received payment for lectures from Novartis and Sandoz A/S. C. Bindslev-Jensen has received a grant from Odense University Hospital Research Foundation, has consultant arrangements with Hal Allergy and Anergis, and has received payment for lectures from Hal Allergy and Thermofisher. The rest of the authors declare that they have no relevant conflicts of interest.	AOKI T, 1989, ACTA DERM-VENEREOL, P100; Blumchen K, 2014, J ALLERGY CLIN IMMUN, V134, P390, DOI 10.1016/j.jaci.2014.03.035; Brunner M, 1928, ARCH INTERN MED, V42, P172, DOI 10.1001/archinte.1928.00130200024002; Prausnitz C., 1921, CENT BAKTERIO, V86, P160; Reitsma M, 2014, MOL NUTR FOOD RES, V58, P194, DOI 10.1002/mnfr.201300204; Yokooji T, 2013, BIOCHEM BIOPH RES CO, V438, P61, DOI 10.1016/j.bbrc.2013.07.024	6	7	7	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					2015	+		10.1016/j.jaci.2016.11.034	http://dx.doi.org/10.1016/j.jaci.2016.11.034			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	28189335	Bronze			2022-12-18	WOS:000402724600042
J	Blankestijn, MA; van de Donk, NWCJ; Sasser, K; Knulst, AC; Otten, HG				Blankestijn, Mark A.; van de Donk, Niels W. C. J.; Sasser, Kate; Knulst, Andre C.; Otten, Henny G.			Could daratumumab be used to treat severe allergy?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MULTIPLE-MYELOMA; LENALIDOMIDE; RESPONSES; IGE		[Blankestijn, Mark A.; Knulst, Andre C.] Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands; [van de Donk, Niels W. C. J.] Vrije Univ Amsterdam, Dept Hematol, Med Ctr, Amsterdam, Netherlands; [Sasser, Kate] Janssen Res & Dev, Spring House, PA USA; [Otten, Henny G.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Johnson & Johnson; Janssen Pharmaceuticals; Utrecht University; Utrecht University Medical Center	Blankestijn, MA (corresponding author), Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands.	m.a.blankestijn@umcutrecht.nl		Blankestijn, Mark/0000-0003-4163-0685; Knulst, Andre/0000-0002-1056-3179; van de Donk, Niels/0000-0002-7445-2603	ThermoFisher Scientific; Celgene; Janssen; Amgen; BMS	ThermoFisher Scientific; Celgene(Bristol-Myers SquibbCelgene Corporation); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amgen(Amgen); BMS(Bristol-Myers Squibb)	M. A. Blankestijn's institution has received payment for lectures from ThermoFisher Scientific. N. W. C. J. van de Donk's institution has received grants from Celgene, Janssen, Amgen, and BMS for other works; has personally received payment for lectures from Celgene, Janssen, Amgen, and BMS. K. Sasser is employed by Janssen PRD. The rest of the authors declare that they have no relevant conflicts of interest.	Baena-Cagnani CE, 2014, CURR OPIN ALLERGY CL, V14, P149, DOI 10.1097/ACI.0000000000000044; Dasgupta A, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-39; Lapalombella R, 2010, BLOOD, V115, P2619, DOI 10.1182/blood-2009-09-242438; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Plesner T, 2016, BLOOD, V128, P1821, DOI 10.1182/blood-2016-07-726729; Rosenberg AS, 2016, CLIN IMMUNOL, V165, P55, DOI 10.1016/j.clim.2016.02.009; Strati P, 2013, BLOOD, V122, P734, DOI 10.1182/blood-2013-04-495341; Wegmann M, 2012, INT ARCH ALLERGY IMM, V158, P43, DOI 10.1159/000330103; WU CY, 1991, J CLIN INVEST, V87, P870, DOI 10.1172/JCI115092	9	7	13	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1677	+		10.1016/j.jaci.2016.12.955	http://dx.doi.org/10.1016/j.jaci.2016.12.955			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28109726	Bronze			2022-12-18	WOS:000400465300028
J	Gardulf, A; Winiarski, J; Thorin, M; Arnlind, MH; von Dobeln, U; Hammarstrom, L				Gardulf, Ann; Winiarski, Jacek; Thorin, Moa; Arnlind, Marianne Heibert; von Dobeln, Ulrika; Hammarstrom, Lennart			Costs associated with treatment of severe combined immunodeficiency-rationale for newborn screening in Sweden	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Gardulf, Ann; Thorin, Moa; Hammarstrom, Lennart] Karolinska Inst, Dept Lab Med, Div Clin Immunol & Transfus Med, Huddinge, Sweden; [Gardulf, Ann; Thorin, Moa; Hammarstrom, Lennart] Karolinska Inst, Dept Lab Med, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, Huddinge, Sweden; [Winiarski, Jacek] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Huddinge, Sweden; [Winiarski, Jacek] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Div Paediat, Huddinge, Sweden; [Arnlind, Marianne Heibert] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [von Dobeln, Ulrika] Karolinska Inst, Karolinska Univ Hosp, Dept Med Biochem & Biophys, Div Mol Metab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Gardulf, A (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Immunol & Transfus Med, Huddinge, Sweden.; Gardulf, A (corresponding author), Karolinska Inst, Dept Lab Med, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, Huddinge, Sweden.	ann.gardulf@ki.se			Jeffrey Modell Foundation, New York; Swedish Research Council, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden	Jeffrey Modell Foundation, New York; Swedish Research Council, Stockholm, Sweden(Swedish Research Council); Karolinska Institutet, Stockholm, Sweden	The study was funded by the Jeffrey Modell Foundation, New York; the Swedish Research Council, Stockholm, Sweden; and research funds from Karolinska Institutet, Stockholm, Sweden.	[Anonymous], 2013, WHITE PAPER NEED NEW; Borte S, 2013, CURR OPIN HEMATOL, V20, P48, DOI 10.1097/MOH.0b013e32835a9130; Chan A, 2011, CLIN IMMUNOL, V138, P3, DOI 10.1016/j.clim.2010.09.010; Clement MC, 2015, J ALLERGY CLIN IMMUN, V135, P1589, DOI 10.1016/j.jaci.2015.02.004; Gaspar HB, 2014, J CLIN IMMUNOL, V34, P393, DOI 10.1007/s10875-014-0029-0; Kubiak C, 2014, J ALLER CL IMM-PRACT, V2, P697, DOI 10.1016/j.jaip.2014.05.013; Puck JM, 2007, J ALLERGY CLIN IMMUN, V120, P760, DOI 10.1016/j.jaci.2007.08.043; The Cochrane and Campbell Economic Methods Group, CCEMG EPPI CTR COST	8	7	7	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1713	+		10.1016/j.jaci.2016.10.043	http://dx.doi.org/10.1016/j.jaci.2016.10.043			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28012934	Bronze			2022-12-18	WOS:000400465300042
J	Jorgensen, SF; Macpherson, ME; Bjoro, K; Karlsen, TH; Reims, HM; Grzyb, K; Fosby, B; Fevang, B; Aukrust, P; Nordoy, I				Jorgensen, Silje F.; Macpherson, Magnhild E.; Bjoro, Kristian; Karlsen, Tom H.; Reims, Henrik M.; Grzyb, Krzysztof; Fosby, Bjarte; Fevang, Borre; Aukrust, Pal; Nordoy, Ingvild			Liver transplantation in patients with primary antibody deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMMON VARIABLE IMMUNODEFICIENCY; NODULAR REGENERATIVE HYPERPLASIA; HEPATITIS-C		[Jorgensen, Silje F.; Macpherson, Magnhild E.; Fevang, Borre; Aukrust, Pal; Nordoy, Ingvild] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Jorgensen, Silje F.; Macpherson, Magnhild E.; Bjoro, Kristian; Karlsen, Tom H.; Fevang, Borre; Aukrust, Pal; Nordoy, Ingvild] Univ Oslo, Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Bjoro, Kristian; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Sect Transplantat Med, Oslo, Norway; [Reims, Henrik M.; Grzyb, Krzysztof] Oslo Univ Hosp, Rikshosp, Dept Pathol, Oslo, Norway; [Fosby, Bjarte] Oslo Univ Hosp, Rikshosp, Sect Transplantat Surg, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Jorgensen, SF (corresponding author), Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway.; Jorgensen, SF (corresponding author), Univ Oslo, Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway.	s.f.jorgensen@medisin.uio.no		Reims, Henrik/0000-0002-2018-7787				Chen Y, 2013, TRANSPL INFECT DIS, V15, P540, DOI 10.1111/tid.12093; Fosby B, 2015, SCAND J GASTROENTERO, V50, P797, DOI 10.3109/00365521.2015.1036359; Gow PJ, 2002, TRANSPL INT, V15, P380, DOI 10.1111/j.1432-2277.2002.tb00183.x; Hadzic N, 2000, NEW ENGL J MED, V342, P320, DOI 10.1056/NEJM200002033420504; Montalti R, 2014, ANN TRANSPL, V19, P541, DOI 10.12659/AOT.890952; Murakawa Y, 2012, PEDIATR TRANSPLANT, V16, pE210, DOI 10.1111/j.1399-3046.2011.01545.x; Park YW, 2006, LUPUS, V15, P686, DOI 10.1177/0961203306070976; Razvi S, 2001, CLIN IMMUNOL, V101, P284, DOI 10.1006/clim.2001.5132; Rodrigues F, 2004, J PEDIATR-US, V145, P333, DOI 10.1016/j.jpeds.2004.05.037; SMITH MSH, 1995, GASTROENTEROLOGY, V108, P879, DOI 10.1016/0016-5085(95)90464-6; Ward C, 2008, CLIN EXP IMMUNOL, V153, P331, DOI 10.1111/j.1365-2249.2008.03711.x	11	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1708	+		10.1016/j.jaci.2016.10.025	http://dx.doi.org/10.1016/j.jaci.2016.10.025			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	27931972	Bronze			2022-12-18	WOS:000400465300040
J	Almejun, MB; Campos, BC; Patino, V; Galicchio, M; Zelazko, M; Oleastro, M; Oppezzo, P; Danielian, S				Belen Almejun, Maria; Carolina Campos, Barbara; Patino, Virginia; Galicchio, Miguel; Zelazko, Marta; Oleastro, Matias; Oppezzo, Pablo; Danielian, Silvia			Noninfectious complications in patients with pediatric-onset common variable immunodeficiency correlated with defects in somatic hypermutation but not in class-switch recombination	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Common variable immunodeficiency; somatic hypermutation; class-switch recombination; hypermutation; pediatric; switch	INDUCED CYTIDINE DEAMINASE; CENTER B-CELLS; AUTOSOMAL RECESSIVE FORM; HYPER-IGM; NONHOMOLOGOUS END; DNA-REPAIR; IMMUNOGLOBULIN; DEFICIENCY; EXPRESSION; AID	Background: Common variable immunodeficiency (CVID) is a heterogeneous syndrome characterized by impaired immunoglobulin production and usually presents with a normal quantity of peripheral B cells. Most attempts aiming to classify these patients havemainly been focused on T-or B-cell phenotypes and their ability to produce protective antibodies, but it is still a major challenge to find a suitable classification that includes the clinical and immunologic heterogeneity of these patients. Objective: In this study we evaluated the late stages of B-cell differentiation in a heterogeneous population of patients with pediatric-onset CVID to clinically correlate and assess their ability to perform somatic hypermutation (SHM), class-switch recombination (CSR), or both. Methods: We performed a previously reported assay, the restriction enzyme hotspot mutation assay (IgkREHMA), to evaluate in vivo SHM status. We amplified switch regions from genomic DNA to investigate the quality of the double-strand break repairs in the class-switch recombination process in vivo. We also tested the ability to generate immunoglobulin germline and circle transcripts and to upregulate the activation-induced cytidine deaminase gene through in vitro T-dependent and T-independent stimuli. Results: Our results showed that patients could be classified into 2 groups according to their degree of SHM alteration. This stratification showed a significant association between patients of group A, severe alteration, and the presence of noninfectious complications. Additionally, 60% of patients presented with increased microhomology use at switched regions. In vitro activation revealed that patients with CVID behaved heterogeneously in terms of responsiveness toT-dependent stimuli. Conclusions: The correlation between noninfectious complications and SHM could be an important tool for physicians to further characterize patients with CVID. This categorization would help to improve elucidation of the complex mechanisms involved in B-cell differentiation pathways.	[Belen Almejun, Maria; Zelazko, Marta; Oleastro, Matias; Danielian, Silvia] Hosp Nacl Pediat Prof Dr Juan P Garrahan, Serv Immunol & Reumatol, RA-1245 Buenos Aires, DF, Argentina; [Carolina Campos, Barbara] Hosp Nacl Pediat Prof Dr Juan P Garrahan, Coordinac Lab, Buenos Aires, DF, Argentina; [Patino, Virginia; Oppezzo, Pablo] Inst Pasteur, Unidad Prot Recombinantes, Montevideo, Uruguay; [Galicchio, Miguel] Hosp Ninos Victor J Vilela, Rosario, Santa Fe, Argentina	Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Almejun, MB (corresponding author), Hosp Nacl Pediat Prof Dr Juan P Garrahan, Serv Immunol & Reumatol, RA-1245 Buenos Aires, DF, Argentina.	mbalmejun@gmail.com		Almejun, Maria Belen/0000-0003-3138-736X; Oppezzo, Pablo/0000-0003-4194-246X	Agencia Nacional de Promocion Cientifica y Tecnologica (PICT) [21235]	Agencia Nacional de Promocion Cientifica y Tecnologica (PICT)(ANPCyT)	Supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT2004 No 21235).	Abolhassani H, 2013, IRAN J PEDIATR, V23, P451; Almejun MB, 2012, J CLIN IMMUNOL, V32, P89, DOI 10.1007/s10875-011-9613-8; Andersen P, 2005, BLOOD, V105, P511, DOI 10.1182/blood-2003-12-4359; Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; de Miranda NFCC, 2011, ANN NY ACAD SCI, V1246, P50, DOI 10.1111/j.1749-6632.2011.06322.x; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; Durandy Anne, 2007, Adv Immunol, V94, P275, DOI 10.1016/S0065-2776(06)94009-7; Durandy A, 2006, HUM MUTAT, V27, P1185, DOI 10.1002/humu.20414; Durandy A, 2009, PHILOS T R SOC B, V364, P577, DOI 10.1098/rstb.2008.0210; Duvvuri B, 2011, IMMUNOGENETICS, V63, P1, DOI 10.1007/s00251-010-0483-7; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; Foster SJ, 1999, EUR J IMMUNOL, V29, P3122, DOI 10.1002/(SICI)1521-4141(199910)29:10<3122::AID-IMMU3122>3.3.CO;2-F; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Imai K, 2003, J CLIN INVEST, V112, P136, DOI 10.1172/JCI200318161; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Kotnis A, 2009, PHILOS T R SOC B, V364, P653, DOI 10.1098/rstb.2008.0196; Kracker S, 2010, CLIN IMMUNOL, V135, P193, DOI 10.1016/j.clim.2010.01.012; Kracker S, 2010, ADV EXP MED BIOL, V685, P166; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mellemkjaer L, 2002, CLIN EXP IMMUNOL, V130, P495, DOI 10.1046/j.1365-2249.2002.02004.x; Montamat-Sicotte Damien, 2013, Current Immunology Reviews, V9, P72; Neuberger MS, 2000, PHILOS T ROY SOC B, V355, P357, DOI 10.1098/rstb.2000.0573; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Offer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012260; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; Pan-Hammarstrom Q, 2006, J EXP MED, V203, P99, DOI 10.1084/jem.20050595; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Pan-Hammarstrom Q, 2003, J IMMUNOL, V170, P3707, DOI 10.4049/jimmunol.170.7.3707; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Peron S, 2007, J EXP MED, V204, P1207, DOI 10.1084/jem.20070087; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Sale JE, 2001, PHILOS T R SOC B, V356, P21, DOI 10.1098/rstb.2000.0744; Schrader CE, 2007, J IMMUNOL, V179, P6064, DOI 10.4049/jimmunol.179.9.6064; Sekine H, 2007, P NATL ACAD SCI USA, V104, P7193, DOI 10.1073/pnas.0700815104; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; van Zelm MC, 2014, J ALLERGY CLIN IMMUN, V134, P135, DOI 10.1016/j.jaci.2013.11.015; Wang J, 2005, J AUTOIMMUN, V25, P57, DOI 10.1016/j.jaut.2005.04.006; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Wehr C, 2008, BLOOD, V112, P446, DOI 10.1182/blood-2008-05-149997; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Werner M, 2010, IMMUNOL REV, V237, P55, DOI 10.1111/j.1600-065X.2010.00934.x; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884	60	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					913	922		10.1016/j.jaci.2016.08.030	http://dx.doi.org/10.1016/j.jaci.2016.08.030			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27713077	Bronze			2022-12-18	WOS:000397295800024
J	Kendzerska, T; To, TM; Aaron, SD; Lougheed, MD; Sadatsafavi, M; FitzGerald, JM; Gershon, AS				Kendzerska, Tetyana; To, Teresa M.; Aaron, Shawn D.; Lougheed, M. Diane; Sadatsafavi, Mohsen; FitzGerald, J. Mark; Gershon, Andrea S.		Canadian Resp Res Network	The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						COPD; asthma; mortality; hospitalization	COPD OVERLAP SYNDROME; HEALTH ADMINISTRATIVE DATABASES; PROPORTIONAL HAZARDS MODEL; PROPENSITY SCORE; INCREASED RISK; BETA-AGONISTS; COHORT; MORTALITY; ADULTS; HOSPITALIZATION	Background: Little is known about the natural history of chronic obstructive pulmonary disease (COPD) that has developed from airway remodeling due to asthma, as compared with other COPD phenotypes. Objective: We compared long-term health outcomes of individuals with COPD with and without a history of asthma in a population-based cohort study. Methods: All individuals with physician-diagnosed COPD between the ages 40 and 55 years from 2009 and 2011 were identified and followed until March 2013 through provincial health administrative data (Ontario, Canada). The exposure was a history of asthma at least 2 years before the diagnosis of COPD to ensure it preceded COPD. The hazards of COPD-, respiratory-, and cardiovascular (CV)-related hospitalizations and all-cause mortality were compared between groups using a Cox regression model controlling for demographic characteristics, comorbidities, and level of health care. Results: Among 9053 patients with COPD, 2717 (30%) had a history of asthma. Over a median of 2.9 years, 712 (8%) individuals had a first COPD hospitalization, 964 (11%) a first respiratory related and 342 (4%) a first CV-related hospitalization, and 556 (6%) died. Controlling for confounding, a history of asthma was significantly associated with COPD and respiratory- related hospitalizations (hazard ratio, 1.53 [95% CI, 1.29-1.82] and hazard ratio, 1.63 [95% CI, 1.14-1.88], respectively), but not with CV-related hospitalizations or all-cause mortality. Additional analyses confirmed that these findings were not likely a result of unmeasured confounding or misclassification. Conclusions: Middle-aged individuals with physician-diagnosed COPD and a history of asthma had a higher hazard of hospitalizations due to COPD and other respiratory diseases than did those without.	[Kendzerska, Tetyana; To, Teresa M.; Lougheed, M. Diane; Gershon, Andrea S.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kendzerska, Tetyana; Gershon, Andrea S.] Sunnybrook Res Inst, Toronto, ON, Canada; [Kendzerska, Tetyana; To, Teresa M.; Gershon, Andrea S.] Univ Toronto, Toronto, ON, Canada; [Kendzerska, Tetyana; Gershon, Andrea S.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [To, Teresa M.; Gershon, Andrea S.] Hosp Sick Children, Toronto, ON, Canada; [Aaron, Shawn D.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Lougheed, M. Diane] Queens Univ, Kingston, ON, Canada; [Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Vancouver, BC, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; University of British Columbia	Kendzerska, T (corresponding author), Univ Toronto, Inst Clin Evaluat Sci, Fac Med, G1 06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	tetyana.kendzerska@mail.utoronto.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Kendzerska, Tetyana/I-7274-2019	Sadatsafayi, Mohsen/0000-0002-0419-7862; Kendzerska, Tetyana/0000-0002-5301-1796; Aaron, Shawn/0000-0002-4762-3542	Canadian Respiratory Research Network (CRRN); Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health; Canadian Lung Association/Canadian Thoracic Society; British Columbia Lung Association; Boehringer-Ingelheim Canada Ltd.; AstraZeneca Canada Inc.; Novartis Canada Ltd.; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Respiratory Research Network (CRRN); Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association/Canadian Thoracic Society; British Columbia Lung Association; Boehringer-Ingelheim Canada Ltd.(Boehringer Ingelheim); AstraZeneca Canada Inc.(AstraZeneca); Novartis Canada Ltd.; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by the Canadian Respiratory Research Network (CRRN). The CRRN is supported by grants from the Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health; Canadian Lung Association/Canadian Thoracic Society; British Columbia Lung Association; and Industry Partners Boehringer-Ingelheim Canada Ltd, AstraZeneca Canada Inc, and Novartis Canada Ltd. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions, and statements expressed herein are those of the author, and not necessarily those of CIHI.	Alshabanat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136065; Andersen H, 2013, CLIN RESPIR J, V7, P342, DOI 10.1111/crj.12013; [Anonymous], 2015, CANADIAN COMMUNITY H; Austin PC, 2014, STAT METH MED RES; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Bailey L., 2005, INTRO EPIDEMIOLOGY; BECKLAKE MR, 1990, RESPIRATION, V57, P137; CAMILLI AE, 1991, AM J EPIDEMIOL, V133, P795, DOI 10.1093/oxfordjournals.aje.a115958; Chen WJ, 2015, LANCET RESP MED, V3, P631, DOI 10.1016/S2213-2600(15)00241-6; Chung WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000755; Colak Y, 2015, AM J RESP CRIT CARE, V192, P172, DOI 10.1164/rccm.201502-0302OC; Cosio BG, 2016, CHEST, V149, P45, DOI 10.1378/chest.15-1055; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Eisner MD, 2001, PUBLIC HEALTH REP, V116, P148, DOI 10.1016/S0033-3549(04)50006-7; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fu JJ, 2014, RESPIRATION, V87, P63, DOI 10.1159/000352053; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2014, JAMA-J AM MED ASSOC, V312, P1114, DOI 10.1001/jama.2014.11432; Gershon AS, 2010, ARCH INTERN MED, V170, P560, DOI 10.1001/archinternmed.2010.17; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Gibson PG, 2014, EUR RESPIR J, V44, P277, DOI 10.1183/09031936.00091214; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403; Hospers JJ, 2000, LANCET, V356, P1313, DOI 10.1016/S0140-6736(00)02815-4; Institute for Clinical Evaluative Sciences, 2015, DAT DICT; Joffe MM, 2004, AM STAT, V58, P272, DOI 10.1198/000313004X5824; Kendzerska T, 2015, AM J RESP CRIT CARE, V191, pA6166; Kim MA, 2015, INT J TUBERC LUNG D, V19, P864, DOI 10.5588/ijtld.14.0327; Lange P, 2016, LANCET RESP MED, V4, P454, DOI 10.1016/S2213-2600(16)00098-9; Laratta CR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/528789; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Perret JL, 2013, AM J RESP CRIT CARE, V187, P42, DOI 10.1164/rccm.201205-0788OC; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Rennard SI, 2015, ANN AM THORAC SOC, V12, P303, DOI 10.1513/AnnalsATS.201403-125OC; Ridgeway G, 2015, TOOLKIT WEIGHTING AN; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; Tomlinson G, 2010, JAMA-J AM MED ASSOC, V303, P267, DOI 10.1001/jama.2009.2017; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006	51	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					835	843		10.1016/j.jaci.2016.06.026	http://dx.doi.org/10.1016/j.jaci.2016.06.026			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27641119	Bronze			2022-12-18	WOS:000397295800016
J	Patel, SV; Tarver, SA; Alvarez, KS; Lutek, KE; Schlebus, J; Khan, DA				Patel, Sheenal V.; Tarver, Scott A.; Alvarez, Kristin S.; Lutek, Kristin E.; Schlebus, James; Khan, David A.			Effectiveness of Interventions to Maintain Penicillin Allergy Label Removal As Part of an Inpatient Penicillin Allergy Testing Protocol	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Patel, Sheenal V.; Alvarez, Kristin S.; Khan, David A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Tarver, Scott A.; Alvarez, Kristin S.; Lutek, Kristin E.; Schlebus, James] Parkland Hlth & Hosp Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas									0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		582	AB183	AB183		10.1016/j.jaci.2016.12.597	http://dx.doi.org/10.1016/j.jaci.2016.12.597			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF		Bronze			2022-12-18	WOS:000401699800483
J	Baribeau, V; Beauchesne, MF; Rey, E; Forget, A; Blais, L				Baribeau, Veronique; Beauchesne, Marie-France; Rey, Evelyne; Forget, Amelie; Blais, Lucie			The use of asthma controller medications during pregnancy and the risk of gestational diabetes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONGENITAL-MALFORMATIONS; PERINATAL OUTCOMES; 1ST TRIMESTER; WOMEN; DATABASE; EXACERBATIONS; COMPLICATIONS; QUEBEC		[Baribeau, Veronique; Beauchesne, Marie-France; Blais, Lucie] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Beauchesne, Marie-France] Ctr Hosp Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Rey, Evelyne; Forget, Amelie] Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Blais, Lucie] Hop Sacre Coeur Montreal, Montreal, PQ, Canada	Universite de Montreal; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Blais, L (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.; Blais, L (corresponding author), Hop Sacre Coeur Montreal, Montreal, PQ, Canada.	lucie.blais@umontreal.ca			Canadian Institutes of Health Research [126153] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alexander S, 1998, OBSTET GYNECOL, V92, P435, DOI 10.1016/S0029-7844(98)00191-4; Blais L, 2006, PHARMACOEPIDEM DR S, V15, P245, DOI 10.1002/pds.1202; Blais L, 2008, J ALLERGY CLIN IMMUN, V121, P1379, DOI 10.1016/j.jaci.2008.02.038; Blais L, 2015, BIRTH DEFECTS RES A, V103, P995, DOI 10.1002/bdra.23366; Blais L, 2015, THORAX, V70, P647, DOI 10.1136/thoraxjnl-2014-206634; Blais L, 2009, J ALLERGY CLIN IMMUN, V124, P1229, DOI 10.1016/j.jaci.2009.09.025; Cossette B, 2013, THORAX, V68, P724, DOI 10.1136/thoraxjnl-2012-203122; Eltonsy S, 2015, J ALLERGY CLIN IMMUN, V135, P123, DOI 10.1016/j.jaci.2014.07.051; Eltonsy S, 2011, BIRTH DEFECTS RES A, V91, P937, DOI 10.1002/bdra.22850; Firoozi F, 2007, THORAX, V62, P581, DOI 10.1136/thx.2006.061572; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC; Thompson D, 2013, CAN J DIABETES, V37, pS168, DOI 10.1016/j.jcjd.2013.01.044; Wang G, 2014, J MATERN-FETAL NEO M, V27, P934, DOI 10.3109/14767058.2013.847080	15	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1732	+		10.1016/j.jaci.2016.06.031	http://dx.doi.org/10.1016/j.jaci.2016.06.031			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27569749	Bronze			2022-12-18	WOS:000390019300037
J	Millon, L; Rognon, B; Valot, B; Barrera, C; Bellanger, AP; Roussel, S; Dalphin, JC; Monod, M; Reboux, G				Millon, Laurence; Rognon, Benedicte; Valot, Benoit; Barrera, Coralie; Bellanger, Anne Pauline; Roussel, Sandrine; Dalphin, Jean-Charles; Monod, Michel; Reboux, Gabriel			Common peptide epitopes induce cross-reactivity in hypersensitivity pneumonitis serodiagnosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FARMERS LUNG SERODIAGNOSIS; IMMUNOREACTIVE PROTEINS; DISEASE		[Millon, Laurence; Rognon, Benedicte; Valot, Benoit; Barrera, Coralie; Bellanger, Anne Pauline; Roussel, Sandrine; Dalphin, Jean-Charles; Reboux, Gabriel] Univ Bourgogne Franche Comte, Chrono Environm, CNRS, Besancon, France; [Millon, Laurence; Rognon, Benedicte; Bellanger, Anne Pauline; Roussel, Sandrine; Reboux, Gabriel] Univ Hosp Besancon, Dept Parasitol Mycol, Besancon, France; [Dalphin, Jean-Charles] Univ Hosp Besancon, Dept Pneumol, Besancon, France; [Monod, Michel] CHU Vaudois, Dept Dermatol, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Millon, L (corresponding author), Univ Bourgogne Franche Comte, Chrono Environm, CNRS, Besancon, France.; Millon, L (corresponding author), Univ Hosp Besancon, Dept Parasitol Mycol, Besancon, France.	laurence.millon@univ-fcomte.fr	Valot, Benoit BV/G-3521-2018; Millon, laurence/AAK-5980-2020	Reboux, Gabriel/0000-0002-7923-0858				Barrera C, 2014, PROTEOM CLIN APPL, V8, P971, DOI 10.1002/prca.201400024; Bourke SJ, 2001, EUR RESPIR J, V18, p81S; GARI M, 1982, MYCOPATHOLOGIA, V78, P151, DOI 10.1007/BF00466069; Girard M, 2009, ALLERGY, V64, P322, DOI 10.1111/j.1398-9995.2009.01949.x; Lacasse Y, 2003, AM J RESP CRIT CARE, V168, P952, DOI 10.1164/rccm.200301-137OC; Millon L, 2015, MYCOSES, V58, P219; Millon L, 2012, J ALLERGY CLIN IMMUN, V130, P803, DOI 10.1016/j.jaci.2012.03.039; PEPYS J, 1994, ALLERGY PROC, V15, P103, DOI 10.2500/108854194778702982; Rognon B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160888; Roussel S, 2011, INT J MED MICROBIOL, V301, P150, DOI 10.1016/j.ijmm.2010.07.002; Tillie-Leblond I, 2011, EUR RESPIR J, V37, P640, DOI 10.1183/09031936.00195009	11	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1738	+		10.1016/j.jaci.2016.06.037	http://dx.doi.org/10.1016/j.jaci.2016.06.037			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27498359				2022-12-18	WOS:000390019300040
J	Jacobino, SR; Nederend, M; Hennus, M; Houben, ML; Ngwuta, JO; Viveen, M; Coenjaerts, FEJ; Hack, CE; van Neerven, RJJ; Graham, BS; Bont, L; Leusen, JHW				Jacobino, Shamir R.; Nederend, Maaike; Hennus, Marije; Houben, Michiel L.; Ngwuta, Joan O.; Viveen, Marco; Coenjaerts, Frank E. J.; Hack, C. Erik; van Neerven, R. J. Joost; Graham, Barney S.; Bont, Louis; Leusen, Jeanette H. W.			Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RSV; IMMUNITY		[Jacobino, Shamir R.; Nederend, Maaike; Hennus, Marije; Hack, C. Erik; Bont, Louis; Leusen, Jeanette H. W.] UMC Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Hennus, Marije; Bont, Louis] Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands; [Ngwuta, Joan O.; Graham, Barney S.] NIAID, Viral Pathogenesis Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Viveen, Marco; Coenjaerts, Frank E. J.] UMC Utrecht, Med Microbiol, Utrecht, Netherlands; [van Neerven, R. J. Joost] Wageningen Univ, Cell Biol & Immunol, Wageningen, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Leusen, JHW (corresponding author), UMC Utrecht, Lab Translat Immunol, Utrecht, Netherlands.	jleusen@umcutrecht.nl	Graham, Barney S./AAC-5898-2019; , Jeanette/AAG-3736-2019; van Neerven, Joost/GWZ-3214-2022; Levi, Marcel/AAZ-8559-2020	Graham, Barney S./0000-0001-8112-0853; Hennus, Marije/0000-0003-1508-0456; Leusen, Jeanette/0000-0003-4982-6914; van Neerven, R.J.Joost/0000-0002-3991-5297				Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4; Simoes EAF, 2011, PEDIATR INFECT DIS J, V30, P778, DOI 10.1097/INF.0b013e318218ab9e; Szabo SM, 2012, PAEDIATR RESPIR REV, V13, pS9	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1477	+		10.1016/j.jaci.2016.06.001	http://dx.doi.org/10.1016/j.jaci.2016.06.001			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27448445				2022-12-18	WOS:000389542700038
J	Kamoun, C; Morsheimer, M; Sullivan, KE; Holland, SM; Rundles, CC; Bunin, N; Heimall, JR				Kamoun, Camilia; Morsheimer, Megan; Sullivan, Kathleen E.; Holland, Steven M.; Rundles, Charlotte Cunningham; Bunin, Nancy; Heimall, Jennifer R.			Successful unrelated cord blood transplant for complete IFN-gamma receptor 2 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							STEM-CELL TRANSPLANTATION; CHILD; SUSCEPTIBILITY		[Kamoun, Camilia] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Morsheimer, Megan; Sullivan, Kathleen E.; Heimall, Jennifer R.] Childrens Hosp Philadelphia, Dept Pediat, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Rundles, Charlotte Cunningham] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Bunin, Nancy] Childrens Hosp Philadelphia, Dept Pediat, Div Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Heimall, JR (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Allergy & Immunol, Philadelphia, PA 19104 USA.	heimallj@email.chop.edu						Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Chantrain CF, 2006, BONE MARROW TRANSPL, V38, P75, DOI 10.1038/sj.bmt.1705399; Fernandes JF, 2012, BLOOD, V119, P2949, DOI 10.1182/blood-2011-06-363572; Moilanen P, 2009, PEDIATR INFECT DIS J, V28, P658, DOI 10.1097/INF.0b013e318195092e; Olbrich P, 2015, PEDIATR BLOOD CANCER, V62, P2036, DOI 10.1002/pbc.25625; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Reuter U, 2002, BLOOD, V100, P4234, DOI 10.1182/blood-2002-02-0433; Roesler J, 2004, J PEDIATR-US, V145, P806, DOI 10.1016/j.jpeds.2004.08.021; Wu UI, 2015, LANCET INFECT DIS, V15, P968, DOI 10.1016/S1473-3099(15)00089-4	9	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1489	+		10.1016/j.jaci.2016.06.017	http://dx.doi.org/10.1016/j.jaci.2016.06.017			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27522156	Bronze			2022-12-18	WOS:000389542700042
J	Lech, Z; Chalubinski, M; Kosinski, S; Smorawska, E; Bassin, C; Akdis, CA; Grzegorczyk, J; Kowalski, ML				Lech, Zuzanna; Chalubinski, Maciej; Kosinski, Slawomir; Smorawska, Ewa; Bassin, Claudio; Akdis, Cezmi A.; Grzegorczyk, Janina; Kowalski, Marek L.			Prostaglandin E2 and lipoxin A4 in PBMCs are associated with immune tolerance during venom immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MECHANISMS; STRESS; CELLS		[Lech, Zuzanna; Chalubinski, Maciej; Kosinski, Slawomir; Smorawska, Ewa; Grzegorczyk, Janina; Kowalski, Marek L.] Med Univ Lodz, Hlth Ageing Res Ctr, Dept Immunol Rheumatol & Allergy, Lodz, Poland; [Chalubinski, Maciej] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lodz, Poland; [Bassin, Claudio; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland	Medical University Lodz; Medical University Lodz; Swiss Institute of Allergy & Asthma Research; University of Zurich	Kowalski, ML (corresponding author), Med Univ Lodz, Hlth Ageing Res Ctr, Dept Immunol Rheumatol & Allergy, Lodz, Poland.	Marek.Kowalski@csk.am.lodz.pl	Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X				Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Jutel M, 2016, J ALLERGY CLIN IMMUN, V137, P358, DOI 10.1016/j.jaci.2015.12.1300; Kondeti V, 2016, J ALLERGY CLIN IMMUN, V137, P289, DOI 10.1016/j.jaci.2015.06.030; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Ozdemir C, 2011, CLIN EXP ALLERGY, V41, P1226, DOI 10.1111/j.1365-2222.2011.03812.x; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Sijben JWC, 2000, POULTRY SCI, V79, P949, DOI 10.1093/ps/79.7.949; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Varni JW, 1996, J BEHAV MED, V19, P515, DOI 10.1007/BF01904901; Wilson KE, 2015, BEHAV SLEEP MED, V13, P412, DOI 10.1080/15402002.2014.940104; Zhang BA, 2010, J IMMUNOL, V185, P7199, DOI 10.4049/jimmunol.1001876	12	7	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1199	1202		10.1016/j.jaci.2016.03.024	http://dx.doi.org/10.1016/j.jaci.2016.03.024			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27221137	Bronze			2022-12-18	WOS:000385499400029
J	Melnik, BC; John, SM; Schmitz, G				Melnik, Bodo C.; John, Swen Malte; Schmitz, Gerd			Milk: An epigenetic inducer of FoxP3 expression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DNA METHYLTRANSFERASE 1; T-CELLS; ASTHMA; CHILDHOOD; MICRORNA; ATOPY		[Melnik, Bodo C.; John, Swen Malte] Univ Osnabruck, Dept Dermatol Environm Med & Hlth Theory, Osnabruck, Germany; [Schmitz, Gerd] Univ Clin Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany	University Osnabruck; University of Regensburg	Melnik, BC (corresponding author), Univ Osnabruck, Dept Dermatol Environm Med & Hlth Theory, Osnabruck, Germany.	melnik@t-online.de						Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kirchner B, 2016, J ALLERGY CLIN IMMUN, V137, P1893, DOI 10.1016/j.jaci.2015.10.028; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P551, DOI 10.1016/j.jaci.2013.06.034; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Melnik BC, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-43; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1	7	7	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					937	938		10.1016/j.jaci.2016.04.039	http://dx.doi.org/10.1016/j.jaci.2016.04.039			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27417024				2022-12-18	WOS:000385496000043
J	Cox, LS; Didier, A; Demoly, P; Wahn, U; Pradalier, A; Frew, AJ; Devillier, P				Cox, Linda S.; Didier, Alain; Demoly, Pascal; Wahn, Ulrich; Pradalier, Andre; Frew, Anthony J.; Devillier, Philippe			Methodological aspects of a meta-analysis of grass pollen allergen sublingual immunotherapy tablets	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RHINOCONJUNCTIVITIS; PHARMACOTHERAPY		[Cox, Linda S.] Nova Southeastern Univ, Coll Osteopath Med, Davie, FL USA; [Didier, Alain] Rangueil Larrey Hosp, Dept Resp Dis, Toulouse, France; [Demoly, Pascal] Univ Hosp Montpellier, Hop Arnaud Villeneuve, Dept Pulmonol, Div Allergy, Montpellier, France; [Demoly, Pascal] Univ Paris 06, Sorbonne Univ, IPLESP, UMR S INSERM 1136,Equipe EPAR, Paris, France; [Wahn, Ulrich] Charite Virchow Klinikum, Dept Pediat Pneumol & Immunol, Berlin, Germany; [Pradalier, Andre] Retired, Paris, France; [Frew, Anthony J.] Royal Sussex Cty Hosp, Dept Resp Med, Brighton, E Sussex, England; [Devillier, Philippe] Univ Versailles St Quentin, Foch Hosp, UPRES EA 220, Suresnes, France	Nova Southeastern University; CHU de Toulouse; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Brighton; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay	Cox, LS (corresponding author), Nova Southeastern Univ, Coll Osteopath Med, Davie, FL USA.	lindaswolfcox@msn.com	Demoly, Pascal/Y-9938-2019; Cox, Linda/AAP-1697-2021; Kelly, Frank J/C-6125-2009	Demoly, Pascal/0000-0001-7827-7964; Cox, Linda/0000-0002-5258-6870; Kelly, Frank J/0000-0003-2558-8392				Devillier P, 2014, ALLERGY, V69, P1689, DOI 10.1111/all.12518; Devillier P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-71; Di Bona D, 2015, JAMA INTERN MED, V175, P1301, DOI 10.1001/jamainternmed.2015.2840; Matricardi PM, 2011, J ALLERGY CLIN IMMUN, V128, P791, DOI 10.1016/j.jaci.2011.03.049; Pfaar O, 2014, ALLERGY, V69, P854, DOI 10.1111/all.12383	5	7	7	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					314	+		10.1016/j.jaci.2016.01.039	http://dx.doi.org/10.1016/j.jaci.2016.01.039			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	27084407	Bronze			2022-12-18	WOS:000379659100045
J	Otte, M; Mahler, V; Kerpes, A; Pabst, O; Voehringer, D				Otte, Manuel; Mahler, Vera; Kerpes, Andrea; Pabst, Oliver; Voehringer, David			Persistence of the IgE repertoire in birch pollen allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPIC-DERMATITIS; PERIPHERAL-BLOOD; CELLS		[Otte, Manuel; Voehringer, David] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Infect Biol, D-91054 Erlangen, Germany; [Mahler, Vera; Kerpes, Andrea] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Dermatol, D-91054 Erlangen, Germany; [Pabst, Oliver] RWTH Univ, Inst Mol Med, Fac Med, Aachen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; RWTH Aachen University	Voehringer, D (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Infect Biol, D-91054 Erlangen, Germany.	david.voehringer@uk-erlangen.de	Voehringer, David/K-2776-2019					Davies JM, 2013, J ALLERGY CLIN IMMUN, V131, P972, DOI 10.1016/j.jaci.2012.12.1569; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Finlay AY, 2005, BRIT J DERMATOL, V152, P861, DOI 10.1111/j.1365-2133.2005.06502.x; Gadermaier E, 2014, INT ARCH ALLERGY IMM, V163, P77, DOI 10.1159/000355947; Hongbo Y, 2005, J INVEST DERMATOL, V125, P659, DOI 10.1111/j.0022-202X.2005.23621.x; Horst A, 2002, CLIN EXP IMMUNOL, V130, P370, DOI 10.1046/j.1365-2249.2002.02025.x; LEHMANN EL, 1963, ANN MATH STAT, V34, P1507, DOI 10.1214/aoms/1177703882; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; MANDLER R, 1993, J IMMUNOL, V150, P407; Marth K, 2010, MOL IMMUNOL, V47, P2323, DOI 10.1016/j.molimm.2010.05.285; MILLS FC, 1995, J IMMUNOL, V155, P3021; Phan NQ, 2012, ACTA DERM-VENEREOL, V92, P502, DOI 10.2340/00015555-1246; Pocock SJ, CLIN TRIALS PRACTICA; Schmitt J, 2013, J ALLERGY CLIN IMMUN, V132, P1337, DOI 10.1016/j.jaci.2013.07.008; Sprenger K B, 1987, J Clin Apher, V3, P185, DOI 10.1002/jca.2920030313; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Wu YCB, 2014, J ALLERGY CLIN IMMUN, V134, P604, DOI 10.1016/j.jaci.2014.07.010; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941	19	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2016	137	6					1884	+		10.1016/j.jaci.2015.12.1333	http://dx.doi.org/10.1016/j.jaci.2015.12.1333			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DO1GT	27001158	Bronze			2022-12-18	WOS:000377527200031
J	Giardino, G; Gallo, V; Somma, D; Farrow, EG; Thiffault, I; D'Assante, R; Donofrio, V; Paciolla, M; Ursini, MV; Leonardi, A; Saunders, CJ; Pignata, C				Giardino, Giuliana; Gallo, Vera; Somma, Domenico; Farrow, Emily G.; Thiffault, Isabelle; D'Assante, Roberta; Donofrio, Vittoria; Paciolla, Mariateresa; Ursini, Matilde Valeria; Leonardi, Antonio; Saunders, Carol J.; Pignata, Claudio			Targeted next-generation sequencing revealed MYD88 deficiency in a child with chronic yersiniosis and granulomatous lymphadenitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IRAK-4; ENTEROCOLITICA; INFECTIONS; HUMANS		[Giardino, Giuliana; Gallo, Vera; D'Assante, Roberta; Pignata, Claudio] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Somma, Domenico; Leonardi, Antonio] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Farrow, Emily G.; Thiffault, Isabelle; Saunders, Carol J.] Childrens Mercy Kansas City, Ctr Pediat Genom Med, Kansas City, MO USA; [Farrow, Emily G.; Thiffault, Isabelle; Saunders, Carol J.] Childrens Mercy Kansas City, Dept Pediat, Kansas City, MO USA; [Farrow, Emily G.; Thiffault, Isabelle; Saunders, Carol J.] Childrens Mercy Kansas City, Dept Pathol, Kansas City, MO USA; [Farrow, Emily G.; Thiffault, Isabelle; Saunders, Carol J.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Donofrio, Vittoria] IGB CNR, AORN Santobono Pausilipon, Dept Pathol, Naples, Italy; [Paciolla, Mariateresa; Ursini, Matilde Valeria] IGB CNR, Int Inst Genet & Biophys, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Children's Mercy Hospital; Children's Mercy Hospital; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Pignata, C (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	pignata@unina.it	leonardi, antonio/A-2887-2009; Giardino, Giuliana/AAF-9841-2021; Giardino, Giuliana/AAC-2008-2019; Somma, Domenico/X-9553-2019; Pignata, Claudio/O-2466-2013; Gallo, Vera/AAA-2942-2022	leonardi, antonio/0000-0001-8636-9623; Somma, Domenico/0000-0003-2486-7250; Pignata, Claudio/0000-0003-1568-9843; D'Assante, Roberta/0000-0001-6729-374X; Gallo, Vera/0000-0002-7928-0599				Alsina L, 2014, NAT IMMUNOL, V15, P1134, DOI 10.1038/ni.3028; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; Foerster C, 2010, J IMMUNOL, V184, P7305, DOI 10.4049/jimmunol.1000434; Hoek KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118528; Kenzel S, 2012, J IMMUNOL, V189, P4582, DOI 10.4049/jimmunol.1200205; Maglione PJ, 2014, BLOOD, V124, P3561, DOI 10.1182/blood-2014-07-587824; Novikova L, 2014, J IMMUNOL, V192, P1209, DOI 10.4049/jimmunol.1203464; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Yamamoto T, 2014, MOL IMMUNOL, V58, P66, DOI 10.1016/j.molimm.2013.11.008	15	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1591	+		10.1016/j.jaci.2015.09.050	http://dx.doi.org/10.1016/j.jaci.2015.09.050			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26632527	Bronze			2022-12-18	WOS:000376180200037
J	Giavina-Bianchi, P; Kalil, J				Giavina-Bianchi, Pedro; Kalil, Jorge			Mycoplasma pneumoniae infection induces asthma onset	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma	PREVALENCE; CHILDREN; HYGIENE; ALLERGY		[Giavina-Bianchi, Pedro; Kalil, Jorge] Univ Sao Paulo, Clin Immunol & Allergy Div, AV Reboucas 1117, BR-05401150 Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Giavina-Bianchi, P (corresponding author), Univ Sao Paulo, Clin Immunol & Allergy, AV Reboucas 1117, BR-05401150 Sao Paulo, SP, Brazil.	pbianchi@usp.br	KALIL, JORGE/C-8029-2012; Giavina-Bianchi, Pedro/I-3112-2014	KALIL, JORGE/0000-0001-8415-4274; Giavina-Bianchi, Pedro/0000-0002-1034-7580				Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Haby MM, 2001, THORAX, V56, P589, DOI 10.1136/thorax.56.8.589; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Koh YY, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e39; Liu AH, 2015, J ALLERGY CLIN IMMUN, V136, P860, DOI 10.1016/j.jaci.2015.08.012; MOK JYQ, 1979, ARCH DIS CHILD, V54, P506, DOI 10.1136/adc.54.7.506; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; SABATO AR, 1984, ARCH DIS CHILD, V59, P1034, DOI 10.1136/adc.59.11.1034; Shapiro H, 2014, CURR OPIN IMMUNOL, V30, P54, DOI 10.1016/j.coi.2014.07.003; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Ye Q, 2014, SCI WORLD J, DOI 10.1155/2014/986527; Yeh JJ, 2016, J ALLERGY CLIN IMMUN, V137, P1017, DOI 10.1016/j.jaci.2015.09.032	16	7	11	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2016	137	4					1024	1025		10.1016/j.jaci.2015.11.011	http://dx.doi.org/10.1016/j.jaci.2015.11.011			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DI2TG	26792205	Bronze			2022-12-18	WOS:000373351200007
J	Vales-Gomez, M; Esteso, G; Aydogmus, C; Blazquez-Moreno, A; Marin, AV; Briones, AC; Garcillan, B; Garcia-Cuesta, EM; Cobo, SL; Haskologlu, S; Moraru, M; Cipe, F; Dobbs, K; Dogu, F; Parolini, S; Notarangelo, LD; Vilches, C; Recio, MJ; Regueiro, JR; Ikinciogullari, A; Reyburn, HT				Vales-Gomez, Mar; Esteso, Gloria; Aydogmus, Cigdem; Blazquez-Moreno, Alfonso; Marin, Ana V.; Briones, Alejandro C.; Garcillan, Beatriz; Garcia-Cuesta, Eva-Maria; Lopez Cobo, Sheila; Haskologlu, Sule; Moraru, Manuela; Cipe, Funda; Dobbs, Kerry; Dogu, Figen; Parolini, Silvia; Notarangelo, Luigi D.; Vilches, Carlos; Recio, Maria J.; Regueiro, Jose R.; Ikinciogullari, Aydan; Reyburn, Hugh T.			Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEVERE COMBINED IMMUNODEFICIENCY; GENE; DEFICIENCY		[Vales-Gomez, Mar; Esteso, Gloria; Blazquez-Moreno, Alfonso; Garcia-Cuesta, Eva-Maria; Lopez Cobo, Sheila; Reyburn, Hugh T.] CSIC, Dept Immunol & Oncol, Natl Biotechnol Ctr, Madrid, Spain; [Aydogmus, Cigdem; Cipe, Funda] Istanbul Kanuni Sultan Suleyman Hosp, Dept Pediat Immunol, Istanbul, Turkey; [Marin, Ana V.; Briones, Alejandro C.; Garcillan, Beatriz; Recio, Maria J.; Regueiro, Jose R.] Univ Complutense, Sch Med, Dept Immunol, E-28040 Madrid, Spain; [Marin, Ana V.; Briones, Alejandro C.; Garcillan, Beatriz; Recio, Maria J.; Regueiro, Jose R.] Hosp 12 Octubre, Hlth Res Inst, E-28041 Madrid, Spain; [Haskologlu, Sule; Dogu, Figen; Ikinciogullari, Aydan] Ankara Univ, Sch Med, Dept Pediat Immunol Allergy, TR-06100 Ankara, Turkey; [Moraru, Manuela; Vilches, Carlos] Inst Invest Sanitaria Puerta de Hierro, Immunogenet HLA, Madrid, Spain; [Dobbs, Kerry; Notarangelo, Luigi D.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Parolini, Silvia] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); Istanbul Kanuni Sultan Suleyman Training & Research Hospital; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Ankara University; Harvard University; Boston Children's Hospital; University of Brescia	Vales-Gomez, M; Reyburn, HT (corresponding author), CSIC, Dept Immunol & Oncol, Natl Biotechnol Ctr, Madrid, Spain.	mvales@cnb.csic.es; htreyburn@cnb.csic.es	Recio, Maria/E-7256-2012; Marin, Ana V./K-2446-2014; Reyburn, Hugh T/B-4338-2009; Regueiro, José R./B-5499-2014; Vales-Gomez, Mar/ABG-7808-2020; García-Cuesta, Eva M./J-6600-2017; Notarangelo, Luigi D/F-9718-2016; Valés-Gómez, Mar/F-5351-2012; Vilches, Carlos/G-1471-2012; Briones, Alejandro/K-3171-2014; Dogu, Figen/AAI-1316-2020; Vilches, Carlos/AAG-9203-2021; İkinciogullari, Aydan/AAQ-3841-2020	Recio, Maria/0000-0002-6461-1586; Marin, Ana V./0000-0002-7541-3729; Reyburn, Hugh T/0000-0003-2855-1595; Regueiro, José R./0000-0001-8442-7762; Vales-Gomez, Mar/0000-0001-7424-3206; García-Cuesta, Eva M./0000-0003-2311-4353; Notarangelo, Luigi D/0000-0002-8335-0262; Valés-Gómez, Mar/0000-0001-7424-3206; Vilches, Carlos/0000-0002-0300-9225; Briones, Alejandro/0000-0003-4016-1848; Dogu, Figen/0000-0002-7869-4941; İkinciogullari, Aydan/0000-0003-1145-0843; PAROLINI, Silvia/0000-0003-1968-7765; Garcillan, Beatriz/0000-0002-4748-8280; Moraru, Manuela/0000-0001-5394-4521; Esteso Tornero, Gloria/0000-0001-6162-013X; Dobbs, Kerry/0000-0002-3432-3137	NIAID NIH HHS [5R01AI100887-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100887] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Guilmot A, 2011, J INNATE IMMUN, V3, P280, DOI 10.1159/000323934; Hollyoake M, 2005, MOL BIOL EVOL, V22, P1661, DOI 10.1093/molbev/msi162; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Luetke-Eversloh M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00499; Nguyen S, 2005, BLOOD, V105, P4135, DOI 10.1182/blood-2004-10-4113; Noyola DE, 2012, EUR J IMMUNOL, V42, P3256, DOI 10.1002/eji.201242752; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Roberts JL, 2007, BLOOD, V109, P3198, DOI 10.1182/blood-2006-08-043166; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; van Til NP, 2012, MOL THER, V20, P1968, DOI 10.1038/mt.2012.110	13	7	7	0	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					942	945		10.1016/j.jaci.2015.07.051	http://dx.doi.org/10.1016/j.jaci.2015.07.051			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26542031	Green Accepted			2022-12-18	WOS:000371897500044
J	Manga, V; Humbert, M; Djukanovic, R; Greenberg, S; Omachi, TA; Trzaskoma, B; Buhl, R				Manga, Volkan; Humbert, Marc; Djukanovic, Ratko; Greenberg, Steve; Omachi, Theodore A.; Trzaskoma, Benjamin; Buhl, Roland			Blood Eosinophils and Serum IgE Predict Response to Omalizumab in Patients with Severe Allergic Asthma: Innovate Trial Post-Hoc Analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 04-07, 2016	Los Angeles, CA	Amer Acad Allergy, Asthma & Immunol					[Manga, Volkan] Novartis Pharma AG, Basel, Switzerland; [Humbert, Marc] Univ Paris 11, Hosp Antoine Beclere, Clamart, France; [Djukanovic, Ratko] Univ Southampton, Southampton, Hants, England; [Greenberg, Steve] Nova Pharmaceut Corp, E Hanover, NJ USA; [Omachi, Theodore A.; Trzaskoma, Benjamin] Genentech Inc, San Francisco, CA 94080 USA; [Buhl, Roland] Univ Hosp, Mainz, Germany	Novartis; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Southampton; Novartis; Roche Holding; Genentech; University Hospital Mainz			Humbert, Marc/ABD-5112-2021						0	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2		S		48	AB16	AB16		10.1016/j.jaci.2015.12.051	http://dx.doi.org/10.1016/j.jaci.2015.12.051			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	DK6BI		Bronze			2022-12-18	WOS:000375005400049
J	Wu, XM; Wang, SH; Han, MM; Song, B; Ye, P; Ma, SS; Li, J; Chen, FH; Xu, G; Ding, QQ; Xia, JH; Li, HB				Wu, Xingmei; Wang, Sihua; Han, Miaomiao; Song, Bin; Ye, Ping; Ma, Shanshan; Li, Jun; Chen, Fenghong; Xu, Geng; Ding, Qingqing; Xia, Jiahong; Li, Huabin			Critical link between glycogen synthase kinase 3 beta and forkhead box P3 in patients with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Wu, Xingmei; Chen, Fenghong; Xu, Geng; Li, Huabin] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Allergy Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Sihua; Ye, Ping; Li, Jun; Xia, Jiahong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, Wuhan 430074, Peoples R China; [Han, Miaomiao; Li, Huabin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg,Allergy Div, Shanghai, Peoples R China; [Han, Miaomiao; Li, Huabin] Shanghai Key Lab Translat Med Ear & Nose Dis, Shanghai, Peoples R China; [Song, Bin; Ma, Shanshan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China; [Ding, Qingqing] Univ Missouri, Dept Pathol, Columbia, MO 65201 USA	Sun Yat Sen University; Huazhong University of Science & Technology; Shanghai Jiao Tong University; Sun Yat Sen University; University of Missouri System; University of Missouri Columbia	Wu, XM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Allergy Ctr, Guangzhou 510275, Guangdong, Peoples R China.	qingqing_ding@hotmail.com; jiahong.xia@hust.edu.cn; allergyli@163.com						Bao Z, 2007, AM J RESP CRIT CARE, V176, P431, DOI 10.1164/rccm.200609-1292OC; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Linke R, 2013, ANN ALLERG ASTHMA IM, V110, P101, DOI 10.1016/j.anai.2012.11.016; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018	9	7	7	1	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1698	1700		10.1016/j.jaci.2015.08.014	http://dx.doi.org/10.1016/j.jaci.2015.08.014			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26431581	Bronze			2022-12-18	WOS:000366044300038
J	Baldo, BA; Pham, NH				Baldo, Brian A.; Pham, Nghia H.			Allergenic significance of cephalosporin side chains	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Baldo, Brian A.; Pham, Nghia H.] Royal N Shore Hosp, Kolling Inst Med Res, Mol Immunol Unit, Sydney, NSW, Australia; [Baldo, Brian A.; Pham, Nghia H.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney	Baldo, BA (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Mol Immunol Unit, Sydney, NSW, Australia.	babaldo@iinet.net.au	caruso, cristiano/AAR-9502-2020	caruso, cristiano/0000-0001-7631-029X				Baldo BA, 2013, DRUG ALLERGY CLIN AS, P159; Pham NH, 1996, J MOL RECOGNIT, V9, P287, DOI 10.1002/(SICI)1099-1352(199607)9:4<287::AID-JMR340>3.3.CO;2-C; Romano A, 2015, J ALLERGY CLIN IMMUN, V136, P685, DOI 10.1016/j.jaci.2015.03.012	3	7	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5					1426	1428		10.1016/j.jaci.2015.06.051	http://dx.doi.org/10.1016/j.jaci.2015.06.051			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CW1YE	26388313	Bronze			2022-12-18	WOS:000364787200044
J	Acosta-Herrera, M; Pino-Yanes, M; Ma, SF; Barreto-Luis, A; Corrales, A; Cumplido, J; Perez-Rodriguez, E; Campo, P; Eng, C; Garcia-Robaina, JC; Quintela, I; Villar, J; Blanca, M; Carracedo, A; Carrillo, T; Garcia, JGN; Torgerson, DG; Burchard, EG; Flores, C				Acosta-Herrera, Marialbert; Pino-Yanes, Maria; Ma, Shwu-Fan; Barreto-Luis, Amalia; Corrales, Almudena; Cumplido, Jose; Perez-Rodriguez, Eva; Campo, Paloma; Eng, Celeste; Carlos Garcia-Robaina, Jose; Quintela, Ines; Villar, Jesus; Blanca, Miguel; Carracedo, Angel; Carrillo, Teresa; Garcia, Joe G. N.; Torgerson, Dara G.; Burchard, Esteban G.; Flores, Carlos			Fine mapping of the myosin light chain kinase (MYLK) gene replicates the association with asthma in populations of Spanish descent	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENOME-WIDE ASSOCIATION; AMERICANS; ADMIXTURE		[Acosta-Herrera, Marialbert; Pino-Yanes, Maria; Barreto-Luis, Amalia; Corrales, Almudena; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Acosta-Herrera, Marialbert; Pino-Yanes, Maria; Barreto-Luis, Amalia; Corrales, Almudena; Flores, Carlos] Hosp Univ NS Candelaria, Res Unit, Tenerife, Spain; [Acosta-Herrera, Marialbert; Villar, Jesus] Hosp Univ Dr Negrin, MOD ERN, Res Unit, Gran Canaria, Spain; [Cumplido, Jose; Carrillo, Teresa] Hosp Univ Dr Negrin, Allergy Unit, Gran Canaria, Spain; [Pino-Yanes, Maria; Eng, Celeste; Torgerson, Dara G.; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ma, Shwu-Fan] Univ Chicago, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Perez-Rodriguez, Eva; Carlos Garcia-Robaina, Jose] Hosp Univ NS Candelaria, Allergy Unit, Tenerife, Spain; [Campo, Paloma; Blanca, Miguel] Reg Univ Hosp Malaga IBIMA, UGC Allergy, Malaga, Spain; [Quintela, Ines] Univ Santiago de Compostela, ISCIII, CEGEN, Grp Med Xenom, Santiago De Compostela, Spain; [Carracedo, Angel] Univ Santiago de Compostela, Fdn Galega Med Xenom SERGAS, Grp Med Xenom, CIBERER, Santiago De Compostela, Spain; [Garcia, Joe G. N.] Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Flores, Carlos] Univ La Laguna, Inst Univ Enfermedades Tropicales & Salud Publ Ca, Genet Lab, Appl Genom Grp G2A, Tenerife, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of California System; University of California San Francisco; University of Chicago; Universidad de Malaga; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; University of Arizona; University of Arizona Health Sciences; University of California System; University of California San Francisco; Universidad de la Laguna	Acosta-Herrera, M (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	cflores@ull.edu.es	Corrales, Almudena/G-5391-2017; Flores, Carlos/R-1159-2019; Villar, Jesús/R-4526-2019; Carracedo, Angel/D-4257-2012; Pino-Yanes, Maria/C-8498-2017	Corrales, Almudena/0000-0002-2207-5463; Villar, Jesús/0000-0001-5687-3562; Carracedo, Angel/0000-0003-1085-8986; Pino-Yanes, Maria/0000-0003-0332-437X; Perez Rodriguez, Eva Maria/0000-0003-3562-5687; Flores, Carlos/0000-0001-5352-069X; Quintela, Ines/0000-0002-0239-7975	NHLBI NIH HHS [K23 HL004464, R01 HL091889, P01 HL126609, HL088133, R01 HL088133, HL004464, HL078885, HL101651, R01 HL117004, HL117004, HL104608] Funding Source: Medline; NIEHS NIH HHS [ES015794, R01 ES015794] Funding Source: Medline; NIGMS NIH HHS [GM007546] Funding Source: Medline; NIMHD NIH HHS [MD006902, P60 MD006902] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133, R01HL117004, R01HL104608, R01HL078885, RC2HL101651, K23HL004464, R01HL091889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Galanter JM, 2014, J ALLERGY CLIN IMMUN, V134, P295, DOI 10.1016/j.jaci.2013.08.055; Gao L, 2007, J ALLERGY CLIN IMMUN, V119, P1111, DOI 10.1016/j.jaci.2007.03.019; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Pino-Yanes MI, 2014, J ALLERGY CLIN IMMUN, V134, P1201, DOI 10.1016/j.jaci.2014.05.031; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888	11	7	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					1116	1118		10.1016/j.jaci.2015.04.025	http://dx.doi.org/10.1016/j.jaci.2015.04.025			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CT7EJ	26025125	Green Accepted			2022-12-18	WOS:000362976300039
J	He, WJ; Jimenez, F; Martinez, H; Harper, NL; Manoharan, MS; Carrillo, A; Ingale, P; Liu, YG; Ahuja, SS; Clark, RA; Rather, CG; Ramirez, DA; Andrews, CP; Jacobs, RL; Ahuja, SK				He, Weijing; Jimenez, Fabio; Martinez, Hernan; Harper, Nathan L.; Manoharan, Muthu Saravanan; Carrillo, Andrew; Ingale, Puraskar; Liu, Ya-Guang; Ahuja, Seema S.; Clark, Robert A.; Rather, Cynthia G.; Ramirez, Daniel A.; Andrews, Charles P.; Jacobs, Robert L.; Ahuja, Sunil K.			Cockroach sensitization mitigates allergic rhinoconjunctivitis symptom severity in patients allergic to house dust mites and pollen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cockroach sensitization; allergen challenge chamber; allergic rhinoconjunctivitis; T-cell activation; aeroallergens; house dust mite; skin prick test; pollen	INNATE LYMPHOID-CELLS; CHALLENGE CHAMBER; CD4/CD8 RATIO; HYGIENE HYPOTHESIS; IMMUNE; ACTIVATION; EXPOSURE; RESPONSES; ASTHMA; DISEASE	Background: Modifiers of symptom severity in patients with allergic rhinoconjunctivitis (AR) are imprecisely characterized. The hygiene hypothesis implicates childhood microbial exposure as a protective factor. Cockroach sensitization (C+) might be a proxy for microbial exposure. Objective: We sought to determine whether C+ assayed by means of skin prick tests influenced AR symptom severity in controlled and natural settings. Methods: Total symptom scores (TSSs) were recorded by 21 participants with house dust mite allergy (M+) in the natural setting and during repeated exposures of 3 hours per day to house dust mite allergen in an allergen challenge chamber (ACC). In M+ participants the peripheral blood and nasal cells were assayed for T-cell activation and transcriptomic profiles (by using RNA sequencing), respectively. Participants allergic to mountain cedar (n = 21), oak (n = 34), and ragweed (n = 23) recorded TSSs during separate out-of-season exposures to these pollens (any pollen sensitization [P+]) in the ACC; a subset recorded TSSs in the pollination seasons. Results: The hierarchy of TSSs (highest to lowest) among M+ participants tracked the following skin prick test sensitization statuses: M+P+C- > M+P+C+ > M+P-C- > M+P-C+. In nasal cells and peripheral blood the immune/inflammatory responses were rapidly resolved in M+P+C+ compared with M+P+C- participants. Among those allergic to pollen, C+ was associated with a lower TSS during pollen challenges and the pollination season. After aggregated analysis of all 4 ACC studies, C+ status was associated with a 2.8-fold greater likelihood of a lower TSS compared with C- status (odds ratio, 2.78; 95% CI, 1.18-6.67; P = .02). Conclusions: C+ status is associated with mitigation of AR symptom severity in adults with AR.	[He, Weijing; Jimenez, Fabio; Martinez, Hernan; Harper, Nathan L.; Manoharan, Muthu Saravanan; Carrillo, Andrew; Ingale, Puraskar; Liu, Ya-Guang; Ahuja, Seema S.; Clark, Robert A.; Ahuja, Sunil K.] South Texas Vet Hlth Care Syst, Vet Adm Ctr Personalized Med, San Antonio, TX USA; [He, Weijing; Jimenez, Fabio; Martinez, Hernan; Harper, Nathan L.; Manoharan, Muthu Saravanan; Carrillo, Andrew; Ingale, Puraskar; Liu, Ya-Guang; Ahuja, Seema S.; Clark, Robert A.; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Jimenez, Fabio; Martinez, Hernan; Harper, Nathan L.] Biomed Res Fdn South Texas, San Antonio, TX USA; [Rather, Cynthia G.; Ramirez, Daniel A.; Andrews, Charles P.; Jacobs, Robert L.] Biogen Res Chamber, San Antonio, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ahuja, SK (corresponding author), 7400 Merton Minter Blvd,Room W200, San Antonio, TX 78229 USA.	ahujas@uthscsa.edu	Manoharan, Muthu Saravanan/L-4851-2019; Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619; Ingale, Puraskar/0000-0003-2769-878X; Andrews, Charles/0000-0002-8944-8404	Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Clinical Scientist in Transitional Research Award; Max and Minnie Tomerlin Voelcker Award; Center for Personalized Medicine at the South Texas Veterans Health Care System [CX00875-01AI]	Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Clinical Scientist in Transitional Research Award; Max and Minnie Tomerlin Voelcker Award; Center for Personalized Medicine at the South Texas Veterans Health Care System	S.K.A. received support from the following grants: the Doris Duke Distinguished Clinical Scientist Award, the Burroughs Wellcome Clinical Scientist in Transitional Research Award, the Max and Minnie Tomerlin Voelcker Award, and the Center for Personalized Medicine (CX00875-01AI) at the South Texas Veterans Health Care System. R.L.J., C.P.A., and D.A.R., are co-owners of Biogenics Research Chamber and have not received financial support. C.G.R. is the Executive Director of Chamber Operations.	ALSAKKAF L, 1989, DIABETOLOGIA, V32, P322, DOI 10.1007/BF00265550; Blaiss MS, 2007, ALLERGY ASTHMA PROC, V28, P393, DOI 10.2500/aap.2007.28.3013; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Brown EM, 2013, SEMIN IMMUNOL, V25, P378, DOI 10.1016/j.smim.2013.09.003; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; Croisant S, 2014, ADV EXP MED BIOL, V795, P17, DOI 10.1007/978-1-4614-8603-9_2; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Diefenbach A, 2013, EUR J MICROBIOL IMMU, V3, P143, DOI 10.1556/EuJMI.3.2013.3.1; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Frieri M, 2014, ALLERGY RHINOL, V5, pE41, DOI 10.2500/ar.2014.5.0083; Golebski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087768; Harmanci E, 1998, Allerg Immunol (Paris), V30, P245; Hoyler T, 2013, CURR OPIN IMMUNOL, V25, P139, DOI 10.1016/j.coi.2013.02.007; Jacobs RL, 2014, J ALLERGY CLIN IMMUN, V133, pe1; Jacobs RL, 2015, J ALLERGY CLIN IMMUN, V135, P1071, DOI 10.1016/j.jaci.2014.09.047; Jacobs RL, 2014, J ALLERGY CLIN IMMUN, V133, P1340, DOI 10.1016/j.jaci.2013.09.051; Jacobs RL, 2012, J ALLERGY CLIN IMMUN, V130, P122, DOI 10.1016/j.jaci.2012.03.031; Kared H, 2014, CURR OPIN IMMUNOL, V29, P79, DOI 10.1016/j.coi.2014.05.003; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Majori M, 1997, RESPIRATION, V64, P45; Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Platts-Mills TAE, 2006, CHEM IMMUNOL ALLERGY, V91, P3; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P117; Spergel JM., 2010, ANN ALLERG ASTHMA IM, V105, P107; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Strindhall J, 2013, AGE, V35, P985, DOI 10.1007/s11357-012-9400-3; Taylor RC, 2006, J ALLERGY CLIN IMMUN, V117, P1148, DOI 10.1016/j.jaci.2006.02.014; Tseng SY, 2002, CURR OPIN CELL BIOL, V14, P575, DOI 10.1016/S0955-0674(02)00370-8; Walker JA, 2013, CURR OPIN IMMUNOL, V25, P148, DOI 10.1016/j.coi.2013.02.010; Wang E, 2005, SPRINGER SEMIN IMMUN, V27, P105, DOI 10.1007/s00281-004-0198-7; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6	40	7	7	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					658	666		10.1016/j.jaci.2015.02.041	http://dx.doi.org/10.1016/j.jaci.2015.02.041			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	26026342				2022-12-18	WOS:000360913300018
J	Leaker, BR; O'Connor, B; Singh, D; Barnes, PJ				Leaker, Brian R.; O'Connor, Brian; Singh, Dave; Barnes, Peter J.			The novel inhaled glucocorticoid receptor agonist GW870086X protects against adenosine-induced bronchoconstriction in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFLAMMATION		[Leaker, Brian R.; O'Connor, Brian] Resp Clin Trials Ltd, London, England; [Singh, Dave] Univ Manchester, Med Evaluat Unit, Univ Hosp South Manchester Fdn Trust, Manchester, Lancs, England; [Barnes, Peter J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Imperial College London	Leaker, BR (corresponding author), Resp Clin Trials Ltd, London, England.	Brian.Leaker@qasmc.com	Singh, Dave/AAH-4342-2020	Singh, Dave/0000-0001-8918-7075; Barnes, Peter/0000-0002-5122-4018	National Institute for Health Research [NF-SI-0611-10148] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Allen A, 2013, CURR DRUG THER, V8, P76, DOI 10.2174/15748855113089990004; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Bareille P, 2013, CURR DRUG THER, V8, P69, DOI 10.2174/1574885511308020001; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; O'Connor BJ, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-60; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Singh D, 2008, BRIT J CLIN PHARMACO, V66, P261, DOI 10.1111/j.1365-2125.2008.03186.x; Taylor DA, 1999, AM J RESP CRIT CARE, V160, P237, DOI 10.1164/ajrccm.160.1.9809046; Uings IJ, 2013, BRIT J PHARMACOL, V169, P1389, DOI 10.1111/bph.12232	13	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					501	+		10.1016/j.jaci.2015.01.034	http://dx.doi.org/10.1016/j.jaci.2015.01.034			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25784273	hybrid			2022-12-18	WOS:000359004900039
J	Stockmann, C; Reilly, CA; Fassl, B; Gaedigk, R; Nkoy, F; Stone, B; Roberts, JK; Uchida, DA; Leeder, JS; Sherwin, CMT; Spigarelli, MG; Yost, GS; Ward, RM				Stockmann, Chris; Reilly, Christopher A.; Fassl, Bernhard; Gaedigk, Roger; Nkoy, Flory; Stone, Bryan; Roberts, Jessica K.; Uchida, Derek A.; Leeder, J. Steven; Sherwin, Catherine M. T.; Spigarelli, Michael G.; Yost, Garold S.; Ward, Robert M.			Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FLUTICASONE		[Stockmann, Chris; Fassl, Bernhard; Nkoy, Flory; Stone, Bryan; Roberts, Jessica K.; Uchida, Derek A.; Sherwin, Catherine M. T.; Spigarelli, Michael G.; Ward, Robert M.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84112 USA; [Stockmann, Chris; Reilly, Christopher A.; Yost, Garold S.; Ward, Robert M.] Univ Utah, Coll Pharm, Dept Pharmacol Toxicol, Salt Lake City, UT 84112 USA; [Gaedigk, Roger; Leeder, J. Steven] Childrens Mercy Hosp, Div Clin Pharmacol Toxicol & Therapeut Innovat, Kansas City, MO 64108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Children's Mercy Hospital	Stockmann, C (corresponding author), Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84112 USA.	Robert.Ward@hsc.utah.edu	Leeder, James Steven/ABD-5438-2021; Sherwin, Catherine Mary Turner/B-2888-2012; Roberts, Jessica Krystle/H-9785-2019	Leeder, James Steven/0000-0001-6688-0504; Sherwin, Catherine Mary Turner/0000-0002-0844-3207; Gaedigk, Roger/0000-0001-5942-1609	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060559] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001425] Funding Source: Medline; NCRR NIH HHS [UL1 RR025764, 5UL1RR025764-02] Funding Source: Medline; NICHD NIH HHS [R01 HD060559] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Drazen JM, 2011, NEW ENGL J MED, V365, P1245, DOI 10.1056/NEJMe1102469; HEDRICK PW, 1987, GENETICS, V117, P331; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Quaranta S, 2006, XENOBIOTICA, V36, P1191, DOI 10.1080/00498250600944300; Roberts JK, 2013, J PHARMACOL EXP THER, V345, P308, DOI 10.1124/jpet.112.202556; Stockmann C, 2013, J PEDIATR-US, V162, P1222, DOI 10.1016/j.jpeds.2012.11.031; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28	10	7	10	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					505	+		10.1016/j.jaci.2015.02.009	http://dx.doi.org/10.1016/j.jaci.2015.02.009			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25825214	Green Accepted			2022-12-18	WOS:000359004900041
J	Westman, M; Stjarne, P; Bergstrom, A; Kull, I; Toskala, E; Cardell, LO; Wickman, M; Holmstrom, M				Westman, Marit; Stjarne, Par; Bergstrom, Anna; Kull, Inger; Toskala, Elina; Cardell, Lars Olaf; Wickman, Magnus; Holmstrom, Mats			Chronic rhinosinusitis is rare but bothersome in adolescents from a Swedish population-based cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA; BIRTH; RISK		[Westman, Marit; Stjarne, Par; Cardell, Lars Olaf; Holmstrom, Mats] Karolinska Inst, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Bergstrom, Anna; Kull, Inger; Wickman, Magnus] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Kull, Inger] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Westman, Marit; Stjarne, Par; Cardell, Lars Olaf; Holmstrom, Mats] Karolinska Univ Hosp, Dept Ear Nose & Throat Dis, Stockholm, Sweden; [Kull, Inger; Wickman, Magnus] Soder Sjukhuset, Sachs Childrens Hosp, S-10064 Stockholm, Sweden; [Toskala, Elina] Temple Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19122 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Westman, M (corresponding author), Karolinska Inst, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	marit.westman@ki.se		Wickman, Magnus/0000-0003-2710-8620; Kull, Inger/0000-0001-6096-3771; Westman, Marit/0000-0003-0041-4249				ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hopkins C, 2009, CLIN OTOLARYNGOL, V34, P447, DOI 10.1111/j.1749-4486.2009.01995.x; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Min YG, 1996, EUR ARCH OTO-RHINO-L, V253, P435; Remenschneider AK, 2015, LARYNGOSCOPE, V125, P7, DOI 10.1002/lary.24715; Tomassen P, 2011, ALLERGY, V66, P556, DOI 10.1111/j.1398-9995.2010.02503.x; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x	12	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					512	+		10.1016/j.jaci.2015.02.019	http://dx.doi.org/10.1016/j.jaci.2015.02.019			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25840723				2022-12-18	WOS:000359004900044
J	Conti, F; Aragao, WC; Prando, C; Deswarte, C; Hubeau, M; Newburger, PE; Casanova, JL; Bustamante, J; Condino-Neto, A				Conti, Francesca; Aragao Filho, Walmir Cutrim; Prando, Carolina; Deswarte, Caroline; Hubeau, Marjorie; Newburger, Peter E.; Casanova, Jean-Laurent; Bustamante, Jacinta; Condino-Neto, Antonio			Phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity in patients with inherited IFN-gamma R1 or IFN-gamma R2 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC GRANULOMATOUS-DISEASE; NADPH OXIDASE; MYCOBACTERIAL DISEASE; IFN-GAMMA; TUBERCULOSIS; IMMUNITY		[Conti, Francesca; Deswarte, Caroline; Hubeau, Marjorie; Casanova, Jean-Laurent; Bustamante, Jacinta] Necker Enfants Malad Hosp, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Conti, Francesca; Deswarte, Caroline; Hubeau, Marjorie; Casanova, Jean-Laurent; Bustamante, Jacinta] Paris Descartes Univ, Imagine Inst, Paris, France; [Conti, Francesca] Univ Roma Tor Vergata, Dept Publ Hlth & Cellular Biol, Rome, Italy; [Aragao Filho, Walmir Cutrim; Condino-Neto, Antonio] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Prando, Carolina] Pel Pequeno Principe Res Inst, Bioinformat Lab, Curitiba, Parana, Brazil; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Casanova, Jean-Laurent] Necker Enfants Malad Hosp, AP HP, Pediat Hematol Immunol Unit, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA; [Bustamante, Jacinta] Necker Enfants Malad Hosp, AP HP, Ctr Study Primary Immunodeficiencies, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Rome Tor Vergata; Universidade de Sao Paulo; Hospital Pequeno Principe; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Conti, F (corresponding author), Necker Enfants Malad Hosp, Necker Branch, Lab Human Genet Infect Dis, Paris, France.	jacinta.bustamante@inserm.fr; antoniocondino@gmail.com	Deswarte, Caroline/H-8018-2017; Condino-Neto, Antonio/D-4762-2012; Bustamante, Jacinta/H-7877-2017; Casanova, Jean-Laurent/I-3418-2017; Conti, Francesca/Q-1845-2019; Prando, Carolina/C-4689-2015	Deswarte, Caroline/0000-0002-8775-3368; Condino-Neto, Antonio/0000-0002-1069-3117; Bustamante, Jacinta/0000-0002-3439-2482; Conti, Francesca/0000-0002-3665-8926; Prando, Carolina/0000-0002-9570-9770; Casanova, Jean-Laurent/0000-0002-7782-4169; Cutrim Aragao-Filho, Walmir/0000-0002-8703-9201; PALUMBO, GIUSEPPE/0000-0002-1010-2946; Newburger, Peter/0000-0002-8615-673X	NCATS NIH HHS [UL1 TR000043, 8UL1TR000043] Funding Source: Medline; NIAID NIH HHS [R37AI095983, R37 AI095983] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI095983] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bustamante J, 2007, J ALLERGY CLIN IMMUN, V120, P32, DOI 10.1016/j.jaci.2007.04.034; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Casbon AJ, 2012, J LEUKOCYTE BIOL, V92, P869, DOI 10.1189/jlb.0512244; Condino-Neto A, 2000, BLOOD, V95, P3548, DOI 10.1182/blood.V95.11.3548.011k36_3548_3554; Deffert C, 2014, CELL MICROBIOL, V16, P1168, DOI 10.1111/cmi.12322; Trivedi A, 2012, ADV MICROB PHYSIOL, V60, P263, DOI 10.1016/B978-0-12-398264-3.00004-8; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1393	+		10.1016/j.jaci.2014.11.004	http://dx.doi.org/10.1016/j.jaci.2014.11.004			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CH4DA	25542884	Green Accepted, Green Published			2022-12-18	WOS:000353980700037
J	Forster, A; Blissenbach, B; Machova, A; Leja, S; Rabenhorst, A; Wilmschen, S; Heger, K; Schmidt-Supprian, M; Roers, A; Hartmann, K; Papadopoulou, N				Foerster, Anja; Blissenbach, Birgit; Machova, Alzbeta; Leja, Silke; Rabenhorst, Anja; Wilmschen, Sarah; Heger, Klaus; Schmidt-Supprian, Marc; Roers, Axel; Hartmann, Karin; Papadopoulou, Nikoletta			Dicer is indispensable for the development of murine mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMMON VARIABLE IMMUNODEFICIENCY; MICE		[Foerster, Anja; Leja, Silke; Rabenhorst, Anja; Hartmann, Karin] Univ Cologne, Dept Dermatol, Cologne, Germany; [Blissenbach, Birgit; Machova, Alzbeta; Wilmschen, Sarah; Papadopoulou, Nikoletta] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Heger, Klaus; Schmidt-Supprian, Marc] Tech Univ Munich, Klinikum Rechts Isar, Dept Hematol & Oncol, D-80290 Munich, Germany; [Roers, Axel] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany	University of Cologne; University of Cologne; Technical University of Munich; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Forster, A (corresponding author), Univ Cologne, Dept Dermatol, Cologne, Germany.	nikol.papadopoulou@uni-koeln.de	Schmidt-Supprian, Marc/F-5893-2011; Hartmann, Karin/N-4865-2015; Rabenhorst, Anja/J-3217-2016	Schmidt-Supprian, Marc/0000-0002-8543-6166; Hartmann, Karin/0000-0002-4595-8226; Illerhaus, Anja/0000-0003-0521-203X				Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Chapel H, 2012, J ALLERGY CLIN IMMUN, V130, P1197, DOI 10.1016/j.jaci.2012.05.046; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Montagner S, 2013, IMMUNOL REV, V253, P12, DOI 10.1111/imr.12042; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Xiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098139; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	11	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					1077	1080		10.1016/j.jaci.2014.10.005	http://dx.doi.org/10.1016/j.jaci.2014.10.005			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25457155				2022-12-18	WOS:000352238600036
J	Cao, ZH; Biondo, M; Rayzman, V; Hardy, M; McDonald, A; Busfield, S; Nolte, MW; Wilson, M; Nash, A; Panousis, C				Cao, Zhihui (Helen); Biondo, Mark; Rayzman, Veronika; Hardy, Matthew; McDonald, Anne; Busfield, Samantha; Nolte, Marc W.; Wilson, Michael; Nash, Andrew; Panousis, Con			Development and Characterization of an Anti-FXIIa Monoclonal Antibody for the Treatment of Hereditary Angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Cao, Zhihui (Helen); Biondo, Mark; Rayzman, Veronika; McDonald, Anne; Busfield, Samantha; Wilson, Michael; Nash, Andrew; Panousis, Con] CSL Ltd, Melbourne, Vic, Australia; [Hardy, Matthew] CSL Ltd, M, Australia; [Nolte, Marc W.] CSL Behring, Marburg, Australia	CSL; CSL; CSL									0	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		629	AB194	AB194		10.1016/j.jaci.2014.12.1570	http://dx.doi.org/10.1016/j.jaci.2014.12.1570			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN					2022-12-18	WOS:000361129600628
J	Kottyan, LC; Weirauch, MT; Rothenberg, ME				Kottyan, Leah C.; Weirauch, Matthew T.; Rothenberg, Marc E.			Making it big in allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Big data; computation; genomics; microbiome	EOSINOPHILIC ESOPHAGITIS; ATOPIC-DERMATITIS; DISEASE; GENOME; SENSITIZATION; MICROBIOTA; ASTHMA		[Kottyan, Leah C.; Weirauch, Matthew T.] Univ Cincinnati, Coll Med, Ctr Autoimmune Genom & Etiol, Cincinnati, OH USA; [Weirauch, Matthew T.] Univ Cincinnati, Coll Med, Div Biomed Informat, Cincinnati, OH USA; [Weirauch, Matthew T.] Univ Cincinnati, Coll Med, Div Dev Biol, Cincinnati, OH USA; [Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave,MLC 7028, Cincinnati, OH 45229 USA.	Rothenberg@cchmc.org	Kottyan, Leah C./H-3050-2019; Weirauch, Matthew/M-5459-2019	Kottyan, Leah C./0000-0003-3979-2220; 				Benoist C, 2012, NAT REV IMMUNOL, V12, P734, DOI 10.1038/nri3300; Bin LH, 2014, J ALLERGY CLIN IMMUN, V134, P848, DOI 10.1016/j.jaci.2014.07.018; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bunyavanich S, 2015, J ALLERGY CLIN IMMUN, V135, P31, DOI 10.1016/j.jaci.2014.10.015; Campbell BC, 2015, J ALLERGY CLIN IMMUN, V135, P133, DOI 10.1016/j.jaci.2014.06.034; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/EPI.12.18, 10.2217/epi.12.18]; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fyhrquist N, 2014, J ALLERGY CLIN IMMUN, V134, P1301, DOI 10.1016/j.jaci.2014.07.059; Harb H, 2015, J ALLERGY CLIN IMMUN, V135, P15, DOI 10.1016/j.jaci.2014.11.009; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Lu TX, 2012, J ALLERGY CLIN IMMUN, V129, P1064, DOI 10.1016/j.jaci.2012.01.060; Pascual M, 2014, J ALLERGY CLIN IMMUN, V134, P972, DOI 10.1016/j.jaci.2014.05.015; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Russell SL, 2015, J ALLERGY CLIN IMMUN, V135, P100, DOI 10.1016/j.jaci.2014.06.027; Sircar Gaurab, 2014, Methods Mol Biol, V1184, P165, DOI 10.1007/978-1-4939-1115-8_9; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	21	7	7	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					43	45		10.1016/j.jaci.2014.10.041	http://dx.doi.org/10.1016/j.jaci.2014.10.041			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25567041				2022-12-18	WOS:000347298200005
J	Bouillet, L; Vilgrain, I				Bouillet, Laurence; Vilgrain, Isabelle			VE-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacks	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Bouillet, Laurence] Grenoble Alpes Univ, Dept Internal Med, Grenoble Univ Hosp, France Natl Reference Ctr Angioedema,INSERM,U1036, Grenoble, France; [Vilgrain, Isabelle] Grenoble Alpes Univ, INSERM, U1036, Grenoble, France; [Vilgrain, Isabelle] CEA, DSV iRTSV, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CEA	Bouillet, L (corresponding author), Grenoble Alpes Univ, Dept Internal Med, Grenoble Univ Hosp, France Natl Reference Ctr Angioedema,INSERM,U1036, Grenoble, France.	lbouillet@chu-grenoble.fr		VILGRAIN, Isabelle/0000-0002-5511-5871				Bouillet L, 2011, J ALLERGY CLIN IMMUN, V128, P232, DOI 10.1016/j.jaci.2011.02.017; Cruez J, 2012, J CLIN IMMUNOL, V32, P61; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Kajdacsi E, 2014, J ALLERGY CLIN IMMUN; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Vilgrain I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080056; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855	7	7	8	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2014	134	1					241	241		10.1016/j.jaci.2014.04.016	http://dx.doi.org/10.1016/j.jaci.2014.04.016			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL2BH	24875615				2022-12-18	WOS:000338930300037
J	Amaral, AFS				Amaral, Andre F. S.			Metabolomics of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Amaral, Andre F. S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Amaral, Andre F. S.] MRC, PHE Ctr Environm & Hlth, London, England	Imperial College London	Amaral, AFS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	a.amaral@imperial.ac.uk	Amaral, Andre F. S./M-4202-2019; Amaral, Andre FS/A-7662-2008	Amaral, Andre F. S./0000-0002-0369-9449; Amaral, Andre FS/0000-0002-0369-9449				Fitzpatrick AM, 2014, J ALLERGY CLIN IMMUN, V133; Floegel A, 2013, EUR J CLIN NUTR, V67, P1100, DOI 10.1038/ejcn.2013.147; Gamble C, 2010, J ALLERGY CLIN IMMUN, V126, P1149, DOI 10.1016/j.jaci.2010.08.049; Loureiro CC, 2014, J ALLERGY CLIN IMMUN, V133	4	7	7	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1497	1499		10.1016/j.jaci.2014.02.010	http://dx.doi.org/10.1016/j.jaci.2014.02.010			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24679844				2022-12-18	WOS:000335450700046
J	Garcillan, B; Mazariegos, MS; Fisch, P; Res, PC; Munoz-Ruiz, M; Gil, J; Lopez-Granados, E; Fernandez-Malave, E; Regueiro, JR				Garcillan, Beatriz; Mazariegos, Marina S.; Fisch, Paul; Res, Pieter C.; Munoz-Ruiz, Miguel; Gil, Juana; Lopez-Granados, Eduardo; Fernandez-Malave, Edgar; Regueiro, Jose R.			Enrichment of the rare CD4(+) gamma delta T-cell subset in patients with atypical CD3 delta deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALPHA-BETA; COMPLEXES; TCR		[Garcillan, Beatriz; Mazariegos, Marina S.; Munoz-Ruiz, Miguel; Fernandez-Malave, Edgar; Regueiro, Jose R.] Complutense Univ & Hosp, Octubre Hlth Res Inst 12, Sch Med, Dept Immunol, Madrid, Spain; [Fisch, Paul] Univ Freiburg, Med Ctr, Dept Pathol, D-79106 Freiburg, Germany; [Res, Pieter C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [Gil, Juana] Univ Gregorio Maranon, Gen Hosp, Div Immunol, Madrid, Spain; [Gil, Juana] Gregorio Maranon Hlth Res Inst, Madrid, Spain; [Lopez-Granados, Eduardo] Hosp Univ La Paz, Dept Immunol, Madrid, Spain; [Lopez-Granados, Eduardo] Hosp Univ La Paz, Res Inst IdiPAZ, Madrid, Spain	University of Freiburg; University of Amsterdam; Academic Medical Center Amsterdam; General University Gregorio Maranon Hospital; Hospital Universitario La Paz; Hospital Universitario La Paz	Garcillan, B (corresponding author), Complutense Univ & Hosp, Octubre Hlth Res Inst 12, Sch Med, Dept Immunol, Madrid, Spain.	regueiro@med.ucm.es	Mazariegos, Marina/ABF-9669-2020; Regueiro, José R./B-5499-2014	Regueiro, José R./0000-0001-8442-7762; Munoz-Ruiz, Miguel/0000-0001-7986-3527; Mazariegos, Marina/0000-0002-3298-9461; Garcillan, Beatriz/0000-0002-4748-8280				Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Alibaud L, 2001, SCAND J IMMUNOL, V54, P155, DOI 10.1046/j.1365-3083.2001.00938.x; Gil J, 2011, J CLIN INVEST, V121, P3872, DOI 10.1172/JCI44254; Lee SY, 2010, SEMIN IMMUNOL, V22, P237, DOI 10.1016/j.smim.2010.04.008; Malissen B, 1999, ADV IMMUNOL, V72, P103, DOI 10.1016/S0065-2776(08)60018-8; Marcus N, 2011, J ALLERGY CLIN IMMUN, V128, P1050, DOI 10.1016/j.jaci.2011.05.031; Morgan NV, 2011, J CLIN INVEST, V121, P695, DOI 10.1172/JCI41931; Munoz-Ruiz M, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-3; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Roifman CM, 2004, CURR OPIN ALLERGY CL, V4, P479, DOI 10.1097/00130832-200412000-00002; SPINOZZI F, 1995, MOL MED, V1, P821, DOI 10.1007/BF03401896; SPITS H, 1991, J IMMUNOL, V147, P1180; Villa A, 2008, J ALLERGY CLIN IMMUN, V122, P1082, DOI 10.1016/j.jaci.2008.09.037	13	7	7	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2014	133	4					1205	1208		10.1016/j.jaci.2013.10.002	http://dx.doi.org/10.1016/j.jaci.2013.10.002			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AD8QW	24290291	Green Accepted			2022-12-18	WOS:000333531700033
J	Knight, JM; Lee, SH; Roberts, L; Smith, CW; Weiss, ST; Kheradmand, F; Corry, DB				Knight, John M.; Lee, Seung-Hyo; Roberts, Luz; Smith, C. Wayne; Weiss, Scott T.; Kheradmand, Farrah; Corry, David B.			CD11a polymorphisms regulate T(H)2 cell homing and T(H)2-related disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; allergic disease; CD11a; T(H)2 cell; homing; polymorphism; allele; congenic; biomarker	FUNCTION-ASSOCIATED ANTIGEN-1; ADHESION MOLECULE-1 ICAM-1; I-DOMAIN; LEISHMANIA-MAJOR; LFA-1; INTEGRIN; MICE; EXPRESSION; ASTHMA; LIGAND	Background: T(H)2-dependent diseases vary in severity according to genotype, but relevant gene polymorphisms remain largely unknown. The integrin CD11a is a critical determinant of allergic responses, and allelic variants of this gene might influence allergic phenotypes. Objective: We sought to determine major CD11a allelic variants in mice and human subjects and their importance to allergic disease expression. Methods: We sequenced mouse CD11a alleles from C57BL/6 and BALB/c strains to identify major polymorphisms; human CD11a single nucleotide polymorphisms were compared with allergic disease phenotypes as part of the international HapMap project. Mice on a BALB/c or C57BL/6 background and congenic for the other strain's CD11a allele were created to determine the importance of mouse CD11a polymorphisms in vivo and in vitro. Results: Compared with the C57BL/6 allele, the BALB/c CD11a allele contained a nonsynonymous change from asparagine to aspartic acid within the metal ion binding domain. In general, the BALB/c CD11a allele enhanced and the C57BL/6 CD11a allele suppressed T(H)2 cell-dependent disease caused by the parasite Leishmania major and allergic lung disease caused by the fungus Aspergillus niger. Relative to the C57BL/6 CD11a allele, the BALB/c CD11a allele conferred both greater T-cell adhesion to CD54 in vitro and enhanced T(H)2 cell homing to lungs in vivo. We further identified a human CD11a polymorphism that significantly associated with atopic disease and relevant allergic indices. Conclusions: Polymorphisms in CD11a critically influence T(H)2 cell homing and diverse T(H)2-dependent immunopathologic states in mice and potentially influence the expression of human allergic disease.	[Knight, John M.; Smith, C. Wayne; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Roberts, Luz; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Smith, C. Wayne] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lee, Seung-Hyo] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Weiss, Scott T.] Brigham & Womens Hosp, Dept Med, Channing Lab, Div Network Med, Boston, MA USA; [Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Corry, DB (corresponding author), Baylor Coll Med, 1 Baylor Plaza,Suite 520B, Houston, TX 77030 USA.	dcorry@bcm.tmc.edu	Lee, Seung Hyo/C-1689-2011; Lee, Seung-Hyo/B-9922-2015	Lee, Seung-Hyo/0000-0003-0010-4072	National Institutes of Health [HL75243, AI057696, AI070973, EY018239]; NATIONAL EYE INSTITUTE [R01EY018239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL075243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057696, P30AI036211, U19AI070973] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Supported by National Institutes of Health grants HL75243, AI057696 and AI070973 (to D. B. C.) and EY018239 (to C.W.S.).	ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Corry DB, 2002, NAT REV DRUG DISCOV, V1, P55, DOI 10.1038/nrd702; CORRY DB, 1994, J IMMUNOL, V153, P4142; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ding ZM, 1999, J IMMUNOL, V163, P5029; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GREEN JM, 1994, EUR J IMMUNOL, V24, P265, DOI 10.1002/eji.1830240141; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Himmelrich H, 2000, J IMMUNOL, V164, P4819, DOI 10.4049/jimmunol.164.9.4819; HOLADAY BJ, 1991, J IMMUNOL, V147, P1653; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lee SH, 2008, J IMMUNOL, V180, P4656, DOI 10.4049/jimmunol.180.7.4656; Lee SH, 2004, TRENDS MOL MED, V10, P258, DOI 10.1016/j.molmed.2004.04.002; Lee SY, 2003, J IND ENG CHEM, V9, P9; Leitinger B, 2000, MOL BIOL CELL, V11, P677, DOI 10.1091/mbc.11.2.677; Little DP, 1997, NAT MED, V3, P1413, DOI 10.1038/nm1297-1413; Mariscalco MM, 1998, BLOOD, V91, P4776, DOI 10.1182/blood.V91.12.4776.412k32_4776_4785; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; McDowall A, 1998, J BIOL CHEM, V273, P27396, DOI 10.1074/jbc.273.42.27396; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Porter PC, 2011, INFECT IMMUN, V79, P4459, DOI 10.1128/IAI.05209-11; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sakthianandeswaren A, 2009, TRENDS PARASITOL, V25, P383, DOI 10.1016/j.pt.2009.05.004; Salomon B, 1998, J IMMUNOL, V161, P5138; Sasaki K, 2003, INT IMMUNOL, V15, P701, DOI 10.1093/intimm/dxg066; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; VANSEVENTER GA, 1992, J IMMUNOL, V149, P3872; Zhang Y, 1997, AM J RESP CRIT CARE, V155, P661, DOI 10.1164/ajrccm.155.2.9032210; 1999, CONTROL CLIN TRIALS, V20, P91	38	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					189	+		10.1016/j.jaci.2013.03.049	http://dx.doi.org/10.1016/j.jaci.2013.03.049			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	23726040	Green Accepted, Green Published			2022-12-18	WOS:000329105700026
J	Persson, C				Persson, Carl			Lysis of primed eosinophils in severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELL-DEATH; DEGRANULATION; AIRWAY		Univ Lund Hosp, Dept Clin Pharmacol, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Persson, C (corresponding author), Univ Lund Hosp, Dept Clin Pharmacol, S-22185 Lund, Sweden.	carl.persson@med.lu.se						Erjefalt JS, 2000, AM J RESP CRIT CARE, V161, P2074, DOI 10.1164/ajrccm.161.6.9906085; Fattahi F, 2013, THORAX, V68, P295, DOI 10.1136/thoraxjnl-2012-203023; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Kano G, 2013, J ALLERGY CLIN IMMUN, V132, P437, DOI 10.1016/j.jaci.2013.03.024; Muniz-Junqueira MI, 2013, ALLERGY, V68, P911, DOI 10.1111/all.12176; Ueki S, 2013, BLOOD, V121, P2074, DOI 10.1182/blood-2012-05-432088; Weiler CR, 1996, J LEUKOCYTE BIOL, V60, P493, DOI 10.1002/jlb.60.4.493	7	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1459	1460		10.1016/j.jaci.2013.09.036	http://dx.doi.org/10.1016/j.jaci.2013.09.036			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	24184146				2022-12-18	WOS:000327538200039
J	Gergen, PJ				Gergen, Peter J.			The challenge of treating preschool wheezing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Wheeze	CHILDHOOD ASTHMA; CHILDREN; PREDNISOLONE; FLUTICASONE		NIAID, Div Allergy Immunol & Transplantat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gergen, PJ (corresponding author), NIAID, Div Allergy Immunol & Transplantat, 6610 Rockledge Dr,Rm 6600, Bethesda, MD 20892 USA.	PGergen@niaid.nih.gov						[Anonymous], 3 NAT HEART LUNG BLO; Bacharier LB, 2007, J ALLERGY CLIN IMMUN, V119, P604, DOI 10.1016/j.jaci.2006.12.607; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Beigelman A, 2013, J ALLERGY CLIN IMMUN, V131, P1518, DOI 10.1016/j.jaci.2013.01.034; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Guilbert TW, 2011, J ALLERGY CLIN IMMUN, V128, P956, DOI 10.1016/j.jaci.2011.06.027; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; STORR J, 1987, LANCET, V1, P879; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647	11	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2013	131	6					1526	1527		10.1016/j.jaci.2013.03.011	http://dx.doi.org/10.1016/j.jaci.2013.03.011			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	166CT	23632298				2022-12-18	WOS:000320532800009
J	Trinath, J; Hegde, P; Balaji, KN; Kaveri, SV; Bayry, J				Trinath, Jamma; Hegde, Pushpa; Balaji, Kithiganahalli N.; Kaveri, Srini V.; Bayry, Jagadeesh			Intravenous immunoglobulin-mediated regulation of Notch ligands on human dendritic cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							T-CELLS; DIFFERENTIATION		[Trinath, Jamma; Hegde, Pushpa; Kaveri, Srini V.; Bayry, Jagadeesh] INSERM, U872, Paris, France; [Trinath, Jamma; Balaji, Kithiganahalli N.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Hegde, Pushpa] Univ Technol Compiegne, Compiegne, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent 1, Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 05, Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Natl Inst Immunohaematol, Int Associated Lab IMPACT, Bombay, Maharashtra, India; [Kaveri, Srini V.; Bayry, Jagadeesh] INSERM, Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Indian Council Med Res, New Delhi, India	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore; Picardie Universites; Universite de Technologie de Compiegne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Institut National de la Sante et de la Recherche Medicale (Inserm); Indian Council of Medical Research (ICMR)	Bayry, J (corresponding author), INSERM, U872, Paris, France.	srini.kaveri@crc.jussieu.fr; jagadeesh.bayry@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053				Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; Massoud AH, 2012, J ALLERGY CLIN IMMUN, V129, P1656, DOI 10.1016/j.jaci.2012.02.050; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Tsukumo S, 2004, J IMMUNOL, V173, P7109, DOI 10.4049/jimmunol.173.12.7109; Yvon ES, 2003, BLOOD, V102, P3815, DOI 10.1182/blood-2002-12-3826	6	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1255	1257		10.1016/j.jaci.2013.01.031	http://dx.doi.org/10.1016/j.jaci.2013.01.031			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23465667	Bronze, Green Accepted			2022-12-18	WOS:000317187200048
J	Chinen, J; Notarangelo, LD; Shearer, WT				Chinen, Javier; Notarangelo, Luigi D.; Shearer, William T.			Advances in basic and clinical immunology in 2012	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunology; primary immunodeficiencies; chronic mucocutaneous candidiasis; IL-17; intravenous immunoglobulin; combined variable immunodeficiency; cell immunity; severe combined immunodeficiency; newborn screening	COMMON VARIABLE IMMUNODEFICIENCY; HYPER-IGE SYNDROME; ADENOSINE-DEAMINASE DEFICIENCY; SPLEEN TYROSINE KINASE; IMMUNE-DEFICIENCY; CELL MATURATION; CROHN DISEASE; B-CELLS; DISORDERS; MUTATION	Basic and clinical immunology articles published in the Journal in 2012 were mostly related to the expanding area of primary immunodeficiencies (PIDs). Novel forms of PID were identified by using whole-exome sequencing or after careful examination of flow cytometric data, as in the reports of lymphocyte-specific protein tyrosine kinase, CD27, and CD21 deficiencies. Absent IgG and IgA memory B cells were described in patients with hyper-IgE syndrome, which is consistent with defective antibody response and suggests a potential benefit of immunoglobulin replacement. Impaired production of antibodies to polysaccharide antigens by the human B-cell subset analog to murine B-1 cells was reported in a child with selective polysaccharide antibody deficiency. Increased production of inflammatory cytokines by monocyte-derived cells on Toll-like receptor activation was reported in patients with X-linked agammaglobulinemia, underscoring the important role of Bruton tyrosine kinase in modulation of inflammation. The mechanisms explaining susceptibility to yeast infections and development of chronic mucocutaneous candidiasis were extensively studied. Universal newborn screening for T-cell deficiencies is being implemented in several states, resulting in the diagnosis of a higher number of immunodeficient newborns than previously estimated. The use of laboratory testing to distinguish PIDs from HIV infection was clarified. In the management of PIDs, refinement of indication and strategies to hematopoietic stem cell transplantation resulted in improved outcomes. The use of anti-IL-6 mAbs showed promise as an alternative treatment in patients with Schnitzler syndrome. (J Allergy Clin Immunol 2013;131:675-82.)	[Chinen, Javier; Shearer, William T.] Texas Childrens Hosp, Immunol Allergy & Rheumatol Sect, Dept Pediat, Baylor Coll Med, Houston, TX 77030 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shearer, WT (corresponding author), Texas Childrens Hosp, 1102 Bates St,FC 330-01, Houston, TX 77030 USA.	wtsheare@texaschildrenshospital.org	Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262; Shearer, William/0000-0002-2483-2130	National Institutes of Health (NIH) [RR0188, AI082978, AI036211, AI06944, HD052102]; David Fund of Texas Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD052102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Fund of Texas Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health (NIH) grants RR0188, AI082978, AI036211, AI06944, and HD052102 and the David Fund of Texas Children's Hospital.	Akdis M, 2012, J ALLERGY CLIN IMMUN, V129, P1438, DOI 10.1016/j.jaci.2012.05.003; Alangari A, 2012, J ALLERGY CLIN IMMUN, V130, P481, DOI 10.1016/j.jaci.2012.05.043; Bloch DB, 2012, J ALLERGY CLIN IMMUN, V129, P1678, DOI 10.1016/j.jaci.2012.01.046; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Buckley RH, 2012, J ALLERGY CLIN IMMUN, V129, P597, DOI 10.1016/j.jaci.2011.12.964; Burns SO, 2012, J ALLERGY CLIN IMMUN, V130, P1428, DOI 10.1016/j.jaci.2012.07.035; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2012, J ALLERGY CLIN IMMUN, V130, P1197, DOI 10.1016/j.jaci.2012.05.046; Chou J, 2012, J ALLERGY CLIN IMMUN, V130, P1414, DOI 10.1016/j.jaci.2012.06.012; Cliffe ST, 2012, J ALLERGY CLIN IMMUN, V130, P735, DOI 10.1016/j.jaci.2012.02.054; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Engelhardt KR, 2012, J ALLERGY CLIN IMMUN, V129, P294, DOI [10.1016/j.jaci.2011.12.966, 10.1016/j.jaci.2011.12.972]; Gingo MR, 2012, J ALLERGY CLIN IMMUN, V129, P708, DOI 10.1016/j.jaci.2011.11.015; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; Grunebaum E, 2012, J ALLERGY CLIN IMMUN, V129, P1588, DOI 10.1016/j.jaci.2012.02.003; Hanson IC, 2012, J ALLERGY CLIN IMMUN, V129, P875, DOI 10.1016/j.jaci.2012.01.065; Hauck F, 2012, J ALLERGY CLIN IMMUN, V130, P1144, DOI 10.1016/j.jaci.2012.07.029; Iwata S, 2012, J ALLERGY CLIN IMMUN, V129, P1594, DOI 10.1016/j.jaci.2012.03.014; Janssen CEI, 2012, J ALLERGY CLIN IMMUN, V129, P1076, DOI 10.1016/j.jaci.2012.02.004; Kesserwan C, 2012, J ALLERGY CLIN IMMUN, V129, P762, DOI 10.1016/j.jaci.2011.10.028; Krause K, 2012, J ALLERGY CLIN IMMUN, V129, P848, DOI 10.1016/j.jaci.2011.10.031; Leiding JW, 2012, J ALLERGY CLIN IMMUN, V130, P1030, DOI 10.1016/j.jaci.2012.07.049; Licciardi PV, 2012, J ALLERGY CLIN IMMUN, V129, P794, DOI 10.1016/j.jaci.2011.11.043; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015; Marashi SM, 2012, J ALLERGY CLIN IMMUN, V129, P1349, DOI 10.1016/j.jaci.2012.02.011; Marodi L, 2012, J ALLERGY CLIN IMMUN, V130, P1019, DOI 10.1016/j.jaci.2012.09.011; Marques OC, 2012, J ALLERGY CLIN IMMUN, V129, P778, DOI 10.1016/j.jaci.2011.10.026; Marron TU, 2012, J ALLERGY CLIN IMMUN, V129, P184, DOI 10.1016/j.jaci.2011.10.009; Martinez CA, 2012, J ALLERGY CLIN IMMUN, V129, P176, DOI 10.1016/j.jaci.2011.10.005; Massoud AH, 2012, J ALLERGY CLIN IMMUN, V129, P1656, DOI 10.1016/j.jaci.2012.02.050; McDonald DR, 2012, J ALLERGY CLIN IMMUN, V129, P1429, DOI 10.1016/j.jaci.2012.03.034; Meyer-Bahlburg A, 2012, J ALLERGY CLIN IMMUN, V129, P559, DOI 10.1016/j.jaci.2011.09.017; Micol R, 2012, J ALLERGY CLIN IMMUN, V129, P770, DOI 10.1016/j.jaci.2011.09.047; Ohnishi H, 2012, J ALLERGY CLIN IMMUN, V129, P578, DOI 10.1016/j.jaci.2011.09.042; Pedroza LA, 2012, J ALLERGY CLIN IMMUN, V129, P464, DOI 10.1016/j.jaci.2011.08.027; Posch W, 2012, J ALLERGY CLIN IMMUN, V130, P1368, DOI 10.1016/j.jaci.2012.08.025; Puck JM, 2012, J ALLERGY CLIN IMMUN, V129, P607, DOI 10.1016/j.jaci.2012.01.032; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rachid R, 2012, J ALLERGY CLIN IMMUN, V129, P628, DOI 10.1016/j.jaci.2011.06.047; Roifman CM, 2012, J ALLERGY CLIN IMMUN, V130, P177, DOI 10.1016/j.jaci.2012.04.029; Saltzman RW, 2012, J ALLERGY CLIN IMMUN, V129, P1666, DOI 10.1016/j.jaci.2011.12.1003; Shearer WT, 2012, J ALLERGY CLIN IMMUN, V129, P715, DOI 10.1016/j.jaci.2012.01.035; SHEERIN KA, 1991, J ALLERGY CLIN IMMUN, V87, P803, DOI 10.1016/0091-6749(91)90126-9; Somech R, 2012, J ALLERGY CLIN IMMUN, V130, P539, DOI 10.1016/j.jaci.2012.03.038; Speckmann C, 2012, J ALLERGY CLIN IMMUN, V130, P991, DOI 10.1016/j.jaci.2012.04.004; Spielberger BD, 2012, J ALLERGY CLIN IMMUN, V130, P1426, DOI 10.1016/j.jaci.2012.07.030; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Touzot F, 2012, J ALLERGY CLIN IMMUN, V129, P473, DOI 10.1016/j.jaci.2011.09.043; Tulic MK, 2012, J ALLERGY CLIN IMMUN, V129, P199, DOI 10.1016/j.jaci.2011.10.016; van de Ven AAJM, 2012, J ALLERGY CLIN IMMUN, V129, P755, DOI 10.1016/j.jaci.2011.10.020; van Montfrans JM, 2012, J ALLERGY CLIN IMMUN, V129, P787, DOI 10.1016/j.jaci.2011.11.013; Verbinnen B, 2012, J ALLERGY CLIN IMMUN, V130, P272, DOI 10.1016/j.jaci.2012.04.040; Verbsky J, 2012, J ALLERGY CLIN IMMUN, V129, P622, DOI 10.1016/j.jaci.2011.12.004	54	7	7	0	17	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					675	682		10.1016/j.jaci.2013.01.012	http://dx.doi.org/10.1016/j.jaci.2013.01.012			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23374612				2022-12-18	WOS:000315587800007
J	Engler, DB; Malick, AA; Saraf, SK; Dargel, LA				Engler, David B.; Malick, Alnoor A.; Saraf, Sunil K.; Dargel, Lisa Adams			Severe Marijuana Allergy Controlled with Omalizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Engler, David B.] Houston Allergy & Asthma Clin, Houston, TX USA; [Malick, Alnoor A.] Allergy Clin, Pasadena, TX USA; [Saraf, Sunil K.] Allergy Clin, The Woodlands, TX USA; [Dargel, Lisa Adams] Allergy Clin, Manvel, TX USA										0	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB215	AB215		10.1016/j.jaci.2012.12.1437	http://dx.doi.org/10.1016/j.jaci.2012.12.1437			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800766
J	Maggina, P; Gennery, AR				Maggina, Paraskevi; Gennery, Andrew R.			Classification of primary immunodeficiencies: Need for a revised approach?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Primary immunodeficiency; severe combined immunodeficiency; profound immunodeficiency; combined immunodeficiency; classification	MUTATIONS; DISEASE; DOCK8		[Maggina, Paraskevi; Gennery, Andrew R.] Royal Victoria Infirm, Great N Childrens Hosp, Dept Pediat Immunol & Haematopoeit Stem Cell Tran, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Primary Immunodeficiency Grp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Gennery, AR (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	a.r.gennery@ncl.ac.uk						Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Albert MH, 2012, BONE MARROW TRANSPL, V47, pS59; Arkwright PD, 2011, ANN NY ACAD SCI, V1238, P7, DOI 10.1111/j.1749-6632.2011.06206.x; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Felgentreff K, 2011, CLIN IMMUNOL, V141, P73, DOI 10.1016/j.clim.2011.05.007; Hernandez-Trujillo HS, 2012, CLIN EXP IMMUNOL, V169, P57, DOI 10.1111/j.1365-2249.2012.04588.x; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Niehues T, 2010, CLIN IMMUNOL, V135, P183, DOI 10.1016/j.clim.2010.01.013; Roifman CM, 2012, J ALLERGY CLIN IMMUN, V130, P177, DOI 10.1016/j.jaci.2012.04.029; SELIGMANN M, 1968, AM J MED, V45, P817, DOI 10.1016/0002-9343(68)90180-0; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Villa A, 2008, J ALLERGY CLIN IMMUN, V122, P1082, DOI 10.1016/j.jaci.2008.09.037	16	7	7	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					292	294		10.1016/j.jaci.2012.10.008	http://dx.doi.org/10.1016/j.jaci.2012.10.008			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23174660				2022-12-18	WOS:000314661500003
J	Martinez-Saguer, I; Graff, J; Rusicke, E; Aygoren-Pursun, E; Klingebiel, T; Kreuz, W				Martinez-Saguer, Inmaculada; Graff, Jochen; Rusicke, Eva; Aygoeren-Puersuen, Emel; Klingebiel, Thomas; Kreuz, Wolfhart			Does Early Clinical Manifestation of Hereditary Angioedema (HAE) Influence the Clinical Course of the Disease?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Martinez-Saguer, Inmaculada; Rusicke, Eva; Aygoeren-Puersuen, Emel; Klingebiel, Thomas] JW Goethe Univ Hosp, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital									0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB30	AB30		10.1016/j.jaci.2012.12.789	http://dx.doi.org/10.1016/j.jaci.2012.12.789			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800111
J	Spielberger, BD; Woellner, C; Dueckers, G; Sawalle-Belohradsky, J; Hagl, B; Anslinger, K; Bayer, B; Siepermann, K; Niehues, T; Grimbacher, B; Belohradsky, BH; Renner, ED				Spielberger, Benedikt D.; Woellner, Cristina; Dueckers, Gregor; Sawalle-Belohradsky, Julie; Hagl, Beate; Anslinger, Katja; Bayer, Birgit; Siepermann, Kathrin; Niehues, Tim; Grimbacher, Bodo; Belohradsky, Bernd H.; Renner, Ellen D.			Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GERM-LINE MOSAICISM; MUTATIONS		[Spielberger, Benedikt D.; Sawalle-Belohradsky, Julie; Hagl, Beate; Belohradsky, Bernd H.; Renner, Ellen D.] Univ Munich, Univ Childrens Hosp, Munich, Germany; [Anslinger, Katja; Bayer, Birgit] Univ Munich, Inst Legal Med, Munich, Germany; [Woellner, Cristina; Grimbacher, Bodo] Univ Freiburg, D-79106 Freiburg, Germany; [Woellner, Cristina; Grimbacher, Bodo] Univ Med Ctr Freiburg, CCI, Freiburg, Germany; [Dueckers, Gregor; Siepermann, Kathrin; Niehues, Tim] Helios Kliniken, Childrens Hosp, Krefeld, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich; University of Freiburg; University of Freiburg; Helios Kliniken	Spielberger, BD (corresponding author), Univ Munich, Univ Childrens Hosp, Munich, Germany.	Ellen.Renner@med.lmu.de	Hagl, Beate/R-9266-2016; Renner, Ellen/R-7168-2016	Renner, Ellen/0000-0001-9816-8538; Spielberger, Benedikt/0000-0002-0300-0730; Hagl, Beate/0000-0002-0717-3508				Anslinger Katja, 2005, Legal Medicine, V7, P164, DOI 10.1016/j.legalmed.2005.01.002; ARVEILER B, 1990, AM J HUM GENET, V46, P906; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Newburger PE, 2010, PEDIATR BLOOD CANCER, V55, P314, DOI 10.1002/pbc.22537; PUCK JM, 1995, J CLIN INVEST, V95, P895, DOI 10.1172/JCI117740; Sandrin-Garcia P, 2002, CLIN GENET, V61, P380, DOI 10.1034/j.1399-0004.2002.610511.x; Schimke LF, 2010, J ALLERGY CLIN IMMUN, V126, P611, DOI 10.1016/j.jaci.2010.06.029; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708	11	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2012	130	6					1426	1428		10.1016/j.jaci.2012.07.030	http://dx.doi.org/10.1016/j.jaci.2012.07.030			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	044RP	22981789				2022-12-18	WOS:000311641100030
J	Aalberse, RC				Aalberse, Rob C.			Science from a black box	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergen-specific IgE; recombinant allergens; allergen microarray; test kits; initiator allergen	ALLERGEN; IGE		[Aalberse, Rob C.] Sanquin Blood Supply Fdn, NL-1066 CX Amsterdam, Netherlands; [Aalberse, Rob C.] Acad Med Ctr, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Aalberse, RC (corresponding author), Sanquin Blood Supply Fdn, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	r.aalberse@sanquin.nl						Aalberse RC, 2004, J ALLERGY CLIN IMMUN, V113, P983, DOI 10.1016/j.jaci.2004.02.046; [Anonymous], DOI HDB; Ball T, 2005, FEBS J, V272, P217, DOI 10.1111/j.1432-1033.2004.04403.x; Fernandez-Rivas M, 2006, ARB P EHRLICH I BUND, V95, P84; Hatzler L, 2012, J ALLERGY CLIN IMMUN, V130, P894, DOI 10.1016/j.jaci.2012.05.053; Suck R, 2006, BBA-PROTEINS PROTEOM, V1764, P1701, DOI 10.1016/j.bbapap.2006.09.015; Willumsen N, 2012, CLIN EXP ALLERGY, V42, P1227, DOI 10.1111/j.1365-2222.2012.04009.x	7	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					902	903		10.1016/j.jaci.2012.08.014	http://dx.doi.org/10.1016/j.jaci.2012.08.014			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	23021141				2022-12-18	WOS:000309594800009
J	Rabinovitch, N				Rabinovitch, Nathan			Household mold as a predictor of asthma risk: Recent progress, limitations, and future directions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; children; mold; remediation	RELATIVE MOLDINESS INDEX; ENDOTOXIN; EXPOSURE; CHILDREN; HOMES; AGE		Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA	National Jewish Health	Rabinovitch, N (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	rabinovitchn@njhealth.org						Akinbami Lara J, 2011, Natl Health Stat Report, P1; Cho SH, 2006, ANN ALLERG ASTHMA IM, V97, P539, DOI 10.1016/S1081-1206(10)60947-7; Hirsch T, 2000, ALLERGY, V55, P79, DOI 10.1034/j.1398-9995.2000.00250.x; Krieger J, 2010, PEDIAT ALLER IMM PUL, V23, P139, DOI 10.1089/ped.2010.0022; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; Rabinovitch N, 2005, J ALLERGY CLIN IMMUN, V116, P1053, DOI 10.1016/j.jaci.2005.08.045; Rabinovitch N, 2011, AM J RESP CRIT CARE, V184, P1350, DOI 10.1164/rccm.201010-1706OC; Reponen T, 2012, J ALLERGY CLIN IMMUN, V130, P639, DOI 10.1016/j.jaci.2012.05.030; Reponen T, 2011, ANN ALLERG ASTHMA IM, V107, P120, DOI 10.1016/j.anai.2011.04.018; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Van Dyken SJ, 2011, J IMMUNOL, V187, P2261, DOI 10.4049/jimmunol.1100972; Vesper S, 2007, J OCCUP ENVIRON MED, V49, P829, DOI 10.1097/JOM.0b013e3181255e98; Vesper SJ, 2007, J EXPO SCI ENV EPID, V17, P88, DOI 10.1038/sj.jes.7500528	13	7	7	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2012	130	3					645	646		10.1016/j.jaci.2012.07.006	http://dx.doi.org/10.1016/j.jaci.2012.07.006			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	001LZ	22857791	Bronze			2022-12-18	WOS:000308463500011
J	von Mutius, E				von Mutius, Erika			A fascinating look at the world with a new microscope	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Microbiome; allergy; probiotics			Univ Munich, Dr von Haunersche Kinderklin, D-80337 Munich, Germany	University of Munich	von Mutius, E (corresponding author), Univ Munich, Dr von Haunersche Kinderklin, Lindwurmstr 4, D-80337 Munich, Germany.	Erika.von.Mutius@med.lmu.de		von Mutius, Erika/0000-0002-8893-4515				Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; de Kruif P, 1996, MICROBE HUNTERS, P1; Heederik D, 2012, J ALLERGY C IN PRESS; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hormannsperger G, 2012, J ALLERGY C IN PRESS; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010	7	7	7	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2012	129	5					1202	1203		10.1016/j.jaci.2011.12.994	http://dx.doi.org/10.1016/j.jaci.2011.12.994			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	934CG	22322008				2022-12-18	WOS:000303418000004
J	Harris, JK; Wagner, BD				Harris, J. Kirk; Wagner, Brandie D.			Bacterial identification and analytic challenges in clinical microbiome studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Microbiome; statistics; feature selection	GUT MICROBIOTA; ATOPIC ECZEMA; INFANTS; MICROFLORA		[Harris, J. Kirk] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA; [Wagner, Brandie D.] Univ Colorado, Dept Biostat & Informat, Colorado Sch Publ Hlth, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Harris, JK (corresponding author), Univ Colorado, Dept Pediat, Anschutz Med Campus,13123 E 16th Ave,Box B395, Aurora, CO 80045 USA.	Jonathan.Harris@ucdenver.edu		Wagner, brandie/0000-0002-2745-0103				Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI 10.1586/ERI.10.14; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Penders J, 2006, CLIN EXP ALLERGY, V36, P1602, DOI 10.1111/j.1365-2222.2006.02599.x; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe S, 2003, J ALLERGY CLIN IMMUN, V111, P587, DOI 10.1067/mai.2003.105; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zhou YH, 2011, BIOINFORMATICS, V27, P2672, DOI 10.1093/bioinformatics/btr449	17	7	8	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2					441	442		10.1016/j.jaci.2011.12.969	http://dx.doi.org/10.1016/j.jaci.2011.12.969			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	887TC	22284932				2022-12-18	WOS:000299951700022
J	Koplin, JJ; Martin, PE; Tang, MLK; Gurrin, LC; Lowe, AJ; Osborne, NJ; Robinson, MN; Ponsonby, A; Dharmage, SC; Allen, KJ				Koplin, J. J.; Martin, P. E.; Tang, M. L. K.; Gurrin, L. C.; Lowe, A. J.; Osborne, N. J.; Robinson, M. N.; Ponsonby, A.; Dharmage, S. C.; Allen, K. J.			Do Factors Known to Alter Infant Microbial Exposures Alter the Risk of Food Allergy and Eczema in a Population-based Infant Study?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Koplin, J. J.; Martin, P. E.; Tang, M. L. K.; Ponsonby, A.; Allen, K. J.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Tang, M. L. K.; Robinson, M. N.; Allen, K. J.] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Gurrin, L. C.; Lowe, A. J.; Dharmage, S. C.] Univ Melbourne, Parkville, Vic 3052, Australia; [Osborne, N. J.] Univ Exeter, European Ctr Environm & Human Hlth, Peninsula Coll Med & Dent, Exeter EX4 4QJ, Devon, England	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Exeter; University of Plymouth			Osborne, Nicholas/D-2086-2011; Tang, Mimi/ABD-8350-2020	Osborne, Nicholas/0000-0002-6700-2284; Tang, Mimi/0000-0002-3839-5293					0	7	7	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB231	AB231		10.1016/j.jaci.2011.12.150	http://dx.doi.org/10.1016/j.jaci.2011.12.150			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133401040
J	Renaudin, J; Jacquenet, S; Metz-Favre, C; Baudouin, E; Engel, F; de Blay, F; Moneret-Vautrin, D				Renaudin, J.; Jacquenet, S.; Metz-Favre, C.; Baudouin, E.; Engel, F.; de Blay, F.; Moneret-Vautrin, D.			Interest Of Specific Ige Measurement For Galactose-alpha-1,3-galactose In Unexplained Recurrent Urticaria With Angioedema, Predominantly Nocturnal: About 6 Cases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Renaudin, J.; Baudouin, E.; Moneret-Vautrin, D.] J Monnet Hosp, Dept Allergol, Epinal, France; [Jacquenet, S.] Genclis SAS, Vandoeuvre Les Nancy, France; [Metz-Favre, C.; Engel, F.; de Blay, F.] Univ Hosp, Dept Pneumol, Strasbourg, France										0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB177	AB177		10.1016/j.jaci.2011.12.226	http://dx.doi.org/10.1016/j.jaci.2011.12.226			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400669
J	Kerkhof, M; Daley, D; Postma, DS; Park, JE; Yeung, MC; Wijga, AH; Gehring, U; de Jongste, JC; Smit, HA; Brunekreef, B; van Schayck, OCP; Becker, A; Koppelman, GH				Kerkhof, Marjan; Daley, Denise; Postma, Dirkje S.; Park, Julie E.; Yeung, Moira Chan; Wijga, Alet H.; Gehring, Ulrike; de Jongste, Johan C.; Smit, Henriette A.; Brunekreef, Bert; van Schayck, Onno C. P.; Becker, Allan; Koppelman, Gerard H.			Opposite effects of allergy prevention depending on CD14 rs2569190 genotype in 3 intervention studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDHOOD ASTHMA; ENDOTOXIN; PROTEINS; EXPOSURE; RISK; AGE		[Kerkhof, Marjan] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Daley, Denise; Park, Julie E.] Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Yeung, Moira Chan] Univ British Columbia, Occupat & Environm Lung Dis Unit, Vancouver, BC V5Z 1M9, Canada; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Gehring, Ulrike; Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [de Jongste, Johan C.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Smit, Henriette A.; Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van Schayck, Onno C. P.] Maastricht Univ, Care & Publ Hlth Res Inst Caphri, Maastricht, Netherlands; [Becker, Allan] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Becker, Allan] Univ Manitoba, Fac Med, Dept Community Hlth Sci, Winnipeg, MB, Canada	University of Groningen; University of Groningen; University of Groningen; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; Netherlands National Institute for Public Health & the Environment; Utrecht University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Utrecht University; Utrecht University Medical Center; Maastricht University; University of Manitoba; University of Manitoba	Kerkhof, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	denise.daley@hli.ubc.ca	Koppelman, Gerard/AAG-9187-2020	brunekreef, bert/0000-0001-9908-0060; Gehring, Ulrike/0000-0003-3612-5780; Koppelman, Gerard/0000-0001-8567-3252	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Chan-Yeung M, 2005, J ALLERGY CLIN IMMUN, V116, P49, DOI 10.1016/j.jaci.2005.03.029; Corver K, 2006, PEDIAT ALLERG IMM-UK, V17, P329, DOI 10.1111/j.1399-3038.2006.00410.x; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; Douwes J, 2006, J ALLERGY CLIN IMMUN, V117, P1067, DOI 10.1016/j.jaci.2006.02.002; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez Fernando D, 2007, Proc Am Thorac Soc, V4, P221, DOI 10.1513/pats.200702-035AW; Sherburn RE, 2004, FEMS IMMUNOL MED MIC, V42, P76, DOI 10.1016/j.femsim.2004.06.011; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; van Schayck OCP, 2007, J ALLERGY CLIN IMMUN, V119, P1323, DOI 10.1016/j.jaci.2007.02.024; Woodcock A, 2004, AM J RESP CRIT CARE, V170, P433, DOI 10.1164/rccm.200401-083OC	11	7	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					256	259		10.1016/j.jaci.2011.08.040	http://dx.doi.org/10.1016/j.jaci.2011.08.040			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	21996339				2022-12-18	WOS:000298634000036
J	Carballada, FJ; Gonzalez-Quintela, A; Nunez, R; Vidal, C; Boquete, M				Carballada, Francisco-Javier; Gonzalez-Quintela, Arturo; Nunez, Ramon; Vidal, Carmen; Boquete, Manuel			Low prevalence of IgE to cross-reactive carbohydrate determinants in beekeepers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNOGLOBULIN-E; ALCOHOL-CONSUMPTION; CLINICAL-RELEVANCE; HYMENOPTERA VENOM; SENSITIZATION; POLLEN		[Carballada, Francisco-Javier; Nunez, Ramon; Boquete, Manuel] Hosp Lucus Augusti, Dept Allergy, Lugo, Spain; [Gonzalez-Quintela, Arturo] Hosp Clin Univ, Dept Med, Santiago De Compostela, Spain; [Vidal, Carmen] Hosp Clin Univ, Dept Allergy, Santiago De Compostela, Spain	Hospital Universitario Lucus Augusti-Lugo; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Carballada, FJ (corresponding author), Hosp Lucus Augusti, Dept Allergy, Lugo, Spain.	arturo.gonzalez.quintela@usc.es		Gonzalez-Quintela, Arturo/0000-0002-6909-1807				AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Carballada FJ, 2010, J INVEST ALLERG CLIN, V20, P484; Coutinho V, 2008, ANN ALLERG ASTHMA IM, V101, P394, DOI 10.1016/S1081-1206(10)60316-X; Gonzalez-Quintela A, 2008, CLIN EXP ALLERGY, V38, P152, DOI 10.1111/j.1365-2222.2007.02863.x; Kochuyt AM, 2005, CLIN EXP ALLERGY, V35, P441, DOI 10.1111/j.1365-2222.2005.02217.x; Linneberg A, 2010, INT ARCH ALLERGY IMM, V153, P86, DOI 10.1159/000301583; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Vidal C, 2012, INT ARCH ALLERGY IMM, V157, P176, DOI 10.1159/000324447	9	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2011	128	6					1350	1352		10.1016/j.jaci.2011.08.002	http://dx.doi.org/10.1016/j.jaci.2011.08.002			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	865WX	21890185	Bronze			2022-12-18	WOS:000298342700028
J	Kuijpers, TW; Baars, PA; aan de Kerk, DJ; Jansen, MH; Derks, IAM; Bredius, RGM; Sanders, EAM; van der Burg, M; Alders, M; van Lier, RAW				Kuijpers, Taco W.; Baars, Paul A.; aan de Kerk, Daan J.; Jansen, Machiel H.; Derks, Ingrid A. M.; Bredius, Robbert G. M.; Sanders, Elisabeth A. M.; van der Burg, Mirjam; Alders, Marielle; van Lier, Rene A. W.			A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC VIRAL-INFECTION; CHAIN		[Kuijpers, Taco W.; aan de Kerk, Daan J.; Jansen, Machiel H.] Emma Childrens Hosp, Amsterdam, Netherlands; [Baars, Paul A.; aan de Kerk, Daan J.; Jansen, Machiel H.; Derks, Ingrid A. M.; van Lier, Rene A. W.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Alders, Marielle] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Bredius, Robbert G. M.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [Sanders, Elisabeth A. M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [van der Burg, Mirjam] Erasmus MC, Dept Immunol, Rotterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Erasmus University Rotterdam; Erasmus MC	Kuijpers, TW (corresponding author), Emma Childrens Hosp, Amsterdam, Netherlands.	t.w.kuijpers@amc.uva.nl	Bredius, Robbert/AAF-2592-2019	van Lier, Rene/0000-0002-3201-7144; Bredius, Robbert/0000-0001-8151-1539				BROOKS EG, 1990, J CLIN INVEST, V86, P1623, DOI 10.1172/JCI114884; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Morelon E, 1996, BLOOD, V88, P1708; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sharfe N, 1997, J CLIN INVEST, V100, P3036, DOI 10.1172/JCI119858; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tepper RS, 2008, J ALLERGY CLIN IMMUN, V122, P760, DOI 10.1016/j.jaci.2008.07.022; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; YAO W, 2010, J ALLERGY CLIN IMMUN, V126; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194	12	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2011	128	6					1360	1363		10.1016/j.jaci.2011.07.001	http://dx.doi.org/10.1016/j.jaci.2011.07.001			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	865WX	21831415				2022-12-18	WOS:000298342700033
J	Elmallah, MK; Khan, Y; Hochhaus, G; Shuster, JJ; Hendeles, L				Elmallah, Mai K.; Khan, Yasmeen; Hochhaus, Guenther; Shuster, Jonathan J.; Hendeles, Leslie			Systemic exposure to fluticasone MDI delivered through antistatic chambers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INHALED CORTICOSTEROIDS; PROPIONATE; CHILDREN; BIOAVAILABILITY		[Elmallah, Mai K.] Univ Florida, Coll Med, Dept Pediat, Div Pulm, Gainesville, FL 32611 USA; [Hochhaus, Guenther] Univ Florida, Dept Pharmaceut, Gainesville, FL USA; [Shuster, Jonathan J.] Univ Florida, Dept Hlth Outcomes & Policy, Gainesville, FL USA; [Hendeles, Leslie] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Khan, Yasmeen] Univ Miami, W Palm, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Elmallah, MK (corresponding author), Univ Florida, Coll Med, Dept Pediat, Div Pulm, Gainesville, FL 32611 USA.	hendeles@cop.ufl.edu	Shuster, Jonathan/ABB-5773-2021	Shuster, Jonathan/0000-0001-9499-5616; Hochhaus, Guenther/0000-0002-7406-5558; ElMallah, Mai/0000-0002-1775-1156	NCRR NIH HHS [C06 RR017568, RR17568, U54RR025208, M01RR00082, M01 RR000082] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017568, M01RR000082] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Eid N, 2002, PEDIATRICS, V109, P217, DOI 10.1542/peds.109.2.217; *GLAXOSMITHKLINE, FULL PRESCR INF FLOV; Khan Y, 2006, J PEDIATR-US, V149, P793, DOI 10.1016/j.jpeds.2006.08.022; Krishnaswami S, 2000, J PHARMACEUT BIOMED, V22, P123, DOI 10.1016/S0731-7085(99)00246-0; Lipworth BJ, 1997, THORAX, V52, P686, DOI 10.1136/thx.52.8.686; Meibohm B, 1999, J PHARMACOKINET BIOP, V27, P127, DOI 10.1023/A:1020670421957; Nair A, 2009, BRIT J CLIN PHARMACO, V67, P191, DOI 10.1111/j.1365-2125.2008.03350.x; Nelson HS, 2002, J CLIN PHARMACOL, V42, P319, DOI 10.1177/00912700222011355; 2011, NATL ASTHMA ED PREVE	9	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2011	128	5					1113	1115		10.1016/j.jaci.2011.06.014	http://dx.doi.org/10.1016/j.jaci.2011.06.014			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	842FJ	21783234	Green Accepted			2022-12-18	WOS:000296578200030
J	Reinartz, SM; van Tongeren, J; van Egmond, D; de Groot, EJJ; Fokkens, WJ; van Drunen, CM				Reinartz, Susanne M.; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J. J.; Fokkens, Wytske J.; van Drunen, Cornelis M.			Dendritic cells in nasal mucosa of subjects with different allergic sensitizations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACCUMULATION; INFLAMMATION; RHINITIS		[Reinartz, Susanne M.; van Tongeren, Joost; van Egmond, Danielle; de Groot, Esther J. J.; Fokkens, Wytske J.; van Drunen, Cornelis M.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Reinartz, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.m.reinartz@amc.uva.nl	Fokkens, Wytske WJ/ABF-2185-2020	van Drunen, Cornelis M/0000-0001-5503-066X				Canonica GW, 2009, CLIN EXP IMMUNOL, V158, P260, DOI 10.1111/j.1365-2249.2009.04017.x; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Ekman AK, 2011, INT ARCH ALLERGY IMM, V155, P234, DOI 10.1159/000320480; Hammad H, 2006, J ALLERGY CLIN IMMUN, V118, P331, DOI 10.1016/j.jaci.2006.03.041; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; Reinartz SM, 2009, RHINOLOGY, V47, P192; Van Pottelberge GR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-35; 2008, ALLERGY, V63, P1124	10	7	7	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2011	128	4					887	+		10.1016/j.jaci.2011.06.001	http://dx.doi.org/10.1016/j.jaci.2011.06.001			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	841UA	21752442				2022-12-18	WOS:000296538100029
J	Bullens, DMA; Kasran, A; Dilissen, E; De Swert, K; Coorevits, L; Van Snick, J; Ceuppens, JL				Bullens, Dominique M. A.; Kasran, Ahmad; Dilissen, Ellen; De Swert, Kathleen; Coorevits, Lieve; Van Snick, Jacques; Ceuppens, Jan L.			In vivo maturation of T-H cells in relation to atopy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGEN; SENSITIZATION; DERMATITIS; LIFE		[Bullens, Dominique M. A.] Katholieke Univ Leuven, Dept Woman & Child, Louvain, Belgium; [Bullens, Dominique M. A.; Kasran, Ahmad; Dilissen, Ellen; De Swert, Kathleen; Coorevits, Lieve; Ceuppens, Jan L.] Katholieke Univ Leuven, Dept Expt Med, Louvain, Belgium; [Van Snick, Jacques] Ludwig Inst Canc Res, Brussels, Belgium	KU Leuven; KU Leuven; Ludwig Institute for Cancer Research	Bullens, DMA (corresponding author), Katholieke Univ Leuven, Dept Woman & Child, Louvain, Belgium.	Dominique.Bullens@med.kuleuven.be	Bullens, Dominique M A/T-6211-2017; ceuppens, jan/F-2819-2010	Bullens, Dominique M A/0000-0002-4595-9579; Ceuppens, Jan/0000-0003-4502-2679				Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Bullens DMA, 1999, CLIN EXP IMMUNOL, V118, P384; Devos S, 2006, CLIN EXP ALLERGY, V36, P174, DOI 10.1111/j.1365-2222.2006.02422.x; Hagendorens MM, 2004, PEDIAT ALLERG IMM-UK, V15, P308, DOI 10.1111/j.1399-3038.2004.00169.x; Herberth G, 2010, PEDIAT ALLERG IMM-UK, V21, P5, DOI 10.1111/j.1399-3038.2009.00890.x; Jenmalm MC, 2001, CLIN EXP ALLERGY, V31, P1528, DOI 10.1046/j.1365-2222.2001.01190.x; Matricardi PM, 2009, ALLERGY, V64, P1093, DOI 10.1111/j.1398-9995.2009.02055.x; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53	10	7	7	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					234	237		10.1016/j.jaci.2011.02.033	http://dx.doi.org/10.1016/j.jaci.2011.02.033			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21439621	Green Accepted			2022-12-18	WOS:000292245600039
J	Kulis, M; Wan, CK; Gorentla, BK; Burks, AW; Zhong, XP				Kulis, Mike; Wan, Chi-Keung; Gorentla, Balachandra K.; Burks, A. Wesley; Zhong, Xiao-Ping			Diacylglycerol kinase zeta deficiency in a non-CD4(+) T-cell compartment leads to increased peanut hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FOOD ALLERGY; RESPONSES; MICE; SENSITIZATION		[Kulis, Mike; Wan, Chi-Keung; Gorentla, Balachandra K.; Burks, A. Wesley; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat Allergy & Immunol, Durham, NC 27706 USA; [Burks, A. Wesley; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Duke University	Kulis, M (corresponding author), Duke Univ, Med Ctr, Dept Pediat Allergy & Immunol, Durham, NC 27706 USA.	Wesley.burks@duke.edu		Wan, Edwin/0000-0003-4783-3029	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079088, F32AI084332, R01AI076357, R21AI079873] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI079088-03, 1R21-AI079873, R01 AI076357-01A1, R01 AI079088, F32AI084332, R01 AI079088-01, R01 AI079088-02, R21 AI079873, R01 AI076357-02, F32 AI084332, R01 AI076357, R21 AI079873-01, R01 AI076357-03, R21 AI079873-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berin MC, 2006, ALLERGY, V61, P64, DOI 10.1111/j.1398-9995.2006.01012.x; Brandtzaeg P, 2010, NAT REV GASTRO HEPAT, V7, P380, DOI 10.1038/nrgastro.2010.80; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Morafo V, 2003, J ALLERGY CLIN IMMUN, V111, P1122, DOI 10.1067/mai.2003.1463; Pons L, 2004, J ALLERGY CLIN IMMUN, V114, P915, DOI 10.1016/j.jaci.2004.06.049; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Shreffler WG, 2009, J ALLERGY CLIN IMMUN, V123, P43, DOI [10.1016/j.jaci.2008.12.1128, 10.1016/j.jaci.2008.09.051]; van Wijk F, 2007, CLIN EXP ALLERGY, V37, P572, DOI 10.1111/j.1365-2222.2007.02681.x; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	9	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					212	214		10.1016/j.jaci.2011.02.035	http://dx.doi.org/10.1016/j.jaci.2011.02.035			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21439625	Green Accepted			2022-12-18	WOS:000292245600028
J	Roussel, L; Robins, S; Schachter, A; Berube, J; Hamid, Q; Rousseau, S				Roussel, Lucie; Robins, Stephanie; Schachter, Amanda; Berube, Julie; Hamid, Qutayba; Rousseau, Simon			Steroids and extracellular signal-regulated kinase 1/2 activity suppress activating transcription factor 3 expression in patients with severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NEGATIVE REGULATOR; INFLAMMATION		[Roussel, Lucie; Robins, Stephanie; Schachter, Amanda; Berube, Julie; Hamid, Qutayba; Rousseau, Simon] McGill Univ, Meakins Christie Labs, Heath Ctr, Res Inst, Montreal, PQ, Canada	McGill University	Roussel, L (corresponding author), McGill Univ, Meakins Christie Labs, Heath Ctr, Res Inst, Montreal, PQ, Canada.	simon.rousseau@mcgill.ca		Rousseau, Simon/0000-0002-8773-575X; Robins, Stephanie/0000-0001-6248-9209				Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162	9	7	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1632	1634		10.1016/j.jaci.2011.03.034	http://dx.doi.org/10.1016/j.jaci.2011.03.034			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21514952				2022-12-18	WOS:000291048500050
J	Koletzko, S; Filipiak-Pittroff, B; von Berg, A; Grubl, A; Heinrich, J; Kramer, U; Wichmann, HE; Bauer, CP; Reinhardt, D; Berdel, D				Koletzko, Sibylle; Filipiak-Pittroff, Birgit; von Berg, Andrea; Gruebl, Armin; Heinrich, Joachim; Kraemer, Ursula; Wichmann, H. -Erich; Bauer, Carl-Peter; Reinhardt, Dietrich; Berdel, Dietrich		German Infant Nutr Intervention	Supplementation with cow's milk at birth is not recommended	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFANT NUTRITIONAL INTERVENTION; HYDROLYZED FORMULAS; ESPGHAN COMMITTEE; ALLERGY; AGE		[Koletzko, Sibylle; Reinhardt, Dietrich] Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany; [Filipiak-Pittroff, Birgit; Heinrich, Joachim; Wichmann, H. -Erich] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [von Berg, Andrea; Berdel, Dietrich] Marien Hosp Wesel, Dept Pediat, Wesel, Germany; [Gruebl, Armin] Tech Univ Munich, Dept Pediat, D-8000 Munich, Germany; [Kraemer, Ursula; Bauer, Carl-Peter] Univ Dusseldorf, Inst Umweltmed Forsch IUF, Dusseldorf, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; St. Marien Hospital; Technical University of Munich; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Koletzko, S (corresponding author), Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany.	sibylle.koletzko@med.uni-muenchen.de	Heinrich, Joachim/N-1720-2013; Wichmann, Heinz Erich/AAA-5695-2022	Heinrich, Joachim/0000-0002-9620-1629; 				Agostoni C, 2006, J PEDIATR GASTR NUTR, V42, P352, DOI 10.1097/01.mpg.0000189358.38427.cd; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Klemola T, 2002, J PEDIATR-US, V140, P219, DOI 10.1067/mpd.2002.121935; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; von Berg A, 2008, J ALLERGY CLIN IMMUN, V121, P1442, DOI 10.1016/j.jaci.2008.04.021; von Berg A, 2007, J ALLERGY CLIN IMMUN, V119, P718, DOI 10.1016/j.jaci.2006.11.017	8	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2011	127	3					836	838		10.1016/j.jaci.2010.11.051	http://dx.doi.org/10.1016/j.jaci.2010.11.051			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730FG	21281962				2022-12-18	WOS:000288018400045
J	Romano, A; Pichler, WJ; Blanca, M				Romano, Antonino; Pichler, Werner J.; Blanca, Miguel			Highlights of the 4th Drug Hypersensitivity Meeting-Rome, April 22-25, 2010 Preface	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									[Romano, Antonino] IRCCS Oasi Maria SS, Troina, Italy; [Pichler, Werner J.] Univ Bern, Inselspital, Div Allergol, Clin Rheumatol & Clin Immunol Allergol, CH-3012 Bern, Switzerland; [Blanca, Miguel] Carlos Haya Hosp, Allergy Serv, Malaga, Spain; [Romano, Antonino] Complesso Integrato Columbus, Allergy Unit, I-00168 Rome, Italy	IRCCS Oasi Maria SS; University of Bern; University Hospital of Bern; Hospital Carlos Haya	Romano, A (corresponding author), Complesso Integrato Columbus, Unita Allergol, Via G Moscati 31, I-00168 Rome, Italy.	antoninoromano@h-columbus.it	Romano, Antonino/D-3102-2017	Romano, Antonino/0000-0001-9742-9898; Pichler, Werner J./0000-0002-8117-359X					0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2011	127	3		S			S59	S59		10.1016/j.jaci.2010.12.1090	http://dx.doi.org/10.1016/j.jaci.2010.12.1090			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	743NJ	21354500				2022-12-18	WOS:000289024700001
J	Chinen, J; Shearer, WT				Chinen, Javier; Shearer, William T.			Advances in basic and clinical immunology in 2010	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunology; primary immunodeficiencies; B cell; innate immunity; hereditary angioedema; drug allergy; cell immunity; severe combined immunodeficiency; newborn screening	SEVERE COMBINED-IMMUNODEFICIENCY; T-CELLS; POLYENDOCRINOPATHY	Reports in basic and clinical immunology in 2010 reflected the use of state-of-the-art genetic and immunologic tools to characterize the pathogenesis of immunologic diseases and the development of novel therapies directed to these conditions. B-cell biology has been explained in greater detail, significantly with lessons from the genetic defects found in the humoral immunodeficiencies. Therapeutic mAbs are given for an increasing number of indications, such as anti-CD20 antibodies or rituximab, which was initially developed for non-Hodgkin lymphomas and is currently used in diverse autoimmune and inflammatory disorders. The report of an infant with severe combined immunodeficiency (SCID) in Massachusetts detected by means of newborn screening and successfully treated with hematopoietic stem cell transplantation validated recent efforts toward newborn screening for SCID. Improvement of survival outcomes for patients with primary immunodeficiencies treated with hematopoietic stem cell transplantation was demonstrated in a large European cohort, with significant appreciation of the type of donor graft, particularly the use of HLA-matched unrelated donors for patients with non-SCID. Progress in cellular mechanisms of drug hypersensitivity included the characterization of nitroso-modified drug metabolites as potent T-cell activators and the identification of the relocation of plasmacytoid dendritic cells from blood to skin as a potential risk factor for reactivation of viral disease. (J Allergy Clin Immunol 2011;127:336-41.)	[Chinen, Javier; Shearer, William T.] Texas Childrens Hosp, Allergy & Immunol Sect, Dept Pediat, Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Chinen, J (corresponding author), Texas Childrens Hosp, Allergy & Immunol Sect, Dept Pediat, Baylor Coll Med, 1102 Bates St FC 330-01, Houston, TX 77030 USA.	jchinen@bcm.edu		Shearer, William/0000-0002-2483-2130	National Institute of Health [RR0188, AI082978, AI36211, AI069441, HD052102]; Texas Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD052102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188, K01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069441, P30AI036211, UM1AI069441] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institute of Health grants RR0188, AI082978, AI36211, AI069441, and HD052102 and the David Fund of Texas Children's Hospital.	Ananworanich J, 2010, J ALLERGY CLIN IMMUN, V126, P1294, DOI 10.1016/j.jaci.2010.09.038; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Balloch A, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.008; Buckley RH, 2010, J ALLERGY CLIN IMMUN, V125, P790, DOI 10.1016/j.jaci.2010.02.012; Burroughs LM, 2010, J ALLERGY CLIN IMMUN, V126, P1000, DOI 10.1016/j.jaci.2010.05.021; Cassani B, 2010, J ALLERGY CLIN IMMUN, V125, P209, DOI 10.1016/j.jaci.2009.10.023; Castrejon JL, 2010, J ALLERGY CLIN IMMUN, V125, P411, DOI 10.1016/j.jaci.2009.10.031; Farcet MR, 2010, J ALLERGY CLIN IMMUN, V125, P198, DOI 10.1016/j.jaci.2009.09.008; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Hale JE, 2010, J ALLERGY CLIN IMMUN, V126, P1073, DOI 10.1016/j.jaci.2010.08.043; Jung JA, 2010, J ALLERGY CLIN IMMUN, V125, P217, DOI 10.1016/j.jaci.2009.10.045; Kainulainen L, 2010, J ALLERGY CLIN IMMUN, V126, P120, DOI 10.1016/j.jaci.2010.04.016; Kaplan AP, 2010, J ALLERGY CLIN IMMUN, V126, P918, DOI 10.1016/j.jaci.2010.08.012; Kwok WW, 2010, J ALLERGY CLIN IMMUN, V125, P1407, DOI 10.1016/j.jaci.2010.03.037; Lee JJ, 2010, J ALLERGY CLIN IMMUN, V126, P1234, DOI 10.1016/j.jaci.2010.08.017; Lee S, 2010, J ALLERGY CLIN IMMUN, V125, P814, DOI 10.1016/j.jaci.2010.02.025; Loock J, 2010, J ALLERGY CLIN IMMUN, V125, P500, DOI 10.1016/j.jaci.2009.10.066; Lopez-Lera A, 2010, J ALLERGY CLIN IMMUN, V126, P1307, DOI 10.1016/j.jaci.2010.07.037; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Mandala WL, 2010, J ALLERGY CLIN IMMUN, V125, P203, DOI 10.1016/j.jaci.2009.10.010; Marodi L, 2010, J ALLERGY CLIN IMMUN, V126, P910, DOI 10.1016/j.jaci.2010.08.009; McDonald DR, 2010, J ALLERGY CLIN IMMUN, V126, P1304, DOI 10.1016/j.jaci.2010.07.034; McDonald DR, 2010, J ALLERGY CLIN IMMUN, V126, P332, DOI 10.1016/j.jaci.2010.05.013; McDonald DR, 2010, J ALLERGY CLIN IMMUN, V126, pe3; McMurchy AN, 2010, J ALLERGY CLIN IMMUN, V126, P1242, DOI 10.1016/j.jaci.2010.09.001; Mooster JL, 2010, J ALLERGY CLIN IMMUN, V126, P127, DOI 10.1016/j.jaci.2010.04.026; Ng WF, 2010, J ALLERGY CLIN IMMUN, V126, P1006, DOI 10.1016/j.jaci.2010.08.027; Puga I, 2010, J ALLERGY CLIN IMMUN, V126, P889, DOI 10.1016/j.jaci.2010.09.026; Roifman CM, 2010, J ALLERGY CLIN IMMUN, V126, P1226, DOI 10.1016/j.jaci.2010.07.029; Sugita K, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.06.004; Trifari S, 2010, J ALLERGY CLIN IMMUN, V125, P439, DOI 10.1016/j.jaci.2009.11.034; Vale AM, 2010, J ALLERGY CLIN IMMUN, V125, P778, DOI 10.1016/j.jaci.2010.02.018; Woellner C, 2010, J ALLERGY CLIN IMMUN, V125, P424, DOI 10.1016/j.jaci.2009.10.059	34	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2					336	341		10.1016/j.jaci.2010.11.042	http://dx.doi.org/10.1016/j.jaci.2010.11.042			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	714KH	21281863	Green Accepted			2022-12-18	WOS:000286808000004
J	Horak, F; Zieglmayer, P; Zieglmayer, R; Lemell, P; Newkirk, M; Manjarrez, K; Randall, TD; Hershberg, R				Horak, F.; Zieglmayer, P.; Zieglmayer, R.; Lemell, P.; Newkirk, M.; Manjarrez, K.; Randall, T. D.; Hershberg, R.			Intranasal Toll-like Receptor 8 Agonist (VTX-1463) Significantly Improves Symptoms of Allergic Rhinitis in a Randomized, Placebo-Controlled Trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Horak, F.; Zieglmayer, P.; Zieglmayer, R.; Lemell, P.] Vienna Challenge Chamber, Vienna, Austria; [Newkirk, M.; Manjarrez, K.; Randall, T. D.; Hershberg, R.] VentiRx Pharmaceut, Seattle, WA USA				Zieglmayer, Petra/AAG-1006-2020						0	7	7	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB199	AB199		10.1016/j.jaci.2010.12.790	http://dx.doi.org/10.1016/j.jaci.2010.12.790			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI		Bronze			2022-12-18	WOS:000295846400771
J	Lumry, WR; Li, HH; Levy, RJ; Potter, PC; Farkas, H; Reshef, A; Moldovan, D; Riedl, M; Li, H; Bloom, BJ				Lumry, W. R.; Li, H. H.; Levy, R. J.; Potter, P. C.; Farkas, H.; Reshef, A.; Moldovan, D.; Riedl, M.; Li, H.; Bloom, B. J.			Results From FAST-3: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Subcutaneous Icatibant in Patients with Acute Hereditary Angioedema (HAE) Attacks	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Lumry, W. R.] Asthma Allergy Res Associates Res Ctr, Dallas, TX USA; [Li, H. H.] Inst Asthma & Allergy, Chevy Chase, MD USA; [Levy, R. J.] Family Allergy & Asthma Ctr, Atlanta, GA USA; [Potter, P. C.] Univ Cape Town, Lung Inst, Mowbray, South Africa; [Farkas, H.] Semmelweis Univ, Budapest, Hungary; [Reshef, A.] Sheba Med Ctr, Tel Aviv, Israel; [Moldovan, D.] Univ Med & Pharm, Targu Mures, Romania; [Riedl, M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Li, H.; Bloom, B. J.] Shire Human Genet Therapies Inc, Cambridge, MA USA	University of Cape Town; Semmelweis University; Chaim Sheba Medical Center; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shire Pharmaceuticals Limited			Reshef, Avner/AAL-3638-2020						0	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB1	AB1		10.1016/j.jaci.2011.01.004	http://dx.doi.org/10.1016/j.jaci.2011.01.004			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400003
J	Katz, Y; Goldberg, MR; Stein, M; Levy, M				Katz, Yitzhak; Goldberg, Michael R.; Stein, Miguel; Levy, Michael			Oral immunotherapy: Ready for prime time?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Katz, Yitzhak; Goldberg, Michael R.; Stein, Miguel; Levy, Michael] Assaf Harofeh Med Ctr, Allergy & Immunol Inst, IL-70300 Zerifin, Israel; [Katz, Yitzhak] Tel Aviv Univ, Sackler Fac Med, Dept Pediat, IL-69978 Tel Aviv, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Katz, Y (corresponding author), Assaf Harofeh Med Ctr, Allergy & Immunol Inst, IL-70300 Zerifin, Israel.	ykatz49@gmail.com						Atkins D, 2009, CURR ALLERGY ASTHM R, V9, P179, DOI 10.1007/s11882-009-0027-0; Frew AJ, 2010, J ALLERGY CLIN IMMUN, V125, pS306, DOI 10.1016/j.jaci.2009.10.064; Thyagarajan A, 2010, J ALLERGY CLIN IMMUN, V126, P31, DOI 10.1016/j.jaci.2010.05.012	3	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					289	290		10.1016/j.jaci.2010.08.053	http://dx.doi.org/10.1016/j.jaci.2010.08.053			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21040954				2022-12-18	WOS:000285917300054
J	Keith, P; Lee, LA				Keith, Paul; Lee, Laurie A.			Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ADOLESCENTS; ADULTS; POLLEN		[Keith, Paul] McMaster Univ, Hamilton, ON, Canada; [Lee, Laurie A.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	McMaster University; GlaxoSmithKline	Keith, P (corresponding author), McMaster Univ, Hamilton, ON, Canada.	laurie.a.lee@gsk.com						Andrews CP, 2009, ALLERGY ASTHMA PROC, V30, P128, DOI 10.2500/aap.2009.30.3204; Antman EM, 2003, CIRCULATION, V108, P2604, DOI 10.1161/01.CIR.0000090571.83005.CE; Baumann D, 2009, CLIN EXP ALLERGY, V39, P1540, DOI 10.1111/j.1365-2222.2009.03306.x; Fokkens WJ, 2007, ALLERGY, V62, P1078, DOI 10.1111/j.1398-9995.2007.01522.x; Guidance for Industry, 2010, GUIDANCE IN IN PRESS; Jacobs R, 2009, CURR MED RES OPIN, V25, P1393, DOI 10.1185/03007990902890512; Kaiser HB, 2007, J ALLERGY CLIN IMMUN, V119, pS232, DOI 10.1016/j.jaci.2006.12.278; Keith PK, 2009, CURR MED RES OPIN, V25, P2021, DOI 10.1185/03007990903094106; Martin BG, 2007, ALLERGY ASTHMA PROC, V28, P216, DOI 10.2500/aap.2007.28.2983; Prenner BM, 2010, J ALLERGY CLIN IMMUN, V125, P1247, DOI 10.1016/j.jaci.2010.03.004; *SCHER PLOUGH, 2008, TRIAL P05067	11	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					288	289		10.1016/j.jaci.2010.08.046	http://dx.doi.org/10.1016/j.jaci.2010.08.046			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21047674				2022-12-18	WOS:000285917300052
J	Vaidyanathan, S; Williamson, P; Clearie, K; Morrison, A; Lipworth, B				Vaidyanathan, Sriram; Williamson, Peter; Clearie, Karine; Morrison, Ashley; Lipworth, Brian			Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Nasal hyperreactivity; nasal provocation; adenosine monophosphate; histamine; peak nasal inspiratory flow rate; nasal airway resistance	ADENOSINE-MONOPHOSPHATE; CORTICOSTEROID RESPONSE; ACOUSTIC RHINOMETRY; CONSENSUS REPORT; INFLAMMATION; PROVOCATION; RHINOMANOMETRY; CETIRIZINE; MEDIATORS; RELEASE	Background: Nasal hyperreactivity is a prominent feature of allergic rhinitis. Variation in nasal hyperreactivity with different challenge agents in and out of the pollen season has not been examined. Objective: We sought to compare nasal hyperreactivity with different challenge agents before, during, and after the pollen season. Methods: Grass pollen-monosensitized patients performed cumulative-dose challenges with nasal AMP (25-800 mg . mL(-1)) and histamine (0.25-8 mg . mL(-1)) before, during, and after the grass pollen season. Outcomes included the provocative concentration of agent causing a 30% decrease in the peak nasal inspiratory flow (PNIF) (PC30), recovery profile, and diary cards. Results: Nineteen participants completed per protocol. AMP PC30 values for PNIF worsened by 1.33 (95% CI, 0.20-2.44; P = .02) doubling dilutions during the season but recovered after the season. The AMP recovery curve showed a 214.39% difference (95% CI, -21.11% to -7.66%; P < .001) during the season and remained abnormal after the season (-8.05% [95% CI, -14.78% to -1.33%; P <.05). Histamine PC30 values did not change during the season, but recovery was prolonged by 214.47% (95% CI, 222.19% to -6.76%, P < .001), returning to baseline values after the season. Nasal symptoms, domiciliary PNIF, and serum eosinophil-derived neurotoxin levels returned to baseline values after the season. Conclusions: There is a reduction in AMP PC threshold but not histamine PC threshold during the pollen season, indicating that AMP is a more sensitive indicator of allergic inflammation. The residual hyperreactivity to nasal AMP, but not histamine, outside of the pollen season, seen as a persistently prolonged recovery curve, suggests the presence of primed airway mucosal mast cells, even in asymptomatic patients, and persistent activation of mediator pathways, such as cysteinyl leukotrienes. (J Allergy Clin Immunol 2011;127:173-8.)	[Vaidyanathan, Sriram; Williamson, Peter; Clearie, Karine; Morrison, Ashley; Lipworth, Brian] Univ Dundee, Asthma & Allergy Res Grp, Ctr Cardiovasc & Lung Biol, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, B (corresponding author), Univ Dundee, Asthma & Allergy Res Grp, Ctr Cardiovasc & Lung Biol, Dundee DD1 9SY, Scotland.	brianlipworth@gmail.com						[Anonymous], 2005, AM J RESP CRIT CARE, V171, P912; Barnes ML, 2006, ALLERGY, V61, P1319, DOI 10.1111/j.1398-9995.2006.01165.x; Bonini S, 2007, ALLERGY, V62, P683, DOI 10.1111/j.1398-9995.2007.01382.x; CHURCH MK, 1983, BRIT J PHARMACOL, V80, P719, DOI 10.1111/j.1476-5381.1983.tb10063.x; Ciprandi G, 1997, ANN ALLERG ASTHMA IM, V79, P507, DOI 10.1016/S1081-1206(10)63057-8; Clement PAR, 2005, RHINOLOGY, V43, P169; Cockcroft DW, 2007, ANN ALLERG ASTHMA IM, V98, P498, DOI 10.1016/S1081-1206(10)60768-5; COCKCROFT DW, 1983, CHEST, V84, P505, DOI 10.1378/chest.84.4.505; Currie GP, 2003, ALLERGY, V58, P762, DOI 10.1034/j.1398-9995.2003.00226.x; Holgate ST, 2002, AM J RESP CRIT CARE, V165, P317, DOI 10.1164/ajrccm.165.3.2112045a; Howarth PH, 1997, ALLERGY, V52, P12, DOI 10.1111/j.1398-9995.1997.tb04878.x; Kurowski M, 2004, ALLERGY, V59, P280, DOI 10.1046/j.1398-9995.2003.00416.x; Lee DKC, 2004, BRIT J CLIN PHARMACO, V57, P714, DOI 10.1111/j.1365-2125.2004.02072.x; Litvyakova LI, 2001, ANN ALLERG ASTHMA IM, V86, P355, DOI 10.1016/S1081-1206(10)62478-7; MIADONNA A, 1987, AM REV RESPIR DIS, V136, P357, DOI 10.1164/ajrccm/136.2.357; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; POLOSA R, 1995, AM J RESP CRIT CARE, V151, P624; Ricca V, 2000, J ALLERGY CLIN IMMUN, V105, P54, DOI 10.1016/S0091-6749(00)90177-5; Sims EJ, 2002, RHINOLOGY, V40, P66; Vaidyanathan S, 2009, CLIN EXP ALLERGY, V39, P409, DOI 10.1111/j.1365-2222.2008.03166.x; Vaidyanathan S, 2009, ANN ALLERG ASTHMA IM, V102, P76, DOI 10.1016/S1081-1206(10)60112-3; van den Berge M, 2002, CLIN EXP ALLERGY, V32, P824, DOI 10.1046/j.1365-2222.2002.01385.x; Venge P, 2004, ALLERGY, V59, P26, DOI 10.1046/j.1398-9995.2003.00386.x; Wilson AM, 2003, RHINOLOGY, V41, P16; Wilson AM, 2003, BRIT J CLIN PHARMACO, V55, P354, DOI 10.1046/j.1365-2125.2003.01776.x; WILSON J, 1988, ANN OTO RHINOL LARYN, V97, P389, DOI 10.1177/000348948809700411; Wuestenberg EG, 2004, AM J RHINOL, V18, P371, DOI 10.1177/194589240401800606	27	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					173	U273		10.1016/j.jaci.2010.09.006	http://dx.doi.org/10.1016/j.jaci.2010.09.006			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21211652				2022-12-18	WOS:000285917300025
J	Matsuda, A; Ebihara, N; Yokoi, N; Maruyama, K; Hamuro, J; Kinoshita, S; Murakami, A				Matsuda, Akira; Ebihara, Nobuyuki; Yokoi, Norihiko; Maruyama, Kazuichi; Hamuro, Junji; Kinoshita, Shigeru; Murakami, Akira			Lymphoid neogenesis in the giant papillae of patients with chronic allergic conjunctivitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							C1 INHIBITOR DYSFUNCTION; VERNAL KERATOCONJUNCTIVITIS; HEREDITARY ANGIOEDEMA; IGE; DANAZOL; CELLS		[Matsuda, Akira; Ebihara, Nobuyuki; Murakami, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Yokoi, Norihiko; Maruyama, Kazuichi; Hamuro, Junji; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Juntendo University; Kyoto Prefectural University of Medicine	Matsuda, A (corresponding author), Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan.	akimatsu@juntendo.ac.jp	Matsuda, Akira/A-9981-2010; Maruyama, Kazuichi/GRX-8129-2022	Matsuda, Akira/0000-0002-0792-3663; Maruyama, Kazuichi/0000-0001-6283-5466				Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Barney NP, 2005, CORNEA FUNDAMENTALS, V2nd, P667; Ebihara N, 2002, JPN J OPHTHALMOL, V46, P357, DOI 10.1016/S0021-5155(02)00507-5; GELFAND JA, 1976, NEW ENGL J MED, V295, P1444, DOI 10.1056/NEJM197612232952602; Gould HJ, 2006, TRENDS IMMUNOL, V27, P446, DOI 10.1016/j.it.2006.08.007; JABARA HH, 1991, J IMMUNOL, V147, P1557; Janciauskiene S, 2004, HEPATOLOGY, V40, P1203, DOI 10.1002/hep.20451; Matsuda A, 2010, INVEST OPHTH VIS SCI, V51, P151, DOI 10.1167/iovs.09-4183; Matsuda A, 2009, INVEST OPHTH VIS SCI, V50, P2871, DOI 10.1167/iovs.08-3022; MONTAN PG, 1995, OPHTHALMOLOGY, V102, P725, DOI 10.1016/S0161-6420(95)30962-1; Pappalardo E, 2003, IMMUNOL LETT, V86, P271, DOI 10.1016/S0165-2478(03)00029-4; Takhar P, 2005, J IMMUNOL, V174, P5024, DOI 10.4049/jimmunol.174.8.5024; WISNIESKI JJ, 1994, J IMMUNOL, V152, P3199; ZAHEDI R, 1995, J CLIN INVEST, V95, P1299, DOI 10.1172/JCI117780; Zahedi R, 1997, J IMMUNOL, V159, P983	15	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2010	126	6					1310	1312		10.1016/j.jaci.2010.06.001	http://dx.doi.org/10.1016/j.jaci.2010.06.001			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	689RZ	20638114				2022-12-18	WOS:000284947800035
J	Basheer, M; Schwalb, H; Nesher, M; Gilon, D; Shefler, I; Mekori, YA; Shapira, OM; Gorodetsky, R				Basheer, Maamoun; Schwalb, Herzl; Nesher, Maoz; Gilon, Dan; Shefler, Irit; Mekori, Yoseph A.; Shapira, Oz M.; Gorodetsky, Raphael			Mast cell activation by fibrinogen-related homologous c-terminal peptides (haptides) modulates systemic blood pressure	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Haptides; fibrin; mast cells; hypotension; histamine; serotonin	ACUTE MYOCARDIAL-INFARCTION; D-DIMER; BETA-CHAIN; STREPTOKINASE; DEGRANULATION; RECEPTORS; CLEAVAGE; PLASMIN; 5-HYDROXYTRYPTAMINE; CLASSIFICATION	Background: Haptides are a family of short peptides homologous to C-termini sequences of fibrinogen chains beta and gamma (haptides C beta and preC gamma, respectively) which were previously shown to penetrate and bind cells. Objectives: This work investigates the systemic effect of the haptides with possible clinical implications. Methods: Intra-arterial monitoring in rats recorded the haptides' effects on systemic blood pressure. In parallel, their effect was also tested in vitro on isolated rat peritoneal mast cells and on human mast cells. Results: Intra-arterial monitoring in rats showed that intravenous administration of low haptides concentrations (35-560 mu g/kg rat) caused a shocklike behavior with transient decrease in the systolic and diastolic blood pressure by up to 55% (P < .05) in a dose-dependent manner and a minor increase in their heart rate. Randomly scrambled sequences of the haptides had no such effect, suggesting a specific interaction with receptors. Intravenous administration of blockers to histamine receptors H1 and H2 before haptides administration attenuated this effect. Furthermore, in vitro incubation of human LAD2 mast cell line or isolated rat peritoneal mast cells with the haptides caused degranulation of the mast cells. We found that the haptides C beta and preC gamma activated mast cells causing histamine release, resulting in a steep decrease in blood pressure, comparable to anaphylactic shock. Conclusion: In treating vascular occlusive diseases, massive fibrinolysis is induced, and haptide-containing sequences are released. We suggest that treatment with histamine receptor blockers or with mast cell stabilizing agents in such pathological conditions may overcome this effect. (J Allergy Clin Immunol 2010;126:1041-8.)	[Basheer, Maamoun; Gorodetsky, Raphael] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Biotechnol & Radiobiol Lab, IL-91120 Jerusalem, Israel; [Schwalb, Herzl; Shapira, Oz M.] Hadassah Hebrew Univ, Med Ctr, Dept Cardiothorac Surg, Cardiothorac & Thorac Res Ctr, IL-91120 Jerusalem, Israel; [Nesher, Maoz] Hadassah Hebrew Univ, Med Ctr, Dept Physiol, IL-91120 Jerusalem, Israel; [Gilon, Dan] Hadassah Hebrew Univ, Med Ctr, Dept Cardiol, IL-91120 Jerusalem, Israel; [Shefler, Irit; Mekori, Yoseph A.] Meir Med Ctr, Lab Allergy & Clin Immunol, Kefar Sava, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Gorodetsky, R (corresponding author), Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Biotechnol & Radiobiol Lab, POB 12000, IL-91120 Jerusalem, Israel.	rafi@hadassah.org.il	, Rafi/GPW-8563-2022		Hoffman-Leadership program; Sizeler Family Limited P/S, New Orleans, La (Joseph Lunenfeld Cardiac Surgery Center)	Hoffman-Leadership program; Sizeler Family Limited P/S, New Orleans, La (Joseph Lunenfeld Cardiac Surgery Center)	Supported in part by the Hoffman-Leadership program (to M.B.) and Sizeler Family Limited P/S, New Orleans, La (Joseph Lunenfeld Cardiac Surgery Center).	Altiay G, 2007, CLIN ONCOL-UK, V19, P494, DOI 10.1016/j.clon.2007.04.002; ARIDOR M, 1990, J CELL BIOL, V111, P909, DOI 10.1083/jcb.111.3.909; Baglin T, 1996, BMJ-BRIT MED J, V312, P683; Bankl HC, 2002, THROMB RES, V105, P359, DOI 10.1016/S0049-3848(02)00016-6; Basheer M, 2010, J VASC RES, V47, P507, DOI 10.1159/000313878; Bhattacharyya SP, 1998, J LEUKOCYTE BIOL, V63, P337, DOI 10.1002/jlb.63.3.337; CHALUPOWICZ DG, 1995, J CELL BIOL, V130, P207, DOI 10.1083/jcb.130.1.207; Devillier P, 2008, CLIN PHARMACOKINET, V47, P217, DOI 10.2165/00003088-200847040-00001; Estelle F, 2008, J ALLERGY CLIN IMMUN, V121, pS402, DOI 10.1016/j.jaci.2007.08.061; FRANCIS CW, 1993, BLOOD CELLS, V19, P291; FU YP, 1995, GENOMICS, V30, P71, DOI 10.1006/geno.1995.0010; GAFFNEY PJ, 1976, CARDIOVASC RES, V10, P421, DOI 10.1093/cvr/10.4.421; GEMMILL JD, 1993, EUR HEART J, V14, P819, DOI 10.1093/eurheartj/14.6.819; Glogar D, 1996, AM HEART J, V132, P465, DOI 10.1016/S0002-8703(96)90337-3; Gorodetsky R, 2004, J CONTROL RELEASE, V95, P477, DOI 10.1016/j.jconrel.2003.12.023; Gorodetsky R, 2003, EXP CELL RES, V287, P116, DOI 10.1016/S0014-4827(03)00120-4; Gorodetsky R, 1998, J LAB CLIN MED, V131, P269, DOI 10.1016/S0022-2143(98)90100-7; HOYER D, 1994, PHARMACOL REV, V46, P157; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; LEW AS, 1985, CIRCULATION, V72, P1321, DOI 10.1161/01.CIR.72.6.1321; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; LUCAS MA, 1983, ANN NY ACAD SCI, V408, P71, DOI 10.1111/j.1749-6632.1983.tb23235.x; MARDER VJ, 1969, J BIOL CHEM, V244, P2111; MARTIN GR, 1994, PHARMACOL THERAPEUT, V62, P283, DOI 10.1016/0163-7258(94)90048-5; Marx G, 2008, J BIOMED MATER RES B, V84B, P571, DOI 10.1002/jbm.b.30905; McRedmond JP, 2000, BLOOD, V95, P1301, DOI 10.1182/blood.V95.4.1301.004k24_1301_1308; Menon V, 2004, CHEST, V126, p549S, DOI 10.1378/chest.126.3_suppl.549S; Michiels Jan Jacques, 2005, Semin Vasc Med, V5, P311, DOI 10.1055/s-2005-922475; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Nee PA, 1997, J ACCID EMERG MED, V14, P2; Oki T, 2006, J IMMUNOL, V176, P52, DOI 10.4049/jimmunol.176.1.52; Pachai A, 1997, APMIS, V105, P650, DOI 10.1111/j.1699-0463.1997.tb05067.x; PAGE IH, 1953, AM J PHYSIOL, V174, P436, DOI 10.1152/ajplegacy.1953.174.3.436; POUNDER R, 1988, BAILLIERE CLIN GASTR, V2, P593, DOI 10.1016/S0950-3528(88)80007-1; RIBES JA, 1989, J CLIN INVEST, V84, P435, DOI 10.1172/JCI114184; Salamon P, 2008, J ALLERGY CLIN IMMUN, V121, P448, DOI 10.1016/j.jaci.2007.08.054; SAXENA PR, 1990, J CARDIOVASC PHARM, V15, pS17, DOI 10.1097/00005344-199001001-00004; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; Shalita-Chesner M, 1998, MOL CELL ENDOCRINOL, V142, P49, DOI 10.1016/S0303-7207(98)00119-1; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; SPORN LA, 1995, BLOOD, V86, P1802, DOI 10.1182/blood.V86.5.1802.bloodjournal8651802; Tick LW, 2008, J INTERN MED, V264, P195, DOI 10.1111/j.1365-2796.2008.01972.x; Villalon CM, 2007, N-S ARCH PHARMACOL, V376, P45, DOI 10.1007/s00210-007-0179-1; Villalon CM, 1997, BRIT J PHARMACOL, V120, P1319, DOI 10.1038/sj.bjp.0701020; Villalon CM, 1997, BRIT J PHARMACOL, V121, P1187, DOI 10.1038/sj.bjp.0701260; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wojtecka-Lukasik E, 1992, J Physiol Pharmacol, V43, P173	49	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2010	126	5					1041	1048		10.1016/j.jaci.2010.07.020	http://dx.doi.org/10.1016/j.jaci.2010.07.020			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	674HB	20832847				2022-12-18	WOS:000283727100022
J	Yanishevsky, Y; Daly, D; Cullinane, C; Hourihane, JO				Yanishevsky, Yarden; Daly, Deirdre; Cullinane, Claire; Hourihane, Jonathan O'B			Differences in treatment of food challenge-induced reactions reflect physicians' protocols more than reaction severity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN		[Yanishevsky, Yarden; Daly, Deirdre; Cullinane, Claire; Hourihane, Jonathan O'B] Natl Univ Ireland Univ Coll Cork, Cork, Ireland	University College Cork	Yanishevsky, Y (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork, Ireland.	yardenya@gmail.com						Jarvinen KM, 2009, J ALLERGY CLIN IMMUN, V124, P1267, DOI 10.1016/j.jaci.2009.10.006; Sicherer SH, 2000, J ALLERGY CLIN IMMUN, V105, P582, DOI 10.1067/mai.2000.104941; Taylor SL, 2009, FOOD CHEM TOXICOL, V47, P1198, DOI 10.1016/j.fct.2009.02.011	3	7	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2010	126	1					182	182		10.1016/j.jaci.2010.03.038	http://dx.doi.org/10.1016/j.jaci.2010.03.038			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	627SE	20569975	Bronze			2022-12-18	WOS:000280061800039
J	Stutius, LM; Pessach, I; Lee, J; Lo, MS; Levy, S; Schram, P; Schizer, M; Wong, J; Phipatanakul, W; Umetsu, DT				Stutius, Lisa M.; Pessach, Itai; Lee, Joanne; Lo, Mindy S.; Levy, Sharon; Schram, Patricia; Schizer, Miriam; Wong, Jackson; Phipatanakul, Wanda; Umetsu, Dale T.			Sublingual desensitization for buprenorphine hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Stutius, Lisa M.; Pessach, Itai; Lo, Mindy S.; Phipatanakul, Wanda; Umetsu, Dale T.] Childrens Hosp Boston, Div Immunol, Boston, MA USA; [Lee, Joanne] Childrens Hosp Boston, Dept Pharm, Boston, MA USA; [Levy, Sharon; Schram, Patricia; Schizer, Miriam] Childrens Hosp Boston, Adolescent Subst Abuse Program, Boston, MA USA; [Wong, Jackson] Childrens Hosp Boston, Med Crit Care Program, Boston, MA USA; [Stutius, Lisa M.; Pessach, Itai; Lo, Mindy S.; Levy, Sharon; Schram, Patricia; Schizer, Miriam; Phipatanakul, Wanda; Umetsu, Dale T.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Stutius, LM (corresponding author), Childrens Hosp Boston, Div Immunol, Boston, MA USA.	lisa.stutius@childrens.harvard.edu			NIAID NIH HHS [T32 AI007512-24, T32 AI007512] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boothby LA, 2007, AM J HEALTH-SYST PH, V64, P266, DOI 10.2146/ajhp060403; HARLE DG, 1989, ANESTHESIOLOGY, V71, P489, DOI 10.1097/00000542-198910000-00003; Hulst KV, 2008, CONTACT DERMATITIS, V59, P366, DOI 10.1111/j.1600-0536.2008.01472.x; Mathelier-Fusade P, 2006, CLIN REV ALLERG IMMU, V30, P19, DOI 10.1385/CRIAI:30:1:019; Nasser SMS, 2001, CLIN EXP ALLERGY, V31, P1014, DOI 10.1046/j.1365-2222.2001.01090.x; *RECK BENCK PHARM, 2006, SUB PACK INS; Scadding G, 2009, J ASTHMA, V46, P322, DOI 10.1080/02770900902785729; Shepherd GM, 2003, MT SINAI J MED, V70, P113; WOODHAM M, 1988, ANAESTHESIA, V43, P806, DOI 10.1111/j.1365-2044.1988.tb05784.x	9	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2010	125	4					938	939		10.1016/j.jaci.2009.12.982	http://dx.doi.org/10.1016/j.jaci.2009.12.982			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	584XP	20226512	Green Accepted			2022-12-18	WOS:000276787900022
J	Sastre, J; Sastre, B; Fernandez-Nieto, M; Perez-Canto, I; Sanchez, JJ; del Pozo, V				Sastre, Joaquin; Sastre, Beatriz; Fernandez-Nieto, Mar; Perez-Canto, Ignacio; Sanchez, Jose Javier; del Pozo, Victoria			Serum ferritin and transferrin levels are not serologic markers of toluene diisocyanate-induced occupational asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Sastre, Joaquin; Fernandez-Nieto, Mar] Minist Hlth, Inst Carlos 3, Dept Allergy, Madrid, Spain; [Sastre, Beatriz; del Pozo, Victoria] Minist Hlth, Inst Carlos 3, Dept Immunol, Fdn Jimenez Diaz Capio, Madrid, Spain; [Sastre, Beatriz; del Pozo, Victoria] Minist Hlth, Inst Carlos 3, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Sanchez, Jose Javier] Univ Autonoma Madrid, Dept Prevent Med, Fac Med, E-28049 Madrid, Spain; [Perez-Canto, Ignacio] Mutua MAZ, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Madrid	Sastre, J (corresponding author), Minist Hlth, Inst Carlos 3, Dept Allergy, Madrid, Spain.	jsastre@fjd.es	Sastre, Beatriz/F-1715-2015	Sastre, Beatriz/0000-0002-2394-6849				Aul DJ, 1999, J ALLERGY CLIN IMMUN, V103, P749, DOI 10.1016/S0091-6749(99)70415-X; Hur GY, 2008, J ALLERGY CLIN IMMUN, V122, P774, DOI 10.1016/j.jaci.2008.07.034; Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103; Sastre J, 2003, CHEST, V123, P1276, DOI 10.1378/chest.123.4.1276; VOGELMEIER C, 1991, INT ARCH OCC ENV HEA, V63, P9, DOI 10.1007/BF00406191	5	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2010	125	3					762	764		10.1016/j.jaci.2009.11.004	http://dx.doi.org/10.1016/j.jaci.2009.11.004			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	573BK	20132970				2022-12-18	WOS:000275883200043
J	Greenberger, PA				Greenberger, Paul A.			Personalized medicine for patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; variability; polymorphisms; corticosteroid; adherence	CHILDHOOD ASTHMA; POLYMORPHISMS; MONTELUKAST; PREDICTORS; OUTCOMES		[Greenberger, Paul A.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Dept Med, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine	Greenberger, PA (corresponding author), 676 N St Clair St,14018, Chicago, IL 60611 USA.	p-greenberger@northwestern.edu	Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498				Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; FitzGerald JM, 2010, J ALLERGY CLIN IMMUN, V125, P307, DOI 10.1016/j.jaci.2009.12.978; Flockhart DA, 2007, PRINCIPLES OF CLINICAL PHARMACOLOGY, 2ND EDITION, P179, DOI 10.1016/B978-012369417-1/50053-5; Global Initiative for Asthma, NIH PUBL, V02-3659; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; GREENBERGER PA, 2009, PATTERSONS ALLERGIC, P333; Hawkins GA, 2008, PHARMACOGENOMICS, V9, P349, DOI 10.2217/14622416.9.3.349; Kazani S, 2010, J ALLERGY CLIN IMMUN, V125, P295, DOI 10.1016/j.jaci.2009.12.014; Knuffman JE, 2009, J ALLERGY CLIN IMMUN, V123, P411, DOI 10.1016/j.jaci.2008.11.016; Lima JJ, 2006, AM J RESP CRIT CARE, V173, P379, DOI 10.1164/rccm.200509-1412OC; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Naik AD, 2009, NEW ENGL J MED, V360, P1929, DOI 10.1056/NEJMp0902195; National Heart Lung and Blood Institute, 2007, NIH PUBL; Niebauer K, 2006, ANN ALLERG ASTHMA IM, V96, P316, DOI 10.1016/S1081-1206(10)61242-2; Peters SP, 2007, J ALLERGY CLIN IMMUN, V119, P1454, DOI 10.1016/j.jaci.2007.03.022; Sharma S, 2008, J ALLERGY CLIN IMMUN, V122, P921, DOI 10.1016/j.jaci.2008.09.004; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Szefler SJ, 2010, J ALLERGY CLIN IMMUN, V125, P285, DOI 10.1016/j.jaci.2009.10.026; Tantisira KG, 2009, J ALLERGY CLIN IMMUN, V124, P422, DOI 10.1016/j.jaci.2009.06.035; Tantisira KG, 2009, PHARMACOGENET GENOM, V19, P244, DOI 10.1097/FPC.0b013e328326e0b1	22	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2					305	306		10.1016/j.jaci.2009.11.038	http://dx.doi.org/10.1016/j.jaci.2009.11.038			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	558RU	20159238	Bronze			2022-12-18	WOS:000274764000003
J	Asero, R; Tedeschi, A; Cugno, M				Asero, Riccardo; Tedeschi, Alberto; Cugno, Massimo			Is the autologous plasma skin test in patients with chronic urticaria really useless?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							TISSUE FACTOR; SERUM		[Asero, Riccardo] Clin San Carlo, Paderno Dugnano, MI, Italy; [Tedeschi, Alberto; Cugno, Massimo] Fdn IRCCS, Osped Maggiore Policlin Mangiagalli & Regina Elen, Unita Operat Allergol & Immunol Clin, Milan, Italy; [Cugno, Massimo] Univ Milan, Fdn IRCCS, Osped Maggiore Policlin Mangiagalli & Regina Elen, Dipartimento Med Interna, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Asero, R (corresponding author), Clin San Carlo, Paderno Dugnano, MI, Italy.	r.asero@libero.it	Cugno, Massimo/K-8106-2016	Cugno, Massimo/0000-0002-9918-0763				Asero R, 2006, J ALLERGY CLIN IMMUN, V117, P1113, DOI 10.1016/j.jaci.2005.12.1343; Asero R, 2007, J ALLERGY CLIN IMMUN, V119, P705, DOI 10.1016/j.jaci.2006.08.043; Cugno M, 2009, INT ARCH ALLERGY IMM, V148, P170, DOI 10.1159/000155748; Fujii K, 2008, J DERMATOL, V35, P308, DOI 10.1111/j.1346-8138.2008.00474.x; Metz M, 2009, J ALLERGY CLIN IMMUN, V123, P705, DOI 10.1016/j.jaci.2008.11.040; Taskapan O, 2008, CLIN EXP DERMATOL, V33, P754, DOI 10.1111/j.1365-2230.2008.02819.x; WANG F, 2009, J ALLERGY CLIN IMMUN	7	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2009	123	6					1417	1417		10.1016/j.jaci.2009.02.039	http://dx.doi.org/10.1016/j.jaci.2009.02.039			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	455WO	19423154				2022-12-18	WOS:000266799100040
J	Misiak, RT; Wegienka, G; Havstad, S; Ownby, DR; Johnson, CC; Zoratti, EM				Misiak, Rana Tawil; Wegienka, Ganesa; Havstad, Suzanne; Ownby, Dennis R.; Johnson, Christine Cole; Zoratti, Edward M.			Specific allergic sensitization in parents and their 18-year-old offspring in the Suburban Detroit Childhood Allergy Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen-specific IgE	GENETIC-CONTROL; IGE; RHINITIS; ASTHMA; RISK; ASSOCIATIONS; RESPONSES; COCKROACH; SYMPTOMS; CHILDREN	Background: Allergic sensitization is increased among offspring of sensitized parents. Objective: We sought to evaluate whether 18-year-old offspring are likely to have the same allergic sensitizations as their parents. Methods: Eighteen-year-old participants in an unselected birth cohort and their parents were tested for total and increased (> 0.35 kU/L) levels of allergen-specific IgE to 6 allergens: Dermatophagoides farinae, dog, cat, grass, ragweed, and Alternaria alternata. Results: In 316 parent-teen triads parental sensitization to any of 6 allergens was associated with teen sensitization to any of those same allergens. An increased risk of matched sensitization (ie, a teen has an increased risk of being sensitized to the same specific allergen as their parent) was found after adjusting for the spouse's sensitivities and adjusting for other allergens (ie, the parent had an allergic sensitization but not to the particular allergen under analysis). Risk of maternal matched sensitization with their teen to cat (adjusted odds ratio [aOR], 2.1; 95% CI, 1.0-4.5), grass (aOR, 2.5; 95% CI, 1.2-5.2), and A alternata (aOR, 2.4; 95% CI, 1.1-5.5) was increased when compared with that seen in teens without parental allergen-specific sensitization. Similarly, a higher than expected risk of paternal matched sensitization with their teen to dog (aOR, 2.7; 95% CI, 1.3-5.9), D farinae (aOR, 2.7; 95% CI, 1.4-5.1), and grass (aOR, 2.7; 95% CI, 1.5-5.9) was observed. Conclusion: Parental allergen-specific IgE increases the likelihood of sensitization to the same allergen in young adult offspring. (J Allergy Clin Immunol 2009;123:1401-6.)	[Misiak, Rana Tawil; Zoratti, Edward M.] Henry Ford Hosp, Dept Internal Med, Div Allergy, Detroit, MI 48202 USA; [Wegienka, Ganesa; Havstad, Suzanne; Johnson, Christine Cole] Henry Ford Hosp, Dept Epidemiol & Biostat, Detroit, MI 48202 USA; [Ownby, Dennis R.] Med Coll Georgia, Div Allergy, Augusta, GA 30912 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University System of Georgia; Augusta University	Misiak, RT (corresponding author), Henry Ford Hlth Syst, 1 Ford Pl 4B, Detroit, MI 48202 USA.	rmisiak1@hfhs.org		Johnson, Christine Cole/0000-0002-6864-6604	National Institute of Allergy and Infectious Disease; Fund for Henry Ford Hospital; Henry Ford Hospital Department of Medical Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051598] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fund for Henry Ford Hospital; Henry Ford Hospital Department of Medical Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institute of Allergy and Infectious Disease, the Fund for Henry Ford Hospital, and the Henry Ford Hospital Department of Medical Education Resident Research Award.	ABDULRAZZAQ YM, 1994, ALLERGY, V49, P737, DOI 10.1111/j.1398-9995.1994.tb02096.x; Abraham CM, 2007, J ALLERGY CLIN IMMUN, V119, P1099, DOI 10.1016/j.jaci.2007.01.024; Alford SH, 2004, J ALLERGY CLIN IMMUN, V114, P1046, DOI 10.1016/j.jaci.2004.08.036; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Canfield SM, 2008, J ALLERGY CLIN IMMUN, V121, P1422, DOI 10.1016/j.jaci.2008.03.011; COOKSON WOCM, 1992, LANCET, V340, P381, DOI 10.1016/0140-6736(92)91468-N; DOLD S, 1992, ARCH DIS CHILD, V67, P1018, DOI 10.1136/adc.67.8.1018; Donfack J, 2000, J ALLERGY CLIN IMMUN, V105, P960, DOI 10.1067/mai.2000.106926; GERRARD JW, 1976, ANN ALLERGY, V36, P10; Hosmer W., 2000, APPL LOGISTIC REGRES, V2nd ed.; Hunninghake GM, 2008, AM J RESP CRIT CARE, V177, P830, DOI 10.1164/rccm.200711-1697OC; Jeal H, 2003, J ALLERGY CLIN IMMUN, V111, P795, DOI 10.1067/mai.2003.176; Karihaloo C, 2002, CLIN EXP ALLERGY, V32, P1316, DOI 10.1046/j.1365-2745.2002.01447.x; Kelso JM, 1996, ANN ALLERG ASTHMA IM, V77, P43, DOI 10.1016/S1081-1206(10)63478-3; Kim YK, 2002, ANN ALLERG ASTHMA IM, V88, P170, DOI 10.1016/S1081-1206(10)61992-8; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; MARSH DG, 1982, J EXP MED, V155, P1439, DOI 10.1084/jem.155.5.1439; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Sarafino EP, 2000, PEDIAT ALLERG IMM-UK, V11, P80, DOI 10.1034/j.1399-3038.2000.00065.x; Tovey ER, 1998, J ALLERGY CLIN IMMUN, V101, P491, DOI 10.1016/S0091-6749(98)70356-2	20	7	8	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2009	123	6					1401	1406		10.1016/j.jaci.2009.03.006	http://dx.doi.org/10.1016/j.jaci.2009.03.006			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	455WO	19409605	Green Accepted			2022-12-18	WOS:000266799100035
J	Tohyama, M; Shirakata, Y; Sayama, K; Hashimoto, K				Tohyama, Mikiko; Shirakata, Yuji; Sayama, Koji; Hashimoto, Koji			The influence of hepatic damage on serum soluble Fas ligand levels of patients with drug rashes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							APOPTOSIS		[Tohyama, Mikiko; Shirakata, Yuji; Sayama, Koji; Hashimoto, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon City, Ehime, Japan	Ehime University	Tohyama, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Dermatol, Toon City, Ehime, Japan.	tohm@m.chime-u.ac.jp						Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Murata J, 2008, J ALLERGY CLIN IMMUN, V122, P992, DOI 10.1016/j.jaci.2008.06.013; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Ryo K, 2000, AM J GASTROENTEROL, V95, P2047; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tohyama M, 2008, BRIT J DERMATOL, V159, P981, DOI 10.1111/j.1365-2133.2008.08750.x; Tokushige K, 2000, AM J GASTROENTEROL, V95, P2040	7	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2009	123	4					971	972		10.1016/j.jaci.2009.01.064	http://dx.doi.org/10.1016/j.jaci.2009.01.064			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	431JW	19348934				2022-12-18	WOS:000265058600034
J	Bush, RK; Peden, DB				Bush, Robert K.; Peden, David B.			Advances in environmental and occupational disorders in 2008	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergens; molds; allergic sensitization; diagnostic approaches; therapeutic approaches	TOBACCO-SMOKE EXPOSURE; ALLERGIC DISEASE; IMMUNE-RESPONSE; LOCAL REACTIONS; AIR-POLLUTION; ASTHMA; IGE; ATOPY; IMMUNOTHERAPY; SENSITIZATION	Substantial progress in understanding the role of environmental factors in allergic disease and asthma has been made in the past year. A number of new allergens have been described, and the impact of exposure to indoor allergens in the development of allergic respiratory disease is further confirmed. Exposures to environmental pollutants, particularly tobacco smoke in children, have furthered our knowledge of the detrimental effects of these exposures. This review highlights key advances in environmental and occupational exposures that contribute to the burden of allergic respiratory disease. (J Allergy Clin Immunol 2009;123:575-8.)	[Bush, Robert K.] Univ Wisconsin, Dept Med, Sect Allergy Immunol Pulm Crit Care & Sleep Med, Madison, WI 53706 USA; [Peden, David B.] Univ N Carolina, Dept Pediat, Div Allergy Immunol Rheumatol & Infect Dis, Sch Med, Chapel Hill, NC 27515 USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bush, RK (corresponding author), K4-910 CSC 9988,600 Highland Ave, Madison, WI 53792 USA.	rkb@medicine.wisc.edu		Peden, David/0000-0003-4526-4627	National Institute of Health; Greer Laboratories; US Environmental Protection Agency	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greer Laboratories; US Environmental Protection Agency(United States Environmental Protection Agency)	Disclosure of potential conflict of interest: R. K. Bush has received research support front the National Institute of Health and Greer Laboratories. D. B. Peden has received research support from the National Institutes of Health and the US Environmental Protection Agency, his provided legal consultation or expert witness testimony in court cases related to air quality, and is a consultant for GlaxoSmithKline and Funxional Therapeutics.	Basagana M, 2008, J ALLERGY CLIN IMMUN, V121, P233, DOI 10.1016/j.jaci.2007.10.008; Bernstein JA, 2008, J ALLERGY CLIN IMMUN, V121, P585, DOI 10.1016/j.jaci.2007.10.045; Bittner C, 2008, J ALLERGY CLIN IMMUN, V121, P744, DOI 10.1016/j.jaci.2007.09.051; Brandt DM, 2008, J ALLERGY CLIN IMMUN, V121, P1053, DOI 10.1016/j.jaci.2007.11.025; Calabria CW, 2008, J ALLERGY CLIN IMMUN, V121, P222, DOI 10.1016/j.jaci.2007.08.016; Chapman MD, 2008, J ALLERGY CLIN IMMUN, V122, P882, DOI 10.1016/j.jaci.2008.07.030; Chew GL, 2008, J ALLERGY CLIN IMMUN, V121, P240, DOI 10.1016/j.jaci.2007.08.024; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Donohue KM, 2008, J ALLERGY CLIN IMMUN, V122, P914, DOI 10.1016/j.jaci.2008.08.034; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Horner WE, 2008, J ALLERGY CLIN IMMUN, V121, P592, DOI 10.1016/j.jaci.2007.11.020; Hur GY, 2008, J ALLERGY CLIN IMMUN, V122, P774, DOI 10.1016/j.jaci.2008.07.034; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Kim JS, 2008, J ALLERGY CLIN IMMUN, V122, P929, DOI 10.1016/j.jaci.2008.08.009; Levan TD, 2008, J ALLERGY CLIN IMMUN, V121, P434, DOI 10.1016/j.jaci.2007.08.050; Pacheco K, 2008, J ALLERGY CLIN IMMUN, V122, P896, DOI 10.1016/j.jaci.2008.08.025; Platts-Mills TAE, 2008, J ALLERGY CLIN IMMUN, V122, P694, DOI 10.1016/j.jaci.2008.07.045; Polosa R, 2008, J ALLERGY CLIN IMMUN, V121, P1428, DOI 10.1016/j.jaci.2008.02.041; Rabinovitch N, 2008, J ALLERGY CLIN IMMUN, V121, P1365, DOI 10.1016/j.jaci.2008.03.016; Rabito FA, 2008, J ALLERGY CLIN IMMUN, V121, P622, DOI 10.1016/j.jaci.2007.11.022; Romieu I, 2008, J ALLERGY CLIN IMMUN, V121, P903, DOI 10.1016/j.jaci.2007.12.004; Salo PM, 2008, J ALLERGY CLIN IMMUN, V121, P678, DOI 10.1016/j.jaci.2007.12.1164; Schmechel D, 2008, J ALLERGY CLIN IMMUN, V121, P763, DOI 10.1016/j.jaci.2007.09.046; Severino MG, 2008, J ALLERGY CLIN IMMUN, V122, P44, DOI 10.1016/j.jaci.2008.03.031; Shea KM, 2008, J ALLERGY CLIN IMMUN, V122, P443, DOI 10.1016/j.jaci.2008.06.032; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vogel K, 2008, J ALLERGY CLIN IMMUN, V122, P307, DOI 10.1016/j.jaci.2008.05.016; Wagner S, 2008, J ALLERGY CLIN IMMUN, V121, P246, DOI 10.1016/j.jaci.2007.08.006; Wang L, 2008, J ALLERGY CLIN IMMUN, V122, P400, DOI 10.1016/j.jaci.2008.04.011; Yang JJ, 2008, J ALLERGY CLIN IMMUN, V122, P820, DOI 10.1016/j.jaci.2008.07.044; Yocoub MR, 2008, J ALLERGY CLIN IMMUN, V122, P831, DOI 10.1016/j.jaci.2008.07.009; Yu M, 2008, J ALLERGY CLIN IMMUN, V122, P640, DOI 10.1016/j.jaci.2008.04.038	32	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2009	123	3					575	578		10.1016/j.jaci.2009.01.062	http://dx.doi.org/10.1016/j.jaci.2009.01.062			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	426TQ	19281905	Green Accepted			2022-12-18	WOS:000264731200014
J	Alvarez-Twose, I; Gonzalez-Olano, D; Sanchez-Munoz, L; Teodosio, C; Jara-Acevedo, M; Sanchez-Matas, I; Matito, A; Garcia-Montero, A; Orfao, A; Escribano, L				Alvarez-Twose, I.; Gonzalez-Olano, D.; Sanchez-Munoz, L.; Teodosio, C.; Jara-Acevedo, M.; Sanchez-Matas, I.; Matito, A.; Garcia-Montero, A.; Orfao, A.; Escribano, L.			Clinical, Biological And Molecular Characteristics Of Mast Cell Activation Disorders: A Prospective Study In 62 Patients By The Spanish Network On Mastocytosis (REMA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Alvarez-Twose, I.; Sanchez-Munoz, L.; Sanchez-Matas, I.; Matito, A.; Escribano, L.] Hosp Virgen Valle, Toledo, Spain; [Gonzalez-Olano, D.] Hosp Fuenlabrada, Madrid, Spain; [Teodosio, C.; Jara-Acevedo, M.; Garcia-Montero, A.; Orfao, A.] Ctr Invest Canc, Salamanca, Spain	Complejo Hospitalario de Toledo; Hospital Universitario Fuenlabrada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)			Montero, Andres/HGA-9093-2022; Garcia-Montero, Andres C/B-6558-2017; Orfao, Alberto/B-5801-2017	Garcia-Montero, Andres C/0000-0003-4360-1386; 					0	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				536	S141	S141		10.1016/j.jaci.2008.12.524	http://dx.doi.org/10.1016/j.jaci.2008.12.524			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301009
J	Crocker, DD; Hopkins, D; Kinyota, S; Dumitru, G; Herman, E; Ligon, C				Crocker, D. D.; Hopkins, D.; Kinyota, S.; Dumitru, G.; Herman, E.; Ligon, C.			A Systematic Review of Home-Based Multi-Trigger Multi-Component Environmental Interventions to Reduce Asthma Morbidity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Crocker, D. D.; Hopkins, D.; Kinyota, S.; Dumitru, G.; Herman, E.; Ligon, C.] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA									0	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				63	S20	S20		10.1016/j.jaci.2008.12.091	http://dx.doi.org/10.1016/j.jaci.2008.12.091			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596300074
J	Pedersen, L; Lund, TK; Molgaard, E; Kharitonov, SA; Barnes, PJ; Backer, V				Pedersen, Lars; Lund, Thomas K.; Molgaard, Ellen; Kharitonov, Sergei A.; Barnes, Peter J.; Backer, Vibeke			The acute effect of swimming on airway inflammation in adolescent elite swimmers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POOL ATTENDANCE; RESPONSIVENESS; ATHLETE; ASTHMA		[Pedersen, Lars; Lund, Thomas K.; Molgaard, Ellen; Backer, Vibeke] Copenhagen Univ Hosp, Dept Resp Med L, Bispebjerg Hosp, Resp & Allergy Res Unit, Copenhagen, Denmark; [Pedersen, Lars; Kharitonov, Sergei A.; Barnes, Peter J.] Univ London Imperial Coll Sci Technol & Med, Airway Dis Sect, Natl Heart & Lung Inst, London, England	University of Copenhagen; Bispebjerg Hospital; Imperial College London	Pedersen, L (corresponding author), Copenhagen Univ Hosp, Dept Resp Med L, Bispebjerg Hosp, Resp & Allergy Res Unit, Copenhagen, Denmark.	lars.pedersen@dadlnet.dk	Backer, Vibeke/AAQ-9379-2021; Pedersen, Lars/AAX-4382-2021; Backer, Vibeke/I-9573-2014	Pedersen, Lars/0000-0002-5950-652X; Backer, Vibeke/0000-0002-7806-7219; Barnes, Peter/0000-0002-5122-4018; Lund, Thomas Kromann/0000-0002-8987-3136				Anderson SD, 2008, J ALLERGY CLIN IMMUN, V122, P225, DOI 10.1016/j.jaci.2008.05.001; Belda J, 2008, BRIT J SPORT MED, V42, P244, DOI 10.1136/bjsm.2007.036335; Bernard A, 2006, ENVIRON HEALTH PERSP, V114, P1567, DOI 10.1289/ehp.8461; Bonsignore MR, 2001, AM J PHYSIOL-LUNG C, V281, pL668, DOI 10.1152/ajplung.2001.281.3.L668; Bonsignore MR, 2003, MED SCI SPORT EXER, V35, P1146, DOI 10.1249/01.MSS.0000074581.08023.25; Boulet LP, 2005, CLIN INVEST MED, V28, P15; Carraro S, 2006, J ALLERGY CLIN IMMUN, V118, P958, DOI 10.1016/j.jaci.2006.07.016; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, P254, DOI 10.1016/j.jaci.2008.07.003; Helenius IJ, 1998, ALLERGY, V53, P346, DOI 10.1111/j.1398-9995.1998.tb03904.x; Morici G, 2004, MED SCI SPORT EXER, V36, P1723, DOI 10.1249/01.MSS.0000142411.27685.72; Pedersen L, 2008, J ALLERGY CLIN IMMUN, V122, P322, DOI 10.1016/j.jaci.2008.04.041	11	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2					502	504		10.1016/j.jaci.2008.11.039	http://dx.doi.org/10.1016/j.jaci.2008.11.039			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	409GU	19203664				2022-12-18	WOS:000263495000033
J	Saltzman, RW; Park, AY; Pien, GC; Stinson, R; Spergel, JM				Saltzman, R. W.; Park, A. Y.; Pien, G. C.; Stinson, R.; Spergel, J. M.			Administration of Influenza Vaccine to Pediatric Patients with Egg Allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Saltzman, R. W.; Park, A. Y.; Pien, G. C.; Stinson, R.; Spergel, J. M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia									0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				668	S175	S175		10.1016/j.jaci.2008.12.659	http://dx.doi.org/10.1016/j.jaci.2008.12.659			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR		Bronze			2022-12-18	WOS:000263596301141
J	Sampson, HA				Sampson, Hugh A.			Role of complementary and alternative medicine in the field of allergy and clinical immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Complementary medicine; alternative medicine; integrative medicine; whole medical systems; mind-body medicine; biologically based practices; manipulative and body-based practices; energy medicine			Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sampson, HA (corresponding author), Mt Sinai Sch Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.	hugh.sampson@mssm.edu						ENGLER RJM, 2009, J ALLERGY C IN PRESS; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Li XM, 2009, J ALLERGY CLIN IMMUN, V123, P297, DOI 10.1016/j.jaci.2008.12.026; LI XM, 2009, J ALLERGY CLIN IMMUN, V132, P443; Mainardi T, 2009, J ALLERGY CLIN IMMUN, V123, P283, DOI 10.1016/j.jaci.2008.12.023; Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024	6	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2					317	318		10.1016/j.jaci.2008.12.1112	http://dx.doi.org/10.1016/j.jaci.2008.12.1112			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	409GU	19203655	Bronze			2022-12-18	WOS:000263495000004
J	Stanek, E; Aubert, R; Xia, F; Frueh, F; Sanders, C; Epstein, R; Weiss, S				Stanek, E.; Aubert, R.; Xia, F.; Frueh, F.; Sanders, C.; Epstein, R.; Weiss, S.			Statin Exposure Reduces the Risk of Asthma-Related Hospitalizations and Emergency Room Visits in Asthmatic Patients on Inhaled Corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Stanek, E.; Aubert, R.; Xia, F.; Frueh, F.; Sanders, C.; Epstein, R.] Medco Hlth Solut Inc, Franklin Lakes, NJ USA; [Weiss, S.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital									0	7	7	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				238	S65	S65		10.1016/j.jaci.2008.12.219	http://dx.doi.org/10.1016/j.jaci.2008.12.219			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596300251
J	Arkwright, PD				Arkwright, Peter D.			Automatic epinephrine device use in children with food allergies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Manchester, Booth Hall Childrens Hosp, Manchester, Lancs, England	Royal Manchester Children's Hospital; University of Manchester	Arkwright, PD (corresponding author), Univ Manchester, Booth Hall Childrens Hosp, Manchester, Lancs, England.	peter_arkwright@lineone.net		Arkwright, Peter/0000-0002-7411-5375				Arkwright PD, 2006, PEDIATR ALLERGY IMMU, V17, P227, DOI 10.1111/j.1399-3038.2006.00392.x; Jarvinen KM, 2008, J ALLERGY CLIN IMMUN, V122, P133, DOI 10.1016/j.jaci.2008.04.031	2	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					267	268		10.1016/j.jaci.2008.08.035	http://dx.doi.org/10.1016/j.jaci.2008.08.035			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	18845329	Bronze			2022-12-18	WOS:000262793900047
J	Szefler, SJ				Szefler, Stanley J.			Advances in pediatric asthma in 2008: Where do we go now?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; asthma control; asthma impairment; asthma risk; asthma severity; early intervention in asthma; biomarkers; genetics; therapeutics	EXERCISE-INDUCED BRONCHOCONSTRICTION; EMERGENCY-DEPARTMENT VISITS; EXHALED NITRIC-OXIDE; PRESCHOOL-CHILDREN; CHILDHOOD ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; ALLERGIC DISEASES; AIR-POLLUTION; PROGRESSION; EXPOSURE	This year's summary focuses on recent advances in pediatric asthma as reported in Journal publications in 2008. New National Asthma Education and Prevention Program asthma guidelines were released in 2007 with a special emphasis on asthma control. Attention was redirected to methods that could reduce impairment, specifically symptom control, and minimize risk, including exacerbations. Journal theme issues in 2008 focused on several relevant asthma topics including asthma exacerbations, exercise-induced bronchospasm, asthma and obesity, and occupational asthma. This review highlights Journal articles and related articles that reinforce principles of the guidelines and also direct us to new information that will advance asthma care for children. A major step forward will be finding ways to implement the asthma guidelines. (J Allergy Clin Immunol 2009;123:28-34.)	[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Immunol, Denver, CO 80206 USA	National Jewish Health; National Jewish Health; National Jewish Health	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Room J304 Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njc.org			Public Health Services Research [HR-16048, HL64288, HL51834, Al-25496, HLO81335, HL075416]; General Clinical Research Center [5 MO1 RR00051]; Colorado Cancer, Cardiovascular and Pulmonary Disease Program; DIVISION OF LUNG DISEASES [N01HR016048] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL051834, U10HL064288, U01HL081335, U01HL075416] Funding Source: NIH RePORTER	Public Health Services Research(United States Department of Health & Human ServicesUnited States Public Health Service); General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Colorado Cancer, Cardiovascular and Pulmonary Disease Program; DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by Public Health Services Research Grants HR-16048, HL64288, HL51834, Al-25496, HLO81335, and HL075416; General Clinical Research Center Grant 5 MO1 RR00051 and the Colorado Cancer, Cardiovascular and Pulmonary Disease Program.	Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Anderson SD, 2008, J ALLERGY CLIN IMMUN, V122, P225, DOI 10.1016/j.jaci.2008.05.001; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Bender B, 2008, J ALLERGY CLIN IMMUN, V122, P490, DOI 10.1016/j.jaci.2008.05.041; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031; Burgess JA, 2008, J ALLERGY CLIN IMMUN, V122, P280, DOI 10.1016/j.jaci.2008.05.018; Bush RK, 2008, J ALLERGY CLIN IMMUN, V121, P1359, DOI 10.1016/j.jaci.2008.03.034; Busse WW, 2008, J ALLERGY CLIN IMMUN, V121, P1167, DOI 10.1016/j.jaci.2008.02.029; Canino G, 2008, J ALLERGY CLIN IMMUN, V121, P665, DOI 10.1016/j.jaci.2007.10.022; Casale TB, 2008, J ALLERGY CLIN IMMUN, V121, P288, DOI 10.1016/j.jaci.2007.11.040; Chatila TA, 2008, J ALLERGY CLIN IMMUN, V121, P812, DOI 10.1016/j.jaci.2008.02.025; Chatterjee R, 2008, J ALLERGY CLIN IMMUN, V122, P202, DOI 10.1016/j.jaci.2008.04.030; Cousins DJ, 2008, J ALLERGY CLIN IMMUN, V121, P803, DOI 10.1016/j.jaci.2008.02.008; Covar RA, 2008, J ALLERGY CLIN IMMUN, V122, P741, DOI 10.1016/j.jaci.2008.08.021; Donohue KM, 2008, J ALLERGY CLIN IMMUN, V122, P914, DOI 10.1016/j.jaci.2008.08.034; Elliott L, 2008, J ALLERGY CLIN IMMUN, V122, P49, DOI 10.1016/j.jaci.2008.04.001; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, P254, DOI 10.1016/j.jaci.2008.07.003; Fitzpatrick AM, 2008, J ALLERGY CLIN IMMUN, V121, P1372, DOI 10.1016/j.jaci.2008.03.008; Foster SB, 2008, J ALLERGY CLIN IMMUN, V122, P159, DOI 10.1016/j.jaci.2008.04.043; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Gupta RS, 2008, J ALLERGY CLIN IMMUN, V121, P639, DOI 10.1016/j.jaci.2007.11.036; Holbrook JT, 2008, J ALLERGY CLIN IMMUN, V122, P828, DOI 10.1016/j.jaci.2008.07.012; Holloway JW, 2008, J ALLERGY CLIN IMMUN, V121, P573, DOI 10.1016/j.jaci.2008.01.007; Holt EW, 2008, J ALLERGY CLIN IMMUN, V121, P1175, DOI 10.1016/j.jaci.2008.02.015; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Kelly JT, 2008, J ALLERGY CLIN IMMUN, V122, P671, DOI 10.1016/j.jaci.2008.08.013; Kim JS, 2008, J ALLERGY CLIN IMMUN, V122, P929, DOI 10.1016/j.jaci.2008.08.009; Kormann MSD, 2008, J ALLERGY CLIN IMMUN, V122, P86, DOI 10.1016/j.jaci.2008.04.039; Kumar R, 2008, J ALLERGY CLIN IMMUN, V122, P754, DOI 10.1016/j.jaci.2008.08.006; Kumar R, 2008, J ALLERGY CLIN IMMUN, V121, P878, DOI 10.1016/j.jaci.2008.01.030; Leigh R, 2008, J ALLERGY CLIN IMMUN, V121, P1238, DOI 10.1016/j.jaci.2008.01.067; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P1075, DOI 10.1016/j.jaci.2008.03.005; Lowe AJ, 2008, J ALLERGY CLIN IMMUN, V121, P1190, DOI 10.1016/j.jaci.2008.01.034; McDonald KL, 2008, J ALLERGY CLIN IMMUN, V121, P626, DOI 10.1016/j.jaci.2007.11.034; McIvor RA, 2008, LANCET, V372, P1021, DOI 10.1016/S0140-6736(08)61423-3; Mehra R, 2008, J ALLERGY CLIN IMMUN, V121, P1096, DOI 10.1016/j.jaci.2008.04.002; Moeller A, 2008, J ALLERGY CLIN IMMUN, V121, P705, DOI 10.1016/j.jaci.2007.11.008; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Institutes of Health, 2007, NIH PUBL, V02-3659; Nicolaou NC, 2008, J ALLERGY CLIN IMMUN, V122, P500, DOI 10.1016/j.jaci.2008.06.033; O'Connor GT, 2008, J ALLERGY CLIN IMMUN, V121, P1133, DOI 10.1016/j.jaci.2008.02.020; Ono E, 2008, J ALLERGY CLIN IMMUN, V122, P768, DOI 10.1016/j.jaci.2008.06.009; Panettieri RA, 2008, J ALLERGY CLIN IMMUN, V121, P607, DOI 10.1016/j.jaci.2008.01.006; Pedersen L, 2008, J ALLERGY CLIN IMMUN, V122, P322, DOI 10.1016/j.jaci.2008.04.041; Petkonen A, 2008, J ALLERGY CLIN IMMUN, V122, P832, DOI 10.1016/j.jaci.2008.07.013; Pistiner M, 2008, J ALLERGY CLIN IMMUN, V122, P274, DOI 10.1016/j.jaci.2008.05.007; Rabinovitch N, 2008, J ALLERGY CLIN IMMUN, V121, P1365, DOI 10.1016/j.jaci.2008.03.016; Rayens MK, 2008, J ALLERGY CLIN IMMUN, V122, P537, DOI 10.1016/j.jaci.2008.06.029; Reed CE, 2008, J ALLERGY CLIN IMMUN, V121, P601, DOI 10.1016/j.jaci.2007.10.032; Romieu I, 2008, J ALLERGY CLIN IMMUN, V121, P903, DOI 10.1016/j.jaci.2007.12.004; Rundell KW, 2008, J ALLERGY CLIN IMMUN, V122, P238, DOI 10.1016/j.jaci.2008.06.014; Sackesen C, 2008, J ALLERGY CLIN IMMUN, V122, P78, DOI 10.1016/j.jaci.2008.03.035; Sears MR, 2008, J ALLERGY CLIN IMMUN, V122, P662, DOI 10.1016/j.jaci.2008.08.003; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Sharma S, 2008, J ALLERGY CLIN IMMUN, V122, P921, DOI 10.1016/j.jaci.2008.09.004; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Sicherer SH, 2008, J ALLERGY CLIN IMMUN, V122, P29, DOI 10.1016/j.jaci.2008.05.019; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Sorkness RL, 2008, J ALLERGY CLIN IMMUN, V122, P838, DOI 10.1016/j.jaci.2008.07.041; Spahn JD, 2008, J ALLERGY CLIN IMMUN, V121, P548, DOI 10.1016/j.jaci.2008.01.012; Steinke JW, 2008, J ALLERGY CLIN IMMUN, V121, pS384, DOI 10.1016/j.jaci.2007.07.029; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stingone JA, 2008, J ALLERGY CLIN IMMUN, V122, P748, DOI 10.1016/j.jaci.2008.08.001; Strunk RC, 2008, J ALLERGY CLIN IMMUN, V122, P1138, DOI 10.1016/j.jaci.2008.09.028; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Szefler SJ, 2008, J ALLERGY CLIN IMMUN, V122, P697, DOI 10.1016/j.jaci.2008.08.022; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Szefler SJ, 2008, J ALLERGY CLIN IMMUN, V121, P614, DOI 10.1016/j.jaci.2007.11.033; Szefler SJ, 2008, J ALLERGY CLIN IMMUN, V121, P598, DOI 10.1016/j.jaci.2007.12.1192; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Taveras EM, 2008, J ALLERGY CLIN IMMUN, V121, P1161, DOI 10.1016/j.jaci.2008.03.021; Tepper RS, 2008, J ALLERGY CLIN IMMUN, V122, P760, DOI 10.1016/j.jaci.2008.07.022; Tovey ER, 2008, J ALLERGY CLIN IMMUN, V122, P114, DOI 10.1016/j.jaci.2008.05.010; Ueda T, 2008, J ALLERGY CLIN IMMUN, V121, P659, DOI 10.1016/j.jaci.2007.10.005; Vercelli D, 2008, J ALLERGY CLIN IMMUN, V122, P267, DOI 10.1016/j.jaci.2008.06.008; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weinberger M, 2008, J ALLERGY CLIN IMMUN, V122, P251, DOI 10.1016/j.jaci.2008.05.030; Zeiger RS, 2008, J ALLERGY CLIN IMMUN, V121, P885, DOI 10.1016/j.jaci.2007.12.1178	87	7	7	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					28	34		10.1016/j.jaci.2008.11.002	http://dx.doi.org/10.1016/j.jaci.2008.11.002			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	19130924	Bronze			2022-12-18	WOS:000262793900005
J	Atkinson, A; Grunebaum, E; Roifman, CM				Atkinson, Adelle; Grunebaum, Eyal; Roifman, Chaim M.			High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BONE-MARROW-TRANSPLANTATION; ATAXIA-TELANGIECTASIA; RANDOMIZED-TRIAL; IMMUNODEFICIENCY		[Atkinson, Adelle] Hosp Sick Children, Dept Pediat, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Atkinson, A (corresponding author), Hosp Sick Children, Dept Pediat, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada.	chaim.roifman@sickkids.ca						BACIGALUPO A, 1983, BLUT, V46, P125, DOI 10.1007/BF00320270; Bener A, 2007, MED PRIN PRACT, V16, P262, DOI 10.1159/000102147; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Chun HH, 2003, MOL GENET METAB, V80, P437, DOI 10.1016/j.ymgme.2003.09.008; Deeg HJ, 2007, BLOOD, V109, P4119, DOI 10.1182/blood-2006-12-041889; Elzaouk L, 2006, EXP DERMATOL, V15, P865, DOI 10.1111/j.1600-0625.2006.00479.x; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Geha RS, 2007, J ALLERGY CLIN IMMUN, V120, P776, DOI 10.1016/j.jaci.2007.08.053; Grunebaum E, 2006, JAMA-J AM MED ASSOC, V295, P508, DOI 10.1001/jama.295.5.508; Lavin MF, 2007, BRIT MED BULL, V81-82, P129, DOI 10.1093/bmb/ldm012; Lee SJ, 2004, BLOOD, V104, P1559, DOI 10.1182/blood-2004-03-0854; Margolis J, 2000, SEMIN ONCOL, V27, P72; NAHAS SA, 2008, CLIN CHEM IN PRESS; Nowak-Wegrzyn A, 2004, J PEDIATR-US, V144, P505, DOI 10.1016/j.jpeds.2003.12.046; Remberger M, 2001, CLIN TRANSPLANT, V15, P147, DOI 10.1034/j.1399-0012.2001.150301.x; Shaughnessy PJ, 2005, BIOL BLOOD MARROW TR, V11, P188, DOI 10.1016/j.bbmt.2004.11.022; Sun X, 2002, J PEDIATR-US, V140, P724, DOI 10.1067/mpd.2002.123879; Van Lint MT, 1998, BLOOD, V92, P2288	19	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1215	1216		10.1016/j.jaci.2008.06.023	http://dx.doi.org/10.1016/j.jaci.2008.06.023			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA	18672279				2022-12-18	WOS:000261711800022
J	Moens, L; Wuyts, G; Boon, L; den Hartog, MT; Ceuppens, JL; Bossuyt, X				Moens, Leen; Wuyts, Greet; Boon, Louis; den Hartog, Marcel T.; Ceuppens, Jan L.; Bossuyt, Xavier			The human polysaccharide- and protein-specific immune response to Streptococcus pneumoniae is dependent on CD4(+) T lymphocytes, CD14(+) monocytes, and the CD40-CD40 ligand interaction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTIBODY-RESPONSE; CELL		[Moens, Leen; Wuyts, Greet; Bossuyt, Xavier] Catholic Univ Louvain, Dept Med Diagnost Sci, Expt Med Lab, B-3000 Louvain, Belgium; [Ceuppens, Jan L.] Catholic Univ Louvain, Expt Immunol Lab, Dept Pathophysiol, B-3000 Louvain, Belgium; [Boon, Louis; den Hartog, Marcel T.] PanGenetics, Utrecht, Netherlands	Universite Catholique Louvain; Universite Catholique Louvain	Moens, L (corresponding author), Catholic Univ Louvain, Dept Med Diagnost Sci, Expt Med Lab, B-3000 Louvain, Belgium.	xavier.bossuyt@uzleuven.ac.be	Bossuyt, Xavier/B-2085-2019; ceuppens, jan/F-2819-2010; Boon, Laurence/HCI-3629-2022	Bossuyt, Xavier/0000-0001-6856-8485; Boon, Louis/0000-0002-0937-9171; Ceuppens, Jan/0000-0003-4502-2679				Agematsu K, 1998, J CLIN INVEST, V102, P853, DOI 10.1172/JCI3409; BRUYN GAW, 1992, CLIN INFECT DIS, V14, P251, DOI 10.1093/clinids/14.1.251; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Jeurissen A, 2006, J IMMUNOL, V176, P529, DOI 10.4049/jimmunol.176.1.529; Jeurissen A, 2004, EUR J IMMUNOL, V34, P850, DOI 10.1002/eji.200324381; Khan AQ, 2004, J IMMUNOL, V172, P532, DOI 10.4049/jimmunol.172.1.532; MELZER U, 2006, INFECT IMMUN, V74, P1890; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Tournoy KG, 1998, EUR J IMMUNOL, V28, P3221, DOI 10.1002/(SICI)1521-4141(199810)28:10<3221::AID-IMMU3221>3.0.CO;2-S	9	7	8	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1231	1233		10.1016/j.jaci.2008.09.006	http://dx.doi.org/10.1016/j.jaci.2008.09.006			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA	18842293	Green Accepted			2022-12-18	WOS:000261711800029
J	Patel, AC; Van Natta, ML; Tonascia, J; Wise, RA; Strunk, RC				Patel, Anand C.; Van Natta, Mark L.; Tonascia, James; Wise, Robert A.; Strunk, Robert C.		Childhood Asthma Management	Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						spirometry; slope ratio; asthma; pediatric; children	MAXIMAL EXPIRATORY FLOW; CURVE CONFIGURATION; INFLAMMATION	Background: Assessment of asthma through spirometric analysis in children is challenging because of often normal FEV1 values. Objective: We used Mead's slope ratio (SR; (d/dV)/((V)V)) to analyze the shape of the flow-volume loop. Methods: We analyzed the effects of time, albuterol, and budesonide on FEV1, FEV1/forced vital capacity (FVC) ratio, forced expiratory flow from 25% to 75% of expired volume, and Mead's SR both early (between 75% and 50% of FVC, SR61) and late (between 75% and 50% of FVC, SR35) in exhalation in the Childhood Asthma Management Program cohort at baseline, 4 months, and the end of the study in participants who received either inhaled placebo or budesomide twice daily. Results: In the placebo group both SR61 and SR35 improved over time. Bronchodilator consistently improved both SR61 and SR35, without change in degree of improvement over time. Similarly. in the budesonide group time and bronchodilator each independently improved both SR61 and SR35. At 4 months and the end of the study, patients receiving budesonide had significant improvements in SR61 relative to patients receiving placebo, which was independent of bronchodilator effect. Budesonide and placebo were not different with respect to prebronchodilator or postbronchodilator SR35. Conclusion: Budesonide-treated patients have less concave flow-volume loops when compared with placebo-treated patients. Time and bronchodilator also make the flow-volume loop less concave. Furthermore, it appears that there are discrete bronchodilator- and corticosteroid-responsive components of airflow obstruction in pediatric asthma.	[Patel, Anand C.; Strunk, Robert C.] Washington Univ, Sch Med, Dept Pediat, Div Allergy Pulm Med, St Louis, MO 63110 USA; [Patel, Anand C.; Strunk, Robert C.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Van Natta, Mark L.; Tonascia, James] Johns Hopkins Bloomberg Sch Publ Hlth, Childhood Asthma Management Program, Coordinating Ctr, Baltimore, MD USA; [Wise, Robert A.] Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Baltimore, MD USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Patel, AC (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Allergy Pulm Med, 660 S Euclid Ave,Campus Box 8052, St Louis, MO 63110 USA.	patel_an@kids.wustl.edu	; Patel, Anand/B-1441-2009	Wise, Robert/0000-0002-8353-2349; Patel, Anand/0000-0002-6570-8582	DIVISION OF LUNG DISEASES [N01HR016044, N01HR016048, N01HR016045, N01HR016046, N01HR016049, N01HR016050, N01HR016052, N01HR016051, N01HR016047] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000036, M01RR000051, M01RR000997, M01RR002719] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL083095, T32HL007317] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000051, RR00036, M01 RR000051-44, M01 RR002719-14, M01 RR000036-461569, M01 RR000036, M01 RR02719-14, M01 RR000036-475309, M01 RR000997-24, M01 RR0099718-24, M01 RR002719, M01 RR00051] Funding Source: Medline; NHLBI NIH HHS [N01HR16044, N01-HR-16045, N01-HR-16052, T32 HL007317, T32 HL007317-29, N01-HR-16049, K08 HL083095, N01-HR-16050, N01-HR-16047, N01-HR-16048, N01-HR-16044, N01-HR-16051, N01-HR-16046] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; COULTAS DB, 1988, AM REV RESPIR DIS, V138, P1386, DOI 10.1164/ajrccm/138.6.1386; HARTLEY D, 1968, NATURE, V219, P861, DOI 10.1038/219861a0; HEALY F, 1984, CHEST, V85, P476, DOI 10.1378/chest.85.4.476; HYATT RE, 1958, J APPL PHYSIOL, V13, P331, DOI 10.1152/jappl.1958.13.3.331; HYATT RE, 1979, LUNG TRANSITION HLTH, P73; *J HOPK U CAMP, 1994, SPIR MAN VERS 3 0; JAYAMANNE DS, 1980, CHEST, V77, P749, DOI 10.1378/chest.77.6.749; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KRAAN J, 1989, THORAX, V44, P1015, DOI 10.1136/thx.44.12.1015; Kraft M, 2007, CURR MED RES OPIN, V23, pS21, DOI 10.1185/030079907X226177; LANDAU LI, 1975, AM REV RESPIR DIS, V111, P725; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MCFADDEN ER, 1972, AM J MED, V52, P725, DOI 10.1016/0002-9343(72)90078-2; MEAD J, 1978, J APPL PHYSIOL, V44, P156, DOI 10.1152/jappl.1978.44.2.156; Meyer FJ, 2002, THORAX, V57, P473, DOI 10.1136/thorax.57.6.473; NELSON HS, 1995, NEW ENGL J MED, V333, P499, DOI 10.1056/NEJM199508243330807; ODONNELL CR, 1986, J APPL PHYSIOL, V61, P2243, DOI 10.1152/jappl.1986.61.6.2243; PALMER KNV, 1969, BRIT MED J, V1, P31, DOI 10.1136/bmj.1.5635.31; PATEL AC, 2005, P AM THOR SOC, V2, pA774; PERMUTT S, 1979, LUNG TRANSITION HLTH, P113; PRIDE NB, 1967, J APPL PHYSIOL, V23, P646, DOI 10.1152/jappl.1967.23.5.646; Tashkin DP, 2002, ALLERGY ASTHMA PROC, V23, P233; TIFFENEAU R, 1949, PARIS MED, V137, P543; TOCKMAN M, 1976, AM REV RESPIR DIS, V114, P711; Walter MJ, 2005, AM J RESP CELL MOL, V32, P483, DOI 10.1165/rcmb.F300	28	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					781	787		10.1016/j.jaci.2008.08.010	http://dx.doi.org/10.1016/j.jaci.2008.08.010			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	19014770	Green Accepted			2022-12-18	WOS:000259989000025
J	von Mutius, E				von Mutius, Erika			Genes and the environment: Two readings of their interaction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							DUST-MITE ALLERGEN; EARLY-LIFE; ASTHMA; EXPOSURE; CHILDHOOD; CHILDREN; SENSITIZATION; COHORT; CAT		Univ Childrens Hosp, D-80337 Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	von Mutius, E (corresponding author), Univ Childrens Hosp, Lindwurmstr 4, D-80337 Munich, Germany.	Erika.Von.Mutius@med.uni-muenchen.de		von Mutius, Erika/0000-0002-8893-4515				Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Corver K, 2006, PEDIAT ALLERG IMM-UK, V17, P329, DOI 10.1111/j.1399-3038.2006.00410.x; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; HUNNINGHAKE GM, 2008, J ALLERGY CLIN  0425; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Polk S, 2004, AM J RESP CRIT CARE, V170, P273, DOI 10.1164/rccm.200310-1348OC; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; SPORIK R, 1993, CLIN EXP ALLERGY, V23, P740, DOI 10.1111/j.1365-2222.1993.tb00361.x; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8	13	7	7	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2008	122	1					99	100		10.1016/j.jaci.2008.05.017	http://dx.doi.org/10.1016/j.jaci.2008.05.017			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	325RD	18547630				2022-12-18	WOS:000257605100016
J	Xie, LP; Schroeder, JT; Langdon, JM; Sora-Scott, RS; Kawakami, T; MacDonald, SM				Xie, Liping; Schroeder, John T.; Langdon, Jacqueline M.; Sora-Scott, Rebecca S.; Kawakami, Toshiaki; MacDonald, Susan M.			Human IgE(+) and IgE(-) are not equivalent to mouse highly cytokinergic IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; allergy; histamine-releasing factor; highly cytokinergic IgE; IL-13; IL-3; phosphorylation; extracellular signal-regulated kinase; basophil; mast cell	HISTAMINE-RELEASING FACTOR; MAST-CELLS; HUMAN BASOPHILS; IL-13 SECRETION; ACTIVATION; INTERLEUKIN-13; HETEROGENEITY; SURVIVAL	Background: We have previously defined IgE(+) as the IgE on basophils from a subset of highly allergic asthmatic subjects that release histamine after stimulation with histamine-releasing factor (HRF). The mechanism of IgE(+) remains an enigma. Recently, there have been reports of monomeric highly cytokinergic IgEs causing mediator release, cytokine release, and phosphorylation events in cultured rodent and human mast cells in the absence of antigen. Objective: We investigated whether human IgE(+) might exist as highly cytokinergic IgE in the human system. Methods: IgE(+) was defined as causing greater than 10% histamine release by using HRF as a stimulus of human basophils. By definition, IgE(-) did not support histamine release to HRF. Once defined, serum and various purified human IgEs were used to stimulate purified human basophils or cultured human mast cells. The cells were examined for histamine release, extracellular signal-regulated kinase (ERK) phosphorylation, and IL-13 secretion. Results: We found that neither IgE(+) nor IgE(-) induced ERK phosphorylation, histamine release, and IL-13 release from freshly isolated basophils in the absence of a specific antigen. However, human IgE alone did stimulate ERK phosphorylation in cultured human mast cells and IL-3-primed human basophils. Conclusion: Human IgE(+) is not an equivalent of the mouse highly cytokinergic IgE. However, human IgE did have effects on cultured mast cells and basophils. The effect of highly cytokinergic IgE on ERK phosphorylation and cytokine secretion might be due to the priming effect of human basophils and mast cells.	[Xie, Liping; Schroeder, John T.; Langdon, Jacqueline M.; Sora-Scott, Rebecca S.; MacDonald, Susan M.] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Kawakami, Toshiaki] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	Johns Hopkins University; Johns Hopkins Medicine; La Jolla Institute for Immunology	MacDonald, SM (corresponding author), 5501 Hopkins Bayview Circle,24-38, Baltimore, MD 21224 USA.	sinacdona@jhini.edu	Kawakami, Toshiaki/O-1616-2015; Xie, li/HGE-6052-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032651, R21AI042221, R01AI042221, R29AI042221] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 32651, AI 42221] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Budde IK, 2000, ALLERGY, V55, P653; Cruse G, 2005, EUR RESPIR J, V25, P858, DOI 10.1183/09031936.05.00091704; GILBERT HS, 1975, BLOOD, V46, P279; Gilchrest H, 2003, LIFE SCI, V73, P2571, DOI 10.1016/S0024-3205(03)00607-6; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Holgate ST, 2005, CLIN EXP ALLERGY, V35, P408, DOI 10.1111/j.1365-2222.2005.02191.x; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; KAWANISHI H, 1986, EUR J IMMUNOL, V16, P689, DOI 10.1002/eji.1830160617; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; KLEINETEBBE J, 1995, J IMMUNOL METHODS, V179, P153, DOI 10.1016/0022-1759(94)00279-6; Lorentz A, 2005, J IMMUNOL, V174, P6751, DOI 10.4049/jimmunol.174.11.6751; MACDONALD SM, 1989, J IMMUNOL, V142, P3527; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MACDONALD SM, 1991, CLIN EXP ALLERGY, V21, P133, DOI 10.1111/j.1365-2222.1991.tb00815.x; MacDonald SM, 1997, INT ARCH ALLERGY IMM, V113, P187, DOI 10.1159/000237542; MACDONALD SM, 1993, ALLERGY PRINCIPLES P, P1; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; Matsuda K, 2005, J ALLERGY CLIN IMMUN, V116, P1357, DOI 10.1016/j.jaci.2005.08.042; Ochensberger B, 1996, BLOOD, V88, P3028, DOI 10.1182/blood.V88.8.3028.bloodjournal8883028; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; Redrup AC, 1998, J IMMUNOL, V160, P1957; Schroeder JT, 1997, J IMMUNOL, V159, P447; Sin AZ, 2001, J ALLERGY CLIN IMMUN, V108, P387; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	29	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2008	121	4					1027	1033		10.1016/j.jaci.2007.12.1157	http://dx.doi.org/10.1016/j.jaci.2007.12.1157			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286YY	18234322				2022-12-18	WOS:000254884000032
J	Bernstein, JA; Levy, R; Wasserman, RL; Bewtra, A; Hurewitz, D; Obtulowicz, K; Reshef, A; Kiessling, PC; Craig, TJ				Bernstein, J. A.; Levy, R.; Wasserman, R. L.; Bewtra, A.; Hurewitz, D.; Obtulowicz, K.; Reshef, A.; Kiessling, P. C.; Craig, T. J.			Treatment of acute abdominal and facial attacks of hereditary angioedema (HAE) with human C1 esterase inhibitor (C1-INH): Results of a global, multicenter, randomized, placebo-controlled, phase II/III study (IMPACT1)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Bernstein, J. A.] Bernstein Clin Res Ctr, Cincinnati, OH USA; [Levy, R.] Family Allergy & Asthma Ctr, Atlanta, GA USA; [Bewtra, A.] Creighton Univ, Sch Med, Omaha, NE 68178 USA; [Hurewitz, D.] Allergy Clin Tulsa Inc, Tulsa, OK USA; [Obtulowicz, K.] Jagiellonian Univ Hosp, Krakow, Poland; [Reshef, A.] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Kiessling, P. C.] CSL Behring, Marburg, Germany; [Craig, T. J.] Penn State Univ, Hershey, PA USA	Creighton University; Jagiellonian University; Collegium Medicum Jagiellonian University; Chaim Sheba Medical Center; CSL; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health			Reshef, Avner/AAL-3638-2020						0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3				LB16	795	795		10.1016/j.jaci.2008.01.052	http://dx.doi.org/10.1016/j.jaci.2008.01.052			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR					2022-12-18	WOS:000253918900069
J	Meyers, DA; Hawkins, GA; Wenzel, SA; Lo, K; Watt, R; Bleecker, ER				Meyers, D. A.; Hawkins, G. A.; Wenzel, S. A.; Lo, K.; Watt, R.; Bleecker, E. R.			Pharmacogenetic identification of increased responsiveness in severe asthma with anti-TNF (Golimumab) therapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Meyers, D. A.; Hawkins, G. A.; Bleecker, E. R.] Wake Forest Univ Hlth Sci, Winston Salem, NC USA; [Wenzel, S. A.] Univ Pittsburgh, Pittsburgh, PA USA; [Lo, K.; Watt, R.] Centocor Inc, Malvern, PA USA	Wake Forest University; Wake Forest University School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc									0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3				LB29	798	798		10.1016/j.jaci.2008.01.065	http://dx.doi.org/10.1016/j.jaci.2008.01.065			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR		Bronze			2022-12-18	WOS:000253918900082
J	Ballas, ZK				Ballas, Zuhair K.			Lmmunomodulators: A brave new world	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							COLONY-STIMULATING FACTOR; DISEASE; ENCEPHALITIS; THERAPIES; CYTOKINES; IMMUNITY; MICE		Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Ballas, ZK (corresponding author), Univ Iowa, Dept Internal Med, C42-E13 GH,200 Hawkind Dr, Iowa City, IA 52242 USA.	Ballasz@uiowa.edu		Ballas, Zuhair/0000-0001-5569-1230; Knaack, Aaron/0000-0001-7712-1415				Berger JR, 2005, NEW ENGL J MED, V353, P414, DOI 10.1056/NEJMe058122; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Casale TB, 2008, J ALLERGY CLIN IMMUN, V121, P288, DOI 10.1016/j.jaci.2007.11.040; Dalrymple SA, 1996, INFECT IMMUN, V64, P3231, DOI 10.1128/IAI.64.8.3231-3235.1996; Danese S, 2006, MINI-REV MED CHEM, V6, P771, DOI 10.2174/138955706777698624; Dinarello CA, 2005, J RHEUMATOL, V32, P40; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hunig T, 2007, ADV IMMUNOL, V95, P111, DOI 10.1016/S0065-2776(07)95004-X; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P13, DOI 10.1016/j.jaci.2007.11.030; Love TM, 2008, J ALLERGY CLIN IMMUN, V121, P309, DOI 10.1016/j.jaci.2007.12.1167; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; PATEL DD, 2008, IN PRESS J ALLERGY C; Pizarro TT, 2000, AM J PHYSIOL-GASTR L, V278, pG665, DOI 10.1152/ajpgi.2000.278.5.G665; Romagnani P, 2005, J NEPHROL, V18, P229; Saliu OY, 2006, J INFECT DIS, V194, P486, DOI 10.1086/505430; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997; Touw IP, 2007, JNCI-J NATL CANCER I, V99, P183, DOI 10.1093/jnci/djk057; Vincenti F, 2008, J ALLERGY CLIN IMMUN, V121, P299, DOI 10.1016/j.jaci.2008.01.002; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	26	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2					331	333		10.1016/j.jaci.2007.12.1158	http://dx.doi.org/10.1016/j.jaci.2007.12.1158			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	265CX	18269924	Bronze			2022-12-18	WOS:000253337800006
J	Bleecker, ER; Nelson, H; Corren, J; Kraft, M; Yancey, S; Ortega, H; ReiIly, D; Emmett, A; Anderson, W				Bleecker, E. R.; Nelson, H.; Corren, J.; Kraft, M.; Yancey, S.; Ortega, H.; ReiIly, D.; Emmett, A.; Anderson, W.			Ary16Gly polymorphism of the beta(2)-adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Bleecker, E. R.] Wake Forest Univ, Med Ctr, Winston Salem, NC USA; [Nelson, H.] Natl Jewish Med & Res Ctr, Denver, CO USA; [Corren, J.] Allergy Med Clin Inc, Los Angeles, CA USA; [Kraft, M.] Duke Univ, Med Ctr, Durham, NC USA; [Yancey, S.; Ortega, H.; ReiIly, D.; Emmett, A.; Anderson, W.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	Wake Forest University; National Jewish Health; Duke University; GlaxoSmithKline									0	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		554	S143	S143		10.1016/j.jaci.2007.12.1109	http://dx.doi.org/10.1016/j.jaci.2007.12.1109			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401018
J	DaVeiga, SP; Caruso, K; Golubski, S; Lang, DM				DaVeiga, S. P.; Caruso, K.; Golubski, S.; Lang, D. M.			A retrospective survey of systemic reaction from allergen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[DaVeiga, S. P.; Caruso, K.; Golubski, S.; Lang, D. M.] Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation									0	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		481	S124	S124		10.1016/j.jaci.2007.12.495	http://dx.doi.org/10.1016/j.jaci.2007.12.495			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ		Bronze			2022-12-18	WOS:000253426400482
J	Nathan, R; Meltzer, E; Derebery, J; Stang, P; Corrao, M; Allen, G; Stanford, R				Nathan, R.; Meltzer, E.; Derebery, J.; Stang, P.; Corrao, M.; Allen, G.; Stanford, R.			Prevalence of nasal symptoms in the United States: Findings from the burden of allergic rhinitis in America survey	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Nathan, R.] Asthma & Allergy Assoc PC & Res Ctr, Colorado Springs, CO USA; [Meltzer, E.] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA; [Derebery, J.] House Ear Res Inst, House Ear Clin, Los Angeles, CA USA; [Stang, P.] Galt Assoc Inc, Blue Bell, PA USA; [Corrao, M.; Stanford, R.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Allen, G.] Gemini Stats Inc, Durham, NC USA	House Research Institute; GlaxoSmithKline			Stang, Peter J./Y-2744-2019						0	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		800	S208	S209		10.1016/j.jaci.2007.12.777	http://dx.doi.org/10.1016/j.jaci.2007.12.777			2	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401264
J	Rosenthal, DW; DeVoti, JA; Schmidtmayerova, H; Steinberg, BM; Bonagura, VR				Rosenthal, D. W.; DeVoti, J. A.; Schmidtmayerova, H.; Steinberg, B. M.; Bonagura, V. R.			Human papillomavirus causes a T(H)2-like chemokine pre-56 dominance in recurrent respiratory papillomatotosis (RPR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Rosenthal, D. W.] Grad Sch Mol Med, Manhasset, NY USA; [Rosenthal, D. W.; DeVoti, J. A.; Schmidtmayerova, H.; Steinberg, B. M.; Bonagura, V. R.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [DeVoti, J. A.; Bonagura, V. R.] N Shore Long Isl Jewish Hlth Syst, Div Allergy Immunol, Great Neck, NY USA; [Steinberg, B. M.] N Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA	Northwell Health; Northwell Health; Northwell Health			Rosenthal, David W/E-2199-2011	Rosenthal, David W/0000-0003-2136-4287					0	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		56	S15	S15		10.1016/j.jaci.2007.12.062	http://dx.doi.org/10.1016/j.jaci.2007.12.062			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426400057
J	Swart, DA; Anders-Bartholo, PM; Tocker, JE				Swart, D. A.; Anders-Bartholo, P. M.; Tocker, J. E.			Effects of IL-4R alpha blockade on lung inflammation and airway hype rresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Swart, D. A.; Anders-Bartholo, P. M.; Tocker, J. E.] Amgen Inc, Seattle, WA USA	Amgen									0	7	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		1034	S267	S267		10.1016/j.jaci.2007.12.1061	http://dx.doi.org/10.1016/j.jaci.2007.12.1061			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401498
J	Schnopp, C; Grosch, J; Ring, J; Ollert, M; Mempel, M				Schnopp, Christina; Grosch, Johanna; Ring, Johannes; Ollert, Markus; Mempel, Martin			Microbial allergen-specific IgE is not suitable to identify the intrinsic form of atopic eczema in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DERMATITIS		[Schnopp, Christina; Grosch, Johanna; Ring, Johannes; Ollert, Markus; Mempel, Martin] Dept Dermatol & Allergy, Biederstein, Germany; [Mempel, Martin] Tech Univ Munich, GSF, Natl Res Ctr Environm & Hlth, Div Environm Dermatol & Allergy, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich	Schnopp, C (corresponding author), Dept Dermatol & Allergy, Biederstein, Germany.	m.mempel@lrz.tum.de	Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152; Ollert, Markus W./0000-0002-8055-0103				Casagrande BF, 2006, J INVEST DERMATOL, V126, P2551, DOI 10.1038/sj.jid.5700499; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, P215, DOI 10.1067/mai.2003.1590; Reefer AJ, 2007, J ALLERGY CLIN IMMUN, V120, P156, DOI 10.1016/j.jaci.2007.03.042	4	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2008	121	1					267	268		10.1016/j.jaci.2007.08.052	http://dx.doi.org/10.1016/j.jaci.2007.08.052			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	251KM	17936886				2022-12-18	WOS:000252372000052
J	Koppelman, GH				Koppelman, Gerard H.			Gene-environment interaction in allergic disease: More questions, more answers?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						gene; environment; interaction; CD14	GENOME-WIDE ASSOCIATION; ASTHMA; CHILDHOOD		[Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol, NL-9700 AB Groningen, Netherlands	University of Groningen	Koppelman, GH (corresponding author), Univ Med Ctr Groningen, Dept Pediat Pulmonol, POB 30-001, NL-9700 RB Groningen, Netherlands.	g.h.koppelman@bkk.umcg.nl	Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252				BIELI C, 2007, J ALLERGY CLIN  1008; Choudhry S, 2005, AM J RESP CRIT CARE, V172, P173, DOI 10.1164/rccm.200409-1232OC; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gern JE, 2004, J ALLERGY CLIN IMMUN, V113, P307, DOI 10.1016/j.jaci.2003.11.017; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Koppelman GH, 2006, CURR ALLERGY ASTHM R, V6, P103, DOI 10.1007/s11882-006-0047-y; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Los H, 2001, Twin Res, V4, P81, DOI 10.1375/twin.4.2.81; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Vercelli D, 2004, J ALLERGY CLIN IMMUN, V113, P381, DOI 10.1016/j.jaci.2004.01.752; von Mutius Erika, 2007, Proc Am Thorac Soc, V4, P212, DOI 10.1513/pats.200701-028AW; Weiss ST, 1999, CLIN EXP ALLERGY, V29, P96, DOI 10.1046/j.1365-2222.1999.00017.x; Weiss ST, 2001, AM J RESP CRIT CARE, V164, P2014, DOI 10.1164/ajrccm.164.11.2110043b; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002	20	7	8	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1266	1268		10.1016/j.jaci.2007.10.007	http://dx.doi.org/10.1016/j.jaci.2007.10.007			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	18073121				2022-12-18	WOS:000251653800003
J	Piacentini, GL; Peroni, DG; Bodini, A; Boner, AL				Piacentini, Giorgio L.; Peroni, Diego G.; Bodini, Alessandro; Boner, Attilio L.			Exhaled nitric oxide in children with asthma at high altitude	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGEN AVOIDANCE		Univ Verona, Dept Pediat, I-37100 Verona, Italy	University of Verona	Piacentini, GL (corresponding author), Univ Verona, Dept Pediat, I-37100 Verona, Italy.	giorgio.piacentini@univr.it	Peroni, Diego G/K-4002-2018; Peroni, Diego/K-8795-2016	Peroni, Diego/0000-0002-0234-1373				Baraldi E, 1999, AM J RESP CRIT CARE, V159, P262, DOI 10.1164/ajrccm.159.1.9804063; Delfino RJ, 2006, ENVIRON HEALTH PERSP, V114, P1736, DOI 10.1289/ehp.9141; Huss-Marp J, 2007, J ALLERGY CLIN IMMUN, V120, P471, DOI 10.1016/j.jaci.2007.03.039; Janson C, 2005, RESP MED, V99, P1015, DOI 10.1016/j.rmed.2005.02.003; Piacentini GL, 1999, J ALLERGY CLIN IMMUN, V104, P1323, DOI 10.1016/S0091-6749(99)70031-X; Piacentini GL, 2001, ALLERGY, V56, P251, DOI 10.1034/j.1398-9995.2001.056003251.x	6	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2007	120	5					1226	1227		10.1016/j.jaci.2007.06.045	http://dx.doi.org/10.1016/j.jaci.2007.06.045			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	231TZ	17716722	Bronze			2022-12-18	WOS:000250973400042
J	Guarino, MD; Perricone, C; Guarino, S; Gambardella, S; D'Apice, MR; Fontana, L; Novelli, G; Perricone, R				Guarino, Maria Domenica; Perricone, Carlo; Guarino, Sabina; Gambardella, Stefano; D'Apice, Maria Rosaria; Fontana, Luigi; Novelli, Giuseje; Perricone, Roberto			Denaturing HIPLC in laboratory diagnosis of hereditary angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HUMAN C1BAR INHIBITOR; C1 INHIBITOR; GENE; MUTATIONS		Univ Roma Tor Vergata, Sch Med, Rome, Italy; Univ Roma Tor Vergata, Sch Med, Dept Internal Med, Rome, Italy; Univ Roma Tor Vergata, Sch Med, Dept Biopathol & Diag Imaging, Rome, Italy; Univ Roma Tor Vergata, Sch Med, Ctr Excellence Genom Risk Assessment Multifunctor, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata	Guarino, MD (corresponding author), Univ Roma Tor Vergata, Sch Med, Rome, Italy.	roberto.peiricone@uniroma2.it	Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022; Gambardella, Stefano/AAN-5212-2020; Gambardella, Stefano/K-4514-2016	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Gambardella, Stefano/0000-0002-3727-4502; Perricone, Roberto/0000-0002-2368-9766; Perricone, Carlo/0000-0003-4771-6981				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; Guarino S, 2006, CLIN GENET, V70, P83, DOI 10.1111/j.1399-0004.2006.00643.x; Kalmar L, 2005, HUM MUTAT, V25, P1, DOI 10.1002/humu.20112; Kosaki K, 2005, MOL GENET METAB, V86, P117, DOI 10.1016/j.ymgme.2005.07.033; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Perricone R, 2000, SCAND J IMMUNOL, V51, P104; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; VERPY E, 1995, J CLIN INVEST, V95, P350, DOI 10.1172/JCI117663	10	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					962	965		10.1016/j.jaci.2007.05.041	http://dx.doi.org/10.1016/j.jaci.2007.05.041			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17659327	Bronze			2022-12-18	WOS:000250157700038
J	Wallace, DV; Bahna, SL; Goldstein, S; Hamilton, RG; Cohn, JR				Wallace, Dana V.; Bahna, Sami L.; Goldstein, Stan; Hamilton, Robert G.; Cohn, John R.			American academy of allergy, asthma & immunology work group report: Allergy diagnosis in clinical practice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RISK		Nova SE Univ, Ft Lauderdale, FL 33314 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Med, Shreveport, LA 71105 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Shreveport, LA 71105 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Nova Southeastern University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Johns Hopkins University; Jefferson University	Wallace, DV (corresponding author), Nova SE Univ, Ft Lauderdale, FL 33314 USA.	john.cohn@mail.tju.edu						Bahna S L, 1995, Pediatr Allergy Immunol, V6 Suppl 8, P49; BERNSTEIN IL, 2007, IN PRESS ANN ALLERGY; COHN JR, AAAAI WORK GROUP REP; *JOINT TASK FORC P, 2005, J ALLERGY CLIN IM S2, V0115, pS 483; Kemp SF, 1997, ANN ALLERG ASTHMA IM, V78, P527, DOI 10.1016/S1081-1206(10)63212-7; Lieberman P, 2005, J ALLERGY CLIN IMMUN, V116, P933, DOI 10.1016/j.jaci.2005.06.021; Oppenheimer J, 2006, ANN ALLERG ASTHMA IM, V96, P19, DOI 10.1016/S1081-1206(10)61034-4; OPPENHEIMER JJ, 1993, ANN ALLERGY, V71, P227; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444, DOI 10.1016/S0091-6749(97)70133-7	9	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2007	120	4					967	969		10.1016/j.jaci.2007.05.049	http://dx.doi.org/10.1016/j.jaci.2007.05.049			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	220LH	17637470	Bronze, Green Submitted			2022-12-18	WOS:000250157700040
J	Foley, SC; Prefontaine, D; D'Antoni, M; Hamid, Q				Foley, Susan C.; Prefontaine, David; D'Antoni, Michelle; Hamid, Qutayba			Regulatory T cells in allergic disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							EXPRESSION; CHILDREN		McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada	McGill University	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	qutayba.hamid@mcgill.ca						Bellinghausen I, 2003, J ALLERGY CLIN IMMUN, V111, P862, DOI 10.1067/mai.2003.1412; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Horner AA, 2006, J ALLERGY CLIN IMMUN, V117, P1133, DOI 10.1016/j.jaci.2006.02.035; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Prefontaine D, 2007, J ALLERGY CLIN IMMUN, V119, pS308, DOI 10.1016/j.jaci.2006.12.577; Seroogy CM, 2005, J ALLERGY CLIN IMMUN, V116, P996, DOI 10.1016/j.jaci.2005.07.015; Tulic MK, 2004, LANCET, V363, P1689, DOI 10.1016/S0140-6736(04)16253-3	13	7	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2007	120	2					482	486		10.1016/j.jaci.2007.06.036	http://dx.doi.org/10.1016/j.jaci.2007.06.036			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	198VF	17666218				2022-12-18	WOS:000248654900043
J	Ly, NP; Celedon, JC				Ly, Ngoc P.; Celedon, Juan C.			Family history, environmental exposures in early life, and childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ATOPY; CHILDREN; RISK		Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pediat, Div Pediat Pulmonary Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Celedon, JC (corresponding author), Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	juan.celedon@channing.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL066289, R01HL073373, R01HL066289, R01HL079966] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL073373, HL079966, HL66289] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Celedon JC, 1999, PEDIATRICS, V104, P495, DOI 10.1542/peds.104.3.495; Celedon JC, 2002, LANCET, V360, P781, DOI 10.1016/S0140-6736(02)09906-3; Dell S, 2001, ARCH PEDIAT ADOL MED, V155, P1261, DOI 10.1001/archpedi.155.11.1261; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Johnson CC, 2004, J ALLERGY CLIN IMMUN, V114, P105, DOI 10.1016/j.jaci.2004.04.007; Kuiper S, 2007, J ALLERGY CLIN IMMUN, V120, P388, DOI 10.1016/j.jaci.2007.03.038; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Ly NP, 2006, PEDIATRICS, V117, pE1132, DOI 10.1542/peds.2005-2271; Mandhane PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1359, DOI 10.1016/j.jaci.2007.01.043; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Polk S, 2004, AM J RESP CRIT CARE, V170, P273, DOI 10.1164/rccm.200310-1348OC; Raby BA, 2005, AM J RESP CRIT CARE, V172, P552, DOI 10.1164/rccm.200501-010OC; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Wright AL, 2000, ADV EXP MED BIOL, V478, P131; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	16	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2007	120	2					271	272		10.1016/j.jaci.2007.05.045	http://dx.doi.org/10.1016/j.jaci.2007.05.045			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	198VF	17666215				2022-12-18	WOS:000248654900006
J	Weinberger, M				Weinberger, Miles			Should corticosteroids be used for first-time young wheezers?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							BRONCHIOLITIS; PREDNISOLONE; RHINOVIRUS; INFECTION; MANAGEMENT; EFFICACY; CHILDREN; INFANCY; ASTHMA		Univ Iowa, Coll Med, Dept Pediat, Pediat Allergy & Pulm Div, Iowa City, IA 52242 USA	University of Iowa	Weinberger, M (corresponding author), Univ Iowa Hosp, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	miles-weinberger@uiowa.edu	Weinberger, Miles/H-6743-2019					*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P707; Cifuentes L, 2003, PEDIATR PULM, V36, P316, DOI 10.1002/ppul.10365; Csonka P, 2003, J PEDIATR-US, V143, P725, DOI 10.1067/S0022-3476(03)00498-0; Ducharme FM, 2003, PEDIATRICS, V111, P376, DOI 10.1542/peds.111.2.376; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Garrison MM, 2000, PEDIATRICS, V105, pCP4, DOI 10.1542/peds.105.4.e44; Goebel J, 2000, CLIN PEDIATR, V39, P213, DOI 10.1177/000992280003900404; Jartti T, 2006, PEDIATR INFECT DIS J, V25, P482, DOI 10.1097/01.inf.0000215226.69696.0c; Korppi M, 2004, PEDIATR INFECT DIS J, V23, P995, DOI 10.1097/01.inf.0000143642.72480.53; Lehtinen P, 2007, J ALLERGY CLIN IMMUN, V119, P570, DOI 10.1016/j.jaci.2006.11.003; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; MCINTOSH K, 1973, J PEDIATR-US, V82, P578, DOI 10.1016/S0022-3476(73)80582-7; McKean M, 2000, Cochrane Database Syst Rev, pCD001107, DOI 10.1002/14651858.CD001107; MINOR TE, 1974, JAMA-J AM MED ASSOC, V227, P292, DOI 10.1001/jama.227.3.292; Nelson R, 2003, LANCET, V361, P939, DOI 10.1016/S0140-6736(03)12791-2; Patel H., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004878; Pelletier AJ, 2006, PEDIATRICS, V118, P2418, DOI 10.1542/peds.2006-1193; Schuh S, 2002, J PEDIATR-US, V140, P27, DOI 10.1067/mpd.2002.120271; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Singh AM, 2007, AM J RESP CRIT CARE, V175, P108, DOI 10.1164/rccm.200603-435PP; VUILLERMIN P, 2006, COCHRANE DB SYST REV, V3; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weinberger M, 2003, J PEDIATR-US, V143, P700, DOI 10.1016/j.jpeds.2003.10.001; Weinberger M, 2003, J PEDIATR-US, V142, pS34, DOI 10.1067/mpd.2003.24	25	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					567	569		10.1016/j.jaci.2006.12.641	http://dx.doi.org/10.1016/j.jaci.2006.12.641			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17258307				2022-12-18	WOS:000244925000006
J	Hebert, J; Danzig, M; Gates, D				Hebert, J.; Danzig, M.; Gates, D.			Mometasone furoate improves total ocular symptom score in patients with allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Hebert, J.] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Danzig, M.; Gates, D.] Schering Plough Res Inst, Kenilworth, NJ USA	Laval University; Merck & Company; Schering-Plough Research Institute									0	7	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		240	S61	S61		10.1016/j.jaci.2006.11.263	http://dx.doi.org/10.1016/j.jaci.2006.11.263			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT		Bronze			2022-12-18	WOS:000251460400240
J	Plunkett, G				Plunkett, G.			Stability of major allergen proteins in extract mixes diluted in Human Serum Albumin (HSA), Normal Saline (NSP), or Glycerin (GLY)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Plunkett, G.] ALK Abello Inc, Round Rock, TX USA	ALK-Abello AS									0	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		414	S105	S105		10.1016/j.jaci.2006.11.629	http://dx.doi.org/10.1016/j.jaci.2006.11.629			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT		Bronze			2022-12-18	WOS:000251460400414
J	Ratner, P; Andrews, C; van Bavel, J; Toler, T; Ellsworth, A; Philpot, E				Ratner, P.; Andrews, C.; van Bavel, J.; Toler, T.; Ellsworth, A.; Philpot, E.			Once-daily fluticasone furoate* nasal spray (FF) effectively treats ocular symptoms of seasonal allergic rhinitis (SAR) caused by mountain cedar pollen *USAN approved name	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	63rd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 23-27, 2007	San Diego, CA	Amer Acad Allergy, Asthma & Immunol					[Ratner, P.] Sylvana Res Associates, San Antonio, TX USA; [Andrews, C.] Diagnost Res Grp, San Antonio, TX USA; [van Bavel, J.] Allergy & Asthma Associates, Austin, TX USA; [Toler, T.; Ellsworth, A.; Philpot, E.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	GlaxoSmithKline									0	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2007	119	1		1		908	S231	S231		10.1016/j.jaci.2006.12.276	http://dx.doi.org/10.1016/j.jaci.2006.12.276			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	238PT					2022-12-18	WOS:000251460401292
J	Kilburn, KH; Gray, M; Kramer, S				Kilburn, Kaye H.; Gray, Michael; Kramer, Sharon			Nondisclosure of conflicts of interest is perilous to the advancement of science	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter																		Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; HARDIN BD, ACOEM POLICIES POSIT; Kelman BJ, 2004, INT J TOXICOL, V23, P3, DOI 10.1080/10915810490265423; PIETRYKOWSI M, 2003, MED ASS MOLD MATTERS, V3, P5; Rand TG, 2005, TOXICOL SCI, V87, P213, DOI 10.1093/toxsci/kfi223; Robbins C A, 2000, Appl Occup Environ Hyg, V15, P773; Terr AI, 2005, ANN ALLERG ASTHMA IM, V95, P215, DOI 10.1016/S1081-1206(10)61216-1	8	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					766	767		10.1016/j.jaci.2006.07.009	http://dx.doi.org/10.1016/j.jaci.2006.07.009			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950307				2022-12-18	WOS:000240649000043
J	Waibel, KH				Waibel, Kirk H.			Aspiration before immunotherapy injection is not required	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FATAL REACTIONS		Dwight D Eisenhower Army Med Ctr, Allergy Immunol Serv, Dept Med, Ft Gordon, GA 30905 USA	United States Department of Defense; United States Army	Waibel, KH (corresponding author), Dwight D Eisenhower Army Med Ctr, Allergy Immunol Serv, Dept Med, Hospital Rd,Bldg 300, Ft Gordon, GA 30905 USA.							Amin HS, 2006, J ALLERGY CLIN IMMUN, V117, P169, DOI 10.1016/j.jaci.2005.10.010; Bernstein DI, 2004, J ALLERGY CLIN IMMUN, V113, P1129, DOI 10.1016/j.jaci.2004.02.006; Joint Task Force on Practice Parameters, 2003, Ann Allergy Asthma Immunol, V90, P1; PERAGALLODITTKO V, 1995, DIABETES EDUCATOR, V21, P291, DOI 10.1177/014572179502100405; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; WATSON JC, 1994, MMWR CDC SURVEIL SUM, V43, P1	6	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2006	118	2					525	526		10.1016/j.jaci.2006.04.008	http://dx.doi.org/10.1016/j.jaci.2006.04.008			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	075IH	16890784				2022-12-18	WOS:000239877700035
J	Castells, MC				Castells, Mariana C.			Extracutaneous mastocytoma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Castells, MC (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg,Room 626A,1 Jimmy Fund Way, Boston, MA 02115 USA.	Mcastells@partners.org						HAAS N, 1995, ARCH DERMATOL RES, V287, P242, DOI 10.1007/BF01105073; KETTELHUT BV, 1994, ANN ALLERGY, V73, P197; Wolff K, 2001, LEUKEMIA RES, V25, P519, DOI 10.1016/S0145-2126(01)00044-3	3	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2006	117	6					1513	1515		10.1016/j.jaci.2006.04.016	http://dx.doi.org/10.1016/j.jaci.2006.04.016			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	053UX	16751029				2022-12-18	WOS:000238332300056
J	Jeong, YY; Park, HS; Choi, JH; Kim, SH; Min, KU				Jeong, YY; Park, HS; Choi, JH; Kim, SH; Min, KU			Two cases of anaphylaxis caused by perilla seed	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGY; SESAME; FRUTESCENS		Gyeongsang Natl Univ, Coll Med, Div Allergy & Resp Med, Jinju, South Korea; Gyeongsang Natl Univ, Coll Med, Inst Hlth Sci, Jinju, South Korea; Ajou Univ, Sch Med, Dept Allergy & Rheumatol, Suwon 441749, South Korea; Bundang Je Saeng Hosp, Div Allergy & Resp Med, Sungnam, South Korea; Seoul Natl Univ, Coll Med, Div Allergy & Clin Immunol, Seoul 151, South Korea	Gyeongsang National University; Gyeongsang National University; Ajou University; Seoul National University (SNU)	Jeong, YY (corresponding author), Gyeongsang Natl Univ, Coll Med, Div Allergy & Resp Med, Jinju, South Korea.		Park, Hae-Sim/S-7974-2019; Min, Kyung-Up/J-5468-2012	Park, Hae-Sim/0000-0003-2614-0303				[Anonymous], 2005, J ALLERGY CLIN IMMUN, V115, pS483; Gangur V, 2005, ANN ALLERG ASTHMA IM, V95, P4, DOI 10.1016/S1081-1206(10)61181-7; Kemp SF, 2002, J ALLERGY CLIN IMMUN, V110, P341, DOI 10.1067/mai.2002.126811; Makino T, 2001, BIOL PHARM BULL, V24, P1206, DOI 10.1248/bpb.24.1206; Pajno GB, 2000, ALLERGY, V55, P199, DOI 10.1034/j.1398-9995.2000.00494.x; Sanbongi C, 2004, CLIN EXP ALLERGY, V34, P971, DOI 10.1111/j.1365-2222.2004.01979.x; Sicherer Scott H., 2003, Journal of Allergy and Clinical Immunology, V111, pS829, DOI 10.1067/mai.2003.152; Ueda H, 2002, BIOL PHARM BULL, V25, P1197, DOI 10.1248/bpb.25.1197; Wolff N, 2003, FOOD CHEM TOXICOL, V41, P1165, DOI 10.1016/S0278-6915(03)00107-8	9	7	7	2	4	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2006	117	6					1505	1506		10.1016/j.jaci.2006.02.044	http://dx.doi.org/10.1016/j.jaci.2006.02.044			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	053UX	16751022	Bronze			2022-12-18	WOS:000238332300049
J	Buchanan, A; Scurlock, AM; Jones, SM; Chrisite, L; Althage, KM; Pons, L; Steele, PH; Burks, AW				Buchanan, A; Scurlock, AM; Jones, SM; Chrisite, L; Althage, KM; Pons, L; Steele, PH; Burks, AW			Oral desensitization and induction of tolerance in peanut-allergic children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Duke Univ, Med Ctr, Durham, NC USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Arkansas Childrens Hosp, Little Rock, AR 72202 USA	Duke University; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital									0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		1262	S327	S327		10.1016/j.jaci.2005.12.1290	http://dx.doi.org/10.1016/j.jaci.2005.12.1290			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865302340
J	Pan, QR; Wang, SM; Shang, HS; Chew, FT				Pan, QR; Wang, SM; Shang, HS; Chew, FT			Identification and characterization of Per a 2, the Bla g 2 allergen homologue from American cockroach (Periplaneta americana)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Natl Univ Singapore, Singapore 117548, Singapore	National University of Singapore			Chew, Fook Tim/E-7259-2010	Chew, Fook Tim/0000-0003-1337-5146					0	7	7	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		450	S115	S115		10.1016/j.jaci.2005.12.461	http://dx.doi.org/10.1016/j.jaci.2005.12.461			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865300450
J	Poole, JA; Barriga, K; Leung, DYM; Hoffman, M; Eisenbarth, GS; Rewers, M; Norris, JM				Poole, JA; Barriga, K; Leung, DYM; Hoffman, M; Eisenbarth, GS; Rewers, M; Norris, JM			Timing of initial exposure to cereal grains and the risk of wheat allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Univ Nebraska, Med Ctr, Omaha, NE USA; Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80202 USA; Hlth Sci Ctr, Denver, CO USA; Natl Jewish Med & Res Ctr, Denver, CO USA; Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80202 USA	University of Nebraska System; University of Nebraska Medical Center; University of Colorado System; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Denver									0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		168	S42	S42		10.1016/j.jaci.2005.12.174	http://dx.doi.org/10.1016/j.jaci.2005.12.174			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865300168
J	Rusicke, E; Martinez-Saguer, I; Aygoren-Pursun, E; Kreuz, W				Rusicke, E; Martinez-Saguer, I; Aygoren-Pursun, E; Kreuz, W			Home treatment in patients with hereditary angiodema (HAE)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					JWG Univ Hosp, Ctr Pediat 3, Dept Hematol Hemostaseol Oncol & Immunodeficiency, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital									0	7	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2		S		700	S180	S180		10.1016/j.jaci.2005.12.716	http://dx.doi.org/10.1016/j.jaci.2005.12.716			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	019VR					2022-12-18	WOS:000235865301197
J	Stocker, M; Klockenbring, T; Huhn, M; Nachreiner, T; Wicklein, D; Petersen, A; Bauer, R; Goerlich, R; Fischer, R; Barth, S				Stocker, M; Klockenbring, T; Huhn, M; Nachreiner, T; Wicklein, D; Petersen, A; Bauer, R; Goerlich, R; Fischer, R; Barth, S			Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						antigen; allergen; EBV transformation; B-cell targeting; allergen toxin	PSEUDOMONAS EXOTOXIN; RECOMBINANT IMMUNOTOXINS; MONOCLONAL-ANTIBODIES; DIPHTHERIA-TOXIN; TIMOTHY-GRASS; IGE; RECEPTOR; BINDING; POLLEN; LINES	Background: With the exception of antigen-specific immunotherapy, current treatments for atopic diseases provide only symptomatic relief. Because of the increasing incidence of such diseases, the development of novel strategies and concepts for the treatment of allergies is urgently needed. Objective: Here we present a new approach for the treatment of atopic diseases. The strategy is comparable to the application of immunotoxins in cancer therapy, in which a cytotoxic peptide is coupled to a cancer cell-specific antibody fragment or ligand. In the case of so-called allergen toxins (ATs), the target cell-specific moiety is an allergen or allergen-derived fragment, which should be bound only by allergen-reactive cells. After receptor-mediated internalization, allergen-specific cells are killed, and the allergic pathogenesis is interrupted. Methods: Proof of the AT principle was shown by using a human ex vivo system in which EBV was used to transform human B cells specific for the timothy grass pollen allergen Phi p 5b. The AT is composed of the major B-cell and T-cell epitopes of the Phi p 5b (P5) allergen fused to a truncated form of the highly toxic Pseudomonas aeruginosa exotoxin A (ETA'). Results: Allergen-specific and nonspecific B cells were challenged with P5-ETA', but only the Phi p 5b-reactive B cells showed selective binding and cytotoxicity. Conclusion: This approach represents an initial step toward a novel therapeutic strategy in the treatment of atopic diseases.	Univ Aachen, Inst Mol Biotechnol, D-52074 Aachen, Germany; Fraunhofer Inst Mol Biol & Appl Ecol, Dept Pharmaceut Prod Dev, Aachen, Germany; Res Ctr Borstel, Div Biochem & Mol Allergy, Borstel, Germany; Dermatol Klin & Poliklin, Bonn, Germany	RWTH Aachen University; Fraunhofer Gesellschaft; Forschungszentrum Borstel; University of Bonn	Barth, S (corresponding author), Univ Aachen, Inst Mol Biotechnol, Worringerweg 1, D-52074 Aachen, Germany.	barth@molbiotech.rwth-aachen.de	Barth, Stefan/F-7301-2012; Huhn, Michael/ABE-2928-2021	Barth, Stefan/0000-0001-9589-653X; 				Appel H, 2000, J BIOL CHEM, V275, P312, DOI 10.1074/jbc.275.1.312; Barth S, 2000, BLOOD, V95, P3909; Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; BENDE RJ, 1992, CELL IMMUNOL, V143, P310, DOI 10.1016/0008-8749(92)90028-N; Brenner T, 1999, IMMUNOL LETT, V68, P403, DOI 10.1016/S0165-2478(99)00089-9; Bruell D, 2003, INT J ONCOL, V23, P1179; BUFE A, 1995, FEBS LETT, V363, P6, DOI 10.1016/0014-5793(95)00259-C; D'Amato Gennaro, 2004, Current Drug Targets - Inflammation and Allergy, V3, P227, DOI 10.2174/1568010043343615; DECAMPOSLIMA PO, 1993, INT J CANCER, V53, P856, DOI 10.1002/ijc.2910530525; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; FERRANTE A, 1978, J IMMUNOL METHODS, V24, P389, DOI 10.1016/0022-1759(78)90143-6; Fishman A, 1997, EUR J IMMUNOL, V27, P486, DOI 10.1002/eji.1830270220; FITZGERALD D, 1993, ANN NY ACAD SCI, V685, P740, DOI 10.1111/j.1749-6632.1993.tb35935.x; FitzGerald DJ, 2004, INT J MED MICROBIOL, V293, P577, DOI 10.1078/1438-4221-00302; Hendeles Leslie, 2004, Paediatr Respir Rev, V5 Suppl A, pS107, DOI 10.1016/S1526-0542(04)90020-6; IRSCH J, 1995, IMMUNOTECHNOLOGY, V1, P115, DOI 10.1016/1380-2933(95)00012-7; KIRKWOOD JM, 1990, CANCER IMMUNOL IMMUN, V32, P228, DOI 10.1007/BF01741705; Klockenbring T, 2001, FOOD AGR IMMUNOL, V13, P171, DOI 10.1080/09540100120075826; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Lavens S, 2004, J VIROL, V78, P8543, DOI 10.1128/JVI.78.16.8543-8551.2004; Lee BK, 2004, CLIN EXP ALLERGY, V34, P1642, DOI 10.1111/j.1365-2222.2004.02077.x; Lee BK, 2001, YONSEI MED J, V42, P91, DOI 10.3349/ymj.2001.42.1.91; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; LI H, 1995, BIOCHEM BIOPH RES CO, V207, P985, DOI 10.1006/bbrc.1995.1282; Linhart B, 2005, J ALLERGY CLIN IMMUN, V115, P1010, DOI 10.1016/j.jaci.2004.12.1142; LUNDGREN K, 1983, J IMMUNOL, V131, P2000; Matthey B, 1999, GENE, V229, P145, DOI 10.1016/S0378-1119(99)00038-4; Mevissen Marcel L. C. M., 1993, Human Antibodies and Hybridomas, V4, P66; Nelson HS, 2004, J ALLERGY CLIN IMMUN, V113, P635, DOI 10.1016/j.jaci.2004.01.741; Norman PS, 2004, J ALLERGY CLIN IMMUN, V113, P1013, DOI 10.1016/j.jaci.2004.03.020; PASTAN I, 1986, CELL, V47, P641, DOI 10.1016/0092-8674(86)90506-4; Pastan I, 1996, BREAST CANCER RES TR, V38, P3, DOI 10.1007/BF01803778; Proby CM, 2000, BRIT J DERMATOL, V142, P321, DOI 10.1046/j.1365-2133.2000.03328.x; Reiners KS, 2004, IMMUNOLOGY, V112, P228, DOI 10.1111/j.1365-2567.2004.01875.x; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; Schramm G, 1999, J IMMUNOL, V162, P2406; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; STEINITZ M, 1979, J CLIN LAB IMMUNOL, V2, P1; Stocker M, 2003, PROTEIN EXPRES PURIF, V28, P211, DOI 10.1016/S1046-5928(02)00709-X; Stokes J, 2004, ANN ALLERG ASTHMA IM, V93, P212, DOI 10.1016/S1081-1206(10)61490-1; Tur MK, 2003, CANCER RES, V63, P8414; VANDERHEIJDEN FL, 1993, J IMMUNOL, V150, P3643; Vrtala S, 2004, METHODS, V32, P313, DOI 10.1016/j.ymeth.2003.08.016; Wiedermann U, 1999, INT IMMUNOL, V11, P1715, DOI 10.1093/oxfordjournals.intimm.a019877	44	7	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2005	116	4					910	915		10.1016/j.jaci.2005.07.022	http://dx.doi.org/10.1016/j.jaci.2005.07.022			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IF	16210069	Bronze			2022-12-18	WOS:000235686600029
J	Bonilla, FA; Geha, RS				Bonilla, FA; Geha, RS			Are you immunodeficient?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						clinical immunology; primary immunodeficiency; infectious diseases; genetics	GENE-THERAPY; MANAGEMENT; DISEASES		Childrens Hosp, Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bonilla, FA (corresponding author), Childrens Hosp, Div Immunol, Enders 809,300 Longwood Ave, Boston, MA 02115 USA.	francisco.bonilla@childrens.harvard.edu						Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Casanova JL, 2005, J ALLERGY CLIN IMMUN, V116, P426, DOI 10.1016/j.jaci.2005.03.053; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084; GUERRA IC, 1986, CLIN IMMUNOL IMMUNOP, V40, P128, DOI 10.1016/0090-1229(86)90076-0; Notarangelo L, 2004, J ALLERGY CLIN IMMUN, V114, P677, DOI 10.1016/j.jaci.2004.06.044; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Orange JS, 2004, J ALLERGY CLIN IMMUN, V114, P650, DOI 10.1016/j.jaci.2004.06.052; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200	12	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2005	116	2					423	425		10.1016/j.jaci.2005.05.026	http://dx.doi.org/10.1016/j.jaci.2005.05.026			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017ID	16083800	Bronze			2022-12-18	WOS:000235686400028
J	Smith, JM				Smith, JM			Atopy and asthma: An epidemic of unknown cause	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE		Univ Iowa Hlth Care, Dept Internal Med, Div Allergy Immunol, Iowa City, IA 52242 USA	University of Iowa	Smith, JM (corresponding author), Univ Iowa Hlth Care, Dept Internal Med, Div Allergy Immunol, 200 Hawkins Dr, Iowa City, IA 52242 USA.							Alford SH, 2004, J ALLERGY CLIN IMMUN, V114, P1046, DOI 10.1016/j.jaci.2004.08.036; Hussain I, 2003, CHEST, V124, P1968, DOI 10.1378/chest.124.5.1968; McIntire JJ, 2003, NATURE, V425, P576, DOI 10.1038/425576a	3	7	11	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					231	232		10.1016/j.jaci.2005.03.008	http://dx.doi.org/10.1016/j.jaci.2005.03.008			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990805	Bronze			2022-12-18	WOS:000235686300040
J	Johansson, SGO				Johansson, SGO			The story of IgND	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item									Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Dept Med, Karolinska Inst,Clin Immunol & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Johansson, SGO (corresponding author), Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Dept Med, Karolinska Inst,Clin Immunol & Allergy Unit, Stockholm, Sweden.								0	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					644	648		10.1016/j.jaci.2004.11.027	http://dx.doi.org/10.1016/j.jaci.2004.11.027			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753923				2022-12-18	WOS:000227687000040
J	Aronica, MA; Swaidani, S; Zhang, YH; Mitchell, D; Mora, AL; McCarthy, S; O'Neal, J; Topham, D; Sheller, JR; Boothby, M				Aronica, MA; Swaidani, S; Zhang, YH; Mitchell, D; Mora, AL; McCarthy, S; O'Neal, J; Topham, D; Sheller, JR; Boothby, M			Susceptibility to allergic lung disease regulated by recall responses of dual-receptor memory T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mucosal antigen; T(H)1/T(H)2 cells; immunoregulation; allergic lung disease; dual-receptor; mice; airway hyperresponsiveness; airway inflammation; asthma	AIRWAY INFLAMMATION; IN-VIVO; VIRAL-INFECTIONS; IGE PRODUCTION; MURINE MODEL; TH2 CELLS; ASTHMA; INDUCTION; ANTIGEN; LYMPHOCYTES	Background: Microbial infections are associated with the initial susceptibility to and flares of asthma. However, immunologic mechanisms whereby infections might alter the asthmatic phenotype are lacking. Objective: To test the hypothesis that memory T cells specific both for a viral antigen and an allergen could influence the pathogenesis of allergic disease in vivo. Methods: We developed a system in which 2 distinct T-cell receptors coexist on the T-cell surface, 1 specific for a virus and the other for an inhaled antigen. Results: We show that a population of dual-receptor T cells, polarized through a virus-specific T-cell receptor to contain T(H)1 or T(H)2 cells, can be reactivated through an unrelated T-cell receptor in recall responses in vivo. Quiescent memory cells derived from a T(H)1-polarized effector population blocked the development of airway hyperreactivity in a model of allergic lung disease, in association with decreased induction of chemokines and eosinophil recruitment. Conversely, reactivation of quiescent TH2 cells after inhalation of antigen or virus infection was sufficient to lead to the development of airway hyperresponsiveness and allergic pulmonary inflammation in mice whose lungs were previously normal. Conclusion: These data provide evidence that dual-receptor memory T cells can regulate allergic disease susceptibility and suggest that they may play a role in mediating the influence of microbes on asthma pathogenesis.	Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Pulm Allergy & Crit Care Med, Cleveland, OH 44195 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Allergy Pulm & Crit Care Med Div, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Rheumatol, Dept Med, Nashville, TN 37212 USA; Univ Rochester, Ctr Med, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Rochester	Aronica, MA (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave,NB3-77, Cleveland, OH 44195 USA.	aronicm@ccf.org		Swaidani, Shadi/0000-0003-1506-4472	NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485] Funding Source: Medline; NHLBI NIH HHS [K08 HL0449, R01 HL61752] Funding Source: Medline; NIDDK NIH HHS [P60 DK20593] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adkins P, 2001, J IMMUNOL, V166, P918, DOI 10.4049/jimmunol.166.2.918; Aronica MA, 1999, J IMMUNOL, V163, P5116; Aronica MA, 2000, CYTOKINE, V12, P578, DOI 10.1006/cyto.1999.0603; Aronica MA, 2004, AM J RESP CRIT CARE, V169, P587, DOI 10.1164/rccm.200301-100OC; Avila PC, 2000, J ALLERGY CLIN IMMUN, V106, P829, DOI 10.1067/mai.2000.111027; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; BUSSE WW, 1990, J ALLERGY CLIN IMMUN, V85, P671, DOI 10.1016/0091-6749(90)90181-3; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; ELLIOTT JI, 1995, J EXP MED, V182, P953, DOI 10.1084/jem.182.4.953; Elliott JI, 1996, EUR J IMMUNOL, V26, P953, DOI 10.1002/eji.1830260436; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Gern JE, 2000, J ALLERGY CLIN IMMUN, V106, P201, DOI 10.1067/mai.2000.108604; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; Hinz T, 2001, INT ARCH ALLERGY IMM, V125, P16, DOI 10.1159/000053792; Holgate ST, 1999, J ALLERGY CLIN IMMUN, V104, P1139, DOI 10.1016/S0091-6749(99)70005-9; Hurst SD, 1997, P NATL ACAD SCI USA, V94, P3920, DOI 10.1073/pnas.94.8.3920; Hussain SF, 2002, J IMMUNOL, V168, P1557, DOI 10.4049/jimmunol.168.4.1557; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Karpus WJ, 1997, J IMMUNOL, V158, P4129; LACK G, 1994, J IMMUNOL, V152, P2546; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Lebrec H, 1996, J TOXICOL ENV HEALTH, V49, P619; Lee WT, 1996, J IMMUNOL, V157, P5300; Liu AH, 2003, J ALLERGY CLIN IMMUN, V111, P471, DOI 10.1067/mai.2003.172; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Peebles R S Jr, 2000, Curr Opin Pulm Med, V6, P10, DOI 10.1097/00063198-200001000-00003; Prescott SL, 1997, INT ARCH ALLERGY IMM, V113, P75, DOI 10.1159/000237512; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Randolph DA, 1999, J IMMUNOL, V162, P2375; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; Sudo N, 1997, J IMMUNOL, V159, P1739; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2; Tsitoura DC, 2000, J ALLERGY CLIN IMMUN, V106, P239; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102; Zhang Y, 1997, AM J RESP CRIT CARE, V155, P661, DOI 10.1164/ajrccm.155.2.9032210	43	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2004	114	6					1441	1448		10.1016/j.jaci.2004.08.025	http://dx.doi.org/10.1016/j.jaci.2004.08.025			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	877NN	15577850				2022-12-18	WOS:000225577400029
J	Bloom, JW				Bloom, JW			Mitogen-activated protein kinase pathways: Therapeutic targets in steroid resistance?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							SMOOTH-MUSCLE-CELLS; N-TERMINAL KINASE; GLUCOCORTICOID-RECEPTOR; INSENSITIVE ASTHMA; PHOSPHORYLATION; TRANSLOCATION; ENHANCEMENT; AGONISTS		Univ Arizona, Coll Med, Arizona Resp Ctr, Dept Pharmacol, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Arizona Resp Ctr, Dept Med, Tucson, AZ 85724 USA	University of Arizona; University of Arizona	Bloom, JW (corresponding author), Univ Arizona, Coll Med, Arizona Resp Ctr, Dept Pharmacol, POB 245030,1501 N Campbell Ave, Tucson, AZ 85724 USA.	jbloom@arc.arizona.edu						Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Galigniana MD, 1999, MOL PHARMACOL, V55, P317, DOI 10.1124/mol.55.2.317; Goleva E, 2002, J IMMUNOL, V169, P5934, DOI 10.4049/jimmunol.169.10.5934; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Leung DYM, 1997, J EXP MED, V186, P1567, DOI 10.1084/jem.186.9.1567; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Li LB, 2004, J ALLERGY CLIN IMMUN, V114, P1059, DOI 10.1016/j.jaci.2004.08.005; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Pariante CM, 1999, ENDOCRINOLOGY, V140, P4359, DOI 10.1210/en.140.9.4359; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Tsitoura DC, 2004, J CLIN INVEST, V113, P619, DOI 10.1172/JCI200418975; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200	19	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2004	114	5					1055	1058		10.1016/j.jaci.2004.09.001	http://dx.doi.org/10.1016/j.jaci.2004.09.001			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	870HI	15536410				2022-12-18	WOS:000225047800010
J	Chinen, J; Shearer, WT				Chinen, J; Shearer, WT			Subcutaneous immunoglobulins: Alternative for the hypogammaglobulinemic patient?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						subcutaneous immunoglobulins; IVIG; primary immunodeficiencies; quality of life; hypogammaglobulinemia	INTRAVENOUS IMMUNOGLOBULIN; HOME TREATMENT; REPLACEMENT; INFUSION; IMMUNODEFICIENCIES; THERAPY; SAFETY		NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Baylor Coll Med, Dept Pediat, Allergy & Immunol Sect, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine	Chinen, J (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, 49 Convent Dr,Bldg 49,Room 4A18, Bethesda, MD 20892 USA.	jchinen@nhgri.nih.gov		Shearer, William/0000-0002-2483-2130				Abrahamsen TG, 1996, PEDIATRICS, V98, P1127; Berger M, 2004, CLIN IMMUNOL, V112, P1, DOI 10.1016/j.clim.2004.02.002; Binstadt BA, 2003, J ALLERGY CLIN IMMUN, V111, P697, DOI 10.1067/mai.2003.1380; BRUTON OC, 1952, PEDIATRICS, V9, P722; Chapel HM, 2000, J CLIN IMMUNOL, V20, P94, DOI 10.1023/A:1006678312925; Gardulf A, 2004, J ALLERGY CLIN IMMUN, V114, P936, DOI 10.1016/j.jaci.2004.06.053; GARDULF A, 1995, LANCET, V345, P365; GARDULF A, 1991, LANCET, V338, P162; Gaspar J, 1998, ARCH DIS CHILD, V79, P48, DOI 10.1136/adc.79.1.48; OCHS HD, 1986, LANCET, V1, P610; Radinsky S, 2003, J ALLERGY CLIN IMMUN, V112, P630, DOI 10.1067/mai.2003.1688; Stiehm ER, 1998, J ALLERGY CLIN IMMUN, V101, P848, DOI 10.1016/S0091-6749(98)70314-8	12	7	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2004	114	4					934	935		10.1016/j.jaci.2004.07.045	http://dx.doi.org/10.1016/j.jaci.2004.07.045			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	861SO	15480338				2022-12-18	WOS:000224439100032
J	Frankland, AW				Frankland, AW			Carl Prausnitz: A personal memoir	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item									London Allergy Clin, London, England; St Marys Hosp, London, England; Guys Hosp, London SE1 9RT, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust	Frankland, AW (corresponding author), London Allergy Clin, London, England.							PRAUSNITZ C, PUBLICATION LIST	1	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2004	114	3					700	705		10.1016/j.jaci.2004.06.040	http://dx.doi.org/10.1016/j.jaci.2004.06.040			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	853AX	15356577				2022-12-18	WOS:000223799600040
J	Spergel, JM; Nurse, N; Taylor, P; ParneixSpake, A				Spergel, JM; Nurse, N; Taylor, P; ParneixSpake, A			Effect of topical pimecrolimus on epicutaneous skin testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPIC-DERMATITIS; ASM-981		Univ Penn, Sch Med, Div Allergy & Immunol, Allergy Sect, Philadelphia, PA 19104 USA; Novartis Pharmaceut Corp, E Hanover, NJ USA	University of Pennsylvania; Novartis	Spergel, JM (corresponding author), Univ Penn, Sch Med, Div Allergy & Immunol, Allergy Sect, Wood 5,34th & Civic Ctr Blvd, Philadelphia, PA 19104 USA.			Spergel, Jonathan/0000-0002-4658-5353				CHANG EE, 2003, J ALLERGY CLIN IMMUN, V111, pS350; Eichenfield LF, 2002, J AM ACAD DERMATOL, V46, P495, DOI 10.1067/mjd.2002.122187; Kapp A, 2002, J ALLERGY CLIN IMMUN, V110, P277, DOI 10.1067/mai.2002.126500; SAMPSON HA, 1985, J PEDIATR-US, V107, P669, DOI 10.1016/S0022-3476(85)80390-5; Zuberbier T, 2001, J ALLERGY CLIN IMMUN, V108, P275, DOI 10.1067/mai.2001.116865	5	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2004	114	3					695	697		10.1016/j.jaci.2004.05.067	http://dx.doi.org/10.1016/j.jaci.2004.05.067			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	853AX	15446295				2022-12-18	WOS:000223799600037
J	von Hertzen, LC; Haahtela, T				von Hertzen, LC; Haahtela, T			Immunization and atopy: Possible implications of ethnicity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy; asthma; atopy; immunization; immigrants; vaccines	KILLED MYCOBACTERIUM-VACCAE; EARLY BCG VACCINATION; REGULATORY T-CELLS; TUBERCULIN REACTIVITY; EARLY-CHILDHOOD; PERTUSSIS VACCINATION; AIRWAY EOSINOPHILIA; ALLERGIC RESPONSE; IMMUNE PATHOLOGY; IMMUNOGLOBULIN-E	The possible effects of immunization on subsequent development of asthma and atopy remains a matter of controversy. Although some studies have suggested that immunization might increase the risk for atopic disease, a number of studies have found no association or have even reported a protective effect for immunization against atopy. Recent studies have provided evidence that ethnicity might affect the susceptibility to the immunomodulatory effects of vaccination. In this review the association between immunization and atopy and the effect of ethnicity on this association are briefly outlined. The focus will be particularly on BCG vaccination.	Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, FIN-00014 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	von Hertzen, LC (corresponding author), Finnish Lung Hlth Assoc, Sibeliuksenkatu 11A1, Helsinki 00250, Finland.							Aaby P, 2000, CLIN EXP ALLERGY, V30, P644, DOI 10.1046/j.1365-2222.2000.00803.x; Alm JS, 1997, LANCET, V350, P400, DOI 10.1016/S0140-6736(97)02207-1; Anderson HR, 2001, AM J PUBLIC HEALTH, V91, P1126, DOI 10.2105/AJPH.91.7.1126; Arkwright PD, 2001, J ALLERGY CLIN IMMUN, V107, P531, DOI 10.1067/mai.2001.113081; Barlan IB, 2002, J ASTHMA, V39, P239, DOI 10.1081/JAS-120002473; Beasley R, 2002, CLIN EXP ALLERGY, V32, P1128, DOI 10.1046/j.1365-2745.2002.01485.x; Blomfield R, 1998, BRIT MED J, V317, P205, DOI 10.1136/bmj.317.7152.205; Camporota L, 2003, EUR RESPIR J, V21, P287, DOI 10.1183/09031936.03.00042103; Cavallo GP, 2002, ARCH OTOLARYNGOL, V128, P1058, DOI 10.1001/archotol.128.9.1058; Choi IS, 2002, ANN ALLERG ASTHMA IM, V88, P584, DOI 10.1016/S1081-1206(10)61890-X; Dechene L, 2002, J ALLERGY CLIN IMMUN, V110, P539, DOI 10.1067/mai.2002.127436; Destefano F, 2002, PEDIATR INFECT DIS J, V21, P498, DOI 10.1097/00006454-200206000-00004; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Farooqi IS, 1998, THORAX, V53, P927, DOI 10.1136/thx.53.11.927; GRIFFIN DE, 1993, J INFECT DIS, V168, P275, DOI 10.1093/infdis/168.2.275; Gruber C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e36; Gruber C, 2002, PEDIAT ALLERG IMM-UK, V13, P177, DOI 10.1034/j.1399-3038.2002.01006.x; Gruber C, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e282; Gruber C, 2002, ALLERGY, V57, P277, DOI 10.1034/j.1398-9995.2002.03379.x; Gruber C, 2001, PEDIAT ALLERG IMM-UK, V12, P296, DOI 10.1034/j.1399-3038.2001.1r046.x; Gruber C, 2002, ALLERGY, V57, P472, DOI 10.1034/j.1398-9995.2002.02155.x; Hattori H, 2002, CLIN EXP ALLERGY, V32, P951, DOI 10.1046/j.1365-2222.2002.01389.x; HEDENSKOG S, 1989, INT ARCH ALLER A IMM, V89, P156, DOI 10.1159/000234939; Henderson J, 1999, BRIT MED J, V318, P1173, DOI 10.1136/bmj.318.7192.1173; Herz U, 1998, J ALLERGY CLIN IMMUN, V102, P867, DOI 10.1016/S0091-6749(98)70030-2; Hopfenspirger MT, 2002, J IMMUNOL, V168, P2516, DOI 10.4049/jimmunol.168.5.2516; Hylkema MN, 2002, AM J RESP CELL MOL, V27, P244, DOI 10.1165/ajrcmb.27.2.4735; Jentoft HF, 2002, ALLERGY, V57, P336, DOI 10.1034/j.1398-9995.2002.1s3342.x; Kemp T, 1997, EPIDEMIOLOGY, V8, P678, DOI 10.1097/00001648-199710000-00011; Krause TG, 2003, JAMA-J AM MED ASSOC, V289, P1012, DOI 10.1001/jama.289.8.1012; Le Souef PN, 2000, LANCET, V356, P242; Leung R, 1996, Respirology, V1, P123, DOI 10.1111/j.1440-1843.1996.tb00020.x; Lewis SA, 1998, CLIN EXP ALLERGY, V28, P1493; LINDSAY DSJ, 1994, INT ARCH ALLERGY IMM, V105, P281, DOI 10.1159/000236770; Major T, 2002, VACCINE, V20, P1532, DOI 10.1016/S0264-410X(01)00496-0; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Marchant A, 1999, J IMMUNOL, V163, P2249; Marks GB, 2003, J ALLERGY CLIN IMMUN, V111, P541, DOI 10.1067/mai.2003.171; Marsh DG, 1997, NAT GENET, V15, P389; Martinati LC, 1997, ALLERGY, V52, P1036; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; Miller JE, 2000, AM J PUBLIC HEALTH, V90, P428, DOI 10.2105/AJPH.90.3.428; Moffatt MF, 2003, HUM MOL GENET, V12, P625, DOI 10.1093/hmg/ddg059; Nilsson L, 1998, ARCH PEDIAT ADOL MED, V152, P734; Nilsson L, 1998, ALLERGY, V53, P1195, DOI 10.1111/j.1398-9995.1998.tb03841.x; Odelram H, 1994, Pediatr Allergy Immunol, V5, P118, DOI 10.1111/j.1399-3038.1994.tb00228.x; ODENT MR, 1994, JAMA-J AM MED ASSOC, V272, P592, DOI 10.1001/jama.1994.03520080034035; Offit PA, 2003, PEDIATRICS, V111, P653, DOI 10.1542/peds.111.3.653; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Omenaas E, 2000, THORAX, V55, P454, DOI 10.1136/thorax.55.6.454; ORME IM, 1993, J IMMUNOL, V151, P518; PAUWELS R, 1983, ALLERGY, V38, P239, DOI 10.1111/j.1398-9995.1983.tb01617.x; Rosenberg R, 1999, Fam Med, V31, P276; SEPULVEDA RL, 1994, AM J RESP CRIT CARE, V149, P620, DOI 10.1164/ajrccm.149.3.8118628; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Shirtcliffe PM, 2001, AM J RESP CRIT CARE, V163, P1410, DOI 10.1164/ajrccm.163.6.2003050; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Strannegard IL, 1998, ALLERGY, V53, P249, DOI 10.1111/j.1398-9995.1998.tb03884.x; Tedeschi A, 2003, CLIN EXP ALLERGY, V33, P449, DOI 10.1046/j.1365-2222.2003.01628.x; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; von Hertzen L, 1999, J ALLERGY CLIN IMMUN, V104, P1211, DOI 10.1016/S0091-6749(99)70015-1; von Mutius E, 2000, THORAX, V55, P449, DOI 10.1136/thorax.55.6.449; Wang CC, 1998, IMMUNOLOGY, V93, P307; Yang X, 2002, IMMUNOLOGY, V105, P336, DOI 10.1046/j.0019-2805.2002.01377.x; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	65	7	7	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2004	113	3					401	406		10.1016/j.jaci.2003.12.010	http://dx.doi.org/10.1016/j.jaci.2003.12.010			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	802DM	15007336	Bronze			2022-12-18	WOS:000220144200007
J	Levetin, E				Levetin, E			An atlas of fungal spores	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article														Levetin, Estelle/0000-0002-2409-5142					0	7	7	1	9	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2004	113	2					366	368		10.1016/j.jaci.2003.09.049	http://dx.doi.org/10.1016/j.jaci.2003.09.049			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	773EX	14767462				2022-12-18	WOS:000188885700035
J	Quirce, S; Parra, A; Anton, E; Fernandez-Nieto, M; Jerez, J; Sastre, J				Quirce, S; Parra, A; Anton, E; Fernandez-Nieto, M; Jerez, J; Sastre, J			Occupational asthma caused by tali and jatoba wood dusts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CROSS-REACTIVITY; OBECHE		Fdn Jimenez Diaz, E-28040 Madrid, Spain; Hosp Juan Canalejo, La Coruna, Spain; Hosp Marques Valdecilla, Santander, Spain	Complejo Hospitalario Universitario A Coruna; Hospital Universitario Marques de Valdecilla (HUMV)	Quirce, S (corresponding author), Fdn Jimenez Diaz, E-28040 Madrid, Spain.		s, q/AAD-7171-2020					CARTIER A, 1986, J ALLERGY CLIN IMMUN, V77, P639, DOI 10.1016/0091-6749(86)90359-3; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; Fernandez-Caldas E, 1998, J ALLERGY CLIN IMMUN, V101, P554, DOI 10.1016/S0091-6749(98)70364-1; GAMBOA PM, 1991, CONTACT DERMATITIS, V24, P309, DOI 10.1111/j.1600-0536.1991.tb01734.x; Higuero NC, 2001, J ALLERGY CLIN IMMUN, V107, P554, DOI 10.1067/mai.2001.112276; HINOJOSA M, 1986, CLIN ALLERGY, V16, P145, DOI 10.1111/j.1365-2222.1986.tb00758.x; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; Quirce S, 2000, J ALLERGY CLIN IMMUN, V106, P400, DOI 10.1067/mai.2000.107601; Quirce S, 2001, ALLERGY, V56, P754, DOI 10.1034/j.1398-9995.2001.056008754.x; Vandenplas O, 2003, EUR RESPIR J, V21, P706, DOI 10.1183/09031936.03.00113303	10	7	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2004	113	2					361	363		10.1016/j.jaci.2003.11.018	http://dx.doi.org/10.1016/j.jaci.2003.11.018			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	773EX	14767459				2022-12-18	WOS:000188885700032
J	Bauer, SL; Wall, GC; Skoglund, KJ; Peters, LK				Bauer, SL; Wall, GC; Skoglund, KJ; Peters, LK			Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PENICILLIN		Drake Univ, Coll Pharm & Hlth Sci, Des Moines, IA 50311 USA; Iowa Methodist Med Ctr, Des Moines, IA USA	Iowa Methodist Medical Center	Bauer, SL (corresponding author), Drake Univ, Coll Pharm & Hlth Sci, 2507 Univ Ave, Des Moines, IA 50311 USA.			Bauer, Seth/0000-0002-0420-0320				Asbel LE, 2000, INFECT DIS CLIN N AM, V14, P435, DOI 10.1016/S0891-5520(05)70256-7; Chen Z, 2000, ALLERGY, V55, P92, DOI 10.1034/j.1398-9995.2000.00360.x; JONES RN, 1989, J ANTIMICROB CHEMOTH, V24, P9, DOI 10.1093/jac/24.suppl_A.9; McConnell SA, 2000, CLIN INFECT DIS, V31, P1512, DOI 10.1086/317507; *MERCK CO INC, PROD INF PRIM 4 IM C; Nakanishi T., 1992, CHEMOTHERAPY-TOKYO, V40, P251; Nathisuwan S, 2001, PHARMACOTHERAPY, V21, P920, DOI 10.1592/phco.21.11.920.34529; Robinson JL, 2002, CLIN INFECT DIS, V35, P26, DOI 10.1086/340740; SAXON A, 1988, J ALLERGY CLIN IMMUN, V82, P213, DOI 10.1016/0091-6749(88)91001-9	9	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					173	175		10.1016/j.jaci.2003.10.055	http://dx.doi.org/10.1016/j.jaci.2003.10.055			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713926				2022-12-18	WOS:000187837900025
J	Wegienka, G; London, SJ; Johnson, CC; Ownby, DR				Wegienka, G; London, SJ; Johnson, CC; Ownby, DR			Interpregnancy interval might affect the risk of childhood atopy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGIC SENSITIZATION; HAY-FEVER; PREECLAMPSIA; AGE		Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; NIEHS, NIH, US Dept HHS, Bethesda, MD USA; Med Coll Georgia, Augusta, GA 30912 USA	Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Georgia; Augusta University	Wegienka, G (corresponding author), Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, 1 Ford Pl, Detroit, MI 48202 USA.		London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290; Johnson, Christine Cole/0000-0002-6864-6604	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049019] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI024156-10] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basso O, 2001, EPIDEMIOLOGY, V12, P624, DOI 10.1097/00001648-200111000-00008; Holt PG, 1998, ENVIRON HEALTH PERSP, V106, P795, DOI 10.2307/3434191; Karmaus W, 2001, AM J EPIDEMIOL, V154, P909, DOI 10.1093/aje/154.10.909; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; OWNBY DR, 1991, J ALLERGY CLIN IMMUN, V88, P555, DOI 10.1016/0091-6749(91)90148-H; Pearson H, 2002, NATURE, V420, P265, DOI 10.1038/420265a; Ponsonby AL, 1998, ARCH DIS CHILD, V79, P328, DOI 10.1136/adc.79.4.328; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; Sunyer J, 2001, CLIN EXP ALLERGY, V31, P1352, DOI 10.1046/j.1365-2222.2001.01187.x	10	7	7	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					169	171		10.1016/j.jaci.2003.10.012	http://dx.doi.org/10.1016/j.jaci.2003.10.012			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713924	Green Accepted			2022-12-18	WOS:000187837900023
J	Ono, SJ; Nakamura, T; Ohbayashi, M; Dawson, M; Ikeda, Y; Nugent, AK; Toda, M; Jay, G				Ono, SJ; Nakamura, T; Ohbayashi, M; Dawson, M; Ikeda, Y; Nugent, AK; Toda, M; Jay, G			Expression profiling: Opportunities and pitfalls and impact on the study and management of allergic diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						gene profiling	GENE-EXPRESSION; HUMAN GENOME; MAST-CELLS; CANCER		UCL, Inst Ophthalmol, Dept Immunol, London EC1V 9EL, England; UCL, Inst Child Hlth, Dept Immunol, London EC1V 9EL, England; Moorfields Eye Hosp NHS Trust, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Ono, SJ (corresponding author), UCL, Inst Ophthalmol, Dept Immunol, 11-43 Bath St, London EC1V 9EL, England.		Toda, Masako/S-9810-2019	Jay, Gregory/0000-0003-1517-8488				AGUILAR LK, 1994, J IMMUNOL, V152, P2645; Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; Covell DG, 2003, MOL CANCER THER, V2, P317; D'ambrosio C, 2003, J ALLERGY CLIN IMMUN, V112, P1162, DOI 10.1016/j.jaci.2003.07.008; Fritz SB, 2003, J ALLERGY CLIN IMMUN, V112, P1057, DOI 10.1016/j.jaci.2003.09.042; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lora JM, 2003, J ALLERGY CLIN IMMUN, V112, P1119, DOI 10.1016/j.jaci.2003.08.042; Lou XJ, 2001, METH MOL B, V175, P323; MIDDLETON LP, 1993, CANCER, V98, P1055; Morrison DA, 2003, DNA CELL BIOL, V22, P357, DOI 10.1089/104454903767650658; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Ono SJ, 2000, ANNU REV IMMUNOL, V18, P347, DOI 10.1146/annurev.immunol.18.1.347; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Toda M, 2002, IMMUNOLOGY, V106, P1, DOI 10.1046/j.1365-2567.2002.01407.x; TSAI M, 1993, EUR J IMMUNOL, V23, P867, DOI 10.1002/eji.1830230415; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wulfkuhle JD, 2003, ADV EXP MED BIOL, V532, P59; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	20	7	8	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2003	112	6					1050	1056		10.1016/j.jaci.2003.09.022	http://dx.doi.org/10.1016/j.jaci.2003.09.022			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	752HC	14657857				2022-12-18	WOS:000187154200004
J	Gruchalla, RS; Jones, J				Gruchalla, RS; Jones, J			Combating high-priority biological agents: What to do with drug-allergic patients and those for whom vaccination is contraindicated?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bioterrorism; category A biologic agents; anthrax; smallpox; botulism; plague; vaccine-related adverse reactions; antibiotic allergy	ANTHRAX VACCINATION; SMALLPOX VACCINATION; PLAGUE IMMUNIZATION; CLINICAL REACTIONS; HEALTH; WEAPON; COMPLICATIONS; BIOTERRORISM; THERAPY	The threat of bioterrorism continues to be a very real one. Regularly, there are news stories on bioterrorism-related topics: What biologic weapons will our enemies likely use to attack the United States? How prepared is our country to successfully counter such attacks? Although these critical questions are being addressed by the leaders of our country, allergists-immunologists, too, will have to grapple with difficult questions during these uncertain and frightening times. We care for a special group of patients with various allergic and immunologic disorders. Some of our patients have immunodeficiency disorders that might preclude them from receiving life-saving vaccines. Our patients with drug allergies are fearful that should they become infected with a biologic agent, they will not be able to receive appropriate treatment. In this article we focus on the various vaccine-related and antibiotic-related adverse effects that the allergist-immunologist might see during treatment of infections caused by Category A agents. Where possible, potential management approaches are outlined.	Univ Texas, SW Med Ctr, Dallas, TX USA; Natl Jewish Med & Res Ctr, Denver, CO USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Jewish Health	Gruchalla, RS (corresponding author), 5323 Harry Hines Ste Q5 302, Dallas, TX 75390 USA.							ALBENGRES E, 1983, THERAPIE, V38, P577; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; ASSOUAD M, 1995, ANN INTERN MED, V122, P396, DOI 10.7326/0003-4819-122-5-199503010-00026; Bernstein IL, 1999, ANN ALLERG ASTHMA IM, V83, pVIII; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Bray M, 2003, ANTIVIR RES, V58, P101, DOI 10.1016/S0166-3542(03)00008-1; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P909; CROOK LD, 1992, ARCH INTERN MED, V152, P1253, DOI 10.1001/archinte.152.6.1253; CURLEY RK, 1987, CLIN EXP DERMATOL, V12, P124, DOI 10.1111/j.1365-2230.1987.tb01879.x; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Engler RJM, 2002, J ALLERGY CLIN IMMUN, V110, P357, DOI 10.1067/mai.2002.128052; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; Fritz SB, 2002, J ALLERGY CLIN IMMUN, V109, P214, DOI 10.1067/mai.2002.121947; GeaBanacloche JC, 1996, J ALLERGY CLIN IMMUN, V97, P1426, DOI 10.1016/S0091-6749(96)70218-X; Geier DA, 2002, CLIN EXP RHEUMATOL, V20, P217; Goschel H, 1997, EXP NEUROL, V147, P96, DOI 10.1006/exnr.1997.6580; Haffer AST, 2002, AM J HEALTH-SYST PH, V59, P1189, DOI 10.1093/ajhp/59.12.1189; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; JOELLENBECK L, 2002, ANTHRAX VACCINE SAFE, P1; Cono Joanne, 2003, MMWR Recomm Rep, V52, P1; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; Lantner RR, 1995, J ALLERGY CLIN IMMUN, V96, P1001, DOI 10.1016/S0091-6749(95)70240-7; LEWISJONES MS, 1988, CLIN EXP DERMATOL, V13, P245, DOI 10.1111/j.1365-2230.1988.tb00690.x; MARSHALL JD, 1974, J INFECT DIS, V129, pS19, DOI 10.1093/infdis/129.Supplement_1.S19; MEYER KF, 1974, J INFECT DIS, V129, pS30, DOI 10.1093/infdis/129.Supplement_1.S30; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pittman PR, 2001, VACCINE, V20, P972, DOI 10.1016/S0264-410X(01)00387-5; REISMAN RE, 1970, J ALLERGY, V46, P49, DOI 10.1016/0021-8707(70)90061-4; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Schumm WR, 2002, PSYCHOL REP, V90, P639, DOI 10.2466/PR0.90.2.639-653; Shapiro LE, 1997, ARCH DERMATOL, V133, P1224, DOI 10.1001/archderm.133.10.1224; Stahlmann R, 2002, TOXICOL LETT, V127, P269, DOI 10.1016/S0378-4274(01)00509-4; Sullivan TJ, 1993, ALLERGY PRINCIPLES P, P1726; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Timmer SJ, 2002, CHEST, V122, P741; *US ARM, 1977, US ARM ACT US BIOL W; Wasserman GM, 2003, J OCCUP ENVIRON MED, V45, P222, DOI 10.1097/01.jom.0000058345.05741.6b; Wiesen AR, 2002, JAMA-J AM MED ASSOC, V287, P1556, DOI 10.1001/jama.287.12.1556	42	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2003	112	4					675	682		10.1016/j.jaci.2003.08.001	http://dx.doi.org/10.1016/j.jaci.2003.08.001			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730LA	14564343				2022-12-18	WOS:000185831200004
J	Nam, HS; Crane, J; Siebers, R				Nam, HS; Crane, J; Siebers, R			Clothing-potentially a significant source of endotoxin exposure	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NEW-ZEALAND; ASTHMA		Wellington Sch Med & Hlth Sci, Wellington Asthma Res Grp, Wellington, New Zealand; Soonchunhyang Univ, Res Ctr Allergy & Resp Dis, Bucheon, South Korea	University of Otago; Soonchunhyang University	Nam, HS (corresponding author), Wellington Sch Med & Hlth Sci, Wellington Asthma Res Grp, POB 7343, Wellington, New Zealand.		Siebers, Robert/A-4102-2009	Siebers, Robert/0000-0002-6359-3144				Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Hall K, 2002, J ALLERGY CLIN IMMUN, V110, P811, DOI 10.1067/mai.2002.128530; HOLLANDER A, 1993, AM IND HYG ASSOC J, V54, P647, DOI 10.1202/0002-8894(1993)054<0647:IAEITA>2.0.CO;2; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; MCDONALD LG, 1992, J ALLERGY CLIN IMMUN, V90, P599, DOI 10.1016/0091-6749(92)90132-L; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Patchett K, 1997, J ALLERGY CLIN IMMUN, V100, P755, DOI 10.1016/S0091-6749(97)70269-0; Reed CE, 2001, J ALLERGY CLIN IMMUN, V108, P157, DOI 10.1067/mai.2001.116862; Siebers RW, 1996, J ALLERGY CLIN IMMUN, V98, P853, DOI 10.1016/S0091-6749(96)70141-0; Tovey ER, 1995, J ALLERGY CLIN IMMUN, V96, P999, DOI 10.1016/S0091-6749(95)70239-3; Wickens K, 2003, INDOOR AIR, V13, P128, DOI 10.1034/j.1600-0668.2003.00187.x	11	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2003	112	3					624	625		10.1067/mai.2003.1644	http://dx.doi.org/10.1067/mai.2003.1644			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	719XW	13679825				2022-12-18	WOS:000185231200025
J	Lau, S; Wahn, U				Lau, S; Wahn, U			Pets - good or bad for individuals with atopic predisposition?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							HOUSE-DUST; EARLY EXPOSURE; BIRTH COHORT; EARLY-LIFE; ASTHMA; SENSITIZATION; CHILDREN; CAT; ALLERGENS; RISK		Humboldt Univ, Childrens Hosp, Dept Pneumol & Immunol, D-13353 Berlin, Germany	Humboldt University of Berlin	Wahn, U (corresponding author), Humboldt Univ, Childrens Hosp, Dept Pneumol & Immunol, Charite Campus Virchow,Augustenburger Pl 1, D-13353 Berlin, Germany.							Almqvist C, 2003, J ALLERGY CLIN IMMUN, V111, P800, DOI 10.1067/mai.2003.1334; Anyo G, 2002, CLIN EXP ALLERGY, V32, P361, DOI 10.1046/j.1365-2222.2002.01254.x; Apelberg BJ, 2001, J ALLERGY CLIN IMMUN, V107, P455, DOI 10.1067/mai.2001.113240; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Custovic A, 2001, J ALLERGY CLIN IMMUN, V108, P537, DOI 10.1067/mai.2001.118599; CUSTOVIC A, 2001, LANCET, V31, P803; Heinrich J, 2001, CLIN EXP ALLERGY, V31, P1839, DOI 10.1046/j.1365-2222.2001.01220.x; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Lanphear BP, 2001, PEDIATRICS, V107, P505, DOI 10.1542/peds.107.3.505; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Litonjua AA, 2002, J ALLERGY CLIN IMMUN, V110, P736, DOI 10.1067/mai.2002.128948; Nafstad P, 2001, ALLERGY, V56, P307, DOI 10.1034/j.1398-9995.2001.00881.x; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Perzanowski MS, 1999, J ALLERGY CLIN IMMUN, V103, P1018, DOI 10.1016/S0091-6749(99)70173-9; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Plaschke P, 1999, J ALLERGY CLIN IMMUN, V104, P58, DOI 10.1016/S0091-6749(99)70114-4; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; SIGSGAARD T, 1992, AM J IND MED, V22, P163, DOI 10.1002/ajim.4700220204; Svanes C, 2003, J ALLERGY CLIN IMMUN, V112, P289, DOI 10.1067/mai.2003.1596; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7	24	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2003	112	2					263	264		10.1067/mai.2003.1668	http://dx.doi.org/10.1067/mai.2003.1668			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	709WY	12897729				2022-12-18	WOS:000184650600004
J	Codlin, S; Soh, C; Lee, T; Lavender, P				Codlin, S; Soh, C; Lee, T; Lavender, P			Characterization of a palindromic enhancer element in the promoters of IL4, IL5, and IL13 cytokine genes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						palindrome; transcriptional regulation; IL-4; IL-5; IL-13; GM-CSF enhancer	TRANSCRIPTION FACTOR GATA-3; HUMAN B-CELLS; CUTTING EDGE; EXPRESSION; INTERLEUKIN-4; IGE; LYMPHOCYTES; ANTIBODY; PROTEINS; BINDING	Background: The genes encoding the cytokines IL-4, IL-5, IL-13, and GM-CSF are located in close proximity on human chromosome 5. We have previously described a motif in the promoters of these genes with a common palindromic sequence: CCAAG...CTTGG. These half sites are variably spaced and, within GMCSF, flank a second internal palindromic site. The GMCSF palindrome was shown to act as a strong enhancer of transcription when linked to a heterologous promoter. Objective: We sought to determine whether the related palindromic elements from IL4, IL5, and IL13 also act as enhancers of gene transcription. Methods: Reporter plasmids driven by palindromic elements were transfected into Jurkat T and HeLa cells to determine enhancer activity, and T-cell extracts were used in electrophoretic mobility shift and methylation interference assays to determine the DNA-binding characteristics of palindrome-binding proteins. Results: Enhancer activity was observed in unactivated T cells and HeLa cells, whereas in T cells the IL4 palindrome mediated an activation-specific response. Mutational analysis of this element revealed that both halves of the CCAAG...CTTGG palindrome and part of the intervening sequence were essential for mediating interaction with protein complexes. Electrophoretic mobility shift assays suggested that the 4 palindromes bound similar factors because complexes formed between Jurkat nuclear extracts and each palindromic element showed identical mobility, and these elements were able to cross-compete for binding. Conclusions: These data suggest that constitutively expressed factors are involved in mediating the enhancer function of these elements in T cells and that these factors might either be present or have closely related homologues in other cell types. Also, an activation-dependent factor might be recruited to modulate the function of the IL4 element.	Univ London Kings Coll, Guys Hosp, Dept Asthma Allergy & Resp Sci, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lavender, P (corresponding author), Univ London Kings Coll, Guys Hosp, Dept Asthma Allergy & Resp Sci, 5th Floor Thomas Guy House, London SE1 9RT, England.			Lavender, Paul/0000-0001-8710-0263; Lee, Tak/0000-0002-7554-4059				Ausubel F., 1999, CURRENT PROTOCOLS MO; CHAND N, 1992, EUR J PHARMACOL, V211, P121, DOI 10.1016/0014-2999(92)90273-7; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; KITA H, 1992, J IMMUNOL, V149, P629; Lavender P, 1997, ONCOGENE, V14, P2721, DOI 10.1038/sj.onc.1201243; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; LUNDGREN M, 1989, EUR J IMMUNOL, V19, P1311, DOI 10.1002/eji.1830190724; MAUSER PJ, 1993, AM REV RESPIR DIS, V148, P1623, DOI 10.1164/ajrccm/148.6_Pt_1.1623; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Ranganath S, 1998, J IMMUNOL, V161, P3822; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Smith PJ, 2001, J IMMUNOL, V167, P2502, DOI 10.4049/jimmunol.167.5.2502; STAYNOV DZ, 1995, P NATL ACAD SCI USA, V92, P3606, DOI 10.1073/pnas.92.8.3606; STAYNOV DZ, 1995, INT ARCH ALLERGY IMM, V107, P217, DOI 10.1159/000236982; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597	19	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2003	111	4					826	832		10.1067/mai.2003.1377	http://dx.doi.org/10.1067/mai.2003.1377			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	667WW	12704365				2022-12-18	WOS:000182258500025
J	More, D; Hagan, L; Whisman, B; Jordan-Wagner, D				More, D; Hagan, L; Whisman, B; Jordan-Wagner, D			Identification of specific IgE to mesquite wood smoke in individuals with mesquite pollen allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CROSS-ALLERGENICITY		Wilford Hall USAF Med Ctr, Dept Allergy & Immunol, Lackland AFB, TX 78236 USA	United States Department of Defense; United States Air Force	More, D (corresponding author), Wilford Hall USAF Med Ctr, Dept Allergy & Immunol, Lackland AFB, TX 78236 USA.							BERNSTEIN IL, 1976, J ALLERGY CLIN IMMUN, V57, P141, DOI 10.1016/0091-6749(76)90033-6; GOETZ DW, 1995, ANN ALLERG ASTHMA IM, V75, P256; Harper DS, 2001, ANN ALLERG ASTHMA IM, V86, P59, DOI 10.1016/S1081-1206(10)62357-5; JOHNS RE, 1986, J OCCUP ENVIRON MED, V28, P1181; JORDANWAGNER DL, 1993, ANN ALLERGY, V71, P70; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NOVEY HS, 1977, J ALLERGY CLIN IMMUN, V59, P359, DOI 10.1016/0091-6749(77)90018-5; STIER R, 1994, J ALLERGY CLIN IMMUN, V93, P174	8	7	8	1	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2002	110	5					814	816		10.1067/mai.2002.129034	http://dx.doi.org/10.1067/mai.2002.129034			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	612NN	12417896				2022-12-18	WOS:000179082500022
J	McFadden, ER				McFadden, ER			Natural rubber latex sensitivity seminar: Conference summary	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material								Latex allergy presents major medical, legal, and public policy problems, yet there is surprisingly little consensus on the fundamental issues that comprise its core. The purpose of the current conference is to distinguish knowledge from conjecture and identify areas that need strengthening so that appropriate guidelines for management and prevention can be developed.	Case Western Reserve Univ, Sch Med, Gen Clin Res Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	McFadden, ER (corresponding author), Metrohlth Med Ctr, Div Pulm & Crit Care Med, 2500 Metrohlth Dr, Cleveland, OH 44106 USA.								0	7	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2		S			S137	S140		10.1067/mai.2002.125596	http://dx.doi.org/10.1067/mai.2002.125596			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	586ET	12170255				2022-12-18	WOS:000177572200020
J	Gaston, B				Gaston, B			Rethinking doctrine: Bronchitis, eosinophils, and bronchoscopy in pediatric asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							INFLAMMATION		Univ Virginia, Div Pediat Resp Med, Charlottesville, VA 22908 USA	University of Virginia	Gaston, B (corresponding author), Univ Virginia, Div Pediat Resp Med, Charlottesville, VA 22908 USA.							BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Brightling CE, 2000, ANN MED, V32, P446, DOI 10.3109/07853890009002019; Just J, 2002, J ALLERGY CLIN IMMUN, V110, P42, DOI 10.1067/mai.2002.123304; Krawiec ME, 2001, AM J RESP CRIT CARE, V163, P1338, DOI 10.1164/ajrccm.163.6.2005116; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Martinez FD, 1997, PEDIATR PULM, P9; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; TABACHNIK E, 1981, J ALLERGY CLIN IMMUN, V67, P339, DOI 10.1016/0091-6749(81)90077-4; *US NAT HEART LUNG, 1997, EXP PAN 2 GUID DIAGN; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; WOOD RE, 1984, PEDIATR CLIN N AM, V31, P785	11	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2002	110	1					24	25		10.1067/mai.2002.125002	http://dx.doi.org/10.1067/mai.2002.125002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	574CF	12110812				2022-12-18	WOS:000176870300003
J	Stempel, DA; Kelly, HW				Stempel, DA; Kelly, HW			Approaching value in asthma management: The need to integrate clinical and economic research with the basic science	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; economics; pharmacoeconomics	INHALED CORTICOSTEROIDS; UNITED-STATES; CARE; CHILDREN; RISK; HOSPITALIZATION; MORTALITY; COSTS; GUIDELINES; DECREASE	In the management of asthma, clinical decision making is primarily directed toward achieving the best outcome for the patient. However, the interests of the provider, insurer, and employer must also be taken into account. Integral to this process is an understanding of the need to weigh therapeutic objectives against economic concerns. This process involves consideration of the potential for clinical benefit as opposed to adverse treatment effects, as well as direct and indirect costs. Data from clinical trials provide the foundation for evaluating these factors. Randomized clinical trials, postmarketing studies, surveillance programs, and observational claims analyses all contribute valuable information to facilitate this process. Taken together, the results of such analyses form a foundation for providing effective, safe, and cost-efficient care through the practice of evidence-based medicine.	Virginia Mason Med Ctr, Seattle, WA 98101 USA; Univ New Mexico, Albuquerque, NM 87131 USA	Virginia Mason Medical Center; University of New Mexico	Stempel, DA (corresponding author), Virginia Mason Med Ctr, 1100 9th Ave, Seattle, WA 98101 USA.							Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Briss PA, 2000, AM J PREV MED, V18, P35, DOI 10.1016/S0749-3797(99)00119-1; Buchner DA, 1997, AM J MANAG CARE, V3, P87; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P1002; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DelMar C, 1997, BRIT MED J, V314, P1526, DOI 10.1136/bmj.314.7093.1526; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; Drummond MF, 1997, JAMA-J AM MED ASSOC, V277, P1552, DOI 10.1001/jama.277.19.1552; Drummond MF., 1996, DRUG INF J, V30, P491; ERNST P, 1992, JAMA-J AM MED ASSOC, V268, P3462, DOI 10.1001/jama.268.24.3462; Fuhlbrigge AL, 2001, J ALLERGY CLIN IMMUN, V107, P61, DOI 10.1067/mai.2001.111590; Genduso L. A., 1996, DRUG INF J, V30, P1003; Gerdtham UG, 1996, MED CARE, V34, P1188, DOI 10.1097/00005650-199612000-00004; Goldfarb SD, 1999, AM J HEALTH-SYST PH, V56, P2206, DOI 10.1093/ajhp/56.21.2206; Goldman M, 2000, J ALLERGY CLIN IMMUN, V105, P71, DOI 10.1016/S0091-6749(00)90180-5; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; Hylan TR, 1998, J AFFECT DISORDERS, V47, P71, DOI 10.1016/S0165-0327(97)00120-1; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; Legorreta AP, 1998, ARCH INTERN MED, V158, P457, DOI 10.1001/archinte.158.5.457; Lozano P, 1997, PEDIATRICS, V99, P757, DOI 10.1542/peds.99.6.757; Lozano P, 1999, J ALLERGY CLIN IMMUN, V104, P957, DOI 10.1016/S0091-6749(99)70075-8; MARICK C, 1997, JAMA-J AM MED ASSOC, V278, P531; Mason J, 1997, PHARMACOECONOMICS, V11, P503, DOI 10.2165/00019053-199711060-00001; Neumann PJ, 2000, HEALTH AFFAIR, V19, P129, DOI 10.1377/hlthaff.19.5.129; Peden DB, 1998, J ALLERGY CLIN IMMUN, V102, P32, DOI 10.1016/S0091-6749(98)70052-1; Sackett DL., 1997, EVIDENCE BASED MED P; SLY RM, 1994, ANN ALLERGY, V73, P439; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Stempel DA, 1996, ANN ALLERG ASTHMA IM, V76, P153, DOI 10.1016/S1081-1206(10)63415-1; Stempel DA, 1996, ARCH FAM MED, V5, P36, DOI 10.1001/archfami.5.1.36; Sueta CA, 1999, AM J CARDIOL, V83, P1303, DOI 10.1016/S0002-9149(99)00117-4; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; SUISSA S, 1994, EUR RESPIR J, V7, P1602, DOI 10.1183/09031936.94.07091602; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV; US Department of Health and Human Services, 1997, NIH PUBL, V01-3680; Weiss KB, 2000, J ALLERGY CLIN IMMUN, V106, P493, DOI 10.1067/mai.2000.109426; Wennergren G, 1996, J ALLERGY CLIN IMMUN, V97, P742, DOI 10.1016/S0091-6749(96)80150-3	40	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2002	109	5		S			S503	S510		10.1067/mai.2002.122714	http://dx.doi.org/10.1067/mai.2002.122714			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	554QH	11994722				2022-12-18	WOS:000175747400004
J	Bukantz, SC				Bukantz, SC			Clemens von Pirquet and the concept of allergie	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ S Florida, Coll Med, Div Allergy, Tampa, FL USA	State University System of Florida; University of South Florida	Bukantz, SC (corresponding author), Univ S Florida, Coll Med, Div Allergy, Tampa, FL USA.		Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984				Arthus M., 1903, COMPT RENDU SOC BIOL, V50, P20; Kennedy D, 2001, SCIENCE, V294, P2429, DOI 10.1126/science.294.5551.2429; Porter R., 1997, GREATEST BENEFIT MAN, P428; ROBERTS J. M., 1999, 20 CENTURY HIST WORL; Silverstein AM, 1989, HIST IMMUNOLOGY, P214; VONPIRQUET C, 1963, ESSENTIALS CLIN IMMU, P805; VONPIRQUET C, 1905, SERUMKRANKHEIT; VONPIRQUET C, 1911, ARCH INTERN MED, V7, P262; VONPIRQUET C, 1906, MUNCHEN MED WOCHEN, V30, P1457; Wagner R., 1968, CLEMENS PIRQUET HIS	10	7	7	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2002	109	4					724	726						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	543YZ	11980437				2022-12-18	WOS:000175132600030
J	Cohen, SG				Cohen, SG			Pioneers and milestones - Clemens von Pirquet, MD (1874-1929)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item									NIAID, NIH, Bethesda, MD 20892 USA; NIH, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Cohen, SG (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							CHICK H, 1929, LANCET, V1163, P624; VONPIRQUET C, PUBLICATION LIST; Wagner R, 1968, C VONPIRQUET HIS LIF; WOLF IJ, 1965, APHORISMS FACETIAE B; 1929, NEUES WIENER J  0303, P62	5	7	8	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2002	109	4					722	724						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	543YZ	11941329				2022-12-18	WOS:000175132600029
J	Baroody, FM; Saengpanich, S; Detineo, M; Haney, L; Votypka, V; Naclerio, RM				Baroody, FM; Saengpanich, S; Detineo, M; Haney, L; Votypka, V; Naclerio, RM			Nasal allergen challenge leads to bilateral maxillary sinus eosinophil influx	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Chicago, Pritzker Sch Med, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA	University of Chicago									0	7	8	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2002	109	1		S		216	S84	S84		10.1016/S0091-6749(02)81352-5	http://dx.doi.org/10.1016/S0091-6749(02)81352-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	519UX		Bronze			2022-12-18	WOS:000173744800215
